GENE	DISEASE	MIM_NUMBER	SOURCE_CODE	LINGKAGE_INFO
A2ML1, OMS	Otitis media, susceptibility to	166760		3
A4GALT, P1PK	 Blood group, P1Pk system, p phenotype	111400		3
A4GALT, P1PK	Blood group, P1Pk system, P phenotype	111400		3
A4GALT, P1PK	 NOR polyagglutination syndrome	111400		3
AA1	Alopecia areata 1	104000	max lod at D18S967	2
AA2	Alopecia areata 2	610753	max lod at D16S415	2
AAA1, AAA	Aortic aneurysm, familial abdominal 1	100070	near D19S416	2
AAA2	Aortic aneurysm, familial abdominal 2	609782	max lod at D4S1644	2
AAA3	Aneurysm, familial abdominal 3	611891	associated with rs10757278	2
AAA4	Aortic aneurysm, familial abdominal, 4	614375	associated with rs1466535	2
AAAS, AAA	Achalasia-addisonianism-alacrimia syndrome	231550		3
AAGAB, p34, PPKP1A, PPKP1, KPPP1	Keratoderma, palmoplantar, punctate type IA	148600		3
AARS1, AARS, CMT2N, DEE29, HDLS2, TTD8	 Charcot-Marie-Tooth disease, axonal, type 2N	613287	mutation identified in 1 HDLS2 family	3
AARS1, AARS, CMT2N, DEE29, HDLS2, TTD8	Developmental and epileptic encephalopathy 29	616339	mutation identified in 1 HDLS2 family	3
AARS1, AARS, CMT2N, DEE29, HDLS2, TTD8	 Leukoencephalopathy, hereditary diffuse, with spheroids 2	619661	mutation identified in 1 HDLS2 family	3
AARS1, AARS, CMT2N, DEE29, HDLS2, TTD8	 Trichothiodystrophy 8, nonphotosensitive	619691	mutation identified in 1 HDLS2 family	3
AARS2, KIAA1270, MTALARS, COXPD8, LKENP	 Combined oxidative phosphorylation deficiency 8	614096		3
AARS2, KIAA1270, MTALARS, COXPD8, LKENP	Leukoencephalopathy, progressive, with ovarian failure	615889		3
AASS	Hyperlysinemia	238700		3
AAT1, FAA1	Aortic aneurysm, familial thoracic 1	607086		2
AAT2, FAA2	Aortic aneurysm, familial thoracic 2	607087		2
ABAT, GABAT	GABA-transaminase deficiency	613163		3
ABCA12, ARCI4A, ARCI4B, ICR2B, LI2	 Ichthyosis, congenital, autosomal recessive 4A	601277		3
ABCA12, ARCI4A, ARCI4B, ICR2B, LI2	Ichthyosis, congenital, autosomal recessive 4B 	242500		3
ABCA1, ABC1, HPALP1, TGD, HDLCQTL13	 HDL deficiency, familial, 1	604091		3
ABCA1, ABC1, HPALP1, TGD, HDLCQTL13	Tangier disease	205400		3
ABCA2, ABC2, IDPOGSA	Intellectual developmental disorder with poor growth and with or without seizures or ataxia	618808		3
ABCA3, ABC3, SMDP3	Surfactant metabolism dysfunction, pulmonary, 3	610921		3
ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2	 Cone-rod dystrophy 3	604116		3
ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2	 Fundus flavimaculatus	248200		3
ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2	 Macular degeneration, age-related, 2	153800		3
ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2	Retinal dystrophy, early-onset severe	248200		3
ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2	 Retinitis pigmentosa 19	601718		3
ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2	 Stargardt disease 1	248200		3
ABCA7, ABCX, AD9	Alzheimer disease 9, susceptibility to	608907		3
ABCB11, BSEP, SPGP, PFIC2, BRIC2	Cholestasis, benign recurrent intrahepatic, 2	605479		3
ABCB11, BSEP, SPGP, PFIC2, BRIC2	 Cholestasis, progressive familial intrahepatic 2	601847		3
ABCB1, PGY1, MDR1, IBD13, CLCs	 Colchicine resistance	120080		3
ABCB1, PGY1, MDR1, IBD13, CLCs	Inflammatory bowel disease 13	612244		3
ABCB4, PGY3, MDR3, ICP3	 Cholestasis, intrahepatic, of pregnancy, 3	614972	within 500kb of MDR1	3
ABCB4, PGY3, MDR3, ICP3	 Cholestasis, progressive familial intrahepatic 3	602347	within 500kb of MDR1	3
ABCB4, PGY3, MDR3, ICP3	Gallbladder disease 1	600803	within 500kb of MDR1	3
ABCB6, MTABC3, MCOPCB7, LAN, DUH3, PSHK2	 Blood group, Langereis system	111600		3
ABCB6, MTABC3, MCOPCB7, LAN, DUH3, PSHK2	 Dyschromatosis universalis hereditaria 3	615402		3
ABCB6, MTABC3, MCOPCB7, LAN, DUH3, PSHK2	Microphthalmia, isolated, with coloboma 7	614497		3
ABCB6, MTABC3, MCOPCB7, LAN, DUH3, PSHK2	 Pseudohyperkalemia, familial, 2, due to red cell leak	609153		3
ABCB7, ABC7, ASAT	Anemia, sideroblastic, with ataxia	301310		3
ABCC11, MRP8, EWWD, WW	Axillary odor, variation in	117800		3
ABCC11, MRP8, EWWD, WW	 Colostrum secretion, variation in	117800		3
ABCC11, MRP8, EWWD, WW	 Earwax, wet/dry	117800		3
ABCC2, CMOAT	Dubin-Johnson syndrome	237500		3
ABCC6, ARA, ABC34, MLP1, PXE, GACI2	 Arterial calcification, generalized, of infancy, 2	614473		3
ABCC6, ARA, ABC34, MLP1, PXE, GACI2	Pseudoxanthoma elasticum	264800		3
ABCC6, ARA, ABC34, MLP1, PXE, GACI2	 Pseudoxanthoma elasticum, forme fruste	177850		3
ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2, PNDM3	 Diabetes mellitus, noninsulin-dependent	125853		3
ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2, PNDM3	Diabetes mellitus, permanent neonatal 3, with or without neurologic features	618857		3
ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2, PNDM3	 Diabetes mellitus, transient neonatal 2	610374		3
ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2, PNDM3	 Hyperinsulinemic hypoglycemia, familial, 1	256450		3
ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2, PNDM3	 Hypoglycemia of infancy, leucine-sensitive	240800		3
ABCC9, SUR2, CMD1O, ATFB12, CANTU, IDMYS	 Atrial fibrillation, familial, 12	614050	mutation identified in 1 ATFB12 patient	3
ABCC9, SUR2, CMD1O, ATFB12, CANTU, IDMYS	Cardiomyopathy, dilated, 1O	608569	mutation identified in 1 ATFB12 patient	3
ABCC9, SUR2, CMD1O, ATFB12, CANTU, IDMYS	 Hypertrichotic osteochondrodysplasia 	239850	mutation identified in 1 ATFB12 patient	3
ABCC9, SUR2, CMD1O, ATFB12, CANTU, IDMYS	 Intellectual disability and myopathy syndrome	619719	mutation identified in 1 ATFB12 patient	3
ABCD1, ALD, AMN	Adrenoleukodystrophy	300100	about 650kb from GCP/RCP	3
ABCD1, ALD, AMN	 Adrenomyeloneuropathy, adult	300100	about 650kb from GCP/RCP	3
ABCD4, PXMP1L, P79R, PMP69, MAHCJ	Methylmalonic aciduria and homocystinuria, cblJ type	614857		3
ABCG2, BCRP, ABCP, UAQTL1, GOUT1	Junior blood group system	614490		3
ABCG2, BCRP, ABCP, UAQTL1, GOUT1	 Uric acid concentration, serum, QTL1	138900		3
ABCG5, STSL2	Sitosterolemia 2	618666		3
ABCG8, GBD4, STSL1	 Gallbladder disease 4	611465		3
ABCG8, GBD4, STSL1	Sitosterolemia 1	210250		3
ABHD12, PHARC	Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract	612674		3
ABHD16A, BAT5, D6S82E, SPG86	Spastic paraplegia 86, autosomal recessive	619735		3
ABHD5, CGI58, IECN2, NCIE2	Chanarin-Dorfman syndrome	275630		3
ABL1, CHDSKM	 Congenital heart defects and skeletal malformations syndrome	617602	fusion hybrid gene with BCR1 in CML	3
ABL1, CHDSKM	Leukemia, Philadelphia chromosome-positive, resistant to imatinib	608232	fusion hybrid gene with BCR1 in CML	3
ABO	Blood group, ABO system	616093	linked to AK1	3
ACACA, ACAC, ACC1, ACACAD	Acetyl-CoA carboxylase deficiency	613933	proximal to q21.33; others put at 17q12	1
ACAD8	Isobutyryl-CoA dehydrogenase deficiency	611283		3
ACAD9, MC1DN20	Mitochondrial complex I deficiency, nuclear type 20	611126		3
ACADM, MCAD	Acyl-CoA dehydrogenase, medium chain, deficiency of	201450		3
ACADSB, SBCAD	2-methylbutyrylglycinuria	610006		3
ACADS, SCAD	Acyl-CoA dehydrogenase, short-chain, deficiency of	201470		3
ACADVL, VLCAD	VLCAD deficiency	201475		3
ACAN, AGC1, CSPG1, MSK16, SEDK, SSOAOD	 Short stature and advanced bone age, with or without early-onset osteoarthritis and/or osteochondritis dissecans	165800	mutation identified in 1 SEDK family	3
ACAN, AGC1, CSPG1, MSK16, SEDK, SSOAOD	 Spondyloepimetaphyseal dysplasia, aggrecan type	612813	mutation identified in 1 SEDK family	3
ACAT1	Alpha-methylacetoacetic aciduria	203750	cluster: cen-STMY2-CLG-STMY1-ter	3
ACBD5, KIAA1996, RDLKD	Retinal dystrophy with leukodystrophy	618863		3
ACD, PTOP, PIP1, TINT1	 Dyskeratosis congenita, autosomal dominant 6	616553	mutation has been identified in 1 DKCA7 and 1 DKCB7 family	3
ACE, DCP1, ACE1, MVCD3, ICH	 Angiotensin I-converting enzyme, benign serum increase	106180		3
ACE, DCP1, ACE1, MVCD3, ICH	 Microvascular complications of diabetes 3	612624		3
ACE, DCP1, ACE1, MVCD3, ICH	 Myocardial infarction, susceptibility to	106180		3
ACE, DCP1, ACE1, MVCD3, ICH	 Renal tubular dysgenesis	267430		3
ACE, DCP1, ACE1, MVCD3, ICH	 SARS, progression of	106180		3
ACE, DCP1, ACE1, MVCD3, ICH	Stroke, hemorrhagic	614519		3
ACF	Cayler cardiofacial syndrome	125520		2
ACHE, YT	Blood group, Yt system	112100	blood group YT (112100) = epitope of ACHE	3
ACKR1, DARC, FY, GPD, WBCQ1	Blood group, Duffy system	110700	by A, 1q22-q23	3
ACKR1, DARC, FY, GPD, WBCQ1	 Malaria, vivax, protection against	611162	by A, 1q22-q23	3
ACKR1, DARC, FY, GPD, WBCQ1	 White blood cell count QTL	611862	by A, 1q22-q23	3
ACO2, ICRD, OPA9	 Infantile cerebellar-retinal degeneration	614559	distal to Ph1 break	3
ACO2, ICRD, OPA9	Optic atrophy 9	616289	distal to Ph1 break	3
ACOX1, ACOX, SCOX, MITCH	Mitchell syndrome	618960		3
ACOX1, ACOX, SCOX, MITCH	 Peroxisomal acyl-CoA oxidase deficiency	264470		3
ACOX2, BRCACOX, CBAS6	Bile acid synthesis defect, congenital, 6	617308		3
ACP33, MAST, SPG21	Mast syndrome	248900		3
ACP4, ACPT, AI1J	Amelogenesis imperfecta, type IJ	617297		3
ACP5, SPENCDI	Spondyloenchondrodysplasia with immune dysregulation	607944	incorrectly assigned to 15 by A	3
ACP	Cerebral palsy, ataxic, autosomal recessive	605388		2
ACRPS	Acropectoral syndrome	605967		2
ACRPV	Acropectorovertebral dysplasia	102510		2
ACSF3	Combined malonic and methylmalonic aciduria	614265		3
ACSL4, FACL4, ACS4, XLID63	Intellectual developmental disorder, X-linked 63	300387		3
ACSL6, FACL6, ACS2	Myelodysplastic syndrome	604443		3
ACSL6, FACL6, ACS2	 Myelogenous leukemia, acute	604443		3
ACSM3, SAH	Hypertension, essential	145505		1
ACTA1, ASMA, NEM3, CFTD1, SHPM	 Myopathy, actin, congenital, with cores	161800	mutation identified in 1 SHPM family	3
ACTA1, ASMA, NEM3, CFTD1, SHPM	 Myopathy, actin, congenital, with excess of thin myofilaments	161800	mutation identified in 1 SHPM family	3
ACTA1, ASMA, NEM3, CFTD1, SHPM	 Myopathy, congenital, with fiber-type disproportion 1	255310	mutation identified in 1 SHPM family	3
ACTA1, ASMA, NEM3, CFTD1, SHPM	 Nemaline myopathy 3, autosomal dominant or recessive	161800	mutation identified in 1 SHPM family	3
ACTA2, ACTSA, AAT6, MYMY5	 Aortic aneurysm, familial thoracic 6	611788		3
ACTA2, ACTSA, AAT6, MYMY5	 Moyamoya disease 5	614042		3
ACTA2, ACTSA, AAT6, MYMY5	Multisystemic smooth muscle dysfunction syndrome	613834		3
ACTB, BRWS1	Baraitser-Winter syndrome 1	243310	~20 pseudogenes also; mutation identified in twin DJO patients	3
ACTB, BRWS1	 Dystonia, juvenile-onset	607371	~20 pseudogenes also; mutation identified in twin DJO patients	3
ACTC1, CMD1R, CMH11, ASD5, LVNC4	 Atrial septal defect 5	612794		3
ACTC1, CMD1R, CMH11, ASD5, LVNC4	 Cardiomyopathy, dilated, 1R	613424		3
ACTC1, CMD1R, CMH11, ASD5, LVNC4	 Cardiomyopathy, hypertrophic, 11	612098		3
ACTC1, CMD1R, CMH11, ASD5, LVNC4	Left ventricular noncompaction 4	613424		3
ACTG1, DFNA20, DFNA26, BRWS2	 Baraitser-Winter syndrome 2	614583		3
ACTG1, DFNA20, DFNA26, BRWS2	Deafness, autosomal dominant 20/26	604717		3
ACTG2, ACTA3, VSCM1, MMIHS5	Megacystis-microcolon-intestinal hypoperistalsis syndrome 5	619431		3
ACTG2, ACTA3, VSCM1, MMIHS5	 Visceral myopathy 1	155310		3
ACTL6B, BAF53B, IDDSSAD, DEE76	Developmental and epileptic encephalopathy 76	618468		3
ACTL6B, BAF53B, IDDSSAD, DEE76	 Intellectual developmental disorder with severe speech and ambulation defects	618470		3
ACTL9, SPGF53	Spermatogenic failure 53	619258		3
ACTN1, BDPLT15	Bleeding disorder, platelet-type, 15	615193		3
ACTN2, CMD1AA, CMH23, MYOCOZ, MPD6	 Cardiomyopathy, dilated, 1AA, with or without LVNC	612158		3
ACTN2, CMD1AA, CMH23, MYOCOZ, MPD6	 Cardiomyopathy, hypertrophic, 23, with or without LVNC	612158		3
ACTN2, CMD1AA, CMH23, MYOCOZ, MPD6	 Myopathy, congenital with structured cores and Z-line abnormalities	618654		3
ACTN2, CMD1AA, CMH23, MYOCOZ, MPD6	Myopathy, distal, 6, adult onset	618655		3
ACTN3, ACTN3D	 Alpha-actinin-3 deficiency	617749		3
ACTN3, ACTN3D	Sprinting performance	617749		3
ACTN4, FSGS1, FSGS	Glomerulosclerosis, focal segmental, 1	603278		3
ACVR1, ACVRLK2, ALK2, FOP	Fibrodysplasia ossificans progressiva	135100		3
ACVR1B, ACVRLK4, ALK4	Pancreatic cancer, somatic	601300		3
ACVR2B, ACTRIIB, HTX4	Heterotaxy, visceral, 4, autosomal	613751		3
ACVRL1, ACVRLK1, ALK1, HHT2	Telangiectasia, hereditary hemorrhagic, type 2	600376		3
ACY1, ACY1D	Aminoacylase 1 deficiency	609924		3
AD10	Alzheimer disease-10	609636	max lod with D7S798	2
AD11	Alzheimer disease-11	609790	between D9S157 and D9S259	2
AD12	Alzheimer disease 12	611073	max lod at D8S1119	2
AD13	Alzheimer disease-13	611152	max lod D1S498	2
AD14	Alzheimer disease-14	611154	max lod at D1S218	2
AD15	Alzheimer disease-15	611155	max lod at D3S1579	2
AD16	Alzheimer disease 16	300756	associated with rs5984894	2
AD17	Alzheimer disease 17	615080	associated with rs75932628T	2
AD5	Alzheimer disease-5	602096		2
AD6	Alzheimer disease 6	605526		2
AD7	Alzheimer disease-7	606187	max LOD at D10S1423	2
AD8	Alzheimer disease 8	607116	?related to CST3	2
ADA2, CECR1, VAIHS, SNEDS	Sneddon syndrome	182410		3
ADA2, CECR1, VAIHS, SNEDS	 Vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome	615688		3
ADA	Adenosine deaminase deficiency, partial	102700		3
ADAM10, MADM, RAK, AD18	Alzheimer disease 18, susceptibility to	615590		3
ADAM10, MADM, RAK, AD18	 Reticulate acropigmentation of Kitamura	615537		3
ADAM22, DEE61	Developmental and epileptic encephalopathy 61	617933		3
ADAM9, MDC9, MCMP, CORD9	Cone-rod dystrophy 9	612775		3
ADAMTS10, WMS1	Weill-Marchesani syndrome 1, recessive	277600		3
ADAMTS13, VWFCP, TTP	Thrombotic thrombocytopenic purpura, hereditary	274150		3
ADAMTS17, WMS4	Weill-Marchesani 4 syndrome, recessive	613195		3
ADAMTS18, MMCAT	Microcornea, myopic chorioretinal atrophy, and telecanthus	615458		3
ADAMTS19, CVDP2	Cardiac valvular dysplasia 2	620067		3
ADAMTS2, NPI, EDSDERMS	Ehlers-Danlos syndrome, dermatosparaxis type	225410		3
ADAMTS3, HKLLS3	Hennekam lymphangiectasia-lymphedema syndrome 3	618154		3
ADAMTSL2, KIAA0605, GPHYSD1	Geleophysic dysplasia 1	231050		3
ADAMTSL4, TSRC1, ECTOL2	Ectopia lentis et pupillae	225200		3
ADAMTSL4, TSRC1, ECTOL2	 Ectopia lentis, isolated, autosomal recessive	225100		3
ADARB1, RED1, NEDHYMS	Neurodevelopmental disorder with hypotonia, microcephaly, and seizures	618862		3
ADAR, DRADA, DSH, DSRAD, IFI4, G1P1, AGS6	 Aicardi-Goutieres syndrome 6	615010		3
ADAR, DRADA, DSH, DSRAD, IFI4, G1P1, AGS6	Dyschromatosis symmetrica hereditaria	127400		3
ADA	 Severe combined immunodeficiency due to ADA deficiency	102700		3
ADAT3, TAD3, NEDBGF	Neurodevelopmental disorder with brain abnormalities, poor growth, and dysmorphic facies	615286		3
ADCK3, COQ8, CABC1, SCAR9, ARCA2, COQ10D4	Coenzyme Q10 deficiency, primary, 4	612016		3
ADCY10, SAC, HCA2	Hypercalciuria, absorptive, susceptibility to	143870		3
ADCY3, BMIQ19	Obesity, susceptibility to, BMIQ19	617885		3
ADCY5, FDFM, DSKOD	Dyskinesia with orofacial involvement, autosomal dominant	606703		3
ADCY5, FDFM, DSKOD	 Dyskinesia with orofacial involvement, autosomal recessive	619647		3
ADCY5, FDFM, DSKOD	 Neurodevelopmental disorder with hyperkinetic movements and dyskinesia	619651		3
ADCY6, LCCS8	Lethal congenital contracture syndrome 8	616287		3
ADD1	Hypertension, essential, salt-sensitive	145500		3
ADD3, ADDL, CPSQ3	Cerebral palsy, spastic quadriplegic, 3	617008	fusion with NUP98 in T-ALL	3
ADFN, ALDS	Albinism-deafness syndrome	300700	~8cM proximal to F9	2
ADGRE2, EMR2, VBU	Vibratory urticaria	125630		3
ADGRG1, GPR56, TM7XN1, BFPP, BPPR	Polymicrogyria, bilateral frontoparietal	606854		3
ADGRG1, GPR56, TM7XN1, BFPP, BPPR	 Polymicrogyria, bilateral perisylvian	615752		3
ADGRG2, GPR64, HE6, CBAVDX	Congenital bilateral absence of vas deferens, X-linked	300985		3
ADGRG6, PR126, VIGR, LCCS9	Lethal congenital contracture syndrome 9	616503		3
ADGRL1, LPHN1, CIRL1, CL1, LEC2, KIAA0821, DEDBANP	Developmental delay, behavioral abnormalities, and neuropsychiatric disorders	620065		3
ADGRV1, GPR98, MASS1, VLGR1, KIAA0686, FEB4, USH2C	 Febrile seizures, familial, 4	604352	mutation identified in 1 FEB4 family	3
ADGRV1, GPR98, MASS1, VLGR1, KIAA0686, FEB4, USH2C	Usher syndrome, type 2C	605472	mutation identified in 1 FEB4 family	3
ADGRV1, GPR98, MASS1, VLGR1, KIAA0686, FEB4, USH2C	 Usher syndrome, type 2C, GPR98/PDZD7 digenic	605472	mutation identified in 1 FEB4 family	3
ADH1B, ADH2	Aerodigestive tract cancer, squamous cell, alcohol-related, protection against	103780		3
ADH1B, ADH2	 Alcohol dependence, protection against	103780		3
ADH1C, ADH3	Alcohol dependence, protection against	103780		3
ADH1C, ADH3	 Parkinson disease, susceptibility to	168600		3
ADH5, FDH, AMEDS, BMFS7	AMED syndrome, digenic	619151	AMEDS is digenic with ALDH2	3
ADHD1	Attention deficit-hyperactivity disorder, susceptibility to, 1	608903	max lod at D16S3114	2
ADHD2	Attention deficit-hyperactivity disorder, susceptibility to, 2	608904		2
ADHD3	Attention deficit-hyperactivity disorder, susceptibility to, 2	608905		2
ADHD4	Attention deficit-hyperactivity disorder, susceptibility to, 4	608906		2
ADHD5	Attention deficit-hyperactivity disorder, susceptibility to, 5	612311	max lod at rs985162	2
ADHD6	Attention deficit-hyperactivity disorder, susceptibility to, 6	612312	max lod at rs1974047	2
ADIPOQ, APM1, GBP28, ADIPQTL1	Adiponectin deficiency	612556		3
ADIPQTL2, CAQ5	Adiponectin, serum level of, QTL2	606770	near D5S817	2
ADIPQTL3, CAQ14	Adiponectin, serum level of, QTL3	606771	between D14S608 and D14S599	2
ADIPQTL4	Adiponectin, serum level of, QTL4	612629	between D11S925 and D11S968	2
ADIPQTL5	Adiponectin, serum level of, QTL5	613836	associated with rs3865188	2
ADK	Hypermethioninemia due to adenosine kinase deficiency	614300		3
ADNP, ADNP1, KIAA0784, HVDAS, MRD28	Helsmoortel-van der Aa syndrome	615873		3
ADPRHL2, ARH3, CONDSIAS	Neurodegeneration, childhood-onset, stress-induced, with variable ataxia and seizures	618170		3
ADRA2C, ADRA2L2	Congestive heart failure and beta-blocker response, modifier of	104250	linked to D4S10	3
ADRB1, ADRB1R, RHR, FNSS2	 Resting heart rate	607276	close linkage to ADRA2R	3
ADRB1, ADRB1R, RHR, FNSS2	Short sleep, familial natural, 2	618591	close linkage to ADRA2R	3
ADRB2	 Asthma, nocturnal, susceptibility to	600807		3
ADRB2	Beta-2-adrenoreceptor agonist, reduced response to	109690		3
ADRB2	 Obesity, susceptibility to	601665		3
ADRB3	Obesity, susceptibility to	601665		3
ADSL	Adenylosuccinase deficiency	103050	ade(-)I; bifunctional	3
ADSS1, ADSSL1, MPD5	Myopathy, distal, 5	617030		3
AEBP1, ACLP	Ehlers-Danlos syndrome, classic-like, 2	618000		3
AF10	Leukemia, acute myeloid	601626	fuses with MLL and HEAB	3
AFF2, FMR2, FRAXE, XLID109	Intellectual developmental disorder, X-linked 109	309548		3
AFF3, LAF4, KINS	KINSSHIP syndrome	619297		3
AFF4, AF5Q31, CHOPS	CHOPS syndrome	616368		3
AFG3L2, SCA28, SPAX5, OPA12	 Optic atrophy 12	618977		3
AFG3L2, SCA28, SPAX5, OPA12	Spastic ataxia 5, autosomal recessive	614487		3
AFG3L2, SCA28, SPAX5, OPA12	 Spinocerebellar ataxia 28	610246		3
AFP, HPAFP, AFPD	 Alpha-fetoprotein deficiency	615969	order: 5'-ALB-3'--5'-AFP-3'	3
AFP, HPAFP, AFPD	Hereditary persistence of alpha-fetoprotein	615970	order: 5'-ALB-3'--5'-AFP-3'	3
AGA1, MPB	Alopecia, androgenetic, 1	109200		2
AGA2	Alopecia, androgenetic, 2	300710	associated with rs6152	2
AGA3	Alopecia, androgenetic, 3	612421	associated with rs1160312	2
AGA	Aspartylglucosaminuria	208400		3
AGBL1, CCP4, FECD8	Corneal dystrophy, Fuchs endothelial, 8	615523		3
AGBL5, CCP5, RP75	Retinitis pigmentosa 75	617023		3
AGK, MULK, MTDPS10, CATC5, CTRCT38	Cataract 38, autosomal recessive	614691		3
AGK, MULK, MTDPS10, CATC5, CTRCT38	 Sengers syndrome	212350		3
AGL, GDE	Glycogen storage disease IIIa	232400		3
AGL, GDE	 Glycogen storage disease IIIb	232400		3
AGO2, EIF2C2, LESKRES	Lessel-Kreienkamp syndrome	619149		3
AGPAT2, LPAAB, BSCL, BSCL1	Lipodystrophy, congenital generalized, type 1	608594		3
AGPS, ADHAPS, RCDP3	Rhizomelic chondrodysplasia punctata, type 3	600121		3
AGRN, CMS8	Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects	615120		3
AGRP, ART, AGRT	Leanness, inherited	601665		3
AGRP, ART, AGRT	 Obesity, late-onset	601665		3
AGSPX	Angio serpiginosum	300652	between DXS8026 and DXS106	2
AGTPBP1, NNA1, KIAA1035, CCP1, CONDCA	Neurodegeneration, childhood-onset, with cerebellar atrophy	618276		3
AGTR1, AGTR1A, AT2R1	Hypertension, essential	145500		3
AGTR1, AGTR1A, AT2R1	 Renal tubular dysgenesis	267430		3
AGT, SERPINA8	 Hypertension, essential, susceptibility to	145500		3
AGT, SERPINA8	 Preeclampsia, susceptibility to	106150		3
AGT, SERPINA8	Renal tubular dysgenesis	267430		3
AGXT2, AGT2, BAIBA	Beta-aminoisobutyric acid, urinary excretion of	210100		3
AGXT, SPAT	Hyperoxaluria, primary, type 1	259900		3
AHCY, SAHH	Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase	613752		3
AHDC1, XIGIS, MRD25	Xia-Gibbs syndrome	615829		3
AHI1	Joubert syndrome 3	608629		3
AIC	Aicardi syndrome	304050	?in p22.31 with FDH as contiguous gene syndrome	2
AICDA, AID, HIGM2	Immunodeficiency with hyper-IgM, type 2	605258		3
AIFM1, PDCD8, AIF, COXPD6, COWCK, CMTX4, DFNX5, SEMDHL	Combined oxidative phosphorylation deficiency 6	300816		3
AIFM1, PDCD8, AIF, COXPD6, COWCK, CMTX4, DFNX5, SEMDHL	 Cowchock syndrome	310490		3
AIFM1, PDCD8, AIF, COXPD6, COWCK, CMTX4, DFNX5, SEMDHL	 Deafness, X-linked 5	300614		3
AIFM1, PDCD8, AIF, COXPD6, COWCK, CMTX4, DFNX5, SEMDHL	 Spondyloepimetaphyseal dysplasia, X-linked, with hypomyelinating leukodystrophy	300232		3
AIMP1, SCYE1, EMAP2, EMAPII, HLD3	Leukodystrophy, hypomyelinating, 3	260600		3
AIMP2, JTV1, HLD17	Leukodystrophy, hypomyelinating, 17	618006		3
AIPL1, LCA4	 Cone-rod dystrophy	604393	LCA1 due to GUCY2D mutation also on 17p13.1	3
AIPL1, LCA4	Leber congenital amaurosis 4	604393	LCA1 due to GUCY2D mutation also on 17p13.1	3
AIPL1, LCA4	 Retinitis pigmentosa, juvenile	604393	LCA1 due to GUCY2D mutation also on 17p13.1	3
AIP, XAP2, ARA9, PITA1	Pituitary adenoma 1, multiple types	102200		3
AIP, XAP2, ARA9, PITA1	 Pituitary adenoma predisposition	102200		3
AIR	Acute insulin response	601676		2
AIRE, APECED, APS1	Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia	240300		3
AIS2, VAMAS3	Autoimmune disease, susceptibility to, 2	608391		2
AIS3, VAMAS4	Autoimmune disease, susceptibility to, 3	608392		2
AIS4, VAMAS5	Autoimmune disease, susceptibility to, 4	609400	between D4S392 and D4S3042	2
AITD1	Autoimmune thyroid disease, susceptibility to, 1	608173		2
AITD2	Autoimmune thyroid disease, susceptibility to, 2	608174		2
AITD4	Autoimmune thyroid disease, susceptibility to, 4	608176		2
AK1	Hemolytic anemia due to adenylate kinase deficiency	612631	proximal to Ph1 break, 9q34.1; AK1 to ORM = 17cM	3
AK2	Reticular dysgenesis	267500		3
AKR1C2, DDH2, DD2, HAKRD, SRXY8	46XY sex reversal 8	614279		3
AKR1C4, CHDR, CDR, HAKRA, DD4	46XY sex reversal 8, modifier of	614279		3
AKR1D1, SRD5B1, CBAS2	Bile acid synthesis defect, congenital, 2	235555		3
AKT1, CWS6	Breast cancer, somatic	114480	proximal to IGH	3
AKT1, CWS6	 Colorectal cancer, somatic	114500	proximal to IGH	3
AKT1, CWS6	 Cowden syndrome 6	615109	proximal to IGH	3
AKT1, CWS6	 Ovarian cancer, somatic	167000	proximal to IGH	3
AKT1, CWS6	 Proteus syndrome, somatic	176920	proximal to IGH	3
AKT2, HIHGHH	Diabetes mellitus, type II	125853		3
AKT2, HIHGHH	 Hypoinsulinemic hypoglycemia with hemihypertrophy	240900		3
AKT3, PKBG, MPPH2	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2	615937		3
ALAD, ALADH, PBGS	 Lead poisoning, susceptibility to	612740	linked to ABO; ORM-ALAD-AK-ABO	3
ALAD, ALADH, PBGS	Porphyria, acute hepatic	612740	linked to ABO; ORM-ALAD-AK-ABO	3
ALAS2, ANH1, ASB, XLEPP, XLSA, SIDBA1	Anemia, sideroblastic, 1	300751		3
ALAS2, ANH1, ASB, XLEPP, XLSA, SIDBA1	 Protoporphyria, erythropoietic, X-linked	300752		3
ALB, ANALBA, FDAH, FDAHT	 Analbuminemia	616000	mutation identified in 1 FDAHT family	3
ALB, ANALBA, FDAH, FDAHT	 Dysalbuminemic hyperthyroxinemia	615999	mutation identified in 1 FDAHT family	3
ALDH18A1, PYCS, GSAS, ARCL3A, SPG9A, SPG9B, ADCL3	 Cutis laxa, autosomal dominant 3	616603	GOT1 and GSAS in same pathway	3
ALDH18A1, PYCS, GSAS, ARCL3A, SPG9A, SPG9B, ADCL3	 Cutis laxa, autosomal recessive, type IIIA	219150	GOT1 and GSAS in same pathway	3
ALDH18A1, PYCS, GSAS, ARCL3A, SPG9A, SPG9B, ADCL3	Spastic paraplegia 9A, autosomal dominant	601162	GOT1 and GSAS in same pathway	3
ALDH18A1, PYCS, GSAS, ARCL3A, SPG9A, SPG9B, ADCL3	 Spastic paraplegia 9B, autosomal recessive	616586	GOT1 and GSAS in same pathway	3
ALDH1A2, RALDH2, DIH4	Diaphragmatic hernia 4, with cardiovascular defects	620025		3
ALDH1A3, ALDH6, MCOP8	Microphthalmia, isolated 8	615113		3
ALDH2	 Alcohol sensitivity, acute	610251		3
ALDH2	Esophageal cancer, alcohol-related, susceptibility to	100650		3
ALDH2	 Hangover, susceptibility to	610251		3
ALDH2	 Sublingual nitroglycerin, susceptibility to poor response to	100650		3
ALDH3A2, ALDH10, SLS, FALDH	Sjogren-Larsson syndrome	270200		3
ALDH4A1, ALDH4, P5CDH	Hyperprolinemia, type II	239510		3
ALDH5A1, SSADH	Succinic semialdehyde dehydrogenase deficiency	271980		3
ALDH6A1, MMSDH	Methylmalonate semialdehyde dehydrogenase deficiency	614105		3
ALDH7A1, ATQ1, EPD, PDE	Epilepsy, pyridoxine-dependent	266100		3
ALDOA, GSD12	Glycogen storage disease XII	611881	pseudogenes on 3 and 10	3
ALDOB	Fructose intolerance, hereditary	229600		3
ALG10B, KCR1, ALG10	Long QT syndrome, acquired, reduced susceptibility to	613688		3
ALG11, KIAA1266, CDG1P	Congenital disorder of glycosylation, type Ip	613661		3
ALG12, CDG1G	Congenital disorder of glycosylation, type Ig	607143		3
ALG13, GLT28D1, CDG1S, DEE36	Developmental and epileptic encephalopathy 36	300884		3
ALG14, CMS15, IDDEBF, MEPCA	Intellectual developmental disorder with epilepsy, behavioral abnormalities, and coarse facies	619031	mutation identified in 1 CMSWTA family	3
ALG14, CMS15, IDDEBF, MEPCA	 Myasthenic syndrome, congenital, 15, without tubular aggregates	616227	mutation identified in 1 CMSWTA family	3
ALG14, CMS15, IDDEBF, MEPCA	 Myopathy, epilepsy, and progressive cerebral atrophy	619036	mutation identified in 1 CMSWTA family	3
ALG1, HMAT1, HMT1, CDG1K	Congenital disorder of glycosylation, type Ik	608540		3
ALG2, CDGII, CMSTA3, CMS14	Congenital disorder of glycosylation, type Ii	607906		3
ALG2, CDGII, CMSTA3, CMS14	 Myasthenic syndrome, congenital, 14, with tubular aggregates	616228		3
ALG3, NOT56L, CDGS4, CDG1D	Congenital disorder of glycosylation, type Id	601110		3
ALG5, PKD7	Polycystic kidney disease 7	620056		3
ALG6, CDG1C	Congenital disorder of glycosylation, type Ic	603147		3
ALG8, CDG1H, PCLD3	Congenital disorder of glycosylation, type Ih	608104		3
ALG8, CDG1H, PCLD3	 Polycystic liver disease 3 with or without kidney cysts	617874		3
ALG9, DIBD1, CDG1L, GIKANIS	 Congenital disorder of glycosylation, type Il	608776		3
ALG9, DIBD1, CDG1L, GIKANIS	Gillessen-Kaesbach-Nishimura syndrome	263210		3
ALKBH8, ABH8, MRT71	Intellectual developmental disorder, autosomal recessive 71	618504		3
ALK, NBLST3	Neuroblastoma, susceptibility to, 3	613014		3
ALL1	Leukemia, acute lymphocytic, susceptibility to, 1	613065	associated with rs10821936	2
ALL2	Leukemia, acute lymphoblastic, susceptibility to, 2	613067	associated with rs11978267	2
ALMS1, ALSS, KIAA0328	Alstrom syndrome	203800		3
ALOX12B, ARCI2	Ichthyosis, congenital, autosomal recessive 2	242100		3
ALOX5AP, FLAP	Stroke, susceptibility to	601367		3
ALOX5	 Asthma, diminished response to antileukotriene treatment in	600807		3
ALOX5	Atherosclerosis, susceptibility to	152390		3
ALOXE3, ARCI3	Ichthyosis, congenital, autosomal recessive 3	606545		3
ALPK1, LAK, KIAA1527, ROSAH	ROSAH syndrome	614979		3
ALPK3, MIDORI, KIAA1330, CMH27	Cardiomyopathy, familial hypertrophic 27	618052		3
ALPL, HOPS, TNSALP, HPPA, HPPO, HPPI, HPPC	 Hypophosphatasia, adult	146300		3
ALPL, HOPS, TNSALP, HPPA, HPPO, HPPI, HPPC	 Hypophosphatasia, childhood	241510		3
ALPL, HOPS, TNSALP, HPPA, HPPO, HPPI, HPPC	 Hypophosphatasia, infantile	241500		3
ALPL, HOPS, TNSALP, HPPA, HPPO, HPPI, HPPC	Odontohypophosphatasia	146300		3
ALPQTL1	Alkaline phosphatase, plasma level of, QTL1	171720	linkage with rs657152	2
ALPQTL2	Alkaline phosphatase, plasma level of, QTL 2	612367	linkage with rs1780324	2
ALPQTL3	Alkaline phosphatase, plasma level of, QTL3	612368	linkage with rs9467160	2
ALPQTL4	Alkaline phosphatase, plasma level of, QTL4	612369	linkage with rs12355784	2
ALS2, ALSJ, PLSJ, IAHSP	 Amyotrophic lateral sclerosis 2, juvenile	205100		3
ALS2, ALSJ, PLSJ, IAHSP	Primary lateral sclerosis, juvenile	606353		3
ALS2, ALSJ, PLSJ, IAHSP	 Spastic paralysis, infantile onset ascending	607225		3
ALS3	Amyotrophic lateral sclerosis 3	606640		2
ALS7	Amyotrophic lateral sclerosis 7	608031	max lod at D20S103	2
ALX1, CART1, FND3	Frontonasal dysplasia 3	613456		3
ALX3, FND1	Frontonasal dysplasia 1	136760		3
ALX4, PFM2, FPP, FND2, CRS5	 Craniosynostosis 5, susceptibility to	615529		3
ALX4, PFM2, FPP, FND2, CRS5	 Frontonasal dysplasia 2	613451		3
ALX4, PFM2, FPP, FND2, CRS5	Parietal foramina 2	609597		3
AMACR, CBAS4, AMACRD	Alpha-methylacyl-CoA racemase deficiency	614307		3
AMACR, CBAS4, AMACRD	 Bile acid synthesis defect, congenital, 4	214950		3
AMBN, AI1F	Amelogenesis imperfecta, type IF	616270	mutation identified in 1 AI1F family	3
AMELX, AMG, AIH1, AMGX, AI1E	Amelogenesis imperfecta, type 1E	301200	also Y	3
AMER1, FAM123B, WTX, OSCS	Osteopathia striata with cranial sclerosis	300373		3
AMH, MIF	Persistent Mullerian duct syndrome, type I	261550		3
AMHR2, AMHR	Persistent Mullerian duct syndrome, type II	261550		3
AMMEC, DELXq22.3, CXDELq22.3	AMME complex	300194	contiguous gene deletion syndrome	4
AMMECR1, MFHIEN	Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis	300990		3
AMN, IGS2	Imerslund-Grasbeck syndrome 2	618882		3
AMPD1, MMDD	Myopathy due to myoadenylate deaminase deficiency	615511		3
AMPD2, SPG63, PCH9	 Pontocerebellar hypoplasia, type 9	615809	mutation identified in 1 SPG63 family	3
AMPD3	AMP deaminase deficiency, erythrocytic	612874		3
AMT, NKH, GCE	Glycine encephalopathy	605899		3
ANAPC1, APC1	Rothmund-Thomson syndrome, type 1	618625		3
ANAPC7, APC7, FERBON	Ferguson-Bonni neurodevelopmental syndrome	619699		3
ANBC	Aneurysmal bone cysts	606179	t(16:17); ?defect at 17p13	2
ANGPT2, ANG2, LMPHM10	Lymphatic malformation 10	619369	close to MCPH1	3
ANGPTL3, ANGPT5, FHBL2	Hypobetalipoproteinemia, familial, 2	605019		3
ANGPTL4, PGAR, HFARP, FIAF, TGQTL	Plasma triglyceride level QTL, low	615881		3
ANG, RNASE5, ALS9	Amyotrophic lateral sclerosis 9	611895	proximal to TCRA/TCRD	3
ANIB10	Aneurysm, intracranial berry, 10	612587	associated with rs10958409	2
ANIB11	Aneurysm, intracranial berry, 11	614252	max lod at D8S552	2
ANIB1	Aneurysm, intracranial berry, 1	105800	in or near ELN	2
ANIB2	Aneurysm, intracranial berry, 2	608542	between D19S245 and D19S246	2
ANIB3	Aneurysm, intracranial berry, 3	609122		2
ANIB4	Aneurysm, intracranial berry, 4	610213	max lod at D5S1954	2
ANIB5	Aneurysm, intracranial berry, 5	300870		2
ANIB6	Aneurysm, intracranial berry, 6	611892	associated with rs10757278	2
ANIB7	Aneurysm, intracranial berry, 7	612161	between rs618176 and rs1940033	2
ANIB8	Aneurysm, intracranial berry, 8	612162	associated with rs767603	2
ANIB9	Aneurysm, intracranial berry, 9	612586	associated with rs700651	2
ANIC	Anosmia, isolated congenital	107200	max lod at D18S1108	2
ANK1, SPH1	Spherocytosis, type 1	182900		3
ANK2, LQT4	 Cardiac arrhythmia, ankyrin-B-related	600919		3
ANK2, LQT4	Long QT syndrome 4	600919		3
ANK3, MRT37	Intellectual developmental disorder, autosomal recessive 37	615493		3
ANKH, HANK, ANK, CMDJ, CCAL2, CPPDD	Chondrocalcinosis 2	118600		3
ANKH, HANK, ANK, CMDJ, CCAL2, CPPDD	 Craniometaphyseal dysplasia	123000		3
ANKLE2, LEM4, KIAA0692, MCPH16	Microcephaly 16, primary, autosomal recessive	616681		3
ANKRD11, ANCO1, KBGS	KBG syndrome	148050		3
ANKRD17, GTAR, CAGS	Chopra-Amiel-Gordon syndrome	619504		3
ANKRD26, KIAA1074, THC2	Thrombocytopenia 2	188000		3
ANKS6, PKDR1, NPHP16	Nephronophthisis 16	615382		3
ANLN, FSFS8	Focal segmental glomerulosclerosis 8	616032		3
ANMA	Anisomastia	605746		2
ANO10, TMEM16K, SCAR10	Spinocerebellar ataxia, autosomal recessive 10	613728		3
ANO3, TMEM16C, C11orf25, DYT24	Dystonia 24	615034		3
ANO5, TMEM16E, GDD1, LGMDR12	 Gnathodiaphyseal dysplasia	166260		3
ANO5, TMEM16E, GDD1, LGMDR12	 Miyoshi muscular dystrophy 3	613319		3
ANO5, TMEM16E, GDD1, LGMDR12	Muscular dystrophy, limb-girdle, autosomal recessive 12	611307		3
ANO6, TMEM16F, SCTS, BDPLT7	Scott syndrome	262890		3
ANON1	Anorexia nervosa, susceptibility to, 1	606788		2
ANOS1, KAL1, KMS, ADMLX, HH1	Hypogonadotropic hypogonadism 1 with or without anosmia 	308700	with ichthyosis in probable microdeletion syndrome	3
ANTXR1, TEM8, ATR, GAPO	GAPO syndrome	230740	mutation identified in 1 HCI patient	3
ANTXR1, TEM8, ATR, GAPO	 Hemangioma, capillary infantile, susceptibility to	602089	mutation identified in 1 HCI patient	3
ANTXR2, CMG2, HFS	Hyaline fibromatosis syndrome	228600		3
ANXA11, ANX11, ALS23, IBMWMA	Amyotrophic lateral sclerosis 23	617839		3
ANXA11, ANX11, ALS23, IBMWMA	 Inclusion body myopathy and brain white matter abnormalities	619733		3
ANXA5, ENX2, RPRGL3	Pregnancy loss, recurrent, susceptibility to, 3	614391		3
AOCH	Acromegaloid features, overgrowth, cleft palate, and hernia	606049	pericentric inversion (46,XY,inv(11)(p15.3;q23.3))	2
AOMS1, SYNX	Abdominal obesity-metabolic syndrome 1	605552	epistatic gene on 17p12	2
AOMS2	Abdominal obesity-metabolic syndrome	605572	second QTL on 3q27	2
AOPEP, C9orf3, DYT31	Dystonia 31	619565		3
AP1B1, ADTB1, BAM22, CLAPB2, KIDAR	Keratitis-ichthyosis-deafness syndrome, autosomal recessive	242150		3
AP1G1, ADTG, CLAPG1, USRISD	 Usmani-Riazuddin syndrome, autosomal dominant	619467		3
AP1G1, ADTG, CLAPG1, USRISD	Usmani-Riazuddin syndrome, autosomal recessive	619548		3
AP1S1, CLAPS1, AP19, MEDNIK	MEDNIK syndrome	609313		3
AP1S2, MRX59, MRXSF, MRXS21, MRXS5, PGS	Pettigrew syndrome	304340		3
AP1S3, PSORS15	Psoriasis 15, pustular, susceptibility to	616106		3
AP2M1, CLAPM1, MRD60	Intellectual developmental disorder 60 with seizures	618587		3
AP2S1, CLAPS2, AP17, HHC3	Hypocalciuric hypercalcemia, type III	600740		3
AP3B1, ADTB3A, HPS2	Hermansky-Pudlak syndrome 2	608233		3
AP3B2, NAPTB, DEE48	Developmental and epileptic encephalopathy 48	617276		3
AP4B1, SPG47, CPSQ5	Spastic paraplegia 47, autosomal recessive	614066		3
AP4E1, SPG51, CPSQ4, STUT1	 Spastic paraplegia 51, autosomal recessive	613744		3
AP4E1, SPG51, CPSQ4, STUT1	Stuttering, familial persistent, 1	184450		3
AP4M1, SPG50, CPSQ3	Spastic paraplegia 50, autosomal recessive	612936		3
AP4S1, CPSQ6, SPG52	Spastic paraplegia 52, autosomal recessive	614067		3
AP5Z1, KIAA0415, SPG48	Spastic paraplegia 48, autosomal recessive	613647		3
APC2, APCL, MRT74	Cortical dysplasia, complex, with other brain malformations 10	618677	mutation identified in 1 MRT74 family	3
APC2, APCL, MRT74	 Intellectual developmental disorder, autosomal recessive 74	617169	mutation identified in 1 MRT74 family	3
APCDD1, HHS, HYPT1, HTS	Hypotrichosis 1	605389		3
APC, GS, FPC, BTPS2, DESMD	 Adenoma, periampullary, somatic	175100	150kb distal to MCC	3
APC, GS, FPC, BTPS2, DESMD	 Adenomatous polyposis coli	175100	150kb distal to MCC	3
APC, GS, FPC, BTPS2, DESMD	 Brain tumor-polyposis syndrome 2	175100	150kb distal to MCC	3
APC, GS, FPC, BTPS2, DESMD	Colorectal cancer, somatic	114500	150kb distal to MCC	3
APC, GS, FPC, BTPS2, DESMD	 Desmoid disease, hereditary	135290	150kb distal to MCC	3
APC, GS, FPC, BTPS2, DESMD	 Gardner syndrome	175100	150kb distal to MCC	3
APC, GS, FPC, BTPS2, DESMD	 Gastric adenocarcinoma and proximal polyposis of the stomach	619182	150kb distal to MCC	3
APC, GS, FPC, BTPS2, DESMD	 Gastric cancer, somatic	613659	150kb distal to MCC	3
APC, GS, FPC, BTPS2, DESMD	 Hepatoblastoma, somatic	114550	150kb distal to MCC	3
APCS, SAP	Amyloidosis, secondary, susceptibility to	104770	probably close to CRP	1
APMR2	Alopecia-intellectual disability syndrome 2	610422	between D3S1564 and D3S2427	2
APMR3	Alopecia-intellectual disability syndrome 3	613930	between D18S866 and D18S811	2
APOA1, HPALP2	 Amyloidosis, 3 or more types	105200		3
APOA1, HPALP2	Hypoalphalipoproteinemia, primary, 2	618463		3
APOA1, HPALP2	 Hypoalphalipoproteinemia, primary, 2, intermediate	619836		3
APOA2	Apolipoprotein A-II deficiency	107670		3
APOA2	 Hypercholesterolemia, familial, modifier of	143890		3
APOA5	Hyperchylomicronemia, late-onset	144650	proximal to APOA1, APOC3, APOA4	3
APOA5	 Hypertriglyceridemia, susceptibility to	145750	proximal to APOA1, APOC3, APOA4	3
APOB, FLDB, LDLCQ4, FCHL2	Hypercholesterolemia, familial, 2	144010	1 gene for liver apo-B100 and gut apo-B48; Ag linked	3
APOB, FLDB, LDLCQ4, FCHL2	 Hypobetalipoproteinemia	615558	1 gene for liver apo-B100 and gut apo-B48; Ag linked	3
APOC2	Hyperlipoproteinemia, type Ib	207750		3
APOC3, HALP2	Apolipoprotein C-III deficiency	614028	2.6kb 3' to APOA1	3
APOE, AD2, LPG, LDLCQ5	Alzheimer disease 2	104310	mutation identified in 1 APOE3-Christchurch patient	3
APOE, AD2, LPG, LDLCQ5	 Alzheimer disease, protection against, due to APOE3-Christchurch	607822	mutation identified in 1 APOE3-Christchurch patient	3
APOE, AD2, LPG, LDLCQ5	 Coronary artery disease, severe, susceptibility to	617347	mutation identified in 1 APOE3-Christchurch patient	3
APOE, AD2, LPG, LDLCQ5	 Hyperlipoproteinemia, type III	617347	mutation identified in 1 APOE3-Christchurch patient	3
APOE, AD2, LPG, LDLCQ5	 Lipoprotein glomerulopathy	611771	mutation identified in 1 APOE3-Christchurch patient	3
APOE, AD2, LPG, LDLCQ5	 Macular degeneration, age-related	603075	mutation identified in 1 APOE3-Christchurch patient	3
APOE, AD2, LPG, LDLCQ5	 Sea-blue histiocyte disease	269600	mutation identified in 1 APOE3-Christchurch patient	3
APOGCDS	Familial apolipoprotein gene cluster deletion syndrome	620058		4
APOL1, FSGS4	Glomerulosclerosis, focal segmental, 4, susceptibility to	612551		3
APOL2	Schizophrenia	181500		1
APOL4	Schizophrenia	181500		1
APOPT1, APOP, MC4DN17	Mitochondrial complex IV deficiency, nuclear type 17	619061		3
APP, AAA, CVAP, AD1	 Alzheimer disease 1, familial	104300	proximal to SOD; very distal q21 or boundary with q22	3
APP, AAA, CVAP, AD1	Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants	605714	proximal to SOD; very distal q21 or boundary with q22	3
APPL1, APPL, MODY14	Maturity-onset diabetes of the young, type 14	616511		3
APRT, APRTD	Adenine phosphoribosyltransferase deficiency	614723	telomeric to GALNS, transcribed in same cen-tel direction	3
APTX, AOA, AOA1	Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia	208920		3
AQP1, CHIP28, CO	Aquaporin-1 deficiency	110450		3
AQP1, CHIP28, CO	 Blood group, Colton	110450		3
AQP2, NDI2	Diabetes insipidus, nephrogenic, 2	125800		3
AQP3	Blood group GIL	607457	incorrectly mapped to chr.7	3
AQP5, PPKB	Palmoplantar keratoderma, Bothnian type	600231		3
AQP7, GLYCQTL	Glycerol quantitative trait locus	614411		3
ARCI7	Ichthyosis, congenital, autosomal recessive 7	615022	between D12S345 and D12S390	2
ARCN1, SSMG	Short stature-micrognathia syndrome	617164	60kb telomeric to MLL	3
AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1	 Androgen insensitivity	300068		3
AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1	Androgen insensitivity, partial, with or without breast cancer	312300		3
AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1	 Hypospadias 1, X-linked	300633		3
AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1	 Prostate cancer, susceptibility to	176807		3
AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1	 Spinal and bulbar muscular atrophy of Kennedy	313200		3
ARF1, PVNH8	Periventricular nodular heterotopia 8	618185		3
ARFGEF1, ARFGEP1, BIG1, P200, DEDISB	Developmental delay, impaired speech, and behavioral abnormalities, with or without seizures	619964		3
ARFGEF2, BIG2, PVNH2	Periventricular heterotopia with microcephaly	608097		3
ARG1	Argininemia	207800		3
ARHGAP26, GRAF	Leukemia, juvenile myelomonocytic, somatic	607785		3
ARHGAP31, CDGAP, KIAA1204, AOS1	Adams-Oliver syndrome 1	100300		3
ARHGDIA, GDIA1, NPHS8	Nephrotic syndrome, type 8	615244		3
ARHGEF18, KIAA0521, RP78	Retinitis pigmentosa 78	617433		3
ARHGEF9, PEM2, KIAA0424, DEE8	Developmental and epileptic encephalopathy 8	300607		3
ARHI1	Age-related hearing impairment 1	612448	between rs3765212 and rs4601326	2
ARHI2	Age-related hearing impairment 2	612976	associated with rs11928865, rs779701, and rs779706	2
ARID1A, C1orf4, B120, SMARCF1, MRD14, CSS2	Coffin-Siris syndrome 2	614607		3
ARID1B, BAF250B, KIAA1235, MRD12, CSS1	Coffin-Siris syndrome 1	135900		3
ARID2, BAF200, KIAA1557, CSS6	Coffin-Siris syndrome 6	617808		3
ARL13B, ARL2L1, JBTS8	Joubert syndrome 8	612291		3
ARL2BP, BART	Retinitis pigmentosa with or without situs inversus	615434		3
ARL3, ARFL3, JBTS35, RP83	 Joubert syndrome 35	618161		3
ARL3, ARFL3, JBTS35, RP83	Retinitis pigmentosa 83	618173		3
ARL6, BBS3, RP55	 Bardet-Biedl syndrome 1, modifier of	209900		3
ARL6, BBS3, RP55	 Bardet-Biedl syndrome 3	600151		3
ARL6, BBS3, RP55	Retinitis pigmentosa 55	613575		3
ARMC2, SPGF38	Spermatogenic failure 38	618433		3
ARMC5, AIMAH2	ACTH-independent macronodular adrenal hyperplasia 2	615954		3
ARMC9, KIAA1868, JBTS30	Joubert syndrome 30	617622		3
ARMD10	Macular degeneration, age-related, 10	611488		2
ARPC1B, ARC41, IMD71	Immunodeficiency 71 with inflammatory disease and congenital thrombocytopenia	617718		3
ARPC4, ARC20, DEVLO	Developmental delay, language impairment, and ocular abnormalities	620141		3
ARR3, MYP26	Myopia 26, X-linked, female-limited	301010		3
ARSA	Metachromatic leukodystrophy	250100		3
ARSB, MPS6	Mucopolysaccharidosis type VI 	253200		3
ARSE, CDPX1, CDPXR	Chondrodysplasia punctata, X-linked recessive	302950	CDPX1 in contiguous gene syndrome with STS	3
ARSG, KIAA1001, USH4	Usher syndrome, type IV	618144		3
ARSK, MPS10	Mucopolysaccharidosis, type X	619698		3
ART4, DO, DOK1	Blood group, Dombrock	616060		3
ARV1, DEE38	Developmental and epileptic encephalopathy 38	617020		3
ARVD3	Arrhythmogenic right ventricular dysplasia 3	602086	?distinct from ARVD1	2
ARVD4	Arrhythmogenic right ventricular dysplasia 4	602087		2
ARVD6	Arrhythmogenic right ventricular dysplasia 6	604401		2
ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	 Developmental and epileptic encephalopathy 1	308350		3
ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	 Hydranencephaly with abnormal genitalia	300215		3
ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	 Intellectual developmental disorder, X-linked 29	300419		3
ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	 Lissencephaly, X-linked 2	300215		3
ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	 Partington syndrome	309510		3
ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	Proud syndrome	300004		3
ASAH1, AC, SMAPME	 Farber lipogranulomatosis	228000		3
ASAH1, AC, SMAPME	Spinal muscular atrophy with progressive myoclonic epilepsy	159950		3
ASB10, GLC1F	Glaucoma 1, open angle, F	603383		3
ASCC1, p50, SMABF2	 Barrett esophagus/esophageal adenocarcinoma	614266		3
ASCC1, p50, SMABF2	Spinal muscular atrophy with congenital bone fractures 2	616867		3
ASD1	Atrial septal defect 1	108800	max lod at D5S406	2
ASH1L, KIAA1420, ASH1, MRD52	Intellectual developmental disorder, autosomal dominant 52	617796		3
ASIP, AGTIL, SHEP9	Skin/hair/eye pigmentation 9, brown/nonbrown eyes	611742		3
ASIP, AGTIL, SHEP9	 Skin/hair/eye pigmentation 9, dark/light hair	611742		3
ASL	Argininosuccinic aciduria	207900		3
ASNS, ASNSD	Asparagine synthetase deficiency	615574	temperature sensitive G1 mutant	3
ASPA	Canavan disease	271900		3
ASPG1	Asperger syndrome susceptibility 1	608638	max lod with D3S3037	2
ASPG2	Asperger syndrome susceptibility 2	608631	breakpoints between CHRNE and GP1BA	2
ASPG3	Asperger syndrome susceptibility 3	608781	max lod at D1S484	2
ASPG4	Asperger syndrome susceptibility 4	609954	max lod at D3S2432	2
ASPH, HAAH, FDLAB	Traboulsi syndrome	601552		3
ASPM, MCPH5	Microcephaly 5, primary, autosomal recessive	608716		3
ASPN, PLAP1, OS3	Lumbar disc degeneration	603932		3
ASPN, PLAP1, OS3	 Osteoarthritis susceptibility 3	607850		3
ASPRV1, SASP, TAPS, MUNO, ADLI	Ichthyosis, lamellar, autosomal dominant	146750		3
ASPSCR1, RCC17, ASPL, ASPS	Alveolar soft-part sarcoma	606243	t(X;17)(p11.2;q25)	3
ASRT3	Asthma-related traits, susceptibility to, 3	609958	max lod at rs2063871	2
ASRT4	Asthma-related traits, susceptibility to, 4	610906	max lod at D1S2890	2
ASRT6	Asthma-related traits, susceptibility to, 6	611403	strongly associated with rs7216389	2
ASRT8	Asthma-related traits, susceptibility to, 8	613207	associated with rs3789873	2
ASS1, ASS	Citrullinemia	215700	14 pseudogenes on 11 chromosomes, including X and Y and ASSP2 on 6p23-q12	3
ASXL1, KIAA0978, BOPS, MDS	 Bohring-Opitz syndrome	605039		3
ASXL1, KIAA0978, BOPS, MDS	Myelodysplastic syndrome, somatic	614286		3
ASXL2, KIAA1685, SHAPNS	Shashi-Pena syndrome	617190		3
ASXL3, KIAA1713, BRPS	Bainbridge-Ropers syndrome	615485		3
ATAD1, THORASE, HKPX4	Hyperekplexia 4	618011		3
ATAD3A, HAYOS, PHRINL	Harel-Yoon syndrome	617183		3
ATAD3A, HAYOS, PHRINL	 Pontocerebellar hypoplasia, hypotonia, and respiratory insufficiency syndrome, neonatal lethal	618810		3
ATCAY, CLAC, KIAA1872	Ataxia, cerebellar, Cayman type	601238		3
ATF6, ACHM7	Achromatopsia 7	616517		3
ATFB1	Atrial fibrillation, familial, 1	608583		2
ATFB2	Atrial fibrillation, familial, 2	608988	max lod between  D6S286 and D6S1021	2
ATFB5	Atrial fibrillation, familial, 5	611494	association with rs2200733 and rs10033464	2
ATFB8	Atrial fibrillation, familial, 8	613055	associated with rs7193343	2
ATG16L1, APG16L, IBD10	Inflammatory bowel disease  10	611081		3
ATG7, APG7L, GSA7, SCAR31	Spinocerebellar ataxia, autosomal recessive 31	619422		3
ATHS, ALP	Atherosclerosis, susceptibility to	108725	closely linked to LDLR; may be LDLR	2
ATIC, PURH, AICAR	AICA-ribosiduria due to ATIC deficiency	608688		3
ATL1, SPG3A, HSN1D	 Neuropathy, hereditary sensory, type ID	613708		3
ATL1, SPG3A, HSN1D	Spastic paraplegia 3A, autosomal dominant	182600		3
ATL3, HSN1F	Neuropathy, hereditary sensory, type IF	615632		3
ATM, ATA, AT1	 Ataxia-telangiectasia	208900		3
ATM, ATA, AT1	 Breast cancer, susceptibility to	114480		3
ATM, ATA, AT1	Lymphoma, B-cell non-Hodgkin, somatic	607585		3
ATM, ATA, AT1	 Lymphoma, mantle cell, somatic	607585		3
ATM, ATA, AT1	 T-cell prolymphocytic leukemia, somatic	607585		3
ATN1, DRPLA, HRS, NOD, CHEDDA	 Congenital hypotonia, epilepsy, developmental delay, and digital anomalies	618494		3
ATN1, DRPLA, HRS, NOD, CHEDDA	Dentatorubral-pallidoluysian atrophy	125370		3
ATOD1	Dermatitis, atopic, susceptibility to, 1	603165	max lod at D3S3606	2
ATOD3	Dermatitis, atopic, susceptibility to, 3	605804	max lod at D20S115	2
ATOD4	Dermatitis, atopic, susceptibility to, 4	605805	maximum lod at D17S1290	2
ATOD5	Dermatitis, atopic, susceptibility to, 5	605844	max lod at D13S218	2
ATOD6	Dermatitis, atopic, susceptibility to, 6	605845	between D5S436 and D5S643	2
ATOD7	Dermatitis, atopic, susceptibility to, 7	613064	associated with rs7927894	2
ATOD8	Dermatitis, atopic, susceptibility to, 8	613518		2
ATOD9	Dermatitis, atopic, susceptibility to, 9	613519	max lod at D3S1768	2
ATOH7, PHPVAR, NCRNA	Persistent hyperplastic primary vitreous, autosomal recessive	221900		3
ATP11A, ATPIS, ATPIH, DFNA84, HLD24	 Deafness, autosomal dominant 84	619810	mutation identified in 1 HLD24 patient	3
ATP13A2, PARK9, KRPPD, SPG78	 Kufor-Rakeb syndrome	606693	mutation identified in 1 family with CLN12	3
ATP13A2, PARK9, KRPPD, SPG78	Spastic paraplegia 78, autosomal recessive	617225	mutation identified in 1 family with CLN12	3
ATP13A3, AFURS1, PPH5	Pulmonary hypertension, primary, 5	265400		3
ATP1A1, CMT2DD, HOMGSMR2	 Charcot-Marie-Tooth disease, axonal, type 2DD	618036		3
ATP1A1, CMT2DD, HOMGSMR2	Hypomagnesemia, seizures, and impaired intellectual development 2	618314		3
ATP1A2, FHM2, MHP2, FARIMPD, DEE98	 Alternating hemiplegia of childhood 1	104290		3
ATP1A2, FHM2, MHP2, FARIMPD, DEE98	Developmental and epileptic encephalopathy 98	619605		3
ATP1A2, FHM2, MHP2, FARIMPD, DEE98	 Fetal akinesia, respiratory insufficiency, microcephaly, polymicrogyria, and dysmorphic facies	619602		3
ATP1A2, FHM2, MHP2, FARIMPD, DEE98	 Migraine, familial basilar	602481		3
ATP1A2, FHM2, MHP2, FARIMPD, DEE98	 Migraine, familial hemiplegic, 2	602481		3
ATP1A3, DYT12, RDP, AHC2, CAPOS, DEE99	Alternating hemiplegia of childhood 2	614820		3
ATP1A3, DYT12, RDP, AHC2, CAPOS, DEE99	 CAPOS syndrome	601338		3
ATP1A3, DYT12, RDP, AHC2, CAPOS, DEE99	 Developmental and epileptic encephalopathy 99	619606		3
ATP1A3, DYT12, RDP, AHC2, CAPOS, DEE99	 Dystonia-12	128235		3
ATP1B1	Blood pressure regulation QTL	145500		2
ATP2A1, SERCA1	Brody myopathy	601003		3
ATP2A2, ATP2B, DAR	Acrokeratosis verruciformis	101900		3
ATP2A2, ATP2B, DAR	 Darier disease	124200		3
ATP2B1, PMCA1, MRD66	Intellectual developmental disorder, autosomal dominant 66	619910		3
ATP2B2, PMCA2, DFNA82	Deafness, autosomal dominant 82	619804		3
ATP2B2, PMCA2, DFNA82	 Deafness, autosomal recessive 12, modifier of	601386		3
ATP2C1, BCPM, HHD	Hailey-Hailey disease	169600		3
ATP5F1A, ATP5A1, ATPM, ATP5A, ORM, MC5DN4, COXPD22	 Combined oxidative phosphorylation deficiency 22	616045	pseudogenes on chr. 2, chr. 9, and chr.16; mutation identified in 1 MC5DN4 family and 1 COXPD22 family	3
ATP5F1D, ATP5D, MC5DN5	Mitochondrial complex V  deficiency	618120		3
ATP5MC3, ATP5G3, DYTSPG	Dystonia, early-onset, and/or spastic paraplegia	619681		3
ATP5MD, USMG5, DAPIT, MC5DN6	Mitochondrial complex V  deficiency, nuclear type 6	618683		3
ATP6AP1, ATP6IP1, ATP6S1, VATPS1	Immunodeficiency 47	300972		3
ATP6AP2, ATP6M8-9, XMRE, MRXSH, XPDS, CDG2R	 Congenital disorder of glycosylation, type IIr	301045	mutation identified in 1 XPDS family	3
ATP6AP2, ATP6M8-9, XMRE, MRXSH, XPDS, CDG2R	Intellectual developmental disorder, X-linked syndromic, Hedera type	300423	mutation identified in 1 XPDS family	3
ATP6AP2, ATP6M8-9, XMRE, MRXSH, XPDS, CDG2R	 Parkinsonism with spasticity, X-linked	300911	mutation identified in 1 XPDS family	3
ATP6V0A1, ATP6N1A, VPP1, DEE104, NEDEBA	 Developmental and epileptic encephalopathy 104	619970		3
ATP6V0A1, ATP6N1A, VPP1, DEE104, NEDEBA	Neurodevelopmental disorder with epilepsy and brain atrophy	619971		3
ATP6V0A2, WSS, ARCL2A	 Cutis laxa, autosomal recessive, type IIA	219200		3
ATP6V0A2, WSS, ARCL2A	Wrinkly skin syndrome	278250		3
ATP6V0A4, ATP6N1B, VPP2, RTA1C, DRTA3	Distal renal tubular acidosis 3, with or without sensorineural hearing loss	602722		3
ATP6V1A, HO68, ARCL2D, DEE93	Cutis laxa, autosomal recessive, type IID	617403		3
ATP6V1A, HO68, ARCL2D, DEE93	 Developmental and epileptic encephalopathy 93	618012		3
ATP6V1B1, ATP6B1, VPP3, DRTA2	Distal renal tubular acidosis 2 with progressive sensorineural hearing loss	267300		3
ATP6V1B2, ATP6B2, VPP3, DOOD, ZLS2	 Deafness, congenital, with onychodystrophy, autosomal dominant	124480		3
ATP6V1B2, ATP6B2, VPP3, DOOD, ZLS2	Zimmermann-Laband syndrome 2	616455		3
ATP6V1E1, ATP6E, ARCL2C	Cutis laxa, autosomal recessive, type IIC	617402		3
ATP7A, MNK, MK, OHS, SMAX3	 Menkes disease	309400	probably Xq13.2-q13.3, ~150kb prox. to PGK1	3
ATP7A, MNK, MK, OHS, SMAX3	Occipital horn syndrome	304150	probably Xq13.2-q13.3, ~150kb prox. to PGK1	3
ATP7A, MNK, MK, OHS, SMAX3	 Spinal muscular atrophy, distal, X-linked 3	300489	probably Xq13.2-q13.3, ~150kb prox. to PGK1	3
ATP7B, WND	Wilson disease	277900		3
ATP8B1, FIC1, BRIC, PFIC1, ICP1	 Cholestasis, benign recurrent intrahepatic	243300		3
ATP8B1, FIC1, BRIC, PFIC1, ICP1	 Cholestasis, intrahepatic, of pregnancy, 1	147480		3
ATP8B1, FIC1, BRIC, PFIC1, ICP1	Cholestasis, progressive familial intrahepatic 1	211600		3
ATR, FRP1, SCKL1, FCTCS	 Cutaneous telangiectasia and cancer syndrome, familial	614564	mutation identified in 1 FCTCS family	3
ATR, FRP1, SCKL1, FCTCS	Seckel syndrome 1	210600	mutation identified in 1 FCTCS family	3
ATRX, XH2, XNP, SHS, SFM1, MRXHF1	Alpha-thalassemia/mental retardation syndrome	301040		3
ATRX, XH2, XNP, SHS, SFM1, MRXHF1	 Alpha-thalassemia myelodysplasia syndrome, somatic	300448		3
ATRX, XH2, XNP, SHS, SFM1, MRXHF1	 Intellectual disability-hypotonic facies syndrome, X-linked	309580		3
ATXN10, SCA10	Spinocerebellar ataxia 10	603516	ATTCTn repeat in intron 9	3
ATXN1, ATX1, SCA1	Spinocerebellar ataxia 1	164400		3
ATXN2, ATX2, SCA2, ASL13	Amyotrophic lateral sclerosis, susceptibility to, 13	183090		3
ATXN2, ATX2, SCA2, ASL13	 Parkinson disease, late-onset, susceptibility to	168600		3
ATXN2, ATX2, SCA2, ASL13	 Spinocerebellar ataxia 2	183090		3
ATXN3, MJD, SCA3	Machado-Joseph disease	109150		3
ATXN7, SCA7, OPCA3	Spinocerebellar ataxia 7	164500		3
ATXN8OS, SCA8, KLHL1AS	Parkinson disease, susceptibility to	168600	due to CTG repeat in untranslated DNA	3
ATXN8OS, SCA8, KLHL1AS	 Spinocerebellar ataxia 8	608768	due to CTG repeat in untranslated DNA	3
ATXN8	Spinocerebellar ataxia 8	608768	CAG repeat results in polyglutamine expansion protein	3
AUH	3-methylglutaconic aciduria, type I	250950		3
AURKA, STK15, AURORA2, BTAK, ARK1, STK6, AIK	Colon cancer, susceptibility to	114500		3
AURKC, STK13, AIE2, SPGF5	Spermatogenic failure 5	243060		3
AUTS10	Autism, susceptibility to, 10	611016	max lod at D7S483	2
AUTS11	Autism susceptibility 11	610836	associated with rs12740310, rs3737296, and rs12310279	2
AUTS12	Autism susceptibility 12	610838	max lod at D21S1437	2
AUTS13	Autism susceptibility 13	610908	linkage with rs1445442	2
AUTS1	Autism susceptibility 1	209850		2
AUTS3	Autism susceptibility 3	608049		2
AUTS4	Autism susceptibility 4	608636		2
AUTS6	Autism susceptibility 6	609378	max lod at D17S1800	2
AUTS7	Autism susceptibility 7	610676	max lod at D17S2180	2
AUTS8	Autism susceptibility 8	607373		2
AUTS9	Autism, susceptibility to, 9	611015	max lod near D7S530	2
AVIL, NPHS21	Nephrotic syndrome, type 21	618594		3
AVP, AVRP, VP	Diabetes insipidus, neurohypophyseal	125700	distal 20p	3
AVPR2, DIR, DI1, ADHR, NDI1	Diabetes insipidus, nephrogenic, 1	304800		3
AVPR2, DIR, DI1, ADHR, NDI1	 Nephrogenic syndrome of inappropriate antidiuresis	300539		3
AVSD1, AVCD	Atrioventricular septal defect, susceptibility to, 1	606215		2
AXIN1, AXIN	 Caudal duplication anomaly	607864	hypermethylation of AXIN1 promoter seen in 1 CDUP patient	3
AXIN1, AXIN	Hepatocellular carcinoma, somatic	114550	hypermethylation of AXIN1 promoter seen in 1 CDUP patient	3
AXIN2, ODCRCS	Colorectal cancer, somatic	114500		3
AXIN2, ODCRCS	 Oligodontia-colorectal cancer syndrome	608615		3
B2M, IMD43	 Immunodeficiency 43	241600	mutation identified in 1 FVA family	3
B3GALNT2, MGC39558, MDDGA11	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, type A, 11	615181		3
B3GALT3, GLCT3, GLOB	 Blood group, globoside system	615021		3
B3GALT3, GLCT3, GLOB	Blood group, P1PK system, P phenotype	111400		3
B3GALT6, SEMDJL1, EDSSPD2, ALGAZ	 Al-Gazali syndrome	609465		3
B3GALT6, SEMDJL1, EDSSPD2, ALGAZ	Ehlers-Danlos syndrome, spondylodysplastic type, 2	615349		3
B3GALT6, SEMDJL1, EDSSPD2, ALGAZ	 Spondyloepimetaphyseal dysplasia with joint laxity, type 1, with or without fractures	271640		3
B3GAT3, GLCATI, JDSCD	Multiple joint dislocations, short stature, craniofacial dysmorphism, with or without congenital heart defects	245600	pseudogene on chr.3	3
B3GLCT, B3GALTL, B3GTL	Peters-plus syndrome	261540		3
B4GALGT2, GALGT2, SD, SDA	Blood group, Sid system	615018		3
B4GALGT2, GALGT2, SD, SDA	 Sd polyagglutination syndrome	615018		3
B4GALNT1, GALGT, GALNACT, SPG26	Spastic paraplegia 26, autosomal recessive	609195		3
B4GALT1, GGTB2, GT1, GTB, CDG2D	Congenital disorder of glycosylation, type IId	607091		3
B4GALT7, XGALT1, XGPT1, EDSSPD1	Ehlers-Danlos syndrome, spondylodysplastic type, 1	130070		3
B4GAT1, B3GNT1, IGNT, IGAT, MDDGA13	Muscular dystrophy-dystroglycanopathy , type A, 13	615287		3
B6QTL1	Vitamin B6 plasma level QTL 1	612957	associated with rs4654748	2
B9D1, MKSR1, MKS9, JBTS27	 Joubert syndrome 27	617120	mutation identified in 1 MKS9 patient	3
B9D2, MKS10, JBTS34	 Joubert syndrome 34	614175	mutation identified in 1 MKS10 family	3
BAAT, HCHO, BACD1	Bile acid conjugation defect 1	619232		3
BACH2, IMD60	Immunodeficiency 60 and autoimmunity	618394		3
BAG3, MFM6	Cardiomyopathy, dilated, 1HH	613881		3
BAG3, MFM6	 Myopathy, myofibrillar, 6	612954		3
BAG5, CMD2F	Cardiomyopathy, dilated, 2F	619747		3
BANF1, BAF, NGPS	Nestor-Guillermo progeria syndrome	614008		3
BAP1, TPDS1, KURIS, UVM2	Kury-Isidor syndrome	619762		3
BAP1, TPDS1, KURIS, UVM2	 Tumor predisposition syndrome 1	614327		3
BAP1, TPDS1, KURIS, UVM2	 Uveal melanoma, susceptibility to, 2	606661		3
BARD1	Breast cancer, susceptibility to	114480		3
BAX	Colorectal cancer, somatic	114500		3
BAX	 T-cell acute lymphoblastic leukemia, somatic	613065		3
BBS10, C12orf58, FLJ23560	Bardet-Biedl syndrome 10	615987		3
BBS12, FLJ35630, C4orf24	Bardet-Biedl syndrome 12	615989	1Mb centromeric to BBS	3
BBS1	Bardet-Biedl syndrome 1	209900		3
BBS2, RP74	 Bardet-Biedl syndrome 2	615981		3
BBS2, RP74	Retinitis pigmentosa 74	616562		3
BBS4	Bardet-Biedl syndrome 4	615982		3
BBS5	Bardet-Biedl syndrome 5	615983		3
BBS7	Bardet-Biedl syndrome 7	615984		3
BCAP31, BAP31, DXS1357E, DDCH	Deafness, dystonia, and cerebral hypomyelination	300475		3
BCAS3, HEMARS	Hengel-Maroofian-Schols syndrome	619641		3
BCC1	Basal cell carcinoma, susceptibility to, 1	605462	associated with rs7538876	2
BCC2	Basal cell carcinoma, susceptibility to, 2	613058	associated with rs801114	2
BCC3	Basal cell carcinoma, susceptibility to, 3	613059		2
BCC4	Basal cell carcinoma, susceptibility to, 4	613061	associated with rs11170164	2
BCC5	Basal cell carcinoma, susceptibility to, 5	613062	associated with rs2151280	2
BCC6	Basal cell carcinoma, susceptibility to, 6	613063	associated with rs157935	2
BCHE, CHE1, BCHED	 Apnea, postanesthetic, susceptibility to, due to BCHE deficiency	617936	distal to CP, TF	3
BCHE, CHE1, BCHED	Butyrylcholinesterase deficiency	617936	distal to CP, TF	3
BCKDHA, MSUD1	Maple syrup urine disease, type Ia	248600		3
BCKDHB, E1B	Maple syrup urine disease, type Ib	248600		3
BCKDK, BDK, BCKDKD	Branched-chain keto acid dehydrogenase kinase deficiency	614923		3
BCL10, IMD37	 Immunodeficiency 37	616098	mutation identified in 1 IMD37 patient	3
BCL10, IMD37	Lymphoma, follicular, somatic	605027	mutation identified in 1 IMD37 patient	3
BCL10, IMD37	 Lymphoma, MALT, somatic	137245	mutation identified in 1 IMD37 patient	3
BCL10, IMD37	 Male germ cell tumor, somatic	273300	mutation identified in 1 IMD37 patient	3
BCL10, IMD37	 Mesothelioma, somatic	156240	mutation identified in 1 IMD37 patient	3
BCL10, IMD37	 Sezary syndrome, somatic	603517	mutation identified in 1 IMD37 patient	3
BCL11A, CTIP1, EVI9, KIAA1809, DILOS	Dias-Logan syndrome	617101		3
BCL11B, CTIP2, IMD49, IDDFSTA	Immunodeficiency 49, severe combined	617237		3
BCL11B, CTIP2, IMD49, IDDFSTA	 Intellectual developmental disorder with dysmorphic facies, speech delay, and T-cell abnormalities	618092		3
BCL2	Leukemia/lymphoma, B-cell, 2	151430	most frequent hematologic malignancy t(14;18)(q32;q21)	3
BCL3	Leukemia/lymphoma, B-cell, 3	109560		2
BCL7A, BCL7	B-cell non-Hodgkin lymphoma, high-grade	601406		3
BCOR, KIAA1575, MCOPS2, MAA2, ANOP2	Microphthalmia, syndromic 2	300166		3
BCORL1, SHUVER	Shukla-Vernon syndrome	301029		3
BCPR	Breast cancer	113721		1
BCR, CML, PHL, ALL	 Leukemia, acute lymphocytic, Philadelphia chromosome positive, somatic	613065	Ph1=t(9;22) (q34.1;q11.21); fused with ABL in CML	4
BCR, CML, PHL, ALL	Leukemia, chronic myeloid, Philadelphia chromosome positive, somatic	608232	Ph1=t(9;22) (q34.1;q11.21); fused with ABL in CML	4
BCS1L, FLNMS, GRACILE, BJS, PTD, MC3DN1	 Bjornstad syndrome	262000		3
BCS1L, FLNMS, GRACILE, BJS, PTD, MC3DN1	GRACILE syndrome	603358		3
BCS1L, FLNMS, GRACILE, BJS, PTD, MC3DN1	 Mitochondrial complex III deficiency, nuclear type 1	124000		3
BDA1B	Brachydactyly, type A1, B	607004		2
BDET	Bleeding disorder, east Texas type	605913		2
BDMR, C2DELq37, DEL2q37	Chromosome 2q37 deletion syndrome	600430		4
BDPLT14	Bleeding disorder, platelet-type, 14	614158		2
BDPLT9	Bleeding disorder, platelet-type, 9	614200		2
BEAN1, BEAN, SCA31	Spinocerebellar ataxia 31	117210		3
BED	Bornholm eye disease	300843	linked to F8	2
BEST1, VMD2, ARB, RP50	 Bestrophinopathy, autosomal recessive	611809	mutation identified in 1 MRCS family	3
BEST1, VMD2, ARB, RP50	Macular dystrophy, vitelliform, 2	153700	mutation identified in 1 MRCS family	3
BEST1, VMD2, ARB, RP50	 Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma 2	193220	mutation identified in 1 MRCS family	3
BEST1, VMD2, ARB, RP50	 Retinitis pigmentosa-50	613194	mutation identified in 1 MRCS family	3
BEST1, VMD2, ARB, RP50	 Retinitis pigmentosa, concentric	613194	mutation identified in 1 MRCS family	3
BEST1, VMD2, ARB, RP50	 Vitreoretinochoroidopathy	193220	mutation identified in 1 MRCS family	3
BFIS1, BFIC1	Seizures, benign familial infantile, 1	601764		2
BFIS4, BFIC4	Seizures, benign familial infantile, 4	612627	between D1S2864 and D1S2830	2
BFSP1, CP115, CTRCT33	Cataract 33, multiple types	611391		3
BFSP2, CP49, CP47, CTRCT12	Cataract 12, multiple types	611597		3
BGN, SEMDX, MRLS	Meester-Loeys syndrome	300989	proximal Xq28	3
BGN, SEMDX, MRLS	 Spondyloepimetaphyseal dysplasia, X-linked	300106	proximal Xq28	3
BHLHA9, BHLHF42, MSSD, CCSPD	 Syndactyly, mesoaxial synostotic, with phalangeal reduction	609432	mutation identified in 1 CCSPD family	3
BHLHE41, BHLHB3, DEC2, SHARP1, FNSS1	Short sleep, familial natural, 1	612975		3
BICC1, BICC, CYSRD	Renal dysplasia, cystic, susceptibility to	601331		3
BICD2, KIAA0699, SMALED2A, SMALED2B	 Spinal muscular atrophy, lower extremity-predominant, 2A, autosomal dominant	615290		3
BICD2, KIAA0699, SMALED2A, SMALED2B	Spinal muscular atrophy, lower extremity-predominant, 2B, autosomal dominant	618291		3
BICRA, GLTSCR1, CSS12	Coffin-Siris syndrome 12	619325		3
BIN1, AMPHL, CNM2	Centronuclear myopathy 2	255200		3
BLK, MODY11	Maturity-onset diabetes of the young, type 11	613375		3
BLOC1S3, BLOS3, HPS8	Hermansky-Pudlak syndrome 8	614077		3
BLOC1S5, BLOS5, MUTED, HPS11	Hermansky-Pudlak syndrome 11	619172		3
BLVRA	Hyperbiliverdinemia	614156		3
BMIQ11	Obesity, susceptibility to, BMIQ11	300306		2
BMIQ13	Body mass index QTL13	612459	associated with rs7566605	2
BMIQ15	Body mass index QTL 15	612967	associated with rs228883 and rs1005651	2
BMIQ16, DEL16p.11.2, C16DELp11.2	 Body mass index QTL16	613444		4
BMIQ16, DEL16p.11.2, C16DELp11.2	Chromosome 16p11.2 deletion syndrome, 220kb	613444		4
BMIQ1	Body mass index QTL1	606641	max lod at D7S1804	2
BMIQ2	Body mass index QTL2	606643	max lod at D13S257	2
BMIQ3	Body mass index QTL3	607446	max lod at D6S305	2
BMIQ5	Body mass index QTL5	608558	near D16S404 and D16S764	2
BMIQ6	Body mass index QTL6	608559	near D20S482 and D20S851	2
BMIQ7	Obesity, susceptibility to, BMIQ7	608410		2
BMIQ8	Obesity, susceptibility to, BMIQ8	603188		2
BMND10	Bone mineral density QTL 10	612113	associated with rs6469804 and rs6993813	2
BMND11	Bone mineral density QTL 11	612114	associated with rs4870044, rs1038304, and rs1999805	2
BMND13	Bone mineral density QTL 13	612727	associated with rs16945612	2
BMND14	Bone mineral density QTL 14	612728	associated with rs17131547	2
BMND2	Bone mineral density QTL 2	605833		2
BMND3	Bone mineral density QTL 3	606928	?another locus at 3p21	2
BMND4	Bone mineral density QTL 4	300536		2
BMND5	Bone mineral density QTL 5	609354	between D11S901 and D11S925	2
BMND6	Bone mineral density QTL 6	609876	max lod at D21S1446	2
BMND7	Osteoporosis	166710	most significant association with haplotype C	2
BMND8	Osteoporosis	166710	between D11S1392 and D11S4102	2
BMND9	Bone mineral density QTL 9	612110	associated with rs9594759	2
BMP15, GDF9B, ODG2, POF4	 Ovarian dysgenesis 2	300510		3
BMP15, GDF9B, ODG2, POF4	Premature ovarian failure 4	300510		3
BMP1, OI13	Osteogenesis imperfecta, type XIII	614856	1kb 3' to SFTP2	3
BMP2, BMP2A, BDA2, SSFSC1	 Brachydactyly, type A2	112600		3
BMP2, BMP2A, BDA2, SSFSC1	 HFE hemochromatosis, modifier of	235200		3
BMP2, BMP2A, BDA2, SSFSC1	Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies 1	617877		3
BMP4, BMP2B1, BMP2B, MCOPS6, OFC11	 Microphthalmia, syndromic 6	607932		3
BMP4, BMP2B1, BMP2B, MCOPS6, OFC11	Orofacial cleft 11	600625		3
BMP6, IO	Iron overload, susceptibility to	620121		3
BMPER, CV2	Diaphanospondylodysostosis	608022		3
BMPR1A, ACVRLK3, ALK3	 Polyposis, juvenile intestinal	174900		3
BMPR1A, ACVRLK3, ALK3	Polyposis syndrome, hereditary mixed, 2	610069		3
BMPR1B, ALK6, AMD3, BDA2, BDA1D	Acromesomelic dysplasia 3	609441		3
BMPR1B, ALK6, AMD3, BDA2, BDA1D	 Brachydactyly, type A1, D	616849		3
BMPR1B, ALK6, AMD3, BDA2, BDA1D	 Brachydactyly, type A2	112600		3
BMPR2, PPH1, POVD1	Pulmonary hypertension, familial primary, 1, with or without HHT	178600		3
BMPR2, PPH1, POVD1	 Pulmonary hypertension, primary, fenfluramine or dexfenfluramine-associated	178600		3
BMPR2, PPH1, POVD1	 Pulmonary venoocclusive disease 1	265450		3
BNC2, LUTO	Lower urinary tract obstruction, congenital	618612		3
BOLA3, MMDS2	Multiple mitochondrial dysfunctions syndrome 2 with hyperglycinemia	614299		3
BOS2	Branchiootic syndrome 2	120502		2
BPGM, ECYT8	Erythrocytosis, familial, 8	222800		3
BPP, PMGX, CBPS	Polymicrogyria, bilateral perisylvian	300388	possible genetic heterogeneity	2
BPPV	Vestibulopathy, familial	193007	max lod at D6S1556	2
BPTF, FALZ, FAC1, NURF301, NEDDFL	Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies	617755		3
BRAF, NS7	 Adenocarcinoma of lung, somatic	211980	pseudogene BRAF2 on Xq13 or 7q	3
BRAF, NS7	 Cardiofaciocutaneous syndrome	115150	pseudogene BRAF2 on Xq13 or 7q	3
BRAF, NS7	 Colorectal cancer, somatic	114500	pseudogene BRAF2 on Xq13 or 7q	3
BRAF, NS7	 LEOPARD syndrome 3	613707	pseudogene BRAF2 on Xq13 or 7q	3
BRAF, NS7	Melanoma, malignant, somatic	155600	pseudogene BRAF2 on Xq13 or 7q	3
BRAF, NS7	 Nonsmall cell lung cancer, somatic	211980	pseudogene BRAF2 on Xq13 or 7q	3
BRAF, NS7	 Noonan syndrome 7	613706	pseudogene BRAF2 on Xq13 or 7q	3
BRAT1, BAAT1, C7orf27, RMFSL, NEDCAS	Neurodevelopmental disorder with cerebellar atrophy and with or without seizures	618056		3
BRAT1, BAAT1, C7orf27, RMFSL, NEDCAS	 Rigidity and multifocal seizure syndrome, lethal neonatal	614498		3
BRCA1, PSCP, BROVCA1, PNCA4, FANCS	 Breast-ovarian cancer, familial, 1	604370		3
BRCA1, PSCP, BROVCA1, PNCA4, FANCS	Fanconi anemia, complementation group S	617883		3
BRCA1, PSCP, BROVCA1, PNCA4, FANCS	 Pancreatic cancer, susceptibility to, 4	614320		3
BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	 Breast cancer, male, susceptibility to	114480		3
BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	 Breast-ovarian cancer, familial, 2	612555		3
BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	Fanconi anemia, complementation group D1	605724		3
BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	 Glioblastoma 3	613029		3
BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	 Medulloblastoma	155255		3
BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	 Pancreatic cancer 2	613347		3
BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	 Prostate cancer	176807		3
BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	 Wilms tumor	194070		3
BRDCS1, DEL21q22, C21DELq22	Braddock-Carey syndrome 1	619980	7.7 - 9.2 Mb deletion	4
BRF1, TAF3C, GTF3B, TF3B90, CFDS	Cerebellofaciodental syndrome	616202		3
BRIP1, BACH1, FANCJ	 Breast cancer, early-onset, susceptibility to	114480	?or 17q23	3
BRIP1, BACH1, FANCJ	Fanconi anemia, complementation group J	609054	?or 17q23	3
BRPF1, BR140, IDDDFP	Intellectual developmental disorder with dysmorphic facies and ptosis	617333		3
BRV2	Vertigo, benign recurrent, 2	613106		2
BRWD3, MRX93, XLID93	Intellectual developmental disorder, X-linked 93	300659		3
BSCL2, SPG17, HMN5, PELD, HMN5C	 Encephalopathy, progressive, with or without lipodystrophy	615924		3
BSCL2, SPG17, HMN5, PELD, HMN5C	Lipodystrophy, congenital generalized, type 2	269700		3
BSCL2, SPG17, HMN5, PELD, HMN5C	 Neuropathy, distal hereditary motor, type VC	619112		3
BSCL2, SPG17, HMN5, PELD, HMN5C	 Silver spastic paraplegia syndrome	270685		3
BSG	Blood group, OK	111380		3
BSND	 Bartter syndrome, type 4a	602522		3
BSND	Sensorineural deafness with mild renal dysfunction	602522		3
BSZQTL2	Bone size QTL	609657		2
BSZQTL3	Bone size quantitative trait locus 3	610649		2
BSZQTL	Bone size QTL	609656		2
BTD	Biotinidase deficiency	253260		3
BTG4, PC3B, OOMD8	Oocyte maturation defect 8	619009		3
BTK, AGMX1, IMD1, XLA, AT, IGHD3	Agammaglobulinemia, X-linked 1	300755		3
BTK, AGMX1, IMD1, XLA, AT, IGHD3	 Isolated growth hormone deficiency, type III, with agammaglobulinemia	307200		3
BTNL2, SS2	Sarcoidosis, susceptibility to, 2	612387		3
BUB1B, BUBR1, MVA1	Colorectal cancer, somatic	114500		3
BUB1B, BUBR1, MVA1	 Mosaic variegated aneuploidy syndrome 1	257300		3
BUB1B, BUBR1, MVA1	 Premature chromatid separation trait	176430		3
BUB1, MCPH30	Colorectal cancer with chromosomal instability, somatic	114500		3
BUB1, MCPH30	 Microcephaly 30, primary, autosomal recessive	620183		3
BULN	Bulimia nervosa, susceptibility to	607499	between D10S1430 and D10S1423	2
BVES, HBVES, POPDC1, LGMDR25	Muscular dystrophy, limb-girdle, autosomal recessive 25	616812		3
BWQTL2	Birth weight QTL 2	613459	associated with rs900400	2
BWQTL4	Birth weight QTL4	615192	associated with rs7756992	2
BZX	Bazex syndrome	301845		2
C11orf80, HYDM4	Hydatidiform mole, recurrent, 4	618432		3
C12orf4, MRT66	Intellectual developmental disorder, autosomal recessive 66	618221		3
C12orf57, C10, TEMTYS	Temtamy syndrome	218340		3
C14orf39, SIX6OS1, SPGF52, POF18	 Premature ovarian failure 18	619203	mutation identified in 1 POF18 patient	3
C14orf39, SIX6OS1, SPGF52, POF18	Spermatogenic failure 52	619202	mutation identified in 1 POF18 patient	3
C16DELq22, DEL16q22	Chromosome 16q22 deletion syndrome	614541		4
C16DUPq12, DUP16q12	Chromosome 16q12 duplication syndrome	619649		4
C19orf12, NBIA4, SPG43	Neurodegeneration with brain iron accumulation 4	614298	mutation identified in 1 SPG43 family	3
C19orf12, NBIA4, SPG43	 Spastic paraplegia 43, autosomal recessive	615043	mutation identified in 1 SPG43 family	3
C1DELp35, DEL1p35	Chromosome 1p35 deletion syndrome	617930	SRO 1.03 Mb containing 23 genes	4
C1DUPp36.33, DUP1p36.33	Chromosome 1p36.33 duplication syndrome, ATAD3 gene cluster	618815		4
C1GALT1C1, COSMC, C1GALT2, TNPS	Tn polyagglutination syndrome, somatic	300622		3
C1NH, HAE1, HAE2, SERPING1	Angioedema, hereditary, 1 and 2	106100		3
C1NH, HAE1, HAE2, SERPING1	 Complement component 4, partial deficiency of	120790		3
C1QA	C1q deficiency	613652		3
C1QB	C1q deficiency	613652		3
C1QBP, HABP1, COXPD33	Combined oxidative phosphorylation deficiency 33	617713		3
C1QC, C1QG	C1q deficiency	613652		3
C1QTNF5, CTRP5, LORD	Retinal degeneration, late-onset, autosomal dominant	605670		3
C1R, EDSPD1	Ehlers-Danlos syndrome, periodontal type, 1	130080		3
C1S, EDSPD2	C1s deficiency	613783		3
C1S, EDSPD2	 Ehlers-Danlos syndrome, periodontal type, 2	617174		3
C2, ARMD14	C2 deficiency	217000	no crossover with BF	3
C2, ARMD14	 Macular degeneration, age-related, 14, reduced risk of	615489	no crossover with BF	3
C2CD3, OFD14	Orofaciodigital syndrome XIV	615948		3
C2orf69, COXPD53	Combined oxidative phosphorylation deficiency 53	619423		3
C3, ARMD9, AHUS5	C3 deficiency	613779	LE ~7cM in males vs. C3 RFLP	3
C3, ARMD9, AHUS5	 Hemolytic uremic syndrome, atypical, susceptibility to, 5	612925	LE ~7cM in males vs. C3 RFLP	3
C3, ARMD9, AHUS5	 Macular degeneration, age-related, 9	611378	LE ~7cM in males vs. C3 RFLP	3
C3orf52, TTMP, HYPT15	Hypotrichosis 15	620177		3
C4A, C4S, C4AD	Blood group, Rodgers	614374	order:  HLA-B, C2, BF, C4A, C4B, CYP21, DR	3
C4A, C4S, C4AD	 C4a deficiency	614380	order:  HLA-B, C2, BF, C4A, C4B, CYP21, DR	3
C4B, C4F, C4BD	C4B deficiency	614379	10kb from C4S	3
C5, C5D, ECLZB	C5 deficiency	609536		3
C5, C5D, ECLZB	 Eculizumab, poor response to	615749		3
C6	C6 deficiency	612446		3
C6	 Combined C6/C7 deficiency	217050		3
C7	C7 deficiency	610102		3
C7orf10, GA3	Glutaric aciduria III	231690		3
C8A	C8 deficiency, type I	613790		3
C8B	C8 deficiency, type II	613789		3
C9, C9D, ARMD15	C9 deficiency	613825		3
C9, C9D, ARMD15	 Macular degeneration, age-related, 15, susceptibility to	615591		3
C9orf72, FTDALS1, FTDALS, ALSFTD	Frontotemporal dementia and/or amyotrophic lateral sclerosis 1	105550		3
CA12	Hyperchlorhidrosis, isolated	143860		3
CA2	Osteopetrosis, autosomal recessive 3, with renal tubular acidosis	259730	CA1, CA2 linked in monkey and mouse	3
CA5A, CA5AD	Hyperammonemia due to carbonic anhydrase VA deficiency	615751	pseudogene on 16p	3
CA8, CALS, CARP, CAMRQ3	Cerebellar ataxia, impaired intellectual development and dysequilibrium syndrome 3	613227		3
CABP2, DFNB93	Deafness, autosomal recessive 93	614899		3
CABP4, CRSD, CSNB2B	Cone-rod synaptic disorder, congenital nonprogressive	610427		3
CACNA1A, CACNL1A4, SCA6, DEE42	 Developmental and epileptic encephalopathy 42	617106		3
CACNA1A, CACNL1A4, SCA6, DEE42	 Episodic ataxia, type 2	108500		3
CACNA1A, CACNL1A4, SCA6, DEE42	 Migraine, familial hemiplegic, 1	141500		3
CACNA1A, CACNL1A4, SCA6, DEE42	 Migraine, familial hemiplegic, 1, with progressive cerebellar ataxia	141500		3
CACNA1A, CACNL1A4, SCA6, DEE42	Spinocerebellar ataxia 6	183086		3
CACNA1B, CACNL1A5, NEDNEH	Neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movements	618497		3
CACNA1C, CACNL1A1, CCHL1A1, TS, LQT8, NEDHLSS	 Brugada syndrome 3	611875		3
CACNA1C, CACNL1A1, CCHL1A1, TS, LQT8, NEDHLSS	 Long QT syndrome 8	618447		3
CACNA1C, CACNL1A1, CCHL1A1, TS, LQT8, NEDHLSS	 Neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures	620029		3
CACNA1C, CACNL1A1, CCHL1A1, TS, LQT8, NEDHLSS	Timothy syndrome	601005		3
CACNA1D, CACNL1A2, CCHL1A2, SANDD, PASNA	Primary aldosteronism, seizures, and neurologic abnormalities	615474		3
CACNA1D, CACNL1A2, CCHL1A2, SANDD, PASNA	 Sinoatrial node dysfunction and deafness	614896		3
CACNA1E, CACNL1A6, DEE69	Developmental and epileptic encephalopathy 69	618285		3
CACNA1F, CSNB2, CORDX3, CSNB2A, AIED, OA2	 Aland Island eye disease	300600		3
CACNA1F, CSNB2, CORDX3, CSNB2A, AIED, OA2	Cone-rod dystrophy, X-linked, 3	300476		3
CACNA1F, CSNB2, CORDX3, CSNB2A, AIED, OA2	 Night blindness, congenital stationary , 2A, X-linked	300071		3
CACNA1G, SCA42, SCA42ND	Spinocerebellar ataxia 42	616795		3
CACNA1G, SCA42, SCA42ND	 Spinocerebellar ataxia 42, early-onset, severe, with neurodevelopmental deficits	618087		3
CACNA1H, EIG6, ECA6, HALD4	Epilepsy, childhood absence, susceptibility to, 6	611942		3
CACNA1H, EIG6, ECA6, HALD4	 Epilepsy, idiopathic generalized, susceptibility to, 6	611942		3
CACNA1H, EIG6, ECA6, HALD4	 Hyperaldosteronism, familial, type IV	617027		3
CACNA1I, KIAA1120, NEDSIS	Neurodevelopmental disorder with speech impairment and with or without seizures	620114		3
CACNA1S, CACNL1A3, CCHL1A3, TTPP1, HOKPP1, MHS5	 Hypokalemic periodic paralysis, type 1	170400		3
CACNA1S, CACNL1A3, CCHL1A3, TTPP1, HOKPP1, MHS5	 Malignant hyperthermia susceptibility 5	601887		3
CACNA1S, CACNL1A3, CCHL1A3, TTPP1, HOKPP1, MHS5	Thyrotoxic periodic paralysis, susceptibility to, 1	188580		3
CACNA2, CACNL2A, DEE110	Developmental and epileptic encephalopathy 110	620149		3
CACNA2D2, KIAA0558, CASVDD	Cerebellar atrophy with seizures and variable developmental delay	618501		3
CACNA2D4, RCD4	Retinal cone dystrophy 4	610478		3
CACNB2	Brugada syndrome 4	611876		3
CACNB4, EJM6, EA5, EIG9	 Epilepsy, idiopathic generalized, susceptibility to, 9	607682		3
CACNB4, EJM6, EA5, EIG9	Epilepsy, juvenile myoclonic, susceptibility to, 6	607682		3
CACNB4, EJM6, EA5, EIG9	 Episodic ataxia, type 5	613855		3
CAD, CDG1Z, DEE50	Developmental and epileptic encephalopathy 50	616457		3
CADM3, IGSF4B, TSLL1, NECL1, SYNCAM3, CMT2FF	Charcot-Marie-Tooth disease, axonal, type 2FF	619519		3
CALCR, CRT	Osteoporosis, postmenopausal, susceptibility	166710	not deleted in Williams syndrome	3
CALM1, PHKD, CPVT4, LQT14	 Long QT syndrome 14	616247		3
CALM1, PHKD, CPVT4, LQT14	Ventricular tachycardia, catecholaminergic polymorphic, 4	614916		3
CALM2, LQT15	Long QT syndrome 15	616249		3
CALM3, LQT16, CPVT6	Long QT syndrome 16	618782	mutation identified in 1 CPVT6 family	3
CALM3, LQT16, CPVT6	 Ventricular tachycardia, catecholaminergic polymorphic 6	618782	mutation identified in 1 CPVT6 family	3
CALR, SSA	Myelofibrosis, somatic	254450	distal to C3, near LDLR	3
CALR, SSA	 Thrombocythemia, somatic	187950	distal to C3, near LDLR	3
CAMK2A, KIAA0968, CAMKA, MRD53, MRT63	Intellectual developmental disorder, autosomal dominant 53	617798	mutation identified in 1 MRT63 family	3
CAMK2A, KIAA0968, CAMKA, MRD53, MRT63	 Intellectual developmental disorder, autosomal recessive 63	618095	mutation identified in 1 MRT63 family	3
CAMK2B, MRD54	Intellectual developmental disorder, autosomal dominant 54	617799		3
CAMK2G, CAMKG, MRD59	Intellectual developmental disorder, autosomal dominant 59	618522	in intron of PCDH15	3
CAMPD1	Camptodactyly 1	114200	between D3S2465 and D3S3044	2
CAMTA1, KIAA0833, CECBA	Cerebellar dysfunction with variable cognitive and behavioral abnormalities	614756		3
CANDF1, CMCT	Candidiasis, familial, 1, autosomal dominant	114580	between D2S367 and D2S2240	2
CANDF3, CANDN1, FCNC	Candidiasis, familial, 3	607644	between D11S1312 and D11S4191	2
CANT1, SCAN1, DBQD1, EDM7	Desbuquois dysplasia 1	251450		3
CANT1, SCAN1, DBQD1, EDM7	 Epiphyseal dysplasia, multiple, 7	617719		3
CAPN10, NIDDM1	Diabetes mellitus, noninsulin-dependent 1	601283		3
CAPN15, SOLH, OGIN	Oculogastrointestinal neurodevelopmental syndrome	619318		3
CAPN1, SPG76	Spastic paraplegia 76, autosomal recessive	616907		3
CAPN3, CANP3, LGMDR1, LGMDD4	 Muscular dystrophy, limb-girdle, autosomal dominant 4	618129		3
CAPN3, CANP3, LGMDR1, LGMDD4	Muscular dystrophy, limb-girdle, autosomal recessive 1	253600		3
CAPN5, HTRA3, VRNI	Vitreoretinopathy, neovascular inflammatory	193235		3
CARD11, CARMA1, BIMP3, PPBL, BENTA, IMD11A	B-cell expansion with NFKB and T-cell anergy	616452		3
CARD11, CARMA1, BIMP3, PPBL, BENTA, IMD11A	 Immunodeficiency 11A	615206		3
CARD11, CARMA1, BIMP3, PPBL, BENTA, IMD11A	 Immunodeficiency 11B with atopic dermatitis	617638		3
CARD14, CARMA2, BIMP2, PSORS2, PSS1, PRP	 Pityriasis rubra pilaris	173200		3
CARD14, CARMA2, BIMP2, PSORS2, PSS1, PRP	Psoriasis 2	602723		3
CARD9, CANDF2, IMD103	Immunodeficiency 103, susceptibility to fungal infection	212050		3
CARMIL2, RLTPR, IMD58	Immunodeficiency 58	618131		3
CARS1, CARS, MDBH	Microcephaly, developmental delay, and brittle hair syndrome	618891		3
CARS2, COXPD27	Combined oxidative phosphorylation deficiency 27	616672		3
CARTPT, CART	Obesity, susceptibility to	601665	mutation identified in 1 family	3
CASK, MICPCH, FGS4, CMG, MRXSNA	 FG syndrome 4	300422		3
CASK, MICPCH, FGS4, CMG, MRXSNA	 Intellectual developmental disorder and microcephaly with pontine and cerebellar hypoplasia	300749		3
CASK, MICPCH, FGS4, CMG, MRXSNA	Intellectual developmental disorder, with or without nystagmus	300422		3
CASP10, MCH4, ALPS2	Autoimmune lymphoproliferative syndrome, type II	603909		3
CASP10, MCH4, ALPS2	 Gastric cancer, somatic	613659		3
CASP10, MCH4, ALPS2	 Lymphoma, non-Hodgkin, somatic	605027		3
CASP12, CASP12P1	Sepsis, susceptibility to	608633		3
CASP14, ARCI12	Ichthyosis, congenital, autosomal recessive 12	617320		3
CASP8, MCH5, ALPS2B	Breast cancer, protection against	114480	mutation identified in 1 CEDS family	3
CASP8, MCH5, ALPS2B	 Caspase 8 lymphadenopathy syndrome	607271	mutation identified in 1 CEDS family	3
CASP8, MCH5, ALPS2B	 Hepatocellular carcinoma, somatic	114550	mutation identified in 1 CEDS family	3
CASP8, MCH5, ALPS2B	 Lung cancer, protection against	211980	mutation identified in 1 CEDS family	3
CASQ1, VMCQA	Myopathy, vacuolar, with CASQ1 aggregates	616231		3
CASQ2	Ventricular tachycardia, catecholaminergic polymorphic, 2	611938		3
CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1	 Epilepsy idiopathic generalized, susceptibility to, 8	612899	15cM from RHO	3
CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1	 Hyperparathyroidism, neonatal	239200	15cM from RHO	3
CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1	 Hypocalcemia, autosomal dominant	601198	15cM from RHO	3
CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1	Hypocalcemia, autosomal dominant, with Bartter syndrome	601198	15cM from RHO	3
CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1	 Hypocalciuric hypercalcemia, type I	145980	15cM from RHO	3
CAST, PLACK	Peeling skin with leukonychia, acral punctate keratoses, cheilitis, and knuckle pads	616295		3
CAT	Acatalasemia	614097	cen-CAT-WT1-AN2-pter	3
CATSPER1, CATSPER, SPGF7	Spermatogenic failure 7	612997		3
CAV1, BSCL3, CGL3, PPH3, LCCNS	 Lipodystrophy, familial partial, type 7	606721	mutation identified in 1 CGL3 family	3
CAV1, BSCL3, CGL3, PPH3, LCCNS	 Pulmonary hypertension, primary, 3	615343	mutation identified in 1 CGL3 family	3
CAV3, LQT9, MPDT, RMD2	 Cardiomyopathy, familial hypertrophic	192600	within 7-10kb of OXTR	3
CAV3, LQT9, MPDT, RMD2	 Creatine phosphokinase, elevated serum	123320	within 7-10kb of OXTR	3
CAV3, LQT9, MPDT, RMD2	 Long QT syndrome 9	611818	within 7-10kb of OXTR	3
CAV3, LQT9, MPDT, RMD2	Myopathy, distal, Tateyama type	614321	within 7-10kb of OXTR	3
CAV3, LQT9, MPDT, RMD2	 Rippling muscle disease 2	606072	within 7-10kb of OXTR	3
CAVIN1, PTRF	Lipodystrophy, congenital generalized, type 4	613327		3
CBFB, PEBP2B, CLCD2	Cleidocranial dysplasia 2	620099	inv(16)(p13;q22); fuses to MYH11	3
CBG, SERPINA6	Corticosteroid-binding globulin deficiency	611489		3
CBL, CBL2, NSLL	 Juvenile myelomonocytic leukemia	607785	mutation identified in 1 JMML family	3
CBL, CBL2, NSLL	Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia	613563	mutation identified in 1 JMML family	3
CBLIF, GIF, IF	Intrinsic factor deficiency	261000		3
CBS	 Homocystinuria, B6-responsive and nonresponsive types	236200	subtelomeric	3
CBS	Thrombosis, hyperhomocysteinemic	236200	subtelomeric	3
CC2D1A, MRT3	Intellectual developmental disorder, autosomal recessive 3	608443		3
CC2D2A, KIAA1345, MKS6, COACH2, RP93	COACH syndrome 2	619111		3
CC2D2A, KIAA1345, MKS6, COACH2, RP93	 Joubert syndrome 9	612285		3
CC2D2A, KIAA1345, MKS6, COACH2, RP93	 Meckel syndrome 6	612284		3
CC2D2A, KIAA1345, MKS6, COACH2, RP93	 Retinitis pigmentosa 93	619845		3
CCAL1	Chondrocalcinosis with early-onset osteoarthritis	600668		2
CCBE1, KIAA1983, HKLLS1	Hennekam lymphangiectasia-lymphedema syndrome 1	235510		3
CCCSX	Cerebral-cerebellar-coloboma syndrome, X-linked	300864		2
CCDC103, SMH, PR46B, CILD17	Ciliary dyskinesia, primary, 17	614679		3
CCDC111, MYP22	Myopia 22, autosomal dominant	615420		3
CCDC115, CCP1, CDG2O	Congenital disorder of glycosylation, type IIo	616828		3
CCDC134, OI22	Osteogenesis imperfecta, type XXII	619795		3
CCDC174, HSPC212, IHPM	Hypotonia, infantile, with psychomotor retardation	616816		3
CCDC22, RTSC2	Ritscher-Schinzel syndrome 2	300963		3
CCDC26, RAM, GLM7	Glioma susceptibility 7	613032		3
CCDC28B, MGC1203	Bardet-Biedl syndrome 1, modifier of	209900		3
CCDC32, CFNDS, C15orf57	Cardiofacioneurodevelopmental syndrome	619123		3
CCDC34, SPGF76	Spermatogenic failure 76	620084		3
CCDC39	Ciliary dyskinesia, primary, 14	613807		3
CCDC40, KIAA1640	Ciliary dyskinesia, primary, 15	613808		3
CCDC47, THNS	Trichohepatoneurodevelopmental syndrome	618268		3
CCDC65, CILD27	Ciliary dyskinesia, primary, 27	615504		3
CCDC8, 3M3	3-M syndrome 3	614205		3
CCDC88C, HKRP2, DAPLE, KIAA1509, HYC1, SCA40	 Hydrocephalus, congenital, 1	236600	mutation identified in 1 SCA40 family	3
CCL11, SCYA11	Asthma, susceptibility to	600807		3
CCL11, SCYA11	 HIV1, resistance to	609423		3
CCL2, SCYA2, MCP1, MCAF	 Coronary artery disease, modifier of	158105		3
CCL2, SCYA2, MCP1, MCAF	 HIV-1, resistance to	609423		3
CCL2, SCYA2, MCP1, MCAF	Mycobacterium tuberculosis, susceptibility to	607948		3
CCL2, SCYA2, MCP1, MCAF	 Spina bifida, susceptibility to	182940		3
CCL3L1, SCYA3L1, LD78	HIV/AIDS, susceptibility to	609423	varies in copy number 1-10	3
CCL3, SCYA3, MIP1A	HIV infection, resistance to	609423	in 47kb, CCL18-CCL3-CCL4	2
CCL5, SCYA5, D17S136E, TCP228	 HIV-1 disease, delayed progression of	609423		3
CCL5, SCYA5, D17S136E, TCP228	HIV-1 disease, rapid progression of	609423		3
CCM2, C7orf22, MGC4067	Cerebral cavernous malformations-2	603284		3
CCN6, WISP3, PPAC, PPRD	Progressive pseudorheumatoid dysplasia	208230		3
CCND1, PRAD1, BCL1	 Colorectal cancer, susceptibility to	114500	pseudogene on 11q13	3
CCND1, PRAD1, BCL1	 Multiple myeloma, susceptibility to	254500	pseudogene on 11q13	3
CCND1, PRAD1, BCL1	von Hippel-Lindau syndrome, modifier of	193300	pseudogene on 11q13	3
CCND2, MPPH3	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3	615938		3
CCNF, FBX1, FTDALS5	Frontotemporal dementia and/or amyotrophic lateral sclerosis 5	619141		3
CCNO, UNG2, CILD29	Ciliary dyskinesia, primary, 29	615872		3
CCR2, CMKBR2	HIV infection, susceptibility/resistance to	601267		3
CCR5, CMKBR5, CCCKR5, IDDM22	 Diabetes mellitus, insulin-dependent, 22	612522		3
CCR5, CMKBR5, CCCKR5, IDDM22	 Hepatitis C virus, resistance to	609532		3
CCR5, CMKBR5, CCCKR5, IDDM22	HIV infection, susceptibility/resistance to	601373		3
CCR5, CMKBR5, CCCKR5, IDDM22	 West nile virus, susceptibility to	610379		3
CCT5, KIAA0098, CCTE	Neuropathy, hereditary sensory, with spastic paraplegia	256840		3
CD151, PETA3, SFA1, MER2, EBS7	Blood group, Raph	179620		3
CD151, PETA3, SFA1, MER2, EBS7	 Epidermolysis bullosa simplex 7, with nephropathy and deafness	609057		3
CD19, CVID3	Immunodeficiency, common variable, 3	613493		3
CD207, LANGERIN, CLEC4K	Birbeck granule deficiency	613393	mutation identified in 1 patient	3
CD209, CDSIGN	 Dengue fever, protection against	614371		3
CD209, CDSIGN	HIV type 1, susceptibility to	609423		3
CD209, CDSIGN	 Mycobacterium tuberculosis, susceptibility to	607948		3
CD244, NAIL, NKR2B4, SLAMF4	Rheumatoid arthritis, susceptibility to	180300		3
CD27, TNFRSF7, S152. LPFS2	Lymphoproliferative syndrome 2	615122		3
CD2AP, CMS	Glomerulosclerosis, focal segmental, 3	607832		3
CD320, 8D6, 8D6A, TCBLR	Methylmalonic aciduria, transient, due to transcobalamin receptor defect	613646		3
CD36, CHDS7, BDPLT10	 Coronary heart disease, susceptibility to, 7	610938		3
CD36, CHDS7, BDPLT10	 Malaria, cerebral, reduced risk of	611162		3
CD36, CHDS7, BDPLT10	 Malaria, cerebral, susceptibility to	611162		3
CD36, CHDS7, BDPLT10	Platelet glycoprotein IV deficiency	608404		3
CD3D, T3D, IMD19	Immunodeficiency 19, severe combined	615617	3 CD3 genes in 50kb	3
CD3E, IMD18	Immunodeficiency 18	615615		3
CD3E, IMD18	 Immunodeficiency 18, SCID variant	615615		3
CD3G, IMD17	Immunodeficiency 17, CD3 gamma deficient	615607		3
CD40, TNFRSF5	Immunodeficiency with hyper-IgM, type 3	606843		3
CD44, MDU2, MDU3, MIC4, IN	Blood group, Indian system	609027		3
CD4, OKT4D, IMD79	Immunodeficiency 79	619238	CD = \'cluster of differentiation\' = nomenclature of leukocyte differentiation antigens	3
CD4, OKT4D, IMD79	 OKT4 epitope deficiency	613949	CD = \'cluster of differentiation\' = nomenclature of leukocyte differentiation antigens	3
CD55, DAF, CROM, CHAPLE	Blood group Cromer	613793		3
CD55, DAF, CROM, CHAPLE	 Complement hyperactivation, angiopathic thrombosis, and protein-losing enteropathy	226300		3
CD59, MIC11	Hemolytic anemia, CD59-mediated, with or without immune-mediated polyneuropathy	612300	in mouse Ly-6 = multigene complex	3
CD70, TNFSF7, CD27L, LPFS3	Lymphoproliferative syndrome 3	618261		3
CD79A, IGA	Agammaglobulinemia 3	613501		3
CD79B, IGB, B29, AGM6	Agammaglobulinemia 6	612692		3
CD81, TAPA1, CVID6	Immunodeficiency, common variable, 6	613496		3
CD8A	CD8 deficiency, familial	608957	distal to IGK	3
CD96, TACTILE	C syndrome	211750		3
CDAGS	CDAGS syndrome	603116		2
CDAN1, CDA1, CDAN1A	Dyserythropoietic anemia, congenital, type Ia	224120		3
CDC14A, DFNB32	Deafness, autosomal recessive 32, with or without immotile sperm	608653		3
CDC42BPB, MRCKB, CHOCNS	Chilton-Okur-Chung neurodevelopmental syndrome	619841		3
CDC42, TKS	Takenouchi-Kosaki syndrome	616737		3
CDC45L, CDC45L2, MGORS7	Meier-Gorlin syndrome 7	617063		3
CDC73, HRPT2, C1orf28	Hyperparathyroidism, familial primary	145000		3
CDC73, HRPT2, C1orf28	 Hyperparathyroidism-jaw tumor syndrome	145001		3
CDC73, HRPT2, C1orf28	 Parathyroid adenoma with cystic changes	145001		3
CDC73, HRPT2, C1orf28	 Parathyroid carcinoma	608266		3
CDCA7, JPO1, ICF3	Immunodeficiency-centromeric instability-facial anomalies syndrome 3	616910		3
CDH11, CAD11, ESWS, TBHS2	 Elsahy-Waters syndrome	211380		3
CDH11, CAD11, ESWS, TBHS2	Teebi hypertelorism syndrome 2	619736		3
CDH15, CDH14, CDH3, MRD3	Intellectual developmental disorder, autosomal dominant 3	612580	tightly linked to Aprt in mouse	3
CDH1, UVO, LCAM, ECAD, BCDS1	 Blepharocheilodontic syndrome 1	119580	near LCAT	3
CDH1, UVO, LCAM, ECAD, BCDS1	 Breast cancer, lobular, somatic	114480	near LCAT	3
CDH1, UVO, LCAM, ECAD, BCDS1	 Diffuse gastric and lobular breast cancer syndrome with or without cleft lip and/or palate	137215	near LCAT	3
CDH1, UVO, LCAM, ECAD, BCDS1	 Endometrial carcinoma, somatic	608089	near LCAT	3
CDH1, UVO, LCAM, ECAD, BCDS1	Ovarian cancer, somatic	167000	near LCAT	3
CDH1, UVO, LCAM, ECAD, BCDS1	 Prostate cancer, susceptibility to	176807	near LCAT	3
CDH23, USH1D, DFNB12, PITA5	 Deafness, autosomal recessive 12	601386	between D10S529 and D10S573	3
CDH23, USH1D, DFNB12, PITA5	 Pituitary adenoma 5, multiple types	617540	between D10S529 and D10S573	3
CDH23, USH1D, DFNB12, PITA5	Usher syndrome, type 1D	601067	between D10S529 and D10S573	3
CDH23, USH1D, DFNB12, PITA5	 Usher syndrome, type 1D/F digenic	601067	between D10S529 and D10S573	3
CDH2, NCAD, ARVD14, ACOGS, ADHD8	 Agenesis of corpus callosum, cardiac, ocular, and genital syndrome	618929	mutation identified in 1 ADHD8 family	3
CDH2, NCAD, ARVD14, ACOGS, ADHD8	Arrhythmogenic right ventricular dysplasia, familial, 14	618920	mutation identified in 1 ADHD8 family	3
CDH2, NCAD, ARVD14, ACOGS, ADHD8	 Attention deficit-hyperactivity disorder 8	619957	mutation identified in 1 ADHD8 family	3
CDH3, CDHP, PCAD, HJMD	 Ectodermal dysplasia, ectrodactyly, and macular dystrophy	225280	in mouse tightly linked to ECAD	3
CDH3, CDHP, PCAD, HJMD	Hypotrichosis, congenital, with juvenile macular dystrophy	601553	in mouse tightly linked to ECAD	3
CDHR1, PCDH21, PRCAD, CORD15, RP65	Cone-rod dystrophy 15	613660		3
CDHR1, PCDH21, PRCAD, CORD15, RP65	 Retinitis pigmentosa 65	613660		3
CDIN1, C15orf41	Dyserythropoietic anemia, congenital, type Ib	615631		3
CDK10, PISSLRE, ALSAS	Al Kaissi syndrome	617694		3
CDK13, CDC2L5, CHED, CHDFIDD	Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder	617360		3
CDK19, KIAA1028, DEE87	Developmental and epileptic encephalopathy 87	618916		3
CDK4, CMM3	Melanoma, cutaneous malignant, 3	609048		3
CDK5RAP2, KIAA1633, MCPH3	Microcephaly 3, primary, autosomal recessive	604804		3
CDK8, IDDHBA	Intellectual developmental disorder with hypotonia and behavioral abnormalities	618748		3
CDKL5, STK9, ISSX, DEE2	Developmental and epileptic encephalopathy 2	300672		3
CDKN1B, KIP1, CDKN4, MEN4	Multiple endocrine neoplasia, type IV	610755		3
CDKN1C, KIP2, BWS, IMAGE	 Beckwith-Wiedemann syndrome	130650	rare cause of BWS	3
CDKN1C, KIP2, BWS, IMAGE	IMAGE syndrome	614732	rare cause of BWS	3
CDKN2A, MTS1, P16, MLM, CMM2	Melanoma and neural system tumor syndrome	155755		3
CDKN2A, MTS1, P16, MLM, CMM2	 Melanoma, cutaneous malignant, 2	155601		3
CDKN2A, MTS1, P16, MLM, CMM2	 Melanoma-pancreatic cancer syndrome	606719		3
CDON, CDO, HPE11	Holoprosencephaly 11	614226		3
CDSN, HTSS1, HYPT2, PSS1	Hypotrichosis 2	146520		3
CDSN, HTSS1, HYPT2, PSS1	 Peeling skin syndrome 1	270300		3
CDT1	Meier-Gorlin syndrome 4	613804		3
CEACAM16, CEAL2, DFNA4B, DFNB113	Deafness, autosomal dominant 4B	614614		3
CEACAM16, CEAL2, DFNA4B, DFNB113	 Deafness, autosomal recessive 113	618410		3
CEBPA, CEBP	 Leukemia, acute myeloid	601626	germline mutation identified in 1 AML family	3
CEBPA, CEBP	Leukemia, acute myeloid, somatic	601626	germline mutation identified in 1 AML family	3
CEBPE, CRP1, SGD1, IMD108	 Specific granule deficiency	245480	mutation identified in 1 IMD108 family	3
CECR, CES	Cat eye syndrome	115470	partial tetrasomy of 22q11	4
CELA2A, ELA2A, AOMS4	Abdominal obesity-metabolic syndrome 4	618620		3
CEL, BSSL, CELL, MODY8	Maturity-onset diabetes of the young, type VIII	609812		3
CELF2, CUGBP2, ETR3, BRUNOL3, DEE97	Developmental and epileptic encephalopathy 97	619561		3
CELIAC10	Celiac disease, susceptibility to, 10	612008	associated with rs17810546	2
CELIAC11	Celiac disease, susceptibility to, 11	612009	associated with rs1464510	2
CELIAC12	Celiac disease, susceptibility to, 12	612010	in LD block containing TAGAP	2
CELIAC13	Celiac disease, susceptibility to, 13	612011	associated with rs3184504	2
CELIAC2	Celiac disease, susceptibility to, 2	609754		2
CELIAC5, GSES	Celiac disease, susceptibility to, 5	607202	in homogeneous Finnish population	2
CELIAC6, AIS5	Autoimmune disease, susceptibility to, 5	611598		2
CELIAC6, AIS5	 Celiac disease, susceptibility to, 6	611598		2
CELIAC7	Celiac disease, susceptibility to, 7	612005	associated with rs2816316	2
CELIAC8	Celiac disease, susceptibility to, 8	612006	associated with rs917997 and rs13015714	2
CELIAC9	Celiac disease, susceptibility to, 9	612007	associated with rs6441961	2
CELSR1, LMPHM9	Lymphatic malformation 9	619319		3
CENPF, CILD31, STROMS	Stromme syndrome	243605		3
CENPJ, CPAP, MCPH6, SCKL4	Microcephaly 6, primary, autosomal recessive	608393	mutation identified in 1 SCKL4 family	3
CENPJ, CPAP, MCPH6, SCKL4	 Seckel syndrome 4	613676	mutation identified in 1 SCKL4 family	3
CEP104, GLYBP, KIAA0562, JBTS25, MRT77	 Intellectual developmental disorder, autosomal recessive 77	619988		3
CEP104, GLYBP, KIAA0562, JBTS25, MRT77	Joubert syndrome 25	616781		3
CEP112, CCDC46, MACOCO, SPGF44	Spermatogenic failure 44	619044		3
CEP120, CCDC100, SRTD13, JBTS31	 Joubert syndrome 31	617761		3
CEP120, CCDC100, SRTD13, JBTS31	Short-rib thoracic dysplasia 13 with or without polydactyly	616300		3
CEP135, KIAA0635, MCPH8	Microcephaly 8, primary, autosomal recessive	614673		3
CEP152, KIAA0912, MCPH9, SCKL5	Microcephaly 9, primary, autosomal recessive	614852		3
CEP152, KIAA0912, MCPH9, SCKL5	 Seckel syndrome 5	613823		3
CEP164, KIAA1052	Nephronophthisis 15	614845		3
CEP19, C3orf34, MOSPGF	Morbid obesity and spermatogenic failure	615703	mutation identified in 1 family	3
CEP250, CEP2, CNAP1, CRDHL2	Cone-rod dystrophy and hearing loss 2	618358		3
CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14	 Bardet-Biedl syndrome 14	615991	mutation identified in 1 BBS14 family	3
CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14	 Joubert syndrome 5	610188	mutation identified in 1 BBS14 family	3
CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14	Leber congenital amaurosis 10	611755	mutation identified in 1 BBS14 family	3
CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14	 Meckel syndrome 4	611134	mutation identified in 1 BBS14 family	3
CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14	 Senior-Loken syndrome 6	610189	mutation identified in 1 BBS14 family	3
CEP41, TSGA14, JBTS15	Joubert syndrome 15	614464		3
CEP55, MARCH	Multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly	236500		3
CEP57, PIG8, TSP57, KIAA0092, MVA2	Mosaic variegated aneuploidy syndrome 2	614114		3
CEP78, CRDHL	Cone-rod dystrophy and hearing loss	617236		3
CEP83, CCDC41, NPHP18	Nephronophthisis 18	615862		3
CEP85L, C6orf204, LIS10	Lissencephaly 10	618873		3
CERKL, RP26	Retinitis pigmentosa 26	608380		3
CERS1, LASS1, UOG1, EPM8	Epilepsy, progressive myoclonic, 8	616230		3
CERS3, LASS3, ARCI9	Ichthyosis, congenital, autosomal recessive 9	615023		3
CES1, SES1	Drug metabolism, altered, CES1-related	618057		3
CETP, HDLCQ10	High density lipoprotein cholesterol level QTL 10	143470		3
CETP, HDLCQ10	 Hyperalphalipoproteinemia	143470		3
CFAP298, C21orf59, CILD26	Ciliary dyskinesia, primary, 26	615500		3
CFAP300, C11orf70, CILD38	Ciliary dyskinesia, primary, 38	618063		3
CFAP410, C21orf2, SMDAX, RDMS	Retinal dystrophy with macular staphyloma	617547		3
CFAP410, C21orf2, SMDAX, RDMS	 Spondylometaphyseal dysplasia, axial	602271		3
CFAP418, C8orf37, CORD16, RP64, BBS21	 Bardet-Biedl syndrome 21	617406		3
CFAP418, C8orf37, CORD16, RP64, BBS21	 Cone-rod dystrophy 16	614500		3
CFAP418, C8orf37, CORD16, RP64, BBS21	Retinitis pigmentosa 64	614500		3
CFAP43, WDR96, C10orf79, SPGF19, HYDNP1	Hydrocephalus, normal pressure, 1	236690	mutation identified in 1 HYDNP1 family	3
CFAP43, WDR96, C10orf79, SPGF19, HYDNP1	 Spermatogenic failure 19	617592	mutation identified in 1 HYDNP1 family	3
CFAP44, WDR52, SPGF20	Spermatogenic failure 20	617593		3
CFAP45, CCDC19, NESG1, HTX11	Heterotaxy, visceral, 11, autosomal, with male infertility	619608		3
CFAP47, CXorf22, SPGFX3	Spermatogenic failure, X-linked 3	301059		3
CFAP52, WDR16, WDRPUH, HTX10	Heterotaxy, visceral, 10, autosomal, with male infertility	619607		3
CFAP53, CCDC11, HTX6	Heterotaxy, visceral, 6, autosomal recessive	614779		3
CFAP58, SPGF49	Spermatogenic failure 49	619144		3
CFAP65, CCDC108, SPGF40	Spermatogenic failure 40	618664		3
CFAP69, C7orf63, SPGF24	Spermatogenic failure 24	617959		3
CFAP91, MAATS1, AAT1, C3orf15, SPGF51	Spermatogenic failure 51	619177		3
CFB, BF, GBG, AHUS4, ARMD14, CFBD	 Hemolytic uremic syndrome, atypical, susceptibility to, 4	612924	mutation identified in 1 CFBD family	3
CFB, BF, GBG, AHUS4, ARMD14, CFBD	 Macular degeneration, age-related, 14, reduced risk of	615489	mutation identified in 1 CFBD family	3
CFC1, CRYPTIC, HTX2	Heterotaxy, visceral, 2, autosomal	605376		3
CFD, ADN	Complement factor D deficiency	613912		3
CFEOM3C, FEOM4	Fibrosis of extraocular muscles, congenital, 3C	609384		2
CFH, HF1, HUS, ARMD4, AHUS1	 Basal laminar drusen	126700		3
CFH, HF1, HUS, ARMD4, AHUS1	 Complement factor H deficiency	609814		3
CFH, HF1, HUS, ARMD4, AHUS1	 Hemolytic uremic syndrome, atypical, susceptibility to, 1	235400		3
CFH, HF1, HUS, ARMD4, AHUS1	Macular degeneration, age-related, 4	610698		3
CFHR1, FHR1, HFL1, CFHL1	 Hemolytic uremic syndrome, atypical, susceptibility to	235400		3
CFHR1, FHR1, HFL1, CFHL1	Macular degeneration, age-related, reduced risk of	603075		3
CFHR3, FHR3, HLF4, CFHL3	 Hemolytic uremic syndrome, atypical, susceptibility to	235400		3
CFHR3, FHR3, HLF4, CFHL3	Macular degeneration, age-related, reduced risk of	603075		3
CFHR5, CFHL5, FHR5, CFHR5D	Nephropathy due to CFHR5 deficiency	614809		3
CFI, FI, AHUS3, ARMD13	 Complement factor I deficiency	610984	40kb distal to EGF	3
CFI, FI, AHUS3, ARMD13	Hemolytic uremic syndrome, atypical, susceptibility to, 3	612923	40kb distal to EGF	3
CFI, FI, AHUS3, ARMD13	 Macular degeneration, age-related, 13, susceptibility to	615439	40kb distal to EGF	3
CFL2, NEM7	Nemaline myopathy 7, autosomal recessive	610687		3
CFM1	Meconium ileus in cystic fibrosis, susceptibility to	603855		2
CFTDX	Myopathy, congenital, with fiber-type disproportion, X-linked	300580	between DXS8019 and DXS99	2
CFTR, ABCC7, CF, MRP7	 Bronchiectasis with or without elevated sweat chloride 1, modifier of	211400	distal and 5' to MET	3
CFTR, ABCC7, CF, MRP7	 Congenital bilateral absence of vas deferens	277180	distal and 5' to MET	3
CFTR, ABCC7, CF, MRP7	Cystic fibrosis	219700	distal and 5' to MET	3
CFTR, ABCC7, CF, MRP7	 Hypertrypsinemia, neonatal	602421	distal and 5' to MET	3
CFTR, ABCC7, CF, MRP7	 Pancreatitis, hereditary	167800	distal and 5' to MET	3
CFTR, ABCC7, CF, MRP7	 Sweat chloride elevation without CF	602421	distal and 5' to MET	3
CGF1	Social cognition	300082	imprinted locus	2
CHAMP1, ZNF828, C13orf8, KIAA1802, NEDHILD	Neurodevelopmental disorder with hypotonia, impaired language, and dysmorphic features	616579		3
CHAT, CMS6	Myasthenic syndrome, congenital, 6, presynaptic	254210		3
CHCHD10, FTDALS2, SMAJ, IMMD	 Frontotemporal dementia and/or amyotrophic lateral sclerosis 2	615911	mutation identified in 1 IMMD family	3
CHCHD10, FTDALS2, SMAJ, IMMD	 Spinal muscular atrophy, Jokela type	615048	mutation identified in 1 IMMD family	3
CHCHD2, PARK22	Parkinson disease 22, autosomal dominant	616710		3
CHD1, PILBOS	Pilarowski-Bjornsson syndrome	617682		3
CHD2, DEE94	Developmental and epileptic encephalopathy 94	615369		3
CHD3, SNIBCPS	Snijders Blok-Campeau syndrome	618205		3
CHD4, SIHIWES	Sifrim-Hitz-Weiss syndrome	617159		3
CHD5, PMNDS	Parenti-Mignot neurodevelopmental syndrome	619873		3
CHD7, HH5	 CHARGE syndrome	214800		3
CHD7, HH5	Hypogonadotropic hypogonadism 5 with or without anosmia	612370		3
CHD8, DUPLIN, KIAA1564, IDDAM	Intellectual developmental disorder with autism and macrocephaly	615032		3
CHDM	Chordoma, susceptibility to	215400	associated with duplication of the T gene	4
CHDS1	Coronary heart disease, susceptibility to	607339		2
CHDS2	Coronary heart disease, susceptibility to, 2	608316		2
CHDS3	Coronary heart disease, susceptibility to, 3	300464		2
CHDS4	Coronary heart disease, susceptibility to, 4	608318	highest LOD with D14S1426	2
CHDS5	Coronary heart disease, susceptibility to, 5	608901		2
CHDS8	Coronary heart disease, susceptibility to, 8	611139	strongest linkage with dbSNP rs1333049	2
CHDS9	Coronary heart disease, susceptibility to, 9	612030	max lod at D8S1106	2
CHDT3	Congenital heart defects, multiple types, 3	614954	max lod at D9S1690	2
CHEK2, RAD53, CHK2, CDS1, LFS2	 Breast cancer, susceptibility to	114480		3
CHEK2, RAD53, CHK2, CDS1, LFS2	Colorectal cancer, susceptibility to	114500		3
CHEK2, RAD53, CHK2, CDS1, LFS2	 Li-Fraumeni syndrome 2	609265		3
CHEK2, RAD53, CHK2, CDS1, LFS2	 Osteosarcoma, somatic	259500		3
CHEK2, RAD53, CHK2, CDS1, LFS2	 Prostate cancer, familial, susceptibility to	176807		3
CHI3L1, GP39, YKL40, ASRT7	Asthma-related traits, susceptibility to, 7	611960		3
CHI3L1, GP39, YKL40, ASRT7	 Schizophrenia, susceptibility to	181500		3
CHIC2, BTL	Leukemia, acute myeloid	601626		3
CHIT, CHITD	Chitotriosidase deficiency	614122		3
CHKA, CHK, NEDMIMS	Neurodevelopmental disorder with microcephaly, movement abnormalities, and seizures	620023		3
CHKB, CHKL, CKEKB, EKB, MDCMC	Muscular dystrophy, congenital, megaconial type	602541		3
CHMP1A, PCOLN3, PRSM1, PCH8	Pontocerebellar hypoplasia, type 8	614961		3
CHMP2B, DMT1, VPS2B, FTDALS7	Frontotemporal dementia and/or amyotrophic lateral sclerosis 7	600795		3
CHMP4B, SNF7, CTPP3, CTRCT31	Cataract 31, multiple types	605387		3
CHM, TCD	Choroideremia	303100		3
CHN1, CHN, ARHGAP2, RHOGAP2, DURS2	Duane retraction syndrome 2	604356		3
CHNG3, RTSH	Hypothyroidism, congenital, nongoitrous, 3	609893	max lod at D15S655	2
CHRDL1, VOPT, MGC1	Megalocornea 1, X-linked	309300		3
CHRM3, PBS, EGBRS	Prune belly syndrome	100100		3
CHRNA1, ACHRD, CMS1B, CMS1A	 Multiple pterygium syndrome, lethal type	253290		3
CHRNA1, ACHRD, CMS1B, CMS1A	 Myasthenic syndrome, congenital, 1A, slow-channel	601462		3
CHRNA1, ACHRD, CMS1B, CMS1A	Myasthenic syndrome, congenital, 1B, fast-channel	608930		3
CHRNA2	Epilepsy, nocturnal frontal lobe, type 4	610353		3
CHRNA3, LNCR2, PAOD2, BAIPRCK	 Bladder dysfunction, autonomic, with impaired pupillary reflex and secondary CAKUT	191800		3
CHRNA3, LNCR2, PAOD2, BAIPRCK	Lung cancer susceptibility 2	612052		3
CHRNA4, ENFL1	 Epilepsy, nocturnal frontal lobe, 1	600513		3
CHRNA4, ENFL1	Nicotine addiction, susceptibility to	188890		3
CHRNA5, LNCR2	 Lung cancer susceptibility 2	612052		3
CHRNA5, LNCR2	Nicotine dependence, susceptibility to	612052		3
CHRNB1, ACHRB, SCCMS, CMS2A, CMS2C	 Myasthenic syndrome, congenital, 2A, slow-channel	616313	mutation identified in 1 CMS2C family	3
CHRNB2, EFNL3	Epilepsy, nocturnal frontal lobe, 3	605375	linked to AMY in mouse	3
CHRND, ACHRD, SCCMS, CMS3A, CMS3B, CMS3C	 Multiple pterygium syndrome, lethal type	253290	mutation identified in 1 CMS3A patient and 1 CMS3C family	3
CHRND, ACHRD, SCCMS, CMS3A, CMS3B, CMS3C	 Myasthenic syndrome, congenital, 3A, slow-channel	616321	mutation identified in 1 CMS3A patient and 1 CMS3C family	3
CHRND, ACHRD, SCCMS, CMS3A, CMS3B, CMS3C	 Myasthenic syndrome, congenital, 3B, fast-channel	616322	mutation identified in 1 CMS3A patient and 1 CMS3C family	3
CHRNE, SCCMS, CMS4A, CMS4B, CMS4C	Myasthenic syndrome, congenital, 4A, slow-channel	605809		3
CHRNE, SCCMS, CMS4A, CMS4B, CMS4C	 Myasthenic syndrome, congenital, 4B, fast-channel	616324		3
CHRNE, SCCMS, CMS4A, CMS4B, CMS4C	 Myasthenic syndrome, congenital, 4C, associated with acetylcholine receptor deficiency	608931		3
CHRNG, ACHRG	 Escobar syndrome	265000	tightly linked to CHRND by RE	3
CHRNG, ACHRG	Multiple pterygium syndrome, lethal type	253290	tightly linked to CHRND by RE	3
CHST14, D4ST1, ATCS, EDSMC1	Ehlers-Danlos syndrome, musculocontractural type 1	601776		3
CHST3, C6ST, C6ST1, HSD	Spondyloepiphyseal dysplasia with congenital joint dislocations	143095		3
CHST6, MCDC1	Macular corneal dystrophy	217800		3
CHSY1, KIAA0990, TPBS	Temtamy preaxial brachydactyly syndrome	605282		3
CHUK, IKBKA, NFKBIKA, IKKA, IKK1, BPS2	 Cocoon syndrome	613630	mutation identified in 1 BPS2 patient and 1 family	3
CIB1, KIP	Epidermodysplasia verruciformis 3	618267		3
CIB2, KIP2	Deafness, autosomal recessive 48	609439		3
CIB2, KIP2	 Usher syndrome, type IJ	614869		3
CIC, KIAA0306, MRD45	Intellectual developmental disorder, autosomal dominant 45	617600		3
CIHL	Hearing loss, cisplatin-induced, susceptibility to	613290	associated with rs12201199	2
CIITA, MHC2TA, C2TA	 Bare lymphocyte syndrome, type II, complementation group A	209920		3
CIITA, MHC2TA, C2TA	Rheumatoid arthritis, susceptibility to	180300		3
CILD4	Ciliary dyskinesia, primary, 4	608646	between D15S1012 and D15S1048	2
CILD8	Ciliary dyskinesia, primary, 8	612274	max lod at D15S154	2
CILP	Lumbar disc disease, susceptibility to	603932		3
CIMT	Carotid intimal medial thickness	608447	161cM from pter; near SCARB1	2
CINN	Cinnamon odor, pleasantness of	611109	max lod at AFM295YES	2
CIROP, LMLN2, HTX12	Heterotaxy, visceral, 12, autosomal	619702		3
CISD2, WFS2, ZCD2, ERIS	Wolfram syndrome 2	604928		3
CISH, BACTS2	 Bacteremia, susceptibility to	614383		3
CISH, BACTS2	Malaria, susceptibility to	611162		3
CISH, BACTS2	 Tuberculosis, susceptibility to	607948		3
CITED2, MRG1, P35SRJ, VSD2, ASD8	Atrial septal defect 8	614433	?pseudogene on 1q22	3
CITED2, MRG1, P35SRJ, VSD2, ASD8	 Ventricular septal defect 2	614431	?pseudogene on 1q22	3
CIT, STK21, CRIK, MCPH17	Microcephaly 17, primary, autosomal recessive	617090		3
CKAP2L, RADMIS	Filippi syndrome	272440		3
CKBE	Creatine kinase, brain type, ectopic expression of	123270	linked to IGH, PI; ?same locus as CKBB	2
CLCC1, MCLC, RP32	Retinitis pigmentosa 32	609913		3
CLCF1, BSF3, CLC, CISS2	Cold-induced sweating syndrome 2	610313		3
CLCN1	 Myotonia congenita, dominant	160800		3
CLCN1	 Myotonia congenita, recessive	255700		3
CLCN1	Myotonia levior, recessive	118425		3
CLCN2, EGMA, ECA2, EGI11, EJM8, LKPAT, HALD2	 Epilepsy, idiopathic generalized, susceptibility to, 11	607628		3
CLCN2, EGMA, ECA2, EGI11, EJM8, LKPAT, HALD2	 Epilepsy, juvenile absence, susceptibility to, 2	607628		3
CLCN2, EGMA, ECA2, EGI11, EJM8, LKPAT, HALD2	 Epilepsy, juvenile myoclonic, susceptibility to, 8	607628		3
CLCN2, EGMA, ECA2, EGI11, EJM8, LKPAT, HALD2	 Hyperaldosteronism, familial, type II	605635		3
CLCN2, EGMA, ECA2, EGI11, EJM8, LKPAT, HALD2	Leukoencephalopathy with ataxia	615651		3
CLCN3, NEDHYBA, NEDSBA	 Neurodevelopmental disorder with hypotonia and brain abnormalities	619512	mutation identified in 1 NEDSBA family	3
CLCN3, NEDHYBA, NEDSBA	Neurodevelopmental disorder with seizures and brain abnormalities	619517	mutation identified in 1 NEDSBA family	3
CLCN4, MRX49, MRX15, MRXSRC	Raynaud-Claes syndrome	300114		3
CLCN5, CLCK2, NPHL2, DENT1, NPHL1	 Dent disease 1	300009		3
CLCN5, CLCK2, NPHL2, DENT1, NPHL1	 Hypophosphatemic rickets	300554		3
CLCN5, CLCK2, NPHL2, DENT1, NPHL1	 Nephrolithiasis, type I	310468		3
CLCN5, CLCK2, NPHL2, DENT1, NPHL1	Proteinuria, low molecular weight, with hypercalciuric nephrocalcinosis	308990		3
CLCN6, CONRIBA	Neurodegeneration, childhood-onset, hypotonia, respiratory insufficiency and brain imaging abnormalities	619173		3
CLCN7, CLC7, OPTA2, OPTB4, HOD	Hypopigmentation, organomegaly, and delayed myelination and development	618541		3
CLCN7, CLC7, OPTA2, OPTB4, HOD	 Osteopetrosis, autosomal dominant 2	166600		3
CLCN7, CLC7, OPTA2, OPTB4, HOD	 Osteopetrosis, autosomal recessive 4	611490		3
CLCNKA	Bartter syndrome, type 4b, digenic	613090	11kb from CLCNKB; simultaneous mutation in CLCNKA and CLCNKB	3
CLCNKB	Bartter syndrome, type 3	607364	unequal crossingover with CLCNKA	3
CLCNKB	 Bartter syndrome, type 4b, digenic	613090	unequal crossingover with CLCNKA	3
CLDN10, OSPL, CPETRL3, HELIX	HELIX syndrome	617671		3
CLDN11, OTM, OSP, HLD22	Leukodystrophy, hypomyelinating, 22	619328		3
CLDN14, DFNB29	Deafness, autosomal recessive 29	614035		3
CLDN16, PCLN1, HOMG3	Hypomagnesemia 3, renal	248250		3
CLDN19, HOMG5	Hypomagnesemia 5, renal, with ocular involvement	248190		3
CLDN1, SEMP1, ILVASC	Ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis	607626		3
CLEC1A, CLEC1	Aspergillosis, susceptibility to	614079		3
CLEC3B, TNA, MCDR4	Macular dystrophy, retinal, 4	619977		3
CLEC7A, CLECSF12, DECTIN1, CANDF4	 Aspergillosis, susceptibility to	614079	in natural killer gene complex	3
CLEC7A, CLECSF12, DECTIN1, CANDF4	Candidiasis, familial, 4, autosomal recessive	613108	in natural killer gene complex	3
CLLS1	Leukemia, chronic lymphocytic, susceptibility to, 1	609630		2
CLLS2, D13S25, DBM	Leukemia, chronic lymphocytic, susceptibility to, 2	109543	>530kb telomeric to RB1	2
CLLS3	Leukemia, chronic lymphocytic, susceptibility to, 3	612557	associated with SNP -6531 upstream of DAPK1 promoter	2
CLLS4	Leukemia, chronic lymphocytic susceptibility to, 4	612558	associated with rs872071	2
CLLS5	Leukemia, chronic lymphocytic susceptibility to, 5	612559	associated with rs735665	2
CLMP, ASAM, ACAM, CSBS	Congenital short bowel syndrome	615237		3
CLN3, BTS	Ceroid lipofuscinosis, neuronal, 3	204200		3
CLN5	Ceroid lipofuscinosis, neuronal, 5	256731		3
CLN6, CLN6A	 Ceroid lipofuscinosis, neuronal, 6A	601780		3
CLN6, CLN6A	Ceroid lipofuscinosis, neuronal, 6B 	204300		3
CLN8, EPMR	 Ceroid lipofuscinosis, neuronal, 8	600143		3
CLN8, EPMR	Ceroid lipofuscinosis, neuronal, 8, Northern epilepsy variant	610003		3
CLP1, HEAB, PCH10	Pontocerebellar hypoplasia, type 10	615803		3
CLPB, SKD3, MGCA7, MEGCANN, SCN9, MGCA7A	 3-methylglutaconic aciduria, type VIIA, autosomal dominant	619835		3
CLPB, SKD3, MGCA7, MEGCANN, SCN9, MGCA7A	 3-methylglutaconic aciduria, type VIIB, autosomal recessive	616271		3
CLPB, SKD3, MGCA7, MEGCANN, SCN9, MGCA7A	Neutropenia, severe congenital, 9, autosomal dominant	619813		3
CLPP, PRLTS3, DFNB81	Perrault syndrome 3	614129		3
CLQTL1, CLF	Cholesterol level QTL 1	604595		2
CLQTL2	Cholesterol level QTL 2	610760	max lod at D2S1360	2
CLRN1, USH3A, USH3, RP61	 Retinitis pigmentosa 61	614180	frequent in Finland; ?digenic interaction with MYO7A	3
CLRN1, USH3A, USH3, RP61	Usher syndrome, type 3A	276902	frequent in Finland; ?digenic interaction with MYO7A	3
CLTC, MRD56	Intellectual developmental disorder, autosomal dominant 56	617854	fusion gene with TFE3 in renal adenocarcinoma	3
CMD1B, CMPD1, FDC	Cardiomyopathy, dilated 1B	600884		2
CMD1F, CDCD3, LGMD1D	Cardiomyopathy, dilated, 1F and limb-girdle muscular dystrophy type 1D	602067		2
CMD1H	Cardiomyopathy, dilated, 1H	604288		2
CMD1K	Cardiomyopathy, dilated, 1K	605582		2
CMD1Q	Cardiomyopathy, dilated, 1Q	609915	between D7S2545 and D7S2554	2
CMH21	Cardiomyopathy, hypertrophic, 21	614676	max lod at D7S669	2
CMM4	Melanoma, cutaneous malignant, 4	608035	between D1S430 and D1S2664	2
CMM7	Melanoma, cutaneous malignant, 7	612263	between rs910873 and rs1885120	2
CMM, MLM, DNS	Melanoma, cutaneous malignant, 1	155600	some linkage studies negative; see 9p	2
CMT2H	Charcot-Marie-Tooth disease, axonal, type 2H	607731	between D8S1807 and D8S548	2
CMTS	Chronic mountain sickness, susceptibility to	616182		2
CMTX2	Charcot-Marie-Tooth neuropathy, X-linked recessive, 2	302801		2
CMTX3	Charcot-Marie-Tooth neuropathy, X-linked recessive, 3	302802	genomic rearrangement between 8q24.3 and Xq27.1	4
CNA1	Cornea plana 1, autosomal dominant	121400	between D12S82 and D12S351	2
CNBP, ZNF9, CNBP1, DM2, PROMM	Myotonic dystrophy 2	602668		3
CNC2	Carney complex, type II	605244		2
CND	Dermoids of cornea	304730		2
CNGA1, CNCG1, RP49	Retinitis pigmentosa 49	613756		3
CNGA3, CNG3, ACHM2	Achromatopsia 2	216900		3
CNGB1, CNCG3L, CNCG2, RP45	Retinitis pigmentosa 45	613767		3
CNGB3, ACHM3, ACHM1	Achromatopsia 3	262300		3
CNKSR2, CNK2, KIAA0902, MRXSHG	Intellectual developmental disorder, X-linked syndromic, Houge type	301008		3
CNNM2, ACDP2, HOMG6, HOMGSMR	Hypomagnesemia 6, renal	613882		3
CNNM2, ACDP2, HOMG6, HOMGSMR	 Hypomagnesemia, seizures, and impaired intellectual development 1	616418		3
CNNM4, ACDP4	Jalili syndrome	217080		3
CNOT1, NOT1, HPE12, VIBOS	 Holoprosencephaly 12, with or without pancreatic agenesis	618500		3
CNOT1, NOT1, HPE12, VIBOS	Vissers-Bodmer syndrome	619033		3
CNOT2, NOT2, IDNADFS	Intellectual developmental disorder with nasal speech, dysmorphic facies, and variable skeletal anomalies	618608		3
CNOT3, NOT3, IDDSADF	Intellectual developmental disorder with speech delay, autism, and dysmorphic facies	618672		3
CNPY3, TNRC5, PRAT4A, ERDA5, DEE60	Developmental and epileptic encephalopathy 60	617929		3
CNSN	Carnosinemia	212200		2
CNTNAP1, CASPR, P190, CHN3	 Hypomyelinating neuropathy, congenital, 3	618186		3
CNTNAP1, CASPR, P190, CHN3	Lethal congenital contracture syndrome 7	616286		3
CNTNAP2, CASPR2, NRXN4, AUTS15, PTHSL1	 Autism susceptibility 15	612100		3
CNTNAP2, CASPR2, NRXN4, AUTS15, PTHSL1	Pitt-Hopkins like syndrome 1	610042		3
COA6, C1orf31, MC4DN13	Mitochondrial complex IV deficiency, nuclear type 13	616501		3
COA7, RESA1, SELRC1, C1orf163, SCAN3	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 3	618387		3
COASY, NBIA6, PCH12	 Neurodegeneration with brain iron accumulation 6	615643		3
COASY, NBIA6, PCH12	Pontocerebellar hypoplasia, type 12	618266		3
COCH, DFNA9, DFNB110	Deafness, autosomal dominant 9	601369	mutation identified in 1 DFNB110 family	3
COCH, DFNA9, DFNB110	 Deafness, autosomal recessive 110	618094	mutation identified in 1 DFNB110 family	3
COD2	Cone dystrophy, progressive X-linked, 2	300085		2
COG1, LDLB, KIAA1381, CDG2G	Congenital disorder of glycosylation, type IIg	611209		3
COG4, COD1, CDG2J, SWILS	Congenital disorder of glycosylation, type IIj	613489		3
COG4, COD1, CDG2J, SWILS	 Saul-Wilson syndrome	618150		3
COG5, GOLTC1, GTC90, CDG2I	Congenital disorder of glycosylation, type IIi	613612		3
COG6, COD2, KIAA1134, CDG2L, SHNS	 Congenital disorder of glycosylation, type IIl	614576		3
COG6, COD2, KIAA1134, CDG2L, SHNS	Shaheen syndrome	615328		3
COG7, CDG2E	Congenital disorder of glycosylation, type IIe	608779		3
COG8, DOR1, CDG2H	Congenital disorder of glycosylation, type IIh	611182		3
COL10A1	Metaphyseal chondrodysplasia, Schmid type	156500		3
COL11A1, STL2, DFNA37	 Deafness, autosomal dominant 37	618533		3
COL11A1, STL2, DFNA37	Fibrochondrogenesis 1	228520		3
COL11A1, STL2, DFNA37	 Lumbar disc herniation, susceptibility to	603932		3
COL11A1, STL2, DFNA37	 Marshall syndrome	154780		3
COL11A1, STL2, DFNA37	 Stickler syndrome, type II	604841		3
COL11A2, DFNA13, DFNB53, FBCG2, OSMEDA, OSMEDB	Deafness, autosomal dominant 13	601868	45kb centromeric of HLA-DPB2; 3'--5'-cen	3
COL11A2, DFNA13, DFNB53, FBCG2, OSMEDA, OSMEDB	 Deafness, autosomal recessive 53	609706	45kb centromeric of HLA-DPB2; 3'--5'-cen	3
COL11A2, DFNA13, DFNB53, FBCG2, OSMEDA, OSMEDB	 Fibrochondrogenesis 2	614524	45kb centromeric of HLA-DPB2; 3'--5'-cen	3
COL11A2, DFNA13, DFNB53, FBCG2, OSMEDA, OSMEDB	 Otospondylomegaepiphyseal dysplasia, autosomal dominant	184840	45kb centromeric of HLA-DPB2; 3'--5'-cen	3
COL11A2, DFNA13, DFNB53, FBCG2, OSMEDA, OSMEDB	 Otospondylomegaepiphyseal dysplasia, autosomal recessive	215150	45kb centromeric of HLA-DPB2; 3'--5'-cen	3
COL12A1, UCMD2, BTHLM2, EDSMYP	Bethlem myopathy 2	616471	mutation identified in 1 UCMD2 family	3
COL12A1, UCMD2, BTHLM2, EDSMYP	 Ullrich congenital muscular dystrophy 2	616470	mutation identified in 1 UCMD2 family	3
COL13A1, CMS19	Myasthenic syndrome, congenital, 19	616720	~550kb proximal to P4HA	3
COL17A1, BPAG2, ERED, JEB4	 Epidermolysis bullosa, junctional 4, intermediate	619787		3
COL17A1, BPAG2, ERED, JEB4	Epithelial recurrent erosion dystrophy	122400		3
COL18A1, KNO1, GLCC	 Glaucoma, primary closed-angle	618880		3
COL18A1, KNO1, GLCC	Knobloch syndrome, type 1	267750		3
COL1A1, OI1, OI2, OI3, OI4, EDSARTH1, CAFYD	 Bone mineral density variation QTL, osteoporosis	166710	fused with PDGFB in DFPB	3
COL1A1, OI1, OI2, OI3, OI4, EDSARTH1, CAFYD	 Caffey disease	114000	fused with PDGFB in DFPB	3
COL1A1, OI1, OI2, OI3, OI4, EDSARTH1, CAFYD	 Combined osteogenesis imperfecta and Ehlers-Danlos syndrome 1	619115	fused with PDGFB in DFPB	3
COL1A1, OI1, OI2, OI3, OI4, EDSARTH1, CAFYD	 Ehlers-Danlos syndrome, arthrochalasia type, 1	130060	fused with PDGFB in DFPB	3
COL1A1, OI1, OI2, OI3, OI4, EDSARTH1, CAFYD	 Osteogenesis imperfecta, type I	166200	fused with PDGFB in DFPB	3
COL1A1, OI1, OI2, OI3, OI4, EDSARTH1, CAFYD	Osteogenesis imperfecta, type II	166210	fused with PDGFB in DFPB	3
COL1A1, OI1, OI2, OI3, OI4, EDSARTH1, CAFYD	 Osteogenesis imperfecta, type III	259420	fused with PDGFB in DFPB	3
COL1A1, OI1, OI2, OI3, OI4, EDSARTH1, CAFYD	 Osteogenesis imperfecta, type IV	166220	fused with PDGFB in DFPB	3
COL1A2, EDSCV, EDSARTH2	 Combined osteogenesis imperfecta and Ehlers-Danlos syndrome 2	619120	~17cM from CF	3
COL1A2, EDSCV, EDSARTH2	 Ehlers-Danlos syndrome, arthrochalasia type, 2	617821	~17cM from CF	3
COL1A2, EDSCV, EDSARTH2	 Ehlers-Danlos syndrome, cardiac valvular type	225320	~17cM from CF	3
COL1A2, EDSCV, EDSARTH2	 Osteogenesis imperfecta, type II	166210	~17cM from CF	3
COL1A2, EDSCV, EDSARTH2	Osteogenesis imperfecta, type III	259420	~17cM from CF	3
COL1A2, EDSCV, EDSARTH2	 Osteogenesis imperfecta, type IV	166220	~17cM from CF	3
COL1A2, EDSCV, EDSARTH2	 Osteoporosis, postmenopausal	166710	~17cM from CF	3
COL25A1, CLAC, CFEOM5	Fibrosis of extraocular muscles, congenital, 5	616219		3
COL27A1, KIAA1870, STLS	Steel syndrome	615155		3
COL2A1	 Achondrogenesis, type II or hypochondrogenesis	200610	mutation identified in 1 VPED family	3
COL2A1	 Avascular necrosis of the femoral head	608805	mutation identified in 1 VPED family	3
COL2A1	 Czech dysplasia	609162	mutation identified in 1 VPED family	3
COL2A1	 Epiphyseal dysplasia, multiple, with myopia and deafness	132450	mutation identified in 1 VPED family	3
COL2A1	 Kniest dysplasia	156550	mutation identified in 1 VPED family	3
COL2A1	 Legg-Calve-Perthes disease	150600	mutation identified in 1 VPED family	3
COL2A1	 Osteoarthritis with mild chondrodysplasia	604864	mutation identified in 1 VPED family	3
COL2A1	 Platyspondylic skeletal dysplasia, Torrance type	151210	mutation identified in 1 VPED family	3
COL2A1	 SED congenita	183900	mutation identified in 1 VPED family	3
COL2A1	 SMED Strudwick type	184250	mutation identified in 1 VPED family	3
COL2A1	 Spondyloepiphyseal dysplasia, Stanescu type	616583	mutation identified in 1 VPED family	3
COL2A1	 Spondyloperipheral dysplasia	271700	mutation identified in 1 VPED family	3
COL2A1	 Stickler syndrome, type I	108300	mutation identified in 1 VPED family	3
COL2A1	 Stickler syndrome, type I, nonsyndromic ocular	609508	mutation identified in 1 VPED family	3
COL3A1, EDSVASC, PMGEDSV	Ehlers-Danlos syndrome, vascular type	130050	in same 35kb segment as COL5A2	3
COL3A1, EDSVASC, PMGEDSV	 Polymicrogyria with or without vascular-type EDS	618343	in same 35kb segment as COL5A2	3
COL4A1, BSVD1, HANAC, ICH, BSVD, RATOR, PADMAL	 Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps	611773	mutation identified in 1 RATOR family	3
COL4A1, BSVD1, HANAC, ICH, BSVD, RATOR, PADMAL	 Brain small vessel disease with or without ocular anomalies	175780	mutation identified in 1 RATOR family	3
COL4A1, BSVD1, HANAC, ICH, BSVD, RATOR, PADMAL	 Hemorrhage, intracerebral, susceptibility to	614519	mutation identified in 1 RATOR family	3
COL4A1, BSVD1, HANAC, ICH, BSVD, RATOR, PADMAL	 Microangiopathy and leukoencephalopathy, pontine, autosomal dominant	618564	mutation identified in 1 RATOR family	3
COL4A2, BSVD2, ICH	Brain small vessel disease 2	614483		3
COL4A2, BSVD2, ICH	 Hemorrhage, intracerebral, susceptibility to	614519		3
COL4A3, ATS2, ATS3	 Alport syndrome 2, autosomal recessive	203780	noncollagenous domain = Goodpasture antigen	3
COL4A3, ATS2, ATS3	 Alport syndrome 3, autosomal dominant	104200	noncollagenous domain = Goodpasture antigen	3
COL4A3, ATS2, ATS3	Hematuria, benign familial	141200	noncollagenous domain = Goodpasture antigen	3
COL4A3BP, GPBP, CERT, MRD34	Intellectual developmental disorder, autosomal dominant 34	616351		3
COL4A4, ATS2, BFH	 Alport syndrome 2, autosomal recessive	203780	head-to-head with COL4A4 in same YAC	3
COL4A4, ATS2, BFH	Hematuria, familial benign	141200	head-to-head with COL4A4 in same YAC	3
COL4A5, ATS1	Alport syndrome 1, X-linked	301050	diffuse leiomyomatosis with Alport syndrome = contiguous gene syndrome with COL4A6	3
COL5A1, EDSCL1, FMDMF	Ehlers-Danlos syndrome, classic type, 1	130000		3
COL5A1, EDSCL1, FMDMF	 Fibromuscular dysplasia, multifocal	619329		3
COL5A2, EDSCL2	Ehlers-Danlos syndrome, classic type, 2	130010	very close to COL3A1	3
COL6A1, BTHLM1, UCHMD1	Bethlem myopathy 1	158810		3
COL6A1, BTHLM1, UCHMD1	 Ullrich congenital muscular dystrophy 1	254090		3
COL6A2, BTHLM1, UCMD1	Bethlem myopathy 1	158810	mutation identified in 1 MYSCL family	3
COL6A2, BTHLM1, UCMD1	 Myosclerosis, congenital	255600	mutation identified in 1 MYSCL family	3
COL6A2, BTHLM1, UCMD1	 Ullrich congenital muscular dystrophy 1	254090	mutation identified in 1 MYSCL family	3
COL6A3, DYT27, BTHLM1, UCMD1	 Bethlem myopathy 1	158810	close to CRBP1	3
COL6A3, DYT27, BTHLM1, UCMD1	 Dystonia 27	616411	close to CRBP1	3
COL6A3, DYT27, BTHLM1, UCMD1	Ullrich congenital muscular dystrophy 1	254090	close to CRBP1	3
COL7A1, NDNC8	 EBD, Bart type	132000		3
COL7A1, NDNC8	 EBD inversa	226600		3
COL7A1, NDNC8	EBD, localisata variant	120120		3
COL7A1, NDNC8	 Epidermolysis bullosa dystrophica, AD	131750		3
COL7A1, NDNC8	 Epidermolysis bullosa dystrophica, AR	226600		3
COL7A1, NDNC8	 Epidermolysis bullosa, pretibial	131850		3
COL7A1, NDNC8	 Epidermolysis bullosa pruriginosa	604129		3
COL7A1, NDNC8	 Toenail dystrophy, isolated	607523		3
COL7A1, NDNC8	 Transient bullous of the newborn	131705		3
COL8A2, FECD1, PPCD2	 Corneal dystrophy, Fuchs endothelial, 1	136800		3
COL8A2, FECD1, PPCD2	Corneal dystrophy, posterior polymorphous 2	609140		3
COL9A1, EDM6, STL4	 Epiphyseal dysplasia, multiple, 6	614135	mutation identified in 1 EDM6 family	3
COL9A1, EDM6, STL4	Stickler syndrome, type IV	614134	mutation identified in 1 EDM6 family	3
COL9A2, EDM2, STL5	Epiphyseal dysplasia, multiple, 2	600204	mutation identified in1 STL5 family	3
COL9A2, EDM2, STL5	 Stickler syndrome, type V	614284	mutation identified in1 STL5 family	3
COL9A3, EDM3, IDD, STL6	 Epiphyseal dysplasia, multiple, 3, with or without myopathy	600969		3
COL9A3, EDM3, IDD, STL6	Intervertebral disc disease, susceptibility to	603932		3
COL9A3, EDM3, IDD, STL6	 Stickler syndrome, type VI	620022		3
COLEC10, CLL1, 3MC3	3MC syndrome 3	248340		3
COLEC11, CLK1, 3MC2	3MC syndrome 2	265050		3
COLGALT1, GLT25D1, BSVD3	Brain small vessel disease 3	618360		3
COLQ, EAD, CMS5	Myasthenic syndrome, congenital, 5	603034		3
COMA	Oculomotor apraxia, congenital, Cogan-type	257550	independent gene or feature of nephronophthisis	2
COMP, EDM1, MED, PSACH, CTS2	 Carpal tunnel syndrome 2	619161		3
COMP, EDM1, MED, PSACH, CTS2	 Epiphyseal dysplasia, multiple, 1	132400		3
COMP, EDM1, MED, PSACH, CTS2	Pseudoachondroplasia	177170		3
COMT	 Panic disorder, susceptibility to	167870		3
COMT	Schizophrenia, susceptibility to	181500		3
COPA, AILJK	Autoimmune interstitial lung, joint, and kidney disease	616414		3
COPB1, COPB, BARMACS	Baralle-Macken syndrome	619255		3
COPB2, MCPH19, OPDD	 Microcephaly 19, primary, autosomal recessive	617800	mutation identified in 1 MCPH19 family	3
COPB2, MCPH19, OPDD	Osteoporosis, childhood- or juvenile-onset, with developmental delay	619884	mutation identified in 1 MCPH19 family	3
COPD	Pulmonary disease, chronic obstructive, severe early-onset	606963	?SERPINE2	2
COQ2, COQ10D1, MSA1	 Coenzyme Q10 deficiency, primary, 1	607426		3
COQ2, COQ10D1, MSA1	Multiple system atrophy, susceptibility to	146500		3
COQ4, COQ10D7	Coenzyme Q10 deficiency, primary, 7	616276		3
COQ6, CGI10, COQ10D6	Coenzyme Q10 deficiency, primary, 6	614650		3
COQ8B, ADCK4, NPHS9	Nephrotic syndrome, type 9	615573		3
COQ9, C16orf49, COQ10D5	Coenzyme Q10 deficiency, primary, 5	614654		3
CORD17	Cone-rod dystrophy 17	615163	between D10S1757 and D10S1782	2
CORD1, CRD1	Cone-rod retinal dystrophy-1	600624		2
CORD8	Cone-rod dystrophy 8	605549		2
CORIN, CRN, TMPRSS10, ATC2, PEE5	Preeclampsia/eclampsia 5	614595		3
CORO1A, TACO, CLIPINA, IMD8	Immunodeficiency 8	615401		3
COX10, MC4DN3	Mitochondrial complex IV deficiency, nuclear type 3	619046		3
COX15, MC4DN6	Mitochondrial complex IV deficiency, nuclear type 6	615119		3
COX16, MC4DN22	Mitochondrial complex IV deficiency, nuclear type 22	619355		3
COX20, FAM36A, MC4DN11	Mitochondrial complex IV deficiency, nuclear type 11	619054		3
COX4I1, COX4, MC4DN16	Mitochondrial complex IV deficiency, nuclear type 16	619060		3
COX4I2	Exocrine pancreatic insufficiency, dyserythropoietic anemia, and calvarial hyperostosis	612714		3
COX6A1, CMTRID	Charcot-Marie-Tooth disease, recessive intermediate D	616039	pseudogenes on chr.7 and chr.6	3
COX6A2, MC4DN18	Mitochondrial complex IV deficiency, nuclear type 18	619062		3
COX6B1, MC4DN7	Mitochondrial complex IV deficiency, nuclear type 7	619051		3
COX7B, LSDMCA2	Linear skin defects with multiple congenital anomalies 2	300887		3
CPA6, CPAH, ETL5, FEB11	 Epilepsy, familial temporal lobe, 5	614417		3
CPA6, CPAH, ETL5, FEB11	Febrile seizures, familial, 11	614418		3
CPAMD8, KIAA1283, ASGD8	Anterior segment dysgenesis 8	617319		3
CP	Cerebellar ataxia	604290	~15cM from TF	3
CPE, BDVS	BDV syndrome	619326		3
CP	 Hemosiderosis, systemic, due to aceruloplasminemia	604290	~15cM from TF	3
CP	 Hypoceruloplasminemia, hereditary	604290	~15cM from TF	3
CPLANE1, C5orf42, JBTS17, OFD6	 Joubert syndrome 17	614615		3
CPLANE1, C5orf42, JBTS17, OFD6	Orofaciodigital syndrome VI	277170		3
CPLX1, CPX1, DEE63	Developmental and epileptic encephalopathy 63	617976		3
CPN1, SCPN, CPN	Carboxypeptidase N deficiency	212070		3
CPOX, HARPO	Coproporphyria	121300		3
CPOX, HARPO	 Harderoporphyria	618892		3
CPROTQ	C-reactive protein QTL	611920	max lod at D10S1239	2
CPS1, PHN	Carbamoylphosphate synthetase I deficiency	237300	urea cycle enzyme	3
CPS1, PHN	 Pulmonary hypertension, neonatal, susceptibility to	615371	urea cycle enzyme	3
CPSF1, CPSF160, MYP27	Myopia 27	618827		3
CPSF3, CPSF73, NEDMHSN	Neurodevelopmental disorder with microcephaly, hypotonia, nystagmus, and seizures	619876		3
CPT1A	CPT deficiency, hepatic, type IA	255120		3
CPT2, IIAE4	 CPT II deficiency, infantile	600649	formerly at 1p13	3
CPT2, IIAE4	 CPT II deficiency, lethal neonatal	608836	formerly at 1p13	3
CPT2, IIAE4	 CPT II deficiency, myopathic, stress-induced	255110	formerly at 1p13	3
CPT2, IIAE4	Encephalopathy, acute, infection-induced, 4, susceptibility to	614212	formerly at 1p13	3
CR1, C3BR	Blood group, Knops system	607486		3
CR1, C3BR	 Malaria, severe, resistance to	611162		3
CR2, C3DR, SLEB9, CVID7	 Immunodeficiency, common variable, 7	614699	mutation identified in CVID7 patient	3
CR2, C3DR, SLEB9, CVID7	Systemic lupus erythematosus, susceptibility to, 9	610927	mutation identified in CVID7 patient	3
CRADD, RAIDD, MRT34	Intellectual developmental disorder, autosomal recessive 34, with variant lissencephaly	614499		3
CRB1, RP12, LCA8	Leber congenital amaurosis 8	613835		3
CRB1, RP12, LCA8	 Pigmented paravenous chorioretinal atrophy	172870		3
CRB1, RP12, LCA8	 Retinitis pigmentosa-12	600105		3
CRB2, FSGS9, VMCKD	Focal segmental glomerulosclerosis 9	616220		3
CRB2, FSGS9, VMCKD	 Ventriculomegaly with cystic kidney disease	219730		3
CRBN, MRT2	Intellectual developmental disorder, autosomal recessive 2	607417	between D3S3525 and D3S1560	3
CRCL	Creatinine clearance QTL	607135	in African Americans	2
CRCS11	Colorectal cancer, susceptibility to, 11	612592	associated with rs961253	2
CRCS2	Colorectal cancer, susceptibility to, 2	611469	associated with rs7014346	2
CRCS5	Colorectal cancer, susceptibility to, 5	612230	associated with rs10795668	2
CRCS6	Colorectal cancer, susceptibility to, 6	612231	associated with rs16892766	2
CRCS7	Colorectal cancer, susceptibility to, 7	612232	associated with rs3802842	2
CRCS8	Colorectal cancer, susceptibility to, 8	612589	associated with rs4444235	2
CRCS9	Colorectal cancer, susceptibility to, 9	612590	associated with rs9929218	2
CREB1	Histiocytoma, angiomatoid fibrous, somatic	612160	fusion gene with EWSR1	3
CREB3L1, OASIS, OI16	Osteogenesis imperfecta, type XVI	616229		3
CREB3L3, CREBH, HYTG2	Hypertriglyceridemia 2	619324		3
CREBBP, CBP, RSTS1, MKHK1	Menke-Hennekam syndrome 1	618332	fusion partner with MORF in AML; fusion partner with MLL in therapy-related acute leukemia; fusion partner with MOZ in AML	3
CREBBP, CBP, RSTS1, MKHK1	 Rubinstein-Taybi syndrome 1	180849	fusion partner with MORF in AML; fusion partner with MLL in therapy-related acute leukemia; fusion partner with MOZ in AML	3
CRELD1, AVSD2	Atrioventricular septal defect, partial, with heterotaxy syndrome	606217		3
CRELD1, AVSD2	 Atrioventricular septal defect, susceptibility to, 2	606217		3
CRIPT, SSMDF	Short stature with microcephaly and distinctive facies	615789		3
CRLF1, CISS1	Cold-induced sweating syndrome 1	272430		3
CRPPA, ISPD, MDDGA7, MDDGC7, LGMDR20	 Muscular dystrophy-dystroglycanopathy , type A, 7	614643		3
CRPPA, ISPD, MDDGA7, MDDGC7, LGMDR20	Muscular dystrophy-dystroglycanopathy , type C, 7	616052		3
CRSA, CRS3	Craniosynostosis, Adelaide type	600593		2
CRTAP, CASP, OI7	Osteogenesis imperfecta, type VII	610682		3
CRTC1, MECT1, KIAA0616, FLJ14027	Mucoepidermoid salivary gland carcinoma	607536	t(11;19)	3
CRX, CORD2, CRD, LCA7	 Cone-rod retinal dystrophy-2	120970		3
CRX, CORD2, CRD, LCA7	Leber congenital amaurosis 7	613829		3
CRY1, PHLL1, DSPD	Delayed sleep phase disorder, susceptibility to	614163		3
CRYAA, CRYA1, CTRCT9	Cataract 9, multiple types	604219		3
CRYAB, CRYA2, CTPP2, CMD1II, CTRCT16, MFM2	 Cardiomyopathy, dilated, 1II	615184		3
CRYAB, CRYA2, CTPP2, CMD1II, CTRCT16, MFM2	 Cataract 16, multiple types	613763		3
CRYAB, CRYA2, CTPP2, CMD1II, CTRCT16, MFM2	 Myopathy, myofibrillar, 2	608810		3
CRYAB, CRYA2, CTPP2, CMD1II, CTRCT16, MFM2	Myopathy, myofibrillar, fatal infantile hypertonic, alpha-B crystallin-related	613869		3
CRYBA1, CRYB1, CTRCT10	Cataract 10, multiple types	600881	centromeric to NF1	3
CRYBA4, CTRCT23	Cataract 23	610425		3
CRYBB1, CATCN3, CTRCT17	Cataract 17, multiple types	611544		3
CRYBB2, CRYB2, CTRCT3, CCA2	Cataract 3, multiple types	601547	2nd CRYB2 gene in same region	3
CRYBB3, CRYB3, CATCN2, CTRCT22	Cataract 22	609741		3
CRYGB, CRYG2, CTRCT39	Cataract 39, multiple types, autosomal dominant	615188		3
CRYGC, CRYG3, CTRCT2, CCL	Cataract 2, multiple types	604307		3
CRYGD, CRYG4, CTRCT4, CACA, CCA3, PCC	Cataract 4, multiple types	115700		3
CRYGS, CRYG8, CTRCT20	Cataract 20, multiple types	116100		3
CRYM, DFNA40	Deafness, autosomal dominant 40	616357		3
CSF1R, FMS, HDLS1, BANDDOS	Brain abnormalities, neurodegeneration, and dysosteosclerosis	618476	FMS2 is 5' end	3
CSF1R, FMS, HDLS1, BANDDOS	 Leukoencephalopathy, diffuse hereditary, with spheroids 1	221820	FMS2 is 5' end	3
CSF2RA, SMDP4	Surfactant metabolism dysfunction, pulmonary, 4	300770	order in PAR: pter-CSF2RA-IL3RA-ANT3-ASMT-MIC2-cen	3
CSF2RB, SMDP5	Surfactant metabolism dysfunction, pulmonary, 5	614370		3
CSF3R, GCSFR, SCN7	Neutropenia, severe congenital, 7, autosomal recessive	617014	mutation identified in 1 HNTP family	3
CSF3R, GCSFR, SCN7	 Neutrophilia, hereditary	162830	mutation identified in 1 HNTP family	3
CSGALNACT1, SDJLABA	Skeletal dysplasia, mild, with joint laxity and advanced bone age	618870		3
CSH1, CSA, PL	Placental lactogen deficiency	150200		1
CSMF	Chondrosarcoma, extraskeletal myxoid	612237	t(9;17)(q22;q11); t(9;22)(q22;q11-q12)	3
CSNK1D, ASPS, FASPS2	Advanced sleep-phase syndrome, familial, 2	615224		3
CSNK2A1, CK2A1, OCNDS	Okur-Chung neurodevelopmental syndrome	617062	pseudogene on 11p15	3
CSNK2B, POBINDS	Poirier-Bienvenu neurodevelopmental syndrome	618732		3
CSPP1, CSPP, JBTS21	Joubert syndrome 21	615636		3
CSRP3, CRP3, CLP, CMD1M, CMH12	 Cardiomyopathy, hypertrophic, 12	612124	mutation identified in 1 CMD1M family	3
CST3, ARMD11	 Cerebral amyloid angiopathy	105150	proximal to 20p11.2	3
CST3, ARMD11	Macular degeneration, age-related, 11	611953	proximal to 20p11.2	3
CSTA, STFA, STF1, AREI, PSS4	Peeling skin syndrome 4	607936		3
CSTB, STFB, EPM1, PME, EPM1A, ULD	Epilepsy, progressive myoclonic 1A 	254800		3
CTBP1, HADDTS	Hypotonia, ataxia, developmental delay, and tooth enamel defect syndrome	617915		3
CTC1, CRMCC, C17orf68, AAF132	Cerebroretinal microangiopathy with calcifications and cysts	612199		3
CTCF, MRD21	Intellectual developmental disorder, autosomal dominant 21	615502		3
CTDP1, FCP1, CCFDN	Congenital cataracts, facial dysmorphism, and neuropathy	604168		3
CTEPH1	Pulmonary hypertension, chronic thromboembolic, without deep vein thrombosis, susceptibility to	612862	associated with DPB1*0202	2
CTH	Cystathioninuria	219500	previously assigned to chr.16	3
CTHRC1	Barrett esophagus/esophageal adenocarcinoma	614266		3
CTLA4, IDDM12, CELIAC3, ALPS5	 Celiac disease, susceptibility to, 3	609755		3
CTLA4, IDDM12, CELIAC3, ALPS5	 Diabetes mellitus, insulin-dependent, 12	601388		3
CTLA4, IDDM12, CELIAC3, ALPS5	 Hashimoto thyroiditis	140300		3
CTLA4, IDDM12, CELIAC3, ALPS5	Immune dysregulation with autoimmunity, immunodeficiency, and lymphoproliferation	616100		3
CTLA4, IDDM12, CELIAC3, ALPS5	 Systemic lupus erythematosus, susceptibility to	152700		3
CTNNA1, MDPT2	Macular dystrophy, patterned, 2	608970		3
CTNNA2, CAPR, CTNR, CDCBM9	Cortical dysplasia, complex, with other brain malformations 9	618174		3
CTNNA3, ARVD13	Arrhythmogenic right ventricular dysplasia, familial, 13	615616		3
CTNNB1, NEDSDV, EVR7	 Colorectal cancer, somatic	114500		3
CTNNB1, NEDSDV, EVR7	Exudative vitreoretinopathy 7	617572		3
CTNNB1, NEDSDV, EVR7	 Hepatocellular carcinoma, somatic	114550		3
CTNNB1, NEDSDV, EVR7	 Medulloblastoma, somatic	155255		3
CTNNB1, NEDSDV, EVR7	 Neurodevelopmental disorder with spastic diplegia and visual defects	615075		3
CTNNB1, NEDSDV, EVR7	 Ovarian cancer, somatic	167000		3
CTNNB1, NEDSDV, EVR7	 Pilomatricoma, somatic	132600		3
CTNND1, CTNND, BCDS2	Blepharocheilodontic syndrome 2	617681		3
CTNS	 Cystinosis, atypical nephropathic	219800	?3 allelic forms	3
CTNS	 Cystinosis, late-onset juvenile or adolescent nephropathic	219900	?3 allelic forms	3
CTNS	Cystinosis, nephropathic	219800	?3 allelic forms	3
CTNS	 Cystinosis, ocular nonnephropathic	219750	?3 allelic forms	3
CTPS1, CTPS, IMD24	Immunodeficiency 24	615897		3
CTRC, CLCR	Pancreatitis, chronic, susceptibility to	167800		3
CTRCT24, CTAA2	Cataract 24, anterior polar	601202		2
CTRCT25, CCSSO	Cataract 25	605728		2
CTRCT26, CAAR	Cataract 26, multiple types	605749		2
CTRCT27, CCNP	Cataract 27, nuclear progressive	607304	near D2S2333	2
CTRCT28, ARCC1	Cataract 28, age-related cortical, susceptibility to	609026		2
CTRCT29	Cataract 29, coralliform	115800	between D2S297 and D2S2269	2
CTRCT32, CTAA1, CAP, CTPP5	Cataract 32, multiple types	115650	between D14S980 and D14S1069	2
CTRCT35, CATCN1	Cataract 35, congenital nuclear	609376	max lod at D19S416	2
CTRCT37, CCA5	Cataract 37, autosomal dominant	614422	between D12S1718 and D12S1723	2
CTRCT7, CCA1	Cataract 7	115660		2
CTRCT8, CCV	Cataract 8, multiple types	115665	linked to Rh in Scottish family	2
CTSA, PPGB, GSL, NGBE, GLB2	Galactosialidosis	256540		3
CTSB, CPSB, RECEUP	Keratolytic winter erythema	148370	KWE due to duplication upstream of CTSB that disrupts a cis-acting regulatory element	4
CTSC, CPPI, PALS, PLS, HMS, PDON1, JPD	 Haim-Munk syndrome	245010		3
CTSC, CPPI, PALS, PLS, HMS, PDON1, JPD	 Papillon-Lefevre syndrome	245000		3
CTSC, CPPI, PALS, PLS, HMS, PDON1, JPD	Periodontitis 1, juvenile	170650		3
CTSD, CPSD, CLN10	Ceroid lipofuscinosis, neuronal, 10	610127		3
CTSF, CLN13	Ceroid lipofuscinosis, neuronal, 13 	615362		3
CTSK	Pycnodysostosis	265800		3
CTU2, C16orf84, NCS2, MFRG	Microcephaly, facial dysmorphism, renal agenesis, and ambiguous genitalia syndrome	618142		3
CUBN, IFCR, IGS1	 Imerslund-Grasbeck syndrome 1	261100		3
CUBN, IFCR, IGS1	Proteinuria, chronic benign	618884		3
CUL3, PHA2E, NEDAUS	Neurodevelopmental disorder with or without autism or seizures	619239		3
CUL3, PHA2E, NEDAUS	 Pseudohypoaldosteronism, type IIE	614496		3
CUL4B, MRXSC, MRXHF2, SFM2, MRXS15	Intellectual developmental disorder, X-linked syndromic, Cabezas type	300354		3
CUL7, 3M1	3-M syndrome 1	273750		3
CUX1, CUTL1, CDP, GDDI	Global developmental delay with or without impaired intellectual development	618330		3
CUX2, CDP2, CUTL2, DEE67	Developmental and epileptic encephalopathy 67	618141		3
CVMRF	Cubitus valgus with mental retardation and unusual facies	300471		2
CWC27, SDCCAG10, RPSKA	Retinitis pigmentosa with or without skeletal anomalies	250410		3
CWF19L1, C19L1, SCAR17	Spinocerebellar ataxia, autosomal recessive 17	616127		3
CX3CR1, GPR13, V28	 Coronary artery disease, resistance to	607339		3
CX3CR1, GPR13, V28	 Macular degeneration, age-related, 12	613784		3
CX3CR1, GPR13, V28	Rapid progression to AIDS from HIV1 infection	609423		3
CXCL12, SDF1	AIDS, resistance to	609423		3
CXCR1, IL8RA	AIDS, slow progression to	609423		3
CXCR4, D2S201E, NPY3R, WHIMS1	 Myelokathexis, isolated	193670		3
CXCR4, D2S201E, NPY3R, WHIMS1	WHIM syndrome 1	193670		3
CXDUPq26.3, DUPXq26.3, XLAG	Chromosome Xq26.3 duplication syndrome	300942		4
CYB561, ORTHYP2	Orthostatic hypotension 2	618182		3
CYB5A, MCB5, METAG	Methemoglobinemia and ambiguous genitalia	250790	pseudogenes on X, 14q, 20p; mutation identified in 1 MET5 patient	3
CYB5R3, DIA1, B5R	Methemoglobinemia, type I	250800		3
CYB5R3, DIA1, B5R	 Methemoglobinemia, type II	250800		3
CYBA, CGD4	Chronic granulomatous disease 4, autosomal recessive	233690		3
CYBB, CGDX, AMCBX2, IMD34	 Chronic granulomatous disease, X-linked	306400	proximal to DMD	3
CYBB, CGDX, AMCBX2, IMD34	Immunodeficiency 34, mycobacteriosis, X-linked	300645	proximal to DMD	3
CYBC1, EROS, C17orf62, CGD5	Chronic granulomatous disease 5, autosomal recessive	618935		3
CYC1, MC3DN6	Mitochondrial complex III deficiency, nuclear type 6	615453		3
CYCS, CYC, THC4	Thrombocytopenia 4	612004		3
CYFIP2, DEE65	Developmental and epileptic encephalopathy 65	618008		3
CYLD, CDMT, EAC, MFT1, KIAA0849, BRSS, FTDALS8	Brooke-Spiegler syndrome	605041	mutation identified in 1 FTDALS8 family	3
CYLD, CDMT, EAC, MFT1, KIAA0849, BRSS, FTDALS8	 Cylindromatosis, familial	132700	mutation identified in 1 FTDALS8 family	3
CYLD, CDMT, EAC, MFT1, KIAA0849, BRSS, FTDALS8	 Frontotemporal dementia and/or amyotrophic lateral sclerosis 8	619132	mutation identified in 1 FTDALS8 family	3
CYLD, CDMT, EAC, MFT1, KIAA0849, BRSS, FTDALS8	 Trichoepithelioma, multiple familial, 1	601606	mutation identified in 1 FTDALS8 family	3
CYP11A1, P450SCC	Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete	613743		3
CYP11B1, P450C11, FHI	 Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency	202010	chimeric CYP11B1/CYP11B2 gene = anti-Lepore-like	3
CYP11B1, P450C11, FHI	Aldosteronism, glucocorticoid-remediable	103900	chimeric CYP11B1/CYP11B2 gene = anti-Lepore-like	3
CYP11B2	 Aldosterone to renin ratio raised	124080		3
CYP11B2	Hypoaldosteronism, congenital, due to CMO I deficiency	203400		3
CYP11B2	 Hypoaldosteronism, congenital, due to CMO II deficiency	610600		3
CYP11B2	 Low renin hypertension, susceptibility to	124080		3
CYP17A1, CYP17, P450C17	17,20-lyase deficiency, isolated	202110	at least 2 genes; distal to GOT1	3
CYP17A1, CYP17, P450C17	 17-alpha-hydroxylase/17,20-lyase deficiency	202110	at least 2 genes; distal to GOT1	3
CYP19A1, CYP19, ARO	Aromatase deficiency	613546	close to CYP11 in mouse	3
CYP19A1, CYP19, ARO	 Aromatase excess syndrome	139300	close to CYP11 in mouse	3
CYP1B1, GLC3A, ASGD6	 Anterior segment dysgenesis 6, multiple subtypes	617315		3
CYP1B1, GLC3A, ASGD6	Glaucoma 3A, primary open angle, congenital, juvenile, or adult onset	231300		3
CYP21A2, CYP21, CA21H	 Adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency	201910	linked to C2, C4, BF; 2 loci, A and B; only B active; pseudogene CYP21P contiguous on 6p	3
CYP21A2, CYP21, CA21H	Hyperandrogenism, nonclassic type, due to 21-hydroxylase deficiency	201910	linked to C2, C4, BF; 2 loci, A and B; only B active; pseudogene CYP21P contiguous on 6p	3
CYP24A1, CYP24, HCINF1	Hypercalcemia, infantile, 1	143880		3
CYP26B1, CYP26A2, P450RAI2, RHFCA	Craniosynostosis with radiohumeral fusions and other skeletal and craniofacial anomalies	614416		3
CYP26C1, FFDD4	Focal facial dermal dysplasia 4	614974		3
CYP27A1, CYP27, CTX	Cerebrotendinous xanthomatosis	213700		3
CYP27B1, VDD1, PDDR	Vitamin D-dependent rickets, type I	264700		3
CYP2A6, CYP2A3, CYP2A, P450C2A	 Coumarin resistance	122700		3
CYP2A6, CYP2A3, CYP2A, P450C2A	Lung cancer, resistance to	211980		3
CYP2A6, CYP2A3, CYP2A, P450C2A	 Nicotine addiction, protection from	188890		3
CYP2B6, CYP2B, EFVM	Efavirenz central nervous system toxicity, susceptibility to	614546	same NotI fragment as CYP2A	3
CYP2B6, CYP2B, EFVM	 Efavirenz, poor metabolism of	614546	same NotI fragment as CYP2A	3
CYP2C8, CYP2C8DM	Drug metabolism, altered, CYP2C8-related	618018		3
CYP2C9	 Tolbutamide poor metabolizer	601130		3
CYP2C9	Warfarin sensitivity	122700		3
CYP2C, CYP2C19	 Clopidogrel, impaired responsiveness to	609535	4 genes in order: cen-C18-C19-C9-C8-tel	3
CYP2C, CYP2C19	 Mephenytoin poor metabolizer	609535	4 genes in order: cen-C18-C19-C9-C8-tel	3
CYP2C, CYP2C19	 Omeprazole poor metabolizer	609535	4 genes in order: cen-C18-C19-C9-C8-tel	3
CYP2C, CYP2C19	Proguanil poor metabolizer	609535	4 genes in order: cen-C18-C19-C9-C8-tel	3
CYP2D6, CPD6, P450DB1	Codeine sensitivity	608902		3
CYP2D6, CPD6, P450DB1	 Debrisoquine sensitivity	608902		3
CYP2R1	Rickets due to defect in vitamin D 25-hydroxylation deficiency	600081		3
CYP2U1, SPG56	Spastic paraplegia 56, autosomal recessive	615030		3
CYP3A4, VDDR3	Vitamin D-dependent rickets, type 3	619073		3
CYP3A5, P450PCN3	Hypertension, salt-sensitive essential, susceptibility to	145500		3
CYP4F22, ARCI5, LI3	Ichthyosis, congenital, autosomal recessive 5	604777		3
CYP4V2, BCD	Bietti crystalline corneoretinal dystrophy	210370		3
CYP7B1, CBAS3, SPG5A	 Bile acid synthesis defect, congenital, 3	613812		3
CYP7B1, CBAS3, SPG5A	Spastic paraplegia 5A, autosomal recessive	270800		3
D2HGDH, D2HGD	D-2-hydroxyglutaric aciduria	600721		3
DA10	Arthrogryposis, distal, type 10	187370	max lod at D2S364	2
DAAM2, KIAA0381, NPHS24	Nephrotic syndrome, type 24	619263		3
DAB1, SCA37	Spinocerebellar ataxia 37	615945		3
DAG1, DAG, MDDGC9, MDDGA9, LGMDR16	Muscular dystrophy-dystroglycanopathy , type A, 9	616538		3
DAG1, DAG, MDDGC9, MDDGA9, LGMDR16	 Muscular dystrophy-dystroglycanopathy , type C, 9	613818		3
DAOA, G72	Schizophrenia	181500		2
DARS1, DARS, HBSL	Hypomyelination with brainstem and spinal cord involvement and leg spasticity	615281		3
DARS2, ASPRS. LBSL	Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation	611105		3
DAZL, DAZH, SPGYLA	Spermatogenic failure, susceptibility to	601486	?founding member of DAZ gene family	3
DBA2	Diamond-Blackfan anemia 2	606129		2
DBH, ORTHYP1	Orthostatic hypotension 1, due to DBH deficiency	223360	tightly linked to ABO	3
DBR1	Encephalitis, acute, infection -induced, susceptibility to, 11	619441		3
DBT, BCATE2	Maple syrup urine disease, type II	248600	pseudogene on 3q24	3
DCAF17, C20orf37	Woodhouse-Sakati syndrome	241080		3
DCC, MRMV1, HGPPS2	 Colorectal cancer, somatic	114500		3
DCC, MRMV1, HGPPS2	 Esophageal carcinoma, somatic	133239		3
DCC, MRMV1, HGPPS2	 Gaze palsy, familial horizontal, with progressive scoliosis, 2	617542		3
DCC, MRMV1, HGPPS2	Mirror movements 1 and/or agenesis of the corpus callosum	157600		3
DCDC2, RU2, KIAA1154, NPHP19, DFNB66, NSC	 Deafness, autosomal recessive 66	610212	mutation identified in 1 DFNB66 family	3
DCDC2, RU2, KIAA1154, NPHP19, DFNB66, NSC	Nephronophthisis 19	616217	mutation identified in 1 DFNB66 family	3
DCDC2, RU2, KIAA1154, NPHP19, DFNB66, NSC	 Sclerosing cholangitis, neonatal	617394	mutation identified in 1 DFNB66 family	3
DCHS1, PCDH16, FIB1, CDH19, VMLDS1, MVP2	Mitral valve prolapse 2	607829		3
DCHS1, PCDH16, FIB1, CDH19, VMLDS1, MVP2	 Van Maldergem syndrome 1	601390		3
DCLRE1B, SNM1B, APOLLO, DKCB8	Dyskeratosis congenita, autosomal recessive 8	620133		3
DCLRE1C, ARTEMIS, SCIDA	 Omenn syndrome	603554		3
DCLRE1C, ARTEMIS, SCIDA	Severe combined immunodeficiency, Athabascan type	602450		3
DCN, CSCD	Corneal dystrophy, congenital stromal	610048	conflicting assignments to 12q23 and 12q13.2	3
DCPS, HINT5, DCS1, ARS	Al-Raqad syndrome	616459		3
DCR, DSCR	Down syndrome	190685	many genes are involved in this phenotype	4
DCTN1, HMN7B	 Amyotrophic lateral sclerosis, susceptibility to	105400		3
DCTN1, HMN7B	Neuronopathy, distal hereditary motor, type VIIB	607641		3
DCTN1, HMN7B	 Perry syndrome	168605		3
DCT, TYRP2, OCA8	Oculocutaneous albinism, type VIII	619165		3
DCX, DBCN, LISX	 Lissencephaly, X-linked	300067		3
DCX, DBCN, LISX	Subcortical laminal heterotopia, X-linked	300067		3
DCXR, P34H, PNTSU	Pentosuria	260800		3
DDB1, WHIKERS	White-Kernohan syndrome	619426		3
DDB2	Xeroderma pigmentosum, group E, DDB-negative subtype	278740		3
DDC	Aromatic L-amino acid decarboxylase deficiency	608643		3
DDD3	Dowling-Degos disease 3	615674	max lod at D17S1529	2
DDH1	Developmental dysplasia of the hip 1	142700		2
DDH2	Developmental dysplasia of the hip 2	615612	between rs4481097 and rs4626072	2
DDHD1, PAPLA1, KIAA1705, SPG28	Spastic paraplegia 28, autosomal recessive	609340		3
DDHD2, KIAA0725, SPG54	Spastic paraplegia 54, autosomal recessive	615033		3
DDOST, OST, OST48, CDG1R	Congenital disorder of glycosylation, type Ir	614507		3
DDR2, NTRKR3, TKT, WRCN	 Spondylometaepiphyseal dysplasia, short limb-hand type	271665		3
DDR2, NTRKR3, TKT, WRCN	Warburg-Cinotti syndrome	618175		3
DDRGK1, UFBP1, C20orf116, SEMDSH	Spondyloepimetaphyseal dysplasia, Shohat type	602557		3
DDX11, CHLR1, KRG2	Warsaw breakage syndrome	613398		3
DDX3X, DDX3, DBX, MRX102, MRXSSB	Intellectual developmental disorder, X-linked syndromic, Snijders Blok type	300958		3
DDX41, ABS, MPLPF	Myeloproliferative/lymphoproliferative neoplasms, familial , susceptibility to	616871		3
DDX58, RIGI, SGMRT2	Singleton-Merten syndrome 2	616298		3
DDX59, OFD5	Orofaciodigital syndrome V	174300		3
DDX6, HLR2, IDDILF	Intellectual developmental disorder with impaired language and dysmorphic facies	618653		3
DEAF1, SPN, ZMYND5, VSVS, NEDHELS	 Neurodevelopmental disorder with hypotonia, impaired expressive language, and with or without seizures	617171		3
DEAF1, SPN, ZMYND5, VSVS, NEDHELS	Vulto-van Silfout-de Vries syndrome	615828		3
DEF6, IBP, SLAT, IMD87	Immunodeficiency 87 and autoimmunity	619573		3
DEGS1, DES1, MLD, HLD18	Leukodystrophy, hypomyelinating, 18	618404		3
DEK, D6S231E	Leukemia, acute nonlymphocytic	125264	fused with CAN in t(6;9)	2
DEL10q23, C10DELq23	Chromosome 10q22.3-q23.2 deletion syndrome	612242		4
DEL10q26, C10q26DEL	Chromosome 10q26 deletion syndrome	609625		4
DEL11p13, C11DELp13	Chromosome 11p13 deletion syndrome, distal	616902		4
DEL11p13, C11DELp13, WAGR	Wilms tumor, aniridia, genitourinary anomalies and mental retardation syndrome	194072	deletion of WT1 and PAX6 genes	4
DEL11p15p14, C11DELp15p14	Chromosome 11p15-p14 deletion syndrome	606528	contiguous gene deletion syndrome	4
DEL13q14, C13DELq14	Chromosome 13q14 deletion syndrome	613884		4
DEL13q33q34, C13DELq33q34	Chromosome 13q33-q34 deletion syndrome	619148		4
DEL14q11q22, C14DELq11q22	Chromosome 14q11-q22 deletion syndrome	613457	contiguous gene syndrome	4
DEL15q11.2, C15DELq11.2	Chromosome 15q11.2 deletion syndrome	615656	deleted region spans 300-500kb between BP1 and BP2	4
DEL15q13.3, MICRODEL15q13.3	Chromosome 15q13.3 microdeletion syndrome	612001		4
DEL15q14, C15DELq14	Chromosome 15q14 deletion syndrome	616898		4
DEL15q15.3, C15DELq15.3	Deafness and male infertility	611102		4
DEL15q25, C15DELq25	Chromosome 15q25 deletion syndrome	614294	chr15:82,889,423-83,552,890, NCBI36	4
DEL15q26qter, C15DELq26qter	Chromosome 15q26-qter deletion syndrome	612626	contiguous gene deletion syndrome	4
DEL16p11.2, C16DELp11.2, AUTS14A	Autism susceptibility 14A	611913		2
DEL16p11.2, C16DELp11.2, AUTS14A	 Chromosome 16p11.2 deletion syndrome, 593kb	611913		4
DEL16p12.1, C16DELp12.1	Chromosome 16p12.1 deletion syndrome, 520kb	136570	between 21.85-22.37 Mb	4
DEL16p12.1p11.2, C16DELp12.1p11.2	Chromosome 16p12.2-p11.2 deletion syndrome	613604	17.1-8.7 Mb contiguous gene deletion syndrome	4
DEL16p13.3, RSTSS	Chromosome 16p13.3 deletion syndrome	610543	contiguous gene deletion syndrome	4
DEL17p13.1, C17DELp13.1	Chromosome 17p13.1 deletion syndrome	613776	contiguous gene deletion syndrome	4
DEL17q11.2, C17DELq11.2	Chromosome 17q11.2 deletion syndrome, 1.4Mb	613675		4
DEL17q12, C17DELq12	Chromosome 17q12 deletion syndrome	614527		4
DEL17q23.1q23.2, C17DELq23.1q23.2	Chromosome 17q23.1-q23.2 deletion syndrome	613355		4
DEL18p, C18DELp	Chromosome 18p deletion syndrome	146390		4
DEL18q	Chromosome 18q deletion syndrome	601808		4
DEL19p13.13, C19DELp13.13, DUP19p13.13, C19DUPp13.13	Chromosome 19p13.13 deletion syndrome	613638	contiguous gene syndrome	4
DEL19p13.13, C19DELp13.13, DUP19p13.13, C19DUPp13.13	 Chromosome 19p13.13 duplication syndrome	613638	contiguous gene syndrome	4
DEL19q13.11d, C19DELq13.11d	Chromosome 19q13.11 deletion syndrome, distal	613026	contiguous gene syndrome	4
DEL19q13.11p, C19DELq13.11p	Chromosome 19q13.11 deletion syndrome, proximal	617219		4
DEL1p36, C1DELp36	Chromosome 1p36 deletion syndrome, distal	607872	contiguous gene deletion syndrome	4
DEL1p36, C1DELp36	Chromosome 1p36 deletion syndrome, proximal	619343		4
DEL1q21, C1DELq21	Chromosome 1q21.1 deletion syndrome	612474	contiguous gene deletion syndrome	4
DEL1q41q42, C1DELq41q42	Chromosome 1q41-q42 deletion syndrome	612530	contiguous gene deletion of 1.7Mb	4
DEL22q11.2, C22DELq11.2	Chromosome 22q11.2 deletion syndrome, distal	611867		4
DEL2p12p11.2, C2DELp12p11.2	Chromosome 2p12-p11.2 deletion syndrome	613564	contiguous gene deletion syndrome	4
DEL2p16.1-p15, C2DELp161-p15	Chromosome 2p16.1-p15 deletion syndrome	612513	contiguous gene deletion syndrome	4
DEL2p21, C2DELp21	Hypotonia-cystinuria syndrome	606407	contiguous gene syndrome disrupting SLC3A1 and PREPL genes	4
DEL2q31	Chromosome 2q31.2 deletion syndrome	612345	contiguous gene deletion syndrome	4
DEL3pterp25, C3DELpterp25	3p- syndrome	613792	contiguous gene deletion syndrome	4
DEL3q13.31, C13DELq13.31	Chromosome 3q13.31 deletion syndrome	615433		4
DEL3q29, MICRODEL3q29	Chromosome 3q29 microdeletion syndrome	609425	contiguous gene deletion syndrome	4
DEL4q21, C4DELq21	Chromosome 4q21 deletion syndrome	613509	contiguous gene deletion if at least 30 genes	4
DEL5q12, C5DELq12	Chromosome 5q12 deletion syndrome	615668		4
DEL6pter, C6DELpter	Chromosome 6pter-p24 deletion syndrome	612582		4
DEL6q11q14, C6DELq11q14	Chromosome 6q11-q14 deletion syndrome	613544	contiguous gene deletion syndrome	4
DEL6q24q25, C6DELq25q25	Chromosome 6q25-q25 deletion syndrome	612863		4
DEL7q11.23, C7DELq11.23	Chromosome 7q11.23 deletion syndrome, distal, 1.2Mb	613729	contiguous gene deletion syndrome	4
DEL8q12q21, C8DELq12q21	Bor-Duane hydrocephalus contiguous gene syndrome	600257		4
DEL8q13, C8DELq13	Mesomelia-synostoses syndrome	600383	contiguous gene deletion of SULF1 and SLCO5A1	4
DEL8q21.11, C8DELq21.11	Chromosome 8q21.11 deletion syndrome	614230	contiguous gene deletion; minimal region (GRCh37, 8:77226464-77766239)	4
DEL9p24.3, C9DELp24.3, SRXY4	46XY sex reversal 4	154230		4
DEL9p, C9DELp	Chromosome 9p deletion syndrome	158170		4
DELXp11.3, CXDELp11.3	Chromosome Xp11.3 deletion syndrome	300578		4
DELXp21, CXDELp21	Chromosome Xp21 deletion syndrome	300679	contiguous gene deletion syndrome	4
DELXq21, CXDELq21	Xq21 deletion syndrome	303110	at least CHM and POU3F4 deleted	4
DELYq11, CYDELq11, SPGFY1	Spermatogenic failure, Y-linked, 1	400042	contiguous gene deletion syndrome	4
DENND5A, RAB6IP1, KIAA1091, DEE49	Developmental and epileptic encephalopathy 49	617281		3
DEPDC5, KIAA0645, FFEVF1	Epilepsy, familial focal, with variable foci 1	604364		3
DER22t11-22	Emanuel syndrome	609029		4
DER22t8-22	Supernumerary dert syndrome	613700		4
DES, CMD1I, MFM1, SCPNK	 Cardiomyopathy, dilated, 1I	604765		3
DES, CMD1I, MFM1, SCPNK	 Myopathy, myofibrillar, 1	601419		3
DES, CMD1I, MFM1, SCPNK	Scapuloperoneal syndrome, neurogenic, Kaeser type	181400		3
DFCTRPS	Deafness, cataract, retinitis pigmentosa, and sperm abnormalities	300719		2
DFNA16	Deafness, autosomal dominant 16	603964		2
DFNA18	Deafness, autosomal dominant 18	606012		2
DFNA24	Deafness, autosomal dominant 24	606282		2
DFNA30	Deafness, autosomal dominant 30	606451		2
DFNA31	Deafness, autosomal dominant 31	608645	between D6S276 and D6S273	2
DFNA33	Deafness, autosomal dominant 33	614211	maximum lod at D13S285	2
DFNA43	Deafness, autosomal dominant 43	608394	max lod at D2S139	2
DFNA47, DFNB83	Deafness, autosomal dominant 47	608652	between D9S268 and D9S942; possibly allelic to DFNB83	2
DFNA48	Deafness, autosomal dominant 48	607841		2
DFNA49	Deafness, autosomal dominant 49	608372	max lod at D1S3784 and D1S3786	2
DFNA51, C9DUPq21.11, DUP9q21.11	Deafness, autosomal dominant 51	613558	259kb duplication involving TJP2 and FAM189A2	4
DFNA52, DFNA42	Deafness, autosomal dominant 52	607683	max lod at D5S2017	2
DFNA53	Deafness, autosomal dominant 53	609965	max lod at D14S1280	2
DFNA54	Deafness, autosomal dominant 54	615649	between D5S1972 and D5S410	2
DFNA58	Deafness, autosomal dominant 58	615654	between D2S2259 and D2S2114	2
DFNA59	Deafness, autosomal dominant 59	612642	between D22S929 and D11S480	2
DFNB118	Deafness, autosomal recessive 118, with cochlear aplasia	619553	deletion of 200kb downstream of GDF6	4
DFNB13	Deafness, autosomal recessive 13	603098		2
DFNB14	Deafness, autosomal recessive 14	603678	?same as DFNB17	2
DFNB17	Deafness, autosomal recessive 17	603010		2
DFNB20	Deafness, autosomal recessive 20	604060		2
DFNB27	Deafness, autosomal recessive 27	605818		2
DFNB33	Deafness, autosomal recessive 33	607239	prev. assignment to chr. 9 an error	2
DFNB38	Deafness, autosomal recessive 38	608219		2
DFNB40	Deafness, autosomal recessive 40	608264		2
DFNB45	Deafness, autosomal recessive 45	612433	between D1S547 and D1S2836	2
DFNB46	Deafness, autosomal recessive 46	609647	between D18S59 and D18S391	2
DFNB47	Deafness, neurosensory, autosomal recessive 47	609946	max lod at D2S1400 and D2S262	2
DFNB51	Deafness, autosomal recessive 51	609941	max lod at D11S4102	2
DFNB55	Deafness, autosomal recessive 55	609952	max lod at D4S2638	2
DFNB5	Deafness, autosomal recessive 5	600792		2
DFNB62	Deafness, autosomal recessive 62	610143	between D12S358 and D12S1042	2
DFNB65	Deafness, autosomal recessive 65	610248	max lod at D20S840	2
DFNB71	Deafness, autosomal recessive 71	612789	max lod at D8S261	2
DFNB83	Deafness, autosomal recessive 83	613685	between rs4742645 and rs1471364	2
DFNB85	Deafness, autosomal recessive 85	613392	between rs230884 and rs12603885	2
DFNB96	Deafness, autosomal recessive 96	614414	between rs3817914 and rs477558	2
DFNM1	Deafness, nonsyndromic, modifier 1	605429		2
DFNX3, DFN4	Deafness, X-linked 3	300030	?same as DMD	2
DFNY1	Deafness, Y-linked 1	400043		2
DGAT1, ARGP1, DIAR7	Diarrhea 7, protein-losing enteropathy type	615863		3
DGCR2, DGS2	DiGeorge syndrome/velocardiofacial syndrome complex-2	601362		2
DGKE, NPHS7, AHUS7	Hemolytic uremic syndrome, atypical, susceptibility to, 7	615008		3
DGKE, NPHS7, AHUS7	 Nephrotic syndrome, type 7	615008		3
DGUOK, DGK, MTDPS3, PEOB4, NCPH1	 Mitochondrial DNA depletion syndrome 3 	251880		3
DGUOK, DGK, MTDPS3, PEOB4, NCPH1	Portal hypertension, noncirrhotic, 1	617068		3
DGUOK, DGK, MTDPS3, PEOB4, NCPH1	 Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4	617070		3
DHCR24, KIAA0018	Desmosterolosis	602398		3
DHCR7, SLOS	Smith-Lemli-Opitz syndrome	270400		3
DHDDS, HDS, RP59, DEDSM	 Congenital disorder of glycosylation, type 1bb	613861	mutation identified in 1 CDG1BB patient	3
DHDDS, HDS, RP59, DEDSM	Developmental delay and seizures with or without movement abnormalities	617836	mutation identified in 1 CDG1BB patient	3
DHDDS, HDS, RP59, DEDSM	 Retinitis pigmentosa 59	613861	mutation identified in 1 CDG1BB patient	3
DHFR	Megaloblastic anemia due to dihydrofolate reductase deficiency	613839		3
DHH, SRXY7, GDMN	46XY gonadal dysgenesis with minifascicular neuropathy	607080		3
DHH, SRXY7, GDMN	 46XY sex reversal 7	233420		3
DHMN1	Neuronopathy, distal hereditary motor, type I	182960	between D7S2513 and D7S637	2
DHND1, FLJ00251, SPGF65	Spermatogenic failure 65	619712		3
DHODH, URA1, POADS	Miller syndrome	263750		3
DHPS, NEDSSWI	Neurodevelopmental disorder with seizures and speech and walking impairment	618480		3
DHS6S1, MCDR1, PBCRA	Chorioretinal atrophy, progressive bifocal	600790	upstream of PRDM13 and CCNC	3
DHS6S1, MCDR1, PBCRA	 Macular dystrophy 1, North Carolina type	136550	upstream of PRDM13 and CCNC	3
DHTKD1, KIAA1630, AAKAD, CMT2Q	 Alpha-aminoadipic and alpha-ketoadipic aciduria	204750	mutation identified in 1 CMT2Q family	3
DHX16, DDX16, DBP2, PRP8, NMOAS	Neuromuscular disease and ocular or auditory anomalies with or without seizures	618733		3
DHX30, DDX30, RETCOR, KIAA0890, NEDMIAL	Neurodevelopmental disorder with severe motor impairment and absent language	617804		3
DHX37, KIAA1517, NEDBAVC, SRXY11	 46, XY sex reversal 11	273250		3
DHX37, KIAA1517, NEDBAVC, SRXY11	Neurodevelopmental disorder with brain anomalies and with or without vertebral or cardiac anomalies	618731		3
DHX38, DDX38, PRP16, RP84	Retinitis pigmentosa 84	618220		3
DIABLO, SMAC, DFNA64	Deafness, autosomal dominant 64	614152		3
DIAPH1, DFNA1, LFHL1, SCBMS	Deafness, autosomal dominant 1, with or without thrombocytopenia	124900		3
DIAPH1, DFNA1, LFHL1, SCBMS	 Seizures, cortical blindness, microcephaly syndrome	616632		3
DIAPH3, DIA2, DRF3, AUNA1, NSDAN	Auditory neuropathy, autosomal dominant 1	609129		3
DICER1, HERNA, KIAA0928, MNG1, RMSE2, GLOW	 GLOW syndrome, somatic mosaic	618272		3
DICER1, HERNA, KIAA0928, MNG1, RMSE2, GLOW	 Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors	138800		3
DICER1, HERNA, KIAA0928, MNG1, RMSE2, GLOW	Pleuropulmonary blastoma	601200		3
DICER1, HERNA, KIAA0928, MNG1, RMSE2, GLOW	 Rhabdomyosarcoma, embryonal, 2	180295		3
DIH1, HCD	Diaphragmatic hernia 1	142340		2
DIH2	Diaphragmatic hernia 2	222400		2
DIO1, TXDI1, THMA2	Thyroid hormone metabolism, abnormal, 2	619855		3
DIP2B, KIAA1463	Intellectual developmental disorder, autosomal dominant, FRA12A type	136630		3
DIS3L2, PRLMNS	Perlman syndrome	267000		3
DISC1, SCZD9	Schizophrenia 9, susceptibility to	604906		3
DISC2	Schizophrenia	181500	noncoding antisense RAN	2
DJ1, PARK7	Parkinson disease 7, autosomal recessive early-onset	606324		3
DKBI	Dyskeratosis, hereditary benign intraepithelial	127600		2
DKC1, DKCX	Dyskeratosis congenita, X-linked	305000		3
DLAT, PDCE2	Pyruvate dehydrogenase E2 deficiency	245348		3
DLC1	Colorectal cancer, somatic	114500		3
DLD, LAD, PHE3, DLDD	Dihydrolipoamide dehydrogenase deficiency	246900		3
DLG3, NEDLG, SAP102, XLID90	Intellectual developmental disorder, X-linked 90	300850		3
DLG4, PSD95, SAP90, MRD62	Intellectual developmental disorder, autosomal dominant 62	618793		3
DLL1, DELTA1, NEDBAS	Neurodevelopmental disorder with nonspecific brain abnormalities and with or without seizures	618709		3
DLL3, SCDO1	Spondylocostal dysostosis 1, autosomal recessive	277300		3
DLL4, AOS6	Adams-Oliver syndrome 6	616589		3
DLST, PGL7	Paragangliomas 7	618475		3
DLX3, TDO, AI4	 Amelogenesis imperfecta, type IV	104510		3
DLX3, TDO, AI4	Trichodontoosseous syndrome	190320		3
DLX5, SHFM1D, SHFM1	Split-hand/foot malformation 1	183600	mutation identified in 1 SHFM1D family	3
DLX5, SHFM1D, SHFM1	 Split-hand/foot malformation 1 with sensorineural hearing loss	220600	mutation identified in 1 SHFM1D family	3
DMD, BMD, CMD3B	Becker muscular dystrophy	300376	dystrophin gene; cen-5'-3'-pter; 2Mb; ?Xp21.13	3
DMD, BMD, CMD3B	 Cardiomyopathy, dilated, 3B	302045	dystrophin gene; cen-5'-3'-pter; 2Mb; ?Xp21.13	3
DMD, BMD, CMD3B	 Duchenne muscular dystrophy	310200	dystrophin gene; cen-5'-3'-pter; 2Mb; ?Xp21.13	3
DMGDH, DMGDHD	Dimethylglycine dehydrogenase deficiency	605850		3
DMP1, ARHR, ARHP	Hypophosphatemic rickets, AR	241520		3
DMPK, DM, DMK	Myotonic dystrophy 1	160900	distal to APOLP2; distal to CKM	3
DMXL2, RC3, KIAA0856, PEPNS, DFNA71, DEE81	 Deafness, autosomal dominant 71	617605	mutation identified in 1 PEPNS family and 1 DFNA71 family	3
DMXL2, RC3, KIAA0856, PEPNS, DFNA71, DEE81	Developmental and epileptic encephalopathy 81	618663	mutation identified in 1 PEPNS family and 1 DFNA71 family	3
DMXL2, RC3, KIAA0856, PEPNS, DFNA71, DEE81	 Polyendocrine-polyneuropathy syndrome	616113	mutation identified in 1 PEPNS family and 1 DFNA71 family	3
DNA2, DNA2L, KIAA0083, PEOA6, SCKL8	 Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 6	615156	mutation identified in 1 SCKL8 family	3
DNAAF1, LRRC50, ODA7, CILD13	Ciliary dyskinesia, primary, 13	613193		3
DNAAF2, KTU, C14orf104, CILD10	Ciliary dyskinesia, primary, 10	612518		3
DNAAF3, PF22, DAB1, CILD2	Ciliary dyskinesia, primary, 2	606763		3
DNAAF4, DYX1C1, DYXC1, DYX1, CILD25	 Ciliary dyskinesia, primary, 25	615482	not confirmed by some studies	3
DNAAF4, DYX1C1, DYXC1, DYX1, CILD25	Dyslexia, susceptibility to, 1	127700	not confirmed by some studies	3
DNAAF5, HEATR2, CILD18	Ciliary dyskinesia, primary, 18	614874		3
DNAH10, SPGF56	Spermatogenic failure 56	619515		3
DNAH11, DNAHC11, CILD7, DNAHBL	Ciliary dyskinesia, primary, 7, with or without situs inversus	611884		3
DNAH17, DNEL2, SPGF39	Spermatogenic failure 39	618643		3
DNAH1, HL11, DNAHC1, HDHC7, SPGF18, CILD37	 Ciliary dyskinesia, primary, 37	617577	mutation identified in 1 CILD37 family	3
DNAH1, HL11, DNAHC1, HDHC7, SPGF18, CILD37	Spermatogenic failure 18	617576	mutation identified in 1 CILD37 family	3
DNAH2, DNAHC2, SPGF45	Spermatogenic failure 45	619094		3
DNAH5, HL1, PCD, CILD3	Ciliary dyskinesia, primary, 3, with or without situs inversus	608644		3
DNAH8, HDHC9, SPGF46	Spermatogenic failure 46	619095		3
DNAH9, DNAH17L, DNEL1, CILD40	Ciliary dyskinesia, primary, 40	618300		3
DNAI1, CILD1, ICS, PCD	Ciliary dyskinesia, primary, 1, with or without situs inversus	244400		3
DNAI2, CILD9	Ciliary dyskinesia, primary, 9, with or without situs inversus	612444		3
DNAJB11, HEDJ, DJ9, ABBP2, PKD6	Polycystic kidney disease 6 with or without polycystic liver disease	618061		3
DNAJB13, TSARG6, CILD34	Ciliary dyskinesia, primary, 34	617091		3
DNAJB2, HSJ1, HSPF3, DSMA5	Spinal muscular atrophy, distal, autosomal recessive, 5	614881		3
DNAJB6, MRJ, DJ4, LGMDD1	Muscular dystrophy, limb-girdle, autosomal dominant 1	603511		3
DNAJC12, JDP1, HPANBH4	Hyperphenylalaninemia, mild, non-BH4-deficient	617384		3
DNAJC19, TIM14	3-methylglutaconic aciduria, type V	610198		3
DNAJC21, DNAJA5, BMFS3	Bone marrow failure syndrome 3	617052		3
DNAJC30, WBSCR18, LHONAR, MC1DN38	Leber hereditary optic neuropathy, autosomal recessive	619382		3
DNAJC3, PRKRI, P58, ACPHD	Ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus	616192	mutation identified in 1 ACPHD family	3
DNAJC5, DNAJC5A, CSP, CLN4	Ceroid lipofuscinosis, neuronal, 4 , autosomal dominant	162350		3
DNAJC6, DJC6, KIAA0473, PARK19	Parkinson disease 19a, juvenile-onset	615528		3
DNAJC6, DJC6, KIAA0473, PARK19	 Parkinson disease 19b, early-onset	615528		3
DNAL1, C14orf168, CILD16	Ciliary dyskinesia, primary, 16	614017		3
DNASE1, DNL1	Systemic lupus erythematosus, susceptibility to	152700		3
DNASE1L3, SLEB16	Systemic lupus erythematosus 16	614420		3
DNASE2, DNL, AIPCS	Autoinflammatory-pancytopenia syndrome	619858		3
DNM1, DEE31	Developmental and epileptic encephalopathy 31	616346		3
DNM1L, DRP1, DVLP, DYMPLE, EMPF1, OPA5	 Encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1	614388		3
DNM1L, DRP1, DVLP, DYMPLE, EMPF1, OPA5	Optic atrophy 5	610708		3
DNM2, CMTDIB, CMTDI1, CMT2M, LCCS5	Centronuclear myopathy 1	160150	1 LCCS5 family identified with mutation	3
DNM2, CMTDIB, CMTDI1, CMT2M, LCCS5	 Charcot-Marie-Tooth disease, axonal type 2M	606482	1 LCCS5 family identified with mutation	3
DNM2, CMTDIB, CMTDI1, CMT2M, LCCS5	 Charcot-Marie-Tooth disease, dominant intermediate B	606482	1 LCCS5 family identified with mutation	3
DNM2, CMTDIB, CMTDI1, CMT2M, LCCS5	 Lethal congenital contracture syndrome 5	615368	1 LCCS5 family identified with mutation	3
DNMBP, TUBA, KIAA1010, CTRCT48	Cataract 48	618415		3
DNMT1, MCMT, HSN1E, ADCADN	 Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant	604121		3
DNMT1, MCMT, HSN1E, ADCADN	Neuropathy, hereditary sensory, type IE	614116		3
DNMT3A, TBRS, HESJAS	 Acute myeloid leukemia, somatic	601626		3
DNMT3A, TBRS, HESJAS	 Heyn-Sproul-Jackson syndrome	618724		3
DNMT3A, TBRS, HESJAS	Tatton-Brown-Rahman syndrome	615879		3
DNMT3B, ICF1, FSHD4	 Facioscapulohumeral muscular dystrophy 4, digenic	619478		3
DNMT3B, ICF1, FSHD4	Immunodeficiency-centromeric instability-facial anomalies syndrome 1	242860		3
DOCK2, IMD40	Immunodeficiency 40	616433		3
DOCK3, NEDIDHA	Neurodevelopmental disorder with impaired intellectual development, hypotonia, and ataxia	618292		3
DOCK6, KIAA1395, AOS2	Adams-Oliver syndrome 2	614219		3
DOCK7, KIAA1771, DEE23	Developmental and epileptic encephalopathy 23	615859		3
DOCK8	Hyper-IgE recurrent infection syndrome, autosomal recessive	243700		3
DOHH, HLRC1, NEDMVIC	Neurodevelopmental disorder with microcephaly, cerebral atrophy, and visual impairment	620066		3
DOK7, C4orf25, CMS10, FADS3	Fetal akinesia deformation sequence 3	618389	mutation identified in 1 FADS3 family	3
DOK7, C4orf25, CMS10, FADS3	 Myasthenic syndrome, congenital, 10	254300	mutation identified in 1 FADS3 family	3
DOLK, TMEM15, DK1, SEC59, KIAA1094, CDG1M	Congenital disorder of glycosylation, type Im	610768		3
DONSON, C21orf60, MISSLA, MIMIS	 Microcephaly-micromelia syndrome	251230		3
DONSON, C21orf60, MISSLA, MIMIS	Microcephaly, short stature, and limb abnormalities	617604		3
DPAGT1, DPAGT2, DGPT, CDG1J, CMSTA2, CMS13	 Congenital disorder of glycosylation, type Ij	608093		3
DPAGT1, DPAGT2, DGPT, CDG1J, CMSTA2, CMS13	Myasthenic syndrome, congenital, 13, with tubular aggregates	614750		3
DPF2, REQ, UBID4, CSS7	Coffin-Siris syndrome 7	618027		3
DPH1, DPH2L1, OVCA1, DEDSSH	Developmental delay with short stature, dysmorphic facial features, and sparse hair	616901		3
DPH2, DPH2L2, DEDSSH2	Developmental delay with short stature, dysmorphic facial features, and sparse hair 2	620062		3
DPH5, HSPC143, NEDSFF	Neurodevelopmental disorder with short stature, prominent forehead, and feeding difficulties	620070		3
DPM1, MPDS, CDGIE	Congenital disorder of glycosylation, type Ie	608799		3
DPM2, CDG1U	Congenital disorder of glycosylation, type Iu	615042		3
DPM3, MDDGC15, MDDGB15	 Muscular dystrophy-dystroglycanopathy , type C, 15	612937	mutation identified in 1 MDDGB15 patient	3
DPP6, VF2, MRD33	Intellectual developmental disorder, autosomal dominant 33	616311		3
DPP6, VF2, MRD33	 Ventricular fibrillation, paroxysmal familial, 2	612956		3
DPY19L2, SPGF9	Spermatogenic failure 9	613958	pseudogene on 7p14.3	3
DPYD, DPD	 5-fluorouracil toxicity	274270		3
DPYD, DPD	Dihydropyrimidine dehydrogenase deficiency	274270		3
DPYS, DHP	Dihydropyrimidinuria	222748		3
DPYSL5, CRMP5, CRAM, RTSC4	Ritscher-Schinzel syndrome 4	619435		3
DRAM2, TMEM77, CORD21	Cone-rod dystrophy 21	616502		3
DRC1, CCDC164, C2orf39, CILD21	Ciliary dyskinesia, primary, 21	615294		3
DRD3, ETM1, FET1	Essential tremor, hereditary, 1	190300		3
DRD3, ETM1, FET1	 Schizophrenia, susceptibility to	181500		3
DRD4	Attention deficit-hyperactivity disorder	143465	proximal to HRAS	3
DRD4	 Autonomic nervous system dysfunction	126452	proximal to HRAS	3
DRD5, DRD1B, DRD1L2	 Attention deficit-hyperactivity disorder, susceptibility to	143465	pseudogenes on 2p11 and 1q21	3
DRD5, DRD1B, DRD1L2	Blepharospasm, primary benign	606798	pseudogenes on 2p11 and 1q21	3
DSC2, DSC3, ARVD11	 Arrhythmogenic right ventricular dysplasia 11	610476		3
DSC2, DSC3, ARVD11	Arrhythmogenic right ventricular dysplasia 11 with mild palmoplantar keratoderma and woolly hair	610476		3
DSC3, DSC4	Hypotrichosis and recurrent skin vesicles	613102		3
DSE, SART2, EDSMC2	Ehlers-Danlos syndrome, musculocontractural type 2	615539		3
DSG1, PPKS1, SPPK1, EPKHE	 Erythroderma, congenital, with palmoplantar keratoderma, hypotrichosis, and hyper IgE	615508	pemphigus foliaceous antigen	3
DSG1, PPKS1, SPPK1, EPKHE	Keratosis palmoplantaris striata I, AD	148700	pemphigus foliaceous antigen	3
DSG2, ARVD10, ARVC10, CMD1BB	 Arrhythmogenic right ventricular dysplasia 10	610193		3
DSG2, ARVD10, ARVC10, CMD1BB	Cardiomyopathy, dilated, 1BB	612877		3
DSG3, ABOLM	Blistering, acantholytic, of oral and laryngeal mucosa	619226		3
DSG4, LAH, HYPT6	Hypotrichosis 6	607903		3
DSP, KPPS2, PPKS2, DCWHKTA	Arrhythmogenic right ventricular dysplasia 8	607450	splice variants result in DP I and DP II	3
DSP, KPPS2, PPKS2, DCWHKTA	 Cardiomyopathy, dilated, with woolly hair and keratoderma	605676	splice variants result in DP I and DP II	3
DSP, KPPS2, PPKS2, DCWHKTA	 Dilated cardiomyopathy with woolly hair, keratoderma, and tooth agenesis	615821	splice variants result in DP I and DP II	3
DSP, KPPS2, PPKS2, DCWHKTA	 Epidermolysis bullosa, lethal acantholytic	609638	splice variants result in DP I and DP II	3
DSP, KPPS2, PPKS2, DCWHKTA	 Keratosis palmoplantaris striata II	612908	splice variants result in DP I and DP II	3
DSP, KPPS2, PPKS2, DCWHKTA	 Skin fragility-woolly hair syndrome	607655	splice variants result in DP I and DP II	3
DSPP, DPP, DGI1, DFNA39, DTDP2	 Deafness, autosomal dominant 39, with dentinogenesis	605594		3
DSPP, DPP, DGI1, DFNA39, DTDP2	 Dentin dysplasia, type II	125420		3
DSPP, DPP, DGI1, DFNA39, DTDP2	 Dentinogenesis imperfecta, Shields type II	125490		3
DSPP, DPP, DGI1, DFNA39, DTDP2	Dentinogenesis imperfecta, Shields type III	125500		3
DSPS	Delayed sleep phase syndrome, susceptibility to	614163	associated with rs28936679 in AANAT	2
DST, BPAG1, DMH, D6S1101, HSAN6, EBS3	 Epidermolysis bullosa simplex 3, localized or generalized intermediate, with bp230 deficiency	615425		3
DST, BPAG1, DMH, D6S1101, HSAN6, EBS3	Neuropathy, hereditary sensory and autonomic, type VI	614653		3
DSTYK, KIAA0472, RIP5, DUSTYPK, CAKUT1, SPG23	Congenital anomalies of kidney and urinary tract 1	610805		3
DSTYK, KIAA0472, RIP5, DUSTYPK, CAKUT1, SPG23	 Spastic paraplegia 23	270750		3
DTNA, D18S892E, DRP3, LVNC1	Left ventricular noncompaction 1, with or without congenital heart defects	604169		3
DTNBP1, HPS7	Hermansky-Pudlak syndrome 7	614076		3
DTYMK, TYMK, CDC8, CONPM	Neurodegeneration, childhood-onset, with progressive microcephaly	619847		3
DUH1, DUH	Dyschromatosis universalis hereditaria 1	127500	max lod at D6S1553	2
DUH2	Dyschromatosis universalis hereditaria 2	612715	between rs1921045 and rs2373584	2
DUOX2, THOX2, TDH6	Thyroid dyshormonogenesis 6	607200		3
DUOXA2, TDH5	Thyroid dyshormonogenesis 5	274900	head-to-head with DUOX2	3
DUP14q32, C14DUPq32	Myeloproliferative neoplasms, familial, susceptibility to	616604	heterozygous germline duplication of 700kb	4
DUP16p11.2, C16DUPp11.2, AUTS14B	 Autism, susceptibility to, 14B	614671		2
DUP16p11.2, C16DUPp11.2, AUTS14B	Chromosome 16p11.2 duplication syndrome	614671		4
DUP16p13.3, C16DUPq13.3	Chromosome 16p13.3 duplication syndrome	613458	contiguous gene duplication syndrome	4
DUP17p13.3, C17DUPp13.3	Chromosome 17p13.3 duplication syndrome	613215	includes LIS1 and/or YWHAE	4
DUP17q11.2, C17DUPq11.2	Chromosome 17q11.2 duplication syndrome, 1.4-Mb	618874		4
DUP17q12, C17DUPq12	Chromosome 17q12 duplication syndrome	614526		4
DUP17q21.31, C17DUPq21.31	Chromosome 17q21.31 duplication syndrome	613533	contiguous gene duplication syndrome	4
DUP17q23.1q23.2, C17DUPq23.1q23.2	Chromosome 17q23.1-q23.2 duplication syndrome	613618	2.2 Mb contiguous gene duplication syndrome	4
DUP18pDEL18q, DUP18qDEL18p	Chromosome 18 pericentric inversion	609334		4
DUP1q21, C1DUPq21	Chromosome 1q21.1 duplication syndrome	612475	contiguous gene duplication syndrome	4
DUP22q11.2	Chromosome 22q11.2 microduplication syndrome	608363	contiguous gene microduplication syndrome	4
DUP22q13, C22DUPq13	Chromosome 22q13 duplication syndrome	615538		4
DUP2q31.1, C2DUPq31.1	Chromosome 2q31.1 duplication syndrome	613681	duplication of 9 HOXD genes and MTX2	4
DUP2q35, C2DUPq35, SDTY1, SD1	Syndactyly, type 1, with or without craniosynostosis	185900		4
DUP3q29, MICRODUP3q29	Chromosome 3q29 microduplication syndrome	611936	contiguous gene duplication syndrome	4
DUP5p13, C5DUPp13	Chromosome 5p13 duplication syndrome	613174		4
DUP7q11.23, C7DUPq11.23	Chromosome 7q11.23 duplication syndrome	609757		4
DUP8q22.1, C8DUPq22.1	Leri pleonosteosis chromosome duplication syndrome	151200	duplication of 0.9-1.2 Mb on 8q22.1	4
DUPC1	Dupuytren contracture 1	126900	max lod at D16S415	2
DUPXp11.22, MRX17, MRX31	Xp11.22 microduplication syndrome	300705	minimal duplicated region 228 kb overlapping HUWE1 and HSD17B10	4
DUPXp11.23p11.22, CXDUPp11.23p11.22	Chromosome Xp11.23-p11.22 duplication syndrome	300801		4
DUPXq13	Chromosome Xq13 duplication syndrome	301069		4
DUPXq25	Xq25 duplication syndrome	300979		4
DUPXq27.3q28, CXDUPq27.3q28	Chromosome Xq27.3-q28 duplication syndrome	300869		4
DUPXq28, CXq28	Chromosome Xq28 duplication syndrome	300815		4
DURS1, DUS	Duane retraction syndrome 1	126800		2
DUSP6, MKP3, PYST1, HH19	Hypogonadotropic hypogonadism 19 with or without anosmia	615269		3
DUT, BMFDMS	Bone marrow failure and diabetes mellitus syndrome	620044		3
DVL1, DRS2	Robinow syndrome, autosomal dominant 2	616331		3
DVL3, DRS3	Robinow syndrome, autosomal dominant 3	616894		3
DWS, C3DELq22q24, DEL3q22q24	Dandy-Walker syndrome	220200	ZIC1 and ZIC4 good candidate genes	4
DYM, FLJ90130, DMC, SMC	 Dyggve-Melchior-Clausen disease	223800		3
DYM, FLJ90130, DMC, SMC	Smith-McCort dysplasia	607326		3
DYNC1H1, DNCL, DNECL, CMT2O, MRD13, SMALED1	Charcot-Marie-Tooth disease, axonal, type 2O	614228		3
DYNC1H1, DNCL, DNECL, CMT2O, MRD13, SMALED1	 Intellectual developmental disorder, autosomal dominant 13	614563		3
DYNC1H1, DNCL, DNECL, CMT2O, MRD13, SMALED1	 Spinal muscular atrophy, lower extremity-predominant 1, AD	158600		3
DYNC1I2, DNCI2, IC2, NEDMIBA	Neurodevelopmental disorder with microcephaly and structural brain anomalies	618492		3
DYNC2H1, DNCH2, DHC2, ATD3, SRPS2B, SRTD3	Short-rib thoracic dysplasia 3 with or without polydactyly	613091	1 patient showed heterozygous NEK2 and DYNC2H1 mutations	3
DYNC2LI1, D2LIC, LIC3, SRTD15	Short-rib thoracic dysplasia 15 with polydactyly	617088		3
DYNLT2B, TCTEX1D2, SRTD17	Short-rib thoracic dysplasia 17 with or without polydactyly	617405		3
DYRK1A, MNBH, MNB, MRD7	Intellectual developmental disorder, autosomal dominant 7	614104	?triplicate state responsible for mental defect in Down syndrome	3
DYRK1B, MIRK, AOMS3	Abdominal obesity-metabolic syndrome 3	615812		3
DYSF, LGMDR2, MMD1	 Miyoshi muscular dystrophy 1	254130		3
DYSF, LGMDR2, MMD1	Muscular dystrophy, limb-girdle, autosomal recessive 2	253601		3
DYSF, LGMDR2, MMD1	 Myopathy, distal, with anterior tibial onset	606768		3
DYT13	Dystonia 13, torsion	607671		2
DYT15	Dystonia-15, myoclonic	607488		2
DYT17	Dystonia-17, primary torsion	612406	between D20S472 and D20S911	2
DYT21	Dystonia 21	614588		2
DYT23	Dystonia 23	614860	linkage to D9S159 and D9S1818	2
DYT7	Dystonia-7, torsion	602124		2
DYX2	Dyslexia, susceptibility to, 2	600202	?between D6S105 and TNFB	2
DYX3	Dyslexia, susceptibility to, 3	604254		2
DYX5	Dyslexia, susceptibility to, 5	606896	?same locus as SSD	2
DYX6, DYXQTL18	Dyslexia, susceptibility to, 6	606616		2
DYX8	Dyslexia, susceptibility to, 8	608995	between D1S552 and D1S1622	2
DYX9	Dyslexia, susceptibility to, 9	300509	max lod at DXS8043	2
DZIP1, KIAA0996, SPGF47, MVP3	 Mitral valve prolapse 3	610840	mutation identified in 1 MVP3 family	3
DZIP1, KIAA0996, SPGF47, MVP3	Spermatogenic failure 47	619102	mutation identified in 1 MVP3 family	3
DZIP1L, DZIP2, PKD5	Polycystic kidney disease 5	617610		3
EA3	Episodic ataxia, type 3	606554	max lod at D1S235	2
EA7	Episodic ataxia, type 7	611907	between rs1366444 and rs952108	2
EA8	Episodic ataxia, type 8	616055	between rs2743201 and rs215791	2
EARS2, KIAA1970, COXPD12	Combined oxidative phosphorylation deficiency 12	614924		3
EBF3, COE3, HADDS	Hypotonia, ataxia, and delayed development syndrome	617330		3
EBP, CDPX2, CPXD, CPX, MEND	 Chondrodysplasia punctata, X-linked dominant	302960		3
EBP, CDPX2, CPXD, CPX, MEND	MEND syndrome	300960		3
ECA1	Epilepsy, childhood absence, 1	600131		2
ECE1	 Hirschsprung disease, cardiac defects, and autonomic dysfunction	613870	mutation identified in 1 HCAD patient	3
ECE1	Hypertension, essential, susceptibility to	145500	mutation identified in 1 HCAD patient	3
ECEL1, XCE, DA5D	Arthrogryposis, distal, type 5D	615065		3
ECHS1, SCEH, ECHS1D	Mitochondrial short-chain enoyl-CoA hydratase 1 deficiency	616277		3
ECM1, URBWD	Urbach-Wiethe disease	247100		3
ECT, BECTS	Centrotemporal epilepsy	117100	previously assigned to 15q14	2
ECTD5	Ectodermal dysplasia 5, hair/nail type	614927	between D10S1239 and D10S1264	2
ECTD6	Ectodermal dysplasia 6, hair/nail type	614928	between D17S839 and D17S1299	2
ECTD8	Ectodermal dysplasia 8, hair/tooth/nail type	602401	between D18S857 and D18S815	2
EDA, ED1, ECTD1, HED1, STHAGX1	 Ectodermal dysplasia 1, hypohidrotic, X-linked	305100		3
EDA, ED1, ECTD1, HED1, STHAGX1	Tooth agenesis, selective, X-linked 1	313500		3
EDARADD, ED3, EDA3, ECTD11B, ECTD11A	 Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant	614940		3
EDARADD, ED3, EDA3, ECTD11B, ECTD11A	Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive	614941		3
EDAR, DL, ED3, EDA3, HRM1, ECTD10A, ECTD10B	 Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant	129490		3
EDAR, DL, ED3, EDA3, HRM1, ECTD10A, ECTD10B	 Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive	224900		3
EDAR, DL, ED3, EDA3, HRM1, ECTD10A, ECTD10B	Hair morphology 1, hair thickness	612630		3
EDEM3, C1orf22, CDG2V	Congenital disorder of glycosylation, type IIv	619493		3
EDN1, ARCND3, QME, HDLCQ7	 Auriculocondylar syndrome 3	615706		3
EDN1, ARCND3, QME, HDLCQ7	High density lipoprotein cholesterol level QTL 7	131240		3
EDN1, ARCND3, QME, HDLCQ7	 Question mark ears, isolated	612798		3
EDN3, WS4B, HSCR4	 Hirschsprung disease, susceptibility to, 4	613712		3
EDN3, WS4B, HSCR4	Waardenburg syndrome, type 4B	613265		3
EDNRA, MFDA	 Mandibulofacial dysostosis with alopecia	616367		3
EDNRA, MFDA	Migraine, resistance to	157300		3
EDNRB, HSCR2, ABCDS, WS4A	 ABCD syndrome	600501	mutation identified in 1 ABCD family	3
EDNRB, HSCR2, ABCDS, WS4A	Hirschsprung disease, susceptibility to, 2	600155	mutation identified in 1 ABCD family	3
EDNRB, HSCR2, ABCDS, WS4A	 Waardenburg syndrome, type 4A	277580	mutation identified in 1 ABCD family	3
EDSS2	Ectodermal dysplasia-syndactyly syndrome 2	613576	between D7S488 and D7S817	2
EED, WAIT1, COGIS	Cohen-Gibson syndrome	617561		3
EEF1A2, DEE33, MRD38	Developmental and epileptic encephalopathy 33	616409		3
EEF1A2, DEE33, MRD38	 Intellectual developmental disorder, autosomal dominant 38	616393		3
EEF1AKNMT, METTL13, FEAT, KIAA0859, DFNB26M	Deafness, autosomal recessive 26, modifier of	605429	mutation identified in 1 family	3
EEGV1, EEGL	Electroencephalographic variant pattern 1	130180		2
EFEMP1, FBNL, DHRD	Doyne honeycomb degeneration of retina	126600		3
EFEMP2, FBLN4, UPH1, ARCL1B	Cutis laxa, autosomal recessive, type IB	614437		3
EFHC1, FLJ10466, EJM1, JAE, EJA1	Epilepsy, juvenile absence, susceptibility to, 1	607631		3
EFHC1, FLJ10466, EJM1, JAE, EJA1	 Myoclonic epilepsy, juvenile, susceptibility to, 1	254770		3
EFL1, RIA1, EFTUD1, FAM42A, SDS2	Shwachman-Diamond syndrome 2	617941		3
EFNB1, EPLG2, CFNS, CFND	Craniofrontonasal dysplasia	304110	?CFNS also on Xp22	3
EFTUD2, KIAA0031, MFDGA	Mandibulofacial dysostosis, Guion-Almeida type	610536		3
EGFR, NISBD2	 Adenocarcinoma of lung, response to tyrosine kinase inhibitor in	211980	same as oncogene ERBB; mutation identified in 1 NISBD2 family	3
EGFR, NISBD2	 Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in	211980	same as oncogene ERBB; mutation identified in 1 NISBD2 family	3
EGFR, NISBD2	 Nonsmall cell lung cancer, susceptibility to	211980	same as oncogene ERBB; mutation identified in 1 NISBD2 family	3
EGLN1, PHD2, HIFPH2, C1orf12, ZMYND6, SM20, ECYT3, HALAH	Erythrocytosis, familial, 3	609820		3
EGLN1, PHD2, HIFPH2, C1orf12, ZMYND6, SM20, ECYT3, HALAH	 Hemoglobin, high altitude adaptation	609070		3
EGR2, KROX20, CHN1	 Charcot-Marie-Tooth disease, type 1D	607678		3
EGR2, KROX20, CHN1	Dejerine-Sottas disease	145900		3
EGR2, KROX20, CHN1	 Hypomyelinating neuropathy, congenital, 1	605253		3
EHBP1, KIAA0903, HPC12	Prostate cancer, hereditary, 12	611868		3
EHMT1, EUHMTASE1, KMT1D, DEL9q34, KLEFS1	Kleefstra syndrome 1	610253		3
EIF2AK2, PRKR, LEUDEN, DYT33	 Dystonia 33	619687	mutation identified in 1 DYT33 patient	3
EIF2AK2, PRKR, LEUDEN, DYT33	Leukoencephalopathy, developmental delay, and episodic neurologic regression syndrome	618877	mutation identified in 1 DYT33 patient	3
EIF2AK3, PEK, PERK, WRS	Wolcott-Rallison syndrome	226980		3
EIF2AK4, GCN2, KIAA1338, PVOD2	Pulmonary venoocclusive disease 2	234810		3
EIF2B1, EIF2BA	Leukoencephalopathy with vanishing white matter	603896		3
EIF2B2	Leukoencephalopathy with vanishing white matter	603896		3
EIF2B2	 Ovarioleukodystrophy	603896		3
EIF2B3	Leukoencephalopathy with vanishing white matter	603896		3
EIF2B4	 Leukoencephalopathy with vanishing white matter	603896		3
EIF2B4	Ovarioleukodystrophy	603896		3
EIF2B5, LVWM, CACH, CLE	 Leukoencephalopathy with vanishing white matter	603896		3
EIF2B5, LVWM, CACH, CLE	Ovarioleukodystrophy	603896		3
EIF2S3, EIF2G, MEHMO, MRXSBRK	MEHMO syndrome	300148		3
EIF3F, EIF3S5, MRT67	Intellectual developmental disorder, autosomal recessive 67	618295		3
EIF4A3, DDX48, MUK34, NMP265, KIAA0111, RCPS	Robin sequence with cleft mandible and limb anomalies	268305		3
EIF4E, EIF4EL1, AUTS19	Autism, susceptibility to, 19	615091	pseudogene on 20	3
EIF4G1, EIF4G, PARK18	Parkinson disease 18	614251	amplified in squamous cell lung cancer	3
EIF5A, FABAS	Faundes-Banka syndrome	619376		3
EIG1	Epilepsy, idiopathic generalized, susceptibility to, 1	600669	?same as EBN2	2
EIG2	Epilepsy, idiopathic generalized, susceptibility to, 2	606972		2
EIG3	Epilepsy, idiopathic generalized, susceptibility to, 3	608762		2
EIG4	Epilepsy, idiopathic generalized, susceptibility to 4	609750	between D16S397 and D16S3095	2
EIG5	Epilepsy, idiopathic generalized, susceptibility to, 5	611934	max lod at D10S1426	2
EIG7, EJM2	Epilepsy, idiopathic generalized, susceptibility to, 7	604827	?role of CHRNA7	2
EIG7, EJM2	 Epilepsy, juvenile myoclonic	604827	?role of CHRNA7	2
EJM3	Epilepsy, juvenile myoclonic 3	608816		2
EJM4	Myoclonic epilepsy, juvenile, 4	611364	max lod at D5S459	2
EJM9	Epilepsy, juvenile myoclonic, susceptibility to, 9	614280	max lod at D2S2248	2
EKD2	Episodic kinesigenic dyskinesia 2	611031	max lod at D16S503	2
ELAC2, HPC2, COXPD17	 Combined oxidative phosphorylation deficiency 17	615440	at ~365cR	3
ELAC2, HPC2, COXPD17	Prostate cancer, hereditary, 2, susceptibility to	614731	at ~365cR	3
ELANE, ELA2, SCN1	Neutropenia, cyclic	162800		3
ELANE, ELA2, SCN1	 Neutropenia, severe congenital 1, autosomal dominant	202700		3
ELF4, MEF, AIFBL2	Autoinflammatory syndrome, familial, X-linked, Behcet-like 2	301074		3
ELMO2, CED12, VMPI	Vascular malformation, primary intraosseous	606893		3
ELMOD3, RBED1, DFNB88, DFNA81	 Deafness, autosomal dominant 81	619500	mutation identified in 1 DFNB88 and 1 DFNA81 family	3
ELN, SVAS, ADCL1	Cutis laxa, autosomal dominant	123700		3
ELN, SVAS, ADCL1	 Supravalvar aortic stenosis	185500		3
ELOVL1, SSC1, IKSHD	Ichthyotic keratoderma, spasticity, hypomyelination, and dysmorphic facies	618527		3
ELOVL4, ADMD, STGD2, STGD3, ISQMR, SCA34	 Ichthyosis, spastic quadriplegia, and impaired intellectual development	614457		3
ELOVL4, ADMD, STGD2, STGD3, ISQMR, SCA34	Spinocerebellar ataxia 34	133190		3
ELOVL4, ADMD, STGD2, STGD3, ISQMR, SCA34	 Stargardt disease 3	600110		3
ELOVL5, HELO1, SCA38	Spinocerebellar ataxia 38	615957		3
ELP1, IKBKAP, IKAP	 Dysautonomia, familial	223900		3
ELP1, IKBKAP, IKAP	Medulloblastoma	155255		3
ELP2, STATIP1, MRT58	Intellectual developmental disorder, autosomal recessive 58	617270		3
EMC10, C19orf63, HSS1, HSM1, NEDDFAS	Neurodevelopmental disorder with dysmorphic facies and variable seizures	619264		3
EMC1, KIAA0090, CAVIPMR	Cerebellar atrophy, visual impairment, and psychomotor retardation	616875		3
EMD, EDMD, STA	Emery-Dreifuss muscular dystrophy 1, X-linked	310300	in distal Xq28	3
EMG1, NEP1, C2F, BWCNS	Bowen-Conradi syndrome	211180		3
EMILIN1, EMILIN, HMN10	Neuronopathy, distal hereditary motor, type X	620080		3
EML1, EMAPL, EMAP, BH	Band heterotopia	600348		3
EMP2, NPHS10	Nephrotic syndrome, type 10	615861		3
EMWX	Episodic muscle weakness, X-linked	300211		2
EMX2	Schizencephaly	269160	close to VAX1	3
ENAM, AIH2, AI1C	 Amelogenesis imperfecta, type IB	104500		3
ENAM, AIH2, AI1C	Amelogenesis imperfecta, type IC	204650		3
ENDO1	Endometriosis, susceptibility to, 1	131200	max lod at D10S587	2
ENDOVESL	ENDOVE syndrome, limb-only type	619217		4
ENFL2	Epilepsy, nocturnal frontal lobe, type 2	603204	some ENFL not on 20q or 15q	2
ENG, END, HHT1, ORW	Telangiectasia, hereditary hemorrhagic, type 1	187300		3
ENO3, GSD13	Glycogen storage disease XIII	612932		3
ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED	 Arterial calcification, generalized, of infancy, 1	208000		3
ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED	 Cole disease	615522		3
ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED	 Diabetes mellitus, non-insulin-dependent, susceptibility to	125853		3
ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED	 Hypophosphatemic rickets, autosomal recessive, 2	613312		3
ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED	Obesity, susceptibility to	601665		3
ENTPD1, CD39, SPG64	Spastic paraplegia 64, autosomal recessive	615683		3
ENUR1	Enuresis, nocturnal, 1	600631		2
ENUR2	Enuresis, nocturnal, 2	600808		2
EOE1, EE	Esophagitis, eosinophilic, 1	610247	associated with rs2302009	2
EOE2	Esophagitis, eosinophilic, 2	613412	association with rs3806932	2
EOGT, EOGT1, C3orf64, AOS4	Adams-Oliver syndrome 4	615297		3
EOS	Eosinophilia, familial	131400		2
EP300, RSTS2, MKHK2	 Colorectal cancer, somatic	114500		3
EP300, RSTS2, MKHK2	Menke-Hennekam syndrome 2	618333		3
EP300, RSTS2, MKHK2	 Rubinstein-Taybi syndrome 2	613684		3
EPAS1, MOP2, HIF2A, ECYT4	Erythrocytosis, familial, 4	611783		3
EPB41, EL1	Elliptocytosis-1	611804		3
EPB42, SPH5	Spherocytosis, type 5	612690		3
EPCAM, ACSTD1, TROP1, M4S1, MIC18, DIAR5, LYNCH8	Diarrhea 5, with tufting enteropathy, congenital	613217	previously assigned to 4q	3
EPCAM, ACSTD1, TROP1, M4S1, MIC18, DIAR5, LYNCH8	 Lynch syndrome 8	613244	previously assigned to 4q	3
EPG5, KIAA1632, HEEW1, VICIS	Vici syndrome	242840		3
EPHA2, ECK, CTPP1, CTPA, ARCC2, CTRCT6	Cataract 6, multiple types	116600		3
EPHB2, EPHT3, DRT, ERK, PCBC, CAPB, BDPLT22	 Prostate cancer/brain cancer susceptibility, somatic	603688	mutation identified in 1 BDPLT22 family	3
EPHB4, HTK, MYK1, HFASD, CMAVM2, LMPHM7	Capillary malformation-arteriovenous malformation 2	618196		3
EPHB4, HTK, MYK1, HFASD, CMAVM2, LMPHM7	 Lymphatic malformation 7	617300		3
EPHX2	Hypercholesterolemia, familial, due to LDLR defect, modifier of	143890		3
EPM2A, MELF, EPM2	Epilepsy, progressive myoclonic 2A 	254780		3
EPO, MVCD2, ECYT5, DBAL	 Diamond-Blackfan anemia-like	617911	mutation identified in 1 DBAL family	3
EPO, MVCD2, ECYT5, DBAL	 Erythrocytosis, familial, 5	617907	mutation identified in 1 DBAL family	3
EPO, MVCD2, ECYT5, DBAL	Microvascular complications of diabetes 2	612623	mutation identified in 1 DBAL family	3
EPOR	Erythrocytosis, familial, 1	133100		3
EPPS	Epilepsy, partial, with pericentral spikes	607221		2
EPRS, PARS, HLD15	Leukodystrophy, hypomyelinating, 15	617951		3
EPS8L2, EPS8R2, DFNB106	Deafness autosomal recessive 106	617637		3
EPX, EPXD	Eosinophil peroxidase deficiency	261500		3
ERAL1, ERAL1A, ERAL1B, PRLTS6	Perrault syndrome 6	617565		3
ERBB2, NGL, NEU, HER2, VSCN2	 Adenocarcinoma of lung, somatic	211980	mutation identified in 1 VSCN2 family	3
ERBB2, NGL, NEU, HER2, VSCN2	Gastric cancer, somatic	613659	mutation identified in 1 VSCN2 family	3
ERBB2, NGL, NEU, HER2, VSCN2	 Glioblastoma, somatic	137800	mutation identified in 1 VSCN2 family	3
ERBB2, NGL, NEU, HER2, VSCN2	 Ovarian cancer, somatic	167000	mutation identified in 1 VSCN2 family	3
ERBB2, NGL, NEU, HER2, VSCN2	 Visceral neuropathy, familial, 2, autosomal recessive	619465	mutation identified in 1 VSCN2 family	3
ERBB3, LCCS2, FERLK, VSCN1	 Erythroleukemia, familial, susceptibility to	133180	mutations identified in 1 LCCS2 family and 1 FERLK family	3
ERBB3, LCCS2, FERLK, VSCN1	 Visceral neuropathy, familial, 1, autosomal recessive	243180	mutations identified in 1 LCCS2 family and 1 FERLK family	3
ERBB4, HER4, ALS19	Amyotrophic lateral sclerosis 19	615515		3
ERCC1, UV20, COFS4	Cerebrooculofacioskeletal syndrome 4	610758	distal to CKM	3
ERCC2, EM9, XPD, COFS2, TTD1	 Cerebrooculofacioskeletal syndrome 2	610756	< 250kb from ERCC1; mutation identified in 1 COFS2 patient	3
ERCC2, EM9, XPD, COFS2, TTD1	 Trichothiodystrophy 1, photosensitive	601675	< 250kb from ERCC1; mutation identified in 1 COFS2 patient	3
ERCC2, EM9, XPD, COFS2, TTD1	Xeroderma pigmentosum, group D	278730	< 250kb from ERCC1; mutation identified in 1 COFS2 patient	3
ERCC3, XPB, TTD2	Trichothiodystrophy 2, photosensitive	616390		3
ERCC3, XPB, TTD2	 Xeroderma pigmentosum, group B	610651		3
ERCC4, XPF, FANCQ, XFEPS	 Fanconi anemia, complementation group Q	615272		3
ERCC4, XPF, FANCQ, XFEPS	 Xeroderma pigmentosum, group F	278760		3
ERCC4, XPF, FANCQ, XFEPS	Xeroderma pigmentosum, type F/Cockayne syndrome	278760		3
ERCC4, XPF, FANCQ, XFEPS	 XFE progeroid syndrome	610965		3
ERCC5, XPG, COFS3	 Cerebrooculofacioskeletal syndrome 3	616570		3
ERCC5, XPG, COFS3	Xeroderma pigmentosum, group G	278780		3
ERCC5, XPG, COFS3	 Xeroderma pigmentosum, group G/Cockayne syndrome	278780		3
ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	 Cerebrooculofacioskeletal syndrome 1	214150	mutation identified in 1 DSCS family	3
ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	 Cockayne syndrome, type B	133540	mutation identified in 1 DSCS family	3
ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	 De Sanctis-Cacchione syndrome	278800	mutation identified in 1 DSCS family	3
ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	 Lung cancer, susceptibility to	211980	mutation identified in 1 DSCS family	3
ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	 Macular degeneration, age-related, susceptibility to, 5	613761	mutation identified in 1 DSCS family	3
ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	 Premature ovarian failure 11	616946	mutation identified in 1 DSCS family	3
ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	UV-sensitive syndrome 1	600630	mutation identified in 1 DSCS family	3
ERCC6L2, RAD26L, BMFS2	Bone marrow failure syndrome 2	615715		3
ERCC8, CKN1, CSA, UVSS2	 Cockayne syndrome, type A	216400		3
ERCC8, CKN1, CSA, UVSS2	UV-sensitive syndrome 2	614621		3
ERF, PE2, CRS4, CHYTS	 Chitayat syndrome	617180		3
ERF, PE2, CRS4, CHYTS	Craniosynostosis 4	600775		3
ERLIN1, SPG62	Spastic paraplegia 62	615681		3
ERLIN2, SPFH2, C8orf2, SPG18	Spastic paraplegia 18, autosomal recessive	611225		3
ERMAP, SC, RD	 Blood group, Radin	111620		3
ERMAP, SC, RD	Blood group, Scianna system	111750		3
ESCO2, RBS, JHS	Juberg-Hayward syndrome	216100		3
ESCO2, RBS, JHS	 Roberts-SC phocomelia syndrome	268300		3
ESPN, USH1M	 Deafness, autosomal recessive 36	609006	mutation identified in 1 USH1M family	3
ESPN, USH1M	Deafness, neurosensory, without vestibular involvement, autosomal dominant	609006	mutation identified in 1 USH1M family	3
ESPN, USH1M	 Usher syndrome, type 1M	618632	mutation identified in 1 USH1M family	3
ESR1, ESR, ESTRR	Breast cancer, somatic	114480		3
ESR1, ESR, ESTRR	 Estrogen resistance	615363		3
ESR1, ESR, ESTRR	 Migraine, susceptibility to	157300		3
ESR1, ESR, ESTRR	 Myocardial infarction, susceptibility to	608446		3
ESRRB, ESRL2, DFNB35	Deafness, autosomal recessive 35	608565		3
ETFA, GA2, MADD	Glutaric acidemia IIA	231680		3
ETFB, MADD	Glutaric acidemia IIB	231680		3
ETFDH, MADD	Glutaric acidemia IIC	231680		3
ETHE1, HSCO, D83198	Ethylmalonic encephalopathy	602473		3
ETL2, FTLE	Epilepsy, familial temporal lobe, 2	608096	max lod at D12S1706	2
ETL3, FMTLE	Epilepsy, familial temporal lobe, 3	611630	max lod at D4S1517	2
ETL4, ETOLM	Epilepsy, familial temporal lobe, 4	611631	between GATA152H04 and D9S253	2
ETL6	Epilepsy, familial temporal lobe, 6	615697	between D3S1584 and D3S3520	2
ETM2, ETM	Essential tremor, hereditary, 2	602134	max lod at D2S272	2
ETM3	Essential tremor, hereditary, 3	611456	max lod at D6S1630 and D6S1605	2
ETV6, TEL, THC5	 Leukemia, acute myeloid, somatic	601626	fused to PDGFRB or AML1 in leukemia	3
ETV6, TEL, THC5	Thrombocytopenia 5	616216	fused to PDGFRB or AML1 in leukemia	3
EVC2, LBN, WAD	Ellis-van Creveld syndrome	225500		3
EVC2, LBN, WAD	 Weyers acrofacial dysostosis	193530		3
EVC	Ellis-van Creveld syndrome	225500	mutation identified in 1 WAD patient	3
EVC	 Weyers acrofacial dysostosis	193530	mutation identified in 1 WAD patient	3
EVR3	Exudative vitreoretinopathy 3	605750		2
EWSR1, EWS	 Ewing sarcoma	612219	t(11;22)(q24;q12); t(21;22)(q22;q12)	3
EWSR1, EWS	Neuroepithelioma	612219	t(11;22)(q24;q12); t(21;22)(q22;q12)	3
EXOC2, SEC5L1, SEC5, NEDFACH	Neurodevelopmental disorder with dysmorphic facies and cerebellar hypoplasia	619306		3
EXOC6B, SEC15B, KIAA0919, SEMDJL3	Spondyloepimetaphyseal dysplasia with joint laxity, type 3	618395		3
EXOC7, EX070, KIAA1067, NEDSEBA	Neurodevelopmental disorder with seizures and brain atrophy	619072		3
EXOSC2, RRP4, SHRF	Short stature, hearing loss, retinitis pigmentosa, and distinctive facies	617763		3
EXOSC3, RRP40, PCH1B	Pontocerebellar hypoplasia, type 1B	614678		3
EXOSC5, RRP46, CABAC	Cerebellar ataxia, brain abnormalities, and cardiac conduction defects	619576		3
EXOSC8, OIP2, RRP43, PCH1C	Pontocerebellar hypoplasia, type 1C	616081		3
EXOSC9, PMSCL1, PCH1D	Pontocerebellar hypoplasia, type 1D	618065		3
EXPH5, SLAC2B, KIAA0624, EBS4	Epidermolysis bullosa simplex 4, localized or generalized intermediate, autosomal recessive	615028		3
EXT1	 Chondrosarcoma	215300	distal to TRPS1	3
EXT1	Exostoses, multiple, type 1	133700	distal to TRPS1	3
EXT2, SSMS	 Exostoses, multiple, type 2	133701		3
EXT2, SSMS	Seizures, scoliosis, and macrocephaly syndrome	616682		3
EXT3	Exostoses, multiple, type 3	600209		2
EXTL3, EXTR1, ISDNA	Immunoskeletal dysplasia with neurodevelopmental abnormalities	617425		3
EYA1, BOR, BOS1, OFC1	 Anterior segment anomalies with or without cataract	602588	mutation identified in 1 OFC1 family	3
EYA1, BOR, BOS1, OFC1	Branchiootic syndrome 1	602588	mutation identified in 1 OFC1 family	3
EYA1, BOR, BOS1, OFC1	 Branchiootorenal syndrome 1, with or without cataracts	113650	mutation identified in 1 OFC1 family	3
EYA1, BOR, BOS1, OFC1	 Otofaciocervical syndrome	166780	mutation identified in 1 OFC1 family	3
EYA4, DFNA10, CMD1J	 Deafness, autosomal dominant 10	601316	mutation identified in 1 CMD1J family	3
EYS, RP25	Retinitis pigmentosa 25	602772		3
EZH2, EZH1, WVS	Weaver syndrome	277590	pseudogene on 21q22	3
F10	Factor X deficiency	227600		3
F11	Factor XI deficiency, autosomal dominant	612416	not closely linked to MNS	3
F11	 Factor XI deficiency, autosomal recessive	612416	not closely linked to MNS	3
F12, HAF, HAE3	Angioedema, hereditary, 3	610618		3
F12, HAF, HAE3	 Factor XII deficiency	234000		3
F13A1, F13A	Factor XIIIA deficiency	613225		3
F13A1, F13A	 Myocardial infarction, protection against	608446		3
F13A1, F13A	 Venous thrombosis, protection against	188050		3
F13B	Factor XIIIB deficiency	613235		3
F2, THPH1, RPRGL2	 Dysprothrombinemia	613679		3
F2, THPH1, RPRGL2	Hypoprothrombinemia	613679		3
F2, THPH1, RPRGL2	 Pregnancy loss, recurrent, susceptibility to, 2	614390		3
F2, THPH1, RPRGL2	 Stroke, ischemic, susceptibility to	601367		3
F2, THPH1, RPRGL2	 Thrombophilia 1 due to thrombin defect	188050		3
F5, THPH2, RPRGL1	 Budd-Chiari syndrome	600880	Order: F5-GRMP-LYAM1-ELAM1 in 300kb segment	3
F5, THPH2, RPRGL1	 Factor V deficiency	227400	Order: F5-GRMP-LYAM1-ELAM1 in 300kb segment	3
F5, THPH2, RPRGL1	 Pregnancy loss, recurrent, susceptibility to, 1	614389	Order: F5-GRMP-LYAM1-ELAM1 in 300kb segment	3
F5, THPH2, RPRGL1	 Stroke, ischemic, susceptibility to	601367	Order: F5-GRMP-LYAM1-ELAM1 in 300kb segment	3
F5, THPH2, RPRGL1	Thrombophilia 2 due to activated protein C resistance	188055	Order: F5-GRMP-LYAM1-ELAM1 in 300kb segment	3
F5, THPH2, RPRGL1	 Thrombophilia, susceptibility to, due to factor V Leiden	188055	Order: F5-GRMP-LYAM1-ELAM1 in 300kb segment	3
F7	 Factor VII deficiency	227500		3
F7	Myocardial infarction, decreased susceptibility to	608446		3
F8, F8C, HEMA, THPH13	 Hemophilia A	306700	cen-G6PD-3' end of F8C-5'-ter; 1.1Mb from telomere	3
F8, F8C, HEMA, THPH13	Thrombophilia 13, X-linked, due to factor VIII defect	301071	cen-G6PD-3' end of F8C-5'-ter; 1.1Mb from telomere	3
F9, HEMB, THPH8	Deep venous thrombosis, protection against	300807	distal to HPRT; proximal part of Xq27	3
F9, HEMB, THPH8	 Hemophilia B	306900	distal to HPRT; proximal part of Xq27	3
F9, HEMB, THPH8	 Thrombophilia 8, X-linked, due to factor IX defect	300807	distal to HPRT; proximal part of Xq27	3
F9, HEMB, THPH8	 Warfarin sensitivity	301052	distal to HPRT; proximal part of Xq27	3
FA2H, FAAH, FAXDC1, FAH1, SCS7, SPG35	Spastic paraplegia 35, autosomal recessive	612319		3
FAAH	Drug addiction, susceptibility to	606581		3
FADD, IMD90	Immunodeficiency 90 with encephalopathy, functional hyposplenia, and hepatic dysfunction	613759		3
FAH	Tyrosinemia, type I	276700		3
FAM111A, KIAA1895, KCS2, GCLEB	 Gracile bone dysplasia	602361		3
FAM111A, KIAA1895, KCS2, GCLEB	Kenny-Caffey syndrome, type 2	127000		3
FAM111B, POIKTMP	Poikiloderma, hereditary fibrosing, with tendon contractures, myopathy, and pulmonary fibrosis	615704		3
FAM149B1, KIAA0974, JBTS36	Joubert syndrome 36	618763		3
FAM161A, RP28	Retinitis pigmentosa 28	606068		3
FAM20A, AIGFS, AI1G	Amelogenesis imperfecta, type IG 	204690		3
FAM20C, DMP4	Raine syndrome	259775		3
FAM50A, DXS9928E, HXC26, MRXSA	Intellectual developmental disorder, X-linked syndromic, Armfield type	300261		3
FAM58A, STAR	STAR syndrome	300707		3
FAM83H, AI3A	Amelogenesis imperfecta, type IIIA	130900		3
FAN1, MTMR15, KIAA1018, KMIN	Interstitial nephritis, karyomegalic	614817		3
FANCA, FACA, FA1, FA, FAA	Fanconi anemia, complementation group A	227650	linkage heterogeneity	3
FANCB, FAAP95, FAAP90, FLJ34064	Fanconi anemia, complementation group B	300514		3
FANCC, FACC	Fanconi anemia, complementation group C	227645		3
FANCD2, FANCD, FACD, FAD	Fanconi anemia, complementation group D2	227646		3
FANCE, FACE	Fanconi anemia, complementation group E	600901		3
FANCF	Fanconi anemia, complementation group F	603467		3
FANCI, KIAA1794	Fanconi anemia, complementation group I	609053		3
FANCM, KIAA1596, SPGF28, POF15	 Spermatogenic failure 28	618086	mutation identified in 1 POF15 family	3
FAR1, MLSTD2, PFCRD, CSPSD	 Cataracts, spastic paraparesis, and speech delay	619338		3
FAR1, MLSTD2, PFCRD, CSPSD	Peroxisomal fatty acyl-CoA reductase 1 disorder	616154		3
FARS2, FARS1, COXPD14, SPG77	Combined oxidative phosphorylation deficiency 14	614946		3
FARS2, FARS1, COXPD14, SPG77	 Spastic paraplegia 77, autosomal recessive	617046		3
FARSB, FARSLB, RILDBC1	Rajab interstitial lung disease with brain calcifications 1	613658		3
FASLG, TNFSF6, APT1LG1, FASL, ALPS1B	Autoimmune lymphoproliferative syndrome, type IB	601859		3
FASLG, TNFSF6, APT1LG1, FASL, ALPS1B	 Lung cancer, susceptibility to	211980		3
FASTKD2, KIAA0971, COXPD44	Combined oxidative phosphorylation deficiency 44	618855		3
FAS, TNFRSF6, APT1, CD95, ALPS1A	 Autoimmune lymphoproliferative syndrome	601859		3
FAS, TNFRSF6, APT1, CD95, ALPS1A	 Autoimmune lymphoproliferative syndrome, type IA	601859		3
FAS, TNFRSF6, APT1, CD95, ALPS1A	Squamous cell carcinoma, burn scar-related, somatic	134637		3
FAT2, MEGF1, SCA45	Spinocerebellar ataxia 45	617769		3
FAT4, VMLDS2, HKLLS2	 Hennekam lymphangiectasia-lymphedema syndrome 2	616006		3
FAT4, VMLDS2, HKLLS2	Van Maldergem syndrome 2	615546		3
FBLN1	Synpolydactyly, 3/3'4, associated with metacarpal and metatarsal synostoses	608180		4
FBLN5, ARMD3, ADCL2, ARCL1A, HNARMD, CMT1H	 Charcot-Marie-Tooth disease, demyelinating, type 1H	619764	mutation identified in 1 ADCL2 patient	3
FBLN5, ARMD3, ADCL2, ARCL1A, HNARMD, CMT1H	 Cutis laxa, autosomal dominant 2	614434	mutation identified in 1 ADCL2 patient	3
FBLN5, ARMD3, ADCL2, ARCL1A, HNARMD, CMT1H	Cutis laxa, autosomal recessive, type IA	219100	mutation identified in 1 ADCL2 patient	3
FBLN5, ARMD3, ADCL2, ARCL1A, HNARMD, CMT1H	 Macular degeneration, age-related, 3	608895	mutation identified in 1 ADCL2 patient	3
FBLN5, ARMD3, ADCL2, ARCL1A, HNARMD, CMT1H	 Neuropathy, hereditary, with or without age-related macular degeneration	608895	mutation identified in 1 ADCL2 patient	3
FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	 Acromicric dysplasia	102370		3
FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	 Ectopia lentis, familial	129600		3
FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	Geleophysic dysplasia 2	614185		3
FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	 Marfan lipodystrophy syndrome	616914		3
FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	 Marfan syndrome	154700		3
FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	 MASS syndrome	604308		3
FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	 Stiff skin syndrome	184900		3
FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	 Weill-Marchesani syndrome 2, dominant	608328		3
FBN2, CCA, EOMD	 Contractural arachnodactyly, congenital	121050		3
FBN2, CCA, EOMD	Macular degeneration, early-onset	616118		3
FBP1	Fructose-1,6-bisphosphatase deficiency	229700		3
FBXL3, FBXL3A, FBL3, IDDSFAS	Intellectual developmental disorder with short stature, facial anomalies, and speech defects	606220		3
FBXL4, FBL4, MTDPS13	Mitochondrial DNA depletion syndrome 13 	615471		3
FBXO11, FBX11, VIT1, PRMT9, IDDFBA	Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities	618089	?2p16	3
FBXO28, FBX28, KIAA0483, DEE100	Developmental and epileptic encephalopathy 100	619777		3
FBXO38, FBX38, MOKA, HMN2D	Neuronopathy, distal hereditary motor, type IID	615575		3
FBXO43, EMI2, ERP1, FBX43, SPGF64, OOMD12	Oocyte maturation defect 12	619697		3
FBXO43, EMI2, ERP1, FBX43, SPGF64, OOMD12	 Spermatogenic failure 64	619696		3
FBXO7, FBX7, FBX, PKPS, PARK15	Parkinson disease 15, autosomal recessive	260300		3
FBXW11, FBXW1B, BTRC2, BTRCP2, NEDJED	Neurodevelopmental, jaw, eye, and digital syndrome	618914		3
FBXW7, AGO, CDC4, DEDHIL	Developmental delay, hypotonia, and impaired language	620012		3
FCGR1A, IGFR1, CD64	IgG receptor I, phagocytic, familial deficiency of	146760		3
FCGR2A, IGFR2, CD32	 Lupus nephritis, susceptibility to	152700	FCG2 and FCG3 within 250kb	3
FCGR2A, IGFR2, CD32	Malaria, severe, susceptibility to	611162	FCG2 and FCG3 within 250kb	3
FCGR2A, IGFR2, CD32	 Pseudomonas aeruginosa, susceptibility to chronic infection by, in cystic fibrosis	219700	FCG2 and FCG3 within 250kb	3
FCGR2B, CD32	 Malaria, resistance to	611162		3
FCGR2B, CD32	Systemic lupus erythematosus, susceptibility to	152700		3
FCGR3A, CD16, IGFR3, IMD20	Immunodeficiency 20	615707	FCGR2A and FCGR3A within 250kb antigen	3
FCHO1, IMD76	Immunodeficiency 76	619164		3
FCN3, HAKA1	Immunodeficiency due to ficolin 3 deficiency	613860		3
FCSK, FUK, CDGF2	Congenital disorder of glycosylation with defective fucosylation 2	618324		3
FCYT, PKHD1, ARPKD, PKD4	Polycystic kidney disease 4, with or without hepatic disease	263200		3
FDFT1, DGPT, SQSD	Squalene synthase deficiency	618156		3
FDPS, FPS, POROK9	Porokeratosis 9, multiple types	616631		3
FDX2, FDX1L, MEOAL	Mitochondrial myopathy, episodic, with optic atrophy and reversible leukoencephalopathy	251900		3
FDXR, ADXR, ANOA	Auditory neuropathy and optic atrophy	617717		3
FEB10	Febrile seizures, familial, 10	612637	between D3S3656 and D3S1232	2
FEB1	Febrile seizures, familial, 1	121210		2
FEB2	Febrile seizures, familial, 2	602477		2
FEB5	Febrile seizures, familial, 5	609255	between D6S1572 and D6S472	2
FEB6	Febrile seizures, familial, 6	609253	max lod at D18S1158	2
FEB7	Febrile seizures, familial, 7	611515	max lod at D21S1910	2
FEB9	Febrile seizures, familial, 9	611634	between D3S3727 and D3S3567	2
FECD2, FCD1	Corneal dystrophy, Fuchs endothelial, 2	610158	max lod at D13S1304	2
FECD5, FCD3	Corneal dystrophy, Fuchs endothelial, 5	613269	flanked by D5S470 and D5S2108	2
FECD7, FCD4	Corneal dystrophy, Fuchs endothelial, 7	613271	max lod at D9S256	2
FECH, FCE, EPP1	Protoporphyria, erythropoietic, 1	177000		3
FERMT1, KIND1, URP1, C20orf42	Kindler syndrome	173650		3
FERMT3, KIND3, URP2, MIG2B	Leukocyte adhesion deficiency, type III	612840		3
FEZF1, FEZ, ZNF312B, HH22	Hypogonadotropic hypogonadism 22, with or without anosmia	616030		3
FFAR4, O3FAR1, GPR120, PGR4, BMIQ10	Obesity, susceptibility to	607514		3
FGA	 Afibrinogenemia, congenital	202400		3
FGA	 Amyloidosis, familial visceral	105200		3
FGA	 Dysfibrinogenemia, congenital	616004		3
FGA	Hypodysfibrinogenemia, congenital	616004		3
FGB	 Afibrinogenemia, congenital	202400	4q31 by A; proximal to GYPB/GYPA	3
FGB	 Dysfibrinogenemia, congenital	616004	4q31 by A; proximal to GYPB/GYPA	3
FGB	Hypofibrinogenemia, congenital	202400	4q31 by A; proximal to GYPB/GYPA	3
FGD1, FGDY, AAS, MRXS16	 Aarskog-Scott syndrome	305400		3
FGD1, FGDY, AAS, MRXS16	Intellectual developmental disorder, X-linked syndromic 16	305400		3
FGD4, FRABIN, CMT4H	Charcot-Marie-Tooth disease, type 4H	609311		3
FGF10	Aplasia of lacrimal and salivary glands	180920		3
FGF10	 LADD syndrome	149730		3
FGF12, FHF1, DEE47	Developmental and epileptic encephalopathy 47	617166		3
FGF13, FGF2, DEE90	Developmental and epileptic encephalopathy 90	301058		3
FGF14, FHF4, SCA27A, SCA27B	Spinocerebellar ataxia 27A	193003		3
FGF14, FHF4, SCA27A, SCA27B	 Spinocerebellar ataxia 27B, late-onset	620174		3
FGF16, MF4	Metacarpal 4-5 fusion	309630	previously mapped to 8q21.3	3
FGF17, HH20	Hypogonadotropic hypogonadism 20 with or without anosmia	615270		3
FGF23, ADHR, HPDR2, PHPTC, HFTC2	 Hypophosphatemic rickets, autosomal dominant	193100		3
FGF23, ADHR, HPDR2, PHPTC, HFTC2	Tumoral calcinosis, hyperphosphatemic, familial, 2	617993		3
FGF3, INT2	Deafness, congenital with inner ear agenesis, microtia, and microdontia	610706	35kb 5' to HST1	3
FGF5, TCMGLY	Trichomegaly	190330		3
FGF8, HH6	Hypogonadotropic hypogonadism 6 with or without anosmia	612702		3
FGF9, SYNS3	Multiple synostoses syndrome 3	612961		3
FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	 Encephalocraniocutaneous lipomatosis, somatic mosaic	613001	fused with BCR, CEP1, FOP, FIM in hematologic malignancies	3
FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	 Hartsfield syndrome	615465	fused with BCR, CEP1, FOP, FIM in hematologic malignancies	3
FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	 Hypogonadotropic hypogonadism 2 with or without anosmia	147950	fused with BCR, CEP1, FOP, FIM in hematologic malignancies	3
FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	 Jackson-Weiss syndrome	123150	fused with BCR, CEP1, FOP, FIM in hematologic malignancies	3
FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	 Osteoglophonic dysplasia	166250	fused with BCR, CEP1, FOP, FIM in hematologic malignancies	3
FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	Pfeiffer syndrome	101600	fused with BCR, CEP1, FOP, FIM in hematologic malignancies	3
FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	 Trigonocephaly 1	190440	fused with BCR, CEP1, FOP, FIM in hematologic malignancies	3
FGFR1OP, FOP	Myeloproliferative disorder	605392	fusion gene with ZNF198, CEP1, and FGFR1	2
FGFR2, BEK, CFD1, JWS, TK14, BBDS	 Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis	207410		3
FGFR2, BEK, CFD1, JWS, TK14, BBDS	 Apert syndrome	101200		3
FGFR2, BEK, CFD1, JWS, TK14, BBDS	 Beare-Stevenson cutis gyrata syndrome	123790		3
FGFR2, BEK, CFD1, JWS, TK14, BBDS	Bent bone dysplasia syndrome	614592		3
FGFR2, BEK, CFD1, JWS, TK14, BBDS	 Craniofacial-skeletal-dermatologic dysplasia	101600		3
FGFR2, BEK, CFD1, JWS, TK14, BBDS	 Craniosynostosis, nonspecific	176943		3
FGFR2, BEK, CFD1, JWS, TK14, BBDS	 Crouzon syndrome	123500		3
FGFR2, BEK, CFD1, JWS, TK14, BBDS	 Gastric cancer, somatic	613659		3
FGFR2, BEK, CFD1, JWS, TK14, BBDS	 Jackson-Weiss syndrome	123150		3
FGFR2, BEK, CFD1, JWS, TK14, BBDS	 LADD syndrome	149730		3
FGFR2, BEK, CFD1, JWS, TK14, BBDS	 Pfeiffer syndrome	101600		3
FGFR2, BEK, CFD1, JWS, TK14, BBDS	 Saethre-Chotzen syndrome	101400		3
FGFR2, BEK, CFD1, JWS, TK14, BBDS	 Scaphocephaly and Axenfeld-Rieger anomaly	176943		3
FGFR2, BEK, CFD1, JWS, TK14, BBDS	 Scaphocephaly, maxillary retrusion, and impaired intellectual development	609579		3
FGFR3, ACH	 Achondroplasia	100800		3
FGFR3, ACH	 Bladder cancer, somatic	109800		3
FGFR3, ACH	 CATSHL syndrome	610474		3
FGFR3, ACH	 Cervical cancer, somatic	603956		3
FGFR3, ACH	 Colorectal cancer, somatic	114500		3
FGFR3, ACH	 Crouzon syndrome with acanthosis nigricans	612247		3
FGFR3, ACH	 Hypochondroplasia	146000		3
FGFR3, ACH	 LADD syndrome	149730		3
FGFR3, ACH	Muenke syndrome	602849		3
FGFR3, ACH	 Nevus, epidermal, somatic	162900		3
FGFR3, ACH	 SADDAN	616482		3
FGFR3, ACH	 Spermatocytic seminoma, somatic	273300		3
FGFR3, ACH	 Thanatophoric dysplasia, type I	187600		3
FGFR3, ACH	 Thanatophoric dysplasia, type II	187601		3
FGFR4	Cancer progression/metastasis	134935	distal to DRD1	3
FGG	 Afibrinogenemia, congenital	202400	linked to MN	3
FGG	Dysfibrinogenemia, congenital	616004	linked to MN	3
FGG	 Hypodysfibrinogenemia	616004	linked to MN	3
FGG	 Hypofibrinogenemia, congenital	202400	linked to MN	3
FGLDS2	Feingold syndrome 2	614326	contiguous gene deletion syndrome	4
FGQTL1	Fasting plasma glucose level QTL 1	612108	associated with rs560887	2
FGQTL2, BWQTL1	 Birth weight QTL 1	613219	associated with rs4607517	2
FGQTL2, BWQTL1	Fasting plasma glucose level QTL 2	613219	associated with rs4607517	2
FGQTL3	Fasting plasma glucose level QTL 3	613233	associated with rs10830963	2
FGQTL4	Fasting plasma glucose level QTL 4	613462	associated with rs2191349	2
FGQTL6, BWQTL3	Birth weight QTL 3	613460	associated with rs11708067 and rs11708067	2
FGQTL6, BWQTL3	 Fasting plasma glucose level QTL 6	613460	associated with rs11708067 and rs11708067	2
FGS3	FG syndrome 3	300406		2
FGS5	FG syndrome 5	300581		2
FH, HLRCC, MCUL1, FMRD	 Fumarase deficiency	606812		3
FH, HLRCC, MCUL1, FMRD	Leiomyomatosis and renal cell cancer	150800		3
FHL1, HPLH1, HLH1	Hemophagocytic lymphohistiocytosis, familial, 1	267700		2
FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B, FCMSU	 Emery-Dreifuss muscular dystrophy 6, X-linked	300696	mutation identified in 1 FCMSU family	3
FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B, FCMSU	Myopathy, X-linked, with postural muscle atrophy	300696	mutation identified in 1 FCMSU family	3
FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B, FCMSU	 Reducing body myopathy, X-linked 1a, severe, infantile or early childhood onset	300717	mutation identified in 1 FCMSU family	3
FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B, FCMSU	 Reducing body myopathy, X-linked 1b, with late childhood or adult onset	300718	mutation identified in 1 FCMSU family	3
FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B, FCMSU	 Scapuloperoneal myopathy, X-linked dominant	300695	mutation identified in 1 FCMSU family	3
FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B, FCMSU	 Uruguay faciocardiomusculoskeletal syndrome	300280	mutation identified in 1 FCMSU family	3
FHOD3, FHOS2, KIAA1695, CMH28	Cardiomyopathy, familial hypertrophic, 28	619402		3
FIBP, TROFAS	Thauvin-Robinet-Faivre syndrome	617107		3
FIG4, KIAA0274, SAC3, ALS11, YVS, BTOP	 Amyotrophic lateral sclerosis 11	612577	mutation identified in 1 BTOP family	3
FIG4, KIAA0274, SAC3, ALS11, YVS, BTOP	 Charcot-Marie-Tooth disease, type 4J	611228	mutation identified in 1 BTOP family	3
FIG4, KIAA0274, SAC3, ALS11, YVS, BTOP	 Polymicrogyria, bilateral temporooccipital	612691	mutation identified in 1 BTOP family	3
FIG4, KIAA0274, SAC3, ALS11, YVS, BTOP	Yunis-Varon syndrome	216340	mutation identified in 1 BTOP family	3
FIGLA, POF6	Premature ovarian failure 6	612310		3
FIQTL1	Fasting insulin level quantitative trait locus 1	606035	max lod at D6S1569	2
FIT2, C20orf142, SIDDIS	Siddiqi syndrome	618635		3
FKBP10, FKBP65, OI11, BRKS1	 Bruck syndrome 1	259450		3
FKBP10, FKBP65, OI11, BRKS1	Osteogenesis imperfecta, type XI	610968		3
FKBP14, EDSKSCL2	Ehlers-Danlos syndrome, kyphoscoliotic type, 2	614557		3
FKBP5, FKBP51	Major depressive disorder and accelerated response to antidepressant drug treatment	608516		3
FKBP6, SPGF77	Spermatogenic failure 77	620103		3
FKRP, MDC1C, LGMDR9, MDDGA5, MDDGB5, MDDGC5	 Muscular dystrophy-dystroglycanopathy , type A, 5	613153		3
FKRP, MDC1C, LGMDR9, MDDGA5, MDDGB5, MDDGC5	Muscular dystrophy-dystroglycanopathy , type B, 5	606612		3
FKRP, MDC1C, LGMDR9, MDDGA5, MDDGB5, MDDGC5	 Muscular dystrophy-dystroglycanopathy , type C, 5	607155		3
FKTN, FCMD, CMD1X, LGMDR13, MDDGA4, MDDGB4, MDDGC4	 Cardiomyopathy, dilated, 1X	611615		3
FKTN, FCMD, CMD1X, LGMDR13, MDDGA4, MDDGB4, MDDGC4	 Muscular dystrophy-dystroglycanopathy , type A, 4	253800		3
FKTN, FCMD, CMD1X, LGMDR13, MDDGA4, MDDGB4, MDDGC4	 Muscular dystrophy-dystroglycanopathy , type B, 4	613152		3
FKTN, FCMD, CMD1X, LGMDR13, MDDGA4, MDDGB4, MDDGC4	Muscular dystrophy-dystroglycanopathy , type C, 4	611588		3
FL1	Follicular lymphoma, susceptibility to, 1	613024	associated with rs6457327	2
FLAD1, FADS, LSMFLAD	Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency	255100		3
FLCN, BHD	Birt-Hogg-Dube syndrome	135150		3
FLCN, BHD	 Colorectal cancer, somatic	114500		3
FLCN, BHD	 Pneumothorax, primary spontaneous	173600		3
FLCN, BHD	 Renal carcinoma, chromophobe, somatic	144700		3
FLD1, NAFLD1	Fatty liver disease, susceptibility to, 1	613282	associated with rs738409	2
FLD1, NAFLD2	Fatty liver disease, susceptibility to, 2	613387	associated with rs2854116, rs2854117	2
FLG2, IFPS, PSS6	Peeling skin syndrome 6	618084		3
FLG, ATOD2	 Dermatitis, atopic, susceptibility to, 2	605803		3
FLG, ATOD2	Ichthyosis vulgaris	146700		3
FLI1, BDPLT21	Bleeding disorder, platelet-type, 21	617443	fused with EWS in Ewing sarcoma	3
FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS, FGS2	 Cardiac valvular dysplasia, X-linked	314400	mutation identified in 1 FGS2 patient	3
FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS, FGS2	 Congenital short bowel syndrome	300048	mutation identified in 1 FGS2 patient	3
FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS, FGS2	 FG syndrome 2	300321	mutation identified in 1 FGS2 patient	3
FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS, FGS2	 Frontometaphyseal dysplasia 1	305620	mutation identified in 1 FGS2 patient	3
FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS, FGS2	 Heterotopia, periventricular, 1	300049	mutation identified in 1 FGS2 patient	3
FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS, FGS2	 Intestinal pseudoobstruction, neuronal	300048	mutation identified in 1 FGS2 patient	3
FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS, FGS2	 Melnick-Needles syndrome	309350	mutation identified in 1 FGS2 patient	3
FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS, FGS2	 Otopalatodigital syndrome, type I	311300	mutation identified in 1 FGS2 patient	3
FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS, FGS2	Otopalatodigital syndrome, type II	304120	mutation identified in 1 FGS2 patient	3
FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS, FGS2	 Terminal osseous dysplasia	300244	mutation identified in 1 FGS2 patient	3
FLNB, SCT, AOI, LRS1	 Atelosteogenesis, type I	108720		3
FLNB, SCT, AOI, LRS1	 Atelosteogenesis, type III	108721		3
FLNB, SCT, AOI, LRS1	 Boomerang dysplasia	112310		3
FLNB, SCT, AOI, LRS1	Larsen syndrome	150250		3
FLNB, SCT, AOI, LRS1	 Spondylocarpotarsal synostosis syndrome	272460		3
FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5	Cardiomyopathy, familial hypertrophic, 26	617047		3
FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5	 Cardiomyopathy, familial restrictive 5	617047		3
FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5	 Myopathy, distal, 4	614065		3
FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5	 Myopathy, myofibrillar, 5	609524		3
FLRT3, HH21	Hypogonadotropic hypogonadism 21 with anosmia	615271		3
FLT3	Leukemia, acute lymphoblastic, somatic	613065		3
FLT3	 Leukemia, acute myeloid, reduced survival in, somatic	601626		3
FLT3	 Leukemia, acute myeloid, somatic	601626		3
FLT4, VEGFR3, PCL, LMPHM1, CHTD7	 Congenital heart defects, multiple types, 7	618780		3
FLT4, VEGFR3, PCL, LMPHM1, CHTD7	Hemangioma, capillary infantile, somatic	602089		3
FLT4, VEGFR3, PCL, LMPHM1, CHTD7	 Lymphatic malformation 1	153100		3
FLVCR1, AXPC1, PCARP	Ataxia, posterior column, with retinitis pigmentosa	609033		3
FLVCR2, C14orf58, CCT, PVHH, EPV	Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome	225790		3
FMN2, MRT47	Intellectual developmental disorder, autosomal recessive 47	616193		3
FMO3, TMAU	Trimethylaminuria	602079		3
FMR1, FRAXA, POF1	 Fragile X syndrome	300624	8-8.7Mb from telomere	3
FMR1, FRAXA, POF1	Fragile X tremor/ataxia syndrome	300623	8-8.7Mb from telomere	3
FMR1, FRAXA, POF1	 Premature ovarian failure 1	311360	8-8.7Mb from telomere	3
FN1, FN, LETS, FNZ, GFND2, SMDCF	 Glomerulopathy with fibronectin deposits 2	601894		3
FN1, FN, LETS, FNZ, GFND2, SMDCF	Spondylometaphyseal dysplasia, corner fracture type	184255		3
FNIP1, KIAA1961, IMD93	Immunodeficiency 93 and hypertrophic cardiomyopathy	619705		3
FOCAD, KIAA1797, SCOLIV	Liver disease, severe congenital	619991		3
FOLR1, NCFTD	Neurodegeneration due to cerebral folate transport deficiency	613068	telomeric of FGF3	3
FOXC1, FKHL7, FREAC3, IRID1, RIEG3, ASGD3	 Anterior segment dysgenesis 3, multiple subtypes	601631		3
FOXC1, FKHL7, FREAC3, IRID1, RIEG3, ASGD3	Axenfeld-Rieger syndrome, type 3	602482		3
FOXC2, FKHL14, MFH1	Lymphedema-distichiasis syndrome	153400		3
FOXC2, FKHL14, MFH1	 Lymphedema-distichiasis syndrome with renal disease and diabetes mellitus	153400		3
FOXD3, AIS1, VAMAS2	Autoimmune disease, susceptibility to, 1	607836		3
FOXE1, FKHL15, TITF2, TTF2, NMTC4, BAMLAZ	Bamforth-Lazarus syndrome	241850		3
FOXE1, FKHL15, TITF2, TTF2, NMTC4, BAMLAZ	 Thyroid cancer, nonmedullary, 4	616534		3
FOXE3, FKHL12, ASMD, CTRCT34, ASGD2, AAT11	Anterior segment dysgenesis 2, multiple subtypes	610256		3
FOXE3, FKHL12, ASMD, CTRCT34, ASGD2, AAT11	 Aortic aneurysm, familial thoracic 11, susceptibility to	617349		3
FOXE3, FKHL12, ASMD, CTRCT34, ASGD2, AAT11	 Cataract 34, multiple types	612968		3
FOXF1, FKHL5, ACDMPV	Alveolar capillary dysplasia with misalignment of pulmonary veins	265380		3
FOXG1, FOXG1B, FKHL1, FKH2, QIN, BF1	Rett syndrome, congenital variant	613454		3
FOXI1, FKHL10, FREAC6	Enlarged vestibular aqueduct	600791	some patients have digenic mutations with SLC26A4	3
FOXJ1, FKHL13, HFH4, CILD43	Ciliary dyskinesia, primary, 43	618699		3
FOXL2, BPES, BPES1, PFRK, POF3	 Blepharophimosis, epicanthus inversus, and ptosis, type 1	110100		3
FOXL2, BPES, BPES1, PFRK, POF3	Blepharophimosis, epicanthus inversus, and ptosis, type 2	110100		3
FOXL2, BPES, BPES1, PFRK, POF3	 Premature ovarian failure 3	608996		3
FOXN1, WHN, TIDAND, TLIND	 T-cell immunodeficiency, congenital alopecia, and nail dystrophy	601705		3
FOXN1, WHN, TIDAND, TLIND	T-cell lymphopenia, infantile, with or without nail dystrophy, autosomal dominant	618806		3
FOXO1A, FKHR	Rhabdomyosarcoma, alveolar	268220	chimeric with PAX3 in t(2;13); fuses with PAX3	3
FOXP1, QRF1	Intellectual developmental disorder with language impairment with or without autistic features	613670		3
FOXP2, SPCH1, TNRC10, CAGH44	Speech-language disorder-1	602081		3
FOXP3, IPEX, AIID, XPID, PIDX	Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked	304790		3
FOXRED1, MC1DN19	Mitochondrial complex I deficiency, nuclear type 19	618241		3
FPH1, MUH, HPP	Hyperpigmentation, familial progressive, 1	614233		2
FRA10AC1, FRA10A, C10orf4, NEDGFC	Neurodevelopmental disorder with growth retardation, dysmorphic facies, and corpus callosum abnormalities	620113		3
FRAS1, FRASRS1	Fraser syndrome 1	219000		3
FRDA2	Friedreich ataxia 2	601992		2
FREM1, C9orf154, BNAR, MOTA, TRIGNO2	 Bifid nose with or without anorectal and renal anomalies	608980		3
FREM1, C9orf154, BNAR, MOTA, TRIGNO2	Manitoba oculotrichoanal syndrome	248450		3
FREM1, C9orf154, BNAR, MOTA, TRIGNO2	 Trigonocephaly 2	614485		3
FREM2, FRASRS2, CRYPTOP	 Cryptophthalmos, unilateral or bilateral, isolated	123570		3
FREM2, FRASRS2, CRYPTOP	Fraser syndrome 2	617666		3
FRIASS, DEL14q22, C14DELq22	Frias syndrome	609640	deletion spans 4.1 Mb on 14q22.1-q22.3	4
FRMD5, NEDEMA	Neurodevelopmental disorder with eye movement abnormalities and ataxia	620094		3
FRMD7, NYS1, XIPAN	 Nystagmus 1, congenital, X-linked	310700		3
FRMD7, NYS1, XIPAN	Nystagmus, infantile periodic alternating, X-linked	310700		3
FRMPD4, PRESO, KIAA0316, XLID104	Intellectual developmental disorder, X-linked 104	300983		3
FRRS1L, C9orf4, CG6, DEE37	Developmental and epileptic encephalopathy 37	616981		3
FRZB, FRZB1, SRFP3, OS1	Osteoarthritis susceptibility 1	165720		3
FSCN2, RFSN, RP30	Retinitis pigmentosa 30	607921	within 200kb of ACTG1	3
FSHB, HH24	Hypogonadotropic hypogonadism 24 without anosmia	229070	distal to AN2	3
FSHD1, FSHD1A	Facioscapulohumeral muscular dystrophy 1	158900	due to D4Z4 macrosatellite repeat on 4q35	4
FSHR, ODG1	 Ovarian dysgenesis 1	233300		3
FSHR, ODG1	 Ovarian hyperstimulation syndrome	608115		3
FSHR, ODG1	Ovarian response to FSH stimulation	276400		3
FSIP2, SPGF34	Spermatogenic failure 34	618153		3
FTCD	Glutamate formiminotransferase deficiency	229100		3
FTL, NBIA3, LFTD	Hyperferritinemia-cataract syndrome	600886		3
FTL, NBIA3, LFTD	 L-ferritin deficiency, dominant and recessive	615604		3
FTL, NBIA3, LFTD	 Neurodegeneration with brain iron accumulation 3	606159		3
FTO, GDFD, BMIQ14	Growth retardation, developmental delay, facial dysmorphism	612938		3
FTO, GDFD, BMIQ14	 Obesity, susceptibility to, BMIQ14	612460		3
FTSJ1, JM23, SPB1, MRX44, MRX9, XLID9	Intellectual developmental disorder, X-linked 9	309549		3
FUCA1	Fucosidosis	230000	8cM distal to RH; pseudogene on 2q31-q32	3
FUS, TLS, ALS6, ETM4	Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia	608030	fused with DDIT3 in myxoid liposarcoma, with ERG in leukemia, and ATF1 in angiomatoid fibrous histiocytoma	3
FUS, TLS, ALS6, ETM4	 Essential tremor, hereditary, 4	614782	fused with DDIT3 in myxoid liposarcoma, with ERG in leukemia, and ATF1 in angiomatoid fibrous histiocytoma	3
FUT1, H, HH	Bombay phenotype	616754	SE tightly linked	3
FUT2, SE, B12QTL1	 Bombay phenotype, digenic	616754	H, SE = alpha-L-fucosyltransferases; from common ancestral genes; tightly linked to FUT1	3
FUT2, SE, B12QTL1	Norwalk virus infection, resistance to	182100	H, SE = alpha-L-fucosyltransferases; from common ancestral genes; tightly linked to FUT1	3
FUT2, SE, B12QTL1	 Vitamin B12 plasma level QTL1	612542	H, SE = alpha-L-fucosyltransferases; from common ancestral genes; tightly linked to FUT1	3
FUT3, LE	Blood group, Lewis	618983	cen-FUT5-23kb-FUT3-14kb-FUT6-ter	3
FUT6	Fucosyltransferase 6 deficiency	613852	in cluster with FUT3, FUT5	3
FUT8, CDGF1	Congenital disorder of glycosylation with defective fucosylation 1	618005		3
FUZ, NTD	Neural tube defects, susceptibility to	182940		3
FWS	Forsythe-Wakeling syndrome	613606	between rs2354462 and rs718883	2
FXN, FRDA, FARR, X25	 Friedreich ataxia	229300		3
FXN, FRDA, FARR, X25	Friedreich ataxia with retained reflexes	229300		3
FXR1, MYORIBF, MYOPMIL	 Myopathy, congenital proximal, with minicore lesions	618823	mutation identified in 1 MYORIBF family and 1 MYOPMIL family	3
FXYD2, ATP1G1, HOMG2	Hypomagnesemia 2, renal	154020		3
FYB1, SLAP130, ADAP, THC3	Thrombocytopenia 3	273900		3
FYCO1, CATC2, CTRCT18	Cataract 18, autosomal recessive	610019		3
FZD2, OMOD2	Omodysplasia 2	164745		3
FZD4, EVR1	 Exudative vitreoretinopathy 1	133780		3
FZD4, EVR1	Retinopathy of prematurity	133780		3
FZD6, NDNC1	Nail disorder, nonsyndromic congenital, 1	161050		3
FZR1, HCDH1, KIAA1242, DEE109	Developmental and epileptic encephalopathy 109	620145		3
G6PC3, UGRP, SCN4	Dursun syndrome	612541		3
G6PC3, UGRP, SCN4	 Neutropenia, severe congenital 4, autosomal recessive	612541		3
G6PC, G6PT	Glycogen storage disease Ia	232200		3
G6PD, G6PD1	Hemolytic anemia, G6PD deficient 	300908		3
G6PD, G6PD1	 Resistance to malaria due to G6PD deficiency	611162		3
GAA	Glycogen storage disease II	232300	distal to TK1	3
GABBR2, GPR51, DEE59, NDPLHS	 Developmental and epileptic encephalopathy 59	617904		3
GABBR2, GPR51, DEE59, NDPLHS	 Neurodevelopmental disorder with poor language and loss of hand skills	617903		3
GABBR2, GPR51, DEE59, NDPLHS	Nicotine dependence, protection against	188890		3
GABBR2, GPR51, DEE59, NDPLHS	 Nicotine dependence, susceptibility to	188890		3
GABRA1, EJM5, ECA4, DEE19	 Developmental and epileptic encephalopathy 19	615744	in same 200kb as GABRG2	3
GABRA1, EJM5, ECA4, DEE19	 Epilepsy, childhood absence, susceptibility to, 4	611136	in same 200kb as GABRG2	3
GABRA1, EJM5, ECA4, DEE19	Epilepsy, juvenile myoclonic, susceptibility to, 5	611136	in same 200kb as GABRG2	3
GABRA2, DEE78	 Alcohol dependence, susceptibility to	103780		3
GABRA2, DEE78	Developmental and epileptic encephalopathy 78	618557		3
GABRA3, EPILX2	Epilepsy, X-linked 2, with or without impaired intellectual development and dysmorphic features	301091	4Mb from telomere	3
GABRA5, DEE79	Developmental and epileptic encephalopathy 79	618559	100kb from GABRB3	3
GABRB1, DEE45	Developmental and epileptic encephalopathy 45	617153		3
GABRB2, DEE92	Developmental and epileptic encephalopathy 92	617829		3
GABRB3, ECA5, DEE43	 Developmental and epileptic encephalopathy 43	617113		3
GABRB3, ECA5, DEE43	Epilepsy, childhood absence, susceptibility to, 5	612269		3
GABRD, GEFSP5, EIG10, EJM7	Epilepsy, idiopathic generalized, 10	613060		3
GABRD, GEFSP5, EIG10, EJM7	 Epilepsy, juvenile myoclonic, susceptibility to	613060		3
GABRD, GEFSP5, EIG10, EJM7	 Generalized epilepsy with febrile seizures plus, type 5, susceptibility to	613060		3
GABRG2, DEE74, FEB8, ECA2, GEFSP3	Developmental and epileptic encephalopathy 74	618396	in alpha/beta/gamma cluster	3
GABRG2, DEE74, FEB8, ECA2, GEFSP3	 Febrile seizures, familial, 8	607681	in alpha/beta/gamma cluster	3
GABRG2, DEE74, FEB8, ECA2, GEFSP3	 Generalized epilepsy with febrile seizures plus, type 3	607681	in alpha/beta/gamma cluster	3
GAD1, SCP, DEE89	Developmental and epileptic encephalopathy 89	619124		3
GALC	Krabbe disease	245200		3
GALE	Galactose epimerase deficiency	230350		3
GALK1	Galactokinase deficiency with cataracts	230200		3
GALM, GLAT, GALAC4	Galactosemia IV	618881		3
GALNS, MPS4A	Mucopolysaccharidosis IVA	253000	centromeric to APRT	3
GALNT12, CRCS1	Colorectal cancer, susceptibility to, 1	608812		3
GALNT2, CDG2T	Congenital disorder of glycosylation, type IIt	618885		3
GALNT3, HHS, HFTC1	Tumoral calcinosis, hyperphosphatemic, familial, 1	211900		3
GALT	Galactosemia	230400		3
GAMT, CCDS2	Cerebral creatine deficiency syndrome 2	612736		3
GANAB, PKD3	Polycystic kidney disease 3	600666		3
GAN, GAN1	Giant axonal neuropathy-1	256850		3
GARS1, GARS, SMAD1, CMT2D, HMN5A, SMAJI	 Charcot-Marie-Tooth disease, type 2D	601472		3
GARS1, GARS, SMAD1, CMT2D, HMN5A, SMAJI	 Neuronopathy, distal hereditary motor, type VA	600794		3
GARS1, GARS, SMAD1, CMT2D, HMN5A, SMAJI	Spinal muscular atrophy, infantile, James type	619042		3
GAS8, GAS11, CILD33	Ciliary dyskinesia, primary, 33	616726		3
GATA1, GF1, ERYF1, NFE1, XLTDA, XLTT, XLANP, HAEADA	 Anemia, X-linked, with/without neutropenia and/or platelet abnormalities	300835		3
GATA1, GF1, ERYF1, NFE1, XLTDA, XLTT, XLANP, HAEADA	 Hemolytic anemia due to elevated adenosine deaminase	301083		3
GATA1, GF1, ERYF1, NFE1, XLTDA, XLTT, XLANP, HAEADA	Leukemia, megakaryoblastic, with or without Down syndrome, somatic	190685		3
GATA1, GF1, ERYF1, NFE1, XLTDA, XLTT, XLANP, HAEADA	 Thrombocytopenia with beta-thalassemia, X-linked	314050		3
GATA1, GF1, ERYF1, NFE1, XLTDA, XLTT, XLANP, HAEADA	 Thrombocytopenia, X-linked, with or without dyserythropoietic anemia	300367		3
GATA2, DCML, MONOMAC, IMD21	 Emberger syndrome	614038		3
GATA2, DCML, MONOMAC, IMD21	 Immunodeficiency 21	614172		3
GATA2, DCML, MONOMAC, IMD21	Leukemia, acute myeloid, susceptibility to	601626		3
GATA2, DCML, MONOMAC, IMD21	 Myelodysplastic syndrome, susceptibility to	614286		3
GATA3, HDR, HDRS	Hypoparathyroidism, sensorineural deafness, and renal dysplasia	146255		3
GATA4, ASD2, VSD1, TACHD, TOF	 Atrial septal defect 2	607941	mutations identified in 1 TACHD family	3
GATA4, ASD2, VSD1, TACHD, TOF	 Atrioventricular septal defect 4	614430	mutations identified in 1 TACHD family	3
GATA4, ASD2, VSD1, TACHD, TOF	 Testicular anomalies with or without congenital heart disease	615542	mutations identified in 1 TACHD family	3
GATA4, ASD2, VSD1, TACHD, TOF	Tetralogy of Fallot	187500	mutations identified in 1 TACHD family	3
GATA4, ASD2, VSD1, TACHD, TOF	 Ventricular septal defect 1	614429	mutations identified in 1 TACHD family	3
GATA5, CHTD5	Congenital heart defects, multiple types, 5	617912		3
GATA6, AVSD5, ASD9, PACHD	Atrial septal defect 9	614475		3
GATA6, AVSD5, ASD9, PACHD	 Atrioventricular septal defect 5	614474		3
GATA6, AVSD5, ASD9, PACHD	 Pancreatic agenesis and congenital heart defects	600001		3
GATA6, AVSD5, ASD9, PACHD	 Persistent truncus arteriosus	217095		3
GATA6, AVSD5, ASD9, PACHD	 Tetralogy of Fallot	187500		3
GATAD2B, KIAA1150, p68, GANDS	GAND syndrome	615074		3
GATC, COXPD42	Combined oxidative phosphorylation deficiency 42	618839		3
GATM, AGAT, CCDS3, FRTS1	Cerebral creatine deficiency syndrome 3	612718		3
GATM, AGAT, CCDS3, FRTS1	 Fanconi renotubular syndrome 1	134600		3
GBA2, KIAA1605, SPG46	Spastic paraplegia 46, autosomal recessive	614409		3
GBA	 Gaucher disease, perinatal lethal	608013	pseudogene GBAP ~16kb 3' to GBA	3
GBA	 Gaucher disease, type I	230800	pseudogene GBAP ~16kb 3' to GBA	3
GBA	 Gaucher disease, type II	230900	pseudogene GBAP ~16kb 3' to GBA	3
GBA	 Gaucher disease, type III	231000	pseudogene GBAP ~16kb 3' to GBA	3
GBA	 Gaucher disease, type IIIC	231005	pseudogene GBAP ~16kb 3' to GBA	3
GBA	Lewy body dementia, susceptibility to	127750	pseudogene GBAP ~16kb 3' to GBA	3
GBA	 Parkinson disease, late-onset, susceptibility to	168600	pseudogene GBAP ~16kb 3' to GBA	3
GBD2	Gallbladder disease 2	609918	between D1S1597 and D1S47	2
GBD3	Gallbladder disease 3	609919	new D2S255	2
GBE1, GSD4, APBD	Glycogen storage disease IV	232500		3
GBE1, GSD4, APBD	 Polyglucosan body disease, adult form	263570		3
GBF1, CMT2GG	Charcot-Marie-Tooth disease, axonal, type 2GG	606483		3
GCCD3, FGD3, GCCD2	Glucocorticoid deficiency 3	609197	between D8S285 and D8S1718	2
GCDH	Glutaricaciduria, type I	231670		3
GCGR, MVAH	Mahvash disease	619290		3
GCH1, DYT5, HPABH4B	Dystonia, DOPA-responsive	128230		3
GCH1, DYT5, HPABH4B	 Hyperphenylalaninemia, BH4-deficient, B	233910		3
GCK, HHF3, PNDM1	 Diabetes mellitus, noninsulin-dependent, late onset	125853	proximal to TCRB	3
GCK, HHF3, PNDM1	 Diabetes mellitus, permanent neonatal 1	606176	proximal to TCRB	3
GCK, HHF3, PNDM1	 Hyperinsulinemic hypoglycemia, familial, 3	602485	proximal to TCRB	3
GCK, HHF3, PNDM1	MODY, type II	125851	proximal to TCRB	3
GCKR, GKRP, FGQTL5	Fasting plasma glucose level QTL 5	613463		3
GCLC, GLCLC	 Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency	230450		3
GCLC, GLCLC	Myocardial infarction, susceptibility to	608446		3
GCLM, GLCLR	Myocardial infarction, susceptibility to	608446		3
GCM2, GCMB, HRPT4, FIH2	 Hyperparathyroidism 4	617343		3
GCM2, GCMB, HRPT4, FIH2	Hypoparathyroidism, familial isolated 2	618883		3
GCNA, ACRC, SPGFX4	Spermatogenic failure, X-linked, 4	301077		3
GCNT2, Ii, CTRCT13	 Adult i phenotype without cataract	110800	previously assigned to 9q21	3
GCNT2, Ii, CTRCT13	Blood group, Ii	110800	previously assigned to 9q21	3
GCNT2, Ii, CTRCT13	 Cataract 13 with adult i phenotype	116700	previously assigned to 9q21	3
GDAP1, CMT4A, CMT2K, CMTRIA	 Charcot-Marie-Tooth disease, axonal, type 2K	607831		3
GDAP1, CMT4A, CMT2K, CMTRIA	Charcot-Marie-Tooth disease, axonal, with vocal cord paresis	607706		3
GDAP1, CMT4A, CMT2K, CMTRIA	 Charcot-Marie-Tooth disease, recessive intermediate, A	608340		3
GDAP1, CMT4A, CMT2K, CMTRIA	 Charcot-Marie-Tooth disease, type 4A	214400		3
GDAP2, SCAR27	Spinocerebellar ataxia, autosomal recessive 27	618369		3
GDF1, DTGA3, DORV, RAI, CHTD6	Congenital heart defects, multiple types, 6	613854		3
GDF1, DTGA3, DORV, RAI, CHTD6	 Right atrial isomerism 	208530		3
GDF2, BMP9, HHT5	Telangiectasia, hereditary hemorrhagic, type 5	615506		3
GDF3, KFS3, MCOPCB6, MCOP7	Klippel-Feil syndrome 3, autosomal dominant	613702		3
GDF3, KFS3, MCOPCB6, MCOP7	 Microphthalmia, isolated 7	613704		3
GDF3, KFS3, MCOPCB6, MCOP7	 Microphthalmia, isolated, with coloboma 6	613703		3
GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B, DUPANS	Acromesomelic dysplasia 2A	200700	mutation identified in 1 AMD2C family	3
GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B, DUPANS	 Acromesomelic dysplasia 2B	228900	mutation identified in 1 AMD2C family	3
GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B, DUPANS	 Acromesomelic dysplasia 2C, Hunter-Thompson type	201250	mutation identified in 1 AMD2C family	3
GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B, DUPANS	 Brachydactyly, type A1, C	615072	mutation identified in 1 AMD2C family	3
GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B, DUPANS	 Brachydactyly, type A2	112600	mutation identified in 1 AMD2C family	3
GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B, DUPANS	 Brachydactyly, type C	113100	mutation identified in 1 AMD2C family	3
GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B, DUPANS	 Multiple synostoses syndrome 2	610017	mutation identified in 1 AMD2C family	3
GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B, DUPANS	 Osteoarthritis-5	612400	mutation identified in 1 AMD2C family	3
GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B, DUPANS	 Symphalangism, proximal, 1B	615298	mutation identified in 1 AMD2C family	3
GDF6, MCOP4, KFS1, MCOPCB6, LCA17, SYNS4	 Klippel-Feil syndrome 1, autosomal dominant	118100		3
GDF6, MCOP4, KFS1, MCOPCB6, LCA17, SYNS4	 Leber congenital amaurosis 17	615360		3
GDF6, MCOP4, KFS1, MCOPCB6, LCA17, SYNS4	 Microphthalmia, isolated 4	613094		3
GDF6, MCOP4, KFS1, MCOPCB6, LCA17, SYNS4	Microphthalmia with coloboma 6, digenic	613703		3
GDF6, MCOP4, KFS1, MCOPCB6, LCA17, SYNS4	 Multiple synostoses syndrome 4	617898		3
GDI1, RABGD1A, MRX41, MRX48, XLID41	Intellectual developmental disorder, X-linked 41	300849		3
GDNF, HSCR3	Hirschsprung disease, susceptibility to, 3	613711		3
GEFSP4	Generalized epilepsy with febrile seizures plus, type 4	609800	max lod at D2S305	2
GEFSP6	Generalized epilepsy with febrile seizures plus, type 6	612279	between D8S1706 and D8S549	2
GEFSP7, FEB3B	Generalized epilepsy with febrile seizures plus, type 7	613863	max lod at D2S2330	2
GEFSP8	Generalized epilepsy with febrile seizures plus, type 8	613828	between D6S962 and D6S287	2
GEMIN4, NEDMCR	Neurodevelopmental disorder with microcephaly, cataracts, and renal abnormalities	617913		3
GEMIN5, NEDCAM	Neurodevelopmental disorder with cerebellar atrophy and motor dysfunction	619333		3
GER	Gastroesophageal reflux	109350		2
GEVQ1	Gene expression, variation in, QTL	608875		2
GEVQ2	Gene expression, variation in, QTL	608878		2
GFAP, ALXDRD	Alexander disease	203450		3
GFER, ERV1, ALR, MPMCD	Myopathy, mitochondrial progressive, with congenital cataract and developmental delay	613076		3
GFI1B, BDPLT17	Bleeding disorder, platelet-type, 17	187900		3
GFI1, ZNF163, SCN2	 Neutropenia, severe congenital 2, autosomal dominant	613107	mutation identified in 1 NICINA patient	3
GFM1, EFG1, GFM, COXPD1	Combined oxidative phosphorylation deficiency 1	609060		3
GFM2, EFG2, RRF	Combined oxidative phosphorylation deficiency 39	618397		3
GFND1	Glomerulopathy with fibronectin deposits 1	137950	max lod at D1S2782	2
GFPT1, GFAT1, GFPT1L, MSLG, CMS12, CMSTA1	Myasthenia, congenital, 12, with tubular aggregates	610542		3
GFRA1, GDNFRA, GDNFR, RHDA4	Renal hypodysplasia/aplasia 4	619887		3
GGCX, VKCFD1	 Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency	610842		3
GGCX, VKCFD1	Vitamin K-dependent clotting factors, combined deficiency of, 1	277450		3
GGN	Spermatogenic failure 69	619826		3
GGPS1, GGPPS1, MDHLO	Muscular dystrophy, congenital hearing loss, and ovarian insufficiency syndrome	619518		3
GGT2	Gamma-glutamyltransferase, familial high serum	137181		2
GH1, GHN, IGHD1A, IGHD1B, IGHD2	 Growth hormone deficiency, isolated, type IA	262400	5'-GH1-CSHP1-CSH1-GH2-CSH2-3'	3
GH1, GHN, IGHD1A, IGHD1B, IGHD2	 Growth hormone deficiency, isolated, type IB	612781	5'-GH1-CSHP1-CSH1-GH2-CSH2-3'	3
GH1, GHN, IGHD1A, IGHD1B, IGHD2	 Growth hormone deficiency, isolated, type II	173100	5'-GH1-CSHP1-CSH1-GH2-CSH2-3'	3
GH1, GHN, IGHD1A, IGHD1B, IGHD2	Kowarski syndrome	262650	5'-GH1-CSHP1-CSH1-GH2-CSH2-3'	3
GHR, GHIP	 Growth hormone insensitivity, partial	604271		3
GHR, GHIP	 Hypercholesterolemia, familial, modifier of	143890		3
GHR, GHIP	 Increased responsiveness to growth hormone	604271		3
GHR, GHIP	Laron dwarfism	262500		3
GHRH, GHRF	Gigantism due to GHRF hypersecretion	139190		1
GHRH, GHRF	 Isolated growth hormone deficiency due to defect in GHRF	139190		1
GHRHR, GHRFR, IGHD4	Growth hormone deficiency, isolated, type IV	618157		3
GHRL	Obesity, susceptibility to	601665		3
GHSR, GHDP	Growth hormone deficiency, isolated partial	615925		3
GIGYF2, KIAA0642, PARK11	Parkinson disease 11	607688		3
GIMAP5, IAN4L1, IMAP3, NCPH2	Portal hypertension, noncirrhotic, 2	619463		3
GINGF2, GGF2, HGF2	Fibromatosis, gingival, 2	605544	formerly GINGF2 used for a locus on 2p16-p13	2
GINGF3, HGF3, GGF3	Fibromatosis, gingival, 3	609955	between D2S2221 and D2S1788	2
GINGF4, HGF4, GGF4	Fibromatosis, gingival, 4	611010	between D11S1984 and D11S1338	2
GINS1, PSF1, KIAA0186, IMD55	Immunodeficiency 55	617827		3
GIPC1, RGS19IP1, C19orf3, OPDM2	Oculopharyngodistal myopathy 2	618940		3
GIPC3, DFNB15, DFNB72, DFNB95	Deafness, autosomal recessive 15	601869		3
GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP3	 Atrioventricular septal defect 3	600309	pseudogene on chr.5	3
GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP3	 Craniometaphyseal dysplasia, autosomal recessive	218400	pseudogene on chr.5	3
GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP3	Erythrokeratodermia variabilis et progressiva 3	617525	pseudogene on chr.5	3
GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP3	 Hypoplastic left heart syndrome 1	241550	pseudogene on chr.5	3
GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP3	 Oculodentodigital dysplasia	164200	pseudogene on chr.5	3
GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP3	 Oculodentodigital dysplasia, autosomal recessive	257850	pseudogene on chr.5	3
GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP3	 Palmoplantar keratoderma with congenital alopecia	104100	pseudogene on chr.5	3
GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP3	 Syndactyly, type III	186100	pseudogene on chr.5	3
GJA3, CX46, CZP3, CAE3, CTRCT14	Cataract 14, multiple types	601885		3
GJA5, CX40, ATFB11	Atrial fibrillation, familial, 11	614049		3
GJA5, CX40, ATFB11	 Atrial standstill, digenic 	108770		3
GJA8, CX50, CTRCT1, CZP1, CAE1	Cataract 1, multiple types	116200		3
GJB1, CX32, CMTX1	Charcot-Marie-Tooth neuropathy, X-linked dominant, 1	302800		3
GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID, BAPS	 Bart-Pumphrey syndrome	149200		3
GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID, BAPS	 Deafness, autosomal dominant 3A	601544		3
GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID, BAPS	 Deafness, autosomal recessive 1A	220290		3
GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID, BAPS	 Hystrix-like ichthyosis with deafness	602540		3
GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID, BAPS	 Keratitis-ichthyosis-deafness syndrome	148210		3
GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID, BAPS	Keratoderma, palmoplantar, with deafness	148350		3
GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID, BAPS	 Vohwinkel syndrome	124500		3
GJB3, CX31, DFNA2B, EKVP1	 Deafness, autosomal dominant 2B	612644	same YAC as GJA4	3
GJB3, CX31, DFNA2B, EKVP1	 Deafness, autosomal dominant, with peripheral neuropathy	603324	same YAC as GJA4	3
GJB3, CX31, DFNA2B, EKVP1	 Deafness, autosomal recessive	603324	same YAC as GJA4	3
GJB3, CX31, DFNA2B, EKVP1	Deafness, digenic, GJB2/GJB3	220290	same YAC as GJA4	3
GJB3, CX31, DFNA2B, EKVP1	 Erythrokeratodermia variabilis et progressiva 1	133200	same YAC as GJA4	3
GJB4, CX30.3, EKVP2	Erythrokeratodermia variabilis et progressiva 2	617524		3
GJB6, CX30, DFNA3B, DFNB1B, ECTD2, HED2	 Deafness, autosomal dominant 3B	612643		3
GJB6, CX30, DFNA3B, DFNB1B, ECTD2, HED2	 Deafness, autosomal recessive 1B	612645		3
GJB6, CX30, DFNA3B, DFNB1B, ECTD2, HED2	 Deafness, digenic GJB2/GJB6	220290		3
GJB6, CX30, DFNA3B, DFNB1B, ECTD2, HED2	Ectodermal dysplasia 2, Clouston type	129500		3
GJC2, GJA12, CX47, PMLDAR, HLD2, SPG44, LMPHM3	 Leukodystrophy, hypomyelinating, 2	608804	mutation identified in 1 SPG44 family	3
GJC2, GJA12, CX47, PMLDAR, HLD2, SPG44, LMPHM3	Lymphatic malformation 3	613480	mutation identified in 1 SPG44 family	3
GJC2, GJA12, CX47, PMLDAR, HLD2, SPG44, LMPHM3	 Spastic paraplegia 44, autosomal recessive	613206	mutation identified in 1 SPG44 family	3
GK	Glycerol kinase deficiency	307030	2Mb distal to DMD; pseudogene on 4q32	3
GLA	 Fabry disease	301500		3
GLA	Fabry disease, cardiac variant	301500		3
GLB1, MPS4B	GM1-gangliosidosis, type I	230500	3p14.2-p11 excluded	3
GLB1, MPS4B	 GM1-gangliosidosis, type II	230600	3p14.2-p11 excluded	3
GLB1, MPS4B	 GM1-gangliosidosis, type III	230650	3p14.2-p11 excluded	3
GLB1, MPS4B	 Mucopolysaccharidosis type IVB 	253010	3p14.2-p11 excluded	3
GLC1B	Glaucoma 1B, primary open angle, adult onset	606689		2
GLC1C	Glaucoma 1C, primary open angle	601682		2
GLC1D	Glaucoma 1D, primary open angle	602429		2
GLC1H	Glaucoma 1, open angle, H	611276	between D2S123 AND D2S2165	2
GLC1I	Glaucoma 1, open angle, I	609745	max lod at GABRB3	2
GLC1K, JOAG3	Glaucoma 1K, primary open angle, juvenile-onset	608696	between D20S189 and D20S104	2
GLC1M	Glaucoma 1, open angle, M	610535	between D5S2051 and D5S2090	2
GLC1N	Glaucoma 1, open angle, N	611274	max lod at D15S125	2
GLC1P	Glaucoma 1, open angle, P	177700	caused by 300kb duplication	4
GLC3B	Glaucoma 3, primary infantile, B	600975		2
GLC3C	Glaucoma 3, primary congenital, C	613085	between D14S61 and D14S1000	2
GLCCI1, TSSN1, GCTR	Glucocorticoid therapy, response to	614400		3
GLDC, HYGN1, GCSP, GCE, NKH	Glycine encephalopathy	605899		3
GLDN, CRGL2, LCCS11	Lethal congenital contracture syndrome 11	617194		3
GLE1, GLE1L, LCCS, LCCS1, CAAHD	 Congenital arthrogryposis with anterior horn cell disease	611890		3
GLE1, GLE1L, LCCS, LCCS1, CAAHD	Lethal congenital contracture syndrome 1	253310		3
GLI1, PAPA8, PPD1	 Polydactyly, postaxial, type A8	618123	mutation identified in 1 PPD1 family	3
GLI1, PAPA8, PPD1	Polydactyly, preaxial I	174400	mutation identified in 1 PPD1 family	3
GLI2, HPE9, CJS	Culler-Jones syndrome	615849		3
GLI2, HPE9, CJS	 Holoprosencephaly 9	610829		3
GLI3, PAPA, PAPB	Greig cephalopolysyndactyly syndrome	175700	amplified in glioblastoma	3
GLI3, PAPA, PAPB	 Pallister-Hall syndrome	146510	amplified in glioblastoma	3
GLI3, PAPA, PAPB	 Polydactyly, postaxial, types A1 and B	174200	amplified in glioblastoma	3
GLI3, PAPA, PAPB	 Polydactyly, preaxial, type IV	174700	amplified in glioblastoma	3
GLIS2, NPHP7	Nephronophthisis 7	611498		3
GLIS3, ZNF515, NDH	Diabetes mellitus, neonatal, with congenital hypothyroidism	610199		3
GLM4	Glioma susceptibility 4	607248	max lod at D15S130	2
GLM5	Glioma susceptibility 5	613030	associated with rs4977756	2
GLM6	Glioma susceptibility 6	613031	associated with rs6010620	2
GLM8	Glioma susceptibility 8	613033	associated with rs2736100	2
GLMN, GVM, VMGLOM	Glomuvenous malformations	138000		3
GLRA1, STHE, HKPX1	Hyperekplexia 1	149400		3
GLRA2, MRXSP	Intellectual developmental disorder, X-linked syndromic, Pilorge type	301076		3
GLRB, HKPX2	Hyperekplexia 2	614619		3
GLRX5, C14orf87, PRO1238, FLB4739, PRSA, SIDBA3, SPAHGC	Anemia, sideroblastic, 3, pyridoxine-refractory	616860		3
GLRX5, C14orf87, PRO1238, FLB4739, PRSA, SIDBA3, SPAHGC	 Spasticity, childhood-onset, with hyperglycinemia	616859		3
GLS, GLS1, DEE71, CASGID, GDPAG	 Developmental and epileptic encephalopathy 71	618328	mutation identified in 1 CASGID patient	3
GLS, GLS1, DEE71, CASGID, GDPAG	Global developmental delay, progressive ataxia, and elevated glutamine	618412	mutation identified in 1 CASGID patient	3
GLS, GLS1, DEE71, CASGID, GDPAG	 Infantile cataract, skin abnormalities, glutamate excess, and impaired intellectual development	618339	mutation identified in 1 CASGID patient	3
GLUD1	Hyperinsulinism-hyperammonemia syndrome	606762	pseudogene on Xq26-q28	3
GLUD2	Parkinson disease, age of onset, modifier	168600		3
GLUL, GLNS	Glutamine deficiency, congenital	610015	pseudogene on chr.9	3
GLYCTK, GLYCTK1	D-glyceric aciduria	220120		3
GM2A	GM2-gangliosidosis, AB variant	272750	pseudogene on chr.3	3
GMNN, MGORS6	Meier-Gorlin syndrome 6	616835		3
GMPPA, AAMR	Alacrima, achalasia, and impaired intellectual development syndrome	615510		3
GMPPB, KIAA1851, MDDGA14, MDDGB14, MDDGC14, LGMDR19	 Muscular dystrophy-dystroglycanopathy , type A, 14	615350		3
GMPPB, KIAA1851, MDDGA14, MDDGB14, MDDGC14, LGMDR19	 Muscular dystrophy-dystroglycanopathy , type B, 14	615351		3
GMPPB, KIAA1851, MDDGA14, MDDGB14, MDDGC14, LGMDR19	Muscular dystrophy-dystroglycanopathy , type C, 14	615352		3
GNA11, HHC2, HYPOC2	 Hypocalcemia, autosomal dominant 2	615361		3
GNA11, HHC2, HYPOC2	Hypocalciuric hypercalcemia, type II	145981		3
GNAI1, NEDHISB	Neurodevelopmental disorder with hypotonia, impaired speech, and behavioral abnormalities	619854		3
GNAI2, GNAI2B, GIP	 Pituitary adenoma, ACTH-secreting, somatic	139360	on 12p13-p12, GNAI2L	3
GNAI2, GNAI2B, GIP	Ventricular tachycardia, idiopathic	192605	on 12p13-p12, GNAI2L	3
GNAI3, ARCND1	Auriculocondylar syndrome 1	602483		3
GNAL, DYT25	Dystonia 25	615073		3
GNAO1, DEE17, NEDIM	Developmental and epileptic encephalopathy 17	615473	close to MT1 in mouse	3
GNAO1, DEE17, NEDIM	 Neurodevelopmental disorder with involuntary movements	617493	close to MT1 in mouse	3
GNAQ, SWS, CMC1	Capillary malformations, congenital, 1, somatic, mosaic	163000	pseudogene on 2q	3
GNAQ, SWS, CMC1	 Sturge-Weber syndrome, somatic, mosaic	185300	pseudogene on 2q	3
GNASAS1, GNASAS, SANG, NESPAS	Pseudohypoparathyroidism, type IB	603233		3
GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C, PITA3	ACTH-independent macronodular adrenal hyperplasia	219080		3
GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C, PITA3	 McCune-Albright syndrome, somatic, mosaic	174800		3
GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C, PITA3	 Osseous heteroplasia, progressive	166350		3
GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C, PITA3	 Pituitary adenoma 3, multiple types, somatic	617686		3
GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C, PITA3	 Pseudohypoparathyroidism Ia	103580		3
GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C, PITA3	 Pseudohypoparathyroidism Ib	603233		3
GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C, PITA3	 Pseudohypoparathyroidism Ic	612462		3
GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C, PITA3	 Pseudopseudohypoparathyroidism	612463		3
GNAT1, CSNBAD3, CSNB1G	Night blindness, congenital stationary, autosomal dominant 3	610444		3
GNAT1, CSNBAD3, CSNB1G	 Night blindness, congenital stationary, type 1G	616389		3
GNAT2, ACHM4	Achromatopsia 4	613856		3
GNB1, MRD42, MDS	 Intellectual developmental disorder, autosomal dominant 42	616973		3
GNB1, MRD42, MDS	 Leukemia, acute lymphoblastic, somatic	613065		3
GNB1, MRD42, MDS	Myelodysplastic syndrome, somatic	614286		3
GNB2, SSS4; NEDHYDF	Neurodevelopmental disorder with hypotonia and dysmorphic facies	619503	mutation identified in 1 SSS4 family	3
GNB2, SSS4; NEDHYDF	 Sick sinus syndrome 4	619464	mutation identified in 1 SSS4 family	3
GNB3, CSNB1H	 Hypertension, essential, susceptibility to	145500		3
GNB3, CSNB1H	Night blindness, congenital stationary, type 1H	617024		3
GNB4, CMTD1F	Charcot-Marie-Tooth disease, dominant intermediate F	615185		3
GNB5, GB5, IDDCA, LADCI	 Intellectual developmental disorder with cardiac arrhythmia	617173		3
GNB5, GB5, IDDCA, LADCI	Language delay and ADHD/cognitive impairment with or without cardiac arrhythmia	617182		3
GNE, GLCNE, IBM2, DMRV, NM	 Nonaka myopathy	605820		3
GNE, GLCNE, IBM2, DMRV, NM	Sialuria	269921		3
GNMT	Glycine N-methyltransferase deficiency	606664		3
GNPAT, DHAPAT, RCDP2	Rhizomelic chondrodysplasia punctata, type 2	222765		3
GNPTAB, GNPTA	 Mucolipidosis II alpha/beta	252500	conflicting assignment to 4q	3
GNPTAB, GNPTA	Mucolipidosis III alpha/beta	252600	conflicting assignment to 4q	3
GNPTAG	Mucolipidosis III gamma	252605		3
GNRHR, LHRHR, HH7	Hypogonadotropic hypogonadism 7 without anosmia	146110	placed at 4q12 or 4q13 by some	3
GNS, G6S	Mucopolysaccharidosis type IIID	252940		3
GON7, C14orf142	Galloway-Mowat syndrome 9	619603		3
GORAB, SCYL1BP1, NTKLBP1, GO	Geroderma osteodysplasticum	231070		3
GOSR2, GS27, EPM6, MYOS	Epilepsy, progressive myoclonic 6	614018		3
GOSR2, GS27, EPM6, MYOS	 Muscular dystrophy, congenital, with or without seizures	620166		3
GOT1, ASTQTL1	Aspartate aminotransferase, serum level of, QTL1	614419	10q26.1 = conflicting localization	3
GOT2, DEE82	Developmental and epileptic encephalopathy 82	618721	?pseudogenes on 12 and 1	3
GP1BA, BSS, BDPLT1, VWDP, BDPLT3	Bernard-Soulier syndrome, type A1 	231200		3
GP1BA, BSS, BDPLT1, VWDP, BDPLT3	 Bernard-Soulier syndrome, type A2 	153670		3
GP1BA, BSS, BDPLT1, VWDP, BDPLT3	 Nonarteritic anterior ischemic optic neuropathy, susceptibility to	258660		3
GP1BA, BSS, BDPLT1, VWDP, BDPLT3	 von Willebrand disease, platelet-type	177820		3
GP1BB, BS, BDPLT1	 Bernard-Soulier syndrome, type B	231200		3
GP1BB, BS, BDPLT1	Giant platelet disorder, isolated	231200		3
GP6, GPIV, BDPLT11	Bleeding disorder, platelet-type, 11	614201		3
GP9	Bernard-Soulier syndrome, type C	231200		3
GPAA1, GAA1, GPIBD15	Glycosylphosphatidylinositol biosynthesis defect 15	617810		3
GPA, WG	Granulomatosis with polyangiitis	608710		2
GPC3, SDYS, SGBS1	 Simpson-Golabi-Behmel syndrome, type 1	312870		3
GPC3, SDYS, SGBS1	Wilms tumor, somatic	194070		3
GPC4, KPTS	Keipert syndrome	301026	centromeric to GPC3	3
GPC6, OMIMD1	Omodysplasia 1	258315		3
GPD1, HTGTI	Hypertriglyceridemia, transient infantile	614480		3
GPD1L, KIAA0089	Brugada syndrome 2	611777		3
GPD2	Type 2 diabetes mellitus, susceptibility to	125853	pseudogene on 19	3
GPHN, GPH, KIAA1385, GEPH, MOCODC	Molybdenum cofactor deficiency C	615501		3
GPIHBP1, HYPL1D	Hyperlipoproteinemia, type 1D	615947		3
GPI	Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency	613470		3
GPNMB, PLCA3	Amyloidosis, primary localized cutaneous, 3	617920		3
GPR101, PAGH2, PITA2	Pituitary adenoma 2, GH-secreting	300943		3
GPR143, OA1, NYS6	 Nystagmus 6, congenital, X-linked	300814	linked to XG	3
GPR143, OA1, NYS6	Ocular albinism, type I, Nettleship-Falls type	300500	linked to XG	3
GPR161	Medulloblastoma predisposition syndrome	155255		3
GPR179, GPR158L, GPR158L1, CSNB1E	Night blindness, congenital stationary , 1E, autosomal recessive	614565		3
GPR68, OGR1, AI2A6	Amelogenesis imperfecta, hypomaturation type, IIA6	617217		3
GPSM2, LGN, PINS, DFNB82, CMCS	Chudley-McCullough syndrome	604213		3
GPT2, ALT2, NEDSPM	Neurodevelopmental disorder with microcephaly and spastic paraplegia	616281		3
GPX1, GPXD	Hemolytic anemia due to glutathione peroxidase deficiency	614164	?pseudogene on 3p11-p12	1
GPX4, SMDS	Spondylometaphyseal dysplasia, Sedaghatian type	250220		3
GRAP, DFNB114	Deafness, autosomal recessive 114	618456		3
GRD1	Graves disease, susceptibility to, 1	275000	associated with rs2268458	2
GRD2	Graves disease, susceptibility to, 2	603388		2
GRDX, GD3	Graves disease, susceptibility to, X-linked	300351		2
GREB1L, C18orf6, KIAA1772, RHDA3, DFNA80	Deafness, autosomal dominant 80	619274		3
GREB1L, C18orf6, KIAA1772, RHDA3, DFNA80	 Renal hypodysplasia/aplasia 3	617805		3
GREM2, PRDC, STHAG9	Tooth agenesis, selective, 9	617275		3
GRHL2, TFCP2L3, DFNA28, ECTDS, PPCD4	 Corneal dystrophy, posterior polymorphous, 4	618031		3
GRHL2, TFCP2L3, DFNA28, ECTDS, PPCD4	Deafness, autosomal dominant 28	608641		3
GRHL2, TFCP2L3, DFNA28, ECTDS, PPCD4	 Ectodermal dysplasia/short stature syndrome	616029		3
GRHL3, SOM, TFCP2L4, VWS2	van der Woude syndrome 2	606713		3
GRHPR, GLXR	Hyperoxaluria, primary, type II	260000		3
GRIA1, GLUR1, MRD67, MRT76	 Intellectual developmental disorder, autosomal dominant 67	619927	mutation identified in 1 MRT76 patient	3
GRIA2, GLUR2, NEDLIB	Neurodevelopmental disorder with language impairment and behavioral abnormalities	618917		3
GRIA3, GLUR3, MRXSW	Intellectual developmental disorder, X-linked syndromic, Wu type	300699		3
GRIA4, GLUR4, NEDSGA	Neurodevelopmental disorder with or without seizures and gait abnormalities	617864		3
GRID2, SCAR18	Spinocerebellar ataxia, autosomal recessive 18	616204		3
GRIK2, GLUR6, MRT6, NEDLAS	 Intellectual developmental disorder, autosomal recessive 6	611092		3
GRIK2, GLUR6, MRT6, NEDLAS	Neurodevelopmental disorder with impaired language and ataxia and with or without seizures	619580		3
GRIN1, NMDAR1, NDHMSR, NDHMSD, DEE101	 Developmental and epileptic encephalopathy 101	619814		3
GRIN1, NMDAR1, NDHMSR, NDHMSD, DEE101	 Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant	614254		3
GRIN1, NMDAR1, NDHMSR, NDHMSD, DEE101	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal recessive	617820		3
GRIN2A, NMDAR2A, FESD, LKS	Epilepsy, focal, with speech disorder and with or without impaired intellectual development	245570		3
GRIN2B, NMDAR2B, MRD6, DEE27	Developmental and epileptic encephalopathy 27	616139		3
GRIN2B, NMDAR2B, MRD6, DEE27	 Intellectual developmental disorder, autosomal dominant 6, with or without seizures	613970		3
GRIN2D, NMDAR2D, DEE46	Developmental and epileptic encephalopathy 46	617162		3
GRIP1, FRASRS3	Fraser syndrome 3	617667		3
GRK1, RHOK, RK	Oguchi disease-2	613411		3
GRM1, MGLUR1, GRM1A, SCAR13, SCA44	 Spinocerebellar ataxia 44	617691		3
GRM1, MGLUR1, GRM1A, SCAR13, SCA44	Spinocerebellar ataxia, autosomal recessive 13	614831		3
GRM6, MGLUR6, CSNB1B	Night blindness, congenital stationary , 1B, autosomal recessive	257270		3
GRM7, MGLUR7, NEDSHBA	Neurodevelopmental disorder with seizures, hypotonia, and brain abnormalities	618922		3
GRN, CLN11	Aphasia, primary progressive	607485		3
GRN, CLN11	 Ceroid lipofuscinosis, neuronal, 11	614706		3
GRN, CLN11	 Frontotemporal lobar degeneration with ubiquitin-positive inclusions	607485		3
GRXCR1	Deafness, autosomal recessive 25	613285		3
GSBS	Hypercholesterolemia, susceptibility to	143890		3
GSC, SAMS	Short stature, auditory canal atresia, mandibular hypoplasia, skeletal abnormalities	602471		3
GSDME, DFNA5	Deafness, autosomal dominant 5	600994		3
GSM1, GSP	Geniospasm	190100		2
GSN	Amyloidosis, Finnish type	105120	40kb proximal to ABL	3
GSR, GSRD	Hemolytic anemia due to glutathione reductase deficiency	618660		3
GSS, GSHS	 Glutathione synthetase deficiency	266130		3
GSS, GSHS	Hemolytic anemia due to glutathione synthetase deficiency	231900		3
GSTZ1, MAAI, MAAID	Maleylacetoacetate isomerase deficiency	617596		3
GSX2, GSH2, DMJDS2	Diencephalic-mesencephalic junction dysplasia syndrome 2	618646		3
GTF2E2, TTD6	Trichothiodystrophy 6, nonphotosensitive	616943		3
GTF2H5, TTD3, TFB5, C6orf175, TTDA	Trichothiodystrophy 3, photosensitive	616395		3
GTPBP2, JABELS	Jaberi-Elahi syndrome	617988		3
GTPBP3, MSS1, COXPD23	Combined oxidative phosphorylation deficiency 23	616198		3
GTS	Tourette syndrome	137580	several loci suspected (e.g., 17q25)	2
GUCA1A, GCAP, COD3, CORD14	 Cone dystrophy-3	602093		3
GUCA1A, GCAP, COD3, CORD14	Cone-rod dystrophy 14	602093		3
GUCA1B, GCAP2, GUCA2, RP48	Retinitis pigmentosa 48	613827		3
GUCY1A3, GUC1A3, GUCSA3, MYMY6	Moyamoya 6 with achalasia	615750		3
GUCY2C, GUC2C, DIAR6, MECIL	Diarrhea 6	614616		3
GUCY2C, GUC2C, DIAR6, MECIL	 Meconium ileus	614665		3
GUCY2D, GUC2D, LCA1, CORD6, RCD2, CACD1, CSNB1I	 Choroidal dystrophy, central areolar 1	215500	mutation identified in 1 CACD1 family	3
GUCY2D, GUC2D, LCA1, CORD6, RCD2, CACD1, CSNB1I	Cone-rod dystrophy 6	601777	mutation identified in 1 CACD1 family	3
GUCY2D, GUC2D, LCA1, CORD6, RCD2, CACD1, CSNB1I	 Leber congenital amaurosis 1	204000	mutation identified in 1 CACD1 family	3
GUCY2D, GUC2D, LCA1, CORD6, RCD2, CACD1, CSNB1I	 Night blindness, congenital stationary, type 1I	618555	mutation identified in 1 CACD1 family	3
GULOP, GULO	Scurvy	240400		3
GUSB, MPS7	Mucopolysaccharidosis VII	253220		3
GUST	Gustavson syndrome	309555		2
GYG1, GSD15	 Polyglucosan body myopathy 2	616199	mutation identified in 1 GSD15 patient	3
GYPA, MN, GPA	 Blood group, MNSs system	111300		3
GYPA, MN, GPA	Malaria, resistance to	611162		3
GYPB, SS	Blood group, Ss	111740		3
GYPB, SS	 Malaria, resistance to	611162		3
GYPC, GE, GPC	Blood group, Gerbich	616089		3
GYPC, GE, GPC	 Malaria, resistance to	611162		3
GYS1, GYS	Glycogen storage disease 0, muscle	611556		3
GYS2	Glycogen storage disease 0, liver	240600		3
GZF1, ZNF336, JLSM	Joint laxity, short stature, and myopia	617662		3
H1-4, HIST1H1E, H1F4, RMNS	Rahman syndrome	617537		3
H3-3A, H3F3A, H3F3, BRYLIB1	Bryant-Li-Bhoj neurodevelopmental syndrome 1	619720		3
H3-3B, H3F3B, BRYLIB2	Bryant-Li-Bhoj neurodevelopmental syndrome 2	619721		3
H4C3, HIST1H4C, H4FG, TEVANED1	Tessadori-van Haaften neurodevelopmental syndrome 1	619758		3
H4C5, HIST1H4E, H4FJ, TEVANED3	Tessadori-van Haaften neurodevelopmental syndrome 3	619950		3
H4C9, HIST1H4I, H4FM, H4M, TEVANED4	Tessadori-van Haaften neurodevelopmental syndrome 4	619951		3
H6PD, GDH, G6PDH, CORTRD1	Cortisone reductase deficiency 1	604931	digenic triallelic mutations with HSD11B1	3
HAAO, VCRL1	Vertebral, cardiac, renal, and limb defects syndrome 1	617660		3
HABP2, PHBP, HGFAL, FSAP, NMTC5	Thyroid cancer, nonmedullary, 5	616535	mutation identified in 1 NMTC5 family	3
HABP2, PHBP, HGFAL, FSAP, NMTC5	 Venous thromboembolism, susceptibility to	188050	mutation identified in 1 NMTC5 family	3
HACD1, PTPLA, MYONP	Myopathy, congenital, nonprogressive	619967		3
HACE1, KIAA1320, SPPRS	Spastic paraplegia and psychomotor retardation with or without seizures	616756		3
HADHA, MTPA	 Fatty liver, acute, of pregnancy	609016		3
HADHA, MTPA	HELLP syndrome, maternal, of pregnancy	609016		3
HADHA, MTPA	 LCHAD deficiency	609016		3
HADHA, MTPA	 Mitochondrial trifunctional protein deficiency	609015		3
HADHB	Trifunctional protein deficiency	609015		3
HADHSC, SCHAD, HHF4	 3-hydroxyacyl-CoA dehydrogenase deficiency	231530		3
HADHSC, SCHAD, HHF4	Hyperinsulinemic hypoglycemia, familial, 4	609975		3
HAGH, GLO2	Glyoxalase II deficiency	614033		1
HAL, HSTD	Histidinemia	235800		3
HAMP, LEAP1, HEPC, HFE2B	Hemochromatosis, type 2B	613313	digenic form with HAMP and HFE mutations	3
HARS1, HARS, USH3B, CMT2W	Charcot-Marie-Tooth disease, axonal, type 2W	616625		3
HARS1, HARS, USH3B, CMT2W	 Usher syndrome type 3B	614504		3
HARS2, HARSL, HARSR, HO3, PRLTS2	Perrault syndrome 2	614926		3
HAVCR2, TIM3, SPTCL	T-cell lymphoma, subcutaneous panniculitis-like	618398		3
HAX1, SCN3	Neutropenia, severe congenital 3, autosomal recessive	610738		3
HBA1, HBH, METHBA, ECYT7	 Erythrocytosis 7	617981	1, 2, or 3 loci; 5'-zeta-pseudozeta-pseudoalpha-alpha-2-alpha-1-3'	3
HBA1, HBH, METHBA, ECYT7	 Heinz body anemias, alpha-	140700	1, 2, or 3 loci; 5'-zeta-pseudozeta-pseudoalpha-alpha-2-alpha-1-3'	3
HBA1, HBH, METHBA, ECYT7	Hemoglobin H disease, nondeletional	613978	1, 2, or 3 loci; 5'-zeta-pseudozeta-pseudoalpha-alpha-2-alpha-1-3'	3
HBA1, HBH, METHBA, ECYT7	 Methemoglobinemia, alpha type	617973	1, 2, or 3 loci; 5'-zeta-pseudozeta-pseudoalpha-alpha-2-alpha-1-3'	3
HBA1, HBH, METHBA, ECYT7	 Thalassemias, alpha-	604131	1, 2, or 3 loci; 5'-zeta-pseudozeta-pseudoalpha-alpha-2-alpha-1-3'	3
HBA2, HBH, ECYT7	 Erythrocytosis 7	617981		3
HBA2, HBH, ECYT7	Heinz body anemia	140700		3
HBA2, HBH, ECYT7	 Hemoglobin H disease, deletional and nondeletional	613978		3
HBA2, HBH, ECYT7	 Thalassemia, alpha-	604131		3
HBB, ECYT6	 Delta-beta thalassemia	141749	pseudogene HBBP1 between HBG and HBD loci	3
HBB, ECYT6	 Erythrocytosis 6	617980	pseudogene HBBP1 between HBG and HBD loci	3
HBB, ECYT6	 Heinz body anemia	140700	pseudogene HBBP1 between HBG and HBD loci	3
HBB, ECYT6	 Hereditary persistence of fetal hemoglobin	141749	pseudogene HBBP1 between HBG and HBD loci	3
HBB, ECYT6	 Malaria, resistance to	611162	pseudogene HBBP1 between HBG and HBD loci	3
HBB, ECYT6	Methemoglobinemia, beta type	617971	pseudogene HBBP1 between HBG and HBD loci	3
HBB, ECYT6	 Sickle cell anemia	603903	pseudogene HBBP1 between HBG and HBD loci	3
HBB, ECYT6	 Thalassemia, beta	613985	pseudogene HBBP1 between HBG and HBD loci	3
HBB, ECYT6	 Thalassemia-beta, dominant inclusion-body	603902	pseudogene HBBP1 between HBG and HBD loci	3
HBD	 Thalassemia, delta-	142000		3
HBD	Thalassemia due to Hb Lepore	142000		3
HBEGF, DTR, DTSF, HEGFL	Diphtheria, susceptibility to	126150		1
HBFQTL2, FCP	Fetal hemoglobin quantitative trait locus 2	142470		2
HBFQTL3, FCP1, FCPX, FCP	Fetal hemoglobin quantitative trait locus 3	305435		2
HBFQTL4	Fetal hemoglobin quantitative trait locus 4	606789		2
HBFQTL5	Fetal hemoglobin QTL5	142335	associated with rs11886868	2
HBG1	Fetal hemoglobin quantitative trait locus 1	141749		3
HBG2, TNCY	 Cyanosis, transient neonatal	613977		3
HBG2, TNCY	Fetal hemoglobin quantitative trait locus 1	141749		3
HBHR, ATR1	Alpha-thalassemia/impaired intellectual development syndrome, deletion type	141750	contiguous gene syndrome involving deletion of HBA1 and HBA2	4
HBT	Telangiectasia, hereditary benign	187260	max lod at D5S641	2
HCA1	Hypercalciuria, absorptive	607258		2
HCCS, MCOPS7, LSDMCA1	Linear skin defects with multiple congenital anomalies 1	309801		3
HCF2, HC2, SERPIND1, THPH10	Thrombophilia 10 due to heparin cofactor II deficiency	612356	proximal to BCR	3
HCFC1, HCF1, MAHCX, XLID3	Methylmalonic aciduria and homocysteinemia, cblX type	309541	50kb distal to V2R	3
HCFP1, MBS2	Facial paresis, hereditary congenital, 1	601471		2
HCFP2	Facial paresis, hereditary congenital, 2	604185		2
HCHGQ1	Hematocrit/hemoglobin quantitative trait locus 1	609319		2
HCHGQ2	Hematocrit/hemoglobin quantitative trait locus 2	609320		2
HCHGQ3	Hematocrit/hemoglobin quantitative trait locus 3	613284	associated with rs855791	2
HCN1, BCNG1, DEE24, GEFSP10	Developmental and epileptic encephalopathy 24	615871		3
HCN1, BCNG1, DEE24, GEFSP10	 Generalized epilepsy with febrile seizures plus, type 10	618482		3
HCN2, BCNG2, GEFSP11, FEB2, EIG17	 Epilepsy, idiopathic generalized, susceptibility to, 17	602477		3
HCN2, BCNG2, GEFSP11, FEB2, EIG17	Febrile seizures, familial, 2	602477		3
HCN2, BCNG2, GEFSP11, FEB2, EIG17	 Generalized epilepsy with febrile seizures plus, type 11	602477		3
HCN4, SSS2, BRGDA8, EIG18	 Brugada syndrome 8	613123	mutation identified in 1 EIG18 family	3
HCN4, SSS2, BRGDA8, EIG18	 Epilepsy, idiopathic generalized, susceptibility to, 18	619521	mutation identified in 1 EIG18 family	3
HCN4, SSS2, BRGDA8, EIG18	Sick sinus syndrome 2	163800	mutation identified in 1 EIG18 family	3
HCVS	Human coronavirus sensitivity	122460		2
HDAC4, HDACA, NEDCHF	Neurodevelopmental disorder with central hypotonia and dysmorphic facies	619797		3
HDAC8, MRXS6, CDLS5	Cornelia de Lange syndrome 5	300882		3
HDC	Gilles de la Tourette syndrome, susceptibility to	137580		3
HDL3, HLN2	Huntington disease-like 3	604802		2
HDLC3	High density lipoprotein cholesterol, low serum, 3	607687		2
HDLCQ14, HYLAP	High density lipoprotein cholesterol level QTL14	605201		2
HDLCQ1	High density lipoprotein cholesterol level QTL 1	606613		2
HDLCQ2	High density lipoprotein cholesterol level QTL 2	607053		2
HDLCQ4	High density lipoprotein cholesterol level QTL 4	610239	between D4S1597 and D4S1539	2
HDLCQ5	High density lipoprotein cholesterol level QTL 5	610761	max lod at D3S3053	2
HDPA	Hodgkin disease susceptibility, pseudoautosomal	300221		2
HEATR3, SYO1, DBA21	Diamond-Blackfan anemia 21	620072		3
HECW2, NEDL2, KIAA1301, NDHSAL	Neurodevelopmental disorder with hypotonia, seizures, and absent language	617268		3
HELLS, LSH, ICF4	Immunodeficiency-centromeric instability-facial anomalies syndrome 4	616911		3
HEPACAM, MLC2A, MLC2B	Megalencephalic leukoencephalopathy with subcortical cysts 2A	613925		3
HEPACAM, MLC2A, MLC2B	 Megalencephalic leukoencephalopathy with subcortical cysts 2B, remitting, with or without impaired intellectual development	613926		3
HERC1, MDFPMR	Macrocephaly, dysmorphic facies, and psychomotor retardation	617011		3
HERC2, SHEP1, MRT38	Intellectual developmental disorder, autosomal recessive 38	615516	mutations in intron 4	3
HERC2, SHEP1, MRT38	 Skin/hair/eye pigmentation 1, blond/brown hair	227220	mutations in intron 4	3
HERC2, SHEP1, MRT38	 Skin/hair/eye pigmentation 1, blue/nonblue eyes	227220	mutations in intron 4	3
HES7, SCDO4	Spondylocostal dysostosis 4, autosomal recessive	613686		3
HESX1, RPX, CPHD5	 Growth hormone deficiency with pituitary anomalies	182230		3
HESX1, RPX, CPHD5	Pituitary hormone deficiency, combined, 5	182230		3
HESX1, RPX, CPHD5	 Septooptic dysplasia	182230		3
HEXA, TSD	 GM2-gangliosidosis, several forms	272800	on 15q+ in APL	3
HEXA, TSD	Hex A pseudodeficiency	272800	on 15q+ in APL	3
HEXA, TSD	 Tay-Sachs disease	272800	on 15q+ in APL	3
HEXB	Sandhoff disease, infantile, juvenile, and adult forms	268800		3
HFE, HLA-H, HFE1, MVCD7, TFQTL2	 Alzheimer disease, susceptibility to	104300		3
HFE, HLA-H, HFE1, MVCD7, TFQTL2	 Hemochromatosis	235200		3
HFE, HLA-H, HFE1, MVCD7, TFQTL2	 Microvascular complications of diabetes 7	612635		3
HFE, HLA-H, HFE1, MVCD7, TFQTL2	 Porphyria cutanea tarda, susceptibility to	176100		3
HFE, HLA-H, HFE1, MVCD7, TFQTL2	Porphyria variegata, susceptibility to	176200		3
HFE, HLA-H, HFE1, MVCD7, TFQTL2	 Transferrin serum level QTL2	614193		3
HFM1, MER3, POF9	Premature ovarian failure 9	615724		3
HGD, AKU	Alkaptonuria	203500		3
HGF, DFNB39	Deafness, autosomal recessive 39	608265		3
HGSNAT, TMEM76, MPS3C, RP73	Mucopolysaccharidosis type IIIC 	252930		3
HGSNAT, TMEM76, MPS3C, RP73	 Retinitis pigmentosa 73	616544		3
HHAT, MART2, SKI1, NNMS	Nivelon-Nivelon-Mabille syndrome	600092		3
HHPP	Hyperhidrosis palmaris et plantaris	144110	between D14S283 and D14S264	2
HHT3, ORW3	Telangiectasia, hereditary hemorrhagic, type 3	601101		2
HHT4	Telangiectasia, hereditary hemorrhagic, type 4	610655	between D7S2252 and D7S510	2
HHV8S	Human herpesvirus 8, susceptibility to	614836		2
HIBCH	3-hydroxyisobutryl-CoA hydrolase deficiency	250620		3
HID1, 17orf28, DMC1, DEE105	Developmental and epileptic encephalopathy 105 with hypopituitarism	619983		3
HIKESHI, C11orf73, HLD13	Leukodystrophy, hypomyelinating, 13	616881		3
HINT1, PRKCNH1, NMAN	Neuromyotonia and axonal neuropathy, autosomal recessive	137200		3
HIVEP2, MRD43	Intellectual developmental disorder, autosomal dominant 43	616977		3
HJV, HFE2A	Hemochromatosis, type 2A	602390	between D1S442 and D1S2347	3
HK1, HKD, HMSNR, RP79, NEDVIBA	 Hemolytic anemia due to hexokinase deficiency	235700		3
HK1, HKD, HMSNR, RP79, NEDVIBA	 Neurodevelopmental disorder with visual defects and brain anomalies	618547		3
HK1, HKD, HMSNR, RP79, NEDVIBA	 Neuropathy, hereditary motor and sensory, Russe type	605285		3
HK1, HKD, HMSNR, RP79, NEDVIBA	Retinitis pigmentosa 79	617460		3
HKDC1, RP92	Retinitis pigmentosa 92	619614		3
HLA-A	Hypersensitivity syndrome, carbamazepine-induced, susceptibility to	608579		3
HLA-B, SPDA1	 Abacavir hypersensitivity, susceptibility to	142830		3
HLA-B, SPDA1	 Drug-induced liver injury due to flucloxacillin	142830		3
HLA-B, SPDA1	 Spondyloarthropathy, susceptibility to, 1	106300		3
HLA-B, SPDA1	 Stevens-Johnson syndrome, susceptibility to	608579		3
HLA-B, SPDA1	Synovitis, chronic, susceptibility to	142830		3
HLA-B, SPDA1	 Toxic epidermal necrolysis, susceptibility to	608579		3
HLA-C, PSORS1	 HIV-1 viremia, susceptibility to	609423		3
HLA-C, PSORS1	Psoriasis susceptibility 1	177900		3
HLA-DPB1	Beryllium disease, chronic, susceptibility to	142858		3
HLA-DQA1, CELIAC1	Celiac disease, susceptibility to	212750		3
HLA-DQB1, CELIAC1	Celiac disease, susceptibility to	212750		3
HLA-DQB1, CELIAC1	 Creutzfeldt-Jakob disease, variant, resistance to	123400		3
HLA-DQB1, CELIAC1	 Multiple sclerosis, susceptibility to, 1	126200		3
HLA-DRB1, SS1	Multiple sclerosis, susceptibility to, 1	126200		3
HLA-DRB1, SS1	 Sarcoidosis, susceptibility to, 1	181000		3
HLA-G	Asthma, susceptibility to	600807		2
HLCS, HCS	Holocarboxylase synthetase deficiency	253270		3
HMBS, PBGD, UPS	 Porphyria, acute intermittent	176000		3
HMBS, PBGD, UPS	Porphyria, acute intermittent, nonerythroid variant	176000		3
HMCN1, FBLN6, FIBL6, ARMD1	Macular degeneration, age-related, 1	603075		3
HMGA1, HMGIY	Type 2 diabetes mellitus, susceptibility to	125853		3
HMGA2, HMGIC, BABL, SRS5	Silver-Russell syndrome 5	618908	fusion partners with RAD51B, ALDH2, COX6C, HEI10 in uterine leiomyomas	3
HMGCL	HMG-CoA lyase deficiency	246450		3
HMGCR, LDLCQ3	 Low density lipoprotein cholesterol level QTL 3	142910		3
HMGCR, LDLCQ3	Statins, attenuated cholesterol lowering by	142910		3
HMGCS2	HMG-CoA synthase-2 deficiency	605911		3
HMMR	Breast cancer, susceptibility to	114480		3
HMOX1, HMOX1D	Heme oxygenase-1 deficiency	614034		3
HMOX1, HMOX1D	 Pulmonary disease, chronic obstructive, susceptibility to	606963		3
HMPS1, CRAC1, CRCS4, DUP15q, C15DUPq	 Colorectal cancer, susceptibility to, 4	601228	duplication of 40kb of 15q resulting in overexpression of GREM1	4
HMPS1, CRAC1, CRCS4, DUP15q, C15DUPq	Polyposis syndrome, hereditary mixed 1	601228	duplication of 40kb of 15q resulting in overexpression of GREM1	4
HMS1, GAY1	Homosexuality, male	306995		2
HMSN5	Hereditary motor and sensory neuropathy V	600361	D4S1552 and D4S2930	2
HMX1, H6	Oculoauricular syndrome	612109		3
HNF1A, TCF1, MODY3, IDDM20	 Diabetes mellitus, insulin-dependent, 20	612520		3
HNF1A, TCF1, MODY3, IDDM20	 Diabetes mellitus, insulin-dependent	222100		3
HNF1A, TCF1, MODY3, IDDM20	 Diabetes mellitus, noninsulin-dependent, 2	125853		3
HNF1A, TCF1, MODY3, IDDM20	Hepatic adenoma, somatic	142330		3
HNF1A, TCF1, MODY3, IDDM20	 MODY, type III	600496		3
HNF1A, TCF1, MODY3, IDDM20	 Renal cell carcinoma	144700		3
HNF1B, TCF2, HNF2, RCAD, T2D, ADTKD3	 Renal cell carcinoma	144700		3
HNF1B, TCF2, HNF2, RCAD, T2D, ADTKD3	 Renal cysts and diabetes syndrome	137920		3
HNF1B, TCF2, HNF2, RCAD, T2D, ADTKD3	Type 2 diabetes mellitus	125853		3
HNF4A, TCF14, MODY1, FRTS4	 Diabetes mellitus, noninsulin-dependent	125853		3
HNF4A, TCF14, MODY1, FRTS4	Fanconi renotubular syndrome 4, with maturity-onset diabetes of the young	616026		3
HNF4A, TCF14, MODY1, FRTS4	 MODY, type I	125850		3
HNFJ3	Hyperuricemic nephropathy, familial juvenile, 3	614227	between rs372139 and rs896986	2
HNMT, MRT51	 Asthma, susceptibility to	600807		3
HNMT, MRT51	Intellectual developmental disorder, autosomal recessive 51	616739		3
HNP1	Hypertensive nephropathy	608026		2
HNRNPA1, IBMPFD3, ALS20	 Amyotrophic lateral sclerosis 20	615426	mutation identified in 1 family with IBMPFD3	3
HNRNPDL, HNRPDL, JKTBP, LGMDD3	Muscular dystrophy, limb-girdle, autosomal dominant 3	609115		3
HNRNPH2, NRPH2, MRXSB	Intellectual developmental disorder, X-linked syndromic, Bain type	300986		3
HNRNPK, HNRPK, AUKS	Au-Kline syndrome	616580		3
HNRNPU, HNRPU, SAFA, DEE54	Developmental and epileptic encephalopathy 54	617391		3
HNRPH1, NEDCDS	Neurodevelopmental disorder with craniofacial dysmorphism and skeletal defects	620083		3
HNRPR, HNRNPR, NEDDFSB	Neurodevelopmental disorder with dysmorphic facies and skeletal and brain abnormalities	620073		3
HOGA1, DHDPSL, HP3	Hyperoxaluria, primary, type III	613616		3
HOXA11, HOX1I, RUSAT1	Radioulnar synostosis with amegakaryocytic thrombocytopenia 1	605432		3
HOXA13, HOX1J	 Guttmacher syndrome	176305	mutation identified in 1 GTMS family	3
HOXA13, HOX1J	Hand-foot-uterus syndrome	140000	mutation identified in 1 GTMS family	3
HOXA1, HOX1F, BSAS	 Athabaskan brainstem dysgenesis syndrome	601536		3
HOXA1, HOX1F, BSAS	Bosley-Salih-Alorainy syndrome	601536		3
HOXA2, MCOHI	 Microtia, hearing impairment, and cleft palate 	612290	mutation identified in 1 MCOHICP family	3
HOXA2, MCOHI	Microtia with or without hearing impairment 	612290	mutation identified in 1 MCOHICP family	3
HOXB13, HPC9	Prostate cancer, hereditary, 9	610997		3
HOXB1, HOX2I, HCFP3	Facial paresis, hereditary congenital, 3	614744		3
HOXC13, HOX3G, ECTD9	Ectodermal dysplasia 9, hair/nail type	614931	fused with NUP98 in AML	3
HOXD10, HOX4D	 Charcot-Marie-Tooth disease, foot deformity of	192950		3
HOXD10, HOX4D	Vertical talus, congenital	192950		3
HOXD13, HOX4I, SPD1, BDSD	 Brachydactyly-syndactyly syndrome	610713	mutation identified in 1 BDSD family	3
HOXD13, HOX4I, SPD1, BDSD	 Brachydactyly, type D	113200	mutation identified in 1 BDSD family	3
HOXD13, HOX4I, SPD1, BDSD	 Brachydactyly, type E	113300	mutation identified in 1 BDSD family	3
HOXD13, HOX4I, SPD1, BDSD	Syndactyly, type V	186300	mutation identified in 1 BDSD family	3
HOXD13, HOX4I, SPD1, BDSD	 Synpolydactyly 1	186000	mutation identified in 1 BDSD family	3
HP	Anhaptoglobinemia	614081	just distal to fra16q22.1	3
HPC10	Prostate cancer, hereditary, 10	611100	strongest assoc. with rs1447295	2
HPC11	Prostate cancer, hereditary, 11	611955	associated with rs4430796 and rs7501939	2
HPC14	Prostate cancer, hereditary, 14	611958	associated with rs7931342	2
HPC15	Prostate cancer, hereditary, 15	611959	associated with rs2735839	2
HPC3	Prostate cancer, susceptibility to, 3	608656		2
HPC4	Prostate cancer, susceptibility to, 4	608658		2
HPC5	Prostate cancer, hereditary, 5	609299	between D3S1270 and D3S4559	2
HPC6	Prostate cancer, susceptibility to	609558	between D22S1265 and D22S277	2
HPC7	Prostate cancer, hereditary, 7	610321		2
HPC9	Prostate cancer, hereditary, 9	610997	max LOD at D17S1820	2
HPCA, DYT2	Dystonia 2, torsion, autosomal recessive	224500		3
HPCQTL19	Prostate cancer aggressiveness QTL	607592	D19S902	2
HPCX1	Prostate cancer, hereditary, X-linked 1	300147	between D3S2390 and bG82i1.0	2
HPCX2	Prostate cancer, hereditary, X-linked 2	300704	associated with rs5945572	2
HPD	Hawkinsinuria	140350		3
HPDL, NEDSWMA, SPG83	Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities	619026		3
HPDL, NEDSWMA, SPG83	 Spastic paraplegia 83, autosomal recessive	619027		3
HPD	 Tyrosinemia, type III	276710		3
HPE1	Holoprosencephaly 1	236100		2
HPE6	Holoprosencephaly 6	605934		2
HPE8	Holoprosencephaly 8	609408	between D14S49 and D14S1014	2
HPGD, PGDH1, PHOAR1	 Cranioosteoarthropathy	259100	mutation identified in 1 DIGC family	3
HPGD, PGDH1, PHOAR1	 Hypertrophic osteoarthropathy, primary, autosomal recessive 1	259100	mutation identified in 1 DIGC family	3
HP	 Hypohaptoglobinemia	614081	just distal to fra16q22.1	3
HPPD	Hypertelorism, preauricular sinus, punctal pits, and deafness	614187		2
HPRHP	Hypophosphatemic rickets and hyperparathyroidism	612089	?due to altered KLOTHO expression	2
HPRT1, HPRT	Hyperuricemia, HRPT-related	300323		3
HPRT1, HPRT	 Lesch-Nyhan syndrome	300322		3
HPS1	Hermansky-Pudlak syndrome 1	203300		3
HPS3	Hermansky-Pudlak syndrome 3	614072		3
HPS4	Hermansky-Pudlak syndrome 4	614073		3
HPS5, RU2, KIAA1017	Hermansky-Pudlak syndrome 5	614074		3
HPS6, RU	Hermansky-Pudlak syndrome 6	614075		3
HPSE2, HPA2, UFS1	Urofacial syndrome 1	236730		3
HPT, HPTX, HYPX	Hypoparathyroidism, X-linked	307700	interstitial deletion/insertion on Xq27.1	4
HRAS	Bladder cancer, somatic	109800	pseudogene HRASP on X	3
HRAS	 Congenital myopathy with excess of muscle spindles	218040	pseudogene HRASP on X	3
HRAS	 Costello syndrome	218040	pseudogene HRASP on X	3
HRAS	 Nevus sebaceous or woolly hair nevus, somatic	162900	pseudogene HRASP on X	3
HRAS	 Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic	163200	pseudogene HRASP on X	3
HRAS	 Spitz nevus or nevus spilus, somatic	137550	pseudogene HRASP on X	3
HRAS	 Thyroid carcinoma, follicular, somatic	188470	pseudogene HRASP on X	3
HR, AU, MUHH1	 Alopecia universalis	203655		3
HR, AU, MUHH1	Atrichia with papular lesions	209500		3
HRG, THPH11	Thrombophilia 11 due to HRG deficiency	613116		3
HRM2	Hair, curly	139450	associated with rs11803731	2
HRPT3	Hyperparathyroidism 3	610071	between D2S2368 and D2S358	2
HRURF, U2HR	Hypotrichosis 4	146550		3
HS2ST1, NFSRA	Neurofacioskeletal syndrome with or without renal agenesis	619194		3
HS6ST1, HS6ST, HH15	Hypogonadotropic hypogonadism 15 with or without anosmia	614880		3
HSCR5	Hirschsprung disease, susceptibility to, 5	600156		2
HSCR6	Hirschsprung disease, susceptibility to, 6	606874		2
HSCR7	Hirschsprung disease, susceptibility to, 7	606875		2
HSCR8	Hirschsprung disease, susceptibility to, 8	608462		2
HSCR9	Hirschsprung disease, susceptibility to, 9	611644	between D4S3049 and D4S1566	2
HSD11B1, HSD11, HSD11L, CORTRD2	Cortisone reductase deficiency 2	614662	digenic triallelic mutations with H6PD	3
HSD11B2, HSD11K, AME	Apparent mineralocorticoid excess	218030		3
HSD17B10, HADH2, ERAB, MRXS10, HSD10MD	HSD10 mitochondrial disease	300438		3
HSD17B13, SCDR9, FLDP	Fatty liver disease, protection from	620116		3
HSD17B3, EDH17B3	Pseudohermaphroditism, male, with gynecomastia	264300		3
HSD17B4, PRLTS1	D-bifunctional protein deficiency	261515		3
HSD17B4, PRLTS1	 Perrault syndrome 1	233400		3
HSD3B2	Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency	201810		3
HSD3B7, CBAS1	Bile acid synthesis defect, congenital, 1	607765		3
HSF2BP, POF19	Premature ovarian failure 19	619245		3
HSF4, CTM, CTRCT5	Cataract 5, multiple types	116800		3
HSN1B	Neuropathy, hereditary sensory, type IB	608088	max lod at D3S2338	2
HSPA9, HSPA9B, MOT2, GRP75, EVPLS, SIDBA4	 Anemia, sideroblastic, 4	182170		3
HSPA9, HSPA9B, MOT2, GRP75, EVPLS, SIDBA4	Even-plus syndrome	616854		3
HSPB1, HSP27, CMT2F, HMN2B	 Charcot-Marie-Tooth disease, axonal, type 2F	606595		3
HSPB1, HSP27, CMT2F, HMN2B	Neuronopathy, distal hereditary motor, type IIB	608634		3
HSPB8, H11, E2IG1, DHMN2, CMT2L, HMN2A	 Charcot-Marie-Tooth disease, axonal, type 2L	608673		3
HSPB8, H11, E2IG1, DHMN2, CMT2L, HMN2A	Neuronopathy, distal hereditary motor, type IIA	158590		3
HSPD1, SPG13, HSP60, HLD4	 Leukodystrophy, hypomyelinating, 4	612233		3
HSPD1, SPG13, HSP60, HLD4	Spastic paraplegia 13, autosomal dominant	605280		3
HSPG2, PLC, SJS, SJA, SJS1	Dyssegmental dysplasia, Silverman-Handmaker type	224410		3
HSPG2, PLC, SJS, SJA, SJS1	 Schwartz-Jampel syndrome, type 1	255800		3
HSR	Handedness	139900		2
HTC2, HCG, CGH, CXINSq27.1	Hypertrichosis, congenital generalized	307150	palindrome-mediated interchromosomal insertion at Xq27.1	4
HTGH, DEL17q24	Hypertrichosis terminalis, generalized, with or without gingival hyperplasia	135400		4
HT	Hashimoto thyroiditis	140300	?chr.12	2
HTR1A, ADRB2RL1, PFMCD	Periodic fever, menstrual cycle dependent	614674		3
HTR2A	Alcohol dependence, susceptibility to	103780		3
HTR2A	 Anorexia nervosa, susceptibility to	606788		3
HTR2A	 Major depressive disorder, response to citalopram therapy in	608516		3
HTR2A	 Obsessive-compulsive disorder, susceptibility to	164230		3
HTR2A	 Schizophrenia, susceptibility to	181500		3
HTR2A	 Seasonal affective disorder, susceptibility to	608516		3
HTRA1, PRSS11, ARMD7, CARASIL, CADASIL2	 CARASIL syndrome	600142		3
HTRA1, PRSS11, ARMD7, CARASIL, CADASIL2	 Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2	616779		3
HTRA1, PRSS11, ARMD7, CARASIL, CADASIL2	 Macular degeneration, age-related, 7	610149		3
HTRA1, PRSS11, ARMD7, CARASIL, CADASIL2	Macular degeneration, age-related, neovascular type	610149		3
HTRA2, OMI, PARK13, PRSS25, MGCA8	 3-methylglutaconic aciduria, type VIII	617248		3
HTRA2, OMI, PARK13, PRSS25, MGCA8	Parkinson disease 13	610297		3
HTT, HD, IT15, LOMARS	 Huntington disease	143100	distal to D4S10	3
HTT, HD, IT15, LOMARS	Lopes-Maciel-Rodan syndrome	617435	distal to D4S10	3
HUWE1, UREB1, KIAA0312, LASU1, MRXST	Intellectual developmental disorder, X-linked syndromic, Turner type	309590		3
HWE1	Epilepsy, hot water, 1	613339	max lod at D10S412	2
HWE2	Epilepsy, hot water, 2	613340	between D4S1572 and D4S2277	2
HYAL1, MPS9	Mucopolysaccharidosis type IX	601492		3
HYCC1, FAM126A, DRCTNNB1A, HLD5	Leukodystrophy, hypomyelinating, 5	610532		3
HYDIN, HYDIN1, CILD5	Ciliary dyskinesia, primary, 5	608647	duplicated copy on 1q21.1	3
HYLS1, FLJ32915	Hydrolethalus syndrome	236680		3
HYPLIP2	Hyperlipidemia, combined, 2	604499		2
HYPOFP	Hypoplastic femurs and pelvis	619545	duplication of ~500kb on 10q24	4
HYPT10	Hypotrichosis 10	614238	between D7S1532 and D7S3047	2
HYPT5, MUHH2	Hypotrichosis 5	612841	max lod at D1S2881	2
HYPT9	Hypotrichosis 9	614237	between D10S538 and D10S2327	2
HYSP3	Hypospadias 3, autosomal	146450	between D7S2519 and D7S2442.	2
HYSP4	Hypospadias 4, X-linked, susceptibility to	300856	associated with rs1934179 and rs7063116	2
HYT1	Hypertension, essential, susceptibility to, 1	145500	~18cM distal to ACE	2
HYT2	Hypertension, essential, susceptibility to, 2	145500		2
HYT3	Hypertension, essential, susceptibility to, 3	145500		2
HYT4	Hypertension, essential, susceptibility to, 4	145500		2
HYT5	Hypertension, essential, susceptibility to, 5	145500		2
HYT6	Hypertension, essential, susceptibility to, 6	145500		2
HYT7	Hypertension, essential, susceptibility to, 7	610948		2
HYT8	Hypertension, essential, susceptibility to, 8	611014	associated with rs1941958 and rs1893379	2
IARS1, IARS, GRIDHH	Growth retardation, impaired intellectual development, hypotonia, and hepatopathy	617093		3
IARS2, CAGSSS	Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia	616007		3
IBA57, C1orf69, MMDS3, SPG74	Multiple mitochondrial dysfunctions syndrome 3	615330		3
IBA57, C1orf69, MMDS3, SPG74	 Spastic paraplegia 74, autosomal recessive	616451		3
IBD11	Inflammatory bowel disease 11	191390	associated with MUC3A	2
IBD12	Inflammatory bowel disease 12	612241		2
IBD15	Inflammatory bowel disease 15	612255	association with rs10761659	2
IBD16	Inflammatory bowel disease 16	612259		2
IBD18	Inflammatory bowel disease 18	612262	associated with rs1373692	2
IBD20	Inflammatory bowel disease 20	612288	associated with rs11190140	2
IBD21	Inflammatory bowel disease 21	612354	associated with rs2542151	2
IBD22	Inflammatory bowel disease 22	612380	associated with rs744166	2
IBD23	Inflammatory bowel disease 23	612381	associated with rs3024505	2
IBD24	Inflammatory bowel disease 24	612566	associated with rs2315008 and rs4809330	2
IBD26	Inflammatory bowel disease 26	612639	associated with rs1558744	2
IBD27	Inflammatory bowel disease 27	612796		2
IBD2	Inflammatory bowel disease 2	601458	mainly ulcerative colitis	2
IBD3	Inflammatory bowel disease 3	604519		2
IBD4	Inflammatory bowel disease 4	606675		2
IBD5	Inflammatory bowel disease 5	606348		2
IBD6	Inflammatory bowel disease 6	606674		2
IBD7	Inflammatory bowel disease 7	605225	associated with rs6426833	2
IBD8	Inflammatory bowel disease 8	606668		2
IBD9	Inflammatory bowel disease 9	608448		2
ICAM1	Malaria, cerebral, susceptibility to	611162	close to Ldlr in mouse	3
ICAM4, CD242, LW	Blood group, Landsteiner-Wiener	111250	close to C3, LU	3
ICK, MRK, KIAA0936, ECO, EJM10	 Endocrine-cerebroosteodysplasia	612651		3
ICK, MRK, KIAA0936, ECO, EJM10	Epilepsy, juvenile myoclonic, susceptibility to, 10	617924		3
ICOS, AILIM, CVID1	Immunodeficiency, common variable, 1	607594		3
ICR1, BWS, WT2, SRS1	 Beckwith-Wiedemann syndrome	130650		3
ICR1, BWS, WT2, SRS1	 Silver-Russell syndrome 1	180860		3
ICR1, BWS, WT2, SRS1	Wilms tumor 2	194071		3
IDDM11	Diabetes mellitus, insulin-dependent, 11	601208		2
IDDM13	Diabetes mellitus, insulin-dependent, 13	601318		2
IDDM15	Diabetes mellitus, insulin-dependent, 15	601666		2
IDDM17	Diabetes mellitus, insulin-dependent, 17	603266		2
IDDM18	Diabetes mellitus, insulin-dependent, 18	605598	close to IL12B	2
IDDM19	Diabetes mellitus, insulin-dependent, 19	610155	associated with rs1990760	2
IDDM1	Diabetes mellitus, insulin-dependent-1	222100	linkage or association, with HLA	2
IDDM21	Diabetes mellitus, insulin-dependent, 21	612521	associated with rs1738074	2
IDDM23	Diabetes mellitus, insulin-dependent, 23	612622	associated with rs6534347	2
IDDM24	Diabetes mellitus, insulin-dependent, 24	613006	associated with rs10509540	2
IDDM3	Diabetes mellitus, insulin-dependent, 3	600318		2
IDDM4	Diabetes mellitus, insulin-dependent, 4	600319		2
IDDM6	Diabetes mellitus, insulin-dependent, 6	601941		2
IDDM7	Diabetes mellitus, insulin-dependent, 7	600321		2
IDDM8	Diabetes mellitus, insulin-dependent, 8	600883		2
IDDMX	Diabetes mellitus, insulin-dependent, X-linked	300136	only with DR3	2
IDH1	Glioma, susceptibility to, somatic	137800		3
IDH2, IDPM, D2HGA2	D-2-hydroxyglutaric aciduria 2	613657		3
IDH3A, RP90	Retinitis pigmentosa 90	619007		3
IDH3B, RP46	Retinitis pigmentosa 46	612572		3
IDS, MPS2, SIDS	Mucopolysaccharidosis II	309900	telomeric IDS2 source of inversion in IDS	3
IDUA, IDA	 Mucopolysaccharidosis Ih	607014		3
IDUA, IDA	 Mucopolysaccharidosis Ih/s	607015		3
IDUA, IDA	Mucopolysaccharidosis Is	607016		3
IER3IP1, MEDS	Microcephaly, epilepsy, and diabetes syndrome	614231		3
IFIH1, MDA5, AGS7, SGMRT1, IMD95	 Aicardi-Goutieres syndrome 7	615846		3
IFIH1, MDA5, AGS7, SGMRT1, IMD95	Immunodeficiency 95	619773		3
IFIH1, MDA5, AGS7, SGMRT1, IMD95	 Singleton-Merten syndrome 1	182250		3
IFITM3	Influenza, severe, susceptibility to	614680		3
IFITM5, OI5	Osteogenesis imperfecta, type V	610967		3
IFNA1, IFNA@	Interferon, alpha, deficiency	147660	very close to IFF by Fd, LD; 15-30 genes	1
IFNAR1, IMD106	Immunodeficiency 106, susceptibility to viral infections	619935		3
IFNAR2, IMD45	Hepatitis B virus, susceptibility to	610424		3
IFNAR2, IMD45	 Immunodeficiency 45	616669		3
IFNG, IFG, IFI, IMD69	 AIDS, rapid progression to	609423	mutation identified in 1 IMD69 family	3
IFNG, IFG, IFI, IMD69	 Aplastic anemia	609135	mutation identified in 1 IMD69 family	3
IFNG, IFG, IFI, IMD69	Hepatitis C virus, response to therapy of	609532	mutation identified in 1 IMD69 family	3
IFNG, IFG, IFI, IMD69	 Immunodeficiency 69, mycobacteriosis	618963	mutation identified in 1 IMD69 family	3
IFNG, IFG, IFI, IMD69	 TSC2 angiomyolipomas, renal, modifier of	613254	mutation identified in 1 IMD69 family	3
IFNG, IFG, IFI, IMD69	 Tuberculosis, protection against	607948	mutation identified in 1 IMD69 family	3
IFNGR1, IMD27A, IMD27B	 Hepatitis B virus infection, susceptibility to	610424		3
IFNGR1, IMD27A, IMD27B	H. pylori infection, susceptibility to	600263		3
IFNGR1, IMD27A, IMD27B	 Immunodeficiency 27A, mycobacteriosis, AR	209950		3
IFNGR1, IMD27A, IMD27B	 Immunodeficiency 27B, mycobacteriosis, AD	615978		3
IFNGR1, IMD27A, IMD27B	 Tuberculosis infection, protection against	607948		3
IFNGR1, IMD27A, IMD27B	 Tuberculosis, susceptibility to	607948		3
IFNGR2, IFNGT1, IFGR2, IMD28	Immunodeficiency 28, mycobacteriosis	614889		3
IFNL3, IL28B	Hepatitis C virus infection, response to therapy of	609532		3
IFT122, WDR10, CED1	Cranioectodermal dysplasia 1	218330		3
IFT140, KIAA0590, SRTD9, MZSDS, RP80	 Retinitis pigmentosa 80	617781		3
IFT140, KIAA0590, SRTD9, MZSDS, RP80	Short-rib thoracic dysplasia 9 with or without polydactyly	266920		3
IFT172, SLB, KIAA1179, SRTD10, RP71, BBS20	 Bardet-Biedl syndrome 20	619471		3
IFT172, SLB, KIAA1179, SRTD10, RP71, BBS20	Retinitis pigmentosa 71	616394		3
IFT172, SLB, KIAA1179, SRTD10, RP71, BBS20	 Short-rib thoracic dysplasia 10 with or without polydactyly	615630		3
IFT27, RABL4, BBS19	Bardet-Biedl syndrome 19	615996		3
IFT43, C14orf179, CED3, SRTD18, RP81	 Retinitis pigmentosa 81	617871	mutation identified in 1 CED3 family and 1 RP81 family	3
IFT43, C14orf179, CED3, SRTD18, RP81	 Short-rib thoracic dysplasia 18 with polydactyly	617866	mutation identified in 1 CED3 family and 1 RP81 family	3
IFT52	Short-rib thoracic dysplasia 16 with or without polydactyly	617102		3
IFT74, CCDC2, CMG1, BBS22, JBTS40, SPGF58	Bardet-Biedl syndrome 22	617119		3
IFT74, CCDC2, CMG1, BBS22, JBTS40, SPGF58	 Joubert syndrome 40	619582		3
IFT74, CCDC2, CMG1, BBS22, JBTS40, SPGF58	 Spermatogenic failure 58	619585		3
IFT80, KIAA1374, WDR56, SRTD2, ATD2	Short-rib thoracic dysplasia 2 with or without polydactyly	611263		3
IFT81, DV1, CDV1R, SRTD19	Short-rib thoracic dysplasia 19 with or without polydactyly	617895		3
IGAD1	Immunoglobulin A deficiency	137100		2
IGAN1	IgA nephropathy, susceptibility to, 1	161950		2
IGAN2	IgA nephropathy, susceptibility to, 2	613944	between D2S1323 and D2S362	2
IGES	Allergy and asthma susceptibility	147061		2
IGF1	Growth retardation with deafness and mental retardation due to IGF1 deficiency	608747		3
IGF1R	Insulin-like growth factor I, resistance to	270450		3
IGF2BP2, IMP2	Diabetes mellitus, noninsulin-dependent, susceptibility to	125853		3
IGF2, GRDF, SRS3	Silver-Russell syndrome 3	616489	mutation identified in 1 GRDF family	3
IGF2R, MPRI	Hepatocellular carcinoma, somatic	114550	behaves as a tumor suppressor	3
IGFALS, ALS, ACLSD	Acid-labile subunit, deficiency of	615961		3
IGFBP7, MAC25, RAMSVPS	Retinal arterial macroaneurysm with supravalvular pulmonic stenosis	614224		3
IGHG2	IgG2 deficiency, selective	147110	5'-G2-17kb-G4-3'; closeness of IGG3 and IGG1 known from Lepore-like myeloma protein	3
IGHMBP2, SMUBP2, CATF1, SMARD1, HMN6, CMT2S	 Charcot-Marie-Tooth disease, axonal, type 2S	616155		3
IGHMBP2, SMUBP2, CATF1, SMARD1, HMN6, CMT2S	Neuronopathy, distal hereditary motor, type VI	604320		3
IGHM, MU, AGM1	Agammaglobulinemia 1	601495		3
IGKC, IGKCD	Kappa light chain deficiency	614102		3
IGLL1, IGO, IGL5, VPREB2, AGM2	Agammaglobulinemia 2	613500	between BCR2 and BCR4; distal to IGLC	3
IGSF1, IGDC1, CHTE	Hypothyroidism, central, and testicular enlargement	300888		3
IHH, BDA1	Acrocapitofemoral dysplasia	607778		3
IHH, BDA1	 Brachydactyly, type A1	112500		3
IH, HHP	Hemihypertrophy	235000	epigenetic or uniparental disomy	2
IHPS1, IHPS	Pyloric stenosis, infantile hypertrophic 1	179010		2
IHPS2	Pyloric stenosis, infantile hypertrophic, 2	610260		2
IHPS3	Pyloric stenosis, infantile hypertrophic, 3	612017	max lod at rs541821	2
IHPS4	Pyloric stenosis, infantile hypertrophic, 4	300711	max lod at rs3027802	2
IHPS5	Pyloric stenosis, infantile hypertrophic, 5	612525	between rs7197068 and rs750740	2
IKBKB, NFKBIKB, IMD15B, IMD15A	 Immunodeficiency 15A	618204		3
IKBKB, NFKBIKB, IMD15B, IMD15A	Immunodeficiency 15B	615592		3
IKBKG, NEMO, FIP3, IP, EDAID1, IMD33, SAIDX	 Autoinflammatory disease, systemic, X-linked	301081		3
IKBKG, NEMO, FIP3, IP, EDAID1, IMD33, SAIDX	 Ectodermal dysplasia and immunodeficiency 1	300291		3
IKBKG, NEMO, FIP3, IP, EDAID1, IMD33, SAIDX	 Immunodeficiency 33	300636		3
IKBKG, NEMO, FIP3, IP, EDAID1, IMD33, SAIDX	Incontinentia pigmenti	308300		3
IKZF1, ZNFN1A1, IK1, LYF1, CVID13	Immunodeficiency, common variable, 13	616873	fused with BCL6 in DLBL	3
IKZF5, ZNFN1A5, PEGASUS, THC7	Thrombocytopenia, autosomal dominant, 7	619130		3
IL10, CSIF, GVHDS	 Graft-versus-host disease, protection against	614395		3
IL10, CSIF, GVHDS	 HIV-1, susceptibility to	609423		3
IL10, CSIF, GVHDS	Rheumatoid arthritis, progression of	180300		3
IL10RA, IL10R, IBD28	Inflammatory bowel disease 28, early onset, autosomal recessive	613148		3
IL10RB, CRFB4, IBD25	Hepatitis B virus, susceptibility to	610424	35kb distal to IFNAR; D21S58	3
IL10RB, CRFB4, IBD25	 Inflammatory bowel disease 25, early onset, autosomal recessive	612567	35kb distal to IFNAR; D21S58	3
IL11RA, CRSDA	Craniosynostosis and dental anomalies	614188		3
IL12B, NKSF2, IMD29	Immunodeficiency 29, mycobacteriosis	614890	between GLR1 and GABRA1	3
IL12RB1, IMD30	Immunodeficiency 30	614891		3
IL13, ALRH, BHR1	 Allergic rhinitis, susceptibility to	607154		3
IL13, ALRH, BHR1	Asthma, susceptibility to	600807		3
IL17RA, IL17R, IMD51	Immunodeficiency 51	613953		3
IL17RC, IL17RL, CANDF9	Candidiasis, familial, 9	616445		3
IL17RD, SEF, HH18	Hypogonadotropic hypogonadism 18 with or without anosmia	615267		3
IL18BP, FVH	Hepatitis, fulminant viral, susceptibility to	618549	mutation identified in 1 FVH patient	3
IL1B	Gastric cancer risk after H. pylori infection	613659	within 430kb of IL1RN, IL1A	3
IL1RAPL1, IL1R8, MRX21, MRX34	Intellectual developmental disorder, X-linked 21	300143		3
IL1RN, MVCD4, DIRA	Gastric cancer risk after H. pylori infection	613659		3
IL1RN, MVCD4, DIRA	 Interleukin 1 receptor antagonist deficiency	612852		3
IL1RN, MVCD4, DIRA	 Microvascular complications of diabetes 4	612628		3
IL21R, IMD56	IgE, elevated level of	147050	fusion partner with BCL6	3
IL21R, IMD56	 Immunodeficiency 56	615207	fusion partner with BCL6	3
IL23R, IBD17	Inflammatory bowel disease 17, protection against	612261		3
IL23R, IBD17	 Psoriasis, protection against	605606		3
IL2RA, CD25, IL2R, IDDM10, IMD41	 Diabetes, mellitus, insulin-dependent, susceptibility to, 10	601942		3
IL2RA, CD25, IL2R, IDDM10, IMD41	Immunodeficiency 41 with lymphoproliferation and autoimmunity	606367		3
IL2RB, IMD63	Immunodeficiency 63 with lymphoproliferation and autoimmunity	618495		3
IL2RG, SCIDX1, SCIDX, IMD4	Combined immunodeficiency, X-linked, moderate	312863	linked to DXS159	3
IL2RG, SCIDX1, SCIDX, IMD4	 Severe combined immunodeficiency, X-linked	300400	linked to DXS159	3
IL36RN, IL1F5, FIL1D, IL1HY1, IL1RP3, PSORP, PSORS14	Psoriasis 14, pustular	614204		3
IL4R, IL4RA	AIDS, slow progression to	609423		3
IL4R, IL4RA	 Atopy, susceptibility to	147050		3
IL6, IFNB2, BSF2, HSF, HGF	 Crohn disease-associated growth failure	266600		3
IL6, IFNB2, BSF2, HSF, HGF	 Intracranial hemorrhage in brain cerebrovascular malformations, susceptibility to	108010		3
IL6, IFNB2, BSF2, HSF, HGF	 Kaposi sarcoma, susceptibility to	148000		3
IL6, IFNB2, BSF2, HSF, HGF	 Rheumatoid arthritis, systemic juvenile	604302		3
IL6, IFNB2, BSF2, HSF, HGF	 Type 1 diabetes mellitus	222100		3
IL6, IFNB2, BSF2, HSF, HGF	Type 2 diabetes mellitus	125853		3
IL6R, IL6RQ, IL6QTL, HIES5	 Hyper-IgE recurrent infection syndrome 5, autosomal recessive	618944	IL6R-like gene on chr.9	3
IL6R, IL6RQ, IL6QTL, HIES5	 Interleukin-6 receptor, soluble, serum level of, QTL	614689	IL6R-like gene on chr.9	3
IL6R, IL6RQ, IL6QTL, HIES5	Interleukin 6, serum level of, QTL	614752	IL6R-like gene on chr.9	3
IL6ST, HIES4A, HIES4B, STWS2, IMD94	 Hyper-IgE recurrent infection syndrome 4A, autosomal dominant	619752	mutation identified in one IMD94 patient	3
IL6ST, HIES4A, HIES4B, STWS2, IMD94	 Hyper-IgE recurrent infection syndrome 4B, autosomal recessive	618523	mutation identified in one IMD94 patient	3
IL6ST, HIES4A, HIES4B, STWS2, IMD94	 Immunodeficiency 94 with autoinflammation and dysmorphic facies	619750	mutation identified in one IMD94 patient	3
IL6ST, HIES4A, HIES4B, STWS2, IMD94	Stuve-Wiedemann syndrome 2	619751	mutation identified in one IMD94 patient	3
IL7	Epidermodysplasia verruciformis, susceptibility to, 5	618309	mutation identified in 1 EV5 family	3
IL7R, IL7RA, CD127, IMD104	Immunodeficiency 104, severe combined	608971		3
ILDR1, DFNB42	Deafness, autosomal recessive 42	609646		3
IMPA1, MRT59	Intellectual developmental disorder, autosomal recessive 59	617323		3
IMPAD1, GPAPP, IMPA3	Chondrodysplasia with joint dislocations, GPAPP type	614078		3
IMPDH1, RP10, LCA11	 Leber congenital amaurosis 11	613837	pseudogene on 16p13.13	3
IMPDH1, RP10, LCA11	Retinitis pigmentosa 10	180105	pseudogene on 16p13.13	3
IMPDH2, IMPD2	IMPDH2 enzyme activity, variation in	617995		3
IMPG1, IPM150, VMD4, RP91	Macular dystrophy, vitelliform, 4	616151		3
IMPG1, IPM150, VMD4, RP91	 Retinitis pigmentosa 91	153870		3
IMPG2, IPM200, RP56, VMD5	 Macular dystrophy, vitelliform, 5	616152		3
IMPG2, IPM200, RP56, VMD5	Retinitis pigmentosa 56	613581		3
INAVA, C1orf106, IBD29	Inflammatory bowel disease 29	618077		3
INDX	Woods-Black-Norbury syndrome	300076		2
INF2, FSGS5, C14orf173, CMTDIE	 Charcot-Marie-Tooth disease, dominant intermediate E	614455		3
INF2, FSGS5, C14orf173, CMTDIE	Glomerulosclerosis, focal segmental, 5	613237		3
ING1	Squamous cell carcinoma, head and neck, somatic	275355		3
INPP5E, MORMS, JBTS1, CORS1	Joubert syndrome 1	213300		3
INPP5E, MORMS, JBTS1, CORS1	 Mental retardation, truncal obesity, retinal dystrophy, and micropenis	610156		3
INPP5K, SKIP, MDCCAID	Muscular dystrophy, congenital, with cataracts and intellectual disability	617404		3
INPPL1, OPSMD	Opsismodysplasia	258480		3
INSL3	Cryptorchidism	219050		3
INS, MODY10, IDDM2, PNDM4	Diabetes mellitus, insulin-dependent, 2	125852	5'--INS-12.6kb-IGF2--3'; cen-HBBC-10cM-INS-2cM-HRAS1-3cM-TH	3
INS, MODY10, IDDM2, PNDM4	 Diabetes mellitus, permanent neonatal 4	618858	5'--INS-12.6kb-IGF2--3'; cen-HBBC-10cM-INS-2cM-HRAS1-3cM-TH	3
INS, MODY10, IDDM2, PNDM4	 Hyperproinsulinemia	616214	5'--INS-12.6kb-IGF2--3'; cen-HBBC-10cM-INS-2cM-HRAS1-3cM-TH	3
INS, MODY10, IDDM2, PNDM4	 Maturity-onset diabetes of the young, type 10	613370	5'--INS-12.6kb-IGF2--3'; cen-HBBC-10cM-INS-2cM-HRAS1-3cM-TH	3
INSR, HHF5	 Diabetes mellitus, insulin-resistant, with acanthosis nigricans	610549	1 gene for alpha and beta subunits	3
INSR, HHF5	 Donohue syndrome	246200	1 gene for alpha and beta subunits	3
INSR, HHF5	 Hyperinsulinemic hypoglycemia, familial, 5	609968	1 gene for alpha and beta subunits	3
INSR, HHF5	Rabson-Mendenhall syndrome	262190	1 gene for alpha and beta subunits	3
INTLQ1	Intelligence QTL1	603783	associated with D4S2943, MSX1, and D4S1607	2
INTLQ2	Intelligence QTL3	610295		2
INTLQ3	Intelligence QTL3	610294		2
INTS1, INT1, KIAA1440, NDCAGF	Neurodevelopmental disorder with cataracts, poor growth, and dysmorphic facies	618571		3
INTU, KIAA1284, PDZK6, SRTD20, OFD17	 Short-rib thoracic dysplasia 20 with polydactyly	617925	mutation identified in 1 SRTD20 patient and 1 OFD17 patient	3
INVS, INV, NPHP2, NPH2	Nephronophthisis 2, infantile	602088		3
IPO8, RANBP8, VISS	VISS syndrome	619472		3
IQCB1, NPHP5, KIAA0036	Senior-Loken syndrome 5	609254		3
IQCE, KIAA1023, PAPA7	Polydactyly, postaxial, type A7	617642		3
IQCN, SPGF78	Spermatogenic failure 78	620170		3
IQSEC1, KIAA0763, IDDSSBA	Intellectual developmental disorder with short stature and behavioral abnormalities	618687		3
IQSEC2, KIAA0522, MRX1, MRX78, XLID1	Intellectual developmental disorder, X-linked 1	309530		3
IRAK3, IRAKM, ASRT5	Asthma susceptibility 5	611064		3
IRAK4, REN64, IPD1, IMD67	Immunodeficiency 67	607676		3
IREB2, NDCAMA	Neurodegeneration, early-onset, with choreoathetoid movements and microcytic anemia	618451		3
IRF1, MAR	 Gastric cancer, somatic	613659		3
IRF1, MAR	 Myelodysplastic syndrome, preleukemic	147575		3
IRF1, MAR	 Myelogenous leukemia, acute	147575		3
IRF1, MAR	Nonsmall cell lung cancer, somatic	211980		3
IRF2BPL, C14orf4, EAP1, NEDAMSS	Neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures	618088		3
IRF3, IIAE7	Encephalopathy, acute, infection-induced , susceptibility to, 7	616532		3
IRF4, LSIRF, SHEP8	Skin/hair/eye pigmentation, variation in, 8	611724	dysregulated in t(6;14)	3
IRF5, IBD14, SLEB10	Inflammatory bowel disease 14	612245		3
IRF5, IBD14, SLEB10	 Systemic lupus erythematosus, susceptibility to, 10	612251		3
IRF6, VWS1, LPS, PIT, PPS1, OFC6	Orofacial cleft 6	608864	OFC6 in enhancer 5' of IRF6	3
IRF6, VWS1, LPS, PIT, PPS1, OFC6	 Popliteal pterygium syndrome 1	119500	OFC6 in enhancer 5' of IRF6	3
IRF6, VWS1, LPS, PIT, PPS1, OFC6	 van der Woude syndrome 1	119300	OFC6 in enhancer 5' of IRF6	3
IRF8, ICSBP1, IMD32A, IMD32B	Immunodeficiency 32A, mycobacteriosis, autosomal dominant	614893		3
IRF8, ICSBP1, IMD32A, IMD32B	 Immunodeficiency 32B, monocyte and dendritic cell deficiency, autosomal recessive	226990		3
IRF9, ISGF3, ISGF3G	Immunodeficiency 65, susceptibility to viral infections	618648		3
IRGM, LRG47, IFI1, IBD19	 Inflammatory bowel disease  19	612278		3
IRGM, LRG47, IFI1, IBD19	Mycobacterium tuberculosis, protection against	607948		3
IRS1	 Coronary artery disease, susceptibility to	147545		3
IRS1	Type 2 diabetes mellitus, susceptibility to	125853		3
IRS2	Diabetes mellitus, noninsulin-dependent	125853		3
IRS4, CHNG9	Hypothyroidism, congenital, nongoitrous, 9	301035		3
IRX5, HMMS	Hamamy syndrome	611174		3
IS1, AIS	Scoliosis, idiopathic 1	181800		2
IS2, AIS2	Scoliosis, idiopathic 2	607354	between D17S947 and D17S798	2
IS3	Scoliosis, isolated, susceptibility to, 3	608765		2
IS4	Scoliosis, idiopathic, susceptibility to, 4	612238	max lod at D9S2157	2
IS5	Scoliosis, idiopathic, susceptibility to, 5	612239	between D17S1806 and 17qter	2
ISCA1, HBLD2, HISCA, MMDS5	Multiple mitochondrial dysfunctions syndrome 5	617613		3
ISCA2, MMDS4	Multiple mitochondrial dysfunctions syndrome 4	616370		3
ISCU, HML	Myopathy with lactic acidosis, hereditary	255125		3
ISG15, G1P2, IFI15, IMD38	Immunodeficiency 38	616126		3
ITCH, AIP4, NAPP1, ADMFD	Autoimmune disease, multisystem, with facial dysmorphism	613385		3
ITGA2B, GP2B, CD41B, GT1, BDPLT2, BDPLT16	 Bleeding disorder, platelet-type, 16, autosomal dominant	187800	3' to GP3A; BAK platelet antigen	3
ITGA2B, GP2B, CD41B, GT1, BDPLT2, BDPLT16	 Glanzmann thrombasthenia 1	273800	3' to GP3A; BAK platelet antigen	3
ITGA2B, GP2B, CD41B, GT1, BDPLT2, BDPLT16	Thrombocytopenia, neonatal alloimmune, BAK antigen related	607759	3' to GP3A; BAK platelet antigen	3
ITGA3, CD49C, GAPB3, JEB7	Epidermolysis bullosa, junctional 7, with interstitial lung disease and nephrotic syndrome	614748		3
ITGA6, JEB6	Epidermolysis bullosa, junctional 6, with pyloric atresia	619817		3
ITGA7	Muscular dystrophy, congenital, due to ITGA7 deficiency	613204		3
ITGA8, RHDA1	Renal hypodysplasia/aplasia 1	191830		3
ITGB2, CD18, LCAMB, LAD	Leukocyte adhesion deficiency	116920	common subunit for CR3, LFA1, and P150,95	3
ITGB3, GP3A, GT2, BDPLT24	Bleeding disorder, platelet-type, 24, autosomal dominant	619271	in same 260kb fragment as GP2B; PL(A) platelet antigen	3
ITGB3, GP3A, GT2, BDPLT24	 Glanzmann thrombasthenia 2	619267	in same 260kb fragment as GP2B; PL(A) platelet antigen	3
ITGB3, GP3A, GT2, BDPLT24	 Myocardial infarction, susceptibility to	608446	in same 260kb fragment as GP2B; PL(A) platelet antigen	3
ITGB3, GP3A, GT2, BDPLT24	 Purpura, posttransfusion	173470	in same 260kb fragment as GP2B; PL(A) platelet antigen	3
ITGB3, GP3A, GT2, BDPLT24	 Thrombocytopenia, neonatal alloimmune	173470	in same 260kb fragment as GP2B; PL(A) platelet antigen	3
ITGB4, JEB5B, JEB5A	 Epidermolysis bullosa, junctional 5A, intermediate	619816		3
ITGB4, JEB5B, JEB5A	Epidermolysis bullosa, junctional 5B, with pyloric atresia	226730		3
ITGB6, AI1H	Amelogenesis imperfecta, type IH	616221		3
ITK, EMT, LPFS1	Lymphoproliferative syndrome 1	613011		3
ITM2B, BRI, ABRI, FBD, RDGCA	 Dementia, familial British	176500	mutation identified in 1 RDGCA family	3
ITM2B, BRI, ABRI, FBD, RDGCA	 Dementia, familial Danish	117300	mutation identified in 1 RDGCA family	3
ITPA, DEE35	 Developmental and epileptic encephalopathy 35	616647		3
ITPA, DEE35	Inosine triphosphatase deficiency	613850		3
ITPR1, SCA15, SCA16, SCA29	Gillespie syndrome	206700		3
ITPR1, SCA15, SCA16, SCA29	 Spinocerebellar ataxia 15	606658		3
ITPR1, SCA15, SCA16, SCA29	 Spinocerebellar ataxia 29, congenital nonprogressive	117360		3
ITPR3, CMT1J	Charcot-Marie-Tooth disease, demyelinating, type 1J	620111		3
ITPR3, CMT1J	 Diabetes, type 1, susceptibility to	222100		2
ITS	Insulinoma	606960		1
IVD	Isovaleric acidemia	243500		3
IVNS1ABP, NS1BP, ND1, IMD70	Immunodeficiency 70	618969		3
IYD, DEHAL1, TDH4	Thyroid dyshormonogenesis 4	274800		3
JAG1, AGS1, AHD, DCHE, CMT2HH	 Alagille syndrome 1	118450	mutation identified in 1 DCHE family	3
JAG1, AGS1, AHD, DCHE, CMT2HH	 Charcot-Marie-Tooth disease, axonal, type 2HH	619574	mutation identified in 1 DCHE family	3
JAG1, AGS1, AHD, DCHE, CMT2HH	 Tetralogy of Fallot	187500	mutation identified in 1 DCHE family	3
JAG2, LGMDR27	Muscular dystrophy, limb-girdle, autosomal recessive 27	619566		3
JAGN1, SCN6	Neutropenia, severe congenital, 6, autosomal recessive	616022		3
JAK1, AIIDE	Autoinflammation, immune dysregulation, and eosinophilia	618999	related gene on 9p24	3
JAK2, THCYT3	Budd-Chiari syndrome, somatic	600880		3
JAK2, THCYT3	 Erythrocytosis, somatic	133100		3
JAK2, THCYT3	 Leukemia, acute myeloid, somatic	601626		3
JAK2, THCYT3	 Myelofibrosis, somatic	254450		3
JAK2, THCYT3	 Polycythemia vera, somatic	263300		3
JAK2, THCYT3	 Thrombocythemia 3	614521		3
JAK3, JAKL	SCID, autosomal recessive, T-negative/B-positive type	600802		3
JAM2, VEJAM, IBGC8	Basal ganglia calcification, idiopathic, 8, autosomal recessive	618824		3
JAM3	Hemorrhagic destruction of the brain, subependymal calcification, and cataracts	613730		3
JARID2, JMJ, DIDDF	Developmental delay with variable intellectual disability and dysmorphic facies	620098		3
JBS	Jacobsen syndrome	147791	contiguous gene deletion syndrome	4
JOAG2	Glaucoma, primary open angle, juvenile-onset, 2	608695	between D9S1803 and D9S196	2
JPH2, JP2, CMH17, CMD2E	Cardiomyopathy, dilated, 2E	619492		3
JPH2, JP2, CMH17, CMD2E	 Cardiomyopathy, hypertrophic, 17	613873		3
JPH3, JP3, HDL2	Huntington disease-like 2	606438	mutation identified in 1 HDL2 family	3
JUP, DP3, PDGB, ARVD12	 Arrhythmogenic right ventricular dysplasia 12	611528	mutation identified in 1 ARVD12 family	3
JUP, DP3, PDGB, ARVD12	Naxos disease	601214	mutation identified in 1 ARVD12 family	3
KANK1, KANK, ANKRD15, KIAA0172, CPSQ2	Cerebral palsy, spastic quadriplegic, 2	612900		3
KANK2, ANKRD25, KIAA1518, PPKWH, NPHS16	Nephrotic syndrome, type 16	617783		3
KANK2, ANKRD25, KIAA1518, PPKWH, NPHS16	 Palmoplantar keratoderma and woolly hair	616099		3
KANSL1, KIAA1267, MSL1V1, KDVS	Koolen-De Vries syndrome	610443		3
KAOGS	Kagami-Ogata syndrome	608149	uniparental isodisomy of imprinted region of chromosome 14	4
KARS1, KARS, CMTRIB, DFNB89, LEPID, DEAPLE	 Charcot-Marie-Tooth disease, recessive intermediate, B	613641	mutation identified in 1 CMTRIB patient	3
KARS1, KARS, CMTRIB, DFNB89, LEPID, DEAPLE	Deafness, autosomal recessive 89	613916	mutation identified in 1 CMTRIB patient	3
KARS1, KARS, CMTRIB, DFNB89, LEPID, DEAPLE	 Deafness, congenital, and adult-onset progressive leukoencephalopathy	619196	mutation identified in 1 CMTRIB patient	3
KARS1, KARS, CMTRIB, DFNB89, LEPID, DEAPLE	 Leukoencephalopathy, progressive, infantile-onset, with or without deafness	619147	mutation identified in 1 CMTRIB patient	3
KAT5, HTATIP, TIP60, ESA1, PLIP, NEDFASB	Neurodevelopmental disorder with dysmorphic facies, sleep disturbance, and brain abnormalities	619103		3
KAT6A, MYST3, MOZ, ZNF220, ARTHS	Arboleda-Tham syndrome	616268		3
KAT6B, MYST4, MORF, GTPTS	 Genitopatellar syndrome	606170		3
KAT6B, MYST4, MORF, GTPTS	SBBYSS syndrome	603736		3
KAT8, MYST1, MOF, LIGOWS	Li-Ghorgani-Weisz-Hubshman syndrome	618974		3
KATNB1, LIS6	Lissencephaly 6, with microcephaly	616212		3
KATNIP, KIAA0556	Joubert syndrome 26	616784		3
KAZA1	Kala-azar, susceptibility to, 1	608207		2
KAZA2	Kala-azar, susceptibility to, 2	611381		2
KAZA3	Kala-azar, susceptibility to, 3	611382		2
KBTBD13, NEM6	Nemaline myopathy 6, autosomal dominant	609273		3
KCNA1, AEMK, EA1	Episodic ataxia/myokymia syndrome	160120	close to VWF	3
KCNA2, DEE32	Developmental and epileptic encephalopathy 32	616366		3
KCNA4, KCNA8, MCIDDS	Microcephaly, cataracts, impaired intellectual development, and dystonia with abnormal striatum	618284	other map to 11p	3
KCNA5, ATFB7	Atrial fibrillation, familial, 7	612240		3
KCNB1, DEE26	Developmental and epileptic encephalopathy 26	616056		3
KCNC1, EPM7	Epilepsy, progressive myoclonic 7	616187		3
KCNC2, DEE103	Developmental and epileptic encephalopathy 103	619913	previously on 19q13.3-q13.4	3
KCNC3, SCA13	Spinocerebellar ataxia 13	605259		3
KCND3, KCND3S, KCND3L, SCA19, SCA22, BRGDA9	 Brugada syndrome 9	616399		3
KCND3, KCND3S, KCND3L, SCA19, SCA22, BRGDA9	Spinocerebellar ataxia 19	607346		3
KCNE1, JLNS, LQT5, JLNS2	Jervell and Lange-Nielsen syndrome 2	612347		3
KCNE1, JLNS, LQT5, JLNS2	 Long QT syndrome 5	613695		3
KCNE2, MIRP1, LQT6, ATFB4	 Atrial fibrillation, familial, 4	611493		3
KCNE2, MIRP1, LQT6, ATFB4	Long QT syndrome 6	613693		3
KCNH1, EAG, TMBTS, ZLS1	 Temple-Baraitser syndrome	611816		3
KCNH1, EAG, TMBTS, ZLS1	Zimmermann-Laband syndrome 1	135500		3
KCNH2, LQT2, HERG, SQT1	 Long QT syndrome 2	613688		3
KCNH2, LQT2, HERG, SQT1	Short QT syndrome 1	609620		3
KCNJ10, SESAME	Enlarged vestibular aqueduct, digenic	600791		3
KCNJ10, SESAME	 SESAME syndrome	612780		3
KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13, PNDM2	 Diabetes mellitus, transient neonatal 3	610582	4.5kb 3' of SUR	3
KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13, PNDM2	 Diabetes mellitus, type 2, susceptibility to	125853	4.5kb 3' of SUR	3
KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13, PNDM2	Diabetes, permanent neonatal 2, with or without neurologic features	618856	4.5kb 3' of SUR	3
KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13, PNDM2	 Hyperinsulinemic hypoglycemia, familial, 2	601820	4.5kb 3' of SUR	3
KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13, PNDM2	 Maturity-onset diabetes of the young, type 13	616329	4.5kb 3' of SUR	3
KCNJ13, SVD, LCA16	 Leber congenital amaurosis 16	614186		3
KCNJ13, SVD, LCA16	Snowflake vitreoretinal degeneration	193230		3
KCNJ16, KIR5.1, HKTD	Hypokalemic tubulopathy and deafness	619406		3
KCNJ18, KIR2.6, TTPP2	Thyrotoxic periodic paralysis, susceptibility to, 2	613239		3
KCNJ1, ROMK1	Bartter syndrome, type 2	241200		3
KCNJ2, HHIRK1, KIR2.1, IRK1, LQT7, SQT3, ATFB9	 Andersen syndrome	170390		3
KCNJ2, HHIRK1, KIR2.1, IRK1, LQT7, SQT3, ATFB9	Atrial fibrillation, familial, 9	613980		3
KCNJ2, HHIRK1, KIR2.1, IRK1, LQT7, SQT3, ATFB9	 Short QT syndrome 3	609622		3
KCNJ5, GIRK4, KATP1, LQT13	 Hyperaldosteronism, familial, type III	613677		3
KCNJ5, GIRK4, KATP1, LQT13	Long QT syndrome 13	613485		3
KCNJ6, GIRK2, KCNJ7, KPLBS	Keppen-Lubinsky syndrome	614098		3
KCNK18, TRESK, TRIK, MGR13	Migraine, with or without aura, susceptibility to, 13	613656		3
KCNK3, TASK, PPH4	Pulmonary hypertension, primary, 4	615344		3
KCNK4, TRAAK, FHEIG	Facial dysmorphism, hypertrichosis, epilepsy, intellectual/developmental delay, and gingival overgrowth syndrome	618381		3
KCNK9, TASK32, BIBARS	Birk-Barel syndrome	612292		3
KCNMA1, SLO, PNKD3, CADEDS, IEG16, LIWAS	 Cerebellar atrophy, developmental delay, and seizures	617643		3
KCNMA1, SLO, PNKD3, CADEDS, IEG16, LIWAS	Epilepsy, idiopathic generalized, susceptibility to, 16	618596		3
KCNMA1, SLO, PNKD3, CADEDS, IEG16, LIWAS	 Liang-Wang syndrome	618729		3
KCNMA1, SLO, PNKD3, CADEDS, IEG16, LIWAS	 Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy	609446		3
KCNMB1	Hypertension, diastolic, resistance to	608622		3
KCNN2, SK2, DYT34, NEDMAB	 Neurodevelopmental disorder with or without variable movement or behavioral abnormalities	619725		3
KCNN3, SK3, SKCA3, ZLS3	Zimmermann-Laband syndrome 3	618658		3
KCNN4, KCA4, SK4, DHS2	Dehydrated hereditary stomatocytosis 2	616689		3
KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2	 Atrial fibrillation, familial, 3	607554		3
KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2	 Jervell and Lange-Nielsen syndrome	220400		3
KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2	 Long QT syndrome 1	192500		3
KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2	 Long QT syndrome 1, acquired, susceptibility to	192500		3
KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2	Short QT syndrome 2	609621		3
KCNQ1OT1, LIT1	Beckwith-Wiedemann syndrome	130650		3
KCNQ2, EBN1, DEE7, BFNS1	Developmental and epileptic encephalopathy 7	613720		3
KCNQ2, EBN1, DEE7, BFNS1	 Myokymia	121200		3
KCNQ2, EBN1, DEE7, BFNS1	 Seizures, benign neonatal, 1	121200		3
KCNQ3, EBN2, BFNC2	Seizures, benign neonatal, 2	121201		3
KCNQ4, DFNA2A	Deafness, autosomal dominant 2A	600101		3
KCNQ5, MRD46	Intellectual developmental disorder, autosomal dominant 46	617601		3
KCNT1, KIAA1422, DEE14, ENFL5	Developmental and epileptic encephalopathy 14	614959		3
KCNT1, KIAA1422, DEE14, ENFL5	 Epilepsy nocturnal frontal lobe, 5	615005		3
KCNT2, SLICK, DEE57	Developmental and epileptic encephalopathy 57	617771		3
KCNV2, KV11.1, RCD3B	Retinal cone dystrophy 3B	610356		3
KCTD17	Dystonia 26, myoclonic	616398		3
KCTD1, SENS	Scalp-ear-nipple syndrome	181270		3
KCTD7, EPM3, CLN14	Epilepsy, progressive myoclonic 3, with or without intracellular inclusions	611726		3
KDELR2, ELP1, OI21	Osteogenesis imperfecta, type XXI	619131		3
KDM1A, LSD1, AOF2, BHC110, KIAA0601, CPRF	Cleft palate, psychomotor retardation, and distinctive facial features	616728		3
KDM3B, C5orf7, KIAA1082, JMJD1B, DIJOS	Diets-Jongmans syndrome	618846		3
KDM4B, JMJD2B, KIAA0876, MRD65	Intellectual developmental disorder, autosomal dominant 65	619320		3
KDM5B, JARID1B, PUT1, PLU1, RBBP2H1A, MRT65	Intellectual developmental disorder, autosomal recessive 65	618109		3
KDM5C, JARID1C, SMCX, DXS1272E, XE169, MRXSCJ	Intellectual developmental disorder, X-linked syndromic, Claes-Jensen type	300534	escapes inactivation	3
KDM6A, UTX, KABUK2	Kabuki syndrome 2	300867	UTY also in mouse and man; escapes inactivation	3
KDM6B, JMJD3, KIAA0346, NEDCFSA	Neurodevelopmental disorder with coarse facies and mild distal skeletal abnormalities	618505		3
KDR	 Hemangioma, capillary infantile, somatic	602089	?mutant in TAPVR1	3
KDR	Hemangioma, capillary infantile, susceptibility to	602089	?mutant in TAPVR1	3
KDSR, FVT1, EKVP4	Erythrokeratodermia variabilis et progressiva 4	617526	~10kb 5' to BCL2	3
KEL	Blood group, Kell	110900		3
KERA, CNA2	Cornea plana 2, autosomal recessive	217300		3
KHDC3L, C6orf221, ECAT1, HYDM2	Hydatidiform mole, recurrent, 2	614293		3
KIAA0442, MRD26, AUTS2	Intellectual developmental disorder, autosomal dominant 26	615834	translocation break at 7q11.2	3
KIAA0586, TALPID3, JBTS23, SRTD14	 Joubert syndrome 23	616490		3
KIAA0586, TALPID3, JBTS23, SRTD14	Short-rib thoracic dysplasia 14 with polydactyly	616546		3
KIAA0753, OFIP, OFD15, JBTS38, SRTD21	 Joubert syndrome 38	619476	mutation identified in 1 OFD15 patient and 1 JBTS38 family	3
KIAA0753, OFIP, OFD15, JBTS38, SRTD21	 Short-rib thoracic dysplasia 21 without polydactyly	619479	mutation identified in 1 OFD15 patient and 1 JBTS38 family	3
KIAA0825, PAPA10	Polydactyly, postaxial, type A10	618498		3
KIAA1109, ALKKUCS	Alkuraya-Kucinskas syndrome	617822		3
KIAA1549, RP86	Retinitis pigmentosa 86	618613		3
KIDINS220, ARMS, SINO, VENARG	Spastic paraplegia, intellectual disability, nystagmus, and obesity	617296		3
KIDINS220, ARMS, SINO, VENARG	 Ventriculomegaly and arthrogryposis	619501		3
KIF11, KNSL1, MCLMR	Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation	152950		3
KIF12, PFIC8	Cholestasis, progressive familial intrahepatic, 8	619662		3
KIF14, KIAA0042, MKS12, MCPH20	 Meckel syndrome 12	616258	mutation identified in 1 MKS12 family	3
KIF14, KIAA0042, MKS12, MCPH20	Microcephaly 20, primary, autosomal recessive	617914	mutation identified in 1 MKS12 family	3
KIF1A, ATSV, UNC104, SPG30, HSN2C, MRD9	NESCAV syndrome	614255	incorrectly assigned to chr.9	3
KIF1A, ATSV, UNC104, SPG30, HSN2C, MRD9	 Neuropathy, hereditary sensory, type IIC	614213	incorrectly assigned to chr.9	3
KIF1A, ATSV, UNC104, SPG30, HSN2C, MRD9	 Spastic paraplegia 30, autosomal dominant	610357	incorrectly assigned to chr.9	3
KIF1A, ATSV, UNC104, SPG30, HSN2C, MRD9	 Spastic paraplegia 30, autosomal recessive	610357	incorrectly assigned to chr.9	3
KIF1B, CMT2A, CMT2A1, NBLST1	 Charcot-Marie-Tooth disease, type 2A1	118210		3
KIF1B, CMT2A, CMT2A1, NBLST1	 Neuroblastoma, susceptibility to, 1	256700		3
KIF1B, CMT2A, CMT2A1, NBLST1	Pheochromocytoma	171300		3
KIF1C, LTXS1, KIAA0706, SPAX2	Spastic ataxia 2, autosomal recessive	611302		3
KIF21A, KIAA1708, FEOM1, CFEOM1, CFEOM3B	 Fibrosis of extraocular muscles, congenital, 1	135700		3
KIF21A, KIAA1708, FEOM1, CFEOM1, CFEOM3B	Fibrosis of extraocular muscles, congenital, 3B	135700		3
KIF22, KNSL4, KID, OBP, SEMDJL2	Spondyloepimetaphyseal dysplasia with joint laxity, type 2	603546		3
KIF23, KNSL5, MKLP1, CDAN3A	Anemia, congenital dyserythropoietic, type IIIA	105600		3
KIF26A, KIAA1236, CDCBM11	Cortical dysplasia, complex, with other brain malformations 11	620156		3
KIF2A, CDCBM3	Cortical dysplasia, complex, with other brain malformations 3	615411		3
KIF3B, KIAA0359, RP89	Retinitis pigmentosa 89	618955		3
KIF5A, NKHC, SPG10, NEIMY, ALS25	 Amyotrophic lateral sclerosis, susceptibility to, 25	617921		3
KIF5A, NKHC, SPG10, NEIMY, ALS25	Myoclonus, intractable, neonatal	617235		3
KIF5A, NKHC, SPG10, NEIMY, ALS25	 Spastic paraplegia 10, autosomal dominant	604187		3
KIF5C, NKHC2, CDCBM2	Cortical dysplasia, complex, with other brain malformations 2	615282		3
KIF7, HLS2, ACLS, JBTS12, AGBK	 Acrocallosal syndrome	200990	mutation identified in 1 HLS2 family and 1 AGBK family	3
KIF7, HLS2, ACLS, JBTS12, AGBK	 Al-Gazali-Bakalinova syndrome	607131	mutation identified in 1 HLS2 family and 1 AGBK family	3
KIF7, HLS2, ACLS, JBTS12, AGBK	 Hydrolethalus syndrome 2	614120	mutation identified in 1 HLS2 family and 1 AGBK family	3
KIF7, HLS2, ACLS, JBTS12, AGBK	Joubert syndrome 12	200990	mutation identified in 1 HLS2 family and 1 AGBK family	3
KIFBP, KIAA1279	Goldberg-Shprintzen megacolon syndrome	609460		3
KIR3DL1, NKAT3, NKB1, AMB11, KIR3DS1	AIDS, delayed/rapid progression to	609423		3
KIRREL1, NEPH1, NPHS23	Nephrotic syndrome, type 23	619201		3
KISS1R, GPR54, HH8, CPPB1	Hypogonadotropic hypogonadism 8 with or without anosmia	614837	mutation identified in 1 CPPB1 patient	3
KISS1R, GPR54, HH8, CPPB1	 Precocious puberty, central, 1	176400	mutation identified in 1 CPPB1 patient	3
KITLG, MGF, SF, SCF, SHEP7, FPHH, DCUA, DFNA69, WS2F	 Deafness, autosomal dominant 69, unilateral or asymmetric	616697	associated with dbSNP rs12821256	3
KITLG, MGF, SF, SCF, SHEP7, FPHH, DCUA, DFNA69, WS2F	Hyperpigmentation with or without hypopigmentation	145250	associated with dbSNP rs12821256	3
KITLG, MGF, SF, SCF, SHEP7, FPHH, DCUA, DFNA69, WS2F	 Skin/hair/eye pigmentation 7, blond/brown hair	611664	associated with dbSNP rs12821256	3
KITLG, MGF, SF, SCF, SHEP7, FPHH, DCUA, DFNA69, WS2F	 Waardenburg syndrome, type 2F	619947	associated with dbSNP rs12821256	3
KIT, PBT, MASTC	Gastrointestinal stromal tumor, familial	606764	same 700bp segment as PDGFRA	3
KIT, PBT, MASTC	 Germ cell tumors, somatic	273300	same 700bp segment as PDGFRA	3
KIT, PBT, MASTC	 Leukemia, acute myeloid, somatic	601626	same 700bp segment as PDGFRA	3
KIT, PBT, MASTC	 Mastocytosis, cutaneous	154800	same 700bp segment as PDGFRA	3
KIT, PBT, MASTC	 Mastocytosis, systemic, somatic	154800	same 700bp segment as PDGFRA	3
KIT, PBT, MASTC	 Piebaldism	172800	same 700bp segment as PDGFRA	3
KIZ, KIZUNA, C20orf19, RP69	Retinitis pigmentosa 69	615780		3
KLC2, SPOAN	Spastic paraplegia, optic atrophy, and neuropathy	609541		3
KLF11, TIEG2, FKLF1, FKLF, MODY7	Maturity-onset diabetes of the young, type VII	610508		3
KLF1, EKLF, INLU, HBFQTL6, CDAN4	Blood group--Lutheran inhibitor	111150		3
KLF1, EKLF, INLU, HBFQTL6, CDAN4	 Dyserythropoietic anemia, congenital, type IV	613673		3
KLF1, EKLF, INLU, HBFQTL6, CDAN4	 Hereditary persistence of fetal hemoglobin	613566		3
KLF6, COPEB, BCD1, ZF9	Gastric cancer, somatic	613659		3
KLF6, COPEB, BCD1, ZF9	 Prostate cancer, somatic	176807		3
KLHDC8B, CHL	Hodgkin lymphoma, susceptibility to	236000		3
KLHL10, SPGF11	Spermatogenic failure 11	615081		3
KLHL15, KIAA1677, XLID103	Intellectual developmental disorder, X-linked 103	300982		3
KLHL24, KRIP6, EBS6	Epidermolysis bullosa simplex 6, generalized, with scarring and hair loss	617294		3
KLHL3, PHA2D	Pseudohypoaldosteronism, type IID	614495		3
KLHL40, SYRP, KBTBD5, NEM8	Nemaline myopathy 8, autosomal recessive	615348		3
KLHL41, KBTBD10, SARCOSIN, NEM9	Nemaline myopathy 9	615731		3
KLHL7, RP42, PERCHING	 PERCHING syndrome	617055		3
KLHL7, RP42, PERCHING	Retinitis pigmentosa 42	612943		3
KLK1, KLKR	Kallikrein, decreased urinary activity of	615953	~10cM distal to APOC2	3
KLK4, EMSP1, PRSS17, AI2A1	Amelogenesis imperfecta, type IIA1	204700		3
KLKB1, KLK3, PKKD	Fletcher factor  deficiency	612423	similar to F11	3
KLLN, CWS4	Cowden syndrome 4	615107		3
KMT2A, MLL, HRX, WDSTS	Wiedemann-Steiner syndrome	605130	fuses with ENL, AF4, AF9, GMPS	3
KMT2B, MLL4, KIAA0304, DYT28, MRD68	 Dystonia 28, childhood-onset	617284		3
KMT2B, MLL4, KIAA0304, DYT28, MRD68	Intellectual developmental disorder, autosomal dominant 68	619934		3
KMT2C, MLL3, KIAA1506, KLEFS2	Kleefstra syndrome 2	617768		3
KMT2D, MLL2, ALR, KABUK1, BCAHH	Branchial arch abnormalities, choanal atresia, athelia, hearing loss, and hypothyroidism syndrome	620186		3
KMT2D, MLL2, ALR, KABUK1, BCAHH	 Kabuki syndrome 1	147920		3
KMT2E, MLL5, ODLURO	O'Donnell-Luria-Rodan syndrome	618512		3
KMT5B, SUV420H1, CGI85, MRD51	Intellectual developmental disorder, autosomal dominant 51	617788		3
KNG1, KNG, HAE6	 Angioedema, hereditary, 6	619363		3
KNG1, KNG, HAE6	 High molecular weight kininogen deficiency	228960		3
KNG1, KNG, HAE6	Kininogen deficiency	228960		3
KNL1, CASC5, AF15Q14, KIAA1570, D40, MCPH4	Microcephaly 4, primary, autosomal recessive	604321		3
KONDS	Kondoh syndrome	606242	linked to rs966321 and rs1441834	2
KPNA3, SPG88	Spastic paraplegia 88, autosomal dominant	620106		3
KPTN, 2E4, MRT41	Intellectual developmental disorder, autosomal recessive 41	615637		3
KRAS, KRAS2, RASK2, NS, CFC2, RALD, OES	 Arteriovenous malformation of the brain, somatic	108010	pseudogene KRAS1P on 6p12-p11	3
KRAS, KRAS2, RASK2, NS, CFC2, RALD, OES	 Bladder cancer, somatic	109800	pseudogene KRAS1P on 6p12-p11	3
KRAS, KRAS2, RASK2, NS, CFC2, RALD, OES	 Breast cancer, somatic	114480	pseudogene KRAS1P on 6p12-p11	3
KRAS, KRAS2, RASK2, NS, CFC2, RALD, OES	 Cardiofaciocutaneous syndrome 2	615278	pseudogene KRAS1P on 6p12-p11	3
KRAS, KRAS2, RASK2, NS, CFC2, RALD, OES	Gastric cancer, somatic	613659	pseudogene KRAS1P on 6p12-p11	3
KRAS, KRAS2, RASK2, NS, CFC2, RALD, OES	 Leukemia, acute myeloid, somatic	601626	pseudogene KRAS1P on 6p12-p11	3
KRAS, KRAS2, RASK2, NS, CFC2, RALD, OES	 Lung cancer, somatic	211980	pseudogene KRAS1P on 6p12-p11	3
KRAS, KRAS2, RASK2, NS, CFC2, RALD, OES	 Noonan syndrome 3	609942	pseudogene KRAS1P on 6p12-p11	3
KRAS, KRAS2, RASK2, NS, CFC2, RALD, OES	 Oculoectodermal syndrome, somatic	600268	pseudogene KRAS1P on 6p12-p11	3
KRAS, KRAS2, RASK2, NS, CFC2, RALD, OES	 Pancreatic carcinoma, somatic	260350	pseudogene KRAS1P on 6p12-p11	3
KRAS, KRAS2, RASK2, NS, CFC2, RALD, OES	 RAS-associated autoimmune leukoproliferative disorder	614470	pseudogene KRAS1P on 6p12-p11	3
KRAS, KRAS2, RASK2, NS, CFC2, RALD, OES	 Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic	163200	pseudogene KRAS1P on 6p12-p11	3
KREMEN1, KRM1, ECTD13	Ectodermal dysplasia 13, hair/tooth type	617392		3
KRIT1, CCM1, CAM	 Cavernous malformations of CNS and retina	116860		3
KRIT1, CCM1, CAM	 Cerebral cavernous malformations-1	116860		3
KRIT1, CCM1, CAM	Hyperkeratotic cutaneous capillary-venous malformations associated with cerebral capillary malformations	116860		3
KRT10, EHK, BCIE, BIE, IHL	 Epidermolytic hyperkeratosis	113800	mutation identified in 1 IHL family	3
KRT10, EHK, BCIE, BIE, IHL	Ichthyosis, annular epidermolytic 1	607602	mutation identified in 1 IHL family	3
KRT10, EHK, BCIE, BIE, IHL	 Ichthyosis histrix, Lambert type	146600	mutation identified in 1 IHL family	3
KRT10, EHK, BCIE, BIE, IHL	 Ichthyosis with confetti	609165	mutation identified in 1 IHL family	3
KRT12, MECD1	Meesmann corneal dystrophy 1	122100		3
KRT13, WSN2	White sponge nevus 2	615785	in same PFGE fragment as KRT10, KRT15	3
KRT14, EBS1A, EBS1B, EBS1C, EBS1D	 Dermatopathia pigmentosa reticularis	125595		3
KRT14, EBS1A, EBS1B, EBS1C, EBS1D	 Epidermolysis bullosa simplex 1A, generalized severe	131760		3
KRT14, EBS1A, EBS1B, EBS1C, EBS1D	 Epidermolysis bullosa simplex 1B, generalized intermediate	131900		3
KRT14, EBS1A, EBS1B, EBS1C, EBS1D	 Epidermolysis bullosa simplex 1C, localized	131800		3
KRT14, EBS1A, EBS1B, EBS1C, EBS1D	Epidermolysis bullosa simplex 1D, generalized, intermediate or severe, autosomal recessive	601001		3
KRT14, EBS1A, EBS1B, EBS1C, EBS1D	 Naegeli-Franceschetti-Jadassohn syndrome	161000		3
KRT16, FNEPPK, PC1	 Pachyonychia congenita 1	167200	probably 17q21-q22	3
KRT16, FNEPPK, PC1	Palmoplantar keratoderma, nonepidermolytic, focal	613000	probably 17q21-q22	3
KRT17, PC2, PCHC1	 Pachyonychia congenita 2	167210	~5' to KRT16; probably 17q21-q22	3
KRT17, PC2, PCHC1	Steatocystoma multiplex	184500	~5' to KRT16; probably 17q21-q22	3
KRT18	Cirrhosis, cryptogenic	215600	contiguous to KRT8, type II heteromer partner	3
KRT18	 Cirrhosis, noncryptogenic, susceptibility to	215600	contiguous to KRT8, type II heteromer partner	3
KRT1, EPPK, NEPPK, EHK, AEI2	 Epidermolytic hyperkeratosis	113800	close to Hox-3 in mouse; class II keratin	3
KRT1, EPPK, NEPPK, EHK, AEI2	Ichthyosis, annular epidermolytic 2	620148	close to Hox-3 in mouse; class II keratin	3
KRT1, EPPK, NEPPK, EHK, AEI2	 Ichthyosis histrix, Curth-Macklin type	146590	close to Hox-3 in mouse; class II keratin	3
KRT1, EPPK, NEPPK, EHK, AEI2	 Keratosis palmoplantaris striata III	607654	close to Hox-3 in mouse; class II keratin	3
KRT1, EPPK, NEPPK, EHK, AEI2	 Palmoplantar keratoderma, epidermolytic	144200	close to Hox-3 in mouse; class II keratin	3
KRT1, EPPK, NEPPK, EHK, AEI2	 Palmoplantar keratoderma, nonepidermolytic	600962	close to Hox-3 in mouse; class II keratin	3
KRT25, K25, KRT24IRS1, ARWH3	Woolly hair, autosomal recessive 3	616760		3
KRT2, KRT2A, KRT2E	Ichthyosis bullosa of Siemens	146800		3
KRT3, MECD2	Meesmann corneal dystrophy 2	618767		3
KRT4, CYK4, WSN1	White sponge nevus 1	193900	class II keratin	3
KRT5, DDD1, EBS2A, EBS2B, EBS2C, EBS2D, EBS2E, EBS2F	 Dowling-Degos disease 1	179850		3
KRT5, DDD1, EBS2A, EBS2B, EBS2C, EBS2D, EBS2E, EBS2F	Epidermolysis bullosa simplex 2A, generalized severe	619555		3
KRT5, DDD1, EBS2A, EBS2B, EBS2C, EBS2D, EBS2E, EBS2F	 Epidermolysis bullosa simplex 2B, generalized intermediate	619588		3
KRT5, DDD1, EBS2A, EBS2B, EBS2C, EBS2D, EBS2E, EBS2F	 Epidermolysis bullosa simplex 2C, localized	619594		3
KRT5, DDD1, EBS2A, EBS2B, EBS2C, EBS2D, EBS2E, EBS2F	 Epidermolysis bullosa simplex 2D, generalized, intermediate or severe, autosomal recessive	619599		3
KRT5, DDD1, EBS2A, EBS2B, EBS2C, EBS2D, EBS2E, EBS2F	 Epidermolysis bullosa simplex 2E, with migratory circinate erythema	609352		3
KRT5, DDD1, EBS2A, EBS2B, EBS2C, EBS2D, EBS2E, EBS2F	 Epidermolysis bullosa simplex 2F, with mottled pigmentation	131960		3
KRT6A, PC3	Pachyonychia congenita 3	615726		3
KRT6B, PC4	Pachyonychia congenita 4	615728		3
KRT6C, PPKNEFD	Palmoplantar keratoderma, nonepidermolytic, focal or diffuse	615735		3
KRT74, K6IRS4, KRT6IRS4, HTSS2, HYPT3, ADWH	 Ectodermal dysplasia 7, hair/nail type	614929	mutation identified in 1 HYPT3 family and ECTD7 family	3
KRT74, K6IRS4, KRT6IRS4, HTSS2, HYPT3, ADWH	 Hypotrichosis 3	613981	mutation identified in 1 HYPT3 family and ECTD7 family	3
KRT74, K6IRS4, KRT6IRS4, HTSS2, HYPT3, ADWH	Woolly hair, autosomal dominant	194300	mutation identified in 1 HYPT3 family and ECTD7 family	3
KRT75, K6HF, PFB	Pseudofolliculitis barbae, susceptibility to	612318		3
KRT81, KRTHB1, HB1	Monilethrix	158000		3
KRT83, KRTHB3, HB3, MNLIX, EKVP5	 Erythrokeratodermia variabilis et progressiva 5	617756		3
KRT83, KRTHB3, HB3, MNLIX, EKVP5	Monilethrix	158000		3
KRT85, KRTHB5, HB5, ECTD4	Ectodermal dysplasia 4, hair/nail type	602032		3
KRT86, KRTHB6, HB6	Monilethrix	158000		3
KRT9, EPPK	Palmoplantar keratoderma, epidermolytic	144200		3
KTCN2	Keratoconus 2	608932		2
KTCN3	Keratoconus 3	608586		2
KTCN4	Keratoconus 4	609271	between D2S305 and D2S2373	2
KTCN5	Keratoconus 5	614622	between D5S2499 and D5S495	2
KTCN6	Keratoconus 6	614623	max lod at 159cM	2
KTCN7	Keratoconus 7	614629	max lod at D13S159	2
KTCN8	Keratoconus 8	614628	between rs1074501 and rs755212	2
KTWS, KTS	Klippel-Trenaunay-Weber syndrome	149000	translocation with 14q13	2
KY, MFM7	Myopathy, myofibrillar, 7	617114		3
KYNU, KYNUU, VCRL2	 Vertebral, cardiac, renal, and limb defects syndrome 2	617661	mutation identified in 1 KYNUU family	3
KYPSC1	Kyphoscoliosis 1	610170		2
L1CAM, CAML1, HSAS1, MASA, SPG1	 Corpus callosum, partial agenesis of	304100	between RCP/GCP cluster and G6PD	3
L1CAM, CAML1, HSAS1, MASA, SPG1	 CRASH syndrome	303350	between RCP/GCP cluster and G6PD	3
L1CAM, CAML1, HSAS1, MASA, SPG1	 Hydrocephalus due to aqueductal stenosis	307000	between RCP/GCP cluster and G6PD	3
L1CAM, CAML1, HSAS1, MASA, SPG1	 Hydrocephalus with congenital idiopathic intestinal pseudoobstruction	307000	between RCP/GCP cluster and G6PD	3
L1CAM, CAML1, HSAS1, MASA, SPG1	 Hydrocephalus with Hirschsprung disease	307000	between RCP/GCP cluster and G6PD	3
L1CAM, CAML1, HSAS1, MASA, SPG1	MASA syndrome	303350	between RCP/GCP cluster and G6PD	3
L2HGDH, C14orf160, L2HGA	L-2-hydroxyglutaric aciduria	236792		3
LACC1, C13orf31, JUVAR	Juvenile arthritis	618795		3
LAGE3, ITBA2, GAMOS2	Galloway-Mowat syndrome 2, X-linked	301006		3
LALL	Leukemia, acute lymphoblastic	247640		2
LAMA1, PTBHS	Poretti-Boltshauser syndrome	615960		3
LAMA2, LAMM, MDC1A	 Muscular dystrophy, congenital, merosin deficient or partially deficient	607855		3
LAMA2, LAMM, MDC1A	Muscular dystrophy, limb-girdle, autosomal recessive 23	618138		3
LAMA3, LOCS, JEB2A, JEB2B, JEB2C	Epidermolysis bullosa, junctional 2A, intermediate	619783		3
LAMA3, LOCS, JEB2A, JEB2B, JEB2C	 Epidermolysis bullosa, junctional 2B, severe	619784		3
LAMA3, LOCS, JEB2A, JEB2B, JEB2C	 Epidermolysis bullosa, junctional 2C, laryngoonychocutaneous	245660		3
LAMA4, LAMA3, CMD1JJ	Cardiomyopathy, dilated, 1JJ	615235		3
LAMA5, NPHS26, BBDS2	 Bent bone dysplasia syndrome 2	620076	mutation identified in 1 BBDS2 family	3
LAMA5, NPHS26, BBDS2	Nephrotic syndrome, type 26	620049	mutation identified in 1 BBDS2 family	3
LAMB1, LIS5	Lissencephaly 5	615191		3
LAMB2, LAMS, NPHS5, PIERS	Nephrotic syndrome, type 5, with or without ocular abnormalities	614199		3
LAMB2, LAMS, NPHS5, PIERS	 Pierson syndrome	609049		3
LAMB3, AI1A, JEB1B, JEB1A	 Amelogenesis imperfecta, type IA	104530		3
LAMB3, AI1A, JEB1B, JEB1A	 Epidermolysis bullosa, junctional 1A, intermediate	226650		3
LAMB3, AI1A, JEB1B, JEB1A	Epidermolysis bullosa, junctional 1B, severe	226700		3
LAMC2, LAMNB2, LAMB2T, JEB3A, JEB3B	 Epidermolysis bullosa, junctional 3A, intermediate	619785		3
LAMC2, LAMNB2, LAMB2T, JEB3A, JEB3B	Epidermolysis bullosa, junctional 3B, severe	619786		3
LAMC3, OCCM	Cortical malformations, occipital	614115		3
LAMP2, LAMPB, LGP110, DND	Danon disease	300257		3
LAMTOR2, MAPBPIP, p14,	Immunodeficiency due to defect in MAPBP-interacting protein	610798	mutation identified in 1 family	3
LARGE, KIAA0609, MDC1D, MDDGA6, MDDGB6	 Muscular dystrophy-dystroglycanopathy , type A, 6	613154		3
LARGE, KIAA0609, MDC1D, MDDGA6, MDDGB6	Muscular dystrophy-dystroglycanopathy , type B, 6	608840		3
LARP7, PIP7S, ALAZS	Alazami syndrome	615071		3
LARS2, PRLTS4, HLASA	 Hydrops, lactic acidosis, and sideroblastic anemia	617021		3
LARS2, PRLTS4, HLASA	Perrault syndrome 4	615300		3
LAS1L, MRXSWTS	Wilson-Turner syndrome	309585		3
LAT, IMD52	Immunodeficiency 52	617514		3
LBMQTL1	Lean body mass QTL 1	612729	associated with rs16892496 and rs7832552	2
LBR, PHA, PHASK	 Greenberg skeletal dysplasia	215140		3
LBR, PHA, PHASK	Pelger-Huet anomaly	169400		3
LBR, PHA, PHASK	 Reynolds syndrome	613471		3
LBR, PHA, PHASK	 Rhizomelic skeletal dysplasia with or without Pelger-Huet anomaly	618019		3
LCA5, C6orf152	Leber congenital amaurosis 5	604537		3
LCAT	Fish-eye disease	136120	very close to HP	3
LCAT	 Norum disease	245900	very close to HP	3
LCRB	Thalassemia, Hispanic gamma-delta-beta	613985		3
LCS1, CHLS	Cholestasis-lymphedema syndrome	214900		2
LCT, LAC, LPH	Lactase deficiency, congenital	223000		3
LDB3, ZASP, CYPHER, KIAA01613, MFM4, CMD1C, CMH24, LVNC3	 Cardiomyopathy, dilated, 1C, with or without LVNC	601493		3
LDB3, ZASP, CYPHER, KIAA01613, MFM4, CMD1C, CMH24, LVNC3	 Cardiomyopathy, hypertrophic, 24	601493		3
LDB3, ZASP, CYPHER, KIAA01613, MFM4, CMD1C, CMH24, LVNC3	Left ventricular noncompaction 3	601493		3
LDB3, ZASP, CYPHER, KIAA01613, MFM4, CMD1C, CMH24, LVNC3	 Myopathy, myofibrillar, 4	609452		3
LDHA, LDH1, GSD11	Glycogen storage disease XI	612933		3
LDHB, LDHBD	Lactate dehydrogenase-B deficiency	614128		3
LDHD, DLACD	D-lactic aciduria with susceptibility to gout	245450		3
LDLRAP1, ARH, FHCB2, FHCB1, FHCL4	Hypercholesterolemia, familial, 4	603813		3
LDLR, FHCL1, FHC, FH, LDLCQ2	 Hypercholesterolemia, familial, 1	143890	~20cM distal to C3	3
LDLR, FHCL1, FHC, FH, LDLCQ2	LDL cholesterol level QTL2	143890	~20cM distal to C3	3
LECD	Corneal dystrophy, Lisch epithelial	300778	max lod between DXYS233 and DXYS228X	2
LEF1	Sebaceous tumors, somatic	153245		3
LEMD2, NET25, CTRCT42, MARUPS	 Cataract 46, juvenile-onset	212500		3
LEMD2, NET25, CTRCT42, MARUPS	Marbach-Rustad progeroid syndrome	619322		3
LEMD3, MAN1	Buschke-Ollendorff syndrome	166700		3
LEMD3, MAN1	 Osteopoikilosis with or without melorheostosis	166700		3
LEP, OB, LEPD	Obesity, morbid, due to leptin deficiency	614962	in mouse cen-Cola-2-Met-ob-Cpa-Tcrb-tel	3
LEPQTL1, LSL	Leptin serum levels QTL1	601694		2
LEPR, OBR, LEPRD	Obesity, morbid, due to leptin receptor deficiency	614963		3
LETM1, CONDMIM	Neurodegeneration, childhood-onset, with multisystem involvement due to mitochondrial dysfunction	620089		3
LFNG, SCDO3	Spondylocostal dysostosis 3, autosomal recessive	609813		3
LGALS2	Myocardial infarction, susceptibility to	608446		3
LGI1, EPT, ETL1, ADLTE, ADPEAF	Epilepsy, familial temporal lobe, 1	600512		3
LGI3, IDDMDS	Intellectual developmental disorder with muscle tone abnormalities and distal skeletal defects	620007		3
LGI4, AMC1	Arthrogryposis multiplex congenita 1, neurogenic, with myelin defect	617468		3
LGMD1H	Muscular dystrophy, limb-girdle, type 1H	613530	between D3S1263 and D3S1277	2
LGR4, GPR48, BNMD17, DPSL	 Bone mineral density, low, susceptibility to	615311	previously mapped to 5q34-q35.1	3
LGR4, GPR48, BNMD17, DPSL	Delayed puberty, self-limited	619613	previously mapped to 5q34-q35.1	3
LGV1	Longevity 1	152430	maximum lod at D4S1564	2
LGV2	Longevity 2	606460	associated with rs2802292	2
LHB, HH23	Hypogonadotropic hypogonadism 23 with or without anosmia	228300	beta chains of FSH, TSH on 11p, 1p, respectively	3
LHCGR, LHR, LCGR	Leydig cell adenoma, somatic, with precocious puberty	176410		3
LHCGR, LHR, LCGR	 Leydig cell hypoplasia with hypergonadotropic hypogonadism	238320		3
LHCGR, LHR, LCGR	 Leydig cell hypoplasia with pseudohermaphroditism	238320		3
LHCGR, LHR, LCGR	 Luteinizing hormone resistance, female	238320		3
LHCGR, LHR, LCGR	 Precocious puberty, male	176410		3
LHFPL5, TMHS, DFNB67	Deafness, autosomal recessive 67	610265		3
LHX3, CPHD3	Pituitary hormone deficiency, combined, 3	221750	in mouse, close to Notch1; centromeric to ABL	3
LHX4, CPHD4	Pituitary hormone deficiency, combined, 4	262700	fused to IGH in ALL	3
LIAS, PDHLD, HGCLAS	Hyperglycinemia, lactic acidosis, and seizures	614462		3
LIFR, STWS, SWS, SJS2	Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome	601559		3
LIG1, IMD96	Immunodeficiency 96	619774		3
LIG3, MTDPS20	Mitochondrial DNA depletion syndrome 20 	619780		3
LIG4, LIG4S	LIG4 syndrome	606593		3
LIG4, LIG4S	 Multiple myeloma, resistance to	254500		3
LIM2, MP19, CTRCT19	Cataract 19, multiple types	615277	same cosmid as ETFB	3
LIMA1, EPLIN, SREBP3, LDLCQ8	Low density lipoprotein cholesterol level QTL 8	618079		3
LINGO1, LRRN6A, LERN1, MRT64	Intellectual developmental disorder, autosomal recessive 64	618103		3
LINS1, WINS1, FLJ10583, MRT27	Intellectual developmental disorder, autosomal recessive 27	614340		3
LIPA, CESD	 Cholesteryl ester storage disease	278000	?close to GOT	3
LIPA, CESD	Wolman disease	278000	?close to GOT	3
LIPC, HL, LIPH, HDLCQ12	Diabetes mellitus, noninsulin-dependent	125853		3
LIPC, HL, LIPH, HDLCQ12	 Hepatic lipase deficiency	614025		3
LIPC, HL, LIPH, HDLCQ12	 High density lipoprotein cholesterol level QTL 12	612797		3
LIPE, LHS, FPLD6	Lipodystrophy, familial partial, type 6	615980		3
LIPH, LAH2, ARWH2, HYPT7	Hypotrichosis 7	604379		3
LIPH, LAH2, ARWH2, HYPT7	 Woolly hair, autosomal recessive 2 with or without hypotrichosis	604379		3
LIPN, LIPL4, ARCI8, LI4	Ichthyosis, congenital, autosomal recessive 8	613943		3
LIPT1, LIPT1D	Lipoyltransferase 1 deficiency	616299		3
LIPT2	Encephalopathy, neonatal severe, with lactic acidosis and brain abnormalities	617668		3
LITAF, CMT1C	Charcot-Marie-Tooth disease, type 1C	601098		3
LMAN1, ERGIC53, F5F8D, MCFD1	Combined factor V and VIII deficiency	227300		3
LMAN2L, VIPL, MRT52, MRD69	 Intellectual developmental disorder, autosomal recessive 52	616887	mutation identified in 1 MRT52 family and in 1 MRD69 family	3
LMBR1, ACHP, C7orf2, PPD2, THYP, LSS, TPTPS	 Acheiropody	200500		3
LMBR1, ACHP, C7orf2, PPD2, THYP, LSS, TPTPS	 Hypoplastic or aplastic tibia with polydactyly	188740		3
LMBR1, ACHP, C7orf2, PPD2, THYP, LSS, TPTPS	 Laurin-Sandrow syndrome	135750		3
LMBR1, ACHP, C7orf2, PPD2, THYP, LSS, TPTPS	 Polydactyly, preaxial type II	174500		3
LMBR1, ACHP, C7orf2, PPD2, THYP, LSS, TPTPS	 Syndactyly, type IV	186200		3
LMBR1, ACHP, C7orf2, PPD2, THYP, LSS, TPTPS	 Triphalangeal thumb-polysyndactyly syndrome	190605		3
LMBR1, ACHP, C7orf2, PPD2, THYP, LSS, TPTPS	Triphalangeal thumb, type I	174500		3
LMBRD1, LMBD1, NESI, MAHCF	Methylmalonic aciduria and homocystinuria, cblF type	277380		3
LMBRD2, DENBA	Developmental delay with variable neurologic and brain abnormalities	619694		3
LMF1, TMEM112	Lipase deficiency, combined	246650		3
LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS	 Cardiomyopathy, dilated, 1A	115200		3
LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS	 Charcot-Marie-Tooth disease, type 2B1	605588		3
LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS	 Emery-Dreifuss muscular dystrophy 2, autosomal dominant	181350		3
LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS	 Emery-Dreifuss muscular dystrophy 3, autosomal recessive	616516		3
LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS	 Heart-hand syndrome, Slovenian type	610140		3
LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS	 Hutchinson-Gilford progeria	176670		3
LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS	 Lipodystrophy, familial partial, type 2	151660		3
LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS	 Malouf syndrome	212112		3
LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS	Mandibuloacral dysplasia	248370		3
LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS	 Muscular dystrophy, congenital	613205		3
LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS	 Restrictive dermopathy 2	619793		3
LMNB1, ADLD, MCPH26	Leukodystrophy, adult-onset, autosomal dominant	169500		3
LMNB1, ADLD, MCPH26	 Microcephaly 26, primary, autosomal dominant	619179		3
LMNB2, LMN2, EPM9, MCPH27	 Epilepsy, progressive myoclonic, 9	616540	mutation identified in 1 EPM9 family	3
LMNB2, LMN2, EPM9, MCPH27	 Lipodystrophy, partial, acquired, susceptibility to	608709	mutation identified in 1 EPM9 family	3
LMNB2, LMN2, EPM9, MCPH27	Microcephaly 27, primary, autosomal dominant	619180	mutation identified in 1 EPM9 family	3
LMO1, RBTN1, RHOM1	Leukemia, T-cell acute lymphoblastic	186921		2
LMO2, RBTNL1, RHOM2, TTG2	Leukemia, acute T-cell	180385	3rd rhombotin gene not on 11	2
LMOD2, CLMOD, CMD2G	Cardiomyopathy, dilated, 2G	619897		3
LMOD3, NEM10	Nemaline myopathy 10	616165		3
LMPHM2	Lymphatic malformation 2	611944	max lod at D6S1671	2
LMX1A, LMX1, DFNA7	Deafness, autosomal dominant 7	601412		3
LMX1B, NPS1, FSGS10	Focal segmental glomerulosclerosis 10	256020		3
LMX1B, NPS1, FSGS10	 Nail-patella syndrome	161200		3
LNCR1	Lung cancer susceptibility	608935	max hlod at D6S2436	2
LNCR3	Lung cancer susceptibility 3	612571	associated with rs402710 and rs2736100	2
LNCR4	Lung cancer susceptibility 4	612593	associated with rs3117582 and rs3131379	2
LNCR5	Lung cancer susceptibility 5	614210	associated with rs4488809	2
LNPK, KIAA1715, NEDEHCC	Neurodevelopmental disorder with epilepsy and hypoplasia of the corpus callosum	618090		3
LOC387715, ARMD8	Macular degeneration, age-related, 8	613778		3
LONP1, PRSS15, LON, CODASS	CODAS syndrome	600373		3
LOR	Vohwinkel syndrome with ichthyosis	604117		3
LOX, AAT10	Aortic aneurysm, familial thoracic 10	617168		3
LOXHD1, DFNB77	Deafness, autosomal recessive 77	613079		3
LOXL1, LOXL	Exfoliation syndrome, susceptibility to	177650		3
LOXL3, MYP28	Myopia 28, autosomal recessive	619781		3
LPA	 Coronary artery disease, susceptibility to	618807	absent in mice	3
LPA	LPA deficiency, congenital	618807	absent in mice	3
LPAR6, P2RY5, P2Y5, LAH3, ARWH1, HYPT8	Hypotrichosis 8	278150	in intron 17 of RB gene	3
LPAR6, P2RY5, P2Y5, LAH3, ARWH1, HYPT8	 Woolly hair, autosomal recessive 1, with or without hypotrichosis	278150	in intron 17 of RB gene	3
LPIN1	Myoglobinuria, acute recurrent, autosomal recessive	268200	related to LSL	3
LPIN2	Majeed syndrome	609628		3
LPL, LIPD, HDLCQ11	 Combined hyperlipidemia, familial	144250		3
LPL, LIPD, HDLCQ11	 High density lipoprotein cholesterol level QTL 11	238600		3
LPL, LIPD, HDLCQ11	Lipoprotein lipase deficiency	238600		3
LPP	 Leukemia, acute myeloid	601626	fused with HMGIC in lipoma; fused with MLL in leukemia	3
LPP	Lipoma	600700	fused with HMGIC in lipoma; fused with MLL in leukemia	3
LPRS2	Leprosy, susceptibility to, 2	607572	association with PARK2	2
LPRS6	Leprosy, susceptibility to, 6	613407	associated with rs9533634 and rs3764147	2
LPRS	Leprosy, paucibacillary type, susceptibility to	609888		2
LPSA, D19S381E	Liposarcoma	164953		1
LRAT, LCA14	Leber congenital amaurosis 14	613341		3
LRAT, LCA14	 Retinal dystrophy, early-onset severe	613341		3
LRAT, LCA14	 Retinitis pigmentosa, juvenile	613341		3
LRBA, LBA, CDC4L, CVID8	Immunodeficiency, common variable, 8, with autoimmunity	614700		3
LRIG2, LIG2, KIAA0806, UFS2	Urofacial syndrome 2	615112		3
LRIT3, FIGLER4, CSNB1F	Night blindness, congenital stationary , 1F, autosomal recessive	615058		3
LRMDA, C10orf11, OCA7	Albinism, oculocutaneous, type VII	615179		3
LRP12, MIG13A	Oculopharyngodistal myopathy 1	164310		3
LRP2, DBS	Donnai-Barrow syndrome	222448		3
LRP4, MEGF7, CLSS, SOST2, CMS17	 Cenani-Lenz syndactyly syndrome	212780	mutation identified in 1 CMS17 family	3
LRP4, MEGF7, CLSS, SOST2, CMS17	 Sclerosteosis 2	614305	mutation identified in 1 CMS17 family	3
LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4, PCLD4	 Bone mineral density variability 1	601884		3
LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4, PCLD4	 Exudative vitreoretinopathy 4	601813		3
LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4, PCLD4	 Hyperostosis, endosteal	144750		3
LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4, PCLD4	Osteopetrosis, autosomal dominant 1	607634		3
LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4, PCLD4	 Osteoporosis	166710		3
LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4, PCLD4	 Osteoporosis-pseudoglioma syndrome	259770		3
LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4, PCLD4	 Osteosclerosis	144750		3
LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4, PCLD4	 Polycystic liver disease 4 with or without kidney cysts	617875		3
LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4, PCLD4	 van Buchem disease, type 2	607636		3
LRP6, ADCAD2, STHAG7	Coronary artery disease, autosomal dominant, 2	610947		3
LRP6, ADCAD2, STHAG7	 Tooth agenesis, selective, 7	616724		3
LRP8, APOER2, MCI1	Myocardial infarction, susceptibility to	608446		3
LRPAP1, A2MRAP, MYP23	Myopia 23, autosomal recessive	615431		3
LRPPRC, LRP130, LSFC, MC4DN5	Mitochondrial complex IV deficiency, nuclear type 5, 	220111		3
LRRC32, GARP, D11S833E, CPPRDD	Cleft palate, proliferative retinopathy, and developmental delay	619074		3
LRRC56, CILD39	Ciliary dyskinesia, primary, 39	618254		3
LRRC6, LRTP, CILD19	Ciliary dyskinesia, primary, 19	614935		3
LRRK1, OSMD	Osteosclerotic metaphyseal dysplasia	615198		3
LRRK2, PARK8	Parkinson disease 8	607060		3
LRSAM1, TAL, RIFLE, CMT2P	Charcot-Marie-Tooth disease, axonal, type 2P	614436		3
LRSL	Larsen-like syndrome	608545		2
LRTOMT, LRTOMT1, LRTOMT2, DFNB63	Deafness, autosomal recessive 63	611451		3
LSS, OSC, CTRCT44, HYPT14, APMR4	 Alopecia-intellectual disability syndrome 4	618840		3
LSS, OSC, CTRCT44, HYPT14, APMR4	 Cataract 44	616509		3
LSS, OSC, CTRCT44, HYPT14, APMR4	Hypotrichosis 14	618275		3
LTA, TNFB	 Leprosy, susceptibility to, 4	610988	cen-DR-21OH-C4-BF-C2-TNF-LTA-HLA-B	3
LTA, TNFB	 Myocardial infarction, susceptibility to	608446	cen-DR-21OH-C4-BF-C2-TNF-LTA-HLA-B	3
LTA, TNFB	Psoriatic arthritis, susceptibility to	607507	cen-DR-21OH-C4-BF-C2-TNF-LTA-HLA-B	3
LTBP1, ARCL2E	Cutis laxa, autosomal recessive, type IIE	619451		3
LTBP2, LTBP3, GLC3D, MSPKA, WMS3	Glaucoma 3, primary congenital, D	613086	mutation identified in 1 WMS3 family	3
LTBP2, LTBP3, GLC3D, MSPKA, WMS3	 Microspherophakia and/or megalocornea, with ectopia lentis and with or without secondary glaucoma	251750	mutation identified in 1 WMS3 family	3
LTBP2, LTBP3, GLC3D, MSPKA, WMS3	 Weill-Marchesani syndrome 3, recessive	614819	mutation identified in 1 WMS3 family	3
LTBP3, LTBP2, DASS, GPHYSD3	Dental anomalies and short stature	601216		3
LTBP3, LTBP2, DASS, GPHYSD3	 Geleophysic dysplasia 3	617809		3
LTBP4, LTBP4S, LTBP4L, ARCL1C	Cutis laxa, autosomal recessive, type IC	613177		3
LTC4S	Leukotriene C4 synthase deficiency	614037		1
LU, AU, BCAM	 Blood group, Auberger system	111200	linked to SE	3
LU, AU, BCAM	 Blood group, Lutheran null	247420	linked to SE	3
LU, AU, BCAM	Blood group, Lutheran system	111200	linked to SE	3
LVNC2	Left ventricular noncompaction 2	609470	max lod at D11S902	2
LVSKS	Levy-Shanske syndrome	614846		4
LYL1	Leukemia, T-cell acute lymphoblastoid	151440		2
LYRM7, MZM1L, MC3DN8	Mitochondrial complex III deficiency, nuclear type 8	615838		3
LYST, CHS1	Chediak-Higashi syndrome	214500		3
LYZ	Amyloidosis, renal	105200		3
LZTFL1, BBS17	Bardet-Biedl syndrome 17	615994		3
LZTR1, SWNTS2, NS10, NS2	 Noonan syndrome 10	616564		3
LZTR1, SWNTS2, NS10, NS2	Noonan syndrome 2	605275		3
LZTR1, SWNTS2, NS10, NS2	 Schwannomatosis-2, susceptibility to	615670		3
LZTS1, F37, FEZ1	Esophageal squamous cell carcinoma, somatic	133239		3
M1AP, SPATA37, C2orf65, SPGF48	Spermatogenic failure 48	619108		3
MAB21L1, COFG	Cerebellar, ocular, craniofacial, and genital syndrome	618479		3
MAB21L2, MCSKS14	Microphthalmia/coloboma and skeletal dysplasia syndrome	615877		3
MACF1, ACF7, KIAA1251, LIS9	Lissencephaly 9 with complex brainstem malformation	618325		3
MACOM	Macrophthalmia, colobomatous, with microcornea	602499		4
MACST	Macrostomia	613545	max lod at D1S2797	2
MAD1L1, TXBP181	 Lymphoma, somatic	602686		3
MAD1L1, TXBP181	Prostate cancer, somatic	176807		3
MADD, DENN, NEDDISH, DEEAH	 DEEAH syndrome	619004		3
MADD, DENN, NEDDISH, DEEAH	Neurodevelopmental disorder with dysmorphic facies, impaired speech and hypotonia	619005		3
MADH9, SMAD9, MADH6, PPH2	Pulmonary hypertension, primary, 2	615342		3
MAFA, RIPE3B1, INSDM	Insulinomatosis and diabetes mellitus	147630		3
MAFB, KRML, MCTO, DURS3	Duane retraction syndrome 3	617041		3
MAFB, KRML, MCTO, DURS3	 Multicentric carpotarsal osteolysis syndrome	166300		3
MAF, CCA4, CTRCT21, AYGRP	 Ayme-Gripp syndrome	601088		3
MAF, CCA4, CTRCT21, AYGRP	Cataract 21, multiple types	610202		3
MAFD1, BPAD, MD1	Major affective disorder 1	125480	?also 18q	2
MAFD2, MDX	Major affective disorder 2	309200	linkage to G6PD,CB in non-Ashkenazi Jews	2
MAFD3, BPEO	Major affective disorder 3, early onset	609633	max lod at D21S1252	2
MAFD4, BPAD	Major affective disorder 4	611247	max lod at D16S769	2
MAFD5	Major affective disorder 5	611535		2
MAFD6, BPAD	Major affective disorder 6	611536		2
MAFD8	Major affective disorder-8, susceptibility to	612357	associated with rs20994336	2
MAFD9	Major affective disorder-9, susceptibility to	612372	associated with rs1006737	2
MAGED2, MAGED, BARTS5	Bartter syndrome, type 5, antenatal, transient	300971		3
MAGEL2, NDNL1, SHFYNG	Schaaf-Yang syndrome	615547		3
MAG, GMA, SPG75	Spastic paraplegia 75, autosomal recessive	616680		3
MAGI2, AIP1, KIAA0705, NPHS15	Nephrotic syndrome, type 15	617609		3
MAGT1, IAP, XMEN, CDG1CC	 Congenital disorder of glycosylation, type Icc	301031		3
MAGT1, IAP, XMEN, CDG1CC	Immunodeficiency, X-linked, with magnesium defect, Epstein-Barr virus infection and neoplasia	300853		3
MAK, RP62	Retinitis pigmentosa 62	614181		3
MALT1, MLT, IMD12	Immunodeficiency 12	615468	fused with API2 in MALT lymphoma	3
MAML2, MAM3	Mucoepidermoid salivary gland carcinoma	607537	t(11;19)	3
MAMLD1, CXorf6, F18, HYSP2	Hypospadias 2, X-linked	300758	near MTM1 in microdeletion	3
MAN1B1, MRT15	Rafiq syndrome	614202		3
MAN2B1, MANB	Mannosidosis, alpha-, types I and II	248500		3
MAN2C1, MANA, CDDG2	Congenital disorder of deglycosylation 2	619775		3
MANBA, MANB1	Mannosidosis, beta	248510	linked in mouse to Adl-3	3
MAOA, BRNRS	Antisocial behavior	300615	NDP, MAOA, MAOB closely linked	3
MAOA, BRNRS	 Brunner syndrome	300615	NDP, MAOA, MAOB closely linked	3
MAP1B, PVNH9, DFNA83	 Periventricular nodular heterotopia 9	618918	mutation identified in 1 DFNA83 family	3
MAP2K1, PRKMK1, MKK1, MEK1, CFC3, MEL	Cardiofaciocutaneous syndrome 3	615279	pseudogene on 8p21	3
MAP2K1, PRKMK1, MKK1, MEK1, CFC3, MEL	 Melorheostosis, isolated, somatic mosaic	155950	pseudogene on 8p21	3
MAP2K2, PRKMK2, MEK2, MKK2, CFC4	Cardiofaciocutaneous syndrome 4	615280	previously assigned to 7q32	3
MAP3K1, MEKK1, MEKK, SRXY6	46XY sex reversal 6	613762		3
MAP3K20, ZAK, MLTK, MRK, SFMMP, CNM6	Centronuclear myopathy 6 with fiber-type disproportion	617760		3
MAP3K20, ZAK, MLTK, MRK, SFMMP, CNM6	 Split-foot malformation with mesoaxial polydactyly	616890		3
MAP3K7, TAK1, CSCF, FMD2	 Cardiospondylocarpofacial syndrome	157800		3
MAP3K7, TAK1, CSCF, FMD2	Frontometaphyseal dysplasia 2	617137		3
MAP3K8, COT, EST, TPL2	Lung cancer, somatic	211980		3
MAPK1, PRKM1, ERK2, NS13	Noonan syndrome 13	619087		3
MAPK8IP1, IB1	Diabetes mellitus, noninsulin-dependent	125853		3
MAPK8IP3, SYD2, JSAP1, JIP3, NEDBA	Neurodevelopmental disorder with or without variable brain abnormalities	618443		3
MAPKAPK5, PRAK, NCFD	Neurocardiofaciodigital syndrome	619869		3
MAPKBP1, JNKBP1, NPHP20	Nephronophthisis 20	617271		3
MAPRE2, EB2, RP1, CSCSC2	Symmetric circumferential skin creases, congenital, 2	616734		3
MAPT, MTBT1, DDPAC, MSTD	 Dementia, frontotemporal, with or without parkinsonism	600274	see 6p21	3
MAPT, MTBT1, DDPAC, MSTD	 Parkinson disease, susceptibility to	168600	see 6p21	3
MAPT, MTBT1, DDPAC, MSTD	 Pick disease	172700	see 6p21	3
MAPT, MTBT1, DDPAC, MSTD	Supranuclear palsy, progressive	601104	see 6p21	3
MAPT, MTBT1, DDPAC, MSTD	 Supranuclear palsy, progressive atypical	260540	see 6p21	3
MARCH6, TEB4, DOA10, KIAA0597, FAME3	Epilepsy, familial adult myoclonic, 3	613608		3
MARS1, MARS, MTRNS, METRS, ILLD, CMT2U, TTD9	 Charcot-Marie-Tooth disease, axonal, type 2U	616280	mutation identified in 1 TTD9 patient	3
MARS1, MARS, MTRNS, METRS, ILLD, CMT2U, TTD9	Interstitial lung and liver disease	615486	mutation identified in 1 TTD9 patient	3
MARS1, MARS, MTRNS, METRS, ILLD, CMT2U, TTD9	 Trichothiodystrophy 9, nonphotosensitive	619692	mutation identified in 1 TTD9 patient	3
MARS2, SPAX3, COXPD25	 Spastic ataxia 3, autosomal recessive	611390	mutation identified in 1 COXPD25 family	3
MARVELD2, MARVD2, TRIC, DFNB49	Deafness, autosomal recessive 49	610153		3
MASP1, CRARF, 3MC1	3MC syndrome 1	257920		3
MASP2	MASP2 deficiency	613791		3
MAST1, SAST, KIAA0973, MCCCHCM	Mega-corpus-callosum syndrome with cerebellar hypoplasia and cortical malformations	618273		3
MAST3, KIAA0561, DEE108	Developmental and epileptic encephalopathy 108	620115		3
MAT1A, MATA1, SAMS1	Hypermethioninemia, persistent, autosomal dominant, due to methionine adenosyltransferase I/III deficiency	250850		3
MAT1A, MATA1, SAMS1	 Methionine adenosyltransferase deficiency, autosomal recessive	250850		3
MATN3, EDM5, HOA, OS2, SEMDBCD	 Epiphyseal dysplasia, multiple, 5	607078		3
MATN3, EDM5, HOA, OS2, SEMDBCD	Osteoarthritis susceptibility 2	140600		3
MATN3, EDM5, HOA, OS2, SEMDBCD	 Spondyloepimetaphyseal dysplasia, Borochowitz-Cormier-Daire type	608728		3
MATR3, MPD2, ALS21	Amyotrophic lateral sclerosis 21	606070		3
MAX	Pheochromocytoma, susceptibility to	171300	interacts with MYC	3
MBCS	Mulchandani-Bhoj-Conlin syndrome	617352	maternal uniparental disomy of imprinted region	3
MBD4, MED1, TPDS2	 Tumor predisposition syndrome 2	619975		3
MBD4, MED1, TPDS2	Uveal melanoma, susceptibility to, 1	606660		3
MBD5, KIAA1461, MRD1	Intellectual developmental disorder, autosomal dominant 1	156200		3
MBL2, MBL, MBP1, MBL2D, MBPD	Chronic infections, due to MBL deficiency	614372	near MEN2A	3
MBNP	Membranous nephropathy, susceptibility to	614692		2
MBOAT7, BB1, LENG4, MRT57	Intellectual developmental disorder, autosomal recessive 57	617188		3
MBTPS2, S2P, IFAP, KFSDX, OLMSX, OI19	 IFAP syndrome with or without BRESHECK syndrome	308205	mutation identified in 1 OLMSX family	3
MBTPS2, S2P, IFAP, KFSDX, OLMSX, OI19	Keratosis follicularis spinulosa decalvans, X-linked	308800	mutation identified in 1 OLMSX family	3
MBTPS2, S2P, IFAP, KFSDX, OLMSX, OI19	 Olmsted syndrome, X-linked	300918	mutation identified in 1 OLMSX family	3
MBTPS2, S2P, IFAP, KFSDX, OLMSX, OI19	 Osteogenesis imperfecta, type XIX	301014	mutation identified in 1 OLMSX family	3
MC1R, SHEP2, CMM5	 Albinism, oculocutaneous, type II, modifier of	203200		3
MC1R, SHEP2, CMM5	Analgesia from kappa-opioid receptor agonist, female-specific	613098		3
MC1R, SHEP2, CMM5	 Melanoma, cutaneous malignant, 5	613099		3
MC1R, SHEP2, CMM5	 Skin/hair/eye pigmentation 2, blond hair/fair skin	266300		3
MC1R, SHEP2, CMM5	 Skin/hair/eye pigmentation 2, red hair/fair skin	266300		3
MC1R, SHEP2, CMM5	 UV-induced skin damage	266300		3
MC2R	Glucocorticoid deficiency, due to ACTH unresponsiveness	202200		3
MC3R, BMIQ9	Obesity, severe, susceptibility to, BMIQ9	602025		3
MC4R, BMIQ20	Obesity 	618406		3
MC4R, BMIQ20	 Obesity, resistance to 	618406		3
MCCC1, MCCA	3-Methylcrotonyl-CoA carboxylase 1 deficiency	210200		3
MCCC2, MCCB	3-Methylcrotonyl-CoA carboxylase 2 deficiency	210210		3
MCC	Colorectal cancer, somatic	114500		3
MCDR3	Macular dystrophy, retinal, 3	608850	maximum lod at D5S630	2
MCEE	Methylmalonyl-CoA epimerase deficiency	251120		3
MCFD2, F5F8D2	Factor V and factor VIII, combined deficiency of	613625		3
MCI2	Myocardial infarction, susceptibility to, 2	608557	defined by 4-SNP haplotype HapA	2
MCIDAS, IDAS, CILD42	Ciliary dyskinesia, primary, 42	618695		3
MCM10, CNA43, IMD80	Immunodeficiency 80 with or without cardiomyopathy	619313		3
MCM3AP, MAP80, GANP, PNRIID	Peripheral neuropathy, autosomal recessive, with or without impaired intellectual development	618124		3
MCM4, NKGCD, NKCD, IMD54	Immunodeficiency 54	609981		3
MCM6	Lactase persistence/nonpersistence	223100	mutations in introns 9 and 13	3
MCM9, MCMDC1, ODG4	Ovarian dysgenesis 4	616185		3
MCOLN1, ML4	Mucolipidosis IV	252650		3
MCOP1	Microphthalmia, isolated 1	251600		2
MCOPCB1	Microphthalmia with coloboma 1	300345		2
MCOPCB2	Microphthalmia with coloboma 2	605738		2
MCOPCT1	Microphthalmia with cataract 1	156850	proximal to HBA1	2
MCOPS8, MMEP	Microphthalmia, syndromic 8	601349	translocation with 13q12	2
MCOR, C13DELq32, DEL13q32	Microcoria, congenital	156600	35-80kb deletion encompassing TGDS and GPR180	4
MCP, CD46, AHUS2	Hemolytic uremic syndrome, atypical, susceptibility to, 2	612922		3
MCPH1	Microcephaly 1, primary, autosomal recessive	251200	genetic heterogeneity	3
MDBS2	Macular dystrophy, butterfly-shaped pigmentary, 2	608970	between D5S433 and D5S410	2
MDC1B	Muscular dystrophy, congenital, 1B	604801		2
MDCMP	Muscular dystrophy, congenital, merosin-positive	609456	max lod at D4S432	2
MDD1	Major depressive disorder 1	608516	max lod with D12S1706	2
MDD2	Major depressive disorder 2	608516		2
MDDC	Macular dystrophy, dominant cystoid	153880	?allelic to RP9	2
MDFIC, HIC, LMPHM12	Lymphatic malformation 12	620014		3
MDH2, DEE51	Developmental and epileptic encephalopathy 51	617339		3
MDLS, MDS, MDCR, DEL17p13.3, C17DELp13.3	Miller-Dieker lissencephaly syndrome	247200		4
MDM2, ACTFS, LSKB	Accelerated tumor formation, susceptibility to	614401	mutation identified in 1 LSKB patient	3
MDM2, ACTFS, LSKB	 Lessel-Kubisch syndrome	618681	mutation identified in 1 LSKB patient	3
MDNS	Mammary-digital-nail syndrome	613689	max lod at D22S277, D22S1142, D22S683, D22S283	2
MDRV	Muscular dystrophy with rimmed vacuoles	601846		2
MDS1	Myelodysplasia syndrome-1	600049	cen--EVI1--MDS1--EAP--tel	3
MECOM, EVI1, RUSAT2	Radioulnar synostosis with amegakaryocytic thrombocytopenia 2	616738		3
MECP2, RTT, PPMX, AUTSX3, MRXSL, MRXS13	 Autism susceptibility, X-linked 3	300496	70kb centromeric of RCP/GCP	3
MECP2, RTT, PPMX, AUTSX3, MRXSL, MRXS13	 Encephalopathy, neonatal severe	300673	70kb centromeric of RCP/GCP	3
MECP2, RTT, PPMX, AUTSX3, MRXSL, MRXS13	 Intellectual developmental disorder, X-linked syndromic 13	300055	70kb centromeric of RCP/GCP	3
MECP2, RTT, PPMX, AUTSX3, MRXSL, MRXS13	 Intellectual developmental disorder, X-linked syndromic, Lubs type	300260	70kb centromeric of RCP/GCP	3
MECP2, RTT, PPMX, AUTSX3, MRXSL, MRXS13	 Rett syndrome	312750	70kb centromeric of RCP/GCP	3
MECP2, RTT, PPMX, AUTSX3, MRXSL, MRXS13	Rett syndrome, atypical	312750	70kb centromeric of RCP/GCP	3
MECP2, RTT, PPMX, AUTSX3, MRXSL, MRXS13	 Rett syndrome, preserved speech variant	312750	70kb centromeric of RCP/GCP	3
MECR, NRBF1, DYTOABG	Dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities	617282		3
MED12L, NOPAR, KIAA1635, NIZIDS	Nizon-Isidor syndrome	618872		3
MED12, TNRC11, TRAP230, HOPA, KIAA0192, OKS, FGS1, OHDOX, HDKR	 Hardikar syndrome	301068		3
MED12, TNRC11, TRAP230, HOPA, KIAA0192, OKS, FGS1, OHDOX, HDKR	Lujan-Fryns syndrome	309520		3
MED12, TNRC11, TRAP230, HOPA, KIAA0192, OKS, FGS1, OHDOX, HDKR	 Ohdo syndrome, X-linked	300895		3
MED12, TNRC11, TRAP230, HOPA, KIAA0192, OKS, FGS1, OHDOX, HDKR	 Opitz-Kaveggia syndrome	305450		3
MED13L, THRAP2, PROSIT240, TRAP240L, KIAA1025, MRFACD	Impaired intellectual development and distinctive facial features with or without cardiac defects	616789		3
MED13, THRAP1, TRAP240, MRD61	Intellectual developmental disorder, autosomal dominant 61	618009		3
MED17, CRSP6, CRSP77, TRAP80, DRIP80	Microcephaly, postnatal progressive, with seizures and brain atrophy	613668		3
MED23, MRT18	Intellectual developmental disorder, autosomal recessive 18, with or without epilepsy	614249		3
MED25, PTOV2, ARC92, BVSYS	Basel-Vanagait-Smirin-Yosef syndrome	616449		3
MED27, CRSP8, CRAP34, NEDSCAC	Neurodevelopmental disorder with spasticity, cataracts, and cerebellar hypoplasia	619286		3
MEF2A, ADCAD1	Coronary artery disease, autosomal dominant, 1	608320		3
MEF2C, C5DELq14.3, DEL5q14.3, NEDHSIL	Chromosome 5q14.3 deletion syndrome	613443		4
MEF2C, C5DELq14.3, DEL5q14.3, NEDHSIL	 Neurodevelopmental disorder with hypotonia, stereotypic hand movements, and impaired language	613443		3
MEFV, MEF, FMF, PAAND	 Familial Mediterranean fever, AD	134610	between D16S80 and D16S283	3
MEFV, MEF, FMF, PAAND	 Familial Mediterranean fever, AR	249100	between D16S80 and D16S283	3
MEFV, MEF, FMF, PAAND	Neutrophilic dermatosis, acute febrile	608068	between D16S80 and D16S283	3
MEGF10, KIAA1780, EMARDD	 Myopathy, areflexia, respiratory distress, and dysphagia, early-onset	614399		3
MEGF10, KIAA1780, EMARDD	Myopathy, areflexia, respiratory distress, and dysphagia, early-onset, mild variant	614399		3
MEGF8, EGFL4, CRPT2	Carpenter syndrome 2	614976		3
MEI1, SPATA38, HYDM3	Hydatidiform mole, recurrent, 3	618431		3
MEIS2, MRG1, CPCMR	Cleft palate, cardiac defects, and mental retardation	600987		3
MEN1	 Adrenal adenoma, somatic	613733	linked distal to PYGM	3
MEN1	 Angiofibroma, somatic	613733	linked distal to PYGM	3
MEN1	 Carcinoid tumor of lung	613733	linked distal to PYGM	3
MEN1	Lipoma, somatic	613733	linked distal to PYGM	3
MEN1	 Multiple endocrine neoplasia 1	131100	linked distal to PYGM	3
MEN1	 Parathyroid adenoma, somatic	613733	linked distal to PYGM	3
MENAQ1	Menarche, age at, QTL	610873	max lod at UT7136	2
MENAQ2	Menarche, age at, QTL2	612882	associated with rs7759938	2
MENAQ3	Menarche, age at, QTL3	612883	associated with rs2090409	2
MENOQ1	Menopause, natural, age at, QTL1	300488		2
MENOQ2	Menopause, natural, age at, QTL2	612884	associated with rs1172822, rs2384687, rs1551562, rs897798	2
MENOQ4	Menopause, natural, age at, QTL4	612886	associated with rs365132, rs7718874, rs402511, rs691141, rs2278493	2
MEOX1, MOX1, KFS2	Klippel-Feil syndrome 2	214300		3
MERTK, RP38	Retinitis pigmentosa 38	613862		3
MESD, MESDC2, BOCA, KIAA0081, OI20	Osteogenesis imperfecta, type XX	618644		3
MESP2, SCDO2	Spondylocostal dysostosis 2, autosomal recessive	608681		3
MET, DFNB97, OSFD, DA11	 Arthrogryposis, distal, type 11	620019	mutation identified in 1 DFNB97 family and 1 DA11 family	3
MET, DFNB97, OSFD, DA11	 Deafness, autosomal recessive 97	616705	mutation identified in 1 DFNB97 family and 1 DA11 family	3
MET, DFNB97, OSFD, DA11	 Hepatocellular carcinoma, childhood type, somatic	114550	mutation identified in 1 DFNB97 family and 1 DA11 family	3
MET, DFNB97, OSFD, DA11	 Osteofibrous dysplasia, susceptibility to	607278	mutation identified in 1 DFNB97 family and 1 DA11 family	3
MET, DFNB97, OSFD, DA11	Renal cell carcinoma, papillary, 1, familial and somatic	605074	mutation identified in 1 DFNB97 family and 1 DA11 family	3
METTL23, C17orf95, MRT44	Intellectual developmental disorder, autosomal recessive 44	615942		3
METTL5, HSPC133, MRT72	Intellectual developmental disorder, autosomal recessive 72	618665		3
MFAP5, MAGP2, AAT9	Aortic aneurysm, familial thoracic 9	616166		3
MFF, C2orf33, EMPF2	Encephalopathy due to defective mitochondrial and peroxisomal fission 2	617086		3
MFHAS1, MASL1	Malignant fibrous histiocytoma	605352		2
MFN2, KIAA0214, CMT2A2A, HMSN6A, CMT2A2B	Charcot-Marie-Tooth disease, axonal, type 2A2A	609260		3
MFN2, KIAA0214, CMT2A2A, HMSN6A, CMT2A2B	 Charcot-Marie-Tooth disease, axonal, type 2A2B	617087		3
MFN2, KIAA0214, CMT2A2A, HMSN6A, CMT2A2B	 Hereditary motor and sensory neuropathy VIA	601152		3
MFRP, MCOP5, NNO2	Microphthalmia, isolated 5	611040		3
MFRP, MCOP5, NNO2	 Nanophthalmos 2	609549		3
MFSD2A, NEDMISBA	Neurodevelopmental disorder with progressive microcephaly, spasticity, and brain abnormalities	616486		3
MFSD8, MGC33302, CLN7, CCMD	 Ceroid lipofuscinosis, neuronal, 7	610951		3
MFSD8, MGC33302, CLN7, CCMD	Macular dystrophy with central cone involvement	616170		3
MFT2, TEM	Trichoepithelioma, multiple familial, 2	612099	max lod at D9S171	2
MGAT2, CDGS2, CDG2A	Congenital disorder of glycosylation, type IIa	212066		3
MGME1, C20orf72, MTDPS11	Mitochondrial DNA depletion syndrome 11	615084		3
MGP	Keutel syndrome	245150		3
MGR10	Migraine with or without aura, susceptibility to, 10	610208		2
MGR11	Migraine with or without aura, susceptibility to, 11	610209		2
MGR12	Migraine, with or without aura, susceptibility to, 12	611706	max lod at 100cM	2
MGR1, MA	Migraine with or without aura, susceptibility to, 1	157300		2
MGR2	Migraine, familial typical, susceptibility to, 2	300125		2
MGR3	Migraine with or without aura, susceptibility to, 3	607498	lod 5.78 at D6S452	2
MGR4, MGOA	Migraine without aura, susceptibility to, 4	607501	between D14S976 and D14S978	2
MGR5	Migraine with or without aura, susceptibility to, 5	607508		2
MGR6, FHM3	 Migraine, familial hemiplegic, 4	607516		2
MGR6, FHM3	Migraine with or without aura, susceptibility to, 6	607516		2
MGR7	Migraine with aura, susceptibility to, 7	609179	between D15S113 and D15S1019	2
MGR8	Migraine, susceptibility to, 8	609570		2
MGR9	Migraine with aura, susceptibility to, 9	609670	max lod at GATA64D03	2
MGS	Mungan syndrome	611376	between D8S1830 and D8S1799	2
MHS2	Malignant hyperthermia susceptibility 2	154275	?due to mutation in SCN4A	2
MHS3	Malignant hyperthermia susceptibility 3	154276	?mutation in CACNA2	2
MHS4	Malignant hyperthermia susceptibility 4	600467		2
MHS6	Malignant hyperthermia susceptibility 6	601888		2
MHW1	Mental health wellness-1	603663	at D4S2949	2
MHW2	Mental health wellness-2	603664	at D4S397	2
MIAT, C22orf35	Myocardial infarction, susceptibility to	608446		3
MIB1, MIB, DIP1, KIAA1323, LVNC7	Left ventricular noncompaction 7	615092		3
MICOS13, C19orf70, MIC13, QIL1	Combined oxidative phosphorylation deficiency 37	618329		3
MICU1, CBARA1, MPXPS	Myopathy with extrapyramidal signs	615673		3
MID1, OGS1, GBBB, FXY, OSX	Opitz GBBB syndrome	300000	type II defect on chr.22	3
MIF	Rheumatoid arthritis, systemic juvenile, susceptibility to	604302	previously assigned to chr.19	3
MINPP1, HIPER1, PCH16	 Pontocerebellar hypoplasia, type 16	619527		3
MINPP1, HIPER1, PCH16	Thyroid carcinoma, follicular	188470		3
MIP, AQP0, CTRCT15	Cataract 15, multiple types	615274	slightly distal to AQP2	3
MIPEP, COXPD31	Combined oxidative phosphorylation deficiency 31	617228		3
MIR140, MIRN140, SEDN	Spondyloepiphyseal dysplasia, Nishimura type	618618		3
MIR184, MIRN184, KTCNCT, EDICT	EDICT syndrome	614303		3
MIR2861, MIRN2861, BMND15	Bone mineral density QTL 15	613418		3
MIR96, MIRN96, DFNA50	Deafness, autosomal dominant 50	613074		3
MITF, WS2A, CMM8, COMMAD	 COMMAD syndrome	617306		3
MITF, WS2A, CMM8, COMMAD	 Melanoma, cutaneous malignant, susceptibility to, 8	614456		3
MITF, WS2A, CMM8, COMMAD	 Tietz albinism-deafness syndrome	103500		3
MITF, WS2A, CMM8, COMMAD	 Waardenburg syndrome/ocular albinism, digenic	103470		3
MITF, WS2A, CMM8, COMMAD	Waardenburg syndrome, type 2A	193510		3
MKKS, HMCS, KMS, MKS, BBS6	 Bardet-Biedl syndrome 6	605231		3
MKKS, HMCS, KMS, MKS, BBS6	McKusick-Kaufman syndrome	236700		3
MKRN3, ZFP127, ZNF127, CPPB2	Precocious puberty, central, 2	615346	expressed only from paternal allele	3
MKS1, MKS, BBS13, JBTS28	Bardet-Biedl syndrome 13	615990	frequent in Finland	3
MKS1, MKS, BBS13, JBTS28	 Joubert syndrome 28	617121	frequent in Finland	3
MKS1, MKS, BBS13, JBTS28	 Meckel syndrome 1	249000	frequent in Finland	3
MLC1, LVM, VL, MLC1	Megalencephalic leukoencephalopathy with subcortical cysts 1	604004		3
MLH1, COCA2, LYNCH2, MMRCS1	Lynch syndrome 2	609310		3
MLH1, COCA2, LYNCH2, MMRCS1	 Mismatch repair cancer syndrome 1	276300		3
MLH1, COCA2, LYNCH2, MMRCS1	 Muir-Torre syndrome	158320		3
MLH3, HNPCC7	 Colorectal cancer, hereditary nonpolyposis, type 7	614385		3
MLH3, HNPCC7	 Colorectal cancer, somatic	114500		3
MLH3, HNPCC7	Endometrial cancer, susceptibility to	608089		3
MLIP, C6orf142, MMCKR	Myopathy with myalgia, increased serum creatine kinase, and with or without episodic rhabdomyolysis	620138		3
MLPH	Griscelli syndrome, type 3	609227		3
MLYCD, MCD	Malonyl-CoA decarboxylase deficiency	248360		3
MMAA	Methylmalonic aciduria, vitamin B12-responsive, cblA type	251100		3
MMAB	Methylmalonic aciduria, vitamin B12-responsive, cblB type	251110		3
MMACHC	Methylmalonic aciduria and homocystinuria, cblC type	277400		3
MMADHC, C2orf25	 Homocystinuria, cblD type, variant 1	277410		3
MMADHC, C2orf25	 Methylmalonic aciduria and homocystinuria, cblD type	277410		3
MMADHC, C2orf25	Methylmalonic aciduria, cblD type, variant 2	277410		3
MMD2	Miyoshi muscular dystrophy 2	613318	max lod at D10S2325	2
MMDK, MDK	Mesomelic dysplasia, Kantaputra type	156232		2
MME, CD10, CALLA, NEP, CMT2T, SCA43	 Charcot-Marie-Tooth disease, axonal, type 2T	617017	mutation identified in 1 SCA43 family	3
MMP13, CLG3, MANDP1, MDST	 Metaphyseal anadysplasia 1	602111	mutation identified in 1 SEMDM family	3
MMP13, CLG3, MANDP1, MDST	 Metaphyseal dysplasia, Spahr type	250400	mutation identified in 1 SEMDM family	3
MMP19, MMP18, CODA	Cavitary optic disc anomalies	611543	triplication in upstream regulatory region	3
MMP1, CLG	COPD, rate of decline of lung function in	606963		3
MMP1, CLG	 Epidermolysis bullosa dystrophica, autosomal recessive, modifier of	226600		3
MMP20, AI2A2	Amelogenesis imperfecta, type IIA2	612529		3
MMP21, HTX7	Heterotaxy, visceral, 7, autosomal	616749		3
MMP2, CLG4A, MONA	Multicentric osteolysis, nodulosis, and arthropathy	259600	near MT1,2	3
MMP3, STMY1, CHDS6	Coronary heart disease, susceptibility to, 6	614466		3
MMP9, CLG4B, MANDP2	Metaphyseal anadysplasia 2	613073		3
MMUT, MUT, MCM	Methylmalonic aciduria, mut type	251000		3
MMVP1, MVP, PMV	Mitral valve prolapse, myxomatous 1	157700		2
MN1, MGCR, CEBALID	CEBALID syndrome	618774	fused with TEL in AML	3
MN1, MGCR, CEBALID	 Meningioma	607174	fused with TEL in AML	3
MNDEC	Microtia with nasolacrimal duct imperforation and eye coloboma	611863	copy number variant (CNV) association	4
MNG2	Goiter, multinodular, 2	300273		2
MNG3	Goiter, multinodular, 3	606082		2
MNRI	Meningioma, radiation-induced	606190		2
MNS1, FLJ11222, HTX9	Heterotaxy, visceral, 9, autosomal, with male infertility	618948		3
MNX1, HLXB9, HOXHB9, SCRA1	Currarino syndrome	176450		3
MOCOS, MCS, XAN2	Xanthinuria, type II	603592		3
MOCS1, MOCODA	Molybdenum cofactor deficiency A	252150		3
MOCS2, MPTS, MOCODB	Molybdenum cofactor deficiency B	252160		3
MOGS, GCS1, CDG2B	Congenital disorder of glycosylation, type IIb	606056		3
MORC2, ZCW3, ZCWCC1, KIAA0852, CMT2Z, DIGFAN	Charcot-Marie-Tooth disease, axonal, type 2Z	616688		3
MORC2, ZCW3, ZCWCC1, KIAA0852, CMT2Z, DIGFAN	 Developmental delay, impaired growth, dysmorphic facies, and axonal neuropathy	619090		3
MPC1, BRP44L, MPYCD	Mitochondrial pyruvate carrier deficiency	614741		3
MPD3	Myopathy, distal, 3	610099	possible locus on 12q13-q22	2
MPDU1, SL15, CDGIF	Congenital disorder of glycosylation, type If	609180		3
MPDZ, MUPP1, HYC2	Hydrocephalus, congenital, 2, with or without brain or eye anomalies	615219		3
MPEG1, MPG1, IMD77	Immunodeficiency 77	619223		3
MPI, PMI1, CDG1B	Congenital disorder of glycosylation, type Ib	602579		3
MPLKIP, C7orf11, ABHS, TTDN1, TTD4	Trichothiodystrophy 4, nonphotosensitive	234050		3
MPL, TPOR, MPLV, THCYT2	Myelofibrosis with myeloid metaplasia, somatic	254450		3
MPL, TPOR, MPLV, THCYT2	 Thrombocythemia 2	601977		3
MPL, TPOR, MPLV, THCYT2	 Thrombocytopenia, congenital amegakaryocytic	604498		3
MPO	Alzheimer disease, susceptibility to	104300	translocated in t(15;17)(q22;q11.2)	3
MPO	 Lung cancer, protection against, in smokers	606989	translocated in t(15;17)(q22;q11.2)	3
MPO	 Myeloperoxidase deficiency	254600	translocated in t(15;17)(q22;q11.2)	3
MPV17, MTDPS6, CMT2EE	Charcot-Marie-Tooth disease, axonal, type 2EE	618400		3
MPV17, MTDPS6, CMT2EE	 Mitochondrial DNA depletion syndrome 6 	256810		3
MPVQTL1	Mean platelet volume QTL1	612573	associated with rs7961894	2
MPVQTL2	Mean platelet volume QTL2	612574	associated with rs12485738	2
MPVQTL3	Mean platelet volume QTL3	612575	associated with rs2138852	2
MPVQTL4	Mean platelet volume QTL4	614644	associated with rs210134	2
MPVQTL5	Mean platelet volume QTL5	614645	associated with rs9399137	2
MPVQTL6	Mean platelet volume QTL6	614646	associated with rs342293	2
MPZ, CMT1B, CMTDID, DSS, CHN2	 Charcot-Marie-Tooth disease, dominant intermediate D	607791		3
MPZ, CMT1B, CMTDID, DSS, CHN2	 Charcot-Marie-Tooth disease, type 1B	118200		3
MPZ, CMT1B, CMTDID, DSS, CHN2	Charcot-Marie-Tooth disease, type 2I	607677		3
MPZ, CMT1B, CMTDID, DSS, CHN2	 Charcot-Marie-Tooth disease, type 2J	607736		3
MPZ, CMT1B, CMTDID, DSS, CHN2	 Dejerine-Sottas disease	145900		3
MPZ, CMT1B, CMTDID, DSS, CHN2	 Hypomyelinating neuropathy, congenital, 2	618184		3
MPZ, CMT1B, CMTDID, DSS, CHN2	 Roussy-Levy syndrome	180800		3
MPZL2, EVA1, EVA, DFNB111	Deafness, autosomal recessive 111	618145		3
MRAP2, C6orf117, BMIQ18	Obesity, susceptibility to, BMIQ18	615457	mutation identified in 1 BMIQ18 individual	3
MRAP, FALP, C21orf61, GCCD2, FGD2	Glucocorticoid deficiency 2	607398		3
MRAS, RRAS3, NS11	Noonan syndrome 11	618499		3
MRD2	Intellectual developmental disorder, autosomal dominant 2	614113	2 patients reported with genomic deletion or rearrangement including disruption of DOCK8	4
MRD4	Intellectual developmental disorder, autosomal dominant 4	612581	translocation t(11;16)(q24.2;q24)	2
MRE11A, MRE11, ATLD	Ataxia-telangiectasia-like disorder 1	604391		3
MRPL3, MRL3, COXPD9	Combined oxidative phosphorylation deficiency 9	614582		3
MRPL44, COXPD16	Combined oxidative phosphorylation deficiency 16	615395		3
MRPS16, COXPD2	Combined oxidative phosphorylation deficiency 2	610498		3
MRPS22, C3orf5, COXPD5, ODG7	 Combined oxidative phosphorylation deficiency 5	611719		3
MRPS22, C3orf5, COXPD5, ODG7	Ovarian dysgenesis 7	618117		3
MRPS2, COXPD36	Combined oxidative phosphorylation deficiency 36	617950		3
MRPS34, MRPS12, COXPD32	Combined oxidative phosphorylation deficiency 32	617664		3
MRSD, CHRS	Intellectual developmental disorder, X-linked, with skeletal dysplasia and abducens palsy	309620		2
MRST	Mental retardation, severe, with spasticity and tapetoretinal degeneration	602685		2
MRT10, MRT20	Intellectual developmental disorder, autosomal recessive 10/20	611096	between rs724466 and rs3901517, rs7197568 and rs71972227	2
MRT11	Intellectual developmental disorder, autosomal recessive 11	611097	between rs2109075 and rs8101149	2
MRT16	Intellectual developmental disorder, autosomal recessive 16	614208	between rs10738277 and rs12376565	2
MRT19	Intellectual developmental disorder, autosomal recessive 19	614343	between rs4606805 and rs1787846	2
MRT23	Intellectual developmental disorder, autosomal recessive 23	614344	between rs604518 and rs10899421	2
MRT24	Intellectual developmental disorder, autosomal recessive 24	614345	between rs651733 and rs1508668	2
MRT25	Intellectual developmental disorder, autosomal recessive 25	614346	between rs4760658 and rs1882033	2
MRT28	Intellectual developmental disorder, autosomal recessive 28	614347	between rs6935718 and rs3886091	2
MRT29	Intellectual developmental disorder, autosomal recessive 29	614333	between rs10518325 and rs10518608	2
MRT30	Intellectual developmental disorder, autosomal recessive 30	614342	between rs4612125 and rs285651	2
MRT31	Intellectual developmental disorder, autosomal recessive 31	614329	between rs11944876 and rs6551838	2
MRT33	Intellectual developmental disorder, autosomal recessive 33	614341	between rs1367950 and rs1826925	2
MRT35	Intellectual developmental disorder, autosomal recessive 35	615162	between rs4792947 and rs11079258	2
MRT4	Intellectual developmental disorder, autosomal recessive 4	611107	between D2S429 and D1S187	2
MRT9, MRT26	Intellectual developmental disorder, autosomal recessive 9/26	611095	between rs1998463 and rs243286	2
MRXS17	Intellectual developmental disorder, X-linked syndromic 17	300858	between rs2748314 and rs5906782	2
MRXS7	Intellectual developmental disorder, X-linked syndromic 7	300218		2
MRXS9	Intellectual developmental disorder, X-linked syndromic 9	300709	between DXS1111 and DXS1197	2
MRXSAB	Intellectual developmental disorder, X-linked syndromic, Abidi type	300262		2
MRXSCS	Intellectual developmental disorder, X-linked syndromic, Chudley-Schwartz type	300861	max lod at DXS1120	2
MRXSMP	Martin-Probst syndrome	300519		2
MRXSS	Intellectual developmental disorder, X-linked, with short stature	300360		2
MS2	Multiple sclerosis, susceptibility to, 2	612594	associated with rs12722489 and rs2104286	2
MS3	Multiple sclerosis, susceptibility to, 3	612595	associated with rs6897932	2
MS4A2, FCER1B	Atopy, susceptibility to	147050		3
MS4	Multiple sclerosis, susceptibility to, 4	612596	associated with rs10492972	2
MSH2, COCA1, FCC1, LYNCH1, MMRCS2	Lynch syndrome 1	120435		3
MSH2, COCA1, FCC1, LYNCH1, MMRCS2	 Mismatch repair cancer syndrome 2	619096		3
MSH2, COCA1, FCC1, LYNCH1, MMRCS2	 Muir-Torre syndrome	158320		3
MSH3, FAP4	 Endometrial carcinoma, somatic	608089	5' to DHFR	3
MSH3, FAP4	Familial adenomatous polyposis 4	617100	5' to DHFR	3
MSH4, POF20, SPGF2	Premature ovarian failure 20	619938		3
MSH4, POF20, SPGF2	 Spermatogenic failure 2	108420		3
MSH5, POF13, SPGF74	 Spermatogenic failure 74	619937	mutation identified in POF13 family	3
MSH6, GTBP, LYNCH5, MMRCS3	 Endometrial cancer, familial	608089	0.5 Mb from MSH2	3
MSH6, GTBP, LYNCH5, MMRCS3	Lynch syndrome 5	614350	0.5 Mb from MSH2	3
MSH6, GTBP, LYNCH5, MMRCS3	 Mismatch repair cancer syndrome 3	619097	0.5 Mb from MSH2	3
MSL3, MSL3L1, MRXSBA	Basilicata-Akhtar syndrome	301032		3
MSMB, HPC13	Prostate cancer, hereditary, 13	611928		3
MSMO1, SC4MOL, ERG25, MCCPD	Microcephaly, congenital cataract, and psoriasiform dermatitis	616834		3
MSN, IMD50	Immunodeficiency 50	300988		3
MSPC	Palmoplantar carcinoma, multiple self-healing	616964	between rs8065368 and rs2322788	2
MSR1, SCARA1, SRA	Barrett esophagus/esophageal adenocarcinoma	614266	~11cM distal to LPL	3
MSRB3, DFNB74	Deafness, autosomal recessive 74	613718		3
MST1R, RON, NPCA3	Nasopharyngeal carcinoma, susceptibility to, 3	617075		3
MSTO1, MMYAT	Myopathy, mitochondrial, and ataxia	617675		3
MSX1, HOX7, HYD1, OFC5, STHAG1, ECTD3	 Ectodermal dysplasia 3, Witkop type	189500		3
MSX1, HOX7, HYD1, OFC5, STHAG1, ECTD3	 Orofacial cleft 5	608874		3
MSX1, HOX7, HYD1, OFC5, STHAG1, ECTD3	Tooth agenesis, selective, 1, with or without orofacial cleft	106600		3
MSX2, CRS2, HOX8	 Craniosynostosis 2	604757		3
MSX2, CRS2, HOX8	 Parietal foramina 1	168500		3
MSX2, CRS2, HOX8	Parietal foramina with cleidocranial dysplasia	168550		3
MTAP, DMSMFH	Diaphyseal medullary stenosis with malignant fibrous histiocytoma	112250		3
MTBS1	Tuberculosis, susceptibility to	607949		2
MTBS2	Mycobacterium tuberculosis, susceptibility to, 2	611046	max lod at D8S1723	2
MTBS3	Mycobacterium tuberculosis, susceptibility to, 3	612929	associated with rs3827103	2
MTBSX	Mycobacterium tuberculosis, susceptibility, X-linked	300259		2
MTFMT, COXPD15, MC1DN27	Combined oxidative phosphorylation deficiency 15	614947		3
MTFMT, COXPD15, MC1DN27	 Mitochondrial complex I deficiency, nuclear type 27	618248		3
MTHFD1, MTHFC, CIMAH	 Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia	617780	trifunctional protein	3
MTHFD1, MTHFC, CIMAH	Neural tube defects, folate-sensitive, susceptibility to	601634	trifunctional protein	3
MTHFR	 Homocystinuria due to MTHFR deficiency	236250		3
MTHFR	 Neural tube defects, susceptibility to	601634		3
MTHFR	 Schizophrenia, susceptibility to	181500		3
MTHFR	 Thromboembolism, susceptibility to	188050		3
MTHFR	Vascular disease, susceptibility to	607093		3
MTHFS, NEDMEHM	Neurodevelopmental disorder with microcephaly, epilepsy, and hypomyelination	618367		3
MTM1, MTMX, CNMX	Myopathy, centronuclear, X-linked	310400	close to F8	3
MTMR14, C3orf29, HJUMPY	Centronuclear myopathy, autosomal, modifier of	160150		3
MTMR2, CMT4B1	Charcot-Marie-Tooth disease, type 4B1	601382		3
MTNR1B	Diabetes mellitus, type 2, susceptibility to	125853		3
MTO1, COXPD10	Combined oxidative phosphorylation deficiency 10	614702		3
MTOR, FRAP1, SKS	Focal cortical dysplasia, type II, somatic	607341		3
MTOR, FRAP1, SKS	 Smith-Kingsmore syndrome	616638		3
MTRFR, C12orf65, COXPD7, SPG55	 Combined oxidative phosphorylation deficiency 7	613559		3
MTRFR, C12orf65, COXPD7, SPG55	Spastic paraplegia 55, autosomal recessive	615035		3
MTR, HMAG	 Homocystinuria-megaloblastic anemia, cblG complementation type	250940		3
MTR, HMAG	Neural tube defects, folate-sensitive, susceptibility to	601634		3
MTRR	Homocystinuria-megaloblastic anemia, cbl E type	236270		3
MTRR	 Neural tube defects, folate-sensitive, susceptibility to	601634		3
MTSS2, MTSS1L, ABBA1, IDDOF	Intellectual developmental disorder with ocular anomalies and distinctive facial features	620086		3
MTTP	 Abetalipoproteinemia	200100		3
MTTP	Metabolic syndrome, protection against	605552		3
MTX2, MDPS	Mandibuloacral dysplasia progeroid syndrome	619127		3
MUC1, PUM, ADTKD2	Tubulointerstitial kidney disease, autosomal dominant, 2	174000	5cM proximal to SPTA1	3
MUC5B	Pulmonary fibrosis, idiopathic, susceptibility to	178500		3
MUC7	Asthma, protection against	600807		3
MUSK, CMS9, FADS1	Fetal akinesia deformation sequence 1	208150		3
MUSK, CMS9, FADS1	 Myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency	616325		3
MUSQTL1	Musical aptitude QTL 1	612343	near D4S423 and D4S2460	2
MUSTQTL1	Muscle strength quantitative trait locus 1	612083		2
MUTYH, MYH	Adenomas, multiple colorectal	608456		3
MUTYH, MYH	 Gastric cancer, somatic	613659		3
MVD, MPD, POROK7	Porokeratosis 7, multiple types	614714		3
MVK, MVLK, POROK3	Hyper-IgD syndrome	260920		3
MVK, MVLK, POROK3	 Mevalonic aciduria	610377		3
MVK, MVLK, POROK3	 Porokeratosis 3, multiple types	175900		3
MXI1	 Neurofibrosarcoma, somatic	600020		3
MXI1	Prostate cancer, somatic	176807		3
MXLPO	Myxoid liposarcoma	613488	fusion of DDIT3 and FUS	4
MYAS1	Myasthenia gravis with thymus hyperplasia	607085		2
MYBPC1, LCCS4, MYOTREM	 Arthrogryposis, distal, type 1B	614335		3
MYBPC1, LCCS4, MYOTREM	 Lethal congenital contracture syndrome 4	614915		3
MYBPC1, LCCS4, MYOTREM	Myopathy, congenital, with tremor	618524		3
MYBPC3, CMH4, CMD1MM, LVNC10	 Cardiomyopathy, dilated, 1MM	615396		3
MYBPC3, CMH4, CMD1MM, LVNC10	Cardiomyopathy, hypertrophic, 4	115197		3
MYBPC3, CMH4, CMD1MM, LVNC10	 Left ventricular noncompaction 10	615396		3
MYB	T-cell acute lymphoblastic leukemia	189990		3
MYC	Burkitt lymphoma, somatic	113970	cen-5'-3'-ter	3
MYCN, NMYC, ODED, MODED	Feingold syndrome 1	164280	proximal to APOB	3
MYD88, MYD88D, IMD68	 Immunodeficiency 68	612260		3
MYD88, MYD88D, IMD68	Macroglobulinemia, Waldenstrom, somatic	153600		3
MYF5, EORVA	Ophthalmoplegia, external, with rib and vertebral anomalies	618155		3
MYH11, AAT4, FAA4, VSCM2	 Aortic aneurysm, familial thoracic 4	132900	fused with CBFB by inversion in acute myelomonocytic leukemia	3
MYH11, AAT4, FAA4, VSCM2	Megacystis-microcolon-intestinal hypoperistalsis syndrome 2	619351	fused with CBFB by inversion in acute myelomonocytic leukemia	3
MYH11, AAT4, FAA4, VSCM2	 Visceral myopathy 2	619350	fused with CBFB by inversion in acute myelomonocytic leukemia	3
MYH14, KIAA2034, DFNA4A, PNMHH	 Deafness, autosomal dominant 4A	600652	mutation identified in 1 PNMHH family	3
MYH2, MYPOP	Proximal myopathy and ophthalmoplegia	605637		3
MYH3, DA2A, DA2B3, DA8, CPSFS1A, CPSFS1B	 Arthrogryposis, distal, type 2A 	193700		3
MYH3, DA2A, DA2B3, DA8, CPSFS1A, CPSFS1B	 Arthrogryposis, distal, type 2B3 	618436		3
MYH3, DA2A, DA2B3, DA8, CPSFS1A, CPSFS1B	Contractures, pterygia, and spondylocarpostarsal fusion syndrome 1A	178110		3
MYH3, DA2A, DA2B3, DA8, CPSFS1A, CPSFS1B	 Contractures, pterygia, and spondylocarpotarsal fusion syndrome 1B	618469		3
MYH6, ASD3, MYHCA, CMD1EE, CMH14, SSS3	 Atrial septal defect 3	614089		3
MYH6, ASD3, MYHCA, CMD1EE, CMH14, SSS3	 Cardiomyopathy, dilated, 1EE	613252		3
MYH6, ASD3, MYHCA, CMD1EE, CMH14, SSS3	 Cardiomyopathy, hypertrophic, 14	613251		3
MYH6, ASD3, MYHCA, CMD1EE, CMH14, SSS3	Sick sinus syndrome 3	614090		3
MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD	 Cardiomyopathy, dilated, 1S	613426	5'-B-4.5kb-A-3'	3
MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD	 Cardiomyopathy, hypertrophic, 1	192600	5'-B-4.5kb-A-3'	3
MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD	Laing distal myopathy	160500	5'-B-4.5kb-A-3'	3
MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD	 Left ventricular noncompaction 5	613426	5'-B-4.5kb-A-3'	3
MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD	 Myopathy, myosin storage, autosomal dominant	608358	5'-B-4.5kb-A-3'	3
MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD	 Myopathy, myosin storage, autosomal recessive	255160	5'-B-4.5kb-A-3'	3
MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD	 Scapuloperoneal syndrome, myopathic type	181430	5'-B-4.5kb-A-3'	3
MYH8, DA7	Carney complex variant	608837		3
MYH8, DA7	 Trismus-pseudocamptodactyly syndrome	158300		3
MYH9, MHA, FTNS, DFNA17, BDPLT6, MATINS	 Deafness, autosomal dominant 17	603622		3
MYH9, MHA, FTNS, DFNA17, BDPLT6, MATINS	Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss	155100		3
MYL11, MLC2B, MRLC2, MYLPF, DA1C	Arthrogryposis, distal, type 1C	619110		3
MYL1, MYOFTA	Myopathy, congenital, with fast-twitch  fiber atrophy	618414		3
MYL2, CMH10, MFM12	Cardiomyopathy, hypertrophic, 10	608758		3
MYL2, CMH10, MFM12	 Myopathy, myofibrillar, 12, infantile-onset, with cardiomyopathy	619424		3
MYL3, CMH8	Cardiomyopathy, hypertrophic, 8	608751		3
MYLK2, MLCK	Cardiomyopathy, hypertrophic, 1, digenic	192600		3
MYLK, MLCK, AAT7, MMIHS1	 Aortic aneurysm, familial thoracic 7	613780	pseudogene on 3p13	3
MYLK, MLCK, AAT7, MMIHS1	Megacystis-microcolon-intestinal hypoperistalsis syndrome 1	249210	pseudogene on 3p13	3
MYMK, TMEM8C	Carey-Fineman-Ziter syndrome	254940		3
MYMY1, MYMY	Moyamoya disease	252350	max lod at D3S3050	2
MYMY3	Moyamoya disease 3	608796	max lod at D8S546	2
MYMY4, CXDELq38	Moyamoya disease 4	300845	contiguous gene deletion syndrome (3.4kb)	4
MYO15A, DFNB3	Deafness, autosomal recessive 3	600316		3
MYO18B, KFS4	Klippel-Feil syndrome 4, autosomal recessive, with myopathy and facial dysmorphism	616549		3
MYO1E, MYO1C, FSGS6	Glomerulosclerosis, focal segmental, 6	614131		3
MYO3A, DFNB30	Deafness, autosomal recessive 30	607101		3
MYO5A, MYH12, GS1	Griscelli syndrome, type 1	214450		3
MYO5B, KIAA1119, DIAR2, MVID1, PFIC10	 Cholestasis, progressive familial intrahepatic, 10	619868		3
MYO5B, KIAA1119, DIAR2, MVID1, PFIC10	Diarrhea 2, with microvillus atrophy, with or without cholestasis	251850		3
MYO6, DFNA22, DFNB37	 Deafness, autosomal dominant 22	606346		3
MYO6, DFNA22, DFNB37	Deafness, autosomal dominant 22, with hypertrophic cardiomyopathy	606346		3
MYO6, DFNA22, DFNB37	 Deafness, autosomal recessive 37	607821		3
MYO7A, USH1B, DFNB2, DFNA11	 Deafness, autosomal dominant 11	601317		3
MYO7A, USH1B, DFNB2, DFNA11	Deafness, autosomal recessive 2	600060		3
MYO7A, USH1B, DFNB2, DFNA11	 Usher syndrome, type 1B	276900		3
MYO9A, CMS24	Myasthenic syndrome, congenital, 24, presynaptic	618198		3
MYO9B, MYR5, CELIAC4	Celiac disease, susceptibility to, 4	609753		3
MYOCD, MGBL	Megabladder, congenital	618719		3
MYOC, TIGR, GLC1A, JOAG, GPOA	Glaucoma 1A, primary open angle	137750		3
MYOD1, MYF3, MYODRIF	Myopathy, congenital, with diaphragmatic defects, respiratory insufficiency, and dysmorphic facies	618975	proximal to CALCA, HBB, BWS, PTH; ?11p14.3	3
MYORG, NET37, KIAA1161, IBGC7	Basal ganglia calcification, idiopathic, 7, autosomal recessive	618317		3
MYOT, TTOD, MFM3	Myopathy, myofibrillar, 3	609200		3
MYOT, TTOD, MFM3	 Myopathy, spheroid body	182920		3
MYOZ2, CMH16	Cardiomyopathy, hypertrophic, 16	613838		3
MYP10	Myopia 10	609259		2
MYP11	Myopia 11	609994	max lod at D4S1564	2
MYP12	Myopia 12	609995	max lod at D2S2344	2
MYP13	Myopia 13	300613	between DXS1210 and DXS1227	2
MYP14	Myopia 14	610320	between D1S552 and D1S1622	2
MYP15	Myopia 15	612717	max lod at D10S1643	2
MYP16	Myopia 16	612554	max lod at D5S2505	2
MYP17, MYP4	Myopia 17	608367	previously assigned to 7q36 (MYP4)	2
MYP18	Myopia 18	255500	between D14S984 and D14S999	2
MYP19	Myopia 19	613969	highest lod at D5S419	2
MYP1	Myopia-1	310460		2
MYP20	Myopia 20, autosomal dominant	614166	associated with rs9318086	2
MYP2	Myopia 2	160700		2
MYP3	Myopia-3	603221		2
MYP5	Myopia 5	608474	between D17S787 and D17S1811	2
MYP7	Myopia 7	609256		2
MYP8	Myopia 8	609257		2
MYP9	Myopia 9	609258		2
MYPN, CMD1DD, CMH22, RCM4, NEM11	 Cardiomyopathy, dilated, 1KK	615248		3
MYPN, CMD1DD, CMH22, RCM4, NEM11	 Cardiomyopathy, familial restrictive, 4	615248		3
MYPN, CMD1DD, CMH22, RCM4, NEM11	Cardiomyopathy, hypertrophic, 22	615248		3
MYPN, CMD1DD, CMH22, RCM4, NEM11	 Nemaline myopathy 11, autosomal recessive	617336		3
MYRF, C11orf9, KIAA0954, MMERV, CUGS	 Cardiac-urogenital syndrome	618280		3
MYRF, C11orf9, KIAA0954, MMERV, CUGS	Encephalitis/encephalopathy, mild, with reversible myelin vacuolization	618113		3
MYSM1, 2ADUB, KIAA1915, BMFS4	Bone marrow failure syndrome 4	618116		3
MYT1L, KIAA1106, MRD39	Intellectual developmental disorder, autosomal dominant 39	616521		3
NAA10, ARD1A, ARD1, TE2, NATD, OGDNS, MCOPS1	Microphthalmia, syndromic 1	309800		3
NAA10, ARD1A, ARD1, TE2, NATD, OGDNS, MCOPS1	 Ogden syndrome	300855		3
NAA15, NARG1, NATH, MRD50	Intellectual developmental disorder, autosomal dominant 50, with behavioral abnormalities	617787		3
NAA20, NAT5, NAT3, MRT73	Intellectual developmental disorder, autosomal recessive 73	619717		3
NACC1, BTBD14B, NECFM	Neurodevelopmental disorder with epilepsy, cataracts, feeding difficulties, and delayed brain myelination	617393		3
NADK2, C5orf33, DECRD	2,4-dienoyl-CoA reductase deficiency	616034		3
NADSYN1, VCRL3	Vertebral, cardiac, renal, and limb defects syndrome 3	618845		3
NAGA	 Kanzaki disease	609242	proximal to Ph1 break	3
NAGA	Schindler disease, type I	609241	proximal to Ph1 break	3
NAGA	 Schindler disease, type III	609241	proximal to Ph1 break	3
NAGLU, MPS3B, CMT2V	 Mucopolysaccharidosis type IIIB 	252920	mutation identified in 1 CMT2V family	3
NAGS	N-acetylglutamate synthase deficiency	237310		3
NAIC	North American Indian childhood cirrhosis	604901		2
NALCN, IHPRF1, CLIFAHDD	Congenital contractures of the limbs and face, hypotonia, and developmental delay	616266		3
NALCN, IHPRF1, CLIFAHDD	 Hypotonia, infantile, with psychomotor retardation and characteristic facies 1	615419		3
NANOS1, NOS1, SPGF12	Spermatogenic failure 12	615413		3
NANS, SAS, SEMDCG	Spondyloepimetaphyseal dysplasia, Camera-Genevieve type	610442		3
NAPB, SNAPB, DEE107	Developmental and epileptic encephalopathy 107	620033		3
NARS1, NARS, ASNRS, NEDMILG, NEDMILEG	 Neurodevelopmental disorder with microcephaly, impaired language, and gait abnormalities, autosomal recessive	619091		3
NARS1, NARS, ASNRS, NEDMILG, NEDMILEG	Neurodevelopmental disorder with microcephaly, impaired language, epilepsy, and gait abnormalities, autosomal dominant	619092		3
NARS2, COXPD24, DFNB94	Combined oxidative phosphorylation deficiency 24	616239	mutation identified in 1 DFNB94 family	3
NARS2, COXPD24, DFNB94	 Deafness, autosomal recessive 94	618434	mutation identified in 1 DFNB94 family	3
NAT2, AAC2	Acetylation, slow	243400	acetylation polymorphism	3
NAXD, CARKD, PEBEL2	Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 2	618321		3
NAXE, APOA1BP, AIBP, PEBEL	Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy	617186		3
NBAS, NAG, SOPH, ILFS2	 Infantile liver failure syndrome 2	616483		3
NBAS, NAG, SOPH, ILFS2	Short stature, optic nerve atrophy, and Pelger-Huet anomaly	614800		3
NBEAL2, KIAA0540, GPS, BDPLT4	Gray platelet syndrome	139090		3
NBEA, NEDEGE	Neurodevelopmental disorder with or without early-onset generalized epilepsy	619157	site of FRA13A	3
NBLST4	Neuroblastoma, susceptibility to, 4	613015	associated with rs6939340, rs4712653, rs9295536	2
NBLST5	Neuroblastoma, susceptibility to, 5	613016	associated with rs6435862, rs3768716	2
NBLST6	Neuroblastoma, susceptibility to, 6	613017	?contiguous gene deletion or duplication disease	2
NBLST7	Neuroblastoma, susceptibility to, 7	616792	associated with rs2168101	2
NBN, NBS1	 Aplastic anemia	609135		3
NBN, NBS1	Leukemia, acute lymphoblastic	613065		3
NBN, NBS1	 Nijmegen breakage syndrome	251260		3
NCAPD3, CAPD3, KIAA0056, MCPH22	Microcephaly 22, primary, autosomal recessive	617984		3
NCAPG2, CAPG2, MTB, 3KS	Khan-Khan-Katsanis syndrome	618460		3
NCDN, KIAA0607, NEDIES	Neurodevelopmental disorder with infantile epileptic spasms	619373		3
NCF1, CGD1	Chronic granulomatous disease 1, autosomal recessive	233700		3
NCF2	Chronic granulomatous disease 2, autosomal recessive	233710		3
NCF4, P40PHOX, CGD3	Chronic granulomatous disease 3, autosomal recessive	613960		3
NCKAP1L, HEM1, IMD72	Immunodeficiency 72 with autoinflammation	618982		3
NCR3, 1C7, NKP30, CD337, MALS	Malaria, mild, susceptibility to	609148		3
NCSTN	Acne inversa, familial, 1	142690		3
NDE1, NUDE, LIS4, MHAC	 Lissencephaly 4 	614019		3
NDE1, NUDE, LIS4, MHAC	Microhydranencephaly	605013		3
NDNC7	Nail disorder, nonsyndromic congenital, 7	605779		2
NDNC9	Nail disorder, nonsyndromic congenital, 9	614149	max lod at D17S1301	2
NDNF, C4orf31, NORD, HH25	Hypogonadotropic hypogonadism 25 with anosmia	618841		3
NDP, ND, EVR2	Exudative vitreoretinopathy 2, X-linked	305390		3
NDP, ND, EVR2	 Norrie disease	310600		3
NDRG1, HMSNL, CMT4D	Charcot-Marie-Tooth disease, type 4D	601455		3
NDST1, HSST, MRT46	Intellectual developmental disorder, autosomal recessive 46	616116		3
NDUFA10, MC1DN22	Mitochondrial complex I deficiency, nuclear type 22	618243		3
NDUFA11, MC1DN14	Mitochondrial complex I deficiency, nuclear type 14	618236		3
NDUFA12, MC1DN23	Mitochondrial complex I deficiency, nuclear type 23	618244		3
NDUFA13, GRIM19, MC1DN28	 Mitochondrial complex I deficiency, nuclear type 28	618249	mutation identified in 1 MC1DN28 family	3
NDUFA13, GRIM19, MC1DN28	Thyroid carcinoma, Hurthle cell	607464	mutation identified in 1 MC1DN28 family	3
NDUFA1, MWFE, MC1DN12	Mitochondrial complex I deficiency, nuclear type 12	301020		3
NDUFA2, MC1DN13	Mitochondrial complex I deficiency, nuclear type 13	618235		3
NDUFA6, MC1DN33	Mitochondrial complex I deficiency, nuclear type 33	618253		3
NDUFA8, MC1DN37	Mitochondrial complex I deficiency, nuclear type 37	619272		3
NDUFA9, MC1DN26	Mitochondrial complex I deficiency, nuclear type 26	618247		3
NDUFAF1, CIA30, CGI65, MC1DN11	Mitochondrial complex I deficiency, nuclear type 11	618234		3
NDUFAF2, NDUFA12L, MMTN, B17.2L, MC1DN10	Mitochondrial complex I deficiency, nuclear type 10	618233	pseudogene on chr.2	3
NDUFAF3, MC1DN18	Mitochondrial complex I deficiency, nuclear type 18	618240		3
NDUFAF4, HRPAP20, C6orf66, MC1DN15	Mitochondrial complex I deficiency, nuclear type 15	618237		3
NDUFAF5, C20orf7, MC1DN16	Mitochondrial complex I deficiency, nuclear type 16	618238		3
NDUFAF6, C8orf38, MC1DN17, FRTS5	 Fanconi renotubular syndrome 5	618913		3
NDUFAF6, C8orf38, MC1DN17, FRTS5	Mitochondrial complex I deficiency, nuclear type 17	618239		3
NDUFAF8, C17orf89, MC1DN34	Mitochondrial complex I deficiency, nuclear type 34	618776		3
NDUFB11, LSDMCA3, MC1DN30	Linear skin defects with multiple congenital anomalies 3	300952	mutation identified in 1 MC1DN30 patient	3
NDUFB11, LSDMCA3, MC1DN30	 Mitochondrial complex I deficiency, nuclear type 30	301021	mutation identified in 1 MC1DN30 patient	3
NDUFB3, MC1DN25	Mitochondrial complex I deficiency, nuclear type 25	618246	pseudogenes on chr. 1, 9, and 14	3
NDUFB8, MC1DN32	Mitochondrial complex I deficiency, nuclear type 32	618252	previously assigned to 12q21	3
NDUFC2, MC1DN36	Mitochondrial complex I deficiency, nuclear type 36	619170		3
NDUFS1, MC1DN5	Mitochondrial complex I deficiency, nuclear type 5	618226		3
NDUFS2, MC1DN6	Mitochondrial complex I deficiency, nuclear type 6	618228		3
NDUFS3, MC1DN8	Mitochondrial complex I deficiency, nuclear type 8	618230		3
NDUFS4, AQDQ, MC1DN1	Mitochondrial complex I deficiency, nuclear type 1	252010		3
NDUFS6, MC1DN9	Mitochondrial complex I deficiency, nuclear type 9	618232		3
NDUFS7, PSST, MC1DN3	Mitochondrial complex I deficiency, nuclear type 3	618224		3
NDUFS8, MC1DN2	Mitochondrial complex I deficiency, nuclear type 2	618222	previously assigned to 3q28	3
NDUFV1, UQOR1, MC1DN4	Mitochondrial complex I deficiency, nuclear type 4	618225		3
NDUFV2, MC1DN7	Mitochondrial complex I deficiency, nuclear type 7	618229	pseudogene on 19q13.3-qter	3
NEB, NEM2, AMC6	 Arthrogryposis multiplex congenita 6	619334		3
NEB, NEM2, AMC6	Nemaline myopathy 2, autosomal recessive	256030		3
NECAP1, DEE21	Developmental and epileptic encephalopathy 21	615833		3
NECTIN1, PVRL1, HVEC, PVRR1, PRR1, ED4, OFC7, CLPED1	Cleft lip/palate-ectodermal dysplasia syndrome	225060		3
NECTIN1, PVRL1, HVEC, PVRR1, PRR1, ED4, OFC7, CLPED1	 Orofacial cleft 7	225060		3
NECTIN 4, PVRL4, PRR4, EDSS1	Ectodermal dysplasia-syndactyly syndrome 1	613573		3
NEDD4L, KIAA0439, RSP5, PVNH7	Periventricular nodular heterotopia 7	617201		3
NEDE	Nephropathy, progressive, with deafness	609469	max lod at D11S4464	2
NEFH, CMT2CC	 Amyotrophic lateral sclerosis, susceptibility to	105400	mutation identified in 1 family with ALS susceptibility	3
NEFH, CMT2CC	Charcot-Marie-Tooth disease, axonal, type 2CC	616924	mutation identified in 1 family with ALS susceptibility	3
NEFL, CMT2E, CMT1F, CMTDIG	 Charcot-Marie-Tooth disease, dominant intermediate G	617882		3
NEFL, CMT2E, CMT1F, CMTDIG	Charcot-Marie-Tooth disease, type 1F	607734		3
NEFL, CMT2E, CMT1F, CMTDIG	 Charcot-Marie-Tooth disease, type 2E	607684		3
NEK10, CILD44	Ciliary dyskinesia, primary, 44	618781		3
NEK1, SRTD6, SRPS2A, ALS24	 Amyotrophic lateral sclerosis, susceptibility to, 24	617892	1 patient showed heterozygous NEK2 and DYNC2H1 mutations	3
NEK1, SRTD6, SRPS2A, ALS24	Short-rib thoracic dysplasia 6 with or without polydactyly	263520	1 patient showed heterozygous NEK2 and DYNC2H1 mutations	3
NEK8, JCK, NPHP9, RHPD2	 Nephronophthisis 9	613824	mutations identified in 1 family with NPHP9	3
NEK8, JCK, NPHP9, RHPD2	Renal-hepatic-pancreatic dysplasia 2	615415	mutations identified in 1 family with NPHP9	3
NEK9, NERCC1, LCCS10, APUG, NC	 Lethal congenital contracture syndrome 10	617022	mutation identified in 1 APUG family	3
NEK9, NERCC1, LCCS10, APUG, NC	 Nevus comedonicus, somatic	617025	mutation identified in 1 APUG family	3
NEMF, SDCCAG1, IDDSAPN	Intellectual developmental disorder with speech delay and axonal peripheral neuropathy	619099		3
NEPRO, C3orf17, ANXD3	Anauxetic dysplasia 3	618853		3
NEU1, NEU, SIAL1	 Sialidosis, type I	256550		3
NEU1, NEU, SIAL1	Sialidosis, type II	256550		3
NEUROD1, T2D	 Maturity-onset diabetes of the young 6	606394		3
NEUROD1, T2D	Type 2 diabetes mellitus, susceptibility to	125853		3
NEUROD2, DEE72	Developmental and epileptic encephalopathy 72	618374		3
NEUROG3, NGN3, ATOH5	Diarrhea 4, malabsorptive, congenital	610370		3
NEXMIF, KIAA2022, XLID98	Intellectual developmental disorder, X-linked 98	300912	inv(X)(q13;p22)	3
NEXN, NELIN, CMD1CC, CMH20	Cardiomyopathy, dilated, 1CC	613122		3
NEXN, NELIN, CMD1CC, CMH20	 Cardiomyopathy, hypertrophic, 20	613876		3
NF1, VRNF, WSS, NFNS	 Leukemia, juvenile myelomonocytic	607785		3
NF1, VRNF, WSS, NFNS	 Neurofibromatosis, familial spinal	162210		3
NF1, VRNF, WSS, NFNS	 Neurofibromatosis-Noonan syndrome	601321		3
NF1, VRNF, WSS, NFNS	 Neurofibromatosis, type 1	162200		3
NF1, VRNF, WSS, NFNS	Watson syndrome	193520		3
NF2	 Meningioma, NF2-related, somatic	607174	loss of heterozygosity	3
NF2	Neurofibromatosis, type 2	101000	loss of heterozygosity	3
NF2	 Schwannomatosis, somatic	162091	loss of heterozygosity	3
NFASC, KIAA0756, NEDCPMD	Neurodevelopmental disorder with central and peripheral motor dysfunction	618356		3
NFE2L2, NRF2, IMDDHH	Immunodeficiency, developmental delay, and hypohomocysteinemia	617744		3
NFIA, BRMUTD	Brain malformations with or without urinary tract defects	613735		3
NFIB, MACID	Macrocephaly, acquired, with impaired intellectual development	618286		3
NFIX, NF1A, MALNS, MRSHSS	 Malan syndrome	614753		3
NFIX, NF1A, MALNS, MRSHSS	Marshall-Smith syndrome	602535		3
NFKB1, CVID12	Immunodeficiency, common variable, 12	616576		3
NFKB2, LYT10, CVID10	Immunodeficiency, common variable, 10	615577		3
NFKBIA, IKBA, EDAID2	Ectodermal dysplasia and immunodeficiency 2	612132		3
NFKBIL1	Rheumatoid arthritis, susceptibility to	180300		3
NFS1, NIFS, COXPD52	Combined oxidative phosphorylation deficiency 52	619386		3
NFU1, HIRIP, MMDS1	Multiple mitochondrial dysfunctions syndrome 1	605711		3
NGF, NGFB, HSAN5	Neuropathy, hereditary sensory and autonomic, type V	608654	same 310kb fragment as TSHB; order: cen-CD2-CD58-ATP1A1-NGF-TSHB-NRAS-tel	3
NGLY1, PNG1, CDDG, CDG1V	Congenital disorder of deglycosylation 1	615273		3
NHEJ1, XLF	Severe combined immunodeficiency with microcephaly, growth retardation, and sensitivity to ionizing radiation	611291		3
NHLRC1, EPM2A, EPM2B	Epilepsy, progressive myoclonic 2B 	254780		3
NHLRC2, FINCA	FINCA syndrome	618278		3
NHP2, NOLA2, DKCB2	Dyskeratosis congenita, autosomal recessive 2	613987		3
NHS, CXN, CTRCT40	Cataract 40, X-linked	302200		3
NHS, CXN, CTRCT40	 Nance-Horan syndrome	302350		3
NIDDM2	Diabetes mellitus, noninsulin-dependent, 2	601407	no mutations found in HNF1A	2
NIDDM4	Diabetes mellitus, noninsulin-dependent	125853		2
NIPA1, SPG6	Spastic paraplegia 6, autosomal dominant	600363		3
NIPAL4, ICHYN, ARCI6	Ichthyosis, congenital, autosomal recessive 6	612281		3
NIPBL, CDLS1	Cornelia de Lange syndrome 1	122470		3
NKAP, MRXSHD	Intellectual developmental disorder, X-linked syndromic, Hackman-Di Donato type	301039		3
NKS1, EC1	Lysis by alloreactive natural killer cells, susceptibility to	272370		2
NKX2-1, TITF1, NKX2A, TTF1, NMTC1	Chorea, hereditary benign	118700		3
NKX2-1, TITF1, NKX2A, TTF1, NMTC1	 Choreoathetosis, hypothyroidism, and neonatal respiratory distress	610978		3
NKX2-1, TITF1, NKX2A, TTF1, NMTC1	 Thyroid cancer, nonmedullary, 1	188550		3
NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2	 Atrial septal defect 7, with or without AV conduction defects	108900	near border with 5q35	3
NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2	 Conotruncal heart malformations, variable	217095	near border with 5q35	3
NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2	Hypoplastic left heart syndrome 2	614435	near border with 5q35	3
NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2	 Hypothyroidism, congenital nongoitrous, 5	225250	near border with 5q35	3
NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2	 Tetralogy of Fallot	187500	near border with 5q35	3
NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2	 Ventricular septal defect 3	614432	near border with 5q35	3
NKX2-6, CSX2, CTHM	 Conotruncal heart malformations	217095		3
NKX2-6, CSX2, CTHM	Persistent truncus arteriosus	217095		3
NKX3-2, BAPX1, SMMD	Spondylo-megaepiphyseal-metaphyseal dysplasia	613330		3
NKX6-2, NKX6B, NKX6.2, SPAX8	Spastic ataxia 8, autosomal recessive, with hypomyelinating leukodystrophy	617560		3
NLGN1	Autism, susceptibility to, 20	618830		3
NLGN3, ASPGX1, AUTSX1	Asperger syndrome susceptibility, X-linked 1	300494		3
NLGN3, ASPGX1, AUTSX1	 Autism susceptibility, X-linked 1	300425		3
NLGN4, KIAA1260, AUTSX2, ASPGX2	Asperger syndrome susceptibility, X-linked 2	300497		3
NLGN4, KIAA1260, AUTSX2, ASPGX2	 Autism susceptibility, X-linked 2	300495		3
NLGN4, KIAA1260, AUTSX2, ASPGX2	 Intellectual developmental disorder, X-linked	300495		3
NLRC4, CARD12, CLAN, IPAF, AIFEC, FCAS4	 Autoinflammation with infantile enterocolitis	616050	mutation identified in 1 FCAS4 family	3
NLRP12, NALP12, PYPAF7, RNO, FCAS2	Familial cold autoinflammatory syndrome 2	611762		3
NLRP1, NALP1, KIAA0926, DEFCAP, CARD7, VAMAS1, MSPC, AIADK, JRRP	 Autoinflammation with arthritis and dyskeratosis	617388	mutation identified in 1 JRRP family	3
NLRP1, NALP1, KIAA0926, DEFCAP, CARD7, VAMAS1, MSPC, AIADK, JRRP	 Palmoplantar carcinoma, multiple self-healing	615225	mutation identified in 1 JRRP family	3
NLRP1, NALP1, KIAA0926, DEFCAP, CARD7, VAMAS1, MSPC, AIADK, JRRP	 Respiratory papillomatosis, juvenile recurrent, congenital	618803	mutation identified in 1 JRRP family	3
NLRP1, NALP1, KIAA0926, DEFCAP, CARD7, VAMAS1, MSPC, AIADK, JRRP	Vitiligo-associated multiple autoimmune disease susceptibility 1	606579	mutation identified in 1 JRRP family	3
NLRP3, CIAS1, FCU, FCAS1, NALP3, PYPAF1, DFNA34, KEFH	CINCA syndrome	607115		3
NLRP3, CIAS1, FCU, FCAS1, NALP3, PYPAF1, DFNA34, KEFH	 Deafness, autosomal dominant 34, with or without inflammation	617772		3
NLRP3, CIAS1, FCU, FCAS1, NALP3, PYPAF1, DFNA34, KEFH	 Familial cold inflammatory syndrome 1	120100		3
NLRP3, CIAS1, FCU, FCAS1, NALP3, PYPAF1, DFNA34, KEFH	 Keratoendothelitis fugax hereditaria	148200		3
NLRP3, CIAS1, FCU, FCAS1, NALP3, PYPAF1, DFNA34, KEFH	 Muckle-Wells syndrome	191900		3
NLRP7, NALP7, NOD12, PYPAF3, HYDM	Hydatidiform mole, recurrent, 1	231090		3
NME5, NM23H5, CILD48	Ciliary dyskinesia, primary, 48, without situs inversus	620032		3
NME8, TXNDC3, SPTRX2, CILD6	Ciliary dyskinesia, primary, 6	610852		3
NMLFS, DEL8q22.1, C8DELq22.1	Nablus mask-like facial syndrome	608156		4
NMNAT1, NMNAT, PNAT1, LCA9, SHILCA	 Leber congenital amaurosis 9	608553		3
NMNAT1, NMNAT, PNAT1, LCA9, SHILCA	Spondyloepiphyseal dysplasia, sensorineural hearing loss, intellectual developmental disorder, and Leber congenital amaurosis	619260		3
NMTC3	Thyroid carcinoma, nonmedullary, 3	606240		2
NNMT	Homocysteine plasma level	600008		2
NNO1	Nanophthalmos-1	600165		2
NNO3	Nanophthalmos 3	611897	max lod at D2S2265	2
NNT, GCCD4	Glucocorticoid deficiency 4, with or without mineralocorticoid deficiency	614736		3
NOBOX, POF5	Premature ovarian failure 5	611548		3
NOD2, CARD15, IBD1, CD, YAOS, BLAUS	Blau syndrome	186580		3
NOD2, CARD15, IBD1, CD, YAOS, BLAUS	 Inflammatory bowel disease 1, Crohn disease	266600		3
NOD2, CARD15, IBD1, CD, YAOS, BLAUS	 Yao syndrome	617321		3
NODAL, HTX5	Heterotaxy, visceral, 5	270100		3
NOG, SYM1, SYNS1A	 Brachydactyly, type B2	611377		3
NOG, SYM1, SYNS1A	 Multiple synostoses syndrome 1	186500		3
NOG, SYM1, SYNS1A	 Stapes ankylosis with broad thumbs and toes	184460		3
NOG, SYM1, SYNS1A	Symphalangism, proximal, 1A	185800		3
NOG, SYM1, SYNS1A	 Tarsal-carpal coalition syndrome	186570		3
NONO, NRB54, MRXS34	Intellectual developmental disorder, X-linked syndromic 34	300967	2Mb proximal to PHKA1	3
NOP10, NOLA3, DKCB1	Dyskeratosis congenita, autosomal recessive 1	224230		3
NOP56, SCA36	Spinocerebellar ataxia 36	614153		3
NOS1AP, CAPON, KIAA0464, NPHS22	Nephrotic syndrome, type 22	619155		3
NOS2A, NOS2	Malaria, resistance to	611162	?cluster of 3 NOS2 genes	3
NOS3	 Alzheimer disease, late-onset, susceptibility to	104300		3
NOS3	Coronary artery spasm 1, susceptibility to	163729		3
NOS3	 Hypertension, pregnancy-induced	189800		3
NOS3	 Hypertension, susceptibility to	145500		3
NOS3	 Ischemic stroke, susceptibility to	601367		3
NOS3	 Placental abruption	163729		3
NOTCH1, TAN1, AOS5, AOVD1	Adams-Oliver syndrome 5	616028		3
NOTCH1, TAN1, AOS5, AOVD1	 Aortic valve disease 1	109730		3
NOTCH2, AGS2, HJCYS	Alagille syndrome 2	610205		3
NOTCH2, AGS2, HJCYS	 Hajdu-Cheney syndrome	102500		3
NOTCH2NLC, NIID, ETM6, OPDM3	 Neuronal intranuclear inclusion disease	603472		3
NOTCH2NLC, NIID, ETM6, OPDM3	 Oculopharyngodistal myopathy 3	619473		3
NOTCH2NLC, NIID, ETM6, OPDM3	Tremor, hereditary essential, 6	618866		3
NOTCH3, CADASIL1, CASIL, IMF2, LMNS	 Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 1	125310	mutation identified in 1 IMF2 family	3
NOTCH3, CADASIL1, CASIL, IMF2, LMNS	Lateral meningocele syndrome	130720	mutation identified in 1 IMF2 family	3
NOTCH3, CADASIL1, CASIL, IMF2, LMNS	 Myofibromatosis, infantile 2	615293	mutation identified in 1 IMF2 family	3
NOVA2, ANOVA, NEDASB	Neurodevelopmental disorder with or without autistic features and/or structural brain abnormalities	618859		3
NPC1L1, LDLCQ7	Ezetimibe, nonresponse to	617966		3
NPC1L1, LDLCQ7	 Low density lipoprotein cholesterol level QTL 7	617966		3
NPC1, NPCA1	Nasopharyngeal carcinoma 1	607107	?associated with acyl-CoA thioesterase 7-like	2
NPC1, NPC	Niemann-Pick disease, type C1	257220	some families not linked to 18; type D prob. allelic	3
NPC1, NPC	 Niemann-Pick disease, type D	257220	some families not linked to 18; type D prob. allelic	3
NPC2, HE1	Niemann-pick disease, type C2	607625		3
NPCA2	Nasopharyngeal carcinoma, susceptibility to, 2	161550	associated with rs2517713 and rs2975042	2
NPHP1, NPH1, SLSN1, JBTS4	Joubert syndrome 4	609583		3
NPHP1, NPH1, SLSN1, JBTS4	 Nephronophthisis 1, juvenile	256100		3
NPHP1, NPH1, SLSN1, JBTS4	 Senior-Loken syndrome-1	266900		3
NPHP3, NPH3, RHPD1, MKS7	 Meckel syndrome 7	267010		3
NPHP3, NPH3, RHPD1, MKS7	Nephronophthisis 3	604387		3
NPHP3, NPH3, RHPD1, MKS7	 Renal-hepatic-pancreatic dysplasia 1	208540		3
NPHP4, SLSN4	 Nephronophthisis 4	606966		3
NPHP4, SLSN4	Senior-Loken syndrome 4	606996		3
NPHS1, NPHN	Nephrotic syndrome, type 1	256300		3
NPM1	Leukemia, acute myeloid, somatic	601626	fused with RARA in APL	3
NPPA, PND, ANP, ATFB6, ATRST2	 Atrial fibrillation, familial, 6	612201		3
NPPA, PND, ANP, ATFB6, ATRST2	Atrial standstill 2	615745		3
NPR2, ANPRB, AMD1, ECDM, SNSK	 Acromesomelic dysplasia 1, Maroteaux type	602875		3
NPR2, ANPRB, AMD1, ECDM, SNSK	Epiphyseal chondrodysplasia, Miura type	615923		3
NPR2, ANPRB, AMD1, ECDM, SNSK	 Short stature with nonspecific skeletal abnormalities	616255		3
NPR3, ANPRC, BOMOS	Boudin-Mortier syndrome	619543		3
NPRL2, FFEVF2	Epilepsy, familial focal, with variable foci 2	617116		3
NPRL3, CGTHBA, FFEVF3	Epilepsy, familial focal, with variable foci 3	617118		3
NPSR1, GPR154, GPRA, VRR1, PGR14, ASRT2	Asthma, susceptibility to, 2	608584		3
NPTX1, NP1, SCA50	Spinocerebellar ataxia 50	620158		3
NQO1, DIA4, NMOR1	 Benzene toxicity, susceptibility to	125860		3
NQO1, DIA4, NMOR1	Breast cancer, poor survival after chemotherapy for	125860		3
NQO1, DIA4, NMOR1	 Leukemia, post-chemotherapy, susceptibility to	125860		3
NQO2, NMOR2	Breast cancer susceptibility	114480		1
NR0B1, DAX1, AHC, AHX, SRXY2	 46XY sex reversal 2, dosage-sensitive	300018	distal to GK	3
NR0B1, DAX1, AHC, AHX, SRXY2	Adrenal hypoplasia, congenital	300200	distal to GK	3
NR0B2, SHP	Obesity, mild, early-onset	601665		3
NR1H4, FXR, RIP14, PFIC5	Cholestasis, progressive familial intrahepatic, 5	617049		3
NR2E3, PNR, ESCS, RP37	 Enhanced S-cone syndrome	268100	near BBS4	3
NR2E3, PNR, ESCS, RP37	Retinitis pigmentosa 37	611131	near BBS4	3
NR2F1, TFCOUP1, ERBAL3, EAR3, BBSOAS	Bosch-Boonstra-Schaaf optic atrophy syndrome	615722		3
NR2F2, TFCOUP2, ARP1, CHTD4, SRXX5	46,XX sex reversal 5	618901		3
NR2F2, TFCOUP2, ARP1, CHTD4, SRXX5	 Congenital heart defects, multiple types, 4	615779		3
NR3C1, GCR, GRL, GCRST	Glucocorticoid resistance	615962		3
NR3C2, MLR, MCR	 Hypertension, early-onset, autosomal dominant, with exacerbation in pregnancy	605115		3
NR3C2, MLR, MCR	Pseudohypoaldosteronism type I, autosomal dominant	177735		3
NR4A2, NURR1, NOT, TINUR, IDLDP	Intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism	619911		3
NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8, SRXX4	46, XX sex reversal 4	617480		3
NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8, SRXX4	 46XY sex reversal 3	612965		3
NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8, SRXX4	 Adrenocortical insufficiency	612964		3
NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8, SRXX4	 Premature ovarian failure 7	612964		3
NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8, SRXX4	 Spermatogenic failure 8	613957		3
NRAMP1, NRAMP, SLC11A1	 Buruli ulcer, susceptibility to	610446	within 220 kb of VIL1	3
NRAMP1, NRAMP, SLC11A1	Mycobacterium tuberculosis, susceptibility to infection by	607948	within 220 kb of VIL1	3
NRAS, ALPS4, NS6, CMNS, NCMS	 Colorectal cancer, somatic	114500	cen-CD2-NGFB-NRAS	3
NRAS, ALPS4, NS6, CMNS, NCMS	 Epidermal nevus, somatic	162900	cen-CD2-NGFB-NRAS	3
NRAS, ALPS4, NS6, CMNS, NCMS	 Melanocytic nevus syndrome, congenital, somatic	137550	cen-CD2-NGFB-NRAS	3
NRAS, ALPS4, NS6, CMNS, NCMS	 Neurocutaneous melanosis, somatic	249400	cen-CD2-NGFB-NRAS	3
NRAS, ALPS4, NS6, CMNS, NCMS	Noonan syndrome 6	613224	cen-CD2-NGFB-NRAS	3
NRAS, ALPS4, NS6, CMNS, NCMS	 RAS-associated autoimmune lymphoproliferative syndrome type IV, somatic	614470	cen-CD2-NGFB-NRAS	3
NRAS, ALPS4, NS6, CMNS, NCMS	 Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic	163200	cen-CD2-NGFB-NRAS	3
NRAS, ALPS4, NS6, CMNS, NCMS	 Thyroid carcinoma, follicular, somatic	188470	cen-CD2-NGFB-NRAS	3
NRCAM, NEDNMS	Neurodevelopmental disorder with neuromuscular and skeletal abnormalities	619833		3
NRCLP2	Narcolepsy 2	605841	max lod at D4S2987	2
NRCLP3	Narcolepsy 3	609039	max lod at D21S1245	2
NRCLP4	Narcolepsy 4	612417	associated with rs5770917	2
NRCLP5	Narcolepsy 5	612851	associated with rs1154155, rs12587781, rs1263646	2
NRCLP6	Narcolepsy 6	614223	associated with rs2305795	2
NRG1, HGL, HRGA, ARIA	Schizophrenia, susceptibility to	603013		1
NRL, D14S46E, RP27	 Retinal degeneration, autosomal recessive, clumped pigment type	162080		3
NRL, D14S46E, RP27	Retinitis pigmentosa 27	613750		3
NRROS, LRRC33, SENEBAC	Seizures, early-onset, with neurodegeneration and brain calcification	618875		3
NRXN1, PTHSL2, SCZD17	Pitt-Hopkins-like syndrome 2	614325		3
NRXN1, PTHSL2, SCZD17	 Schizophrenia, susceptibility to, 17	614332		3
NSD1, ARA267, STO, SOTOS	Sotos syndrome	117550	fusion gene with NUP98 in AML	3
NSD2, WHSC1, MMSET, RAUST	Rauch-Steindl syndrome	619695		3
NSDHL	 CHILD syndrome	308050		3
NSDHL	CK syndrome	300831		3
NSF, DEE96	Developmental and epileptic encephalopathy 96	619340		3
NSMCE2, NSE2, MMS21	Seckel syndrome 10	617253		3
NSMCE3, NDNL2, MAGEG1, LICS	Lung disease, immunodeficiency, and chromosome breakage syndrome	617241		3
NSMF, NELF, HH9	Hypogonadotropic hypogonadism 9 with or without anosmia	614838		3
NSRP1, NSRP70, CCDC55, NEDSSBA	Neurodevelopmental disorder with spasticity, seizures, and brain abnormalities	620001		3
NSUN2, TRM4, SAKI, MISU, MRT5	Intellectual developmental disorder, autosomal recessive 5	611091		3
NSUN3, COXPD48	Combined oxidative phosphorylation deficiency 48	619012		3
NT5C2, NT5B, PNT5, SPG45	Spastic paraplegia 45, autosomal recessive	613162		3
NT5C3A, NT5C3, UMPH1, PSN1	Anemia, hemolytic, due to UMPH1 deficiency	266120	pseudogenes on chr.4 and chr.7	3
NT5E, NT5	Calcification of joints and arteries	211800		3
NTF4 , NTF5, NT5, NT4, GLC1O	Glaucoma 1, open angle, 1O	613100	3 genes, ? functional, also on 19	3
NTHL1, OCTS3, FAP3	Familial adenomatous polyposis 3	616415		3
NTN1, NTN1L, MRMV4	Mirror movements 4	618264		3
NTNG2, NEDBASH	Neurodevelopmental disorder with behavioral abnormalities, absent speech, and hypotonia	618718		3
NTRK1, TRKA	Insensitivity to pain, congenital, with anhidrosis	256800	TRK = chimera of TPM3 and NTRK1	3
NTRK2, TRKB, OBHD, DEE58	Developmental and epileptic encephalopathy 58	617830		3
NTRK2, TRKB, OBHD, DEE58	 Obesity, hyperphagia, and developmental delay	613886		3
NUBPL, IND1, MC1DN21	Mitochondrial complex I deficiency, nuclear type 21	618242		3
NUDT15, MTH2, NUDT15D	Thiopurines, poor metabolism of, 2	616903		3
NUDT2, APAH1, IDDPN	Intellectual developmental disorder with or without peripheral neuropathy	619844		3
NUMA1	Leukemia, acute promyelocytic, somatic	612376	fused with RARA in APL	3
NUP107, NUP84, NPHS11, ODG6; GAMOS7	 Galloway-Mowat syndrome 7	618348	mutation identified in 1 ODG6 family	3
NUP107, NUP84, NPHS11, ODG6; GAMOS7	 Nephrotic syndrome, type 11	616730	mutation identified in 1 ODG6 family	3
NUP133, NPHS18, GAMOS8	 Nephrotic syndrome, type 18	618177	mutation identified in 1 GAMOS8 family	3
NUP188, KIAA1069, SANDSTEF	Sandestig-Stefanova syndrome	618804		3
NUP214, D9S46E, CAN, CAIN, IIAE9	 Encephalopathy, acute, infection-induced, susceptibility to, 9	618426	fused with DEK in AML; fused with ABL1 in T-ALL	3
NUP214, D9S46E, CAN, CAIN, IIAE9	 Leukemia, acute myeloid, somatic	601626	fused with DEK in AML; fused with ABL1 in T-ALL	3
NUP214, D9S46E, CAN, CAIN, IIAE9	Leukemia, T-cell acute lymphoblastic, somatic	613065	fused with DEK in AML; fused with ABL1 in T-ALL	3
NUP62, SNDI, IBSN	Striatonigral degeneration, infantile	271930		3
NUP85, PCNT1, PCNT, NPHS17	Nephrotic syndrome, type 17	618176		3
NUP88, FADS4	Fetal akinesia deformation sequence 4	618393		3
NUP93, NIC96, KIAA0095, NPHS12	Nephrotic syndrome, type 12	616892		3
NUS1, NGBR, C6orf68, CDG1AA, MRD55	 Congenital disorder of glycosylation, type 1aa	617082	mutation identified in 1 CDG1AA family	3
NUS1, NGBR, C6orf68, CDG1AA, MRD55	Intellectual developmental disorder, autosomal dominant 55, with seizures	617831	mutation identified in 1 CDG1AA family	3
NXN, RRS2	Robinow syndrome, autosomal recessive 2	618529		3
NYS2, NYSA	Nystagmus 2, congenital, autosomal dominant	164100		2
NYS3	Nystagmus 3, congenital, autosomal dominant	608345	translocation t(7;15)(p11.2;q11.2)	2
NYS5	Nystagmus 5, congenital, X-linked	300589	max lod at DXS993	2
NYS7	Nystagmus 7, congenital, autosomal dominant	614826	between D1S218 and D1S2655	2
NYX, CSNB1A, NBM1	Night blindness, congenital stationary , 1A, X-linked	310500		3
OAS1, OIAS, IMD100	Immunodeficiency 100 with pulmonary alveolar proteinosis and hypogammaglobulinemia	618042		3
OASD	Ocular albinism with sensorineural deafness	300650	?allelic to OA1	2
OAT, GACR	Gyrate atrophy of choroid and retina with or without ornithinemia	258870	pseudogene at Xp11.2	3
OBSL1, KIAA0657, 3M2	3-M syndrome 2	612921		3
OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1	 Albinism, brown oculocutaneous	203200	?hypopigmentation in PWS and AS	3
OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1	 Albinism, oculocutaneous, type II	203200	?hypopigmentation in PWS and AS	3
OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1	 Skin/hair/eye pigmentation 1, blond/brown hair	227220	?hypopigmentation in PWS and AS	3
OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1	Skin/hair/eye pigmentation 1, blue/nonblue eyes	227220	?hypopigmentation in PWS and AS	3
OCA5	Albinism, oculocutaneous, type V	615312	max lod at D4S961	2
OCLN, BLCPMG, PTORCH1	Pseudo-TORCH syndrome 1	251290		3
OCRL, LOCR, OCRL1, NPHL2, DENT2	Dent disease 2	300555		3
OCRL, LOCR, OCRL1, NPHL2, DENT2	 Lowe syndrome	309000		3
ODAD1, CCDC114, CILD20	Ciliary dyskinesia, primary, 20	615067		3
ODAD2, ARMC4, CILD23	Ciliary dyskinesia, primary, 23	615451		3
ODAD2, CCDC151, CILD30	Ciliary dyskinesia, primary, 30	616037		3
ODAPH, C4orf26	Amelogenesis imperfecta, type IIA4	614832		3
ODC1, BABS	Bachmann-Bupp syndrome	619075	pseudogene ODCP on 7q31-qter	3
ODS1	Opioid dependence, susceptibility to, 1	610064		2
OFC12	Orofacial cleft 12	612858	associated with rs987525	2
OFC13	Orofacial cleft 13	613857	associated with rs3827730	2
OFC14	Orofacial cleft 14	615892		2
OFC1, CL	Orofacial cleft-1	119530	probable heterogeneity	2
OFC2	Orofacial cleft 2	602966	?relation to TGFA	2
OFC3	Orofacial cleft 3	600757	?role of BCL3	2
OFC4	Orofacial cleft 4	608371		2
OFC9	Orofacial cleft 9	610361	associated with rs1830756	2
OFD1, CXorf5, SGBS2, JBTS10, RP23	 Joubert syndrome 10	300804	mutation identified in 1 RP23 family	3
OFD1, CXorf5, SGBS2, JBTS10, RP23	 Orofaciodigital syndrome I	311200	mutation identified in 1 RP23 family	3
OFD1, CXorf5, SGBS2, JBTS10, RP23	 Retinitis pigmentosa 23	300424	mutation identified in 1 RP23 family	3
OFD1, CXorf5, SGBS2, JBTS10, RP23	Simpson-Golabi-Behmel syndrome, type 2	300209	mutation identified in 1 RP23 family	3
OFD8	Orofaciodigital syndrome VIII	300484		2
OGDHL, KIAA1290, YOBELN	Yoon-Bellen neurodevelopmental syndrome	619701		3
OGG1	Renal cell carcinoma, clear cell, somatic	144700		3
OGT, XLID106	Intellectual developmental disorder, X-linked 106	300997		3
OHDS	Orthostatic hypotensive disorder of Streeten	143850		2
OLR1, LOX1	Myocardial infarction, susceptibility to	608446		3
OPA1, NTG, NPG, BERHS, MTDPS14	 Behr syndrome	210000	mutation identified in 1 MTDPS14 family	3
OPA1, NTG, NPG, BERHS, MTDPS14	 Glaucoma, normal tension, susceptibility to	606657	mutation identified in 1 MTDPS14 family	3
OPA1, NTG, NPG, BERHS, MTDPS14	 Mitochondrial DNA depletion syndrome 14 	616896	mutation identified in 1 MTDPS14 family	3
OPA1, NTG, NPG, BERHS, MTDPS14	 Optic atrophy 1	165500	mutation identified in 1 MTDPS14 family	3
OPA1, NTG, NPG, BERHS, MTDPS14	Optic atrophy plus syndrome	125250	mutation identified in 1 MTDPS14 family	3
OPA2	Optic atrophy 2, X-linked	311050		2
OPA3, MGA3	3-methylglutaconic aciduria, type III	258501		3
OPA3, MGA3	 Optic atrophy 3 with cataract	165300		3
OPA4	Optic atrophy 4	605293		2
OPA6	Optic atrophy 6	258500	between D8S1702 and D8S1794	2
OPA8	Optic atrophy 8	616648	max lod at D16S752	2
OPCML	Ovarian cancer, somatic	167000		3
OPDG, GPDS1, PDS1	Ocular pigment dispersion with or without glaucoma	600510		2
OPHLC, C1DUPp31.3, DUP1p31.3	Omphalocele due to duplication of 1p31.3	164750	duplication of 710kb at 1p31.3	4
OPHN1, MRXSBL	Intellectual developmental disorder, X-linked syndromic, Billuart type	300486		3
OPLAH, OPLAHD	5-oxoprolinase deficiency	260005		3
OPN1LW, RCP, CBP, CBBM	Blue cone monochromacy	303700	5' to CBD	3
OPN1LW, RCP, CBP, CBBM	 Colorblindness, protan	303900	5' to CBD	3
OPN1MW, GCP, CBD, CBBM	 Blue cone monochromacy	303700	linked to G6PD; multiple genes	3
OPN1MW, GCP, CBD, CBBM	Colorblindness, deutan	303800	linked to G6PD; multiple genes	3
OPN1SW, BCP, CBT	Colorblindness, tritan	190900		3
OPTN, GLC1E, FIP2, HYPL, NRP, ALS12	 Amyotrophic lateral sclerosis 12 with or without frontotemporal dementia	613435		3
OPTN, GLC1E, FIP2, HYPL, NRP, ALS12	Glaucoma 1, open angle, E	137760		3
OPTN, GLC1E, FIP2, HYPL, NRP, ALS12	 Glaucoma, normal tension, susceptibility to	606657		3
OR2J3, C3HEXS	C3HEX, ability to smell	615082		3
ORAI1, TMEM142A, CRACM1, IMD9, TAM2	Immunodeficiency 9	612782		3
ORAI1, TMEM142A, CRACM1, IMD9, TAM2	 Myopathy, tubular aggregate, 2	615883		3
ORC1, ORC1L	Meier-Gorlin syndrome 1	224690		3
ORC4, ORC4L	Meier-Gorlin syndrome 2	613800		3
ORC6, ORC6L	Meier-Gorlin syndrome 3	613803		3
OS4, GOA1	Osteoarthritis susceptibility 4	610839	max lod at D2S2358	2
OS6	Osteoarthritis susceptibility 6	612401	associated with rs11718863 and rs7639618	2
OSBPL2, ORP2, KIAA0772, DNFA67	Deafness, autosomal dominant 67	616340		3
OSGEP, FLJ20411, GAMOS3	Galloway-Mowat syndrome 3	617729		3
OSMR, OSMRB, PLCA1	Amyloidosis, primary localized cutaneous, 1	105250		3
OSTM1, GL, OPTB5	Osteopetrosis, autosomal recessive 5	259720		3
OTC	Ornithine transcarbamylase deficiency	311250	proximal to DMD, CGD	3
OTDD, DEL11q13, C11DELq13	Otodental dysplasia chromosome deletion syndrome	166750	between rs9666584 and rs41408348	4
OTOA, DFNB22	Deafness, autosomal recessive 22	607039		3
OTOF, DFNB9, NSRD9, AUNB1	Auditory neuropathy, autosomal recessive, 1	601071	symbolized DFNB6 by authors	3
OTOF, DFNB9, NSRD9, AUNB1	 Deafness, autosomal recessive 9	601071	symbolized DFNB6 by authors	3
OTOGL, C12orf64, DFNB84B	Deafness, autosomal recessive 84B	614944		3
OTOG, OTGN, DFNB18B	Deafness, autosomal recessive 18B	614945		3
OTSC10	Otosclerosis 10	615589		2
OTSC1, OTS	Otosclerosis 1	166800		2
OTSC2	Otosclerosis 2	605727		2
OTSC3	Otosclerosis 3	608244		2
OTSC4	Otosclerosis 4	611571	between D16S3107 and D16S3097	2
OTSC5	Otosclerosis 5	608787	max lod at D3S1569	2
OTSC7	Otosclerosis 7	611572	between D6S1036 and D6S300	2
OTSC8	Otosclerosis 8	612096	between D9S970 and D9S1799	2
OTUD5, DUBA, MCAND	Multiple congenital anomalies-neurodevelopmental syndrome, X-linked	301056		3
OTUD6B, DUBA5, IDDFSDA	Intellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies	617452		3
OTULIN, FAM105B, GUM, AIPDS, IMD107	Autoinflammation, panniculitis, and dermatosis syndrome	617099		3
OTULIN, FAM105B, GUM, AIPDS, IMD107	 Immunodeficiency 107, susceptibility to invasive staphylococcus aureus infection	619986		3
OTX2, MCOPS5, CPHD6	 Microphthalmia, syndromic 5	610125		3
OTX2, MCOPS5, CPHD6	 Pituitary hormone deficiency, combined, 6	613986		3
OTX2, MCOPS5, CPHD6	Retinal dystrophy, early-onset, with or without pituitary dysfunction	610125		3
OVCAS1	Ovarian cancer, susceptibility to	607893	between D3S1597 and D3S3611	2
OVOL2, ZNF339, PPCD1	Corneal dystrophy, posterior polymorphous, 1	122000		3
OXCT1, OXCT, SCOT	Succinyl CoA:3-oxoacid CoA transferase deficiency	245050		3
OXR1, CHEGDD	Cerebellar hypoplasia/atrophy, epilepsy, and global developmental delay	213000		3
P2RX2, P2X2, DFNA41	Deafness, autosomal dominant 41	608224		3
P2RY12, P2Y12, BDPLT8	Bleeding disorder, platelet-type, 8	609821		3
P3H1, LEPRE1, GROS1, OI8	Osteogenesis imperfecta, type VIII	610915		3
P3H2, LEPREL1, MCVD	Myopia, high, with cataract and vitreoretinal degeneration	614292		3
P4HA2, MYP25	Myopia 25, autosomal dominant	617238		3
P4HB, PROHB, CLCRP1	Cole-Carpenter syndrome 1	112240		3
P4HTM, PH4, HIDEA	Hypotonia, hypoventilation, impaired intellectual development, dysautonomia, epilepsy, and eye abnormalities	618493		3
PABPN1, PABP2, PAB2	Oculopharyngeal muscular dystrophy	164300		3
PACD	Corneal dystrophy, posterior amorphous	612868	contiguous gene deletion syndrome	4
PACS1, SHMS, MRD17	Schuurs-Hoeijmakers syndrome	615009		3
PACS2, KIAA0602, DEE66	Developmental and epileptic encephalopathy 66	618067		3
PADI3, UHS1	Uncombable hair syndrome	191480		3
PADI6, PREMBL2	Preimplantation embryonic lethality 2	617234		3
PAFAH1B1, LIS1	 Lissencephaly 1	607432		3
PAFAH1B1, LIS1	Subcortical laminar heterotopia	607432		3
PAH, PKU1	Hyperphenylalaninemia, non-PKU mild	261600	close to IGF1	3
PAH, PKU1	 Phenylketonuria	261600	close to IGF1	3
PAI1, PLANH1, SERPINE1	Plasminogen activator inhibitor-1 deficiency	613329		3
PAI1, PLANH1, SERPINE1	 Transcription of plasminogen activator inhibitor, modulator of	173360		3
PAK1, IDDMSSD	Intellectual developmental disorder with macrocephaly, seizures, and speech delay	618158		3
PAK3, MRX30, MRX47, XLID30	Intellectual developmental disorder, X-linked 30	300558		3
PALB2, FANCN, PNCA3	Breast cancer, susceptibility to	114480		3
PALB2, FANCN, PNCA3	 Fanconi anemia, complementation group N	610832		3
PALB2, FANCN, PNCA3	 Pancreatic cancer, susceptibility to, 3	613348		3
PALLD, KIAA0992, PNCA1	Pancreatic cancer, susceptibility to, 1	606856		3
PAM16, MAGMAS, SMDMDM	Spondylometaphyseal dysplasia, Megarbane-Dagher-Melike type	613320		3
PAND1	Panic disorder syndrome 1	167870		2
PAND2	Panic disorder 2	607853	max lod at D9S271	2
PAND3	Panic disorder 3	609985	max lod at D4S413	2
PANK2, NBIA1, PKAN, HARP	HARP syndrome	607236		3
PANK2, NBIA1, PKAN, HARP	 Neurodegeneration with brain iron accumulation 1	234200		3
PANX1, PX1, OOMD7	Oocyte maturation defect 7	618550		3
PAOD1	Peripheral arterial occlusive disease 1	606787		2
PAPA2	Postaxial polydactyly, type A2	602085		2
PAPA3	Polydactyly, postaxial, type A3	607324	between D19S1165 and D19S929	2
PAPA4	Polydactyly, postaxial, type A4	608562	highest lod with D7S1799	2
PAPA5	Polydactyly, postaxial, type A5	263450	between D13S1288 and D13S632	2
PAPPA2, PAPPE, SSDA	Short stature, Dauber-Argente type	619489		3
PAPSS2, ATPSK2, BCYM4	Brachyolmia 4 with mild epiphyseal and metaphyseal changes	612847		3
PARK10, AAOPD	Parkinson disease 10	606852	max lod at D1S2652; ?associated with CDCP2	2
PARK12	Parkinson disease 12	300557	max lod with DXS1106, DXS8055, DXS1001	2
PARK16	Parkinson disease 16	613164	associated with rs823128	2
PARK21	Parkinson disease 21	616361	conflicting mapping on 20pter-p12	2
PARK3	Parkinson disease 3	602404		2
PARN, DAN, DKCB6, PFBMFT4	Dyskeratosis congenita, autosomal recessive 6	616353		3
PARN, DAN, DKCB6, PFBMFT4	 Pulmonary fibrosis and/or bone marrow failure, telomere-related, 4	616371		3
PARS2, DEE75	Developmental and epileptic encephalopathy 75	618437		3
PATL2, PAT1A, OOMD4	Oocyte maturation defect 4	617743		3
PAURT1	Preauricular tag, isolated, autosomal dominant, 1	610420	between D14S990 and D14S264	2
PAX1, OFC2	Otofaciocervical syndrome 2	615560		3
PAX2, PAPRS, FSGS7	Glomerulosclerosis, focal segmental, 7	616002		3
PAX2, PAPRS, FSGS7	 Papillorenal syndrome	120330		3
PAX3, WS1, HUP2, CDHS, WS3	Craniofacial-deafness-hand syndrome	122880		3
PAX3, WS1, HUP2, CDHS, WS3	 Rhabdomyosarcoma 2, alveolar	268220		3
PAX3, WS1, HUP2, CDHS, WS3	 Waardenburg syndrome, type 1	193500		3
PAX3, WS1, HUP2, CDHS, WS3	 Waardenburg syndrome, type 3	148820		3
PAX4, MODY9, KPD	Diabetes mellitus, ketosis-prone, susceptibility to	612227		3
PAX4, MODY9, KPD	 Diabetes mellitus, type 2	125853		3
PAX4, MODY9, KPD	 Maturity-onset diabetes of the young, type IX	612225		3
PAX5, BSAP, ALL3	Leukemia, acute lymphoblastic, susceptibility to, 3	615545		3
PAX6, AN2, MGDA, FVH1, ASGD5	 Aniridia	106210	mutation identified in 1 patient each with MDGA, COLBN, or COLB	3
PAX6, AN2, MGDA, FVH1, ASGD5	 Anterior segment dysgenesis 5, multiple subtypes	604229	mutation identified in 1 patient each with MDGA, COLBN, or COLB	3
PAX6, AN2, MGDA, FVH1, ASGD5	 Cataract with late-onset corneal dystrophy	106210	mutation identified in 1 patient each with MDGA, COLBN, or COLB	3
PAX6, AN2, MGDA, FVH1, ASGD5	 Coloboma, ocular	120200	mutation identified in 1 patient each with MDGA, COLBN, or COLB	3
PAX6, AN2, MGDA, FVH1, ASGD5	 Coloboma of optic nerve	120430	mutation identified in 1 patient each with MDGA, COLBN, or COLB	3
PAX6, AN2, MGDA, FVH1, ASGD5	 Foveal hypoplasia 1	136520	mutation identified in 1 patient each with MDGA, COLBN, or COLB	3
PAX6, AN2, MGDA, FVH1, ASGD5	 Keratitis	148190	mutation identified in 1 patient each with MDGA, COLBN, or COLB	3
PAX6, AN2, MGDA, FVH1, ASGD5	 Morning glory disc anomaly	120430	mutation identified in 1 patient each with MDGA, COLBN, or COLB	3
PAX6, AN2, MGDA, FVH1, ASGD5	Optic nerve hypoplasia	165550	mutation identified in 1 patient each with MDGA, COLBN, or COLB	3
PAX7, RMS2, MYOSCO	 Myopathy, congenital, progressive, with scoliosis	618578	fused with FKHR in rhabdomyosarcoma	3
PAX7, RMS2, MYOSCO	Rhabdomyosarcoma 2, alveolar	268220	fused with FKHR in rhabdomyosarcoma	3
PAX8	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia	218700		3
PAX9, STHAG3	Tooth agenesis, selective, 3	604625		3
PBC1	Biliary cirrhosis, primary, 1	109720	associated with rs6441286 and rs574808	2
PBC2	Biliary cirrhosis, primary, 2	613007	associated with rs2856683	2
PBC3	Biliary cirrhosis, primary, 3	613008	associated with rs3790567	2
PBC4	Biliary cirrhosis, primary, 4	614220	associated with rs10488631	2
PBC5	Biliary cirrhosis, primary, 5	614221	associated with rs9303277	2
PBLT	Panbronchiolitis, diffuse	604809		2
PBX1, CAKUHED	Congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay	617641	pseudogene PBXP1 on chr.3	3
PCAP	Prostate cancer, susceptibility to	602759		2
PCARE, C2orf71, RP54	Retinitis pigmentosa 54	613428		3
PCBD1, DCOH	Hyperphenylalaninemia, BH4-deficient, D	264070		3
PCCA	Propionicacidemia	606054		3
PCCB	Propionicacidemia	606054	pccB complementation group	3
PCDH12, VECAD2, DMJDS1	Diencephalic-mesencephalic junction dysplasia syndrome 1	251280		3
PCDH15, DFNB23, USH1F	 Deafness, autosomal recessive 23	609533		3
PCDH15, DFNB23, USH1F	Usher syndrome, type 1D/F digenic	601067		3
PCDH15, DFNB23, USH1F	 Usher syndrome, type 1F	602083		3
PCDH19, KIAA1313, EFMR, DEE9	Developmental and epileptic encephalopathy 9	300088		3
PCDHGC4, NEDGS	Neurodevelopmental disorder with poor growth and skeletal anomalies	619880		3
PCGF2, RNF110, ZNF144, MEL18, TPFS	Turnpenny-Fry syndrome	618371		3
PCK2, PEPCK2	PEPCK deficiency, mitochondrial	261650		1
PCNT, PCNT2, KEN, SCKL4, MOPD2	Microcephalic osteodysplastic primordial dwarfism, type II	210720		3
PCOS1, PCO1, PCO	Polycystic ovary syndrome 1	184700	max lod at D19S884	2
PC	Pyruvate carboxylase deficiency	266150		3
PCSK1, NEC1, PC1, PC3, BMIQ12	 Endocrinopathy due to proprotein convertase 1/3 deficiency	600955		3
PCSK1, NEC1, PC1, PC3, BMIQ12	Obesity, susceptibility to, BMIQ12	612362		3
PCSK9, NARC1, HCHOLA3, FH3, LDLCQ1, FHCL3	 Hypercholesterolemia, familial, 3	603776		3
PCSK9, NARC1, HCHOLA3, FH3, LDLCQ1, FHCL3	Low density lipoprotein cholesterol level QTL 1	603776		3
PCYT1A, CTPCT, PCYT1, SMDCRD	Spondylometaphyseal dysplasia with cone-rod dystrophy	608940		3
PCYT2, ET, SPG82	Spastic paraplegia 82, autosomal recessive	618770		3
PDA1	Patent ductus arteriosus, susceptibility to	607411		2
PDB4	Paget disease of bone 4	606263		2
PDCD10, TFAR15, CCM3	Cerebral cavernous malformations-3	603285		3
PDCD1, SLEB2	Multiple sclerosis, disease progression, modifier of	126200		3
PDCD1, SLEB2	 Systemic lupus erythematosus, susceptibility to, 2	605218		3
PDCN, NPHS2, SRN1	Nephrotic syndrome, type 2	600995	modifies phenotype of NPHS1 mutations to FSGS	3
PDCOS	Podoconiosis, susceptibility to	614590		2
PDE10A, IOLOD, ADSD2	 Dyskinesia, limb and orofacial, infantile-onset	616921		3
PDE10A, IOLOD, ADSD2	Striatal degeneration, autosomal dominant	616922		3
PDE11A, PDE11A1, PDE11A2, PDE11A3, PPNAD2	Pigmented nodular adrenocortical disease, primary, 2	610475		3
PDE2A, IDDPADS	Intellectual developmental disorder with paroxysmal dyskinesia or seizures	619150		3
PDE3A, HTNB	Hypertension and brachydactyly syndrome	112410		3
PDE4D, DPDE3, ACRDYS2	Acrodysostosis 2, with or without hormone resistance	614613		3
PDE6A, PDEA, RP43	Retinitis pigmentosa 43	613810		3
PDE6B, PDEB, RP40, CSNBAD2	 Night blindness, congenital stationary, autosomal dominant 2	163500		3
PDE6B, PDEB, RP40, CSNBAD2	Retinitis pigmentosa-40	613801		3
PDE6C, PDEA2, COD4	Cone dystrophy 4	613093		3
PDE6D, JBTS22	Joubert syndrome 22	615665		3
PDE6G, PDEG, RP57	Retinitis pigmentosa 57	613582		3
PDE6H, RCD3, ACHM6	 Achromatopsia 6	610024		3
PDE6H, RCD3, ACHM6	Retinal cone dystrophy 3	610024		3
PDE8B, PPNAD3, ADSD	Pigmented nodular adrenocortical disease, primary, 3	614190		3
PDE8B, PPNAD3, ADSD	 Striatal degeneration, autosomal dominant	609161		3
PDGFB, SIS, IBGC5	 Basal ganglia calcification, idiopathic, 5	615483	fused with COL1A1 in DFSP	3
PDGFB, SIS, IBGC5	 Dermatofibrosarcoma protuberans	607907	fused with COL1A1 in DFSP	3
PDGFB, SIS, IBGC5	Meningioma, SIS-related	607174	fused with COL1A1 in DFSP	3
PDGFRA	Gastrointestinal stromal tumor/GIST-plus syndrome, somatic or familial	175510	same 700bp segment as KIT; fused to BCR or FIP1L1	3
PDGFRA	 Hypereosinophilic syndrome, idiopathic, resistant to imatinib	607685	same 700bp segment as KIT; fused to BCR or FIP1L1	3
PDGFRB, PDGFR, IBGC4, IMF1, PENTT, KOGS	 Basal ganglia calcification, idiopathic, 4	615007	fusion gene with ETV6, HIP1, RABPT5, or H4 in chronic myeloproliferative disorders	3
PDGFRB, PDGFR, IBGC4, IMF1, PENTT, KOGS	 Kosaki overgrowth syndrome	616592	fusion gene with ETV6, HIP1, RABPT5, or H4 in chronic myeloproliferative disorders	3
PDGFRB, PDGFR, IBGC4, IMF1, PENTT, KOGS	 Myeloproliferative disorder with eosinophilia	131440	fusion gene with ETV6, HIP1, RABPT5, or H4 in chronic myeloproliferative disorders	4
PDGFRB, PDGFR, IBGC4, IMF1, PENTT, KOGS	 Myofibromatosis, infantile, 1	228550	fusion gene with ETV6, HIP1, RABPT5, or H4 in chronic myeloproliferative disorders	3
PDGFRB, PDGFR, IBGC4, IMF1, PENTT, KOGS	Premature aging syndrome, Penttinen type	601812	fusion gene with ETV6, HIP1, RABPT5, or H4 in chronic myeloproliferative disorders	3
PDGFRL, PDGRL, PRLTS	 Colorectal cancer, somatic	114500		3
PDGFRL, PDGRL, PRLTS	Hepatocellular cancer, somatic	114550		3
PDHA1, PHE1A, PDHAD	Pyruvate dehydrogenase E1-alpha deficiency	312170		3
PDHA2, SPGF70	Spermatogenic failure 70	619828		3
PDHB, PDHBD	Pyruvate dehydrogenase E1-beta deficiency	614111		3
PDHX, PDX1, E3BP, PDHXD	Lacticacidemia due to PDX1 deficiency	245349		3
PDON2	Periodontitis, aggressive, 2	608526	between D1S196 and D1S533	2
PDP1, PPM2C, PDPC	Pyruvate dehydrogenase phosphatase deficiency	608782		3
PDSS1, TPT, COQ1, COQ10D2	Coenzyme Q10 deficiency, primary, 2	614651		3
PDSS2, DLP1, C6orf210, COQ10D3	Coenzyme Q10 deficiency, primary, 3	614652		3
PDX1, IPF1, MODY4, PAGEN1	Diabetes mellitus, type II, susceptibility to	125853		3
PDX1, IPF1, MODY4, PAGEN1	 MODY, type IV	606392		3
PDX1, IPF1, MODY4, PAGEN1	 Pancreatic agenesis 1	260370		3
PDXK, PNK, PKH, HMSN6C	Neuropathy, hereditary motor and sensory, type VIC, with optic atrophy	618511		3
PDYN, SCA23	Spinocerebellar ataxia 23	610245		3
PDZD7, DFNB57	Deafness, autosomal recessive 57	618003		3
PDZD7, DFNB57	 Retinal disease in Usher syndrome type IIA, modifier of	276901		3
PDZD7, DFNB57	 Usher syndrome, type IIC, GPR98/PDZD7 digenic	605472		3
PDZD8, IDDADF	Intellectual developmental disorder with autism and dysmorphic facies	620021		3
PEE1, PREG1	Preeclampsia/eclampsia 1	189800	?distinct loci at 2p25 and 9p13	2
PEE2	Preeclampsia/eclampsia 2	609402		2
PEE3	Preeclampsia/eclampsia 3	609403		2
PEPD	Prolidase deficiency	170100	closely linked to APOC2	3
PERCC1, ICR, DIAR11	Diarrhea 11, malabsorptive, congenital	618662	Intestine Critical Region (ICR) upstream of PERCC1 deleted in DIAR11	3
PERP, OLMS2, EKVP7	Erythrokeratodermia variabilis et progressiva 7	619209		3
PERP, OLMS2, EKVP7	 Olmsted syndrome 2	619208		3
PET100, C19orf79, MC4DN12	Mitochondrial complex IV deficiency, nuclear type 12	619055		3
PEX10, NALD, PBD6A, PBD6B	Peroxisome biogenesis disorder 6A 	614870		3
PEX10, NALD, PBD6A, PBD6B	 Peroxisome biogenesis disorder 6B	614871		3
PEX11B, PEX14B	Peroxisome biogenesis disorder 14B	614920		3
PEX12, PBD3A	 Peroxisome biogenesis disorder 3A 	614859		3
PEX12, PBD3A	Peroxisome biogenesis disorder 3B	266510		3
PEX13, ZWS, NALD, PBD11A, PBD11B	Peroxisome biogenesis disorder 11A 	614883		3
PEX13, ZWS, NALD, PBD11A, PBD11B	 Peroxisome biogenesis disorder 11B	614885		3
PEX14, PBD13A	Peroxisome biogenesis disorder 13A 	614887		3
PEX16, PBD8A, PBD8B	 Peroxisome biogenesis disorder 8A 	614876		3
PEX16, PBD8A, PBD8B	Peroxisome biogenesis disorder 8B	614877		3
PEX19, PXF, HK33, D1S2223E, PBD12A	Peroxisome biogenesis disorder 12A 	614886		3
PEX1, ZWS1, PBD1A, PBD1B, HMLR1	Heimler syndrome 1	234580		3
PEX1, ZWS1, PBD1A, PBD1B, HMLR1	 Peroxisome biogenesis disorder 1A 	214100		3
PEX1, ZWS1, PBD1A, PBD1B, HMLR1	 Peroxisome biogenesis disorder 1B 	601539		3
PEX26, PBD7A, PBD7B	 Peroxisome biogenesis disorder 7A 	614872		3
PEX26, PBD7A, PBD7B	Peroxisome biogenesis disorder 7B	614873		3
PEX2, PAF1, PMP35, PBD5A, PBD5B, PXMP3	Peroxisome biogenesis disorder 5A 	614866		3
PEX2, PAF1, PMP35, PBD5A, PBD5B, PXMP3	 Peroxisome biogenesis disorder 5B	614867		3
PEX3, PBD10A, PBD10B	Peroxisome biogenesis disorder 10A 	614882	mutation identified in 1 PBD10B patient	3
PEX3, PBD10A, PBD10B	 Peroxisome biogenesis disorder 10B	617370	mutation identified in 1 PBD10B patient	3
PEX5, PXR1, PTS1R, PBD2A, PBD2B, RCDP5	 Peroxisome biogenesis disorder 2A 	214110		3
PEX5, PXR1, PTS1R, PBD2A, PBD2B, RCDP5	Peroxisome biogenesis disorder 2B	202370		3
PEX5, PXR1, PTS1R, PBD2A, PBD2B, RCDP5	 Rhizomelic chondrodysplasia punctata, type 5	616716		3
PEX6, PXAAA1, PAF2, PBD4A, PDB4B, HMLR2	 Heimler syndrome 2	616617		3
PEX6, PXAAA1, PAF2, PBD4A, PDB4B, HMLR2	 Peroxisome biogenesis disorder 4A 	614862		3
PEX6, PXAAA1, PAF2, PBD4A, PDB4B, HMLR2	Peroxisome biogenesis disorder 4B	614863		3
PEX7, RCDP1, PBD9B	 Peroxisome biogenesis disorder 9B	614879		3
PEX7, RCDP1, PBD9B	Rhizomelic chondrodysplasia punctata, type 1	215100		3
PFBI	Malaria, intensity of infection	248310		2
PFC, PFD	Properdin deficiency, X-linked	312060		3
PFFE1	Plasmodium falciparum fever episodes QTL1	611384		2
PFHB2	Progressive familial heart block, type II	140400	between D1S70 and D1S505	2
PFKL	Hemolytic anemia due to phosphofructokinase deficiency	171860		1
PFKM, GSD7	Glycogen storage disease VII	232800	incorrectly assigned to chr.1	3
PFM3	Parietal foramina 3	609566	maximum lod between D4S2986 and D4S421	2
PFN1, ALS18	Amyotrophic lateral sclerosis 18	614808		3
PGAM2, PGAMM, GSD10	Glycogen storage disease X	261670		3
PGAP1, NEDDSBA	Neurodevelopmental disorder with dysmorphic features, spasticity, and brain abnormalities	615802		3
PGAP2, FRAG1, HPMRS3, MRT17, MRT21	Hyperphosphatasia with impaired intellectual development syndrome 3	614207		3
PGAP3, PERLD1, CAB2, MGC9753, HPMRS4	Hyperphosphatasia with impaired intellectual development syndrome 4	615716		3
PGK1, PGKA	Phosphoglycerate kinase 1 deficiency	300653	?Xq13.3; pseudogenes PGK1P1 on Xq, PGK1P2 on chr. 6	3
PGM1, GSD14, CDG1T	Congenital disorder of glycosylation, type It	614921	distal to ACADM; formerly 1p22.1	3
PGM3, AGM1, IMD23	Immunodeficiency 23	615816		3
PGN, SPG7, CMAR, CAR	Spastic paraplegia 7, autosomal recessive	607259		3
PHA2A, PHA2	Pseudohypoaldosteronism, type IIA	145260		2
PHACTR1, KIAA1733, DEE70	Developmental and epileptic encephalopathy 70	618298		3
PHB1	Breast cancer, susceptibility to	114480		3
PHEX, HYP, HPDR1, LXHR	Hypophosphatemic rickets, X-linked dominant	307800		3
PHF21A, BHC80, KIAA1696, IDDBCS	Intellectual developmental disorder with behavioral abnormalities and craniofacial dysmorphism with or without seizures	618725		3
PHF6, BFLS	Borjeson-Forssman-Lehmann syndrome	301900		3
PHF8, ZNF422, KIAA1111, MRXSSD	Intellectual developmental disorder, X-linked syndromic, Siderius type	300263		3
PHF9, FANCL	Fanconi anemia, complementation group L	614083		3
PHGDH, NLS1, PHGDHD	Neu-Laxova syndrome 1	256520		3
PHGDH, NLS1, PHGDHD	 Phosphoglycerate dehydrogenase deficiency	601815		3
PHIP, CHUJANS, DIDOD	Chung-Jansen syndrome	617991		3
PHKA1	Muscle glycogenosis	300559	?proximal and close to PGKA;	3
PHKA2, PHK, XLG, PYKL, GSD9A	 Glycogen storage disease, type IXa1	306000		3
PHKA2, PHK, XLG, PYKL, GSD9A	Glycogen storage disease, type IXa2	306000		3
PHKB	Phosphorylase kinase deficiency of liver and muscle, autosomal recessive	261750		3
PHKG2, GSD9C	Glycogen storage disease IXc	613027		3
PHOBS	Phobia, specific	608251		2
PHOX2A, ARIX, CFEOM2	Fibrosis of extraocular muscles, congenital, 2	602078		3
PHOX2B, NBPHOX, PMX2B, NBLST2, CCHS	 Central hypoventilation syndrome, congenital, 1, with or without Hirschsprung disease	209880		3
PHOX2B, NBPHOX, PMX2B, NBLST2, CCHS	Neuroblastoma, susceptibility to, 2	613013		3
PHOX2B, NBPHOX, PMX2B, NBLST2, CCHS	 Neuroblastoma with Hirschsprung disease	613013		3
PHYH, PAHX	Refsum disease	266500		3
PHYKPL, AGXT2L2, PHLU	Phosphohydroxylysinuria	615011	mutation identified in 1 PHLU patient	3
PI4KA, PIK4CA, PMGYCHA, SPG84, GIDID2	 Gastrointestinal defects and immunodeficiency syndrome 2	619708		3
PI4KA, PIK4CA, PMGYCHA, SPG84, GIDID2	 Polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis	616531		3
PI4KA, PIK4CA, PMGYCHA, SPG84, GIDID2	Spastic paraplegia 84, autosomal recessive	619621		3
PIBF1, JBTS33	Joubert syndrome 33	617767		3
PICALM, CALM, CLTH, LAP	Leukemia, acute myeloid, somatic	601626	fuses with AF10 in t(10;11)	3
PIDD1, LRDD, MRT75	Intellectual developmental disorder, autosomal recessive 75, with neuropsychiatric features and variant lissencephaly	619827		3
PIEZO1, FAM38A, MIB, DHS, LMPHM6	 Dehydrated hereditary stomatocytosis with or without pseudohyperkalemia and/or perinatal edema	194380		3
PIEZO1, FAM38A, MIB, DHS, LMPHM6	Lymphatic malformation 6	616843		3
PIEZO2, FAM38B, DA5, DA3, MWKS, DAIPT	 Arthrogryposis, distal, type 3	114300	mutation identified in 1 MWKS patient	3
PIEZO2, FAM38B, DA5, DA3, MWKS, DAIPT	Arthrogryposis, distal, type 5	108145	mutation identified in 1 MWKS patient	3
PIEZO2, FAM38B, DA5, DA3, MWKS, DAIPT	 Arthrogryposis, distal, with impaired proprioception and touch	617146	mutation identified in 1 MWKS patient	3
PIEZO2, FAM38B, DA5, DA3, MWKS, DAIPT	 Marden-Walker syndrome	248700	mutation identified in 1 MWKS patient	3
PIGA, PNH1, MCAHS2, NEDEPH	 Multiple congenital anomalies-hypotonia-seizures syndrome 2	300868	pseudogene on chr.12	3
PIGA, PNH1, MCAHS2, NEDEPH	 Neurodevelopmental disorder with epilepsy and hemochromatosis	301072	pseudogene on chr.12	3
PIGA, PNH1, MCAHS2, NEDEPH	Paroxysmal nocturnal hemoglobinuria, somatic	300818	pseudogene on chr.12	3
PIGB, DEE80	Developmental and epileptic encephalopathy 80	618580		3
PIGC, GPI2, GPIBD16, MRT62	Glycosylphosphatidylinositol biosynthesis defect 16	617816		3
PIGF, OORS	Onychodystrophy, osteodystrophy, impaired intellectual development, and seizures syndrome	619356	pseudogene on 5	3
PIGG, GPI7, NEDHSCA, EMM	Blood group, EMM system	619812		3
PIGG, GPI7, NEDHSCA, EMM	 Neurodevelopmental disorder with or without hypotonia, seizures, and cerebellar atrophy	616917		3
PIGH	Glycosylphosphatidylinositol biosynthesis defect 17	618010		3
PIGK, GPI8, NEDHCAS	Neurodevelopmental disorder with hypotonia and cerebellar atrophy, with or without seizures	618879		3
PIGL, CHIME	CHIME syndrome	280000		3
PIGM	Glycosylphosphatidylinositol deficiency	610293		3
PIGN, MCAHS1	Multiple congenital anomalies-hypotonia-seizures syndrome 1	614080		3
PIGO, HPMRS2	Hyperphosphatasia with impaired intellectual development syndrome 2	614749		3
PIGP, DSCR5, DEE55	Developmental and epileptic encephalopathy 55	617599		3
PIGQ, MCAHS4, DEE77, GPIBD19	Multiple congenital anomalies-hypotonia-seizures syndrome 4	618548		3
PIGS, GPIBD18, DEE95	Developmental and epileptic encephalopathy 95	618143		3
PIGT, NDAP, PNH2, MCAHS3	 Multiple congenital anomalies-hypotonia-seizures syndrome 3	615398	mutation identified in 1 PNH2 family	3
PIGU, CDC91L1, GPIBD21, NEDBSS	Neurodevelopmental disorder with brain anomalies, seizures, and scoliosis	618590		3
PIGV, HPMRS1	Hyperphosphatasia with impaired intellectual development syndrome 1	239300		3
PIGW, HPMRS5	Glycosylphosphatidylinositol biosynthesis defect 11	616025		3
PIGY, HPMRS6	Hyperphosphatasia with impaired intellectual development syndrome 6	616809		3
PIH1D3, CILD36	Ciliary dyskinesia, primary, 36, X-linked	300991		3
PIK3C2A, CPK, OCSKD	Oculoskeletodental syndrome	618440		3
PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5, CLAPO, CCM4	 Breast cancer, somatic	114480		3
PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5, CLAPO, CCM4	 Cerebral cavernous malformations 4, somatic	619538		3
PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5, CLAPO, CCM4	 CLAPO syndrome, somatic	613089		3
PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5, CLAPO, CCM4	CLOVE syndrome, somatic	612918		3
PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5, CLAPO, CCM4	 Colorectal cancer, somatic	114500		3
PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5, CLAPO, CCM4	 Cowden syndrome 5	615108		3
PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5, CLAPO, CCM4	 Gastric cancer, somatic	613659		3
PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5, CLAPO, CCM4	 Hepatocellular carcinoma, somatic	114550		3
PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5, CLAPO, CCM4	 Keratosis, seborrheic, somatic	182000		3
PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5, CLAPO, CCM4	 Macrodactyly, somatic	155500		3
PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5, CLAPO, CCM4	 Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic	602501		3
PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5, CLAPO, CCM4	 Nevus, epidermal, somatic	162900		3
PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5, CLAPO, CCM4	 Nonsmall cell lung cancer, somatic	211980		3
PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5, CLAPO, CCM4	 Ovarian cancer, somatic	167000		3
PIK3CD, APDS, IMD14A, IMD14B, ROCHIS	Immunodeficiency 14A, autosomal dominant	615513	mutation identified in 1 ROCHIS family	3
PIK3CD, APDS, IMD14A, IMD14B, ROCHIS	 Immunodeficiency 14B, autosomal recessive	619281	mutation identified in 1 ROCHIS family	3
PIK3CD, APDS, IMD14A, IMD14B, ROCHIS	 Roifman-Chitayat syndrome, digenic	613328	mutation identified in 1 ROCHIS family	3
PIK3CG, IMD97	Immunodeficiency 97 with autoinflammation	619802		3
PIK3R1, GRB1, AGM7, SHORT, IMD36	 Agammaglobulinemia 7, autosomal recessive	615214	mutation identified in 1 AGM7 family	3
PIK3R1, GRB1, AGM7, SHORT, IMD36	Immunodeficiency 36	616005	mutation identified in 1 AGM7 family	3
PIK3R1, GRB1, AGM7, SHORT, IMD36	 SHORT syndrome	269880	mutation identified in 1 AGM7 family	3
PIK3R2, MPPH1	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1	603387		3
PIK3R5, p101	Ataxia-oculomotor apraxia 3	615217		3
PIKFYVE, PIP5K3	Corneal fleck dystrophy	121850		3
PINK1, PARK6	Parkinson disease 6, early onset	605909		3
PIP5K1C, LCCS3	Lethal congenital contractural syndrome 3	611369		3
PISD, PSD, PSSC, LIBF	Liberfarb syndrome	618889		3
PITPNM3, NIR1, CORD5	Cone-rod dystrophy 5	600977		3
PITRM1, MP1, PREP, SCAR30	Spinocerebellar ataxia, autosomal recessive 30	619405		3
PITX1, PTX1, BFT, POTX, CCF, LBNBG	 Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly	119800		3
PITX1, PTX1, BFT, POTX, CCF, LBNBG	Liebenberg syndrome	186550		4
PITX2, IDG2, RIEG1, RGS, IGDS2, ASGD4	 Anterior segment dysgenesis 4	137600		3
PITX2, IDG2, RIEG1, RGS, IGDS2, ASGD4	 Axenfeld-Rieger syndrome, type 1	180500		3
PITX2, IDG2, RIEG1, RGS, IGDS2, ASGD4	Ring dermoid of cornea	180550		3
PITX3, CTPP4, CTRCT11, ASGD1	 Anterior segment dysgenesis 1, multiple subtypes	107250		3
PITX3, CTPP4, CTRCT11, ASGD1	Cataract 11, multiple types	610623		3
PITX3, CTPP4, CTRCT11, ASGD1	 Cataract 11, syndromic, autosomal recessive	610623		3
PJVK, DFNB59	Deafness, autosomal recessive 59	610220		3
PKD1L1, HTX8	Heterotaxy, visceral, 8, autosomal	617205		3
PKD1	Polycystic kidney disease 1	173900		3
PKD2	Polycystic kidney disease 2	613095		3
PKDCC, VLK, SGK493, RLSDF	Rhizomelic limb shortening with dysmorphic features	618821		3
PKDTS	Polycystic kidney disease, infantile severe, with tuberous sclerosis	600273	contiguous gene syndrome caused by deletion of TSC2 and PKD1	4
PKLR, PK1	Adenosine triphosphate, elevated, of erythrocytes	102900		3
PKLR, PK1	 Pyruvate kinase deficiency	266200		3
PKP1, EDSFS	Ectodermal dysplasia/skin fragility syndrome	604536		3
PKP2, ARVD9	Arrhythmogenic right ventricular dysplasia 9	609040	pseudogene on 12p13	3
PKS	Pallister-Killian syndrome	601803		4
PLA2G2A, PLA2B, PLA2L, MOM1	Colorectal cancer, susceptibility to	114500	germline mutation identified in 1 CRC patient	3
PLA2G4A, PLA2G4, GURDP	Gastrointestinal ulceration, recurrent, with dysfunctional platelets	618372		3
PLA2G5, FRFB	Fleck retina, familial benign	228980		3
PLA2G6, IPLA2, INAD1, NBIA2B, NBIA2A, PARK14	 Infantile neuroaxonal dystrophy 1	256600		3
PLA2G6, IPLA2, INAD1, NBIA2B, NBIA2A, PARK14	 Neurodegeneration with brain iron accumulation 2B	610217		3
PLA2G6, IPLA2, INAD1, NBIA2B, NBIA2A, PARK14	Parkinson disease 14, autosomal recessive	612953		3
PLA2G7, PAFAH, PAFAD	 Asthma, susceptibility to	600807		3
PLA2G7, PAFAH, PAFAD	 Atopy, susceptibility to	147050		3
PLA2G7, PAFAH, PAFAD	Platelet-activating factor acetylhydrolase deficiency	614278		3
PLAA, PLAP, NDMSBA	Neurodevelopmental disorder with progressive microcephaly, spasticity, and brain anomalies	617527		3
PLAG1, SGPA, PSA, SRS4	Adenomas, salivary gland pleomorphic, somatic	181030	fused with CTNNB1 in SGPA	3
PLAG1, SGPA, PSA, SRS4	 Silver-Russell syndrome 4	618907	fused with CTNNB1 in SGPA	3
PLAU, URK, QPD, BDPLT5	 Alzheimer disease, late-onset, susceptibility to	104300	proximal to HOX11	3
PLAU, URK, QPD, BDPLT5	Quebec platelet disorder	601709	proximal to HOX11	3
PLCB1, KIAA0581, PLCB1A, PLCB1B, DEE12	Developmental and epileptic encephalopathy 12	613722		3
PLCB2	Platelet PLC beta-2 deficiency	604114		1
PLCB3, SMDCD	Spondylometaphyseal dysplasia with corneal dystrophy	618961	within 900kb of MEN1	3
PLCB4, ARCND2	Auriculocondylar syndrome 2	614669		3
PLCD1, NDNC3	Nail disorder, nonsyndromic congenital, 3, 	151600		3
PLCE1, KIAA1516, NPHS3	Nephrotic syndrome, type 3	610725		3
PLCG2, FCAS3, APLAID	Autoinflammation, antibody deficiency, and immune dysregulation syndrome	614878		3
PLCG2, FCAS3, APLAID	 Familial cold autoinflammatory syndrome 3	614468		3
PLCH1, PLCL3, KIAA1069, HPE14	Holoprosencephaly 14	619895		3
PLCZ1, SPGF17	Spermatogenic failure 17	617214		3
PLD1, CVDP1	Cardiac valvular dysplasia 1	212093		3
PLEC1, PLEC, PLTN, LGMDR17, EBS5A, EBS5B, EBS5C, EBS5D	 Epidermolysis bullosa simplex 5A, Ogna type	131950	mutation identified in 1 EBS5D family	3
PLEC1, PLEC, PLTN, LGMDR17, EBS5A, EBS5B, EBS5C, EBS5D	 Epidermolysis bullosa simplex 5B, with muscular dystrophy	226670	mutation identified in 1 EBS5D family	3
PLEC1, PLEC, PLTN, LGMDR17, EBS5A, EBS5B, EBS5C, EBS5D	 Epidermolysis bullosa simplex 5C, with pyloric atresia	612138	mutation identified in 1 EBS5D family	3
PLEC1, PLEC, PLTN, LGMDR17, EBS5A, EBS5B, EBS5C, EBS5D	 Muscular dystrophy, limb-girdle, autosomal recessive 17	613723	mutation identified in 1 EBS5D family	3
PLEKHG2, CLG, LDAMD	Leukodystrophy and acquired microcephaly with or without dystonia	616763		3
PLEKHG5, KIAA0720, DSMA4, CMTRIC	 Charcot-Marie-Tooth disease, recessive intermediate C	615376		3
PLEKHG5, KIAA0720, DSMA4, CMTRIC	Spinal muscular atrophy, distal, autosomal recessive, 4	611067		3
PLEKHM1, AP162, KIAA0356, OPTB6, OPTA3	 Osteopetrosis, autosomal dominant 3	618107	mutation identified in 1 OPTB6 family	3
PLF	Pulmonary function	608852	close to D6S281	2
PLG, HAE4	 Angioedema, hereditary, 4	619360	20cM from TCP10A	3
PLG, HAE4	Dysplasminogenemia	217090	20cM from TCP10A	3
PLG, HAE4	 Plasminogen deficiency, type I	217090	20cM from TCP10A	3
PLIN1, PLIN, FPLD4	Lipodystrophy, familial partial, type 4	613877		3
PLI, SERPINF2	Alpha-2-plasmin inhibitor deficiency	262850		3
PLK4, STK18, SAK, MCCRP2	Microcephaly and chorioretinopathy, autosomal recessive, 2	616171		3
PLN, PLB, CMD1P, CMH18	Cardiomyopathy, dilated, 1P	609909		3
PLN, PLB, CMD1P, CMH18	 Cardiomyopathy, hypertrophic, 18	613874		3
PLOD1, LH1, LLH, EDSKCL1	Ehlers-Danlos syndrome, kyphoscoliotic type, 1	225400		3
PLOD2, LH2, TLH, BRKS2	Bruck syndrome 2	609220		3
PLOD3, LH3	Lysyl hydroxylase 3 deficiency	612394	previously assigned to 7q36	3
PLP1, PMD, HLD1, SPG2	Pelizaeus-Merzbacher disease	312080		3
PLP1, PMD, HLD1, SPG2	 Spastic paraplegia 2, X-linked	312920		3
PLPBP, PROSC, EPVB6D	Epilepsy, early-onset, vitamin B6-dependent	617290		3
PLS1, DFNA76	Deafness, autosomal dominant 76	618787		3
PLS3, BMND18	Bone mineral density QTL18, osteoporosis	300910		3
PLSA1, PLSA	Primary lateral sclerosis, adult, 1	611637	max lod at D4S2936	2
PLTP, HDLCQ9	High density lipoprotein cholesterol level QTL 9	172425		3
PLVAP, PV1, DIAR10	Diarrhea 10, protein-losing enteropathy type	618183		3
PLXNA1, NOVP, NOV, PLXN1, DWOPNED	Dworschak-Punetha neurodevelopmental syndrome	619955		3
PMFBP1, STAP, SPGF31	Spermatogenic failure 31	618112		3
PML, MYL	Leukemia, acute promyelocytic, PML/RARA type	102578	fused with RARA in APL	3
PMM2, CDG1A	Congenital disorder of glycosylation, type Ia	212065		3
PMP22, CMT1A, CMT1E, DSS, CIDP	Charcot-Marie-Tooth disease, type 1A	118220	mutation identified in 1 CIDP family	3
PMP22, CMT1A, CMT1E, DSS, CIDP	 Charcot-Marie-Tooth disease, type 1E	118300	mutation identified in 1 CIDP family	3
PMP22, CMT1A, CMT1E, DSS, CIDP	 Dejerine-Sottas disease	145900	mutation identified in 1 CIDP family	3
PMP22, CMT1A, CMT1E, DSS, CIDP	 Neuropathy, inflammatory demyelinating	139393	mutation identified in 1 CIDP family	3
PMP22, CMT1A, CMT1E, DSS, CIDP	 Neuropathy, recurrent, with pressure palsies	162500	mutation identified in 1 CIDP family	3
PMP22, CMT1A, CMT1E, DSS, CIDP	 Roussy-Levy syndrome	180800	mutation identified in 1 CIDP family	3
PMP2, CMT1G	Charcot-Marie-Tooth disease, demyelinating, type 1G	618279		3
PMPCA, KIAA0123, SCAR2	Spinocerebellar ataxia, autosomal recessive 2	213200		3
PMPCB, MPPB	Multiple mitochondrial dysfunctions syndrome 6	617954		3
PMS2, PMSL2, HNPCC4, LYNCH4	Lynch syndrome 4	614337		3
PMS2, PMSL2, HNPCC4, LYNCH4	 Mismatch repair cancer syndrome 4	619101		3
PMVK, PMK, POROK1	Porokeratosis 1, multiple types	175800		3
PNKD2	Paroxysmal nonkinesigenic dyskinesia 2	611147	between D2S2188 and D2S364	2
PNKD, R1, TAHCCP2, KIPP1184, BRP17, FPD1, PDC, DYT8	Paroxysmal nonkinesigenic dyskinesia 1	118800		3
PNKP, PNK, MCSZ, AOA4, CMT2B2	 Ataxia-oculomotor apraxia 4	616267	mutation identified in 1 CMT2B2 family	3
PNKP, PNK, MCSZ, AOA4, CMT2B2	 Microcephaly, seizures, and developmental delay	613402	mutation identified in 1 CMT2B2 family	3
PNLDC1, TRIMMER, SPGF57	Spermatogenic failure 57	619528		3
PNPLA1, ARCI10	Ichthyosis, congenital, autosomal recessive 10	615024		3
PNPLA2, TTS2, ATGL	Neutral lipid storage disease with myopathy	610717		3
PNPLA6, NTE, SPG39, NTEMND, BNHS, LNMS, OMCS	 Boucher-Neuhauser syndrome	215470	mutation identified in 1 LMNS family	3
PNPLA6, NTE, SPG39, NTEMND, BNHS, LNMS, OMCS	 Laurence-Moon syndrome	245800	mutation identified in 1 LMNS family	3
PNPLA6, NTE, SPG39, NTEMND, BNHS, LNMS, OMCS	 Oliver-McFarlane syndrome	275400	mutation identified in 1 LMNS family	3
PNPLA6, NTE, SPG39, NTEMND, BNHS, LNMS, OMCS	Spastic paraplegia 39, autosomal recessive	612020	mutation identified in 1 LMNS family	3
PNP, NP	Immunodeficiency due to purine nucleoside phosphorylase deficiency	613179	centromeric to TCRA	3
PNPO	Pyridoxamine 5'-phosphate oxidase deficiency	610090		3
PNPT1, OLD35, COXPD13, DFNB70, SCA25	 Combined oxidative phosphorylation deficiency 13	614932		3
PNPT1, OLD35, COXPD13, DFNB70, SCA25	 Deafness, autosomal recessive 70, with or without adult-onset neurodegeneration	614934		3
PNPT1, OLD35, COXPD13, DFNB70, SCA25	Spinocerebellar ataxia 25	608703		3
POC1A, PIX2, SOFT	Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis	614813		3
POC1B, PIX1, CORD20	Cone-rod dystrophy 20	615973		3
POFUT1, OFUCT1, KIAA0180, DDD2	Dowling-Degos disease 2	615327		3
POGLUT1, CLP46, KTELC1, RUMI, C3orf9, DDD4, LGMDR21	Dowling-Degos disease 4	615696		3
POGLUT1, CLP46, KTELC1, RUMI, C3orf9, DDD4, LGMDR21	 Muscular dystrophy, limb-girdle, autosomal recessive 21	617232		3
POGZ, KIAA0461, MRD37, WHSUS	White-Sutton syndrome	616364		3
POLA1, VEODS	Pigmentary disorder, reticulate, with systemic manifestations, X-linked	301220		3
POLA1, VEODS	 Van Esch-O'Driscoll syndrome	301030		3
POLD1, CRCS10, MDPL	 Colorectal cancer, susceptibility to, 10	612591		3
POLD1, CRCS10, MDPL	Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome	615381		3
POLE, CRCS12, FILS, IMAGEI	Colorectal cancer, susceptibility to, 12	615083		3
POLE, CRCS12, FILS, IMAGEI	 FILS syndrome	615139		3
POLE, CRCS12, FILS, IMAGEI	 IMAGE-I syndrome	618336		3
POLG2, POLGB, PEOA4, MTDPS16A, MTDPS16B	 Mitochondrial DNA depletion syndrome 16 	618528	mutation identified in 1 MTDPS16A patient and 1 MTDPS16B patient	3
POLG2, POLGB, PEOA4, MTDPS16A, MTDPS16B	 Mitochondrial DNA depletion syndrome 16B 	619425	mutation identified in 1 MTDPS16A patient and 1 MTDPS16B patient	3
POLG2, POLGB, PEOA4, MTDPS16A, MTDPS16B	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4	610131	mutation identified in 1 MTDPS16A patient and 1 MTDPS16B patient	3
POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS	 Mitochondrial DNA depletion syndrome 4A 	203700	PEO also digenic with C10orf2	3
POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS	 Mitochondrial DNA depletion syndrome 4B 	613662	PEO also digenic with C10orf2	3
POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS	Mitochondrial recessive ataxia syndrome 	607459	PEO also digenic with C10orf2	3
POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS	 Progressive external ophthalmoplegia, autosomal dominant 1	157640	PEO also digenic with C10orf2	3
POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS	 Progressive external ophthalmoplegia, autosomal recessive 1	258450	PEO also digenic with C10orf2	3
POLH, XPV	Xeroderma pigmentosum, variant type	278750		3
POLR1A, RPA194, AFDCIN	Acrofacial dysostosis, Cincinnati type	616462		3
POLR1B, TCS4	Treacher-Collins syndrome 4	618939		3
POLR1C, RPA39, RPA40, RPAC1, RPA5, TCS3, HLD11	Leukodystrophy, hypomyelinating, 11	616494		3
POLR1C, RPA39, RPA40, RPAC1, RPA5, TCS3, HLD11	 Treacher Collins syndrome 3	248390		3
POLR1D, RPA16, RPAC2, TCS2	Treacher Collins syndrome 2	613717		3
POLR2A, RPOL2, NEDHIB	Neurodevelopmental disorder with hypotonia and variable intellectual and behavioral abnormalities	618603		3
POLR3A, RPC1, RPC155, ADDH, HLD7, WDRTS	 Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism	607694		3
POLR3A, RPC1, RPC155, ADDH, HLD7, WDRTS	Wiedemann-Rautenstrauch syndrome	264090		3
POLR3B, RPC2, C128, HLD8, CMT1I	 Charcot-Marie-Tooth disease, demyelinating, type 1I	619742		3
POLR3B, RPC2, C128, HLD8, CMT1I	Leukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism	614381		3
POLR3GL, SOFM	Short stature, oligodontia, dysmorphic facies, and motor delay	619234		3
POLR3K, RPC11, HLD21	Leukodystrophy, hypomyelinating, 21	619310		3
POLRMT, APOLMT, COXPD55	Combined oxidative phosphorylation deficiency 55	619743		3
POMC, OBAIRH	 Obesity, adrenal insufficiency, and red hair due to POMC deficiency	609734		3
POMC, OBAIRH	Obesity, early-onset, susceptibility to	601665		3
POMGNT1, MEB, MDDGA3, MDDGB3, MDDGC3, RP76, LGMDR15	 Muscular dystrophy-dystroglycanopathy , type A, 3	253280		3
POMGNT1, MEB, MDDGA3, MDDGB3, MDDGC3, RP76, LGMDR15	 Muscular dystrophy-dystroglycanopathy , type B, 3	613151		3
POMGNT1, MEB, MDDGA3, MDDGB3, MDDGC3, RP76, LGMDR15	Muscular dystrophy-dystroglycanopathy , type C, 3	613157		3
POMGNT1, MEB, MDDGA3, MDDGB3, MDDGC3, RP76, LGMDR15	 Retinitis pigmentosa 76	617123		3
POMGNT2, GTDC2, C3orf39, AGO61, MDDGA8, MDDGC8	Muscular dystrophy-dystroglycanopathy , type A, 8	614830		3
POMGNT2, GTDC2, C3orf39, AGO61, MDDGA8, MDDGC8	 Muscular dystrophy-dystroglycanopathy  type C, 8	618135		3
POMK, SGK196, MDDGA12, MDDGC12	 Muscular dystrophy-dystroglycanopathy , type A, 12	615249	mutation in 1 MDDGC12 family has been reported	3
POMP, UMP1, PRAAS2	 Keratosis linearis with ichthyosis congenita and sclerosing keratoderma	601952		3
POMP, UMP1, PRAAS2	Proteasome-associated autoinflammatory syndrome 2	618048		3
POMT1, MDDGA1, MDDGB1, MDDGC1, LGMDR11	Muscular dystrophy-dystroglycanopathy , type A, 1	236670		3
POMT1, MDDGA1, MDDGB1, MDDGC1, LGMDR11	 Muscular dystrophy-dystroglycanopathy , type B, 1	613155		3
POMT1, MDDGA1, MDDGB1, MDDGC1, LGMDR11	 Muscular dystrophy-dystroglycanopathy , type C, 1	609308		3
POMT2, MDDGA2, MDDGB2, MDDGC2, LGMDR14	 Muscular dystrophy-dystroglycanopathy , type A, 2	613150		3
POMT2, MDDGA2, MDDGB2, MDDGC2, LGMDR14	 Muscular dystrophy-dystroglycanopathy , type B, 2	613156		3
POMT2, MDDGA2, MDDGB2, MDDGC2, LGMDR14	Muscular dystrophy-dystroglycanopathy , type C, 2	613158		3
PON1, PON, ESA, MVCD5	 Coronary artery disease, susceptibility to	168820		3
PON1, PON, ESA, MVCD5	Coronary artery spasm 2, susceptibility to	168820		3
PON1, PON, ESA, MVCD5	 Microvascular complications of diabetes 5	612633		3
PON1, PON, ESA, MVCD5	 Organophosphate poisoning, sensitivity to	168820		3
PON2	Coronary artery disease, susceptibility to	602447		3
POP1, ANXD2	Anauxetic dysplasia 2	617396		3
POPDC3, POP3, LGMDR26	Muscular dystrophy, limb-girdle, autosomal recessive 26	618848		3
POR	Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis	201750		3
PORCN, PORC, DHOF, FODH	Focal dermal hypoplasia	305600		3
POR	 Disordered steroidogenesis due to cytochrome P450 oxidoreductase	613571		3
POROK2, PPPD1	Porokeratosis 2, palmar, plantar, and disseminated	175850	between D12S1613 and D12S1341	2
POROK4, DSAP2	Porokeratosis 4, disseminated superficial actinic	607728	between D15S1023 and D15S1030	2
POROK5, DSAP3	Porokeratosis 5, disseminated superficial actinic	612293	between D1S438 and D1S464	2
POROK6, DSAP4	Porokeratosis 6, multiple types	612353	between telomere and D18S391	2
POT1, CMM10, GLM9	Glioma susceptibility 9	616568		3
POT1, CMM10, GLM9	 Melanoma, cutaneous malignant, susceptibility to, 10	615848		3
POU1F1, PIT1, CPHD1	Pituitary hormone deficiency, combined or isolated, 1	613038		3
POU3F3, SNIBFIS	Snijders Blok-Fisher syndrome	618604		3
POU3F4, DFN3, DFNX2	Deafness, X-linked 2	304400		3
POU4F1, BRN3A, ATITHS	Ataxia, intention tremor, and hypotonia syndrome, childhood-onset	619352		3
POU4F3, BRN3C	Deafness, autosomal dominant 15	602459		3
POU6F2, WTSL, WT5	Wilms tumor susceptibility-5	601583		3
PPA2, SCFI, SCFAI	 Sudden cardiac failure, infantile	617222	mutation identified in 1 SCFAI family	3
PPARA, PPAR	Hyperapobetalipoproteinemia, susceptibility to	170998		3
PPARG, PPARG1, PPARG2, CIMT1, GLM1	 Carotid intimal medial thickness 1	609338	PPARG1, PPARG2 from same gene	3
PPARG, PPARG1, PPARG2, CIMT1, GLM1	Diabetes, type 2	125853	PPARG1, PPARG2 from same gene	3
PPARG, PPARG1, PPARG2, CIMT1, GLM1	 Insulin resistance, severe, digenic	604367	PPARG1, PPARG2 from same gene	3
PPARG, PPARG1, PPARG2, CIMT1, GLM1	 Lipodystrophy, familial partial, type 3	604367	PPARG1, PPARG2 from same gene	3
PPARG, PPARG1, PPARG2, CIMT1, GLM1	 Obesity, resistance to	601487	PPARG1, PPARG2 from same gene	3
PPARG, PPARG1, PPARG2, CIMT1, GLM1	 Obesity, severe	601665	PPARG1, PPARG2 from same gene	3
PPCS, CMD2C	Cardiomyopathy, dilated, 2C	618189		3
PPFIBP1, NEDSMBA	Neurodevelopmental disorder with seizures, microcephaly, and brain abnormalities	620024		3
PPIB, CYPB, OI9	Osteogenesis imperfecta, type IX	259440		3
PPIL1, CYPL1, PCH14	Pontocerebellar hypoplasia, type 14	619301	previously assigned to chr.2	3
PPIP5K2, HISPPD1, VIP2, KIAA0433, DFNB100	Deafness, autosomal recessive 100	618422		3
PPKP1B	Keratoderma, palmoplantar, punctate type IB	614936	between D8S1804 and D8S1720	2
PPM1D, WIP1, JDVS	Breast cancer, somatic	114480	amplified in breast cancer	3
PPM1D, WIP1, JDVS	 Jansen de Vries syndrome	617450	amplified in breast cancer	3
PPNAD4	Pigmented nodular adrenocortical disease, primary, 4	615830	duplication of 294kb to 2.7Mb on 19p13	4
PPOX	Porphyria variegata	176200		3
PPP1CB, NSLH2	Noonan syndrome-like disorder with loose anagen hair 2	617506		3
PPP1R12A, MYPT1, GUBS	Genitourinary and/or/brain malformation syndrome	618820		3
PPP1R15B, CREP, MSSGM2	Microcephaly, short stature, and impaired glucose metabolism 2	616817		3
PPP1R21, CCDC128, KLRAQ1, NEDHFBA	Neurodevelopmental disorder with hypotonia, facial dysmorphism, and brain abnormalities	619383		3
PPP1R3A, PPP1R3	Insulin resistance, severe, digenic	125853		3
PPP2CA, NEDLBA	Neurodevelopmental disorder and language delay with or without structural brain abnormalities	618354		3
PPP2R1A, MRD36	Intellectual developmental disorder, autosomal dominant 36	616362		3
PPP2R1B	Lung cancer, somatic	211980		3
PPP2R2B	Spinocerebellar ataxia 12	604326		3
PPP2R3C, G5PR, MEGD, SPGF36	 Myoectodermal gonadal dysgenesis syndrome	618419		3
PPP2R3C, G5PR, MEGD, SPGF36	Spermatogenic failure 36	618420		3
PPP2R5D, MRD35	Intellectual developmental disorder, autosomal dominant 35	616355		3
PPP3CA, PPP2B, CALNA, CNA1, DEE91, ACCIID	Arthrogryposis, cleft palate, craniosynostosis, and impaired intellectual development	618265		3
PPP3CA, PPP2B, CALNA, CNA1, DEE91, ACCIID	 Developmental and epileptic encephalopathy 91	617711		3
PPR1	Photoparoxysmal response 1	132100	max lod at D6S2427	2
PPR2	Photoparoxysmal response 2	609572	max lod at D13S1230	2
PPR3	Photoparoxysmal response 3	609573	max lod at D7S1804	2
PPT1, CLN1	Ceroid lipofuscinosis, neuronal, 1	256730		3
PQBP1, NPW38, SHS, MRX55, MRXS3, RENS1, MRXS8	Renpenning syndrome	309500		3
PRBNS	Pierre Robin syndrome	261800	between D17S795 and D17S929	2
PRCC, RCCP1	Renal cell carcinoma, papillary	605074	t(X;1)(p11;q21); fuses with TFE3 in RCCP	3
PRCD, RP36	Retinitis pigmentosa 36	610599		3
PRDM12, HSAN8	Neuropathy, hereditary sensory and autonomic, type VIII	616488		3
PRDM13, CDIDHH, PCH17	 Cerebellar dysfunction, impaired intellectual development, and hypogonadotropic hypogonadism	619761		3
PRDM13, CDIDHH, PCH17	Pontocerebellar hypoplasia, type 17	619909		3
PRDM16, MEL1, LVNC8, CMD1LL	 Cardiomyopathy, dilated, 1LL	615373		3
PRDM16, MEL1, LVNC8, CMD1LL	Left ventricular noncompaction 8	615373		3
PRDM5, BCS2	Brittle cornea syndrome 2	614170		3
PRDM6, PRISM, PDA3	Patent ductus arteriosus 3	617039		3
PRDX1, PRXI, PAGA, NKEFA	Methylmalonic aciduria and homocystinuria, cblC type, digenic	277400	pseudogene PAGB on 9p22	3
PRDX3, AOP1, SCAR32, PPPCD	 Corneal dystrophy, punctiform and polychromatic pre-Descemet	619871		3
PRDX3, AOP1, SCAR32, PPPCD	Spinocerebellar ataxia, autosomal recessive 32	619862		3
PREPL, KIAA0436, CMS22	Myasthenic syndrome, congenital, 22	616224		3
PRF1, HPLH2, FLH2	 Aplastic anemia	609135	mistakenly assigned to chr.17	3
PRF1, HPLH2, FLH2	Hemophagocytic lymphohistiocytosis, familial, 2	603553	mistakenly assigned to chr.17	3
PRF1, HPLH2, FLH2	 Lymphoma, non-Hodgkin	605027	mistakenly assigned to chr.17	3
PRG4, CACP, MSF, SZP, HAPO	Camptodactyly-arthropathy-coxa vara-pericarditis syndrome	208250		3
PRICKLE1, RILP, EPM1B	Epilepsy, progressive myoclonic 1B	612437		3
PRICKLE3, LMO6, LOAM	Leber hereditary optic neuropathy, modifier of	308905		3
PRIM1, PDIL	Primordial dwarfism-immunodeficiency-lipodystrophy syndrome	620005		3
PRKACA, CAFD1	 Cardioacrofacial dysplasia 1	619142		3
PRKACA, CAFD1	Cushing syndrome, ACTH-independent adrenal, somatic	615830		3
PRKACB, CAFD2	Cardioacrofacial dysplasia 2	619143		3
PRKAG2, WPWS, CMH6	 Cardiomyopathy, hypertrophic 6	600858		3
PRKAG2, WPWS, CMH6	Glycogen storage disease of heart, lethal congenital	261740		3
PRKAG2, WPWS, CMH6	 Wolff-Parkinson-White syndrome	194200		3
PRKAG3, SMGMQTL	Skeletal muscle glycogen content and metabolism QTL	619030		3
PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1	 Acrodysostosis 1, with or without hormone resistance	101800	fused with RET to form PTC2	3
PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1	 Adrenocortical tumor, somatic	188830	fused with RET to form PTC2	3
PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1	 Carney complex, type 1	160980	fused with RET to form PTC2	3
PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1	 Myxoma, intracardiac	255960	fused with RET to form PTC2	3
PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1	Pigmented nodular adrenocortical disease, primary, 1	610489	fused with RET to form PTC2	3
PRKAR1B, MASNS	Marbach-Schaaf neurodevelopmental syndrome	619680		3
PRKCA, PKCA	Pituitary tumor, invasive	176960	cen-COL1A1-PKCA-GH1	3
PRKCD, CVID9, ALPS3	Autoimmune lymphoproliferative syndrome, type III	615559	mutation identified in 1 family	3
PRKCG, PKCC, PKCG, SCA14	Spinocerebellar ataxia 14	605361		3
PRKCH, PKCL, PRKCL	Cerebral infarction, susceptibility to	601367		3
PRKCSH, G19P1, PCLD1	Polycystic liver disease 1	174050		3
PRKD1, PRKCM, PKD, CHDED	Congenital heart defects and ectodermal dysplasia	617364		3
PRKDC, HYRC1, DNPK1, IMD26	Immunodeficiency 26, with or without neurologic abnormalities	615966		3
PRKG1, PRKG1B, PRKGR1B, AAT8	Aortic aneurysm, familial thoracic 8	615436		3
PRKG2, PRKGR2, AMD4, SMDP	 Acromesomelic dysplasia 4	619636	mutation identified in 1 SMDP family	3
PRKG2, PRKGR2, AMD4, SMDP	Spondylometaphyseal dysplasia, Pagnamenta type	619638	mutation identified in 1 SMDP family	3
PRKN, PARK2, PDJ	Adenocarcinoma of lung, somatic	211980	shares 5' regulatory region and both 3' UTRs with PACRG	3
PRKN, PARK2, PDJ	 Ovarian cancer, somatic	167000	shares 5' regulatory region and both 3' UTRs with PACRG	3
PRKN, PARK2, PDJ	 Parkinson disease, juvenile, type 2	600116	shares 5' regulatory region and both 3' UTRs with PACRG	3
PRKRA, PACT, RAX, DYT16	Dystonia 16	612067		3
PRLR, MFAB, HPRL	 Hyperprolactinemia	615555		3
PRLR, MFAB, HPRL	Multiple fibroadenomas of the breast	615554		3
PRMT7, KIAA1933, SBIDDS	Short stature, brachydactyly, intellectual developmental disability, and seizures	617157		3
PRNP, PRIP, KURU, CJD	 Cerebral amyloid angiopathy, PRNP-related	137440	pter-PRNP-SCG1-BMP2A-PAX1-cen	3
PRNP, PRIP, KURU, CJD	 Creutzfeldt-Jakob disease	123400	pter-PRNP-SCG1-BMP2A-PAX1-cen	3
PRNP, PRIP, KURU, CJD	 Gerstmann-Straussler disease	137440	pter-PRNP-SCG1-BMP2A-PAX1-cen	3
PRNP, PRIP, KURU, CJD	 Huntington disease-like 1	603218	pter-PRNP-SCG1-BMP2A-PAX1-cen	3
PRNP, PRIP, KURU, CJD	 Insomnia, fatal familial	600072	pter-PRNP-SCG1-BMP2A-PAX1-cen	3
PRNP, PRIP, KURU, CJD	 Kuru, susceptibility to	245300	pter-PRNP-SCG1-BMP2A-PAX1-cen	3
PRNP, PRIP, KURU, CJD	Spongiform encephalopathy with neuropsychiatric features	606688	pter-PRNP-SCG1-BMP2A-PAX1-cen	3
PROC, PC, THPH3, THPH4	Thrombophilia 3 due to protein C deficiency, autosomal dominant	176860		3
PROC, PC, THPH3, THPH4	 Thrombophilia 3 due to protein C deficiency, autosomal recessive	612304		3
PRODH, PRODH2, SCZD4	 Hyperprolinemia, type I	239500		3
PRODH, PRODH2, SCZD4	Schizophrenia, susceptibility to, 4	600850		3
PROK2, PK2, BV8, HH4	Hypogonadotropic hypogonadism 4 with or without anosmia	610628		3
PROKR2, PKR2, GPR73L1, HH3	Hypogonadotropic hypogonadism 3 with or without anosmia	244200		3
PROM1, PROML1, AC133, RP41, CORD12, CD133, MCDR2, STGD4	 Cone-rod dystrophy 12	612657		3
PROM1, PROML1, AC133, RP41, CORD12, CD133, MCDR2, STGD4	Macular dystrophy, retinal, 2	608051		3
PROM1, PROML1, AC133, RP41, CORD12, CD133, MCDR2, STGD4	 Retinitis pigmentosa 41	612095		3
PROM1, PROML1, AC133, RP41, CORD12, CD133, MCDR2, STGD4	 Stargardt disease 4	603786		3
PROP1, CPHD2	Pituitary hormone deficiency, combined, 2	262600		3
PRORP, KIAA0391, COXPD54	Combined oxidative phosphorylation deficiency 54	619737		3
PROS1, THPH5, THPH6	 Thrombophilia 5 due to protein S deficiency, autosomal dominant	612336	pseudogene PROSP contiguous on chr.3	3
PROS1, THPH5, THPH6	Thrombophilia 5 due to protein S deficiency, autosomal recessive	614514	pseudogene PROSP contiguous on chr.3	3
PROZ, PZ	Protein Z deficiency	614024		3
PRPF31, PRP31, RP11	Retinitis pigmentosa 11	600138		3
PRPF3, HPRP3, RP18	Retinitis pigmentosa 18	601414		3
PRPF4, PRP4, HPRP4, RP70	Retinitis pigmentosa 70	615922		3
PRPF6, PRP6, ANT1, TOM, C20orf14	Retinitis pigmentosa 60	613983		3
PRPF8, PRPC8, RP13	Retinitis pigmentosa 13	600059		3
PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	 Choroidal dystrophy, central areolar 2	613105	digenic RP with ROM1	3
PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	 Leber congenital amaurosis 18	608133	digenic RP with ROM1	3
PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	Macular dystrophy, patterned, 1	169150	digenic RP with ROM1	3
PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	 Macular dystrophy, vitelliform, 3	608161	digenic RP with ROM1	3
PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	 Retinitis pigmentosa 7 and digenic form	608133	digenic RP with ROM1	3
PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	 Retinitis punctata albescens	136880	digenic RP with ROM1	3
PRPH	Amyotrophic lateral sclerosis, susceptibility to	105400		3
PRPS1, CMTX5, DFNX1, DFN2	Arts syndrome	301835		3
PRPS1, CMTX5, DFNX1, DFN2	 Charcot-Marie-Tooth disease, X-linked recessive, 5	311070		3
PRPS1, CMTX5, DFNX1, DFN2	 Deafness, X-linked 1	304500		3
PRPS1, CMTX5, DFNX1, DFN2	 Gout, PRPS-related	300661		3
PRPS1, CMTX5, DFNX1, DFN2	 Phosphoribosylpyrophosphate synthetase superactivity	300661		3
PRR12, KIAA1205, NOC	Neuroocular syndrome	619539		3
PRRT2, PKC, DYT10, EKD1, BFIS2, BFIC2, ICCA	Convulsions, familial infantile, with paroxysmal choreoathetosis	602066		3
PRRT2, PKC, DYT10, EKD1, BFIS2, BFIC2, ICCA	 Episodic kinesigenic dyskinesia 1	128200		3
PRRT2, PKC, DYT10, EKD1, BFIS2, BFIC2, ICCA	 Seizures, benign familial infantile, 2	605751		3
PRRX1, PMX1, PHOX1, AGOTC	Agnathia-otocephaly complex	202650		3
PRS, MRXS2	Prieto syndrome	309610		2
PRSS12, BSSP3, MRT1	Intellectual developmental disorder, autosomal recessive 1	249500		3
PRSS1, TRY1	Pancreatitis, hereditary	167800	8 trypsinogen genes embedded in TCRB locus	3
PRSS2, TRY2	Pancreatitis, chronic, protection against	167800		3
PRSS56, MCOP6	Microphthalmia, isolated 6	613517		3
PRUNE1, DRES17, NMIHBA	Neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies	617481		3
PRX, CMT4F	Charcot-Marie-Tooth disease, type 4F	614895		3
PRX, CMT4F	 Dejerine-Sottas disease	145900		3
PSAP, SAP1, PSAPD, PARK24	Combined SAP deficiency	611721		3
PSAP, SAP1, PSAPD, PARK24	 Gaucher disease, atypical	610539		3
PSAP, SAP1, PSAPD, PARK24	 Krabbe disease, atypical	611722		3
PSAP, SAP1, PSAPD, PARK24	 Metachromatic leukodystrophy due to SAP-b deficiency	249900		3
PSAP, SAP1, PSAPD, PARK24	 Parkinson disease 24, autosomal dominant, susceptibility to	619491		3
PSAT1, PSAT, EPIP, PSATD, NLS2	Neu-Laxova syndrome 2	616038	mutation identified in 1 PSATD family	3
PSAT1, PSAT, EPIP, PSATD, NLS2	 Phosphoserine aminotransferase deficiency	610992	mutation identified in 1 PSATD family	3
PSC	Cholangitis, primary sclerosing	613806		2
PSEN1, AD3, ACNINV3	 Acne inversa, familial, 3	613737	mutation identified in 1 ACNINV3 family	3
PSEN1, AD3, ACNINV3	 Alzheimer disease, type 3	607822	mutation identified in 1 ACNINV3 family	3
PSEN1, AD3, ACNINV3	 Alzheimer disease, type 3, with spastic paraparesis and apraxia	607822	mutation identified in 1 ACNINV3 family	3
PSEN1, AD3, ACNINV3	 Alzheimer disease, type 3, with spastic paraparesis and unusual plaques	607822	mutation identified in 1 ACNINV3 family	3
PSEN1, AD3, ACNINV3	 Cardiomyopathy, dilated, 1U	613694	mutation identified in 1 ACNINV3 family	3
PSEN1, AD3, ACNINV3	 Dementia, frontotemporal	600274	mutation identified in 1 ACNINV3 family	3
PSEN1, AD3, ACNINV3	Pick disease	172700	mutation identified in 1 ACNINV3 family	3
PSEN2, AD4, STM2, CMD1V	Alzheimer disease-4	606889		3
PSEN2, AD4, STM2, CMD1V	 Cardiomyopathy, dilated, 1V	613697		3
PSENEN, PEN2, ACNINV2	Acne inversa, familial, 2, with or without Dowling-Degos disease	613736		3
PSHK2	Pseudohyperkalemia, familial, 2, due to red cell leak	609153	max lod at D2S1338	2
PSMA6, PROS27, P27K	Myocardial infarction, susceptibility to	608446		3
PSMB10, MECL1, LMP10, PRAAS5	Proteasome-associated autoinflammatory syndrome 5	619175	3.1kb from LCAT	3
PSMB8, LMP7, RING10, JMP, NKJO, ALDD, PRAAS1	Proteasome-associated autoinflammatory syndrome 1 and digenic forms	256040	between TAP1 and TAP2	3
PSMC3IP, TBPIP, GT198, HOP2, ODG3	Ovarian dysgenesis 3	614324		3
PSMD12, P55, STISS	Stankiewicz-Isidor syndrome	617516		3
PSMNSW	Parasomnia, sleepwalking type	613938	between 55.6 and 61.4 cM	2
PSNP2	Supranuclear palsy, progressive, 2	609454	between D1S238 and D1S2823	2
PSNP3	Supranuclear palsy, progressive, 3	610898		2
PSORS10	Psoriasis susceptibility 10	612410	between D18S63 and D18S967	2
PSORS11	Psoriasis susceptibility 11	612599	associated with rs10045431	2
PSORS12	Psoriasis susceptibility 12	612950	associated with rs495337	2
PSORS3	Psoriasis susceptibility 3	601454		2
PSORS4	Psoriasis susceptibility 4	603935		2
PSORS5	Psoriasis susceptibility 5	604316		2
PSORS6	Psoriasis susceptibility 6	605364		2
PSORS7	Psoriasis susceptibility 7	605606		2
PSORS8	Psoriasis susceptibility 8	610707	proximal to D16S3034	2
PSORS9	Psoriasis susceptibility 9	607857	max lod at D4S1597	2
PSPH, PSP, PSPHD	Phosphoserine phosphatase deficiency	614023		3
PSS	Potocki-Shaffer syndrome	601224	contiguous gene syndrome caused by deletion of 11p11.2	4
PSTPIP1, PSTPIP, CD2BP1, PAPAS	Pyogenic sterile arthritis, pyoderma gangrenosum, and acne	604416		3
PTCH1, NBCCS, BCNS, HPE7	Basal cell carcinoma, somatic	605462		3
PTCH1, NBCCS, BCNS, HPE7	 Basal cell nevus syndrome	109400		3
PTCH1, NBCCS, BCNS, HPE7	 Holoprosencephaly 7	610828		3
PTCH2	 Basal cell carcinoma, somatic	605462		3
PTCH2	 Basal cell nevus syndrome	109400		3
PTCH2	Medulloblastoma, somatic	155255		3
PTCHD1, AUTSX4	Autism, susceptibility to, X-linked 4	300830		3
PTCPRN, PRN1	Thyroid carcinoma, papillary, with papillary renal neoplasia	605642		2
PTDSS1, PSS1, KIAA0024, LMHD	Lenz-Majewski hyperostotic dwarfism	151050		3
PTEN, MMAC1, GLM2, CWS1	 Cowden syndrome 1	158350		3
PTEN, MMAC1, GLM2, CWS1	Glioma susceptibility 2	613028		3
PTEN, MMAC1, GLM2, CWS1	 Lhermitte-Duclos disease	158350		3
PTEN, MMAC1, GLM2, CWS1	 Macrocephaly/autism syndrome	605309		3
PTEN, MMAC1, GLM2, CWS1	 Meningioma	607174		3
PTEN, MMAC1, GLM2, CWS1	 Prostate cancer, somatic	176807		3
PTF1A, PACA, PAGEN2	 Pancreatic agenesis 2	615935		3
PTF1A, PACA, PAGEN2	Pancreatic and cerebellar agenesis	609069		3
PTGDR, AS1, ASRT1	Asthma, susceptibility to, 1	607277		3
PTGER2	Asthma, aspirin-induced, susceptibility to	208550		3
PTGIS, CYP8A1, PGIS, CYP8	Hypertension, essential	145500		3
PTH1R, PTHR1, PTHR, PFE, EKNS	 Chondrodysplasia, Blomstrand type	215045		3
PTH1R, PTHR1, PTHR, PFE, EKNS	 Eiken syndrome	600002		3
PTH1R, PTHR1, PTHR, PFE, EKNS	 Failure of tooth eruption, primary	125350		3
PTH1R, PTHR1, PTHR, PFE, EKNS	Metaphyseal chondrodysplasia, Murk Jansen type	156400		3
PTHB1, BBS9	Bardet-Biedl syndrome 9	615986		3
PTH, FIH1	Hypoparathyroidism, familial isolated 1	146200	~9cM distal to CALC1; distal to MYOD	3
PTHLH, BDE2	Brachydactyly, type E2	613382		3
PTLAH, FPAH	Patella aplasia or hypoplasia	168860		2
PTLS	Potocki-Lupski syndrome	610883	contiguous gene syndrome	4
PTOS1	Ptosis, hereditary congenital, 1	178300		2
PTOS2, PTOSX	Ptosis, hereditary congenital 2	300245		2
PTPN11, PTP2C, SHP2, NS1, JMML, METCDS	 LEOPARD syndrome 1	151100		3
PTPN11, PTP2C, SHP2, NS1, JMML, METCDS	 Leukemia, juvenile myelomonocytic, somatic	607785		3
PTPN11, PTP2C, SHP2, NS1, JMML, METCDS	 Metachondromatosis	156250		3
PTPN11, PTP2C, SHP2, NS1, JMML, METCDS	Noonan syndrome 1	163950		3
PTPN12, PTPG1	Colon cancer, somatic	114500		3
PTPN14, PEZ, CATLPH	Choanal atresia and lymphedema	613611		3
PTPN1, PTP1B	Insulin resistance, susceptibility to	125853	20pter-q12 by REa	3
PTPN22, PEP, PTPN8, LYP	 Diabetes, type 1, susceptibility to	222100		3
PTPN22, PEP, PTPN8, LYP	Rheumatoid arthritis, susceptibility to	180300		3
PTPN22, PEP, PTPN8, LYP	 Systemic lupus erythematosus susceptibility to	152700		3
PTPN23, KIAA1471, HDPTP, NEDBASS	Neurodevelopmental disorder and structural brain anomalies with or without seizures and spasticity	618890		3
PTPRC, CD45, LCA, IMD105	Immunodeficiency 105, severe combined	619924		3
PTPRJ, DEP1	Colon cancer, somatic	114500		3
PTPRO, GLEPP1, NPHS6	Nephrotic syndrome, type 6	614196		3
PTPRQ, PTPGMC1, DFNB84A, DFNA73	Deafness, autosomal dominant 73	617663	mutation identified in 1 DFNA73 family	3
PTPRQ, PTPGMC1, DFNB84A, DFNA73	 Deafness, autosomal recessive 84A	613391	mutation identified in 1 DFNA73 family	3
PTRH2, BIT1, IMNEPD	Infantile-onset multisystem neurologic, endocrine, and pancreatic disease	616263		3
PTS	Hyperphenylalaninemia, BH4-deficient, A	261640		3
PUF60, FIR, SIAHBP1, VRJS	Verheij syndrome	615583		3
PUM1, KIAA0099, SCA47	Spinocerebellar ataxia 47	617931		3
PURA, PUR1, NEDRIHF	Neurodevelopmental disorder with neonatal respiratory insufficiency, hypotonia, and feeding difficulties	616158		3
PURAQTL1	Polyunsaturated fatty acids plasma level QTL1	612795	associated with rs174537	2
PUS1, MLASA1	Myopathy, lactic acidosis, and sideroblastic anemia 1	600462		3
PUS3, MRT55, NEDMIGS	Neurodevelopmental disorder with microcephaly and gray sclerae	617051		3
PUS7, KIAA1897, IDDABS	Intellectual developmental disorder with abnormal behavior, microcephaly, and short stature	618342		3
PVNH3	Periventricular nodular heterotopia 3	608098		2
PVNH5	Periventricular nodular heterotopia 5	612881	deletion range 6.3-17Mb, common range 5.8Mb	4
PVOP1	Pelvic organ prolapse, susceptibility to, 1	176780	associated with rs10911193	2
PVOP2	Pelvic organ prolapse, susceptibility to, 2	613088	between rs4077632 and rs10868525	2
PWS	Prader-Willi syndrome	176270	loss of paternal allele	4
PXDN, D2S448E, KIAA0230, PRG2, PXN, COPOA, ASGD7	Anterior segment dysgenesis 7, with sclerocornea	269400		3
PYCR1, PRO3, ARCL2B, ARCL3B	 Cutis laxa, autosomal recessive, type IIB	612940		3
PYCR1, PRO3, ARCL2B, ARCL3B	Cutis laxa, autosomal recessive, type IIIB	614438		3
PYCR2, HLD10	Leukodystrophy, hypomyelinating, 10	616420		3
PYGL	Glycogen storage disease VI	232700		3
PYGM	McArdle disease	232600		3
PYROXD1, MFM8	Myopathy, myofibrillar, 8	617258		3
QARS1, QARS, GLNRS, MSCCA	Microcephaly, progressive, seizures, and cerebral and cerebellar atrophy	615760		3
QDPR, DHPR	Hyperphenylalaninemia, BH4-deficient, C	261630		3
QRICH1, VERBRAS	Ververi-Brady syndrome	617982		3
QRICH2, SPGF35	Spermatogenic failure 35	618341		3
QRSL1, GATA, COXPD40	Combined oxidative phosphorylation deficiency 40	618835		3
QTV	QT interval, variation in	610141	associated with rs12143842	2
RAB11B, NDAGSCW	Neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter	617807		3
RAB18, WARBM3	Warburg micro syndrome 3	614222		3
RAB23	Carpenter syndrome	201000		3
RAB27A, RAM, GS2	Griscelli syndrome, type 2	607624		3
RAB28, CORD18	Cone-rod dystrophy 18	615374		3
RAB33B, SMC2	Smith-McCort dysplasia 2	615222		3
RAB39B, XLID72, WSMN, MRX72	Intellectual developmental disorder, X-linked 72	300271		3
RAB39B, XLID72, WSMN, MRX72	 Waisman syndrome	311510		3
RAB3GAP1, WARBM1, P130, MARTS2	Martsolf syndrome 2	619420		3
RAB3GAP1, WARBM1, P130, MARTS2	 Warburg micro syndrome 1	600118		3
RAB3GAP2, RAB3GAP150, p150, KIAA0839, WARBM2, MARTS1	Martsolf syndrome 1	212720		3
RAB3GAP2, RAB3GAP150, p150, KIAA0839, WARBM2, MARTS1	 Warburg micro syndrome 2	614225		3
RAB7, CMT2B, PSN	Charcot-Marie-Tooth disease, type 2B	600882		3
RABL3, PNCA5	Pancreatic cancer, susceptibility to, 5	618680	mutation identified in 1 PNCA5 family	3
RAC1, MRD48	Intellectual developmental disorder, autosomal dominant 48	617751		3
RAC2, IMD73A, IMD73B, IMD73C	Immunodeficiency 73A with defective neutrophil chemotaxix and leukocytosis	608203	mutation identified in 1 IMD73C family	3
RAC2, IMD73A, IMD73B, IMD73C	 Immunodeficiency 73B with defective neutrophil chemotaxis and lymphopenia	618986	mutation identified in 1 IMD73C family	3
RAC2, IMD73A, IMD73B, IMD73C	 Immunodeficiency 73C with defective neutrophil chemotaxis and hypogammaglobulinemia	618987	mutation identified in 1 IMD73C family	3
RAC3	Neurodevelopmental disorder with structural brain anomalies and dysmorphic facies	618577		3
RAD21, SCC1, NXP1, KIAA0078, CDLS4, MGS	Cornelia de Lange syndrome 4	614701	mutation identified in 1 MGS family	3
RAD21, SCC1, NXP1, KIAA0078, CDLS4, MGS	 Mungan syndrome	611376	mutation identified in 1 MGS family	3
RAD50, NBSLD	Nijmegen breakage syndrome-like disorder	613078		3
RAD51C, FANCO, BROVCA3	Breast-ovarian cancer, familial, susceptibility to, 3	613399		3
RAD51C, FANCO, BROVCA3	 Fanconi anemia, complementation group O	613390		3
RAD51D, RAD51L3, BROVCA4	Breast-ovarian cancer, familial, susceptibility to, 4	614291		3
RAD51, RECA, MRMV2, FANCR	 Breast cancer, susceptibility to	114480		3
RAD51, RECA, MRMV2, FANCR	 Fanconi anemia, complementation group R	617244		3
RAD51, RECA, MRMV2, FANCR	Mirror movements 2	614508		3
RAD54B	Colon cancer, somatic	114500		3
RAD54B	 Lymphoma, non-Hodgkin, somatic	605027		3
RAD54L, HR54, HRAD54	 Adenocarcinoma, colonic, somatic	603615		3
RAD54L, HR54, HRAD54	Breast cancer, invasive ductal	114480		3
RAD54L, HR54, HRAD54	 Lymphoma, non-Hodgkin, somatic	605027		3
RAF1, CRAF, NS5, CMD1NN	Cardiomyopathy, dilated, 1NN	615916		3
RAF1, CRAF, NS5, CMD1NN	 LEOPARD syndrome 2	611554		3
RAF1, CRAF, NS5, CMD1NN	 Noonan syndrome 5	611553		3
RAG1	 Alpha/beta T-cell lymphopenia with gamma/delta T-cell expansion, severe cytomegalovirus infection, and autoimmunity	609889	assignment to 14 in error	3
RAG1	 Combined cellular and humoral immune defects with granulomas	233650	assignment to 14 in error	3
RAG1	Omenn syndrome	603554	assignment to 14 in error	3
RAG1	 Severe combined immunodeficiency, B cell-negative	601457	assignment to 14 in error	3
RAG2	 Combined cellular and humoral immune defects with granulomas	233650	assignment to 14 in error	3
RAG2	 Omenn syndrome	603554	assignment to 14 in error	3
RAG2	Severe combined immunodeficiency, B cell-negative	601457	assignment to 14 in error	3
RAI1, SMCR, SMS	Smith-Magenis syndrome	182290		3
RALA, HINCONS	Hiatt-Neu-Cooper neurodevelopmental syndrome	619311		3
RALGAPA1, GARNL1, TULIP1, GRIPE, KIAA0884, NEDHRIT	Neurodevelopmental disorder with hypotonia, neonatal respiratory insufficiency, and thermodysregulation	618797	pseudogene on 9q31.1	3
RANBP2, NUP358, ANE1, IIAE3	Encephalopathy, acute, infection-induced, 3, susceptibility to	608033		3
RAP1GDS1	Lymphocytic leukemia, acute T-cell	179502	fusion partner with NUP98 in ALL	3
RAPSN, CMS1D, CMS11, FADS2	Fetal akinesia deformation sequence 2	618388		3
RAPSN, CMS1D, CMS11, FADS2	 Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency	616326		3
RARA	Leukemia, acute promyelocytic	612376	fused with MYL in APL	1
RARB, HAP, MCOPS12	Microphthalmia, syndromic 12	615524	= HAP = HBV-activated protein	3
RA	Rheumatoid arthritis, susceptibility to	180300	associated with SNP rs10499194 and rs6920220	2
RARS1, RARS, HLD9	Leukodystrophy, hypomyelinating, 9	616140		3
RARS2, RARSL, PCH6	Pontocerebellar hypoplasia, type 6	611523		3
RASA1, GAP, CMAVM1, PKWS	 Basal cell carcinoma, somatic	605462		3
RASA1, GAP, CMAVM1, PKWS	Capillary malformation-arteriovenous malformation 1	608354		3
RASGRP1, IMD64	Immunodeficiency 64	618534		3
RAX2, RAXL1, QRX, CORD11, ARMD6, RP95	 Cone-rod dystrophy 11	610381	mutation identified in 1 ARMD6 patient	3
RAX2, RAXL1, QRX, CORD11, ARMD6, RP95	 Macular degeneration, age-related, 6	613757	mutation identified in 1 ARMD6 patient	3
RAX2, RAXL1, QRX, CORD11, ARMD6, RP95	Retinitis pigmentosa 95	620102	mutation identified in 1 ARMD6 patient	3
RAX, RX, MCOPS16	Microphthalmia, syndromic 16	611038		3
RB1	 Bladder cancer, somatic	109800		3
RB1CC1, CC1, KIAA0203	Breast cancer, somatic	114480		3
RB1	 Osteosarcoma, somatic	259500		3
RB1	 Retinoblastoma	180200		3
RB1	 Retinoblastoma, trilateral	180200		3
RB1	Small cell cancer of the lung, somatic	182280		3
RBBP8, RIM, SCKL2, JWDS	 Jawad syndrome	251255		3
RBBP8, RIM, SCKL2, JWDS	 Pancreatic carcinoma, somatic	604124		3
RBBP8, RIM, SCKL2, JWDS	Seckel syndrome 2	606744		3
RBCK1, HOIL1, PGBM1, PBMEI, C20orf18	Polyglucosan body myopathy 1 with or without immunodeficiency	615895		3
RBL2, BRUWAG	Brunet-Wagner neurodevelopmental syndrome	619690		3
RBM10, DXS8237E, KIAA0122, TARPS	TARP syndrome	311900		3
RBM12, KIAA0765, SCZD19	Schizophrenia 19, susceptibility to	617629		3
RBM20	Cardiomyopathy, dilated, 1DD	613172		3
RBM8A, RBM8B, TAR, C1DELq21.1, DEL1q21.1	Thrombocytopenia-absent radius syndrome	274000	pseudogene on chr.14	3
RBP4, RDCCAS, MCOPCB10	Microphthalmia, isolated, with coloboma 10	616428	just centromeric of CYP2C cluster	3
RBP4, RDCCAS, MCOPCB10	 Retinal dystrophy, iris coloboma, and comedogenic acne syndrome	615147	just centromeric of CYP2C cluster	3
RBPJ, RBPSUH, IGKJRB1, AOS3	Adams-Oliver syndrome 3	614814	pseudogenes at 9q13, 9p13, and 3q25	3
RC14S	Ring chromosome 14 syndrome	616606		4
RCBTB1, CLLD7, GLP, RDEOA	Retinal dystrophy with or without extraocular anomalies	617175		3
RCM2	Cardiomyopathy, familial restrictive, 2	609578	max lod at D10S1242	2
RD3, LCA12, C1orf36	Leber congenital amaurosis 12	610612		3
RDH12, LCA13	Leber congenital amaurosis 13	612712	near RDH11	3
RDH5	Fundus albipunctatus	136880		3
RDX, DFNB24	Deafness, autosomal recessive 24	611022		3
REC114, OOMD10	Oocyte maturation defect 10	619176		3
RECQL2, RECQ3, WRN	Werner syndrome	277700		3
RECQL3, RECQ2, BLM, BS, MGRISCE1	Bloom syndrome	210900		3
RECQL4, RTS, RECQ4	Baller-Gerold syndrome	218600		3
RECQL4, RTS, RECQ4	 RAPADILINO syndrome	266280		3
RECQL4, RTS, RECQ4	 Rothmund-Thomson syndrome, type 2	268400		3
REEP1, C2orf23, SPG31, HMN5B, DSMA6	 Spastic paraplegia 31, autosomal dominant	610250	mutation identified in 1 HMN5B family	3
REEP1, C2orf23, SPG31, HMN5B, DSMA6	 Spinal muscular atrophy, distal, autosomal recessive, 6	620011	mutation identified in 1 HMN5B family	3
REEP2, C5orf19, SPG72	 Spastic paraplegia 72, autosomal recessive	615625	mutation identified in 1 family each SPG72 AR and AD	3
REEP6, DP1L1, TB2L1, C19orf32, RP77	Retinitis pigmentosa 77	617304		3
REL, IMD92	Immunodeficiency 92	619652		3
RELN, RL, LIS2, ETL7	Epilepsy, familial temporal lobe, 7	616436		3
RELN, RL, LIS2, ETL7	 Lissencephaly 2 	257320		3
RELT, TNFRSF19L, AI3C	Amelogenesis imperfecta, type IIIC	618386		3
REN, RTD, ADTKD4	 Hyperproreninemia	179820	~24cM distal to AT3	3
REN, RTD, ADTKD4	Renal tubular dysgenesis	267430	~24cM distal to AT3	3
REN, RTD, ADTKD4	 Tubulointerstitial kidney disease, autosomal dominant, 4	613092	~24cM distal to AT3	3
RERE, NEDBEH	Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart	616975		3
REST, NRSF, WT6, GINGF5, HGF5, DFNA27	Deafness, autosomal dominant 27	612431		3
REST, NRSF, WT6, GINGF5, HGF5, DFNA27	 Fibromatosis, gingival, 5	617626		3
REST, NRSF, WT6, GINGF5, HGF5, DFNA27	 Wilms tumor 6, susceptibility to	616806		3
RET, MEN2A, HSCR1	 Hirschsprung disease, protection against	142623		3
RET, MEN2A, HSCR1	Hirschsprung disease, susceptibility to, 1	142623		3
RET, MEN2A, HSCR1	 Medullary thyroid carcinoma	155240		3
RET, MEN2A, HSCR1	 Multiple endocrine neoplasia IIA	171400		3
RET, MEN2A, HSCR1	 Multiple endocrine neoplasia IIB	162300		3
RET, MEN2A, HSCR1	 Pheochromocytoma	171300		3
RETN, RSTN, FIZZ3	 Diabetes mellitus, noninsulin-dependent, susceptibility to	125853		3
RETN, RSTN, FIZZ3	Hypertension, insulin resistance-related, susceptibility to	125853		3
RETREG1, FAM134B, HSAN2B	Neuropathy, hereditary sensory and autonomic, type IIB	613115		3
RFC1, RECC1, CANVAS	Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome	614575		3
RFH1, AORF	Nephropathy-hypertension	161900		2
RFT1, CDG1N	Congenital disorder of glycosylation, type In	612015		3
RFX5	Bare lymphocyte syndrome, type II, complementation group C	209920		3
RFX5	 Bare lymphocyte syndrome, type II, complementation group E	209920		3
RFX6, RFXDC1, MTCHRS	Mitchell-Riley syndrome	615710		3
RFXANK	Bare lymphocyte syndrome, type II, complementation group B	209920		3
RFXAP	Bare lymphocyte syndrome, type II, complementation group D	209920		3
RGR, RP44	Retinitis pigmentosa 44	613769		3
RGS5	Blood pressure regulation QTL	145500		2
RGS9BP, R9AP, RGS9, PERRS	Bradyopsia	608415		3
RGS9, PERRS	Bradyopsia	608415		3
RHAG, RH50A, OHST, RHNR	 Anemia, hemolytic, Rh-null, regulator type	268150		3
RHAG, RH50A, OHST, RHNR	Overhydrated hereditary stomatocytosis	185000		3
RHBDF2, IRHOM2, TOC	Tylosis with esophageal cancer	148500		3
RHCE, RHNA	Rh-null disease, amorph type	617970		3
RHD, HDFNRH	 Blood group, RH system	111690		3
RHD, HDFNRH	Hemolytic disease of fetus and newborn, RH-induced	619462		3
RHOA, ARHA, ARH12, RHOH12, EDFAOB	Ectodermal dysplasia with facial dysmorphism and acral, ocular, and brain anomalies, somatic mosaic	618727		3
RHOBTB2, DBC2, KIAA0717, DEE64	Developmental and epileptic encephalopathy 64	618004		3
RHOH, ARHH, TTF	Epidermodysplasia verruciformis, susceptibility to, 4	618307	mutation identified in 1 EV4 family	3
RHO, RP4, OPN2, CSNBAD1	Night blindness, congenital stationary, autosomal dominant 1	610445		3
RHO, RP4, OPN2, CSNBAD1	 Retinitis pigmentosa 4, autosomal dominant or recessive	613731		3
RHO, RP4, OPN2, CSNBAD1	 Retinitis punctata albescens	136880		3
RIC1, CIP150, KIAA1432, CATIFA	CATIFA syndrome	618761		3
RIEG2, RGS2	Rieger syndrome, type 2	601499		2
RIL	Osteoporosis, susceptibility to	166710		3
RILPL1, RLP1, GOSPEL, OPDM4	Oculopharyngodistal myopathy 4	619790		3
RIMS1, RIM1, RIM, KIAA0340, CORD7	Cone-rod dystrophy 7	603649		3
RIMS2, KIAA0751, RIM2, OBOE, CRSDS	Cone-rod synaptic disorder syndrome, congenital nonprogressive	618970		3
RIN2, MACS	Macrocephaly, alopecia, cutis laxa, and scoliosis	613075		3
RINT1, ILFS3	Infantile liver failure syndrome 3	618641		3
RIPK1, RIP1, RIP, IMD57, AIEFL	 Autoinflammation with episodic fever and lymphadenopathy	618852		3
RIPK1, RIP1, RIP, IMD57, AIEFL	Immunodeficiency 57 with autoinflammation	618108		3
RIPK4, NKRD3, DIK, PPS2, CHANDS	CHAND syndrome	214350		3
RIPK4, NKRD3, DIK, PPS2, CHANDS	 Popliteal pterygium syndrome, Bartsocas-Papas type 1	263650		3
RIPOR2, FAM65B, C6orf32, KIAA0386, PL48, DFNB104, DFNA21	Deafness, autosomal dominant 21	607017	mutation identified in 1 DFNB104 family	3
RIPOR2, FAM65B, C6orf32, KIAA0386, PL48, DFNB104, DFNA21	 Deafness, autosomal recessive 104	616515	mutation identified in 1 DFNB104 family	3
RIT1, RIT, ROC1, NS8	Noonan syndrome 8	615355		3
RLBP1	Bothnia retinal dystrophy	607475		3
RLBP1	 Fundus albipunctatus	136880		3
RLBP1	 Newfoundland rod-cone dystrophy	607476		3
RLBP1	 Retinitis punctata albescens	136880		3
RLIM, RNF12, TOKAS	Tonne-Kalscheuer syndrome	300978		3
RLS1	Restless legs syndrome 1	102300	between D12S1044 and D12S78	2
RLS2	Restless legs syndrome 2	608831	max lod at D14S288	2
RLS3	Restless legs syndrome 3	610438	associated with rs4626664 and rs1975197	2
RLS4	Restless legs syndrome 4	610439	between D2S311 and D2S317	2
RLS5	Restless legs syndrome 5	611242	max lod at D20S849	2
RLS6	Restless legs syndrome 6	611185	associated with rs9296249 and rs9357271	2
RLS7	Restless legs syndrome 7	612853	associated with rs2300478	2
RLS8	Restless legs syndrome 8	615197		2
RMD1	Rippling muscle disease-1	600332		2
RMND1, COXPD11	Combined oxidative phosphorylation deficiency 11	614922		3
RMRP, RMRPR, CHH	Anauxetic dysplasia 1	607095		3
RMRP, RMRPR, CHH	 Cartilage-hair hypoplasia	250250		3
RMRP, RMRPR, CHH	 Metaphyseal dysplasia without hypotrichosis	250460		3
RNASEH1, PEOB2	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 2	616479	pseudogenes on chr. 17 and chr.1	3
RNASEH2A, RNHIA, AGS4	Aicardi-Goutieres syndrome 4	610333		3
RNASEH2B, DLEU8, FLJ11712, AGS2	Aicardi-Goutieres syndrome 2	610181		3
RNASEH2C, AYP1, FLJ20974, AGS3	Aicardi-Goutieres syndrome 3	610329		3
RNASEL, RNS4, PRCA1, HPC1	Prostate cancer 1	601518		3
RNASET2, RNASE6PL	Leukoencephalopathy, cystic, without megalencephaly	612951		3
RNF113A, ZNF183, TTD5	Trichothiodystrophy 5, nonphotosensitive	300953		3
RNF125, TRAC1, TNORS	Tenorio syndrome	616260		3
RNF139, TRC8, RCA1	Renal cell carcinoma	144700		3
RNF13, DEE73	Developmental and epileptic encephalopathy 73	618379		3
RNF168, RIDL	RIDDLE syndrome	611943		3
RNF170, SNAX1, SPG85	Ataxia, sensory, 1, autosomal dominant	608984		3
RNF170, SNAX1, SPG85	 Spastic paraplegia 85, autosomal recessive	619686		3
RNF212, ZHP3, SPGF62	 Recombination rate QTL 1	612042	mutation identified in 1 SPGF62 family	3
RNF213, ALO17, KIAA1618, MYMY2	Moyamoya disease 2, susceptibility to	607151		3
RNF216, TRIAD3, ZIN, CAHH	Cerebellar ataxia and hypogonadotropic hypogonadism	212840		3
RNF220, HLD23	Leukodystrophy, hypomyelinating, 23, with ataxia, deafness, liver dysfunction, and dilated cardiomyopathy	619688		3
RNF2, RING2, RING1B, HIPI3, DING, BAP1, LUSYAM	Luo-Schoch-Yamamoto syndrome	619460		3
RNF43, RNF124, SSPCS	Sessile serrated polyposis cancer syndrome	617108		3
RNF6	Esophageal carcinoma, somatic	133239		3
RNPC3, SNRNP65, KIAA1839, CPHD7	Pituitary hormone deficiency, combined or isolated, 7	618160		3
RNU4ATAC, U4ATAC, MOPD1, TALS, RFMN, LWS	 Lowry-Wood syndrome	226960		3
RNU4ATAC, U4ATAC, MOPD1, TALS, RFMN, LWS	 Microcephalic osteodysplastic primordial dwarfism, type I	210710		3
RNU4ATAC, U4ATAC, MOPD1, TALS, RFMN, LWS	Roifman syndrome	616651		3
RNU7-1, RNU7, AGS9	Aicardi-Goutieres syndrome 9	619487		3
ROBO2, SAX3, KIAA1568	Vesicoureteral reflux 2	610878		3
ROBO3, RBIG1, RIG1, HGPPS1	Gaze palsy, familial horizontal, with progressive scoliosis, 1	607313		3
ROBO4, AOVD3	Aortic valve disease 3	618496		3
ROGDI, KTZS	Kohlschutter-Tonz syndrome	226750		3
ROM1, ROSP1, RP7	Retinitis pigmentosa 7, digenic form	608133	digenic RP with RDS	3
ROR2, BDB1, BDB, NTRKR2	Brachydactyly, type B1	113000		3
ROR2, BDB1, BDB, NTRKR2	 Robinow syndrome, autosomal recessive	268310		3
RORA, IDDECA	Intellectual developmental disorder with or without epilepsy or cerebellar ataxia	618060		3
RORB, RZRB, EIG15	Epilepsy, idiopathic generalized, susceptibility to, 15	618357		3
RORC, RORG, RZRG, IMD42	Immunodeficiency 42	616622		3
RP17	Retinitis pigmentosa 17	600852	contiguous gene disorder	4
RP1L1, OCMD, RP88	Occult macular dystrophy	613587		3
RP1L1, OCMD, RP88	 Retinitis pigmentosa 88	618826		3
RP1, ORP1	Retinitis pigmentosa 1	180100		3
RP22	Retinitis pigmentosa 22	602594		2
RP24	Retinitis pigmentosa 24	300155		2
RP29	Retinitis pigmentosa 29	612165	maximum lod at D4S415	2
RP2	Retinitis pigmentosa 2	312600		3
RP34	Retinitis pigmentosa 34	300605		2
RP63	Retinitis pigmentosa 63	614494	between D6S457 and D6S1656	2
RPA1, PFBMFT6	Pulmonary fibrosis and/or bone marrow failure, telomere-related, 6	619767		3
RPE65, RP20, LCA2	 Leber congenital amaurosis 2	204100		3
RPE65, RP20, LCA2	Retinitis pigmentosa 20	613794		3
RPE65, RP20, LCA2	 Retinitis pigmentosa 87 with choroidal involvement	618697		3
RPGRIP1, LCA6, CORD13	Cone-rod dystrophy 13	608194		3
RPGRIP1, LCA6, CORD13	 Leber congenital amaurosis 6	613826		3
RPGRIP1L, KIAA1005, JBTS7, MKS5, COACH3	 COACH syndrome 3	619113	mutation identified in 1 COACH patient	3
RPGRIP1L, KIAA1005, JBTS7, MKS5, COACH3	Joubert syndrome 7	611560	mutation identified in 1 COACH patient	3
RPGRIP1L, KIAA1005, JBTS7, MKS5, COACH3	 Meckel syndrome 5	611561	mutation identified in 1 COACH patient	3
RPGR, RP3, CRD, RP15, COD1, CORDX1	 Cone-rod dystrophy, X-linked, 1	304020		3
RPGR, RP3, CRD, RP15, COD1, CORDX1	 Macular degeneration, X-linked atrophic	300834		3
RPGR, RP3, CRD, RP15, COD1, CORDX1	 Retinitis pigmentosa 3	300029		3
RPGR, RP3, CRD, RP15, COD1, CORDX1	Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness	300455		3
RPIA, RPI, RPIAD	Ribose 5-phosphate isomerase deficiency	608611		3
RPL10, DXS648, QM, AUTSX5, MRXS35	Autism, susceptibility to, X-linked 5	300847		3
RPL10, DXS648, QM, AUTSX5, MRXS35	 Intellectual developmental disorder, X-linked syndromic 35	300998		3
RPL11, DBA7	Diamond-Blackfan anemia 7	612562		3
RPL13, BBC1, D16S44E, SEMDIST	Spondyloepimetaphyseal dysplasia, Isidor-Toutain type	618728		3
RPL21, HYPT12	Hypotrichosis 12	615885		3
RPL35A, DBA5	Diamond-Blackfan anemia 5	612528	previous assignment to chr.18 in error	3
RPL3L, CMD2D	Cardiomyopathy, dilated, 2D	619371		3
RPL5, DBA6	Diamond-Blackfan anemia 6	612561		3
RPS10, DBA9	Diamond-Blackfan anemia 9	613308		3
RPS14, EMTB	Macrocytic anemia, refractory, due to 5q deletion, somatic	153550		3
RPS17, RPS17L1, RPS17L2, DBA4	Diamond-Blackfan anemia 4	612527	previously on chr.11; pseudogenes on 5q33-qter and 17q	3
RPS19, DBA, DBA1	Diamond-Blackfan anemia 1	105650		3
RPS23, BTDD, MCINS	Brachycephaly, trichomegaly, and developmental delay	617412		3
RPS24, DBA3	Diamond-blackfan anemia 3	610629		3
RPS26, DBA10	Diamond-Blackfan anemia 10	613309		3
RPS28, DBA15	Diamond Blackfan anemia 15 with mandibulofacial dysostosis	606164		3
RPS29, DBA13	Diamond-Blackfan anemia 13	615909		3
RPS6KA3, RSK2, XLID19	 Coffin-Lowry syndrome	303600		3
RPS6KA3, RSK2, XLID19	Intellectual developmental disorder, X-linked 19	300844		3
RPS7, DBA8	Diamond-Blackfan anemia 8	612563		3
RPSA, LAMR1, LAMBR, ICAS	Asplenia, isolated congenital	271400		3
RPY	Retinitis pigmentosa, Y-linked	400004		2
RRAGD, RAGD, HOMG7	Hypomagnesemia 7, renal, with or without dilated cardiomyopathy	620152		3
RRAS2, TC21, NS12	 Noonan syndrome 12	618624		3
RRAS2, TC21, NS12	Ovarian carcinoma	600098		3
RRDX	Radial ray deficiency	300378		2
RRIS	Respiratory rhythmicity in sleep	609116		2
RRM2B, P53R2, PEOA5, MTDPS8A, MTDPS8B, RCDFRD	 Mitochondrial DNA depletion syndrome 8A 	612075		3
RRM2B, P53R2, PEOA5, MTDPS8A, MTDPS8B, RCDFRD	Mitochondrial DNA depletion syndrome 8B 	612075		3
RRM2B, P53R2, PEOA5, MTDPS8A, MTDPS8B, RCDFRD	 Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 5	613077		3
RRM2B, P53R2, PEOA5, MTDPS8A, MTDPS8B, RCDFRD	 Rod-cone dystrophy, sensorineural deafness, and Fanconi-type renal dysfunction	268315		3
RS1, XLRS1	Retinoschisis	312700	25cM from XG	3
RSCIS	Radiation sensitivity/chromosome instability syndrome, autosomal dominant	605463		1
RSPH1, TSGA2, TSA2, CILD24	Ciliary dyskinesia, primary, 24	615481		3
RSPH3, RSHL2, RSP3, CILD32	Ciliary dyskinesia, primary, 32	616481		3
RSPH4A, CILD11	Ciliary dyskinesia, primary, 11	612649		3
RSPH9, CILD12	Ciliary dyskinesia, primary, 12	612650		3
RSPO1, FLJ40906	Palmoplantar hyperkeratosis and true hermaphroditism	610644		3
RSPO1, FLJ40906	 Palmoplantar hyperkeratosis with squamous cell carcinoma of skin and sex reversal	610644		3
RSPO2, CRISTIN2, TETAMS2, HHRRD	 Tetraamelia syndrome 2	618021	mutation identified in 1 HHRRD family	3
RSPO4, CRISTIN4	Anonychia congenita	206800		3
RSPRY1, KIAA1972, SEMDFA	Spondyloepimetaphyseal dysplasia, Faden-Alkuraya type	616723		3
RSRC1, SRRP53, MRT70	Intellectual developmental disorder, autosomal recessive 70	618402		3
RTEL1, C20orf41, NHL, KIAA1088, DKCB5, DKCA4, PFBMFT3	 Dyskeratosis congenita, autosomal dominant 4	615190		3
RTEL1, C20orf41, NHL, KIAA1088, DKCB5, DKCA4, PFBMFT3	 Dyskeratosis congenita, autosomal recessive 5	615190		3
RTEL1, C20orf41, NHL, KIAA1088, DKCB5, DKCA4, PFBMFT3	Pulmonary fibrosis and/or bone marrow failure, telomere-related, 3	616373		3
RTN2, NSPL1, SPG12	Spastic paraplegia 12, autosomal dominant	604805		3
RTN4IP1, NIMP, OPA10	Optic atrophy 10 with or without ataxia, impaired intellectual development and seizures	616732		3
RTN4R, NOGOR	Schizophrenia, susceptibility to	181500		3
RTTN, MSSP	Microcephaly, short stature, and polymicrogyria with seizures	614833		3
RUBCN, RUBICON, KIAA0226, SCAR15	Spinocerebellar ataxia, autosomal recessive 15	615705		3
RUNX1, CBFA2, AML1	 Leukemia, acute myeloid	601626		3
RUNX1, CBFA2, AML1	Platelet disorder, familial, with associated myeloid malignancy	601399		3
RUNX2, CBFA1, PEBP2A1, AML3, CCD, CLCD	 Cleidocranial dysplasia	119600		3
RUNX2, CBFA1, PEBP2A1, AML3, CCD, CLCD	 Cleidocranial dysplasia, forme fruste, dental anomalies only	119600		3
RUNX2, CBFA1, PEBP2A1, AML3, CCD, CLCD	 Cleidocranial dysplasia, forme fruste, with brachydactyly	119600		3
RUNX2, CBFA1, PEBP2A1, AML3, CCD, CLCD	Metaphyseal dysplasia with maxillary hypoplasia with or without brachydactyly	156510		3
RUSC2, KIAA0375, IPORIN, MRT61	Intellectual developmental disorder, autosomal recessive 61	617773		3
RXYLT1, TMEM5, MDDGA10	Muscular dystrophy-dystroglycanopathy , type A, 10	615041		3
RYR1, MHS, CCO, KDS	 Central core disease	117000		3
RYR1, MHS, CCO, KDS	 King-Denborough syndrome	619542		3
RYR1, MHS, CCO, KDS	 Malignant hyperthermia susceptibility 1	145600		3
RYR1, MHS, CCO, KDS	 Minicore myopathy with external ophthalmoplegia	255320		3
RYR1, MHS, CCO, KDS	Neuromuscular disease, congenital, with uniform type 1 fiber	117000		3
RYR2, VTSIP, ARVD2, ARVC2, VACRDS	 Arrhythmogenic right ventricular dysplasia 2	600996		3
RYR2, VTSIP, ARVD2, ARVC2, VACRDS	 Ventricular arrhythmias due to cardiac ryanodine receptor calcium release deficiency syndrome	115000		3
RYR2, VTSIP, ARVD2, ARVC2, VACRDS	Ventricular tachycardia, catecholaminergic polymorphic, 1	604772		3
S1PR2, EDG5, DFNB68	Deafness, autosomal recessive 68	610419		3
SACS, ARSACS	Spastic ataxia, Charlevoix-Saguenay type	270550		3
SAG, RP47	 Oguchi disease-1	258100		3
SAG, RP47	Retinitis pigmentosa 47	613758		3
SALL1, HSAL1, TBS	 Townes-Brocks branchiootorenal-like syndrome	107480		3
SALL1, HSAL1, TBS	Townes-Brocks syndrome 1	107480		3
SALL4, HSAL4, DRRS, IVIC	 Duane-radial ray syndrome	607323	mutation identified in 1 IVIC family	3
SAMD12	Epilepsy, familial adult myoclonic, 1	601068		3
SAMD9L, ATXPC, M7MLS1, SCA49	Ataxia-pancytopenia syndrome	159550		3
SAMD9L, ATXPC, M7MLS1, SCA49	 Monosomy 7 myelodysplasia and leukemia syndrome 1	252270		3
SAMD9L, ATXPC, M7MLS1, SCA49	 Spinocerebellar ataxia 49	619806		3
SAMD9, NFTC, MIRAGE, M7MLS2	 MIRAGE syndrome	617053		3
SAMD9, NFTC, MIRAGE, M7MLS2	 Monosomy 7 myelodysplasia and leukemia syndrome 2	619041		3
SAMD9, NFTC, MIRAGE, M7MLS2	Tumoral calcinosis, familial, normophosphatemic	610455		3
SAMHD1, AGS5, DCIP, CHBL2	 Aicardi-Goutieres syndrome 5	612952	mutation identified in 1 CHBL2 family	3
SAR1B, CMRD, SARA2, ANDD	Chylomicron retention disease	246700		3
SARDH, SARD, SAR	Sarcosinemia	268900		3
SARS1, SARS, SERS, NEDMAS	Neurodevelopmental disorder with microcephaly, ataxia, and seizures	617709		3
SARS2	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis	613845		3
SASH1, KIAA0790, CAPOK, DUH1	 Cancer, alopecia, pigment dyscrasia, onychodystrophy, and keratoderma	618373	mutation identified in 1 CAPOK family	3
SASH1, KIAA0790, CAPOK, DUH1	Dyschromatosis universalis hereditaria 1	127500	mutation identified in 1 CAPOK family	3
SASH3, HACS2, CXorf9, SLY, IMD102	Immunodeficiency 102	301082		3
SASS6, SAS6, MCPH14	Microcephaly 14, primary, autosomal recessive	616402		3
SATB1, DEFDA, KTZSL	 Developmental delay with dysmorphic facies and dental anomalies	619228		3
SATB1, DEFDA, KTZSL	Kohlschutter-Tonz syndrome-like	619229		3
SATB2, KIAA1034, GLSS	Glass syndrome	612313		3
SBDS, SDS	Aplastic anemia, susceptibility to	609135		3
SBDS, SDS	 Shwachman-Diamond syndrome 1	260400		3
SBF1, MTMR5, CMT4B3	Charcot-Marie-Tooth disease, type 4B3	615284		3
SBF2, MTMR13, CMT4B2	Charcot-Marie-Tooth disease, type 4B2	604563		3
SC5D, ERG3	Lathosterolosis	607330		3
SCA18, SMNA	Spinocerebellar ataxia 18	607458	between D7S2418 and D7S1804	2
SCA20, DUP11q12, C11DUPq12	Spinocerebellar ataxia 20	608687	contiguous gene duplication syndrome	4
SCA32	Spinocerebellar ataxia 32	613909	between rs3847110 and rs2241728	2
SCA4	Spinocerebellar ataxia 4	600223		2
SCAPER, KIAA1454, IDDRP	Intellectual developmental disorder and retinitis pigmentosa	618195		3
SCAR3, SCABD	Spinocerebellar ataxia, autosomal recessive 3	271250		2
SCAR6, CLA3	Spinocerebellar ataxia, autosomal recessive 6	608029	between D20S471 and D20S119	2
SCARB1, CD36L1, CLA1, HDLQTL6	High density lipoprotein cholesterol level QTL6	610762		3
SCARB2, CD36L2, LIMPII, AMRF, EPM4	Epilepsy, progressive myoclonic 4, with or without renal failure	254900		3
SCARF2, SREC2, VDEGS	Van den Ende-Gupta syndrome	600920		3
SCAX5	Spinocerebellar ataxia, X-linked 5	300703	between DXS1047 and DXS1227	2
SCGB3A2, UGRP1	Asthma, susceptibility to	600807		3
SCLC1	Small-cell cancer of lung	182280	centromeric to ERBA2	2
SCLL	Chromosome 8p11 myeloproliferative syndrome	613523	translocation of FGFR1 (8p11) and various partners	4
SCN10A, FEPS2	Episodic pain syndrome, familial, 2	615551		3
SCN11A, HSAN7, FEPS3	Episodic pain syndrome, familial, 3	615552		3
SCN11A, HSAN7, FEPS3	 Neuropathy, hereditary sensory and autonomic, type VII	615548		3
SCN1A, GEFSP2, SMEI, FEB3A, DEE6A, DRVT, FHM3, DEE6B	Developmental and epileptic encephalopathy 6B, non-Dravet	619317		3
SCN1A, GEFSP2, SMEI, FEB3A, DEE6A, DRVT, FHM3, DEE6B	 Dravet syndrome	607208		3
SCN1A, GEFSP2, SMEI, FEB3A, DEE6A, DRVT, FHM3, DEE6B	 Febrile seizures, familial, 3A	604403		3
SCN1A, GEFSP2, SMEI, FEB3A, DEE6A, DRVT, FHM3, DEE6B	 Generalized epilepsy with febrile seizures plus, type 2	604403		3
SCN1A, GEFSP2, SMEI, FEB3A, DEE6A, DRVT, FHM3, DEE6B	 Migraine, familial hemiplegic, 3	609634		3
SCN1B, GEFSP1, BRGDA5, ATFB13, DEE52	 Atrial fibrillation, familial, 13	615377		3
SCN1B, GEFSP1, BRGDA5, ATFB13, DEE52	 Brugada syndrome 5	612838		3
SCN1B, GEFSP1, BRGDA5, ATFB13, DEE52	 Cardiac conduction defect, nonspecific	612838		3
SCN1B, GEFSP1, BRGDA5, ATFB13, DEE52	 Developmental and epileptic encephalopathy 52	617350		3
SCN1B, GEFSP1, BRGDA5, ATFB13, DEE52	Generalized epilepsy with febrile seizures plus, type 1	604233		3
SCN2A, SCN2A1, BFIC3, DEE11, BFIS3, BFNIS, EA9	 Developmental and epileptic encephalopathy 11	613721	4 related genes on chr.2	3
SCN2A, SCN2A1, BFIC3, DEE11, BFIS3, BFNIS, EA9	 Episodic ataxia, type 9	618924	4 related genes on chr.2	3
SCN2A, SCN2A1, BFIC3, DEE11, BFIS3, BFNIS, EA9	Seizures, benign familial infantile, 3	607745	4 related genes on chr.2	3
SCN2B, ATFB14	Atrial fibrillation, familial, 14	615378		3
SCN3A, FFEVF4, DEE62	 Developmental and epileptic encephalopathy 62	617938		3
SCN3A, FFEVF4, DEE62	Epilepsy, familial focal, with variable foci 4	617935		3
SCN3B, SCNB3, BRGDA7, ATFB16	Atrial fibrillation, familial, 16	613120		3
SCN3B, SCNB3, BRGDA7, ATFB16	 Brugada syndrome 7	613120		3
SCN4A, HYPP, NAC1A, HOKPP2, CMS16	 Hyperkalemic periodic paralysis, type 2	170500	21.5kb from GH1	3
SCN4A, HYPP, NAC1A, HOKPP2, CMS16	 Hypokalemic periodic paralysis, type 2	613345	21.5kb from GH1	3
SCN4A, HYPP, NAC1A, HOKPP2, CMS16	 Myasthenic syndrome, congenital, 16	614198	21.5kb from GH1	3
SCN4A, HYPP, NAC1A, HOKPP2, CMS16	 Myotonia congenita, atypical, acetazolamide-responsive	608390	21.5kb from GH1	3
SCN4A, HYPP, NAC1A, HOKPP2, CMS16	Paramyotonia congenita	168300	21.5kb from GH1	3
SCN4B, LQT10, ATFB17	Atrial fibrillation, familial, 17	611819		3
SCN4B, LQT10, ATFB17	 Long QT syndrome 10	611819		3
SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	 Atrial fibrillation, familial, 10	614022		3
SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	 Brugada syndrome 1	601144		3
SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	 Cardiomyopathy, dilated, 1E	601154		3
SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	 Heart block, nonprogressive	113900		3
SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	 Heart block, progressive, type IA	113900		3
SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	 Long QT syndrome 3	603830		3
SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	 Sick sinus syndrome 1	608567		3
SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	 Sudden infant death syndrome, susceptibility to	272120		3
SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	Ventricular fibrillation, familial, 1	603829		3
SCN8A, CIAT, DEE13, BFIS5, MYOCL2	 Cognitive impairment with or without cerebellar ataxia	614306	mutation identified in 1 MYOCL2 family	3
SCN8A, CIAT, DEE13, BFIS5, MYOCL2	 Developmental and epileptic encephalopathy 13	614558	mutation identified in 1 MYOCL2 family	3
SCN8A, CIAT, DEE13, BFIS5, MYOCL2	 Seizures, benign familial infantile, 5	617080	mutation identified in 1 MYOCL2 family	3
SCN9A, NENA, PN1, SFNP, HSAN2D	Erythermalgia, primary	133020		3
SCN9A, NENA, PN1, SFNP, HSAN2D	 Insensitivity to pain, congenital	243000		3
SCN9A, NENA, PN1, SFNP, HSAN2D	 Neuropathy, hereditary sensory and autonomic, type IID	243000		3
SCN9A, NENA, PN1, SFNP, HSAN2D	 Paroxysmal extreme pain disorder	167400		3
SCN9A, NENA, PN1, SFNP, HSAN2D	 Small fiber neuropathy	133020		3
SCNM1, MGC3180, OFD19	Orofaciodigital syndrome XIX	620107		3
SCNN1A, BESC2, LIDLS3, PHA1B1	 Bronchiectasis with or without elevated sweat chloride 2	613021	mutation identified in 1 LIDLS3 patient	3
SCNN1A, BESC2, LIDLS3, PHA1B1	 Liddle syndrome 3	618126	mutation identified in 1 LIDLS3 patient	3
SCNN1A, BESC2, LIDLS3, PHA1B1	Pseudohypoaldosteronism, type IB1, autosomal recessive	264350	mutation identified in 1 LIDLS3 patient	3
SCNN1B, BESC1, LIDLS1, PHA1B2	Bronchiectasis with or without elevated sweat chloride 1	211400		3
SCNN1B, BESC1, LIDLS1, PHA1B2	 Liddle syndrome 1	177200		3
SCNN1B, BESC1, LIDLS1, PHA1B2	 Pseudohypoaldosteronism, type IB2, autosomal recessive	620125		3
SCNN1G, PHA1B3, BESC3, LDLS2	Bronchiectasis with or without elevated sweat chloride 3	613071	same 400kb fragment as SCNN1B	3
SCNN1G, PHA1B3, BESC3, LDLS2	 Liddle syndrome 2	618114	same 400kb fragment as SCNN1B	3
SCNN1G, PHA1B3, BESC3, LDLS2	 Pseudohypoaldosteronism, type IB3, autosomal recessive	620126	same 400kb fragment as SCNN1B	3
SCO1, SCOD1, MC4DN4	Mitochondrial complex IV deficiency, nuclear type 4	619048		3
SCO2, MC4DN2, MYP6	 Mitochondrial complex IV deficiency, nuclear type 2	604377		3
SCO2, MC4DN2, MYP6	Myopia 6	608908		3
SCUBE3, SSFSC2	Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies	619184		3
SCYL1, NTKL, SCAR21	Spinocerebellar ataxia, autosomal recessive 21	616719		3
SCYL2, CVAK104, KIAA1360, AMC4	Arthrogryposis multiplex congenita 4, neurogenic, with agenesis of the corpus callosum	618766		3
SCZD10	Schizophrenia 10	605419	between D15S1042 and D15S659	2
SCZD11	Schizophrenia	181500	between D10S1677 and D10S1753	2
SCZD12	Schizophrenia 12	181500	max lod at D1S1612	2
SCZD13	Schizophrenia, susceptibility to, 13	613025	associated with deletion at 15q13.3	2
SCZD14	Schizophrenia, susceptibility to, 14	612361	associated with rs1344706	2
SCZD16, C16DUPq36.3, DUP7q36.3	Schizophrenia 16	613959	362kb duplication that includes VIPR2	4
SCZD1	Schizophrenia	181500	max lod at D5S820	2
SCZD2	Schizophrenia	181500		2
SCZD3	Schizophrenia	181500	?same as DTNBP1; cognitive deficit type	2
SCZD5	Schizophrenia	181500	max lod at D6S1626 and D6S292	2
SCZD6	Schizophrenia	181500	?neuregulin 1	2
SCZD7	Schizophrenia	181500		2
SCZD8	Schizophrenia	181500		2
SDC3, SYND3, SDCN	Obesity, association with	601665		3
SDCCAG8, CCCAP, SLSN7, BBS16	 Bardet-Biedl syndrome 16	615993		3
SDCCAG8, CCCAP, SLSN7, BBS16	Senior-Loken syndrome 7	613615		3
SDHAF1, MC2DN2	Mitochondrial complex II deficiency, nuclear type 2	619166		3
SDHAF2, SDH5, PGL2	Paragangliomas 2	601650		3
SDHA, SDH1, SDHF, CMD1GG, PGL5, MC2DN1, NDAXOA	Cardiomyopathy, dilated, 1GG	613642	copy on 3q29	3
SDHA, SDH1, SDHF, CMD1GG, PGL5, MC2DN1, NDAXOA	 Mitochondrial complex II deficiency, nuclear type 1	252011	copy on 3q29	3
SDHA, SDH1, SDHF, CMD1GG, PGL5, MC2DN1, NDAXOA	 Neurodegeneration with ataxia and late-onset optic atrophy	619259	copy on 3q29	3
SDHA, SDH1, SDHF, CMD1GG, PGL5, MC2DN1, NDAXOA	 Paragangliomas 5	614165	copy on 3q29	3
SDHB, SDH2, SDHIP, PGL4, MC2DN4	 Gastrointestinal stromal tumor	606764	1 of 2 polypeptides	3
SDHB, SDH2, SDHIP, PGL4, MC2DN4	 Mitochondrial complex II deficiency, nuclear type 4	619224	1 of 2 polypeptides	3
SDHB, SDH2, SDHIP, PGL4, MC2DN4	 Paraganglioma and gastric stromal sarcoma	606864	1 of 2 polypeptides	3
SDHB, SDH2, SDHIP, PGL4, MC2DN4	Paragangliomas 4	115310	1 of 2 polypeptides	3
SDHB, SDH2, SDHIP, PGL4, MC2DN4	 Pheochromocytoma	171300	1 of 2 polypeptides	3
SDHC, PGL3	 Gastrointestinal stromal tumor	606764		3
SDHC, PGL3	 Paraganglioma and gastric stromal sarcoma	606864		3
SDHC, PGL3	Paragangliomas 3	605373		3
SDHD, PGL1, MC2DN3	 Mitochondrial complex II deficiency, nuclear type 3	619167		3
SDHD, PGL1, MC2DN3	 Paraganglioma and gastric stromal sarcoma	606864		3
SDHD, PGL1, MC2DN3	Paragangliomas 1, with or without deafness	168000		3
SDHD, PGL1, MC2DN3	 Pheochromocytoma	171300		3
SDR9C7, SDRO, ARCI13	Ichthyosis, congenital, autosomal recessive 13	617574		3
SDSX, MRXSDS	Intellectual developmental disorder, X-linked, syndromic, Stocco dos Santos type	300434		2
SEC23A, CLSD	Craniolenticulosutural dysplasia	607812		3
SEC23B, CDAN2, HEMPAS, CWS7	 Dyserythropoietic anemia, congenital, type II	224100	mutation identified in 1 CWS7 family	3
SEC24D, KIAA0755, CLCRP2	Cole-Carpenter syndrome 2	616294		3
SEC61A1, SEC61, ADTKD5	Tubulointerstitial kidney disease, autosomal dominant, 5	617056		3
SEC63, PCLD2	Polycystic liver disease 2	617004		3
SECISBP2, SBP2, THMA1	Thyroid hormone metabolism, abnormal, 1	609698		3
SECISBP2, SBP2, THMA1	 Thyroid hormone metabolism, abnormal	609698		3
SELENBP1, SP56, EHMTO	Extraoral halitosis due to MTO deficiency	618148		3
SELENOI, SELI, SPG81	Spastic paraplegia 81, autosomal recessive	618768		3
SELENON, SEPN1, SELN, RSMD1, CFTD	 Muscular dystrophy, rigid spine, 1	602771		3
SELENON, SEPN1, SELN, RSMD1, CFTD	Myopathy, congenital, with fiber-type disproportion	255310		3
SEMA3A, SEMAD, COLL1, HH16	Hypogonadotropic hypogonadism 16 with or without anosmia	614897		3
SEMA4A, SEMB, RP35, CORD10	 Cone-rod dystrophy 10	610283		3
SEMA4A, SEMB, RP35, CORD10	Retinitis pigmentosa 35	610282		3
SEMA6B, EPM11	Epilepsy, progressive myoclonic, 11	618876		3
SEMA7A, SEMAL, SEMAK1, CDW108, JMH, PFIC11	 Blood group, John-Milton-Hagen system	614745	mutation identified in 1 PFIC11 patient	3
SEPSECS, SLA, LP, PCH2D	Pontocerebellar hypoplasia type 2D	613811		3
SEPT12, SPGF10	Spermatogenic failure 10	614822		3
SEPT9, MSF, MSF1, NAPB	Amyotrophy, hereditary neuralgic	162100		3
SERAC1, MEGDEL	3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome	614739		3
SERPINA1, PI, AAT	 Emphysema-cirrhosis, due to AAT deficiency	613490		3
SERPINA1, PI, AAT	 Emphysema due to AAT deficiency	613490		3
SERPINA1, PI, AAT	Hemorrhagic diathesis due to antithrombin Pittsburgh	613490		3
SERPINA3, AACT, ACT	Alpha-1-antichymotrypsin deficiency	107280	220kb from PI	3
SERPINA3, AACT, ACT	 Cerebrovascular disease, occlusive	107280	220kb from PI	3
SERPINB7, MEGSIN, PPKN	Palmoplantar keratoderma, Nagashima type	615598		3
SERPINB8, PI8, CAP2, PSS5	Peeling skin syndrome 5	617115		3
SERPINC1, AT3, AT3D, THPH7	Thrombophilia 7 due to antithrombin III deficiency	613118	~17cM distal to FY	3
SERPINF1, PEDF, OI6	Osteogenesis imperfecta, type VI	613982	same region as RP13	3
SERPINH1, SERPINH2, PPROM, CBP2, CBP1, OI10	 Osteogenesis imperfecta, type X	613848		3
SERPINH1, SERPINH2, PPROM, CBP2, CBP1, OI10	Preterm premature rupture of the membranes, susceptibility to	610504		3
SERPINI1, PI12	Encephalopathy, familial, with neuroserpin inclusion bodies	604218		3
SETBP1, KIAA0437, SEB, MRD29	 Intellectual developmental disorder, autosomal dominant 29	616078	fused with NUP98 in ALL	3
SETBP1, KIAA0437, SEB, MRD29	Schinzel-Giedion midface retraction syndrome	269150	fused with NUP98 in ALL	3
SETD1A, SET1A, SET1, KIAA0339, EPEDD, NEDSID	Epilepsy, early-onset, with or without developmental delay	618832		3
SETD1A, SET1A, SET1, KIAA0339, EPEDD, NEDSID	 Neurodevelopmental disorder with speech impairment and dysmorphic facies	619056		3
SETD1B, SET1B, KIAA1076, IDDSELD	Intellectual developmental disorder with seizures and language delay	619000		3
SETD2, SET2, HYPB, HBP231, KIAA1732, LLS, RAPAS, MRD70	 Intellectual developmental disorder, autosomal dominant 70	620157		3
SETD2, SET2, HYPB, HBP231, KIAA1732, LLS, RAPAS, MRD70	Luscan-Lumish syndrome	616831		3
SETD2, SET2, HYPB, HBP231, KIAA1732, LLS, RAPAS, MRD70	 Rabin-Pappas syndrome	620155		3
SETD5, KIAA1757, MRD23	Intellectual developmental disorder, autosomal dominant 23	615761		3
SET, MRD58	Intellectual developmental disorder, autosomal dominant 58	618106	fused with CAIN in acute undifferentiated leukemia	3
SETX, SCAN2, AOA2, ALS4	 Amyotrophic lateral sclerosis 4, juvenile	602433		3
SETX, SCAN2, AOA2, ALS4	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2	606002		3
SF3B1, SF3B155, SAP155, MDS	Myelodysplastic syndrome, somatic	614286		3
SF3B2, SF3B145, SAP145, CFM	Craniofacial microsomia	164210		3
SF3B4, SF3B49, SAP49, AFD1	Acrofacial dysostosis 1, Nager type	154400		3
SF	Blood group, Stoltzfus system	111800	~25cM from MNSs	2
SFRP4, FRPHE, PYL	Pyle disease	265900		3
SFTPA1, SFTP1, ILD1	Interstitial lung disease 1	619611	contiguous with SFTPA2	3
SFTPA2, SPA2, COLEC5, ILD2	Interstitial lung disease 2	178500	contiguous with SFTPA1	3
SFTPB, SFTB3, SMDP1	Surfactant metabolism dysfunction, pulmonary, 1	265120		3
SFTPC, SFTP2, SMDP2	Surfactant metabolism dysfunction, pulmonary, 2	610913		3
SFXN4, COXPD18	Combined oxidative phosphorylation deficiency 18	615578		3
SGCA, ADL, DAG2, LGMDR3	Muscular dystrophy, limb-girdle, autosomal recessive 3	608099		3
SGCB, LGMDR4	Muscular dystrophy, limb-girdle, autosomal recessive 4	604286		3
SGCD, SGD, LGMDR6, CMD1L	Cardiomyopathy, dilated, 1L	606685	mutant in Syrian hamster cardiomyopathy	3
SGCD, SGD, LGMDR6, CMD1L	 Muscular dystrophy, limb-girdle, autosomal recessive 6	601287	mutant in Syrian hamster cardiomyopathy	3
SGCE, DYT11	Dystonia-11, myoclonic	159900	pseudogene on 2q21; maternally imprinted	3
SGCG, LGMDR5, DMDA1, SCG3	Muscular dystrophy, limb-girdle, autosomal recessive 5	253700		3
SGMS2, SMS2, CDL	Calvarial doughnut lesions with bone fragility with or without spondylometaphyseal dysplasia	126550		3
SGOL1, SGO, SGO1, CAID	Chronic atrial and intestinal dysrhythmia	616201		3
SGPL1, SPL, NPHS14	Nephrotic syndrome, type 14	617575		3
SGSH, MPS3A, SFMD	Mucopolysaccharidosis type IIIA 	252900		3
SH2B3, LNK	 Erythrocytosis, somatic	133100		3
SH2B3, LNK	 Myelofibrosis, somatic	254450		3
SH2B3, LNK	Thrombocythemia, somatic	187950		3
SH2D1A, LYP, IMD5, XLP, XLPD1	Lymphoproliferative syndrome, X-linked, 1	308240	1cM from DXS42; no recombination with DXS37	3
SH3BP2, CRPM	Cherubism	118400		3
SH3GL1, EEN	Leukemia, acute myeloid	601626		1
SH3PXD2B, TKS4, KIAA1295, FTHS	Frank-ter Haar syndrome	249420		3
SH3TC2, KIAA1985, MNMN	Charcot-Marie-Tooth disease, type 4C	601596		3
SH3TC2, KIAA1985, MNMN	 Mononeuropathy of the median nerve, mild	613353		3
SHANK2, CORTBP1, AUTS17	Autism susceptibility 17	613436		3
SHANK3, PSAP2, PROSAP2, KIAA1650, DEL22q13.3, SCZD15	Phelan-McDermid syndrome	606232		3
SHANK3, PSAP2, PROSAP2, KIAA1650, DEL22q13.3, SCZD15	 Schizophrenia 15	613950		3
SHFL1, SHFLD	Split-hand/foot malformation with long bone deficiency 1	119100	between rs1124110 and rs535043	2
SHFLD2	Split-hand/foot malformation with long bone deficiency 2	610685	between rs623155 and rs1547251	2
SHFLD3, DUP17p13.3, C17DUPp13.3	Split-hand/foot malformation with long bone deficiency 3	612576	max lod at or near D17S1533; contiguous gene duplication syndrome	4
SHFM2, SHFD2	Split hand/foot malformation 2	313350		2
SHFM3, SHSF3, DUP10q24, C10DUPq24	Split-hand/foot malformation 3, gene duplication syndrome	246560	contiguous gene duplication syndrome	4
SHFM5	Split-hand/foot malformation 5	606708	between EVX2 and D2S294	2
SHH, HPE3, HLP3, SMMCI, MCOPCB5	 Holoprosencephaly 3	142945	separate from TPT1	3
SHH, HPE3, HLP3, SMMCI, MCOPCB5	Microphthalmia with coloboma 5	611638	separate from TPT1	3
SHH, HPE3, HLP3, SMMCI, MCOPCB5	 Schizencephaly	269160	separate from TPT1	3
SHH, HPE3, HLP3, SMMCI, MCOPCB5	 Single median maxillary central incisor	147250	separate from TPT1	3
SHMT2, GLYA, NEDCASB	Neurodevelopmental disorder with cardiomyopathy, spasticity, and brain abnormalities	619121	glycine A auxotroph	3
SHOC1, C9orf84, ZIP2, SPGF75	Spermatogenic failure 75	619949		3
SHOC2, SIAA0862, SOC2, SUR8, NSLH1	Noonan syndrome-like with loose anagen hair 1	607721		3
SHOX, GCFX, SS, PHOG	 Langer mesomelic dysplasia	249700	pseudoautosomal; ?gene causing short stature in Turner syndrome	3
SHOX, GCFX, SS, PHOG	 Leri-Weill dyschondrosteosis	127300	pseudoautosomal; ?gene causing short stature in Turner syndrome	3
SHOX, GCFX, SS, PHOG	Short stature, idiopathic familial	300582	pseudoautosomal; ?gene causing short stature in Turner syndrome	3
SHOXY	 Langer mesomelic dysplasia	249700	pseudoautosomal	3
SHOXY	 Leri-Weill dyschondrosteosis	127300	pseudoautosomal	3
SHOXY	Short stature, idiopathic familial	300582	pseudoautosomal	3
SHPK, CARKL	Sedoheptulokinase deficiency	617213		3
SHQ1, DYT35, NEDDS	 Dystonia 35, childhood-onset	619921	mutation identified in 1 DYT35 family	3
SHQ1, DYT35, NEDDS	Neurodevelopmental disorder with dystonia and seizures	619922	mutation identified in 1 DYT35 family	3
SIAE, AIS6	Autoimmune disease, susceptibility to, 6	613551		3
SIAH1, BURHAS	Buratti-Harel syndrome	619314		3
SIAT9, ST3GALV, SPDRS	Salt and pepper developmental regression syndrome	609056		3
SIGMAR1, SRBP, ALS16, DSMA2	 Amyotrophic lateral sclerosis 16, juvenile	614373	mutation identified in 1 ALS16 family and 1 DSMA2 family	3
SIK1, SNF1LK, MSK, DEE30	Developmental and epileptic encephalopathy 30	616341		3
SIL1, BAP, MSS	Marinesco-Sjogren syndrome	248800		3
SIN3A, WITKOS	Witteveen-Kolk syndrome	613406		3
SI	Sucrase-isomaltase deficiency, congenital	222900		3
SIX1, BOS3, DFNA23	 Branchiootic syndrome 3	608389		3
SIX1, BOS3, DFNA23	Deafness, autosomal dominant 23	605192		3
SIX3, HPE2	 Holoprosencephaly 2	157170		3
SIX3, HPE2	Schizencephaly	269160		3
SIX5, DMAHP, BOR2	Branchiootorenal syndrome 2	610896		3
SIX6, ODRMD	Optic disc anomalies with retinal and/or macular dystrophy	212550		3
SKIC2, SKIV2L, SKI2, SKI2W, THES2	Trichohepatoenteric syndrome 2	614602		3
SKIC3, TTC37, KIAA0372	Trichohepatoenteric syndrome 1	222470		3
SKI, SGS	Shprintzen-Goldberg syndrome	182212	formerly mapped to 1q22-q24	3
SLC10A1, NTCP1, FHCA2	Hypercholanemia, familial 2	619256		3
SLC10A7, SSASKS	Short stature, amelogenesis imperfecta, and skeletal dysplasia with scoliosis	618363		3
SLC11A2, NRAMP2, DCT1, DMT1, AHMIO1	Anemia, hypochromic microcytic, with iron overload 1	206100		3
SLC12A1, NKCC2	Bartter syndrome, type 1	601678		3
SLC12A2, NKCC1, KILQS	 Deafness, autosomal dominant 78	619081		3
SLC12A2, NKCC1, KILQS	 Delpire-McNeill syndrome	619083		3
SLC12A2, NKCC1, KILQS	Kilquist syndrome	619080		3
SLC12A3, NCCT, TSC	Gitelman syndrome	263800		3
SLC12A5, KCC2, KIAA1176, DEE34, EIG14	 Developmental and epileptic encephalopathy 34	616645		3
SLC12A5, KCC2, KIAA1176, DEE34, EIG14	Epilepsy, idiopathic generalized, susceptibility to, 14	616685		3
SLC12A6, KCC3A, KCC3B, KCC3, ACCPN, CMT2II	Agenesis of the corpus callosum with peripheral neuropathy	218000		3
SLC12A6, KCC3A, KCC3B, KCC3, ACCPN, CMT2II	 Charcot-Marie-Tooth disease, axonal, type 2II	620068		3
SLC13A3, NADC3, ARLIAK	Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate	618384		3
SLC13A5, NACT, DEE25	Developmental and epileptic encephalopathy 25, with amelogenesis imperfecta	615905		3
SLC14A1, JK, UTE, UT1	Blood group, Kidd	111000	previous suggestion of chr.7 or chr.2	3
SLC16A12, MCT12, CTRCT47	Cataract 47, juvenile, with microcornea	612018	mutation identified in 1 CTRCT47 family	3
SLC16A1, MCT1, HHF7, MCT1D	 Erythrocyte lactate transporter defect	245340		3
SLC16A1, MCT1, HHF7, MCT1D	Hyperinsulinemic hypoglycemia, familial, 7	610021		3
SLC16A1, MCT1, HHF7, MCT1D	 Monocarboxylate transporter 1 deficiency	616095		3
SLC16A2, DXS128, XPCT	Allan-Herndon-Dudley syndrome	300523		3
SLC17A3, NPT4, UAQTL4, GOUT4	 Gout susceptibility 4	612671		3
SLC17A3, NPT4, UAQTL4, GOUT4	Uric acid concentration, serum, QTL4	612671		3
SLC17A5, SIASD, SLD	Salla disease	604369		3
SLC17A5, SIASD, SLD	 Sialic acid storage disorder, infantile	269920		3
SLC17A8, VGLUT3, DFNA25	Deafness, autosomal dominant 25	605583		3
SLC17A9, C20orf59, POROK8	Porokeratosis 8, disseminated superficial actinic type	616063		3
SLC18A3, VACHT, CMS21	Myasthenic syndrome, congenital, 21, presynaptic	617239		3
SLC19A2, THTR1, TRMA, THMD1	Thiamine-responsive megaloblastic anemia syndrome	249270		3
SLC19A3, THMD2, BBGD	Thiamine metabolism dysfunction syndrome 2 	607483		3
SLC1A1, EAAC1, SCZD18, DCBXA	Dicarboxylic aminoaciduria	222730	mutation identified in 1 SCZD18 family	3
SLC1A1, EAAC1, SCZD18, DCBXA	 Schizophrenia susceptibility 18	615232	mutation identified in 1 SCZD18 family	3
SLC1A2, EAAT2, DEE41	Developmental and epileptic encephalopathy 41	617105		3
SLC1A3, EAAT1, EA6	Episodic ataxia, type 6	612656		3
SLC1A4, SATT, ASCT1, SPATCCM	Spastic tetraplegia, thin corpus callosum, and progressive microcephaly	616657		3
SLC20A2, MLVAR, GLVR2, IBGC1, IBGC2	Basal ganglia calcification, idiopathic, 1	213600		3
SLC22A12, OAT4L, URAT1	Hypouricemia, renal	220150		3
SLC22A1L, BWSCR1A, IMPT1	Breast cancer, somatic	114480		3
SLC22A1L, BWSCR1A, IMPT1	 Lung cancer, somatic	211980		3
SLC22A1L, BWSCR1A, IMPT1	 Rhabdomyosarcoma, somatic	268210		3
SLC22A4, OCTN1	Rheumatoid arthritis, susceptibility to	180300		3
SLC22A5, OCTN2, CDSP, SCD	Carnitine deficiency, systemic primary	212140		3
SLC24A1, NCKX1, CSNB1D	Night blindness, congenital stationary , 1D, autosomal recessive	613830		3
SLC24A4, NCKX4, SHEP6, AI2A5	 Amelogenesis imperfecta, type IIA5	615887		3
SLC24A4, NCKX4, SHEP6, AI2A5	Skin/hair/eye pigmentation 6, blond/brown hair	210750		3
SLC24A4, NCKX4, SHEP6, AI2A5	 Skin/hair/eye pigmentation 6, blue/green eyes	210750		3
SLC24A5, NCKX5, SHEP4, OCA6	 Albinism, oculocutaneous, type VI	113750		3
SLC24A5, NCKX5, SHEP4, OCA6	Skin/hair/eye pigmentation 4, fair/dark skin	113750		3
SLC25A11, SLC20A4, OGC, PGL6	Paragangliomas 6	618464		3
SLC25A12, ARALAR, DEE39	Developmental and epileptic encephalopathy 39	612949		3
SLC25A13, CTLN2, NICCD	 Citrullinemia, adult-onset type II	603471		3
SLC25A13, CTLN2, NICCD	Citrullinemia, type II, neonatal-onset	605814		3
SLC25A15, ORNT1, HHH	Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome	238970	with deficiency of factors VII and X in 3 unrelated cases	3
SLC25A19, DNC, MUP1, MCPHA, THMD3, THMD4	Microcephaly, Amish type	607196		3
SLC25A19, DNC, MUP1, MCPHA, THMD3, THMD4	 Thiamine metabolism dysfunction syndrome 4 	613710		3
SLC25A1, SLC20A3, CTP, D2L2AD, CMS23	Combined D-2- and L-2-hydroxyglutaric aciduria	615182		3
SLC25A1, SLC20A3, CTP, D2L2AD, CMS23	 Myasthenic syndrome, congenital, 23, presynaptic	618197		3
SLC25A20, CACT, CAC	Carnitine-acylcarnitine translocase deficiency	212138	pseudogene on 6p12	3
SLC25A22, GC1, DEE3	Developmental and epileptic encephalopathy 3	609304		3
SLC25A24, SCAMC1	Fontaine progeroid syndrome	612289		3
SLC25A26, SAMC, COXPD28	Combined oxidative phosphorylation deficiency 28	616794		3
SLC25A38, SIDBA2	Anemia, sideroblastic, 2, pyridoxine-refractory	205950		3
SLC25A3, PHC	Mitochondrial phosphate carrier deficiency	610773		3
SLC25A42, MECREN	Metabolic crises, recurrent, with variable encephalomyopathic features and neurologic regression	618416		3
SLC25A46, HMSN6B, PCH1E	Neuropathy, hereditary motor and sensory, type VIB	616505		3
SLC25A46, HMSN6B, PCH1E	 Pontocerebellar hypoplasia, type 1E	619303		3
SLC25A4, ANT1, T1, PEO3, PEO2, MTDPS12A, PEOA2	 Mitochondrial DNA depletion syndrome 12A  AD	617184		3
SLC25A4, ANT1, T1, PEO3, PEO2, MTDPS12A, PEOA2	Mitochondrial DNA depletion syndrome 12B  AR	615418		3
SLC25A4, ANT1, T1, PEO3, PEO2, MTDPS12A, PEOA2	 Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2	609283		3
SLC26A2, DTD, DTDST, D5S1708, EDM4	 Achondrogenesis Ib	600972	distal to APC	3
SLC26A2, DTD, DTDST, D5S1708, EDM4	 Atelosteogenesis, type II	256050	distal to APC	3
SLC26A2, DTD, DTDST, D5S1708, EDM4	 De la Chapelle dysplasia	256050	distal to APC	3
SLC26A2, DTD, DTDST, D5S1708, EDM4	 Diastrophic dysplasia	222600	distal to APC	3
SLC26A2, DTD, DTDST, D5S1708, EDM4	 Diastrophic dysplasia, broad bone-platyspondylic variant	222600	distal to APC	3
SLC26A2, DTD, DTDST, D5S1708, EDM4	Epiphyseal dysplasia, multiple, 4	226900	distal to APC	3
SLC26A3, DRA, CLD	Diarrhea 1, secretory chloride, congenital	214700	5' and close to PDS	3
SLC26A4, PDS, DFNB4, EVA, TDH2B	Deafness, autosomal recessive 4, with enlarged vestibular aqueduct	600791	some patients have digenic mutations with FOXI1	3
SLC26A4, PDS, DFNB4, EVA, TDH2B	 Pendred syndrome	274600	some patients have digenic mutations with FOXI1	3
SLC26A8, TAT1, SPGF3	Spermatogenic failure 3	606766		3
SLC27A4, FATP4, IPS	Ichthyosis prematurity syndrome	608649		3
SLC28A1, CNT1, URCTU	Uridine-cytidineuria	618477		3
SLC29A3, ENT3, PHID, HCLAP	Histiocytosis-lymphadenopathy plus syndrome	602782		3
SLC2A10, GLUT10, ATORS	Arterial tortuosity syndrome	208050		3
SLC2A1, GLUT1, HTLVR, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN	Dystonia 9	601042	probably in 1p33	3
SLC2A1, GLUT1, HTLVR, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN	 Epilepsy, idiopathic generalized, susceptibility to, 12	614847	probably in 1p33	3
SLC2A1, GLUT1, HTLVR, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN	 GLUT1 deficiency syndrome 1, infantile onset, severe	606777	probably in 1p33	3
SLC2A1, GLUT1, HTLVR, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN	 GLUT1 deficiency syndrome 2, childhood onset	612126	probably in 1p33	3
SLC2A1, GLUT1, HTLVR, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN	 Stomatin-deficient cryohydrocytosis with neurologic defects	608885	probably in 1p33	3
SLC2A2, GLUT2	 Diabetes mellitus, noninsulin-dependent	125853		3
SLC2A2, GLUT2	Fanconi-Bickel syndrome	227810		3
SLC2A9, GLUT9, UAQTL2	 Hypouricemia, renal, 2	612076		3
SLC2A9, GLUT9, UAQTL2	Uric acid concentration, serum, QTL 2	612076		3
SLC30A10, ZNT10, HMNDYT1	Hypermanganesemia with dystonia 1	613280		3
SLC30A2, ZNT2, TNZD	Zinc deficiency, transient neonatal	608118		3
SLC30A8, ZNT8	Diabetes mellitus, noninsulin-dependent, susceptibility to	125853		3
SLC30A9, C4orf1, HUEL, BILAPES	Birk-Landau-Perez syndrome	617595		3
SLC33A1, ACATN, AT1, SPG42, CCHLND	 Congenital cataracts, hearing loss, and neurodegeneration	614482		3
SLC33A1, ACATN, AT1, SPG42, CCHLND	Spastic paraplegia 42, autosomal dominant	612539		3
SLC34A1, SLC17A2, NPT2, NPHLOP1, FRTS2, HCINF2	 Hypercalcemia, infantile, 2	616963	mutation identified in 1 FRTS2 family	3
SLC34A1, SLC17A2, NPT2, NPHLOP1, FRTS2, HCINF2	 Nephrolithiasis/osteoporosis, hypophosphatemic, 1	612286	mutation identified in 1 FRTS2 family	3
SLC34A2, PULAM	Pulmonary alveolar microlithiasis	265100		3
SLC34A3, NPTIIC, HHRH	Hypophosphatemic rickets with hypercalciuria	241530		3
SLC35A1, CST, CDG2F	Congenital disorder of glycosylation, type IIf	603585		3
SLC35A2, UGALT, UGTL, UGT2, CDGX, CDG2M	Congenital disorder of glycosylation, type IIm	300896		3
SLC35A3, AMRS	Arthrogryposis, impaired intellectual development, and seizures	615553		3
SLC35C1, FUCT1, CDG2C	Congenital disorder of glycosylation, type IIc	266265		3
SLC35D1, UGTREL7, KIAA0260, SHNKND	Schneckenbecken dysplasia	269250		3
SLC36A2, PAT2	 Hyperglycinuria	138500		3
SLC36A2, PAT2	Iminoglycinuria, digenic	242600		3
SLC37A4, G6PT1, CDG2W	 Congenital disorder of glycosylation, type IIw	619525		3
SLC37A4, G6PT1, CDG2W	Glycogen storage disease Ib	232220		3
SLC37A4, G6PT1, CDG2W	 Glycogen storage disease Ic	232240		3
SLC38A3, SN1, G17, DEE102	Developmental and epileptic encephalopathy 102	619881		3
SLC38A8, FVH2	Foveal hypoplasia 2, with or without optic nerve misrouting and/or anterior segment dysgenesis	609218		3
SLC39A13, ZIP13, EDSSPD3	Ehlers-Danlos syndrome, spondylodysplastic type, 3	612350		3
SLC39A14, ZIP14, KIAA0062, HMNDYT2, HCIN	 Hypermanganesemia with dystonia 2	617013	mutation identified in 1 HCTN family	3
SLC39A4, ZIP4	Acrodermatitis enteropathica	201100		3
SLC39A5, MYP24	Myopia 24, autosomal dominant	615946		3
SLC39A7, D6S2244E, HKE4, AGM9	Agammaglobulinemia 9, autosomal recessive	619693		3
SLC39A8, BIGM103, CDG2N	Congenital disorder of glycosylation, type IIn	616721		3
SLC3A1, ATR1, D2H, NBAT	Cystinuria	220100		3
SLC40A1, SLC11A3, FPN1, IREG1, HFE4	Hemochromatosis, type 4	606069		3
SLC44A1, CTL1, CDW92, CONATOC	Neurodegeneration, childhood-onset, with ataxia, tremor, optic atrophy, and cognitive decline	618868		3
SLC45A1, DNB5, IDDNPF	Intellectual developmental disorder with neuropsychiatric features	617532		3
SLC45A2, MATP, AIM1, SHEP5, OCA4	 Albinism, oculocutaneous, type IV	606574		3
SLC45A2, MATP, AIM1, SHEP5, OCA4	 Skin/hair/eye pigmentation 5, black/nonblack hair	227240		3
SLC45A2, MATP, AIM1, SHEP5, OCA4	 Skin/hair/eye pigmentation 5, dark/fair skin	227240		3
SLC45A2, MATP, AIM1, SHEP5, OCA4	Skin/hair/eye pigmentation 5, dark/light eyes	227240		3
SLC46A1, HCP1, PCFT	Folate malabsorption, hereditary	229050		3
SLC4A11, BTR1, NABC1, CHED, CDPD, FECD4	 Corneal dystrophy, Fuchs endothelial, 4	613268		3
SLC4A11, BTR1, NABC1, CHED, CDPD, FECD4	 Corneal endothelial dystrophy and perceptive deafness	217400		3
SLC4A11, BTR1, NABC1, CHED, CDPD, FECD4	Corneal endothelial dystrophy, autosomal recessive	217700		3
SLC4A1, AE1, EPB3, SPH4, SAO, CHC	 Blood group, Diego	110500		3
SLC4A1, AE1, EPB3, SPH4, SAO, CHC	 Blood group, Froese	601551		3
SLC4A1, AE1, EPB3, SPH4, SAO, CHC	Blood group, Swann	601550		3
SLC4A1, AE1, EPB3, SPH4, SAO, CHC	 Blood group, Waldner	112010		3
SLC4A1, AE1, EPB3, SPH4, SAO, CHC	 Blood group, Wright	112050		3
SLC4A1, AE1, EPB3, SPH4, SAO, CHC	 Cryohydrocytosis	185020		3
SLC4A1, AE1, EPB3, SPH4, SAO, CHC	 Distal renal tubular acidosis 1	179800		3
SLC4A1, AE1, EPB3, SPH4, SAO, CHC	 Distal renal tubular acidosis 4 with hemolytic anemia	611590		3
SLC4A1, AE1, EPB3, SPH4, SAO, CHC	 Malaria, resistance to	611162		3
SLC4A1, AE1, EPB3, SPH4, SAO, CHC	 Ovalocytosis, SA type	166900		3
SLC4A1, AE1, EPB3, SPH4, SAO, CHC	 Spherocytosis, type 4	612653		3
SLC4A4, NBC1, KNBC	Renal tubular acidosis, proximal, with ocular abnormalities	604278		3
SLC52A1, GPR172B, GPCR42, PAR2, FLJ10060, RBFVD	Riboflavin deficiency	615026		3
SLC52A2, GPR172A, GPCR41, PAR1, FLJ11856, BVVLS2	Brown-Vialetto-Van Laere syndrome 2	614707		3
SLC52A3, C20orf54, RFT2, BVVLS1	 Brown-Vialetto-Van Laere syndrome 1	211530	mutation identified in 1 FZLD family	3
SLC5A1, SGLT1	Glucose/galactose malabsorption	606824		3
SLC5A2, SGLT2	Renal glucosuria	233100		3
SLC5A5, NIS, TDH1	Thyroid dyshormonogenesis 1	274400		3
SLC5A6, SMVT, NERIB, SMVTD, COMNB	 Peripheral motor neuropathy, childhood-onset, biotin-responsive	619903		3
SLC5A6, SMVT, NERIB, SMVTD, COMNB	Sodium-dependent multivitamin transporter deficiency	618973		3
SLC5A7, CHT1, HMN7A, CMS20	 Myasthenic syndrome, congenital, 20, presynaptic	617143		3
SLC5A7, CHT1, HMN7A, CMS20	Neuronopathy, distal hereditary motor, type VIIA	158580		3
SLC6A17, NTT4, MRT48	Intellectual developmental disorder, autosomal recessive 48	616269		3
SLC6A19, HND	 Hartnup disorder	234500		3
SLC6A19, HND	 Hyperglycinuria	138500		3
SLC6A19, HND	Iminoglycinuria, digenic	242600		3
SLC6A1, GABATR, MAE	Myoclonic-atonic epilepsy	616421		3
SLC6A20, XT3	 Hyperglycinuria	138500		3
SLC6A20, XT3	Iminoglycinuria, digenic	242600		3
SLC6A3, DAT1, PKDYS1	 Nicotine dependence, protection against	188890		3
SLC6A3, DAT1, PKDYS1	Parkinsonism-dystonia, infantile, 1	613135		3
SLC6A4, HTT, OCD1	 Anxiety-related personality traits	607834		3
SLC6A4, HTT, OCD1	Obsessive-compulsive disorder	164230		3
SLC6A5, GLYT2, HKPX3	Hyperekplexia 3	614618		3
SLC6A6, TAUT, HTRDC	Hypotaurinemic retinal degeneration and cardiomyopathy	145350		3
SLC6A8, CRTR, CCDS1	Cerebral creatine deficiency syndrome 1	300352	distal to G6PD	3
SLC6A9, GLYT1, GCENSG	Glycine encephalopathy with normal serum glycine	617301		3
SLC7A14, KIAA1613, RP68	Retinitis pigmentosa 68	615725		3
SLC7A6OS, EPM12	Epilepsy, progressive myoclonic, 12	619191		3
SLC7A7, LPI	Lysinuric protein intolerance	222700		3
SLC7A9, CSNU3	Cystinuria	220100		3
SLC9A1, NHE1, APNH, LIKNS	Lichtenstein-Knorr syndrome	616291		3
SLC9A3, NHE3, DIAR8	Diarrhea 8, secretory sodium, congenital	616868	pseudogene on chr.10	3
SLC9A3R1, EBP50, NHERF1, NPHLOP2	Nephrolithiasis/osteoporosis, hypophosphatemic, 2	612287		3
SLC9A6, NHE6, MRXSCH	Intellectual developmental disorder, X-linked syndromic, Christianson type	300243		3
SLC9A7, NHE7, MRX108	Intellectual developmental disorder, X-linked 108	301024		3
SLC9A9, AUTS16	Autism susceptibility 16	613410	mutation identified in 1 family	3
SLCO1B1, LST1, OATP2, OATPC, OATP1B1, HBLRR	Hyperbilirubinemia, Rotor type, digenic	237450	HBLRR digenic with SLCO1B3	3
SLCO1B3, OATP8, OATP1B3, SLC21A8, HBLRR	Hyperbilirubinemia, Rotor type, digenic	237450	HBLRR digenic with SLCO1B1	3
SLCO2A1, OATP2A1, PGT, SLC21A2, PHOAR2, PHOAD	Hypertrophic osteoarthropathy, primary, autosomal dominant	167100		3
SLCO2A1, OATP2A1, PGT, SLC21A2, PHOAR2, PHOAD	 Hypertrophic osteoarthropathy, primary, autosomal recessive 2	614441		3
SLEB12	Systemic lupus erythematosus, susceptibility to, 12	612254	associated with rs13277113	2
SLEB13	Systemic lupus erythematosus, susceptibility to, 13	612378	associated with rs5029939	2
SLEB14	Systemic lupus erythematosus, susceptibility to, 14	613145	associated with rs3093061	2
SLEB15	Systemic lupus erythematosus, susceptibility to, 15	300809	associated with rs17435	2
SLEB3	Systemic lupus erythematosus, susceptibility to, 3	605480		2
SLEB4	Systemic lupus erythematosus, susceptibility to, 4	608437		2
SLEB5	Systemic lupus erythematosus, susceptibility to, 5	609903	max lod at D13S892	2
SLEB6	Systemic lupus erythematosus, susceptibility to, 6	609939		2
SLEB7	Systemic lupus erythematosus, susceptibility to, 7	610065		2
SLEB8	Systemic lupus erythematosus, susceptibility to, 8	610066		2
SLEH1	Systemic lupus erythematosus with hemolytic anemia	607279		2
SLEN1	Systemic lupus erythematosus with nephritis, susceptibility to, 1	607965		2
SLEN2	Systemic lupus erythematosus with nephritis, susceptibility to, 2	607966		2
SLEN3	Systemic lupus erythematosus with nephritis, susceptibility to, 3	607967		2
SLFN14, BDPLT20	Bleeding disorder, platelet-type, 20	616913		3
SLI1	Specific language impairment QTL, 1	606711		2
SLI2	Specific language impairment QTL, 2	606712		2
SLI3	Specific language impairment QTL, 3	607134	max with D13S1317	2
SLI4	Specific language impairment 4	612514	associated with rs1723629	2
SLITRK1, KIAA1910, TTM	Tourette syndrome	137580	mutation identified in 1 TTM patient	3
SLITRK1, KIAA1910, TTM	 Trichotillomania	613229	mutation identified in 1 TTM patient	3
SLITRK6, DFNMYP	Deafness and myopia	221200		3
SLSN3	Senior-Loken syndrome 3	606995	?allelic with NPHP3	2
SLURP1, MDM	Meleda disease	248300		3
SLX4, BTBD12, MUS312, KIAA1784, KIAA1987, FANCP	Fanconi anemia, complementation group P	613951		3
SM1	Schistosoma mansoni infection, susceptibility/resistance to	181460		2
SM2	Hepatic fibrosis susceptibility due to Schistosoma mansoni infection	604201	?polymorphism of INFGR1	2
SMAD2, MADH2, JV18, LDS6, CHTD8	 Congenital heart defects, multiple types, 8, with or without heterotaxy	619657		3
SMAD2, MADH2, JV18, LDS6, CHTD8	Loeys-Dietz syndrome 6	619656		3
SMAD3, MADH3, LDS3	Loeys-Dietz syndrome 3	613795		3
SMAD4, MADH4, DPC4, JIP, MYHRS	 Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome	175050		3
SMAD4, MADH4, DPC4, JIP, MYHRS	 Myhre syndrome	139210		3
SMAD4, MADH4, DPC4, JIP, MYHRS	Pancreatic cancer, somatic	260350		3
SMAD4, MADH4, DPC4, JIP, MYHRS	 Polyposis, juvenile intestinal	174900		3
SMAD6, MADH6, AOVD2	Aortic valve disease 2	614823		3
SMAD6, MADH6, AOVD2	 Craniosynostosis 7, susceptibility to	617439		3
SMAD6, MADH6, AOVD2	 Radioulnar synostosis, nonsyndromic	179300		3
SMAD7, MADH7, CRCS3	Colorectal cancer, susceptibility to, 3	612229		3
SMARCA2, SNF2L2, NCBRS, BIS	 Blepharophimosis-impaired intellectual development syndrome	619293		3
SMARCA2, SNF2L2, NCBRS, BIS	Nicolaides-Baraitser syndrome	601358		3
SMARCA4, BRG1, RTPS2, MRD16, CSS4	Coffin-Siris syndrome 4	614609		3
SMARCA4, BRG1, RTPS2, MRD16, CSS4	 Rhabdoid tumor predisposition syndrome 2	613325		3
SMARCAD1, KIAA1122, ETL1, HEL1, ADERM, BASNS, HRZ	 Adermatoglyphia	136000		3
SMARCAD1, KIAA1122, ETL1, HEL1, ADERM, BASNS, HRZ	Basan syndrome	129200		3
SMARCAD1, KIAA1122, ETL1, HEL1, ADERM, BASNS, HRZ	 Huriez syndrome	181600		3
SMARCAL1, HARP, SIOD	Schimke immunoosseous dysplasia	242900		3
SMARCB1, SNF5, INI1, RDT, RTPS1, MRD15, SWNTS1, CSS3	 Coffin-Siris syndrome 3	614608		3
SMARCB1, SNF5, INI1, RDT, RTPS1, MRD15, SWNTS1, CSS3	 Rhabdoid tumor predisposition syndrome 1	609322		3
SMARCB1, SNF5, INI1, RDT, RTPS1, MRD15, SWNTS1, CSS3	Rhabdoid tumors, somatic	609322		3
SMARCB1, SNF5, INI1, RDT, RTPS1, MRD15, SWNTS1, CSS3	 Schwannomatosis-1, susceptibility to	162091		3
SMARCC2, BAF170, CSS8	Coffin-Siris syndrome 8	618362		3
SMARCD1, BAF60A, CSS11	Coffin-Siris syndrome 11	618779		3
SMARCD2, BAF60B, SGD2	Specific granule deficiency 2	617475		3
SMARCE1, BAF57, CSS5	 Coffin-Siris syndrome 5	616938		3
SMARCE1, BAF57, CSS5	Meningioma, familial, susceptibility to	607174		3
SMAR	Spinal muscular atrophy, chronic distal, autosomal recessive	607088	no mutations found in IGHMBP2	2
SMC1A, SMC1L1, SMC1, DXS423E, KIAA0178, CDLS2, DEE85	Cornelia de Lange syndrome 2	300590	escapes lyonization	3
SMC1A, SMC1L1, SMC1, DXS423E, KIAA0178, CDLS2, DEE85	 Developmental and epileptic encephalopathy 85, with or without midline brain defects	301044	escapes lyonization	3
SMC3, CSPG6, HCAP, BAM, CDLS3	Cornelia de Lange syndrome 3	610759		3
SMCHD1, KIAA0650, BAMS	Bosma arhinia microphthalmia syndrome	603457		3
SMCHD1, KIAA0650, BAMS	 Fascioscapulohumeral muscular dystrophy 2, digenic	158901		3
SMG8, C17orf71, ALKUS	Alzahrani-Kuwahara syndrome	619268		3
SMG9, C19orf61, HBMS, NEDITPO	Heart and brain malformation syndrome	616920		3
SMG9, C19orf61, HBMS, NEDITPO	 Neurodevelopmental disorder with intention tremor, pyramidal signs, dyspraxia, and ocular anomalies	619995		3
SMIM1, VEL	Blood group, Vel system	615264		3
SMN1, SMA1, SMA2, SMA3, SMA4	 Spinal muscular atrophy-1	253300		3
SMN1, SMA1, SMA2, SMA3, SMA4	Spinal muscular atrophy-2	253550		3
SMN1, SMA1, SMA2, SMA3, SMA4	 Spinal muscular atrophy-3	253400		3
SMN1, SMA1, SMA2, SMA3, SMA4	 Spinal muscular atrophy-4	271150		3
SMN2	Spinal muscular atrophy, type III, modifier of	253400		3
SMOC1, OAS	Microphthalmia with limb anomalies	206920		3
SMOC2, SMAP2, DTDP1	Dentin dysplasia, type I, with microdontia and misshapen teeth	125400		3
SMO, SMOH, CRJS, PHLS	 Basal cell carcinoma, somatic	605462		3
SMO, SMOH, CRJS, PHLS	 Curry-Jones syndrome, somatic mosaic	601707		3
SMO, SMOH, CRJS, PHLS	Pallister-Hall-like syndrome	241800		3
SMPD1, NPD	 Niemann-Pick disease, type A	257200		3
SMPD1, NPD	Niemann-Pick disease, type B	607616		3
SMPD4, NSMASE3, KIAA1418, NEDMABA	Neurodevelopmental disorder with microcephaly, arthrogryposis, and structural brain anomalies	618622		3
SMPX, DFNX4, MPD7	 Deafness, X-linked 4	300066		3
SMPX, DFNX4, MPD7	Myopathy, distal, 7, adult-onset, X-linked	301075		3
SMS, SRS, MRXSSR	Intellectual developmental disorder, X-linked syndromic, Snyder-Robinson type	309583		3
SNAI2, SLUG, WS2D	 Piebaldism	172800		3
SNAI2, SLUG, WS2D	Waardenburg syndrome, type 2D	608890		3
SNAP29, CEDNIK	Cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndrome	609528		3
SNCA, NACP, PARK1, PARK4	Dementia, Lewy body	127750		3
SNCA, NACP, PARK1, PARK4	 Parkinson disease 1	168601		3
SNCA, NACP, PARK1, PARK4	 Parkinson disease 4	605543		3
SNCB	Dementia, Lewy body	127750		3
SNIP1, NEDHCS	Neurodevelopmental disorder with hypotonia, craniofacial abnormalities, and seizures	614501		3
SNORA31, IIAE10	Encephalopathy, acute, infection-induced , susceptibility to, 10	619396		3
SNORD118, LCC	Leukoencephalopathy, brain calcifications, and cysts	614561		3
SNRNP200, ASCC3L1, KIAA0788, RP33	Retinitis pigmentosa 33	610359		3
SNRPB, CCMS	Cerebrocostomandibular syndrome	117650		3
SNRPE, HYPT11	Hypotrichosis 11	615059		3
SNTA1, SNT1, TACIP1, LQT12	Long QT syndrome 12	612955		3
SNX10, OPTB8	Osteopetrosis, autosomal recessive 8	615085		3
SNX14, SCAR20	Spinocerebellar ataxia, autosomal recessive 20	616354		3
SOCS1, SSI1, CIS1, CISH1, AISIMD	Autoinflammatory syndrome, familial, with or without immunodeficiency	619375		3
SOD1, ALS1, STAHP	 Amyotrophic lateral sclerosis 1	105400	mid q22.1	3
SOD1, ALS1, STAHP	Spastic tetraplegia and axial hypotonia, progressive	618598	mid q22.1	3
SOD2, MNSOD, MVCD6	Microvascular complications of diabetes 6	612634		3
SOD3	Superoxide dismutase, elevated extracellular	185490		3
SOHLH1, NOHLH, TEB2, ODG5, SPGF32	Ovarian dysgenesis 5	617690		3
SOHLH1, NOHLH, TEB2, ODG5, SPGF32	 Spermatogenic failure 32	618115		3
SON, TOKIMS	ZTTK syndrome	617140		3
SORD, SORD1, SORDD	Sorbitol dehydrogenase deficiency with peripheral neuropathy	618912		3
SORT1, NT3, LDLCQ6	Low density lipoprotein cholesterol level QTL6	613589		3
SOS1, GINGF, GF1, HGF, NS4	 Fibromatosis, gingival, 1	135300	mutation identified in 1 GINGF1 family	3
SOS1, GINGF, GF1, HGF, NS4	Noonan syndrome 4	610733	mutation identified in 1 GINGF1 family	3
SOS2, NS9	Noonan syndrome 9	616559		3
SOST, VBCH, CDD, SOST1	 Craniodiaphyseal dysplasia, autosomal dominant	122860		3
SOST, VBCH, CDD, SOST1	Sclerosteosis 1	269500		3
SOX10, WS4, WS4C, PCWH	 PCWH syndrome	609136	megacolon and spotting in mice	3
SOX10, WS4, WS4C, PCWH	 Waardenburg syndrome, type 2E, with or without neurologic involvement	611584	megacolon and spotting in mice	3
SOX10, WS4, WS4C, PCWH	Waardenburg syndrome, type 4C	613266	megacolon and spotting in mice	3
SOX11, MRD27, CSS9	Coffin-Siris syndrome 9	615866		3
SOX17, VUR3	Vesicoureteral reflux 3	613674		3
SOX18, HLTS, HLTRS	 Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome	137940		3
SOX18, HLTS, HLTRS	Hypotrichosis-lymphedema-telangiectasia syndrome	607823		3
SOX2, MCOPS3	 Microphthalmia, syndromic 3	206900		3
SOX2, MCOPS3	Optic nerve hypoplasia and abnormalities of the central nervous system	206900		3
SOX3, MRGH	Intellectual developmental disorder, X-linked, with isolated growth hormone deficiency	300123	P mutant in BFLS	3
SOX3, MRGH	 Panhypopituitarism, X-linked	312000	P mutant in BFLS	3
SOX4, CSS10	Coffin-Siris syndrome 10	618506		3
SOX5, LAMSHF	Lamb-Shaffer syndrome	616803	some LAMSHF patients have 12p12 deletions	3
SOX6, TOLCAS	Tolchin-Le Caignec syndrome	618971		3
SOX9, CMD1, SRA1	 Acampomelic campomelic dysplasia	114290		3
SOX9, CMD1, SRA1	 Campomelic dysplasia	114290		3
SOX9, CMD1, SRA1	Campomelic dysplasia with autosomal sex reversal	114290		3
SP110, IFI41, IFI75, VODI	 Hepatic venoocclusive disease with immunodeficiency	235550		3
SP110, IFI41, IFI75, VODI	Mycobacterium tuberculosis, susceptibility to	607948		3
SP6, KLF14, EPFN, AI1K	Amelogenesis imperfecta, type IK	620104		3
SP7, OSX, OI12	Osteogenesis imperfecta, type XII	613849		3
SPAG1, CILD28	Ciliary dyskinesia, primary, 28	615505		3
SPARC, ON, OI17	Osteogenesis imperfecta, type XVII	616507		3
SPART, KIAA0610, SPG20	Troyer syndrome	275900		3
SPAST, SPG4	Spastic paraplegia 4, autosomal dominant	182601		3
SPATA5L1, DFNB119, NEDHLS	Deafness, autosomal recessive 119	619615		3
SPATA5L1, DFNB119, NEDHLS	 Neurodevelopmental disorder with hearing loss and spasticity	619616		3
SPATA5, SPAF, NEDHSB	Neurodevelopmental disorder with hearing loss, seizures, and brain abnormalities	616577		3
SPATA7, HSD3, LCA3, RP94	Leber congenital amaurosis 3	604232		3
SPATA7, HSD3, LCA3, RP94	 Retinitis pigmentosa 94, variable age at onset, autosomal recessive	604232		3
SPD3	Synpolydactyly 3	610234	max lod at D14S264	2
SPDA2	Spondyloarthropathy, susceptibility to, 2	183840	max lod at D9S1776	2
SPDA3	Spondyloarthropathy, susceptibility to, 3	613238	max lod at D2S2228	2
SPDT	Spondyloepiphyseal dysplasia tarda, autosomal dominant	184100		2
SPECC1L, KIAA0376, OBLFC1, TBHS1	 Facial clefting, oblique, 1	600251	mutation identified in 1 OBLFC1 patient	3
SPECC1L, KIAA0376, OBLFC1, TBHS1	Teebi hypertelorism syndrome 1	145420	mutation identified in 1 OBLFC1 patient	3
SPEF2, KPL2, KIAA1770, SPGF43	Spermatogenic failure 43	618751		3
SPEG, APEG1, CNM5	Centronuclear myopathy 5	615959		3
SPEN, MINT, SHARP, HIAA0929, RATARS	Radio-Tartaglia syndrome	619312		3
SPG11, KIAA1840, FLJ21439, ALS5, CMT2X	Amyotrophic lateral sclerosis 5, juvenile	602099		3
SPG11, KIAA1840, FLJ21439, ALS5, CMT2X	 Charcot-Marie-Tooth disease, axonal, type 2X	616668		3
SPG11, KIAA1840, FLJ21439, ALS5, CMT2X	 Spastic paraplegia 11, autosomal recessive	604360		3
SPG14	Spastic paraplegia 14, autosomal recessive	605229		2
SPG16	Spastic paraplegia 16, X-linked, complicated	300266		2
SPG19	Spastic paraplegia 19, autosomal dominant	607152		2
SPG24	Spastic paraplegia 24, autosomal recessive	607584		2
SPG25	Spastic paraplegia 25, autosomal recessive	608220		2
SPG27	Spastic paraplegia 27, autosomal recessive	609041	between  D10S606 and D10S1758	2
SPG29	Spastic paraplegia 29, autosomal dominant	609727	max lod at D1S2865	2
SPG32	Spastic paraplegia 32, autosomal recessive	611252	between D14S264 and D14S978	2
SPG34	Spastic paraplegia 34, X-linked	300750	max lod at DXS8057	2
SPG36	Spastic paraplegia 36, autosomal dominant	613096	between D12S360 and D12S354	2
SPG37	Spastic paraplegia 37, autosomal dominant	611945	max lod at D8S601	2
SPG38	Spastic paraplegia 38, autosomal dominant	612335	between D4S432 and D4S1599	2
SPI1, SFPI1, AGM10	Agammaglobulinemia 10, autosomal dominant	619707		3
SPIDR, KIAA0146, ODG9	Ovarian dysgenesis 9	619665		3
SPINK1, PSTI, PCTT, TATI, TCP	 Fibrocalculous pancreatic diabetes, susceptibility to	608189		3
SPINK1, PSTI, PCTT, TATI, TCP	 Pancreatitis, hereditary	167800		3
SPINK1, PSTI, PCTT, TATI, TCP	Tropical calcific pancreatitis	608189		3
SPINK5, LEKTI	Netherton syndrome	256500		3
SPINT2, HAI2, DIAR3	Diarrhea 3, secretory sodium, congenital, syndromic	270420		3
SPOP, NSDVS1, NSDVS2	Nabais Sa-de Vries syndrome, type 1	618828		3
SPOP, NSDVS1, NSDVS2	 Nabais Sa-de Vries syndrome, type 2	618829		3
SPPL2A, IMP3, IMD86	Immunodeficiency 86, mycobacteriosis	619549		3
SPR	Dystonia, dopa-responsive, due to sepiapterin reductase deficiency	612716		3
SPRED1, NFLS, LGSS	Legius syndrome	611431		3
SPRED2, NS14	Noonan syndrome 14	619745		3
SPRTN, DVC1, C1orf124, RJALS	Ruijs-Aalfs syndrome	616200		3
SPRY2, IGAN3	IgA nephropathy, susceptibility to, 3	616818	mutation identified in 1 IGAN3 family	3
SPRY4, HH17	Hypogonadotropic hypogonadism 17 with or without anosmia	615266		3
SPTA1, EL2, SPH3, HS3, HPP	 Elliptocytosis-2	130600	17cM proximal to FY	3
SPTA1, EL2, SPH3, HS3, HPP	 Pyropoikilocytosis	266140	17cM proximal to FY	3
SPTA1, EL2, SPH3, HS3, HPP	Spherocytosis, type 3	270970	17cM proximal to FY	3
SPTAN1, NEAS, DEE5	Developmental and epileptic encephalopathy 5	613477		3
SPTBN1, DDISBA	Developmental delay, impaired speech, and behavioral abnormalities	619475		3
SPTBN2, SCA5, SCAR14	Spinocerebellar ataxia 5	600224		3
SPTBN2, SCA5, SCAR14	 Spinocerebellar ataxia, autosomal recessive 14	615386		3
SPTBN4, QV, NEDHND, CMND	Neurodevelopmental disorder with hypotonia, neuropathy, and deafness	617519		3
SPTB, SPH2, EL3, HS2	Anemia, neonatal hemolytic, fatal or near-fatal	617948		3
SPTB, SPH2, EL3, HS2	 Elliptocytosis-3	617948		3
SPTB, SPH2, EL3, HS2	 Spherocytosis, type 2	616649		3
SPTLC1, LBC1, SPT1, HSN1, HSAN	Neuropathy, hereditary sensory and autonomic, type IA	162400		3
SPTLC2, KIAA0526, SPT2, LCB2, HSN1C, NSAN1C	Neuropathy, hereditary sensory and autonomic, type IC	613640		3
SQOR, SQRDL	Sulfide:quinone oxidoreductase deficiency	619221		3
SQSTM1, P62, PDB3, FTDALS3, NADGP, DMRV	 Frontotemporal dementia and/or amyotrophic lateral sclerosis 3	616437		3
SQSTM1, P62, PDB3, FTDALS3, NADGP, DMRV	 Myopathy, distal, with rimmed vacuoles	617158		3
SQSTM1, P62, PDB3, FTDALS3, NADGP, DMRV	Neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset	617145		3
SQSTM1, P62, PDB3, FTDALS3, NADGP, DMRV	 Paget disease of bone 3	167250		3
SQTL1	Smoking as a quantitative trait locus 1	611003	near D10S1432	2
SQTL2	Smoking as a quantitative trait locus 2	611004	max lod at D22S315	2
SRCAP, SWR1, KIAA0309, FLHS, DEHMBA	Developmental delay, hypotonia, musculoskeletal defects, and behavioral abnormalities	619595		3
SRCAP, SWR1, KIAA0309, FLHS, DEHMBA	 Floating-Harbor syndrome	136140		3
SRC, ASV, SRC1, THC6	 Colon cancer, advanced, somatic	114500	mutation identified in 1 THC6 family	3
SRD5A2	Pseudovaginal perineoscrotal hypospadias	264600		3
SRD5A3, SRD5A2L, CDG1Q, KRIZI	 Congenital disorder of glycosylation, type Iq	612379		3
SRD5A3, SRD5A2L, CDG1Q, KRIZI	Kahrizi syndrome	612713		3
SREBF1, IFAP2, HMD	Ichthyosis, follicular, with atrichia and photophobia syndrome 2	619016		3
SREBF1, IFAP2, HMD	 Mucoepithelial dysplasia, hereditary	158310		3
SRGAP1, KIAA1304, NMTC2	Thyroid cancer, nonmedullary, 2	188470		3
SRP54, SCN8	Neutropenia, severe congenital, 8, autosomal dominant	618752		3
SRP72, BMFS1	Bone marrow failure syndrome 1	614675		3
SRS2	Silver-Russell syndrome 2	618905	maternal uniparental disomy of chromosome 7; 7p13-p11.2 and 7q32 have been implicated	4
SRTD1, ATD1	Short-rib thoracic dysplasia 1 with or without polydactyly	208500		2
SRXX2, DUP17q24.3	46XX sex reversal 2	278850	duplication or triplication of 68kb XXSR regulatory region upstream of SOX9	4
SRXX3	46XX sex reversal 3	300833	due to deletion/duplication/rearrangement upstream of SOX3	4
SRXY10	46XY sex reversal 10	616425	deletion of 32.5kb XYSR regulatory region upstream of SOX9	4
SRY, TDF, TDY, SRXX1, SRXY1	 46XX sex reversal 1	400045		4
SRY, TDF, TDY, SRXX1, SRXY1	46XY sex reversal 1	400044		3
SS18, SSXT, SYT	Sarcoma, synovial	600192	5' SYST/3' SSRC in t(X;18)	1
SS3	Sarcoidosis, susceptibility to, 3	612388	associated with rs2789679 and rs1049550	2
SSBP1, SSBP, OPA13	Optic atrophy 13 with retinal and foveal abnormalities	165510		3
SSD	Speech-sound disorder	608445	?same locus as DYX5	2
SSR4, TRAPD, CDG1Y	Congenital disorder of glycosylation, type Iy	300934		3
ST12, PAC1	Prostate adenocarcinoma	601188		2
ST14, MTSP1, ARCI11	Ichthyosis, congenital, autosomal recessive 11	602400		3
ST3	Cervical carcinoma	191181		2
ST3GAL3, SIAT6, ST3GALII, MRT12, DEE15	Developmental and epileptic encephalopathy 15	615006		3
ST3GAL3, SIAT6, ST3GALII, MRT12, DEE15	 Intellectual developmental disorder, autosomal recessive 12	611090		3
STAC3, NAM, MYPBB	Myopathy, congenital, Baily-Bloch	255995		3
STAG1, MRD47	Intellectual developmental disorder, autosomal dominant 47	617635		3
STAG2, SA2, MKMS, HPE13	Holoprosencephaly 13, X-linked	301043		3
STAG2, SA2, MKMS, HPE13	 Mullegama-Klein-Martinez syndrome	301022		3
STAG3, POF8, SPGF61	 Premature ovarian failure 8	615723		3
STAG3, POF8, SPGF61	Spermatogenic failure 61	619672		3
STAMBP, AMSH, MICCAP	Microcephaly-capillary malformation syndrome	614261		3
STARD7, GTT1, FAME2	Epilepsy, familial adult myoclonic, 2	607876		3
STAR	Lipoid adrenal hyperplasia	201710		3
STAT1, CANDF7, IMD31A, IMD31B, IMD31C	 Immunodeficiency 31A, mycobacteriosis, autosomal dominant	614892		3
STAT1, CANDF7, IMD31A, IMD31B, IMD31C	 Immunodeficiency 31B, mycobacterial and viral infections, autosomal recessive	613796		3
STAT1, CANDF7, IMD31A, IMD31B, IMD31C	Immunodeficiency 31C, chronic mucocutaneous candidiasis, autosomal dominant	614162		3
STAT2, IMD44, PTORCH3	 Immunodeficiency 44	616636		3
STAT2, IMD44, PTORCH3	Pseudo-TORCH syndrome 3	618886		3
STAT3, APRF, HIES, ADMIO1	 Autoimmune disease, multisystem, infantile-onset, 1	615952		3
STAT3, APRF, HIES, ADMIO1	Hyper-IgE recurrent infection syndrome	147060		3
STAT4, SLEB11	Systemic lupus erythematosus, susceptibility to, 11	612253		3
STAT5B, GHISID2	Growth hormone insensitivity with immune dysregulation 1, autosomal recessive	245590	fused with RARA in PML	3
STAT5B, GHISID2	 Growth hormone insensitivity with immune dysregulation 2, autosomal dominant	618985	fused with RARA in PML	3
STAT5B, GHISID2	 Leukemia, acute promyelocytic, somatic	102578	fused with RARA in PML	3
STBMS1	Strabismus, susceptibility to, 1	185100	max lod at marker 1911/1912	2
STHAG2, HYD2	Tooth agenesis, selective, 2	602639		2
STHAG5	Tooth agenesis, selective, 5	610926	D10S604 and D10S568	2
STIL, SIL, MCPH7	Microcephaly 7, primary, autosomal recessive	612703	within about 250kb of SCL	3
STIM1, TAM1, IMD10, STRMK	 Immunodeficiency 10	612783		3
STIM1, TAM1, IMD10, STRMK	Myopathy, tubular aggregate, 1	160565		3
STIM1, TAM1, IMD10, STRMK	 Stormorken syndrome	185070		3
STING1, TMEM173, MPYS, SAVI	STING-associated vasculopathy, infantile-onset	615934		3
STK11, PJS, LKB1	Melanoma, malignant, somatic	155600		3
STK11, PJS, LKB1	 Pancreatic cancer, somatic	260350		3
STK11, PJS, LKB1	 Peutz-Jeghers syndrome	175200		3
STK11, PJS, LKB1	 Testicular tumor, somatic	273300		3
STK4, MST1, KRS2, TIIAC	T-cell immunodeficiency, recurrent infections, autoimmunity, and cardiac malformations	614868		3
STN1, OBFC1, AAF44	Cerebroretinal microangiopathy with calcifications and cysts 2	617341		3
STOX1, PEE4	Preeclampsia/eclampsia 4	609404		3
STQTL10	Stature QTL 10	612221	associated with rs6440003	2
STQTL11	Stature QTL 11	612223	associated with rs2282978	2
STQTL12	Stature QTL 12	612224	associated with rs6854783	2
STQTL13	Stature QTL 13	612226	associated with rs16896068	2
STQTL14	Stature QTL 14	612228	associated with rs6060373	2
STQTL15	Stature QTL 15	612578	associated with rs2220456	2
STQTL16	Stature QTL 16	612579	associated with rs8038652	2
STQTL17	Stature QTL 17	612737	associated with rs1635852 and rs849140	2
STQTL18	Stature QTL 18	612892	associated with rs10946808	2
STQTL19	Stature QTL 19	612893	associated with rs1776897	2
STQTL1	Stature QTL 1	606255	associated with rs4896582 and rs3748069	2
STQTL20	Stature QTL 20	612894	associated with rs3118914	2
STQTL21	Stature QTL 21	613440	associated with rs6717918	2
STQTL22	Stature QTL 22	613547	linked to rs299956 and rs2076962	2
STQTL23	Stature QTL 23	613548	linked to rs628667	2
STQTL24	Stature QTL 24	613549	linked to rs1520446	2
STQTL2	Stature QTL 2	606256	max lod at D7S195	2
STQTL3	Stature QTL 3	606257	max lod at D12S398 and D12S10990	2
STQTL4	Stature QTL 4	606258	max lod at D13S779 and D13S797	2
STQTL5	Stature QTL 5	608982	max lod between D3S1297 and D3S1304	2
STQTL6	Stature QTL 6	300591	max lod at DXS8067	2
STQTL7	Stature QTL 7	609822	max lod at D1S1631	2
STQTL8	Stature QTL 8	610114	between GATA81C04M and ATA18A07M	2
STQTL9	Stature QTL 9	611547	associated with rs1042725	2
STRA6, MCOPS9, MCOPCB8	 Microphthalmia, isolated, with coloboma 8	601186		3
STRA6, MCOPS9, MCOPCB8	Microphthalmia, syndromic 9	601186		3
STRADA, STRAD, LYK5	Polyhydramnios, megalencephaly, and symptomatic epilepsy	611087		3
STRC, DFNB16	Deafness, autosomal recessive 16	603720		3
STRK1	Stroke, susceptibility to, 1	606799	association with PDE4D	2
STS, ARSC1, ARSC, SSDD, XLI	Ichthyosis, X-linked	308100	nonlyonizing	3
STT3A, ITM1, TMC, CDG1WAR, CDG1WAD	Congenital disorder of glycosylation, type Iw, autosomal dominant	619714		3
STT3A, ITM1, TMC, CDG1WAR, CDG1WAD	 Congenital disorder of glycosylation, type Iw, autosomal recessive	615596		3
STT3B, SIMP, CDG1X	Congenital disorder of glycosylation, type Ix	615597		3
STUB1, CHIP, SCAR16, SCA48	Spinocerebellar ataxia 48	618093		3
STUB1, CHIP, SCAR16, SCA48	 Spinocerebellar ataxia, autosomal recessive 16	615768		3
STUT2	Stuttering, familial persistent, 2	609261	max lod with PAH	2
STUT3	Stuttering, familial persistent, 3	614655	max lod at D3S1310	2
STUT4	Stuttering, familial persistent, 4	614668	max lod at D16S3043	2
STX11, FHL4, HPLH4, HLH4	Hemophagocytic lymphohistiocytosis, familial, 4	603552		3
STX16, SYN16	Pseudohypoparathyroidism, type IB	603233		3
STX1B, GEFSP9	Generalized epilepsy with febrile seizures plus, type 9	616172		3
STX3, STX3A, DIAR12, MVID2, RDMVID	 Diarrhea 12, with microvillus atrophy	619445		3
STX3, STX3A, DIAR12, MVID2, RDMVID	Retinal dystrophy and microvillus inclusion disease	619446		3
STXBP1, UNC18, DEE4	Developmental and epileptic encephalopathy 4	612164		3
STXBP2, UNC18B, FHL5	Hemophagocytic lymphohistiocytosis, familial, 5, with or without microvillus inclusion disease	613101		3
SUCLA2, MTDPS5	Mitochondrial DNA depletion syndrome 5 	612073		3
SUCLG1, SUCLA1, MTDPS9	Mitochondrial DNA depletion syndrome 9 	245400		3
SUFU, SUFUXL, SUFUH, JBTS32	 Basal cell nevus syndrome	109400		3
SUFU, SUFUXL, SUFUH, JBTS32	 Joubert syndrome 32	617757		3
SUFU, SUFUXL, SUFUH, JBTS32	 Medulloblastoma	155255		3
SUFU, SUFUXL, SUFUH, JBTS32	Meningioma, familial, susceptibility to	607174		3
SULT2B1, ARCI14	Ichthyosis, congenital, autosomal recessive 14	617571		3
SUMF1, FGE	Multiple sulfatase deficiency	272200		3
SUMO4, IDDM5	Diabetes mellitus, insulin-dependent, 5	600320		3
SUN5, TSARG4, SPAG4L, SPGF16	Spermatogenic failure 16	617187		3
SUOX	Sulfite oxidase deficiency	272300		3
SUPT16H, SPT16, NEDDFAC	Neurodevelopmental disorder with dysmorphic facies and thin corpus callosum	619480		3
SURF1, CMT4K, MC4DN1	Charcot-Marie-Tooth disease, type 4K	616684	distal to ABL, CAN	3
SURF1, CMT4K, MC4DN1	 Mitochondrial complex IV deficiency, nuclear type 1	220110	distal to ABL, CAN	3
SUZ12, JJAZ1, KIAA0160, IMMAS	Imagawa-Matsumoto syndrome	618786		3
SVBP, CCDC23, NEDAHM	Neurodevelopmental disorder with ataxia, hypotonia, and microcephaly	618569		3
SVIL, MFM10	Myofibrillar myopathy 10	619040		3
SXGQTL1	Sex hormone-binding globulin circulating level QTL 1	613498	associated with rs1799941	2
SXI2	X inactivation, familial skewed, 2	300179		2
SYCE1, POF12, SPGF15	 Premature ovarian failure 12	616947	mutation identified in 1 POF12 and 1 SPGF15 family	3
SYCP2, SCP2, SPGF1	Spermatogenic failure 1	258150		3
SYCP3, SCP3, COR1, SPGF4, RPRGL4	Pregnancy loss, recurrent, 4	270960		3
SYCP3, SCP3, COR1, SPGF4, RPRGL4	 Spermatogenic failure 4	270960		3
SYK, IMD82	Immunodeficiency 82 with systemic inflammation	619381		3
SYN1, EPILX1, MRX50	Epilepsy, X-linked 1, with variable learning disabilities and behavior disorders	300491		3
SYN1, EPILX1, MRX50	 Intellectual developmental disorder, X-linked 50	300115		3
SYN2	Schizophrenia, susceptibility to	181500		3
SYNE1, KIAA0796, KIAA1756, KIAA1262, SCAR8, EDMD4, AMC3	Arthrogryposis multiplex congenita 3, myogenic type	618484		3
SYNE1, KIAA0796, KIAA1756, KIAA1262, SCAR8, EDMD4, AMC3	 Emery-Dreifuss muscular dystrophy 4, autosomal dominant	612998		3
SYNE1, KIAA0796, KIAA1756, KIAA1262, SCAR8, EDMD4, AMC3	 Spinocerebellar ataxia, autosomal recessive 8	610743		3
SYNE2, NUANCE, KIAA1011, EDMD5	Emery-Dreifuss muscular dystrophy 5, autosomal dominant	612999		3
SYNE4, NESP4, C19orf46, DFNB76	Deafness, autosomal recessive 76	615540		3
SYNGAP1, MRD5	Intellectual developmental disorder, autosomal dominant 5	612621		3
SYNJ1, PARK20, DEE53	 Developmental and epileptic encephalopathy 53	617389		3
SYNJ1, PARK20, DEE53	Parkinson disease 20, early-onset	615530		3
SYNSTH	Synesthesia	612759	max lod at D2S142	2
SYP, XLID96	Intellectual developmental disorder, X-linked 96	300802		3
SYT1, BAGOS	Baker-Gordon syndrome	618218		3
SYT2, CMS7A, MYSPC, CMS7B	Myasthenic syndrome, congenital, 7A, presynaptic, and distal motor neuropathy, autosomal dominant	616040		3
SYT2, CMS7A, MYSPC, CMS7B	 Myasthenic syndrome, congenital, 7B, presynaptic, autosomal recessive	619461		3
SZT2, KIAA0467, DEE18	Developmental and epileptic encephalopathy 18	615476		3
T2D3	Type 2 diabetes mellitus 3	603694		2
TAB2, MAP3K7IP2, KIAA0733, CHTD2	Congenital heart defects, nonsyndromic, 2	614980		3
TAC3, NKNB, HH10	Hypogonadotropic hypogonadism 10 with or without anosmia	614839		3
TACO1, CCDC44, MC4DN8	Mitochondrial complex IV deficiency, nuclear type 8	619052		3
TACR3, NK3R, HH11	Hypogonadotropic hypogonadism 11 with or without anosmia	614840		3
TACSTD2, TROP2, M1S1	Corneal dystrophy, gelatinous drop-like	204870		3
TAF13, TAF2K, MRT60	Intellectual developmental disorder, autosomal recessive 60	617432		3
TAF15, TAF2N, RBP56	Chondrosarcoma, extraskeletal myxoid	612237	fusion gene with CSMF	1
TAF1, TAF2A, CCG1, BA2R, DYT3, MRXS33	 Dystonia-Parkinsonism, X-linked	314250	SVA retrotransposon insertion	3
TAF1, TAF2A, CCG1, BA2R, DYT3, MRXS33	Intellectual developmental disorder, X-linked syndromic 33	300966	SVA retrotransposon insertion	3
TAF2, TAF2B, TAFII150, CIF150, MRT40	Intellectual developmental disorder, autosomal recessive 40	615599		3
TAF6, TAF2E, TAFII80, ALYUS	Alazami-Yuan syndrome	617126		3
TAF8, TBN, NEDMLHB	Neurodevelopmental disorder with severe motor impairment, absent language, cerebral hypomyelination, and brain atrophy	619972		3
TAFAZZIN, TAZ, EFE2, BTHS, CMD3A, LVNCX	Barth syndrome	302060		3
TAL1, TCL5, SCL	Leukemia, T-cell acute lymphocytic, somatic	613065	proximal to MYCL1	3
TAL2	Leukemia, T-cell acute lymphocytic, somatic	613065	33kb from breakpoint in t(7;9)	3
TALDO1	Transaldolase deficiency	606003	pseudogene on chr.1	3
TAMM41, RAM41, C3orf31, COXPD56	Combined oxidative phosphorylation deficiency 56	620139		3
TAM, MST	Leukemia, transient, of Down syndrome	159595		2
TANC2, KIAA1636, IDDALDS	Intellectual developmental disorder with autistic features and language delay, with or without seizures	618906		3
TANGO2, C22orf25, MECRCN	Metabolic encephalomyopathic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration	616878		3
TAOK1, PSK2, TAO1, MARKK, DDIB	Developmental delay with or without intellectual impairment or behavioral abnormalities	619575		3
TAP1, ABCB2, RING4, PSF1	Bare lymphocyte syndrome, type I	604571	~7kb telomeric to TAP2	3
TAP2, ABCB3, PSF2, RING11	Bare lymphocyte syndrome, type I, due to TAP2 deficiency	604571	tel-TAP1-LMP2-LMP1-TAP2-cen	3
TAPBP, TPSN	Bare lymphocyte syndrome, type I	604571		3
TAPT1, CMVFR, OCLSBG	Osteochondrodysplasia, complex lethal, Symoens-Barnes-Gistelinck type	616897		3
TAPVR1	Total anomalous pulmonary venous return	106700	between D4S1630 and D4S3019; ?mutation in KDR	2
TARDBP, TDP43, ALS10	 Amyotrophic lateral sclerosis 10, with or without FTD	612069	pseudogenes on 2, 6, 8, 13, 20	3
TARDBP, TDP43, ALS10	Frontotemporal lobar degeneration, TARDBP-related	612069	pseudogenes on 2, 6, 8, 13, 20	3
TARS1, TARS, TTD7	Trichothiodystrophy 7, nonphotosensitive	618546	linked to LARS	3
TARS2, COXPD21	Combined oxidative phosphorylation deficiency 21	615918		3
TAS2R16, T2R16, BGLPT	Alcohol dependence, susceptibility to	103780		3
TAS2R16, T2R16, BGLPT	 Beta-glycopyranoside tasting	617956		3
TAS2R38, T2R61, PTC, THIOT	Phenylthiocarbamide tasting	171200		3
TASP1, C20orf13, SULEHS	Suleiman-El-Hattab syndrome	618950		3
TAT	Tyrosinemia, type II	276600		3
TBC1D20, C20orf140, WARBM4	Warburg micro syndrome 4	615663		3
TBC1D23, PCH11	Pontocerebellar hypoplasia, type 11	617695		3
TBC1D24, KIAA1171, FIME, DEE16, DOORS, DFNB86, DFNA65, EPRPDC	 Deafness, autosomal dominant 65	616044		3
TBC1D24, KIAA1171, FIME, DEE16, DOORS, DFNB86, DFNA65, EPRPDC	Deafness, autosomal recessive 86	614617		3
TBC1D24, KIAA1171, FIME, DEE16, DOORS, DFNB86, DFNA65, EPRPDC	 Developmental and epileptic encephalopathy 16	615338		3
TBC1D24, KIAA1171, FIME, DEE16, DOORS, DFNB86, DFNA65, EPRPDC	 DOORS syndrome	220500		3
TBC1D24, KIAA1171, FIME, DEE16, DOORS, DFNB86, DFNA65, EPRPDC	 Epilepsy, rolandic, with paroxysmal exercise-induce dystonia and writer's cramp	608105		3
TBC1D24, KIAA1171, FIME, DEE16, DOORS, DFNB86, DFNA65, EPRPDC	 Myoclonic epilepsy, infantile, familial	605021		3
TBC1D2B, KIAA1055, NEDSGO	Neurodevelopmental disorder with seizures and gingival overgrowth	619323		3
TBC1D4, AS160, KIAA0603, NIDDM5	Diabetes mellitus, noninsulin-dependent, 5	616087		3
TBC1D7, PIG51, TBC7, MGCPH	Macrocephaly/megalencephaly syndrome, autosomal recessive	248000		3
TBC1D8B, NPHS20	Nephrotic syndrome, type 20	301028		3
TBCD, PEBAT	Encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum	617193		3
TBCE, KCS, KCS1, HRD, PEAMO	 Encephalopathy, progressive, with amyotrophy and optic atrophy	617207		3
TBCE, KCS, KCS1, HRD, PEAMO	 Hypoparathyroidism-retardation-dysmorphism syndrome	241410		3
TBCE, KCS, KCS1, HRD, PEAMO	Kenny-Caffey syndrome, type 1	244460		3
TBCK, IHPRF3	Hypotonia, infantile, with psychomotor retardation and characteristic facies 3	616900		3
TBG, TBGQTL	Thyroxine-binding globulin QTL	300932		3
TBK1, NAK, FTDALS4, IIAE8	Encephalopathy, acute, infection-induced , susceptibility to, 8	617900		3
TBK1, NAK, FTDALS4, IIAE8	 Frontotemporal dementia and/or amyotrophic lateral sclerosis 4	616439		3
TBL1XR1, TBLR1, IRA1, C21, MRD41	Intellectual developmental disorder, autosomal dominant 41	616944		3
TBL1XR1, TBLR1, IRA1, C21, MRD41	 Pierpont syndrome	602342		3
TBL1X, TBL1, CHNG8	Hypothyroidism, congenital, nongoitrous, 8	301033		3
TBP, SCA17, HDL4	 Parkinson disease, susceptibility to	168600		3
TBP, SCA17, HDL4	Spinocerebellar ataxia 17	607136		3
TBR1, IDDAS	Intellectual developmental disorder with autism and speech delay	606053		3
TBX15	Cousin syndrome	260660		3
TBX18, CAKUT2	Congenital anomalies of kidney and urinary tract 2	143400		3
TBX19	Adrenocorticotropic hormone deficiency	201400		3
TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR	 Conotruncal anomaly face syndrome	217095		3
TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR	 DiGeorge syndrome	188400		3
TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR	Tetralogy of Fallot	187500		3
TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR	 Velocardiofacial syndrome	192430		3
TBX20, ASD4	Atrial septal defect 4	611363		3
TBX21, TBET, IMD88	Asthma and nasal polyps	208550	mutation identified in 1 IMD88 patient	3
TBX21, TBET, IMD88	 Asthma, aspirin-induced, susceptibility to	208550	mutation identified in 1 IMD88 patient	3
TBX21, TBET, IMD88	 Immunodeficiency 88	619630	mutation identified in 1 IMD88 patient	3
TBX22, CPX, ABERS	 Abruzzo-Erickson syndrome	302905	1 ABERS family identified with mutation	3
TBX22, CPX, ABERS	Cleft palate with ankyloglossia	303400	1 ABERS family identified with mutation	3
TBX2, VETD	Vertebral anomalies and variable endocrine and T-cell dysfunction	618223		3
TBX3	Ulnar-mammary syndrome	181450		3
TBX4, ICPPS, PAPPAS	 Amelia, posterior, with pelvic and pulmonary hypoplasia syndrome	601360		3
TBX4, ICPPS, PAPPAS	Ischiocoxopodopatellar syndrome with or without pulmonary arterial hypertension	147891		3
TBX5	Holt-Oram syndrome	142900		3
TBX6, SCDO5	Spondylocostal dysostosis 5	122600		3
TBXA2R, BDPLT13	Bleeding disorder, platelet-type, 13, susceptibility to	614009		3
TBXAS1, GHOSAL, CYP5	Ghosal hematodiaphyseal syndrome	231095		3
TBXT, T, TFT, SAVA	 Neural tube defects, susceptibility to	182940		3
TBXT, T, TFT, SAVA	Sacral agenesis with vertebral anomalies	615709		3
TCAP, LGMDR7, CMH25	Cardiomyopathy, hypertrophic, 25	607487		3
TCAP, LGMDR7, CMH25	 Muscular dystrophy, limb-girdle, autosomal recessive 7	601954		3
TCF12, HTF4, CRS3, HH26	Craniosynostosis 3	615314		3
TCF12, HTF4, CRS3, HH26	 Hypogonadotropic hypogonadism 26 with or without anosmia	619718		3
TCF20, SPBP, AR1, DDVIBA	Developmental delay with variable intellectual impairment and behavioral abnormalities	618430		3
TCF3, E2A, AGM8A, AGM8B	 Agammaglobulinemia 8A, autosomal dominant	616941		3
TCF3, E2A, AGM8A, AGM8B	Agammaglobulinemia 8B, autosomal recessive	619824		3
TCF4, SEF2, ITF2, PTHS, FECD3	 Corneal dystrophy, Fuchs endothelial, 3	613267		3
TCF4, SEF2, ITF2, PTHS, FECD3	Pitt-Hopkins syndrome	610954		3
TCF7L2, TCF4	Diabetes mellitus, type 2, susceptibility to	125853		3
TCIRG1, TIRC7, OC116, OPTB1	Osteopetrosis, autosomal recessive 1	259700		3
TCL1A, TCL1	Leukemia/lymphoma, T-cell	186960		2
TCL1B, TML1	Leukemia/lymphoma, T-cell	603769		2
TCL4	Leukemia/lymphoma, T-cell	186860		2
TCN2, TC2	Transcobalamin II deficiency	275350	linked to P1	3
TCOF1, MFD1, TCS1	Treacher Collins syndrome 1	154500	prox. to SPARC	3
TCO	Thyroid carcinoma, nonmedullary, with cell oxyphilia	603386		2
TCTN2, TECT2, MKS8, JBTS24	Joubert syndrome 24	616654	mutation identified in 1 MKS8 family	3
TCTN2, TECT2, MKS8, JBTS24	 Meckel syndrome 8	613885	mutation identified in 1 MKS8 family	3
TCTN3, TECT3, C10orf61, OFD4, JBTS18	Joubert syndrome 18	614815		3
TCTN3, TECT3, C10orf61, OFD4, JBTS18	 Orofaciodigital syndrome IV	258860		3
TDGF1	Forebrain defects	187395		3
TDO2, TPH2, TRPO, HYPTRP	Hypertryptophanemia	600627	mutation identified in 1 HYPTRP patient	3
TDP2, TTRAP	Spinocerebellar ataxia, autosomal recessive 23	616949		3
TDRD7, KIAA1529, TRAP, CATC4, CTRCT36	Cataract 36	613887		3
TEAD1, TCF13, REF1	Sveinsson chorioretinal atrophy	108985		3
TECPR2, KIAA0329, HSAN9	Neuropathy, hereditary sensory and autonomic, type IX, with developmental delay	615031		3
TECR, GPSN2, TER, SC2, MRT14	Intellectual developmental disorder, autosomal recessive 14	614020		3
TECRL, TERL, SRD5A2L2, GPSN2L, CPVT3	Ventricular tachycardia, catecholaminergic polymorphic, 3	614021		3
TECT1, JBTS13	Joubert syndrome 13	614173		3
TECTA, DFNA8, DFNA12, DFNB21	Deafness, autosomal dominant 8/12	601543		3
TECTA, DFNA8, DFNA12, DFNB21	 Deafness, autosomal recessive 21	603629		3
TEC	Transient erythroblastopenia of childhood	227050		2
TEK, TIE2, VMCM, GLC3E	 Glaucoma 3, primary congenital, E	617272		3
TEK, TIE2, VMCM, GLC3E	Venous malformations, multiple cutaneous and mucosal	600195		3
TELM	Telomere length, mean leukocyte	609113	suggestive QTL on 12, 10q, 3p	2
TELO2, TEL2, CLK2, KIAA0683, HCLK2, YHFS	You-Hoover-Fong syndrome	616954		3
TEMPS	Temple syndrome	616222		4
TENM3, ODZ3, TNM3, KIAA1455, MCOPCB9, MCOPS15	 Microphthalmia, isolated, with coloboma 9	615145	mutation identified in 1 MCOPCB9 family	3
TENM3, ODZ3, TNM3, KIAA1455, MCOPCB9, MCOPS15	Microphthalmia, syndromic 15	615145	mutation identified in 1 MCOPCB9 family	3
TENM4, ODZ4, TNM4, DOC4, KIAA1302, ETM5	Essential tremor, hereditary, 5	616736		3
TENT5A, FAM46A, C6orf37, OI18	Osteogenesis imperfecta, type XVIII	617952		3
TERB1, CCDC79, SPGF60	Spermatogenic failure 60	619646		3
TERC, TRC3, TR, DKCA1, PFBMFT2	 Aplastic anemia	614743		3
TERC, TRC3, TR, DKCA1, PFBMFT2	 Dyskeratosis congenita, autosomal dominant 1	127550		3
TERC, TRC3, TR, DKCA1, PFBMFT2	Pulmonary fibrosis, idiopathic, susceptibility to	614743		3
TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9	Dyskeratosis congenita, autosomal dominant 2	613989	deleted in cri du chat	3
TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9	 Dyskeratosis congenita, autosomal recessive 4	613989	deleted in cri du chat	3
TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9	 Leukemia, acute myeloid	601626	deleted in cri du chat	3
TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9	 Melanoma, cutaneous malignant, 9	615134	deleted in cri du chat	3
TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9	 Pulmonary fibrosis and/or bone marrow failure, telomere-related, 1	614742	deleted in cri du chat	3
TET18P	Tetrasomy 18p	614290		4
TET2, KIAA1546, MDS, IMD75	 Immunodeficiency 75	619126		3
TET2, KIAA1546, MDS, IMD75	Myelodysplastic syndrome, somatic	614286		3
TET3, KIAA0401, BEFAHRS	Beck-Fahrner syndrome	618798		3
TEX11, SPGFX2	Spermatogenic failure, X-linked 2	309120		3
TEX14, SPGF23	Spermatogenic failure 23	617707		3
TEX15, SPGF25	Spermatogenic failure 25	617960		3
TFAP2A, AP2TF, BOFS	Branchiooculofacial syndrome	113620		3
TFAP2B, CHAR, PDA2	 Char syndrome	169100		3
TFAP2B, CHAR, PDA2	Patent ductus arteriosus 2	617035		3
TFE3, RCCX1, MRXSPF	Intellectual developmental disorder, X-linked syndromic, with pigmentary mosaicism and coarse facies	301066	fuses with PRCC in RCCP	3
TFE3, RCCX1, MRXSPF	 Renal cell carcinoma, papillary, 1	300854	fuses with PRCC in RCCP	3
TFG, HMSNP, SPG57	 Hereditary motor and sensory neuropathy, Okinawa type	604484	fused with NR4A3 or NTRK1; mutation identified in 1 SPG57 family	3
TFR2, HFE3	Hemochromatosis, type 3	604250		3
TFRC, TFR, CD71, IMD46	Immunodeficiency 46	616740		3
TF, TFQTL1	Atransferrinemia	209300		3
TG, AITD3, TDH3	Autoimmune thyroid disease, susceptibility to, 3	608175	distal to MYC	3
TG, AITD3, TDH3	 Thyroid dyshormonogenesis 3	274700	distal to MYC	3
TGCT1	Testicular germ cell tumor	300228		2
TGDS, SDR2E1, CATMANS	Catel-Manzke syndrome	616145		3
TGFB1, DPD1, CED, IBDIMDE	 Camurati-Engelmann disease	131300		3
TGFB1, DPD1, CED, IBDIMDE	 Cystic fibrosis lung disease, modifier of	219700		3
TGFB1, DPD1, CED, IBDIMDE	Inflammatory bowel disease, immunodeficiency, and encephalopathy	618213		3
TGFB2, LDS4	Loeys-Dietz syndrome 4	614816		3
TGFB3, ARVD1, RNHF, LDS5	Arrhythmogenic right ventricular dysplasia 1	107970		3
TGFB3, ARVD1, RNHF, LDS5	 Loeys-Dietz syndrome 5	615582		3
TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	Corneal dystrophy, Avellino type	607541		3
TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	 Corneal dystrophy, epithelial basement membrane	121820		3
TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	 Corneal dystrophy, Groenouw type I	121900		3
TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	 Corneal dystrophy, lattice type I	122200		3
TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	 Corneal dystrophy, lattice type IIIA	608471		3
TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	 Corneal dystrophy, Reis-Bucklers type	608470		3
TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	 Corneal dystrophy, Thiel-Behnke type	602082		3
TGFBR1, ALK5, AAT5, LDS1, MSSE	 Loeys-Dietz syndrome 1	609192		3
TGFBR1, ALK5, AAT5, LDS1, MSSE	Multiple self-healing squamous epithelioma, susceptibility to	132800		3
TGFBR2, HNPCC6, AAT3, MFS2, LDS2	 Colorectal cancer, hereditary nonpolyposis, type 6	614331		3
TGFBR2, HNPCC6, AAT3, MFS2, LDS2	 Esophageal cancer, somatic	133239		3
TGFBR2, HNPCC6, AAT3, MFS2, LDS2	Loeys-Dietz syndrome 2	610168		3
TGIF1, HPE4	Holoprosencephaly 4	142946		3
TGM1, ICR2, ARCI1	Ichthyosis, congenital, autosomal recessive 1	242300		3
TGM5, TGX, PSS2	Peeling skin syndrome 2	609796		3
TGM6, TG6, TGY, SCA35	Spinocerebellar ataxia 35	613908		3
THAP1, DYT6	Dystonia 6, torsion	602629		3
THAS, TAS	Thoracoabdominal syndrome	313850		2
THBD, THRM, AHUS6, THPH12	 Hemolytic uremic syndrome, atypical, susceptibility to, 6	612926		3
THBD, THRM, AHUS6, THPH12	Thrombophilia 12 due to thrombomodulin defect	614486		3
THBS2	Lumbar disc herniation, susceptibility to	603932		3
THG1L, THG1, ICF45, IHG1, SCAR28	Spinocerebellar ataxia, autosomal recessive 28	618800		3
THOC2, THO2, XLID12	Intellectual developmental disorder, X-linked 12	300957		3
THOC6, FSAP35, BBIS	Beaulieu-Boycott-Innes syndrome	613680		3
THPO, MGDF, MPLLG, TPO, THCYT1	Thrombocythemia 1	187950		3
THRA, ERBA1, THRA1, CHNG6	Hypothyroidism, congenital, nongoitrous, 6	614450		3
THRB, ERBA2, THR1, PRTH	 Thyroid hormone resistance	188570		3
THRB, ERBA2, THR1, PRTH	Thyroid hormone resistance, autosomal recessive	274300		3
THRB, ERBA2, THR1, PRTH	 Thyroid hormone resistance, selective pituitary	145650		3
THSD4, ADAMTSL6, AAT12	Aortic aneurysm, familial thoracic 12	619825		3
TH, TYH	Segawa syndrome, recessive	605407	distal to HRAS1	3
THUMPD1, NEDSOA	Neurodevelopmental disorder with speech delay and variable ocular anomalies	619989		3
TIA1, WDM, ALS26	 Amyotrophic lateral sclerosis 26 with or without frontotemporal dementia	619133		3
TIA1, WDM, ALS26	Welander distal myopathy	604454		3
TIAM1, NEDLDS	Neurodevelopmental disorder with language delay and seizures	619908		3
TICAM1, TRIF, IIAE6	Encephalopathy, acute, infection-induced , susceptibility to, 6	614850		3
TIE, JTK14, TIE1, LMPHM11	Lymphatic malformation 11	619401		3
TIMM50, TIM50, MGCA9	3-methylglutaconic aciduria, type IX	617698		3
TIMM8A, DFN1, DDP, MTS, DDP1	Mohr-Tranebjaerg syndrome	304700		3
TIMMDC1, C3orf1, MC1DN31	Mitochondrial complex I deficiency, nuclear type 31	618251		3
TIMP3, SFD	Sorsby fundus dystrophy	136900		3
TINF2, TIN2, DKCA3	Dyskeratosis congenita, autosomal dominant 3	613990		3
TINF2, TIN2, DKCA3	 Revesz syndrome	268130		3
TIRAP, BACTS1	 Bacteremia, protection against	614382		3
TIRAP, BACTS1	Malaria, protection against	611162		3
TIRAP, BACTS1	 Tuberculosis, protection against	607948		3
TJP2, ZO2, PFIC4, FHCA1	 Cholestasis, progressive familial intrahepatic 4	615878		3
TJP2, ZO2, PFIC4, FHCA1	Hypercholanemia, familial 1	607748		3
TK2, MTDPS2, PEOB3	Mitochondrial DNA depletion syndrome 2 	609560	mutation identified in 1 PEOB3 family	3
TK2, MTDPS2, PEOB3	 Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 3	617069	mutation identified in 1 PEOB3 family	3
TKCR, TKC	Goeminne TKCR syndrome	314300	distal to G6PD	2
TKFC, DAK, TKFCD	Triokinase and FMN cyclase deficiency syndrome	618805		3
TKT, SDDHD	Short stature, developmental delay, and congenital heart defects	617044		3
TLCD3B, FAM57B, CORD22	Cone-rod dystrophy 22	619531		3
TLE6, GRG6, PREMBL	Preimplantation embryonic lethality	616814		3
TLK2, MRD57	Intellectual developmental disorder, autosomal dominant 57	618050		3
TLL1, TLL, ASD6	Atrial septal defect 6	613087		3
TLR1, TIL. LPRS5	 Leprosy, protection against	613223		3
TLR1, TIL. LPRS5	Leprosy, susceptibility to, 5	613223		3
TLR2, TIL4	Colorectal cancer, susceptibility to	114500		3
TLR2, TIL4	 Leprosy, susceptibility to	246300		3
TLR2, TIL4	 Mycobacterium tuberculosis, susceptibility to	607948		3
TLR3, IMD83	HIV1 infection, resistance to	609423		3
TLR3, IMD83	 Immunodeficiency 83, susceptibility to viral infections	613002		3
TLR5, TIL3, SLEB1, MELIOS	 Legionnaire disease, susceptibility to	608556		3
TLR5, TIL3, SLEB1, MELIOS	Melioidosis, susceptibility to	615557		3
TLR5, TIL3, SLEB1, MELIOS	 Systemic lupus erythematosus, resistance to	601744		3
TLR5, TIL3, SLEB1, MELIOS	 Systemic lupus erythematosus, susceptibility to, 1	601744		3
TLR7, IMD74, SLEB17	Immunodeficiency 74, COVID19-related, X-linked	301051	centromeric to TLR8	3
TLR7, IMD74, SLEB17	 Systemic lupus erythematosus 17	301080	centromeric to TLR8	3
TLR8, IMD98	Immunodeficiency 98 with autoinflammation, X-linked	301078	16kb telomeric to TLR7	3
TM4SF20, SLI5	Specific language impairment 5	615432		3
TMC1, DFNB7, DFNB11, DFNA36	Deafness, autosomal dominant 36	606705		3
TMC1, DFNB7, DFNB11, DFNA36	 Deafness, autosomal recessive 7	600974		3
TMC6, EVER1, EV1	Epidermodysplasia verruciformis	226400		3
TMC8, EVER2, EV2	Epidermodysplasia verruciformis 2	618231	previously mapped to 2p24-p21	3
TMCO1, CFSMR1	Craniofacial dysmorphism, skeletal anomalies, and impaired intellectual development 1	213980		3
TMEM106B, HLD16	Leukodystrophy, hypomyelinating, 16	617964		3
TMEM107, MKS13, JBTS29	 Joubert syndrome 29	617562	mutation identified in 1 JBTS29	3
TMEM107, MKS13, JBTS29	 Meckel syndrome 13	617562	mutation identified in 1 JBTS29	3
TMEM107, MKS13, JBTS29	Orofaciodigital syndrome XVI	617563	mutation identified in 1 JBTS29	3
TMEM126A, OPA7	Optic atrophy 7	612989		3
TMEM126B, MC1DN29	Mitochondrial complex I deficiency, nuclear type 29	618250		3
TMEM127	Pheochromocytoma, susceptibility to	171300		3
TMEM132E, DFNB99	Deafness, autosomal recessive 99	618481		3
TMEM138, JBTS16	Joubert syndrome 16	614465		3
TMEM147, NEDFLPH	Neurodevelopmental disorder with facial dysmorphism, absent language, and pseudo-Pelger-Huet anomaly	620075		3
TMEM165, FT27, CDG2K	Congenital disorder of glycosylation, type IIk	614727		3
TMEM199, VMA12, VPH2, C17orf32, CDG2P	Congenital disorder of glycosylation, type IIp	616829		3
TMEM216, JBTS2, CORS2, MKS2	Joubert syndrome 2	608091		3
TMEM216, JBTS2, CORS2, MKS2	 Meckel syndrome 2	603194		3
TMEM218, JBTS39	Joubert syndrome 39	619562		3
TMEM222, C1orf160, NEDMOSBA	Neurodevelopmental disorder with motor and speech delay and behavioral abnormalities	619470		3
TMEM231, JBTS20, MKS11	Joubert syndrome 20	614970		3
TMEM231, JBTS20, MKS11	 Meckel syndrome 11	615397		3
TMEM237, ALS2CR4, JBTS14	Joubert syndrome 14	614424		3
TMEM240, C1orf70, SCA21	Spinocerebellar ataxia 21	607454		3
TMEM251, C14orf109, DMAN	Dysostosis multiplex, Ain-Naz type	619345		3
TMEM260, C14orf101, SHDRA	Structural heart defects and renal anomalies syndrome	617478		3
TMEM38B, TRICB, OI14	Osteogenesis imperfecta, type XIV	615066		3
TMEM43, ARVD5, ARVC5, EDMD7, AUNA3	Arrhythmogenic right ventricular dysplasia 5	604400		3
TMEM43, ARVD5, ARVC5, EDMD7, AUNA3	 Auditory neuropathy, autosomal dominant 3	619832		3
TMEM43, ARVD5, ARVC5, EDMD7, AUNA3	 Emery-Dreifuss muscular dystrophy 7, AD	614302		3
TMEM53, NET4, CTDI	Craniotubular dysplasia, Ikegawa type	619727		3
TMEM63A, KIAA0792, HLD19	Leukodystrophy, hypomyelinating, 19, transient infantile	618688		3
TMEM63C, SPG87	Spastic paraplegia 87, autosomal recessive	619966		3
TMEM67, MKS3, JBTS6, NPHP11	 Bardet-Biedl syndrome 14, modifier of	615991	mutation identified in 1 RHYNS patient	3
TMEM67, MKS3, JBTS6, NPHP11	 COACH syndrome 1	216360	mutation identified in 1 RHYNS patient	3
TMEM67, MKS3, JBTS6, NPHP11	 Joubert syndrome 6	610688	mutation identified in 1 RHYNS patient	3
TMEM67, MKS3, JBTS6, NPHP11	 Meckel syndrome 3	607361	mutation identified in 1 RHYNS patient	3
TMEM67, MKS3, JBTS6, NPHP11	Nephronophthisis 11	613550	mutation identified in 1 RHYNS patient	3
TMEM67, MKS3, JBTS6, NPHP11	 RHYNS syndrome	602152	mutation identified in 1 RHYNS patient	3
TMEM70, MC5DN2	Mitochondrial complex V  deficiency, nuclear type 2	614052		3
TMEM94, KIAA0195, IDDCDF	Intellectual developmental disorder with cardiac defects and dysmorphic facies	618316		3
TMEM98, NNO4	Nanophthalmos 4	615972		3
TMIE, DFNB6	Deafness, autosomal recessive 6	600971		3
TMLHE, BBOX2, TMLH, TMLHED, AUTSX6	Autism, susceptibility to, X-linked 6	300872		3
TMPRSS15, PRSS7, ENTK	Enterokinase deficiency	226200		3
TMPRSS3, ECHOS1, DFNB8, DFNB10	Deafness, autosomal recessive 8/10	601072		3
TMPRSS6, IRIDA	Iron-refractory iron deficiency anemia	206200		3
TMTC3, SMILE, LIS8	Lissencephaly 8	617255		3
TMX2, NEDMCMS	Neurodevelopmental disorder with microcephaly, cortical malformations, and spasticity	618730		3
TNC, HXB, DFNA56	Deafness, autosomal dominant 56	615629	proximal to ABL	3
TNDM1	Diabetes mellitus, transient neonatal 1	601410	disordered imprinting of PLAGL1 and HYMAI	4
TNFAIP3, A20, OTUD7C, AIFBL1	Autoinflammatory syndrome, familial, Behcet-like 1	616744		3
TNFRSF10B, DR5, TRAILR2	Squamous cell carcinoma, head and neck	275355		3
TNFRSF11A, RANK, ODFR, FEO, OPTB7, PDB2	 Osteolysis, familial expansile	174810		3
TNFRSF11A, RANK, ODFR, FEO, OPTB7, PDB2	Osteopetrosis, autosomal recessive 7	612301		3
TNFRSF11A, RANK, ODFR, FEO, OPTB7, PDB2	 Paget disease of bone 2, early-onset	602080		3
TNFRSF11B, OPG, OCIF, PDB5	Paget disease of bone 5, juvenile-onset	239000		3
TNFRSF13B, TACI, CVID2	Immunodeficiency, common variable, 2	240500		3
TNFRSF13B, TACI, CVID2	 Immunoglobulin A deficiency 2	609529		3
TNFRSF13C, BAFFR, CVID4	Immunodeficiency, common variable, 4	613494		3
TNFRSF1A, TNFR1, TNFAR, FPF, MS5	Multiple sclerosis, susceptibility to, 5	614810		3
TNFRSF1A, TNFR1, TNFAR, FPF, MS5	 Periodic fever, familial	142680		3
TNFSF11, OPGL, TRANCE, OPTB2	Osteopetrosis, autosomal recessive 2	259710		3
TNFSF4, GP34, OX4OL	Myocardial infarction, susceptibility to	608446		3
TNFSF5, CD40LG, HIGM1, IGM	Immunodeficiency, X-linked, with hyper-IgM	308230	Between DSX144E and DSX300	3
TNF, TNFA	 Asthma, susceptibility to	600807	5'-LTA--TNF-3' in 7kb segment (pter-cen); 210kb from HLA-B	3
TNF, TNFA	 Dementia, vascular, susceptibility to	191160	5'-LTA--TNF-3' in 7kb segment (pter-cen); 210kb from HLA-B	3
TNF, TNFA	 Malaria, cerebral, susceptibility to	611162	5'-LTA--TNF-3' in 7kb segment (pter-cen); 210kb from HLA-B	3
TNF, TNFA	Migraine without aura, susceptibility to	157300	5'-LTA--TNF-3' in 7kb segment (pter-cen); 210kb from HLA-B	3
TNF, TNFA	 Septic shock, susceptibility to	191160	5'-LTA--TNF-3' in 7kb segment (pter-cen); 210kb from HLA-B	3
TNIK, KIAA0551, MRT54	Intellectual developmental disorder, autosomal recessive 54	617028		3
TNNC1, CMD1Z, CMH13	Cardiomyopathy, dilated, 1Z	611879		3
TNNC1, CMD1Z, CMH13	 Cardiomyopathy, hypertrophic, 13	613243		3
TNNC2, MYONRI	Myopathy, congenital, with neonatal respiratory insufficiency	620161		3
TNNI2, AMCD2B, DA2B1, FSSV	Arthrogryposis, distal, type 2B1	601680		3
TNNI3, CMH7, CMD2A, RCM1, CMD1FF	 Cardiomyopathy, dilated, 1FF	613286	mutation identified in 1 CMD2A family	3
TNNI3, CMH7, CMD2A, RCM1, CMD1FF	 Cardiomyopathy, familial restrictive, 1	115210	mutation identified in 1 CMD2A family	3
TNNI3, CMH7, CMD2A, RCM1, CMD1FF	 Cardiomyopathy, hypertrophic, 7	613690	mutation identified in 1 CMD2A family	3
TNNI3K, CCDD	Cardiac conduction disease with or without dilated cardiomyopathy	616117		3
TNNT1, ANM, NEM5	Nemaline myopathy 5, Amish type	605355		3
TNNT2, CMH2, CMD1D, RCM3, LVNC6	Cardiomyopathy, dilated, 1D	601494		3
TNNT2, CMH2, CMD1D, RCM3, LVNC6	 Cardiomyopathy, familial restrictive, 3	612422		3
TNNT2, CMH2, CMD1D, RCM3, LVNC6	 Cardiomyopathy, hypertrophic, 2	115195		3
TNNT2, CMH2, CMD1D, RCM3, LVNC6	 Left ventricular noncompaction 6	601494		3
TNNT3, AMCD2B, DA2B2, FSSV	Arthrogryposis, distal, type 2B2	618435		3
TNPO2, TRN2, KPNB2B, IDDHISD	Intellectual developmental disorder with hypotonia, impaired speech, and dysmorphic facies	619556		3
TNPO3, TRNSR, LGMDD2	Muscular dystrophy, limb-girdle, autosomal dominant 2	608423		3
TNRC6B, KIAA1093, GDSBA	Global developmental delay with speech and behavioral abnormalities	619243		3
TNR, NEDSTO	Neurodevelopmental disorder, nonprogressive, with spasticity and transient opisthotonus	619653		3
TNXB, TNX, TNXB1, TNXBS, TNXB2, EDSCLL1, VUR8	Ehlers-Danlos syndrome, classic-like, 1	606408		3
TNXB, TNX, TNXB1, TNXBS, TNXB2, EDSCLL1, VUR8	 Vesicoureteral reflux 8	615963		3
TOE1, PCH7	Pontocerebellar hypoplasia, type 7	614969		3
TOGARAM1, FAM179B, KIAA0423, JBTS37	Joubert syndrome 37	619185		3
TONSL, NFKBIL2, IKBR, SEMDSP	Spondyloepimetaphyseal dysplasia, sponastrime type	271510		3
TOP1	DNA topoisomerase I, camptothecin-resistant	126420	pseudogenes on chr.1 and 22	3
TOP2A, TOP2	DNA topoisomerase II, resistance to inhibition of, by amsacrine	126430		3
TOP2B, BILU	B-cell immunodeficiency, distal limb anomalies, and urogenital malformations	609296		3
TOP3A, MGRISCE2, PEOB5	 Microcephaly, growth restriction, and increased sister chromatid exchange 2	618097	mutation identified in 1 PEOB5 patient	3
TOPORS, P53BP3, LUN, RP31	Retinitis pigmentosa 31	609923		3
TOR1A, DYT1, AMC5	 Arthrogryposis multiplex congenita 5	618947		3
TOR1A, DYT1, AMC5	Dystonia-1, modifier of	605204		3
TOR1A, DYT1, AMC5	 Dystonia-1, torsion	128100		3
TP53, P53, LFS1 , BCC7, BMFS5	 Adrenocortical carcinoma, pediatric	202300		3
TP53, P53, LFS1 , BCC7, BMFS5	Basal cell carcinoma 7	614740		3
TP53, P53, LFS1 , BCC7, BMFS5	 Bone marrow failure syndrome 5	618165		3
TP53, P53, LFS1 , BCC7, BMFS5	 Breast cancer, somatic	114480		3
TP53, P53, LFS1 , BCC7, BMFS5	 Choroid plexus papilloma	260500		3
TP53, P53, LFS1 , BCC7, BMFS5	 Colorectal cancer	114500		3
TP53, P53, LFS1 , BCC7, BMFS5	 Glioma susceptibility 1	137800		3
TP53, P53, LFS1 , BCC7, BMFS5	 Hepatocellular carcinoma, somatic	114550		3
TP53, P53, LFS1 , BCC7, BMFS5	 Li-Fraumeni syndrome	151623		3
TP53, P53, LFS1 , BCC7, BMFS5	 Nasopharyngeal carcinoma, somatic	607107		3
TP53, P53, LFS1 , BCC7, BMFS5	 Osteosarcoma	259500		3
TP53, P53, LFS1 , BCC7, BMFS5	 Pancreatic cancer, somatic	260350		3
TP53RK, PRPK, GAMOS4	Galloway-Mowat syndrome 4	617730		3
TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	 ADULT syndrome	103285		3
TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3	604292		3
TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	 Hay-Wells syndrome	106260		3
TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	 Limb-mammary syndrome	603543		3
TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	 Orofacial cleft 8	618149		3
TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	 Rapp-Hodgkin syndrome	129400		3
TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	 Split-hand/foot malformation 4	605289		3
TP73, CILD47	Ciliary dyskinesia, primary, 47, and lissencephaly	619466	imprinted	3
TPCN2, TPC2, SHEP10	Skin/hair/eye pigmentation 10, blond/brown hair	612267		3
TPH2, NTPH, ADHD7	Attention deficit-hyperactivity disorder, susceptibility to, 7	613003	mutation identified in 1 ADHD7 family	3
TPH2, NTPH, ADHD7	 Unipolar depression, susceptibility to	608516	mutation identified in 1 ADHD7 family	3
TPI1, TPID	Hemolytic anemia due to triosephosphate isomerase deficiency	615512		3
TPK1, THMD5	Thiamine metabolism dysfunction syndrome 5 	614458		3
TPM1, CMH3, CMD1Y , LVNC9	 Cardiomyopathy, dilated, 1Y	611878		3
TPM1, CMH3, CMD1Y , LVNC9	 Cardiomyopathy, hypertrophic, 3	115196		3
TPM1, CMH3, CMD1Y , LVNC9	Left ventricular noncompaction 9	611878		3
TPM2, TMSB, AMCD1, DA1, DA2B4, NEM4	 Arthrogryposis, distal, type 1A	108120		3
TPM2, TMSB, AMCD1, DA1, DA2B4, NEM4	Arthrogryposis, distal, type 2B4	108120		3
TPM2, TMSB, AMCD1, DA1, DA2B4, NEM4	 CAP myopathy 2	609285		3
TPM2, TMSB, AMCD1, DA1, DA2B4, NEM4	 Nemaline myopathy 4, autosomal dominant	609285		3
TPM3, NEM1, CFTD, CAPM1	CAP myopathy 1	609284	TRK = chimera of TPM3 and NTRK1; NEM1 to 1q21-q23 by Fd	3
TPM3, NEM1, CFTD, CAPM1	 Myopathy, congenital, with fiber-type disproportion	255310	TRK = chimera of TPM3 and NTRK1; NEM1 to 1q21-q23 by Fd	3
TPM3, NEM1, CFTD, CAPM1	 Nemaline myopathy 1, autosomal dominant or recessive	609284	TRK = chimera of TPM3 and NTRK1; NEM1 to 1q21-q23 by Fd	3
TPMT, TPMTD	Thiopurines, poor metabolism of, 1	610460		3
TPO, TPX, TDH2A	Thyroid dyshormonogenesis 2A	274500		3
TPP1, CLN2, SCAR7	Ceroid lipofuscinosis, neuronal, 2	204500		3
TPP1, CLN2, SCAR7	 Spinocerebellar ataxia, autosomal recessive 7	609270		3
TPP2, IMD78	Immunodeficiency 78 with autoimmunity and developmental delay	619220		3
TPRKB, GAMOS5	Galloway-Mowat syndrome 5	617731		3
TPRN, C9orf75, DFNB79	Deafness, autosomal recessive 79	613307		3
TRAC, TRCA, TRA, IMD7	Immunodeficiency 7, TCR-alpha/beta deficient	615387	cen--V-C--ter	3
TRAF3, CD40BP, LAP1, CAP1, CRAF1, IIAE5	Encephalopathy, acute, infection-induced , susceptibility to, 5	614849	mutation identified in 1 IIAE5 patient	3
TRAF3IP1, MIPT3, SLSN9	Senior-Loken syndrome 9	616629		3
TRAF3IP2, C6orf5, ACT1, CIKS, C6orf4, C6orf6, PSORS13, CANDF8	 Psoriasis susceptibility 13	614070	mutation identified in 1 family with CANDF8	3
TRAF7, RFWD1, CAFDADD	Cardiac, facial, and digital anomalies with developmental delay	618164		3
TRAIP, TRIP, RNF206, SCKL9	Seckel syndrome 9	616777		3
TRAK1, OIP106, KIAA1042, DEE68	Developmental and epileptic encephalopathy 68	618201		3
TRAPPC10, TMEM1, EHOC1, NEDMISS	Neurodevelopmental disorder with microcephaly, short stature, and speech delay	620027	near PWP2H	3
TRAPPC11, C4orf41, LGMDR18	Muscular dystrophy, limb-girdle, autosomal recessive 18	615356		3
TRAPPC12, TTC15, PEBAS	Encephalopathy, progressive, early-onset, with brain atrophy and spasticity	617669		3
TRAPPC2L, PERRB	Encephalopathy, progressive, early-onset, with episodic rhabdomyolysis	618331		3
TRAPPC2, SEDL, SEDT	Spondyloepiphyseal dysplasia tarda	313400		3
TRAPPC4, NEDESBA	Neurodevelopmental disorder with epilepsy, spasticity, and brain atrophy	618741		3
TRAPPC6B, TPC6, NEDMEBA	Neurodevelopmental disorder with microcephaly, epilepsy, and brain atrophy	617862		3
TRAPPC9, NIBP, KIAA1882, MRT13	Intellectual developmental disorder, autosomal recessive 13	613192		3
TRDN, TDN, CARDAR	Cardiac arrhythmia syndrome, with or without skeletal muscle weakness	615441		3
TREH, TREHD	Trehalase deficiency	612119		3
TREM2, PLOSL2	Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2	618193		3
TREX1, AGS1, CRV, HERNS, RVCLS	 Aicardi-Goutieres syndrome 1, dominant and recessive	225750		3
TREX1, AGS1, CRV, HERNS, RVCLS	 Chilblain lupus	610448		3
TREX1, AGS1, CRV, HERNS, RVCLS	 Systemic lupus erythematosus, susceptibility to	152700		3
TREX1, AGS1, CRV, HERNS, RVCLS	Vasculopathy, retinal, with cerebral leukoencephalopathy and systemic manifestations	192315		3
TRHR, CHNG7	Hypothyroidism, congenital, nongoitrous, 7	618573		3
TRH	Thyrotropin-releasing hormone deficiency	275120		1
TRICY1	Trichilemmal cyst 1	609649	max lod at D3S1277	2
TRIM2, KIAA0517, CMT2R	Charcot-Marie-Tooth disease, type 2R	615490		3
TRIM32, HT2A, LGMDR8, BBS11	 Muscular dystrophy, limb-girdle, autosomal recessive 8	254110	mutation identified in 1 BBS11 family	3
TRIM37, MUL, KIAA0898	Mulibrey nanism	253250		3
TRIM71, LIN41, HYDCC1	Hydrocephalus, congenital communicating, 1	618667		3
TRIM8, RNF27, GERP, FSGSNEDS	Focal segmental glomerulosclerosis and neurodevelopmental syndrome	619428		3
TRIOBP, KIAA1662	Deafness, autosomal recessive 28	609823		3
TRIO, MRD44, MRD63	Intellectual developmental disorder, autosomal dominant 44, with microcephaly	617061		3
TRIO, MRD44, MRD63	 Intellectual developmental disorder, autosomal dominant 63, with macrocephaly	618825		3
TRIP11, TRIP230, CEV14, ACG1A, ODCD1	 Achondrogenesis, type IA	200600		3
TRIP11, TRIP230, CEV14, ACG1A, ODCD1	Odontochondrodysplasia 1	184260		3
TRIP12, MRD49	Intellectual developmental disorder, autosomal dominant 49	617752		3
TRIP13, 16E1BP, MVA3, OOMD9	 Mosaic variegated aneuploidy syndrome 3	617598		3
TRIP13, 16E1BP, MVA3, OOMD9	Oocyte maturation defect 9	619011		3
TRIP4, ASC1, SMABF1, MDCDC	 Spinal muscular atrophy with congenital bone fractures 1	616866	mutation identified in 1 MDCDC family	3
TRIP4q32.1q32.2, C4TRIPq32.1q32.2	Chromosome 4q32.1-q32.2 triplication syndrome	613603		4
TRIT1, IPT, COXPD35	Combined oxidative phosphorylation deficiency 35	617873		3
TRMT10A, RG9MTD2, MSSGM1	Microcephaly, short stature, and impaired glucose metabolism 1	616033		3
TRMT10C, RG9MTD1, MRPP1, COXPD30	Combined oxidative phosphorylation deficiency 30	616974		3
TRMT1, TRM1, MRT68	Intellectual developmental disorder, autosomal recessive 68	618302		3
TRMT5, TRM5, KIAA1393, PNSED	Peripheral neuropathy with variable spasticity, exercise intolerance, and developmental delay	616539		3
TRMU, MTO2	Deafness, mitochondrial, modifier of	580000		3
TRMU, MTO2	 Liver failure, transient infantile	613070		3
TRNT1, SIFD, RPEM	 Retinitis pigmentosa and erythrocytic microcytosis	616959	pseudogenes on chromosomes 1 and 22	3
TRNT1, SIFD, RPEM	Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay	616084	pseudogenes on chromosomes 1 and 22	3
TRPC6, TRP6, FSGS2	Glomerulosclerosis, focal segmental, 2	603965		3
TRPM1, MLSN1, CSNB1C	Night blindness, congenital stationary , 1C, autosomal recessive	613216		3
TRPM4, PFHB1B, EKVP6	 Erythrokeratodermia variabilis et progressiva 6	618531		3
TRPM4, PFHB1B, EKVP6	Progressive familial heart block, type IB	604559		3
TRPM6, CHAK2, HOMG1	Hypomagnesemia 1, intestinal	602014		3
TRPM7, LTRPC7, CHAK, ALSPDC	Amyotrophic lateral sclerosis-parkinsonism/dementia complex, susceptibility to	105500		3
TRPS1	 Trichorhinophalangeal syndrome, type I	190350		3
TRPS1	Trichorhinophalangeal syndrome, type III	190351		3
TRPS2, LGCR, LGS	Trichorhinophalangeal syndrome, type II	150230	contiguous gene syndrome involving TRPS1 and EXT1	4
TRPV3, OLMS1, FNEPPK2	 Olmsted syndrome 1	614594	mutation identified in 1 FNEPPK2 family	3
TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	 Avascular necrosis of femoral head, primary, 2	617383	mutation identified in 1 ANFH2 family	3
TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	 Brachyolmia type 3	113500	mutation identified in 1 ANFH2 family	3
TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	 Digital arthropathy-brachydactyly, familial	606835	mutation identified in 1 ANFH2 family	3
TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	 Hereditary motor and sensory neuropathy, type IIc	606071	mutation identified in 1 ANFH2 family	3
TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	 Metatropic dysplasia	156530	mutation identified in 1 ANFH2 family	3
TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	 Neuronopathy, distal hereditary motor, type VIII	600175	mutation identified in 1 ANFH2 family	3
TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	 Parastremmatic dwarfism	168400	mutation identified in 1 ANFH2 family	3
TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	 Scapuloperoneal spinal muscular atrophy	181405	mutation identified in 1 ANFH2 family	3
TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	 SED, Maroteaux type	184095	mutation identified in 1 ANFH2 family	3
TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	 Sodium serum level QTL 1	613508	mutation identified in 1 ANFH2 family	3
TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	Spondylometaphyseal dysplasia, Kozlowski type	184252	mutation identified in 1 ANFH2 family	3
TRPV6, ECAC2, CAT1, CATL, HRPTTN	Hyperparathyroidism, transient neonatal	618188		3
TRRAP, DEDDFA, DFNA75	 Developmental delay with or without dysmorphic facies and autism	618454	?mutation identified in 1 DFNA75 family	3
TSC1, LAM	Focal cortical dysplasia, type II, somatic	607341	linked to ABO, ABL	3
TSC1, LAM	 Lymphangioleiomyomatosis	606690	linked to ABO, ABL	3
TSC1, LAM	 Tuberous sclerosis-1	191100	linked to ABO, ABL	3
TSC2, LAM	 Focal cortical dysplasia, type II, somatic	607341	somatic mutation identified in 1 FCORD2 patient	3
TSC2, LAM	Lymphangioleiomyomatosis, somatic	606690	somatic mutation identified in 1 FCORD2 patient	3
TSC2, LAM	 Tuberous sclerosis-2	613254	somatic mutation identified in 1 FCORD2 patient	3
TSEN15, SEN15, C1orf19, PCH2F	Pontocerebellar hypoplasia, type 2F	617026		3
TSEN2, SEN2, PCH2B	Pontocerebellar hypoplasia type 2B	612389		3
TSEN54, SEN54, PCH2A, PCH4, PCH5	Pontocerebellar hypoplasia type 2A	277470	mutation identified in 1 PCH5 patient	3
TSEN54, SEN54, PCH2A, PCH4, PCH5	 Pontocerebellar hypoplasia type 4	225753	mutation identified in 1 PCH5 patient	3
TSEN54, SEN54, PCH2A, PCH4, PCH5	 Pontocerebellar hypoplasia type 5	610204	mutation identified in 1 PCH5 patient	3
TSFM, COXPD3	Combined oxidative phosphorylation deficiency 3	610505		3
TSG11	Nonsmall cell lung cancer	603040		2
TSHB, CHNG4	Hypothyroidism, congenital, nongoitrous 4	275100	centromeric to NGFB	3
TSHQTL1	Thyroid-stimulating hormone level QTL 1	612306	associated with rs4704397	2
TSHR, CHNG1	Hyperthyroidism, familial gestational	603373		3
TSHR, CHNG1	 Hyperthyroidism, nonautoimmune	609152		3
TSHR, CHNG1	 Hypothyroidism, congenital, nongoitrous, 1	275200		3
TSHR, CHNG1	 Thyroid adenoma, hyperfunctioning, somatic	603372		3
TSHR, CHNG1	 Thyroid carcinoma with thyrotoxicosis, somatic	603372		3
TSHZ1, TSH1, CAA	Aural atresia, congenital	607842		3
TSPAN12, NET2, EVR5	Exudative vitreoretinopathy 5	613310		3
TSPAN7, TM4SF2, MXS1, A15, XLID58	Intellectual developmental disorder, X-linked 58	300210		3
TSPEAR, C21orf29, DFNB98, ECTD14, STHAG10	 Deafness, autosomal recessive 98	614861	mutation identified in 1 DFNB98 family	3
TSPEAR, C21orf29, DFNB98, ECTD14, STHAG10	 Ectodermal dysplasia 14, hair/tooth type with or without hypohidrosis	618180	mutation identified in 1 DFNB98 family	3
TSPEAR, C21orf29, DFNB98, ECTD14, STHAG10	Tooth agenesis, selective, 10	620173	mutation identified in 1 DFNB98 family	3
TSPYL1, TSPYL, SIDDT	Sudden infant death with dysgenesis of the testes syndrome	608800		3
TST1	Tuberculin skin test reactivity, absence of	613636	at chr11:26.37M	2
TST2	Tuberculin skin test reactivity QTL	613637	max lod at 16:2.70Mb	2
TTBK2, SCA11	Spinocerebellar ataxia 11	604432		3
TTC12, TPARM, CILD45	Ciliary dyskinesia, primary, 45	618801		3
TTC19, MC3DN2	Mitochondrial complex III deficiency, nuclear type 2	615157		3
TTC21A, STI2, SPGF37	Spermatogenic failure 37	618429		3
TTC21B, THM1, NPHP12, SRTD4, ATD4	 Nephronophthisis 12	613820		3
TTC21B, THM1, NPHP12, SRTD4, ATD4	Short-rib thoracic dysplasia 4 with or without polydactyly	613819		3
TTC25, CILD35	Ciliary dyskinesia, primary, 35	617092		3
TTC26, IFT56, BRENS	Biliary, renal, neurologic, and skeletal syndrome	619534		3
TTC29, SPGF42	Spermatogenic failure 42	618745		3
TTC5, NEDCAFD	Neurodevelopmental disorder with cerebral atrophy and variable facial dysmorphism	619244		3
TTC7A, TTC7, KIAA1140, MINAT, GIDID	Gastrointestinal defects and immunodeficiency syndrome	243150		3
TTC8, BBS8, RP51	Bardet-Biedl syndrome 8	615985	mutation identified in 1 RP51 family	3
TTC8, BBS8, RP51	 Retinitis pigmentosa 51	613464	mutation identified in 1 RP51 family	3
TTI2, C8orf41, MRT39	Intellectual developmental disorder, autosomal recessive 39	615541		3
TTLL5, STAMP, KIAA0998, CORD19	Cone-rod dystrophy 19	615860		3
TTN, CMD1G, TMD, LGMDR10, MPRM, HMERF, SALMY	 Cardiomyopathy, dilated, 1G	604145		3
TTN, CMD1G, TMD, LGMDR10, MPRM, HMERF, SALMY	 Cardiomyopathy, familial hypertrophic, 9	613765		3
TTN, CMD1G, TMD, LGMDR10, MPRM, HMERF, SALMY	Muscular dystrophy, limb-girdle, autosomal recessive 10	608807		3
TTN, CMD1G, TMD, LGMDR10, MPRM, HMERF, SALMY	 Myopathy, myofibrillar, 9, with early respiratory failure	603689		3
TTN, CMD1G, TMD, LGMDR10, MPRM, HMERF, SALMY	 Salih myopathy	611705		3
TTN, CMD1G, TMD, LGMDR10, MPRM, HMERF, SALMY	 Tibial muscular dystrophy, tardive	600334		3
TTPA, TTP1, AVED	Ataxia with isolated vitamin E deficiency	277460		3
TTPP3	Thyrotoxic periodic paralysis, susceptibility to, 3	614834	associated with rs312691	2
TTR, PALB	Amyloidosis, hereditary, transthyretin-related	105210		3
TTR, PALB	 Carpal tunnel syndrome, familial	115430		3
TTR, PALB	 Dystransthyretinemic hyperthyroxinemia	145680		3
TUBA1A, TUBA3, LIS3	Lissencephaly 3	611603		3
TUBA3D, KTCN9	Keratoconus 9	617928		3
TUBA4A, TUBA1, ALS22	Amyotrophic lateral sclerosis 22 with or without frontotemporal dementia	616208		3
TUBA8, TUBAL2, MACTHC2	Macrothrombocytopenia, isolated, 2, autosomal dominant	619840		3
TUBB1, MACTHC1	Macrothrombocytopenia, isolated, 1, autosomal dominant	613112		3
TUBB2A, CDCBM5	Cortical dysplasia, complex, with other brain malformations 5	615763		3
TUBB2B, CDCBM7	Cortical dysplasia, complex, with other brain malformations 7	610031	TUBB2A is 70kb telomeric to TUBB2B	3
TUBB3, TUBB4, CFEOM3A, CDCBM1	 Cortical dysplasia, complex, with other brain malformations 1	614039		3
TUBB3, TUBB4, CFEOM3A, CDCBM1	Fibrosis of extraocular muscles, congenital, 3A	600638		3
TUBB4A, DYT4, HLD6	Dystonia 4, torsion, autosomal dominant	128101		3
TUBB4A, DYT4, HLD6	 Leukodystrophy, hypomyelinating, 6	612438		3
TUBB4B, TUBB2C, LCAEOD	Leber congenital amaurosis with early-onset deafness	617879		3
TUBB8, OOMD2	Oocyte maturation defect 2	616780		3
TUBB, TUBB5, M40, CDCBM6, CSCSC1	 Cortical dysplasia, complex, with other brain malformations 6	615771		3
TUBB, TUBB5, M40, CDCBM6, CSCSC1	Symmetric circumferential skin creases, congenital, 1	156610		3
TUBG1, CDCBM4	Cortical dysplasia, complex, with other brain malformations 4	615412		3
TUBGCP2, GCP2, GRIP103, SPC97, ALP4, PAMDDFS	Pachygyria, microcephaly, developmental delay, and dysmorphic facies, with or without seizures	618737		3
TUBGCP4, GCP4, MCCRP3	Microcephaly and chorioretinopathy, autosomal recessive, 3	616335		3
TUBGCP6, GCP6, KIAA1669, MCCRP1	Microcephaly and chorioretinopathy, autosomal recessive, 1	251270		3
TUFM, EFTU, COXPD4	Combined oxidative phosphorylation deficiency 4	610678	pseudogene on chr.17	3
TUKLS	Tukel syndrome	609428	max lod at D21S1259	2
TULP1, RP14, LCA15	Leber congenital amaurosis 15	613843		3
TULP1, RP14, LCA15	 Retinitis pigmentosa 14	600132		3
TULP3, HRCDF	Hepatorenocardiac degenerative fibrosis	619902		3
TUSC3, M33, D8S1992, MRT7, MRT22	Intellectual developmental disorder, autosomal recessive 7	611093		3
TWIST1, ACS3, SCS, CRS1, SWCOS	Craniosynostosis 1	123100		3
TWIST1, ACS3, SCS, CRS1, SWCOS	 Robinow-Sorauf syndrome	180750		3
TWIST1, ACS3, SCS, CRS1, SWCOS	 Saethre-Chotzen syndrome with or without eyelid anomalies	101400		3
TWIST1, ACS3, SCS, CRS1, SWCOS	 Sweeney-Cox syndrome	617746		3
TWIST2, DERMO1, SETLSS, FFDD3, BBRSAY, AMS	Ablepharon-macrostomia syndrome	200110		3
TWIST2, DERMO1, SETLSS, FFDD3, BBRSAY, AMS	 Barber-Say syndrome	209885		3
TWIST2, DERMO1, SETLSS, FFDD3, BBRSAY, AMS	 Focal facial dermal dysplasia 3, Setleis type	227260		3
TWNK, C10orf2, TWINKLE, PEOA3, IOSCA, MTDPS7, PRLTS5	Mitochondrial DNA depletion syndrome 7 	271245	PEO digenic with POLG	3
TWNK, C10orf2, TWINKLE, PEOA3, IOSCA, MTDPS7, PRLTS5	 Perrault syndrome 5	616138	PEO digenic with POLG	3
TWNK, C10orf2, TWINKLE, PEOA3, IOSCA, MTDPS7, PRLTS5	 Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3	609286	PEO digenic with POLG	3
TXNDC15, C5orf14, BUG, MKS14	Meckel syndrome 14	619879		3
TXNL4A, DIM1, BMKS	Burn-McKeown syndrome	608572		3
TYK2, IMD35	Immunodeficiency 35	611521		3
TYMP, ECGF1, MNGIE, PDECGF, MEDPS1, MTDPS1	Mitochondrial DNA depletion syndrome 1 	603041		3
TYMS, TS, TMS, DKCD	Dyskeratosis congenita, digenic	620040	DKCD is digenic with C-A-ins haplotype	3
TYROBP, DAP12, PLOSL1	Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1	221770		3
TYRP1, CAS2, GP75, SHEP11	 Albinism, oculocutaneous, type III	203290		3
TYRP1, CAS2, GP75, SHEP11	Skin/hair/eye pigmentation, variation in, 11 	612271		3
TYR, SHEP3, CMM8, OCA1A, ATN	 Albinism, oculocutaneous, type IA	203100		3
TYR, SHEP3, CMM8, OCA1A, ATN	 Albinism, oculocutaneous, type IB	606952		3
TYR, SHEP3, CMM8, OCA1A, ATN	 Melanoma, cutaneous malignant, susceptibility to, 8	601800		3
TYR, SHEP3, CMM8, OCA1A, ATN	 Skin/hair/eye pigmentation 3, blue/green eyes	601800		3
TYR, SHEP3, CMM8, OCA1A, ATN	Skin/hair/eye pigmentation 3, light/dark/freckling skin	601800		3
TYR, SHEP3, CMM8, OCA1A, ATN	 Waardenburg syndrome/albinism, digenic	103470		3
UAQTL5	Uric acid concentration, serum, QTL5	614746	associated with rs150414818	2
UAQTL6	Uric acid concentration, serum, QTL6	614747	associated with C/T variant at chr1_142697422	2
UBA1, UBE1, GXP1, A1ST, SMAX2, AMCX1, VEXAS	Spinal muscular atrophy, X-linked 2, infantile	301830	escapes inactivation	3
UBA1, UBE1, GXP1, A1ST, SMAX2, AMCX1, VEXAS	 VEXAS syndrome, somatic	301054	escapes inactivation	3
UBA2, SAE2, ACCES	ACCES syndrome	619959		3
UBA5, UBE1DC1, DEE44, SCAR24	 Developmental and epileptic encephalopathy 44	617132	mutation identified in 1 SCAR24 family	3
UBAP1, UBAP, SPG80	Spastic paraplegia 80, autosomal dominant	618418		3
UBE2A, RAD6A, MRXSN, MRXS30	Intellectual developmental disorder, X-linked syndromic, Nascimento type	300860		3
UBE2T, HSPC150, FANCT	Fanconi anemia, complementation group T	616435		3
UBE3A, ANCR	Angelman syndrome	105830	same location as PWS	3
UBE3B, BPIDS, KOS	Kaufman oculocerebrofacial syndrome	244450		3
UBE4A, UFD2, E4, NEDHMS	Neurodevelopmental disorder with hypotonia and gross motor and seech delay	619639		3
UBIAD1, TERE1, SCCD	Corneal dystrophy, Schnyder type	121800		3
UBQLN2, PLIC2, CHAP1, ALS15	Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia	300857		3
UBR1, JBS	Johanson-Blizzard syndrome	243800		3
UBR7, LICAS	Li-Campeau syndrome	619189		3
UBTF, UBF, CONDBA	Neurodegeneration, childhood-onset, with brain atrophy	617672		3
UCHL1, PARK5, SPG79, NDGOA	 Parkinson disease 5, susceptibility to	613643	mutation identified in 1 PARK5 family	3
UCHL1, PARK5, SPG79, NDGOA	Spastic paraplegia 79, autosomal recessive	615491	mutation identified in 1 PARK5 family	3
UCP2, BMIQ4	Obesity, susceptibility to, BMIQ4	607447		3
UCP3	Obesity, severe, and type II diabetes	601665		3
UFC1, NEDSG	Neurodevelopmental disorder with spasticity and poor growth	618076		3
UFM1, HLD14	Leukodystrophy, hypomyelinating, 14	617899		3
UFSP2, C4orf20, BHD, SEMDDR, DEE106	 Developmental and epileptic encephalopathy 106	620028	mutation identified in 1 BHD family	3
UFSP2, C4orf20, BHD, SEMDDR, DEE106	 Spondyloepimetaphyseal dysplasia, Di Rocco type	617974	mutation identified in 1 BHD family	3
UGDH, UDPGDH, DEE84	Developmental and epileptic encephalopathy 84	618792		3
UGP2, UGPP2, DEE83	Developmental and epileptic encephalopathy 83	618744		3
UGT1A1, UGT1, GNT1, BILIQTL1	 Bilirubin, serum level of, QTL1	601816		3
UGT1A1, UGT1, GNT1, BILIQTL1	Crigler-Najjar syndrome, type I	218800		3
UGT1A1, UGT1, GNT1, BILIQTL1	 Crigler-Najjar syndrome, type II	606785		3
UGT1A1, UGT1, GNT1, BILIQTL1	 Gilbert syndrome	143500		3
UGT1A1, UGT1, GNT1, BILIQTL1	 Hyperbilirubinemia, familial transient neonatal	237900		3
UGT2B17, BMND12	Bone mineral density QTL 12, osteoporosis	612560		3
UMOD, ADTKD1	Tubulointerstitial kidney disease, autosomal dominant, 1	162000		3
UMPS, OPRT	Orotic aciduria	258900		3
UNC119, HRG4, IMD13	 Cone-rod dystrophy	604011	mutation identified in 1 IMD13 family and CORD family	3
UNC13D, MUNC13-4, HPLH3, HLH3, FHL3	Hemophagocytic lymphohistiocytosis, familial, 3	608898		3
UNC45A, SMAP1, GCUNC45, OOHE	Osteootohepatoenteric syndrome	619377		3
UNC45B, SMUNC45, CTRCT43, MFM11	 Myofibrillar myopathy 11	619178	mutation identified in 1 CTRCT43 family	3
UNC80, C2orf21, KIAA1843	Hypotonia, infantile, with psychomotor retardation and characteristic facies 2	616801		3
UNC93B1, IIAE1	Encephalopathy, acute, infection-induced , susceptibility to, 1	610551		3
UNG, DGU, HIGM5	Immunodeficiency with hyper IgM, type 5	608106		3
UOX	Urate oxidase deficiency	191540	nonsense mutations responsible for absence of enzyme in man and hominoid primates	1
UPB1, BUP1	Beta-ureidopropionase deficiency	613161		3
UPF3B, RENT3B, MRXS14	Intellectual developmental disorder, X-linked syndromic 14	300676		3
UQCC2, C6orf126, M19, MC3DN7	Mitochondrial complex III deficiency, nuclear type 7	615824		3
UQCRB, UQBP, QPC, MC3DN3	Mitochondrial complex III deficiency, nuclear type 3	615158		3
UQCRC1, PKNPY	Parkinsonism with polyneuropathy	619279	close upstream of COL7A1	3
UQCRC2, MC3DN5	Mitochondrial complex III deficiency, nuclear type 5	615160		3
UQCRFS1, MC3DN10	Mitochondrial complex III deficiency, nuclear type 10	618775		3
UQCRQ, QPC, MC3DN4	Mitochondrial complex III deficiency, nuclear type 4	615159		3
UROD	 Porphyria cutanea tarda	176100		3
UROD	Porphyria, hepatoerythropoietic	176100		3
UROS	Porphyria, congenital erythropoietic	263700		3
USB1, C16orf57, PN	Poikiloderma with neutropenia	604173		3
USF1, HYPLIP1	Hyperlipidemia, familial combined, susceptibility to	602491		3
USH1C, DFNB18A	 Deafness, autosomal recessive 18A	602092	Acadian and Samaritan variety	3
USH1C, DFNB18A	Usher syndrome, type 1C	276904	Acadian and Samaritan variety	3
USH1E	Usher syndrome, type 1E	602097		2
USH1G, SANS	Usher syndrome, type 1G	606943	?allelic to DFNA20	3
USH1H	Usher syndrome, type 1H	612632	max lod at D15S980	2
USH1K	Usher syndrome, type IK	614990	max lod at D10S539	2
USH2A, RP39	 Retinitis pigmentosa 39	613809		3
USH2A, RP39	Usher syndrome, type 2A	276901		3
USP18, UBP43, ISG43, PTORCH2	Pseudo-TORCH syndrome 2	617397		3
USP27X, USP22L, XLID105	Intellectual developmental disorder, X-linked 105	300984		3
USP53, KIAA1350, PFIC7	Cholestasis, progressive familial intrahepatic, 7, with or without hearing loss	619658		3
USP7, HAUSP, HAFOUS	Hao-Fountain syndrome	616863		3
USP8, HUMORF8, PITA4	Pituitary adenoma 4, ACTH-secreting, somatic	219090		3
USP9X, DFFRX, XLID99, MRXS99F	Intellectual developmental disorder, X-linked 99	300919		3
USP9X, DFFRX, XLID99, MRXS99F	 Intellectual developmental disorder, X-linked 99, syndromic, female-restricted	300968		3
USP9Y, DFFRY, SPGFY2	Spermatogenic failure, Y-linked, 2	415000		3
UVM2	Melanoma, uveal, susceptibility to, 2	606661		2
UVSSA, KIAA1530, UVSS3	UV-sensitive syndrome 3	614640		3
VAC14, TAX1BP2, TRX, SNDC	Striatonigral degeneration, childhood-onset	617054		3
VAMAS6	Vitiligo-associated multiple autoimmune disease susceptibility 6	193200	possible second locus on 1p31.3-p32.2	2
VAMP1, SYB1, SPAX1, CMS25	Myasthenic syndrome, congenital, 25	618323		3
VAMP1, SYB1, SPAX1, CMS25	 Spastic ataxia 1, autosomal dominant	108600		3
VAMP2, SYB2, NEDHAHM	Neurodevelopmental disorder with hypotonia and autistic features with or without hyperkinetic movements	618760		3
VANGL1, STBM2	 Caudal regression syndrome	600145		3
VANGL1, STBM2	Neural tube defects, susceptibility to	182940		3
VANGL2, LTAP	Neural tube defects	182940		3
VAPBC, VAPB, VAPC, ALS8	 Amyotrophic lateral sclerosis 8	608627		3
VAPBC, VAPB, VAPC, ALS8	Spinal muscular atrophy, late-onset, Finkel type	182980		3
VARS1, VARS, G7A, VARS2, NDMSCA	Neurodevelopmental disorder with microcephaly, seizures, and cortical atrophy	617802		3
VARS2, KIAA1885, COXPD20	Combined oxidative phosphorylation deficiency 20	615917		3
VBCH	van Buchem disease	239100	52-kb deletion 35 kb downlstream of SOST	4
VCAN, CSPG2, WGN, WGN1, ERVR	Wagner syndrome 1	143200		3
VCL, CMD1W, CMH15	Cardiomyopathy, dilated, 1W	611407		3
VCL, CMD1W, CMH15	 Cardiomyopathy, hypertrophic, 15	613255		3
VCP, IBMPFD1, CMT2Y, FTDALS6	 Charcot-Marie-Tooth disease, type 2Y	616687		3
VCP, IBMPFD1, CMT2Y, FTDALS6	Frontotemporal dementia and/or amyotrophic lateral sclerosis 6	613954		3
VCP, IBMPFD1, CMT2Y, FTDALS6	 Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia 1	167320		3
VDR	Rickets, vitamin D-resistant, type IIA	277440		3
VEGFC, VRP, LMPHM4	Lymphatic malformation 4	615907		3
VEGF, MVCD1	Microvascular complications of diabetes 1	603933		3
VHL	 Erythrocytosis, familial, 2	263400		3
VHL	Hemangioblastoma, cerebellar, somatic	608537		3
VHL	 Pheochromocytoma	171300		3
VHL	 Renal cell carcinoma, somatic	144700		3
VHL	 von Hippel-Lindau syndrome	193300		3
VIM, CTRCT30	Cataract 30, pulverulent	116300		3
VIPAS39, VIPAR, SPE39, C14orf133	Arthrogryposis, renal dysfunction, and cholestasis 2	613404		3
VKORC1, VKOR, VKCFD2, FLJ00289	Vitamin K-dependent clotting factors, combined deficiency of, 2	607473		3
VKORC1, VKOR, VKCFD2, FLJ00289	 Warfarin resistance	122700		3
VLDLR, CAMRQ1	Cerebellar hypoplasia, impaired intellectual development, and dysequilibrium syndrome 1	224050		3
VMA21, XMEA	Myopathy, X-linked, with excessive autophagy	310440		3
VNN1, HDLCQ8	High density lipoprotein cholesterol level QTL 8	603570		3
VOCBO	Vestibulocerebellar disorder with predominant ocular signs	193003		2
VPS11, HLD12; DYT32	 Leukodystrophy, hypomyelinating, 12	616683	mutation identified in 1 DYT32 patient	3
VPS13A, CHAC	Choreoacanthocytosis	200150		3
VPS13B, KIAA0532, COH1	Cohen syndrome	216550		3
VPS13C, KIAA1421, PARK23	Parkinson disease 23, autosomal recessive, early onset	616840		3
VPS13D, SCAR4	Spinocerebellar ataxia, autosomal recessive 4	607317		3
VPS16, DYT30	Dystonia 30	619291		3
VPS33A, MPSPS	Mucopolysaccharidosis-plus syndrome	617303		3
VPS33B, KDIDAR, PFIC12	 Arthrogryposis, renal dysfunction, and cholestasis 1	208085		3
VPS33B, KDIDAR, PFIC12	 Cholestasis, progressive familial intrahepatic, 12	620010		3
VPS33B, KDIDAR, PFIC12	Keratoderma-ichthyosis-deafness syndrome, autosomal recessive	620009		3
VPS35, MEM3, PARK17	Parkinson disease 17	614203		3
VPS36L, C16orf62, EC97, RTSC3	Ritscher-Schinzel syndrome 3	619135		3
VPS37A, HCRP1, SPG53	Spastic paraplegia 53, autosomal recessive	614898		3
VPS41, SCAR29	Spinocerebellar ataxia, autosomal recessive 29	619389		3
VPS45, VPS45A, SCN5	Neutropenia, severe congenital, 5, autosomal recessive	615285		3
VPS4A, VPS4, CIMDAG	CIMDAG syndrome	619273		3
VPS50, CCDC132, KIAA1861, NEDMSC	Neurodevelopmental disorder with microcephaly, seizures, and neonatal cholestasis	619685		3
VPS51, ANG2, PCH13	Pontocerebellar hypoplasia, type 13	618606		3
VPS53, HCCS1, PCH2E	Pontocerebellar hypoplasia, type 2E	615851		3
VRK1, PCH1A	Pontocerebellar hypoplasia type 1A	607596		3
VSPA	 Turner syndrome-associated neurocognitive phenotype	313000		2
VSPA	Visuospatial/perceptual abilities	313000		2
VSX1, RINX, KTCN1, CAASDS	 Keratoconus 1	148300	mutation identified in 1 CAASDS family	3
VSX2, CHX10, HOX10, MCOP2, MCOPCB3	Microphthalmia, isolated 2	610093		3
VSX2, CHX10, HOX10, MCOP2, MCOPCB3	 Microphthalmia with coloboma 3	610092		3
VUR1	Vesicoureteral reflux 1	193000		2
VUR4	Vesicoureteral reflux 4	614317	closest marker rs1501656	2
VUR5	Vesicoureteral reflux 5	614318	nearest marker rs4476030	2
VUR6	Vesicoureteral reflux 6	614319	closest marker rs1054986	2
VUR7	Vesicoureteral reflux 7	615390	max lod at D12S1048	2
VVS	Syncope, familial vasovagal	609289		2
VWA1, WARP, HMNMYO	Neuropathy, hereditary motor, with myopathic features	619216		3
VWF, F8VWF	von Willebrand disease, type 1	193400	pseudogene on chr. 22	3
VWF, F8VWF	 von Willebrand disease, type 3	277480	pseudogene on chr. 22	3
VWF, F8VWF	 von Willebrand disease, types 2A, 2B, 2M, and 2N	613554	pseudogene on chr. 22	3
WAC, KIAA1844, DESSH	Desanto-Shinawi syndrome	616708		3
WAGRO, DEL11p14p12	WAGRO syndrome	612469	contiguous gene deletion syndrome	4
WARS1, WARS, HMN9	Neuronopathy, distal hereditary motor, type IX	617721		3
WARS2, NEMMLAS, PKDYS3	 Neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures	617710		3
WARS2, NEMMLAS, PKDYS3	Parkinsonism-dystonia 3, childhood-onset	619738		3
WASF1, WAVE, WAVE1, SCAR1, NEDALVS	Neurodevelopmental disorder with absent language and variable seizures	618707		3
WASHC4, KIAA1033, SWIP, MRT43	Intellectual developmental disorder, autosomal recessive 43	615817		3
WASHC5, KIAA0196, SPG8, RTSC1	Ritscher-Schinzel syndrome 1	220210		3
WASHC5, KIAA0196, SPG8, RTSC1	 Spastic paraplegia 8, autosomal dominant	603563		3
WAS, IMD2, THC1, SCNX	 Neutropenia, severe congenital, X-linked	300299	t(18;X)(q11.2;p11.2); distal to TIMP	3
WAS, IMD2, THC1, SCNX	 Thrombocytopenia, X-linked	313900	t(18;X)(q11.2;p11.2); distal to TIMP	3
WAS, IMD2, THC1, SCNX	 Thrombocytopenia, X-linked, intermittent	313900	t(18;X)(q11.2;p11.2); distal to TIMP	3
WAS, IMD2, THC1, SCNX	Wiskott-Aldrich syndrome	301000	t(18;X)(q11.2;p11.2); distal to TIMP	3
WBP11, NPWBP, SIPP1, VCTERL	Vertebral, cardiac, tracheoesophageal, renal, and limb defects	619227		3
WBP2, DFNB107	Deafness, autosomal recessive 107	617639		3
WBS, WMS, WS, DEL7q11, C7DELq11	Williams-Beuren syndrome	194050	contiguous gene syndrome	4
WDPCP, C2orf86, BBS15, CHDTHP	 Congenital heart defects, hamartomas of tongue, and polysyndactyly	217085	mutation identified in 1 BBS15 family	3
WDR11, DR11, KIAA1351, BRWD2, HH14	Hypogonadotropic hypogonadism 14 with or without anosmia	614858		3
WDR19, SRTD5, ATD5, NPHP13, CED4, SPGF72	 Cranioectodermal dysplasia 4	614378	mutation identified in 1 CED4 family and 1 SRTD5 family	3
WDR19, SRTD5, ATD5, NPHP13, CED4, SPGF72	Nephronophthisis 13	614377	mutation identified in 1 CED4 family and 1 SRTD5 family	3
WDR19, SRTD5, ATD5, NPHP13, CED4, SPGF72	 Senior-Loken syndrome 8	616307	mutation identified in 1 CED4 family and 1 SRTD5 family	3
WDR19, SRTD5, ATD5, NPHP13, CED4, SPGF72	 Short-rib thoracic dysplasia 5 with or without polydactyly	614376	mutation identified in 1 CED4 family and 1 SRTD5 family	3
WDR19, SRTD5, ATD5, NPHP13, CED4, SPGF72	 Spermatogenic failure 72	619867	mutation identified in 1 CED4 family and 1 SRTD5 family	3
WDR1, PFITS	Periodic fever, immunodeficiency, and thrombocytopenia syndrome	150550		3
WDR26, SKDEAS	Skraban-Deardorff syndrome	617616		3
WDR34, SRTD11	Short-rib thoracic dysplasia 11 with or without polydactyly	615633		3
WDR35, NAOFEN, KIAA1336, CED2, SRTD7	 Cranioectodermal dysplasia 2	613610		3
WDR35, NAOFEN, KIAA1336, CED2, SRTD7	Short-rib thoracic dysplasia 7 with or without polydactyly	614091		3
WDR36, TAWDRP, GLC1G	Glaucoma 1, open angle, G	609887		3
WDR37, NOCGUS	Neurooculocardiogenitourinary syndrome	618652		3
WDR45B, WIPI3, WDR45L, NEDSBAS	Neurodevelopmental disorder with spastic quadriplegia and brain abnormalities with or without seizures	617977		3
WDR45, WIPI4, NBIA5	Neurodegeneration with brain iron accumulation 5	300894	?pseudogene on 4q31.3	3
WDR4, MIGSB, GAMOS6	Galloway-Mowat syndrome 6	618347		3
WDR4, MIGSB, GAMOS6	 Microcephaly, growth deficiency, seizures, and brain malformations	618346		3
WDR60, SRTD8, SRPS6	Short-rib thoracic dysplasia 8 with or without polydactyly	615503		3
WDR62, C19orf14, MCPH2	Microcephaly 2, primary, autosomal recessive, with or without cortical malformations	604317		3
WDR66, CFAP251, SPGF33	Spermatogenic failure 33	618152		3
WDR72, AI2A3	Amelogenesis imperfecta, type IIA3	613211		3
WDR73, HSPC264, GAMOS1	Galloway-Mowat syndrome 1	251300		3
WDR81, CAMRQ2, HYC3	Cerebellar ataxia, impaired intellectual development, and dysquilibrium syndrome 2	610185		3
WDR81, CAMRQ2, HYC3	 Hydrocephalus, congenital, 3, with brain anomalies	617967		3
WEE2, WEE1B, OOMD5	Oocyte maturation defect 5	617996		3
WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41	 Cataract 41	116400	mutation identified in 1 CTRCT41 family	3
WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41	Deafness, autosomal dominant 6/14/38	600965	mutation identified in 1 CTRCT41 family	3
WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41	 Diabetes mellitus, noninsulin-dependent, association with	125853	mutation identified in 1 CTRCT41 family	3
WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41	 Wolfram-like syndrome, autosomal dominant	614296	mutation identified in 1 CTRCT41 family	3
WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41	 Wolfram syndrome 1	222300	mutation identified in 1 CTRCT41 family	3
WHRN, CIP98, KIAA1526, DFNB31, USH2D	Deafness, autosomal recessive 31	607084		3
WHRN, CIP98, KIAA1526, DFNB31, USH2D	 Usher syndrome, type 2D	611383		3
WHS	Wolf-Hirschhorn syndrome	194190	contiguous gene syndrome; critical region 200kb region 1.9Mb from telomere	4
WIPF1, WASPIP, WIP, WAS2	Wiskott-Aldrich syndrome 2	614493		3
WLS, GPR177, EVI, ZKS	Zaki syndrome	619648		3
WM2	Macroglobulinemia, Waldenstrom, susceptibility to, 2	610430	between D4S2910 and D4S1539	2
WNK1, PRKWNK1, KDP, PHA2C, HSAN2, HSN2	Neuropathy, hereditary sensory and autonomic, type II	201300		3
WNK1, PRKWNK1, KDP, PHA2C, HSAN2, HSN2	 Pseudohypoaldosteronism, type IIC	614492		3
WNK4, PRKWNK4, PHA2B	Pseudohypoaldosteronism, type IIB	614491		3
WNT10A, SSPS, STHAG4, OODD	 Odontoonychodermal dysplasia	257980		3
WNT10A, SSPS, STHAG4, OODD	Schopf-Schulz-Passarge syndrome	224750		3
WNT10A, SSPS, STHAG4, OODD	 Tooth agenesis, selective, 4	150400		3
WNT10B, SHFM6, STHAG8	 Split-hand/foot malformation 6	225300		3
WNT10B, SHFM6, STHAG8	Tooth agenesis, selective, 8	617073		3
WNT1, INT1, OI15, BMND16	 Osteogenesis imperfecta, type XV	615220		3
WNT1, INT1, OI15, BMND16	Osteoporosis, early-onset, susceptibility to, autosomal dominant	615221		3
WNT2B, WNT13, XWNT2	Diarrhea 9	618168		3
WNT4, SERKAL	 Mullerian aplasia and hyperandrogenism	158330	mutation identified in 1 SERKAL family	3
WNT5A	Robinow syndrome, autosomal dominant 1	180700		3
WNT7A	Fuhrmann syndrome	228930		3
WNT7A	 Ulna and fibula, absence of, with severe limb deficiency	276820		3
WRAP53, TCAB1, WDR79, DKCB3	Dyskeratosis congenita, autosomal recessive 3	613988		3
WS2B	Waardenburg syndrome, type 2B	600193		2
WS2C	Waardenburg syndrome, type 2C	606662		2
WT1, NPHS4	 Denys-Drash syndrome	194080	clumped: pter-FSHB-AN2-WT1-CAT	3
WT1, NPHS4	 Frasier syndrome	136680	clumped: pter-FSHB-AN2-WT1-CAT	3
WT1, NPHS4	 Meacham syndrome	608978	clumped: pter-FSHB-AN2-WT1-CAT	3
WT1, NPHS4	Mesothelioma, somatic	156240	clumped: pter-FSHB-AN2-WT1-CAT	3
WT1, NPHS4	 Nephrotic syndrome, type 4	256370	clumped: pter-FSHB-AN2-WT1-CAT	3
WT1, NPHS4	 Wilms tumor, type 1	194070	clumped: pter-FSHB-AN2-WT1-CAT	3
WT3	Wilms tumor, type 3	194090	loss of heterozygosity	2
WT4	Wilms tumor, type 4	601363		2
WWC1, KIBRA, KIAA0869, MEMRYQTL	Memory, enhanced, QTL	615602		3
WWOX, FOR, SCAR12, DEE28	 Developmental and epileptic encephalopathy 28	616211		3
WWOX, FOR, SCAR12, DEE28	Esophageal squamous cell carcinoma, somatic	133239		3
WWOX, FOR, SCAR12, DEE28	 Spinocerebellar ataxia, autosomal recessive 12	614322		3
XBP1, XBP2	Major affective disorder-7, susceptibility to	612371	pseudogene on chr.5	3
XDH, XAN1	Xanthinuria, type I	278300		3
XECD	Corneal dystrophy, endothelial, X-linked	300779	between DXS8057 and DXS1047	2
XGR, XG	XG blood group system, Xg phenotype	314700		3
XIAP, BIRC4, API3, XLP2	Lymphoproliferative syndrome, X-linked, 2	300635		3
XIC, XCE, XIST, SXI1	X-inactivation, familial skewed	300087	q13-q21; metaphase bend, or fold, at q13.3-q21.1	3
XK, MCLDS	McLeod syndrome with or without chronic granulomatous disease	300842	~500kb distal to CGD	3
XLID14, MRX14	Intellectual developmental disorder, X-linked 14	300062		2
XLID20, MRX20	Intellectual developmental disorder, X-linked 20	300047		2
XLID23, MRX23	Intellectual developmental disorder, X-linked 23	300046	other MRX in same region MRX27, MRX30, MRX35, MRX47, MRX80	2
XLID2, MRX2	Intellectual developmental disorder, X-linked 2	300428		2
XLID42, MRX42	Intellectual developmental disorder, X-linked 42	300372	?pericentromeric region	2
XLID45, MRX45	Intellectual developmental disorder, X-linked 45	300498		2
XLID46, MRX46	Intellectual developmental disorder, X-linked 46	300436	between DXS8072 and DXS294	2
XLID53, MRX53	Intellectual developmental disorder, X-linked 53	300324		2
XLID73, MRX73	Intellectual developmental disorder, X-linked 73	300355	between DXS8019 and DXS365	2
XLID77, MRX77	Intellectual developmental disorder, X-linked 77	300454		2
XLID81, MRX81	Intellectual developmental disorder, X-linked 81	300433	between DXS1039 and DXS1216	2
XLID82, MRX82	Intellectual developmental disorder, X-linked 82	300518	between DXS6805 and DXS7346	2
XLID84, MRX84	Intellectual developmental disorder, X-linked 84	300505	29 other MRX loci in same region	2
XLID88, MRX88	Intellectual developmental disorder, X-linked 88	300852		2
XLID89, MRX89	Intellectual developmental disorder, X-linked 89	300848	t(X;7)(p11.3;q11.21)	2
XLID91, MRX91	Intellectual developmental disorder, X-linked 91	300577	t(X;15)(q13.3;cen)	4
XLID92, MRX92	Intellectual developmental disorder, X-linked 92	300851	previously associated with ZNF674	2
XLID95, MRX95	Intellectual developmental disorder, X-linked 95	300716		2
XPA, XPAC	Xeroderma pigmentosum, group A	278700		3
XPC, XPCC	Xeroderma pigmentosum, group C	278720		3
XPNPEP2, AEACEI	Angioedema induced by ACE inhibitors, susceptibility to	300909		3
XPNPEP3, APP3, NPHPL1	Nephronophthisis-like nephropathy 1	613159		3
XPR1, SYG1, IBGC6	Basal ganglia calcification, idiopathic, 6	616413		3
XRCC2, FANCU, SPGF50, POF17	 Fanconi anemia, complementation group U	617247	mutation identified in 1 FANCU patient and 1 POF17 patient	3
XRCC2, FANCU, SPGF50, POF17	 Premature ovarian failure 17	619146	mutation identified in 1 FANCU patient and 1 POF17 patient	3
XRCC2, FANCU, SPGF50, POF17	Spermatogenic failure 50	619145	mutation identified in 1 FANCU patient and 1 POF17 patient	3
XRCC3, CMM6	Breast cancer, susceptibility to	114480		3
XRCC3, CMM6	 Melanoma, cutaneous malignant, 6	613972		3
XRCC4, SSMED	Short stature, microcephaly, and endocrine dysfunction	616541	between D5S427 and D5S401	3
XRCC9, FANCG	Fanconi anemia, complementation group G	614082		3
XYLT1, XT1, DBQD2	Desbuquois dysplasia 2	615777		3
XYLT1, XT1, DBQD2	 Pseudoxanthoma elasticum, modifier of severity of	264800		3
XYLT2, XT2, SOS	Pseudoxanthoma elasticum, modifier of severity of	264800		3
XYLT2, XT2, SOS	 Spondyloocular syndrome	605822		3
YAP1, COB1	Coloboma, ocular, with or without hearing impairment, cleft lip/palate, and/or impaired intellectual development	120433		3
YARS1, YARS, CMTDIC, TYRRS, YTS, YRS, IMNEPD2	 Charcot-Marie-Tooth disease, dominant intermediate C	608323		3
YARS1, YARS, CMTDIC, TYRRS, YTS, YRS, IMNEPD2	Infantile-onset multisystem neurologic, endocrine, and pancreatic disease 2	619418		3
YARS2, TYRRS, MLASA2	Myopathy, lactic acidosis, and sideroblastic anemia 2	613561		3
YIF1B, KABAMAS	Kaya-Barakat-Masson syndrome	619125		3
YIPF5, SMAP5, YIP1A, MEDS2	Microcephaly, epilepsy, and diabetes syndrome 2	619278		3
YRDC, IRIP, GAMOS10	Galloway-Mowat syndrome 10	619609		3
YUHAL	Yuan-Harel-Lupski syndrome	616652	contiguous gene duplication syndrome	4
YWHAG, DEE56	Developmental and epileptic encephalopathy 56	617665		3
YY1AP1, YAP, HCCA2, GRNG	Grange syndrome	602531		3
YY1, GADEVS	Gabriele-de Vries syndrome	617557		3
ZAP70, SRK, ADMIO2, IMD48	 Autoimmune disease, multisystem, infantile-onset, 2	617006		3
ZAP70, SRK, ADMIO2, IMD48	Immunodeficiency 48	269840		3
ZBTB11, MRT69	Intellectual developmental disorder, autosomal recessive 69	618383		3
ZBTB16, ZNF145, PLZF	Leukemia, acute promyelocytic, PL2F/RARA type	176797	fused with RARA in APL of t(11;17) type	3
ZBTB18, ZNF238, RP58, MRD22	Intellectual developmental disorder, autosomal dominant 22	612337		3
ZBTB20, ZNF288, DPZF, PRIMS	Primrose syndrome	259050		3
ZBTB24, PATZ2, ZNF450, KIAA0441, ICF2	Immunodeficiency-centromeric instability-facial anomalies syndrome 2	614069		3
ZBTB7A, FBI1, LRF, MNDLFH	Macrocephaly, neurodevelopmental delay, lymphoid hyperplasia, and persistent fetal hemoglobin	619769		3
ZC3H14, SUT2, MRT56	Intellectual developmental disorder, autosomal recessive 56	617125		3
ZC4H2, KIAA1166, WRWF, MRXS4, WRWFFR	Wieacker-Wolff syndrome	314580		3
ZC4H2, KIAA1166, WRWF, MRXS4, WRWFFR	 Wieacker-Wolff syndrome, female-restricted	301041		3
ZD1	Zygodactyly 1	609815	max lod at D3S2409	2
ZDHHC9, DHHC9, MRXSR	Intellectual developmental disorder, X-linked syndromic, Raymond type	300799		3
ZEB1, TCF8, NIL2A, PPCD3, FECD6	 Corneal dystrophy, Fuchs endothelial, 6	613270		3
ZEB1, TCF8, NIL2A, PPCD3, FECD6	Corneal dystrophy, posterior polymorphous, 3	609141		3
ZEB2, ZFHX1B, SMADIP1, SIP1	Mowat-Wilson syndrome	235730		3
ZFAT1, ZNF406, AITD3	Autoimmune thyroid disease, susceptibility to, 3	608175		3
ZFHX3, ATBF1	Prostate cancer, somatic	176807		3
ZFP36L2, ERF2, TIS11D, OOMD13	Oocyte maturation defect 13	620154		3
ZFP57, TNDM1	Diabetes mellitus, transient neonatal 1	601410		3
ZFPM2, FOG2, DIH3, SRXY9	 46XY sex reversal 9	616067		3
ZFPM2, FOG2, DIH3, SRXY9	Diaphragmatic hernia 3	610187		3
ZFPM2, FOG2, DIH3, SRXY9	 Tetralogy of Fallot	187500		3
ZFYVE19, ANCHR, PFIC9	Cholestasis, progressive familial intrahepatic, 9	619849		3
ZFYVE26, KIAA0321, SPG15	Spastic paraplegia 15, autosomal recessive	270700		3
ZFYVE27, SPG33	Spastic paraplegia 33, autosomal dominant	610244		3
ZIC1, CRS6, BAIDCS	 Structural brain anomalies with impaired intellectual development and craniosynostosis	618736	mutation identified in 1 CRS6 family	3
ZIC2, HPE5	Holoprosencephaly 5	609637		3
ZIC3, HTX1, HTX, VACTERLX	Congenital heart defects, nonsyndromic, 1, X-linked	306955		3
ZIC3, HTX1, HTX, VACTERLX	 Heterotaxy, visceral, 1, X-linked	306955		3
ZIC3, HTX1, HTX, VACTERLX	 VACTERL association, X-linked	314390		3
ZMIZ1, RAI17, KIAA1224, ZIMP10, NEDDFSA	Neurodevelopmental disorder with dysmorphic facies and distal skeletal anomalies	618659		3
ZMPSTE24, FACE1, STE24, MADB, RSDM1	Mandibuloacral dysplasia with type B lipodystrophy	608612		3
ZMPSTE24, FACE1, STE24, MADB, RSDM1	 Restrictive dermopathy 1	275210		3
ZMYM2, ZNF198, RAMP, FIM, NECRC	Neurodevelopmental-craniofacial syndrome with variable renal and cardiac abnormalities	619522		3
ZMYND10, BLU	Ciliary dyskinesia, primary, 22	615444		3
ZMYND11, BS69, BRAM1, MRD30	Intellectual developmental disorder, autosomal dominant 30	616083		3
ZNF142, NEDISHM	Neurodevelopmental disorder with impaired speech and hyperkinetic movements	618425		3
ZNF148, ZFP148, GDACCF	Global developmental delay, absent or hypoplastic corpus callosum, and dysmorphic facies	617260		3
ZNF292, ZFP292, KIAA0530, MRD64	Intellectual developmental disorder, autosomal dominant 64	619188		3
ZNF335, NIF1, NIF2, MCPH10	Microcephaly 10, primary, autosomal recessive	615095		3
ZNF341, HIES3	Hyper-IgE recurrent infection syndrome 3, autosomal recessive	618282		3
ZNF365, UAN	Nephrolithiasis, uric acid, susceptibility to	605990		3
ZNF407, SIMHA	SIMHA syndrome	619557		3
ZNF408, EVR6, RP72	 Exudative vitreoretinopathy 6	616468	mutation identified in 1 EVR6 family	3
ZNF408, EVR6, RP72	Retinitis pigmentosa 72	616469	mutation identified in 1 EVR6 family	3
ZNF423, ZFP423, OAZ, KIAA0760, NPHP14, JBTS19	 Joubert syndrome 19	614844		3
ZNF423, ZFP423, OAZ, KIAA0760, NPHP14, JBTS19	Nephronophthisis 14	614844		3
ZNF462, KIAA1803, WSKA	Weiss-Kruszka syndrome	618619		3
ZNF469, KIAA1858, BCS1	Brittle cornea syndrome 1	229200		3
ZNF526, KIAA1951, DENNED	Dentici-Novelli neurodevelopmental syndrome	619877		3
ZNF644, MYP21	Myopia 21, autosomal dominant	614167		3
ZNF687, KIAA1441, PDB6	Paget disease of bone 6	616833	fused with AML1 in t(1;21)	3
ZNF699, FLJ38144, DEGCAGS	DEGCAGS syndrome	619488		3
ZNF711, ZNF6, CMPX1, XLID97	Intellectual developmental disorder, X-linked 97	300803		3
ZNFX1, IMD91	Immunodeficiency 91 and hyperinflammation	619644		3
ZNHIT3, TRIP3, PEHO	PEHO syndrome	260565		3
ZP1, OOMD1	Oocyte maturation defect 1	615774		3
ZP2, OOMD6	Oocyte maturation defect 6	618353		3
ZP3, ZP3A, ZP3B, OOMD3	Oocyte maturation defect 3	617712		3
ZSWIM6, KIAA1577, AFND, NEDMAGA	 Acromelic frontonasal dysostosis	603671		3
ZSWIM6, KIAA1577, AFND, NEDMAGA	Neurodevelopmental disorder with movement abnormalities, abnormal gait, and autistic features	617865		3
ZSWIM7, SWS1, SPGF71, ODG10	 Ovarian dysgenesis 10	619834	mutation identified in 1 ODG10 family	3
ZSWIM7, SWS1, SPGF71, ODG10	Spermatogenic failure 71	619831	mutation identified in 1 ODG10 family	3
